-DOCSTART- NN -X-

A DT O
41 CD B-Age
- : I-Age
year NN I-Age
- : I-Age
old JJ I-Age
man NN O
with IN O
weight JJ B-Sign_symptom
loss NN I-Sign_symptom
, , O
nausea NN B-Sign_symptom
, , O
vomiting NN B-Sign_symptom
, , O
and CC O
abdominal JJ B-Biological_structure
pain NN B-Sign_symptom
was VBD O
referred VBN O
for IN O
an DT O
abdominal JJ B-Biological_structure
CT NNP B-Diagnostic_procedure
scan NN I-Diagnostic_procedure
to TO O
rule VB O
out RP O
intraabdominal JJ B-Disease_disorder
pathology NN I-Disease_disorder
. . O

A DT O
dedicated JJ O
CT NNP B-Diagnostic_procedure
of IN O
the DT O
abdomen NNS B-Biological_structure
was VBD O
performed VBN O
at IN O
our PRP$ O
institution NN B-Nonbiological_location
according VBG O
to TO O
our PRP$ O
standard JJ B-Detailed_description
venous JJ I-Detailed_description
phase NN I-Detailed_description
protocol NN I-Detailed_description
. . O

Following VBG O
ingestion NN O
of IN O
positive JJ B-Diagnostic_procedure
oral JJ I-Diagnostic_procedure
contrast NN I-Diagnostic_procedure
material NN O
( ( O
barium JJ B-Medication
sulfate NN I-Medication
suspension NN I-Medication
2 CD B-Dosage
. . I-Dosage
1 CD I-Dosage
% NN I-Dosage
w NN I-Dosage
/ NNP I-Dosage
v NN I-Dosage
, , O
Mallinckrodt NNP B-Detailed_description
) ) O
and CC O
injection NN O
of IN O
125 CD B-Dosage
ml NN I-Dosage
of IN O
iopromide NN B-Medication
, , O
300 CD B-Dosage
mg NN I-Dosage
I PRP I-Dosage
/ VBP I-Dosage
mL NNS I-Dosage
( ( O
Ultravist NNP B-Detailed_description
, , I-Detailed_description
Bayer NNP I-Detailed_description
HealthCare NNP I-Detailed_description
) ) O
, , O
helical JJ B-Detailed_description
CT NNP O
was VBD O
obtained VBN O
with IN O
a DT O
65 CD B-Detailed_description
- : I-Detailed_description
s NN I-Detailed_description
delays NNS I-Detailed_description
using VBG O
a DT O
64 CD B-Detailed_description
- : I-Detailed_description
slice NN I-Detailed_description
GE NNP I-Detailed_description
Lightspeed NNP I-Detailed_description
VCT NNP I-Detailed_description
scanner NN I-Detailed_description
( ( O
GE NNP B-Detailed_description
Medical NNP I-Detailed_description
Systems NNPS I-Detailed_description
; : I-Detailed_description
Milwaukee NNP I-Detailed_description
, , I-Detailed_description
WI NNP I-Detailed_description
) ) O
. . O

Axial JJ B-Diagnostic_procedure
sections NNS I-Diagnostic_procedure
of IN O
the DT O
abdomen NNS B-Biological_structure
showed VBD O
a DT O
large JJ B-Lab_value
( ( O
18 CD B-Volume
× RB I-Volume
22 CD I-Volume
× JJ I-Volume
22 CD I-Volume
cm NN I-Volume
) ) O
heterogeneous JJ B-Detailed_description
retroperitoneal JJ B-Biological_structure
mass NN B-Sign_symptom
probably RB O
arising VBG O
from IN O
the DT O
left JJ B-Biological_structure
adrenal JJ I-Biological_structure
gland NN I-Biological_structure
containing VBG O
multiple JJ B-Detailed_description
areas NNS I-Detailed_description
of IN I-Detailed_description
macroscopic NN I-Detailed_description
fat NN I-Detailed_description
( ( O
Fig NNP O
. . O
1 CD O
) ) O
. . O

The DT O
patient NN O
had VBD O
no DT O
documented JJ O
clinical JJ O
or CC O
laboratory JJ O
evidence NN O
of IN O
adrenal JJ O
hormonal JJ O
excess NN O
. . O

On IN O
the DT O
basis NN O
of IN O
the DT O
clinical JJ O
history NN O
and CC O
CT NNP O
findings NNS O
, , O
the DT O
patient JJ O
underwent JJ O
surgical JJ B-Therapeutic_procedure
resection NN I-Therapeutic_procedure
of IN O
the DT O
left JJ B-Biological_structure
adrenal JJ I-Biological_structure
mass NN B-Sign_symptom
, , O
which WDT O
was VBD O
found VBN O
on IN O
pathologic JJ B-Diagnostic_procedure
examination NN I-Diagnostic_procedure
to TO O
represent VB O
a DT O
low JJ B-Severity
- : I-Severity
grade NN I-Severity
adrenocortical JJ B-Disease_disorder
carcinoma NN I-Disease_disorder
. . O

-DOCSTART- NN -X-

A DT O
61 CD B-Age
- : I-Age
year NN I-Age
- : I-Age
old JJ I-Age
male JJ O
patient NN O
had VBD O
a DT O
history NN O
of IN O
chronic JJ O
obstructive JJ O
pulmonary JJ O
disease NN O
under IN O
regular JJ O
bronchodilator NN O
treatment NN O
. . O

In IN O
2014 CD O
, , O
he PRP O
suffered VBD O
from IN O
severe JJ B-Severity
productive JJ B-Detailed_description
cough NN B-Sign_symptom
with IN O
mucus NN B-Detailed_description
sputum NN I-Detailed_description
for IN B-Duration
several JJ I-Duration
months NNS I-Duration
and CC O
unintentional JJ B-Detailed_description
body NN O
weight VBD B-Sign_symptom
loss NN I-Sign_symptom
6 CD B-Lab_value
kg NN I-Lab_value
within IN B-Duration
6 CD I-Duration
months NNS I-Duration
. . O

After IN O
sputum JJ B-Diagnostic_procedure
analysis NN I-Diagnostic_procedure
and CC O
chest NN B-Biological_structure
imaging NN B-Diagnostic_procedure
examinations NNS I-Diagnostic_procedure
in IN O
May NNP O
2014 CD O
, , O
he PRP O
was VBD O
diagnosed VBN O
of IN O
squamous JJ B-Disease_disorder
cell NN I-Disease_disorder
carcinoma NN I-Disease_disorder
in IN O
right JJ B-Biological_structure
upper JJ I-Biological_structure
lobe NN I-Biological_structure
lung NN I-Biological_structure
( ( O
cT3N2M0 NN B-Lab_value
, , O
stage NN B-Lab_value
IIIa NNP I-Lab_value
) ) O
. . O

Then RB O
he PRP O
received VBD O
neoadjuvant JJ B-Detailed_description
chemoradiotherapy NN B-Therapeutic_procedure
( ( O
etoposide JJ B-Medication
70 CD B-Dosage
mg NN I-Dosage
[ VBD I-Dosage
45 CD I-Dosage
mg NN I-Dosage
/ NNP I-Dosage
m2 NN I-Dosage
] NNP I-Dosage
+ NNP O
cisplatin VBD B-Medication
79 CD B-Dosage
mg NN I-Dosage
[ VBD I-Dosage
50 CD I-Dosage
mg NN I-Dosage
/ NNP I-Dosage
m2 NN I-Dosage
] NN I-Dosage
; : O
4500 CD B-Dosage
cGY NN I-Dosage
in IN I-Dosage
25 CD I-Dosage
fractions NNS I-Dosage
) ) O
from IN B-Duration
June NNP I-Duration
to TO I-Duration
July NNP I-Duration
2014 CD I-Duration
. . O

In IN O
October NNP O
2014 CD O
, , O
surgical JJ B-Therapeutic_procedure
intervention NN I-Therapeutic_procedure
was VBD O
arranged VBN O
. . O

Because IN O
the DT O
tumor NN B-Sign_symptom
was VBD O
located VBN O
at IN O
right JJ B-Biological_structure
hilum NN I-Biological_structure
and CC O
invaded VBD O
main JJ B-Biological_structure
bronchus NN I-Biological_structure
and CC O
major JJ B-Biological_structure
vessels NNS I-Biological_structure
, , O
video SYM B-Detailed_description
- : I-Detailed_description
assisted VBN I-Detailed_description
thoracoscopic NN B-Detailed_description
surgery NN B-Therapeutic_procedure
with IN O
right JJ B-Detailed_description
side NN I-Detailed_description
intrapericardial JJ B-Biological_structure
pneumonectomy NN B-Therapeutic_procedure
was VBD O
performed VBN O
. . O

Postoperatively RB O
, , O
pathological JJ B-Diagnostic_procedure
exams NN I-Diagnostic_procedure
revealed VBD O
squamous JJ B-Disease_disorder
cell NN I-Disease_disorder
carcinoma NN I-Disease_disorder
, , O
T3N0M0 NNP B-Lab_value
, , O
stage NN B-Lab_value
IIB NNP I-Lab_value
. . O

The DT O
postoperative JJ B-Therapeutic_procedure
course NN I-Therapeutic_procedure
was VBD O
smooth JJ B-Lab_value
but CC O
he PRP O
suffered VBD O
from IN O
severe JJ B-Severity
cough NN B-Sign_symptom
and CC O
right JJ B-Biological_structure
chest NN I-Biological_structure
pain NN B-Sign_symptom
one CD O
month NN O
later RB O
. . O

Laboratory NNP B-Diagnostic_procedure
exams NNS I-Diagnostic_procedure
revealed VBD O
leukocytosis NN B-Sign_symptom
( ( O
white JJ B-Diagnostic_procedure
blood NN I-Diagnostic_procedure
cells NNS I-Diagnostic_procedure
= VBP O
21,860 CD B-Lab_value
μL NN I-Lab_value
) ) O
and CC O
elevated VBN B-Lab_value
C NNP B-Diagnostic_procedure
- : I-Diagnostic_procedure
reactive JJ I-Diagnostic_procedure
protein NN I-Diagnostic_procedure
to TO O
23 CD B-Lab_value
. . I-Lab_value
94 CD I-Lab_value
mg JJ I-Lab_value
/ NNP I-Lab_value
dL NN I-Lab_value
. . O

Chest NNP B-Biological_structure
X NNP B-Diagnostic_procedure
- : I-Diagnostic_procedure
ray NN I-Diagnostic_procedure
showed VBD O
cavitary JJ B-Detailed_description
lesion NN B-Sign_symptom
and CC O
computed VBD B-Diagnostic_procedure
tomography NN I-Diagnostic_procedure
showed VBD O
pleural JJ B-Sign_symptom
effusion NN I-Sign_symptom
and CC O
fluid NN B-Sign_symptom
collection NN I-Sign_symptom
with IN O
mottled VBN B-Detailed_description
gas NN I-Detailed_description
appearance NN I-Detailed_description
in IN O
the DT O
dependent JJ B-Biological_structure
portion NN I-Biological_structure
of IN I-Biological_structure
right JJ I-Biological_structure
hemithorax NN I-Biological_structure
( ( O
Fig NNP O
. . O
1A CD O
) ) O
. . O

According VBG O
to TO O
the DT O
patient NN O
` `` O
s JJ O
history NN O
, , O
results NNS O
of IN O
laboratory JJ O
exams NNS O
, , O
and CC O
imaging VBG O
findings NNS O
, , O
postpneumonectomy NN B-Detailed_description
empyema NN B-Sign_symptom
was VBD O
diagnosed VBN O
and CC O
bronchopleural JJ B-Disease_disorder
fistula NN I-Disease_disorder
was VBD O
highly RB O
suspected VBN O
. . O

After IN O
admission NN O
, , O
chest VBP B-Biological_structure
tube NN B-Therapeutic_procedure
drainage NN I-Therapeutic_procedure
was VBD O
inserted VBN O
and CC O
bronchoscopic JJ B-Detailed_description
tissue NN B-Therapeutic_procedure
glue NN I-Therapeutic_procedure
sealing NN I-Therapeutic_procedure
was VBD O
performed VBN O
. . O

However RB O
, , O
persistent JJ B-Detailed_description
air NN B-Sign_symptom
leakage NN I-Sign_symptom
was VBD O
presented VBN O
and CC O
we PRP O
decided VBD O
to TO O
repair VB B-Therapeutic_procedure
the DT O
bronchial JJ B-Biological_structure
stump NN I-Biological_structure
with IN O
flap JJ B-Therapeutic_procedure
coverage NN I-Therapeutic_procedure
. . O

Because IN O
the DT O
patient NN O
just RB O
received VBN O
neoadjuvant JJ B-Detailed_description
chemoradiotherapy NN B-Therapeutic_procedure
a DT O
few JJ O
months NNS O
ago RB O
, , O
the DT O
flaps NNS O
harvested VBN O
from IN O
chest JJ O
area NN O
were VBD O
not RB O
appropriate JJ O
because IN O
the DT O
pedicle NN O
arteries NNS O
might MD O
have VB O
been VBN O
injured VBN O
by IN O
irradiation NN O
. . O

After IN O
discussing VBG O
with IN O
the DT O
plastic NN O
surgeon NN O
, , O
we PRP O
decided VBD O
to TO O
repair VB B-Therapeutic_procedure
the DT O
bronchial JJ B-Biological_structure
stump NN I-Biological_structure
by IN O
a DT O
TRAM NNP B-Therapeutic_procedure
flap NN I-Therapeutic_procedure
. . O

Intraoperatively RB O
, , O
the DT O
patient NN O
was VBD O
placed VBN B-Therapeutic_procedure
in IN I-Therapeutic_procedure
supine NN I-Therapeutic_procedure
. . O

Right JJ B-Detailed_description
side NN I-Detailed_description
exploratory NN B-Detailed_description
thoracotomy NN B-Diagnostic_procedure
was VBD O
performed VBN O
and CC O
the DT O
bronchial JJ B-Biological_structure
stump NN I-Biological_structure
was VBD O
located VBN O
. . O

The DT O
superior JJ B-Biological_structure
epigastric JJ I-Biological_structure
vascular JJ I-Biological_structure
artery NN I-Biological_structure
and CC O
right JJ B-Biological_structure
rectus NN I-Biological_structure
abdominis NN I-Biological_structure
muscle NN I-Biological_structure
was VBD O
identified VBN O
and CC O
the DT O
location NN O
of IN O
the DT O
TRAM NNP B-Therapeutic_procedure
flap NN I-Therapeutic_procedure
was VBD O
marked VBN B-Detailed_description
on IN I-Detailed_description
the DT I-Detailed_description
skin NN I-Detailed_description
( ( O
Fig NNP O
. . O
2A CD O
) ) O
. . O

Then RB O
the DT O
TRAM NNP B-Therapeutic_procedure
flap NN I-Therapeutic_procedure
was VBD O
harvested VBN B-Therapeutic_procedure
from IN O
right JJ B-Biological_structure
rectus NN I-Biological_structure
abdominis NN I-Biological_structure
( ( O
Fig NNP O
. . O
2B CD O
) ) O
and CC O
was VBD O
deepithelialized VBN B-Therapeutic_procedure
( ( O
Fig NNP O
. . O
2C CD O
) ) O
. . O

Through IN O
a DT O
subcutaneous JJ B-Therapeutic_procedure
tunnel NN I-Therapeutic_procedure
, , O
the DT O
TRAM NNP B-Therapeutic_procedure
flap NN I-Therapeutic_procedure
was VBD O
moved VBN O
toward IN O
the DT O
right JJ B-Biological_structure
thoracic NN I-Biological_structure
space NN I-Biological_structure
with IN O
no DT O
tension NN B-Sign_symptom
or CC O
kinking VBG B-Sign_symptom
on IN O
the DT O
pedicle NN B-Biological_structure
( ( O
Fig NNP O
. . O
2D CD O
) ) O
. . O

Then RB O
the DT O
TRAM NNP B-Therapeutic_procedure
flap NN I-Therapeutic_procedure
was VBD O
fixed VBN O
to TO O
posterior VB B-Biological_structure
chest JJS I-Biological_structure
wall NN I-Biological_structure
to TO O
cover VB O
the DT O
bronchial JJ B-Biological_structure
stump NN I-Biological_structure
( ( O
Fig NNP O
. . O
2E CD O
) ) O
and CC O
the DT O
tissue NN B-Therapeutic_procedure
glue NN I-Therapeutic_procedure
was VBD O
also RB O
applied VBN O
to TO O
the DT O
bronchial JJ B-Biological_structure
stump NN I-Biological_structure
under IN O
bronchoscope NN B-Diagnostic_procedure
. . O

The DT O
donor JJ B-Biological_structure
site NN I-Biological_structure
of IN I-Biological_structure
flap NN I-Biological_structure
was VBD O
closed VBN O
with IN O
mesh JJ B-Therapeutic_procedure
repair NN I-Therapeutic_procedure
. . O

The DT O
postoperative JJ B-Therapeutic_procedure
course NN I-Therapeutic_procedure
was VBD O
smooth JJ B-Lab_value
and CC O
the DT O
air NN B-Sign_symptom
leak NN I-Sign_symptom
was VBD O
diminished VBN B-Lab_value
gradually RB O
. . O

Then RB O
the DT O
patient NN O
was VBD O
discharge VBN O
under IN O
stable JJ B-Sign_symptom
condition NN I-Sign_symptom
and CC O
was VBD O
free JJ O
from IN O
air NN B-Sign_symptom
leak NN I-Sign_symptom
after IN O
following VBG O
for IN O
12 CD O
months NNS O
( ( O
Fig NNP O
. . O
1B CD O
) ) O
. . O

The DT O
patient NN O
provided VBD O
written VBN O
informed JJ O
consent NN O
for IN O
publication NN O
of IN O
this DT O
report NN O
and CC O
all DT O
accompanying VBG O
images NNS O
. . O

-DOCSTART- NN -X-

A DT O
53 CD B-Age
- : I-Age
year NN I-Age
- : I-Age
old JJ I-Age
woman NN O
presented VBD O
to TO O
our PRP$ O
institution NN B-Nonbiological_location
with IN O
progressive JJ B-Detailed_description
abdominal JJ B-Biological_structure
distention NN B-Sign_symptom
and CC O
irregular JJ B-Detailed_description
vaginal JJ B-Biological_structure
bleeding NN B-Sign_symptom
of IN O
several JJ B-Duration
weeks NNS I-Duration
` `` O
duration NN O
. . O

A DT O
contrast NN B-Detailed_description
CT NNP B-Diagnostic_procedure
abdomen NNS B-Biological_structure
and CC O
pelvis NN B-Biological_structure
revealed VBD O
an DT O
ill JJ B-Detailed_description
- : I-Detailed_description
defined VBN I-Detailed_description
, , O
irregular JJ B-Detailed_description
mass NN B-Sign_symptom
in IN O
the DT O
lower JJR B-Biological_structure
uterine JJ I-Biological_structure
/ NNP O
cervical JJ B-Biological_structure
region NN I-Biological_structure
( ( O
Figure NNP O
1 CD O
) ) O
. . O

There EX O
were VBD O
multiple JJ B-Detailed_description
peritoneal NN B-Biological_structure
and CC O
omental JJ B-Biological_structure
masses NNS B-Sign_symptom
, , O
enlarged VBD B-Sign_symptom
pelvic NN B-Biological_structure
and CC O
paraaortic JJ B-Biological_structure
lymph NN B-Biological_structure
nodes NNS I-Biological_structure
, , O
and CC O
large JJ B-Detailed_description
- : I-Detailed_description
volume NN I-Detailed_description
ascites NNS B-Sign_symptom
. . O

The DT O
initial JJ O
CBC NNP B-Diagnostic_procedure
was VBD O
significant JJ O
for IN O
hemoglobin NN B-Diagnostic_procedure
of IN O
9 CD B-Lab_value
. . I-Lab_value
2 CD I-Lab_value
g JJ I-Lab_value
/ NNP I-Lab_value
dL NN I-Lab_value
, , O
leukocytosis NN B-Sign_symptom
of IN O
36 CD B-Lab_value
790 CD I-Lab_value
per IN I-Lab_value
microliter NN I-Lab_value
, , O
and CC O
thrombocytosis NN B-Sign_symptom
of IN O
625 CD B-Lab_value
000 CD I-Lab_value
per IN I-Lab_value
microliter NN I-Lab_value
. . O

Serum NNP B-Biological_structure
calcium NN B-Diagnostic_procedure
was VBD O
elevated VBN B-Lab_value
at IN O
13 CD B-Lab_value
. . I-Lab_value
1 CD I-Lab_value
mg JJ I-Lab_value
/ NNP I-Lab_value
dL NN I-Lab_value
. . O

BUN NNP B-Diagnostic_procedure
and CC O
creatinine NN B-Diagnostic_procedure
were VBD O
within IN B-Lab_value
normal JJ I-Lab_value
limits NNS I-Lab_value
. . O

Hepatic JJ B-Diagnostic_procedure
function NN I-Diagnostic_procedure
was VBD O
within IN B-Lab_value
normal JJ I-Lab_value
limits NNS I-Lab_value
. . O

A DT O
pelvic JJ B-Diagnostic_procedure
exam NN I-Diagnostic_procedure
revealed VBD O
a DT O
fungating JJ B-Detailed_description
vaginal JJ B-Biological_structure
mass NN B-Sign_symptom
. . O

The DT O
patient JJ O
underwent JJ O
biopsies NNS B-Diagnostic_procedure
of IN O
the DT O
endometrium NN B-Biological_structure
and CC O
the DT O
vaginal JJ B-Biological_structure
mass NN O
, , O
which WDT O
revealed VBD O
a DT O
high JJ B-Severity
- : I-Severity
grade NN I-Severity
tumor NN B-Sign_symptom
with IN O
predominantly RB B-Detailed_description
oval JJ I-Detailed_description
- : I-Detailed_description
shaped JJ I-Detailed_description
cells NNS I-Detailed_description
. . O

Immunohistochemical JJ B-Diagnostic_procedure
staining NN I-Diagnostic_procedure
was VBD O
positive JJ B-Lab_value
for IN O
vimentin NN B-Diagnostic_procedure
, , O
CD10 NNP B-Diagnostic_procedure
, , O
and CC O
cyclin NN B-Diagnostic_procedure
D1 NNP I-Diagnostic_procedure
, , O
consistent NN O
with IN O
a DT O
diagnosis NN O
of IN O
high JJ B-Severity
- : I-Severity
grade NN I-Severity
endometrial JJ B-Disease_disorder
stromal JJ I-Disease_disorder
sarcoma NN I-Disease_disorder
( ( O
Figure NNP O
2 CD O
) ) O
. . O

The DT O
tumor NN O
was VBD O
negative JJ B-Lab_value
for IN O
ER NNP B-Diagnostic_procedure
, , O
with IN O
rare JJ B-Detailed_description
cells NNS I-Detailed_description
positive JJ B-Lab_value
for IN O
PR NNP B-Diagnostic_procedure
. . O

Although IN O
immunohistochemical JJ B-Diagnostic_procedure
staining VBG I-Diagnostic_procedure
for IN O
cytokeratins NNS B-Diagnostic_procedure
was VBD O
negative JJ B-Lab_value
, , O
a DT O
biphasic JJ B-Sign_symptom
component NN I-Sign_symptom
could MD O
not RB O
be VB O
entirely RB O
ruled VBN O
out RP O
given VBN O
the DT O
small JJ O
size NN O
of IN O
the DT O
biopsy NN O
specimen NNS O
relative VBP O
to TO O
the DT O
tumor NN O
. . O

The DT O
patient NN O
` `` O
s JJ O
Ca125 NNP B-Diagnostic_procedure
was VBD O
markedly RB O
elevated VBN B-Lab_value
at IN O
1624 CD B-Lab_value
U NNP I-Lab_value
/ NNP I-Lab_value
mL NN I-Lab_value
( ( O
nl JJ O
≤ NNP O
34 CD O
) ) O
. . O

Contrast NNP B-Detailed_description
CT NNP B-Diagnostic_procedure
chest NN B-Biological_structure
revealed VBD O
a DT O
right JJ B-Detailed_description
- : I-Detailed_description
sided VBD I-Detailed_description
pleural JJ B-Disease_disorder
effusion NN I-Disease_disorder
but CC O
no DT O
suspicious JJ B-Detailed_description
nodules NNS B-Sign_symptom
or CC O
lymphadenopathy NN B-Disease_disorder
. . O

The DT O
patient NN O
was VBD O
deemed VBN O
to TO O
have VB O
operable JJ B-Disease_disorder
disease NN I-Disease_disorder
and CC O
was VBD O
scheduled VBN O
for IN O
debulking VBG B-Therapeutic_procedure
surgery NN I-Therapeutic_procedure
. . O

However RB O
, , O
preoperative JJ O
laboratory NN B-Diagnostic_procedure
studies NNS I-Diagnostic_procedure
showed VBD O
that IN O
her PRP$ O
serum NN B-Biological_structure
calcium NN B-Diagnostic_procedure
had VBD O
further RBR O
increased VBN B-Lab_value
to TO O
19 CD B-Lab_value
. . I-Lab_value
2 CD I-Lab_value
mg JJ I-Lab_value
/ NNP I-Lab_value
dL NN I-Lab_value
. . O

She PRP O
had VBD O
also RB O
developed VBN O
evidence NN O
of IN O
acute JJ B-Detailed_description
kidney NN B-Biological_structure
injury NN B-Disease_disorder
, , O
with IN O
her PRP$ O
BUN NNP B-Diagnostic_procedure
rising NN B-Lab_value
to TO O
37 CD B-Lab_value
mg NNS I-Lab_value
/ JJ I-Lab_value
dL NN I-Lab_value
and CC O
creatinine NN B-Diagnostic_procedure
to TO O
1 CD B-Lab_value
. . I-Lab_value
81 CD I-Lab_value
mg JJ I-Lab_value
/ NNP I-Lab_value
dL NN I-Lab_value
. . O

On IN O
physical JJ B-Diagnostic_procedure
exam NN I-Diagnostic_procedure
, , O
she PRP O
was VBD O
noted VBN O
to TO O
be VB O
lethargic JJ B-Sign_symptom
, , O
with IN O
dry JJ B-Sign_symptom
mucous JJ B-Biological_structure
membranes NNS I-Biological_structure
. . O

The DT O
surgery NN B-Therapeutic_procedure
was VBD O
cancelled VBN O
due JJ O
to TO O
the DT O
patient NN O
` `` O
s RB O
medical JJ B-Disease_disorder
instability NN I-Disease_disorder
. . O

Further RB O
workup NN O
revealed VBD O
an DT O
elevated JJ B-Lab_value
PTHrP NNP B-Diagnostic_procedure
of IN O
301 CD B-Lab_value
pg NNS I-Lab_value
/ JJ I-Lab_value
mL NN I-Lab_value
( ( O
nl JJ O
14 CD O
- : O
27 CD O
) ) O
, , O
a DT O
depressed JJ B-Lab_value
PTH NNP B-Diagnostic_procedure
level NN O
of IN O
3 CD B-Lab_value
pg NNS I-Lab_value
/ JJ I-Lab_value
mL NN I-Lab_value
( ( O
nl JJ O
15 CD O
- : O
65 CD O
) ) O
, , O
and CC O
a DT O
depressed JJ B-Lab_value
25 CD B-Diagnostic_procedure
- : I-Diagnostic_procedure
OH NNP I-Diagnostic_procedure
vitamin FW I-Diagnostic_procedure
D NNP I-Diagnostic_procedure
level NN O
of IN O
16 CD B-Lab_value
ng JJ I-Lab_value
/ NN I-Lab_value
mL NN I-Lab_value
( ( O
nl JJ O
30 CD O
- : O
100 CD O
) ) O
, , O
consistent JJ O
with IN O
humoral JJ B-Disease_disorder
hypercalcemia NN I-Disease_disorder
of IN I-Disease_disorder
malignancy NN I-Disease_disorder
. . O

The DT O
patient NN O
was VBD O
treated VBN O
with IN O
pamidronate NN B-Medication
, , O
calcitonin NN B-Medication
, , O
and CC O
intravenous JJ O
fluids NNS B-Medication
. . O

She PRP O
eventually RB O
required VBD O
temporary JJ B-Detailed_description
hemodialysis NN B-Therapeutic_procedure
and CC O
denosumab NN B-Medication
for IN O
refractory NN B-Detailed_description
hypercalcemia NN B-Sign_symptom
. . O

The DT O
patient NN O
improved VBN O
with IN O
regard NN O
to TO O
her PRP$ O
electrolyte JJ O
abnormalities NNS O
. . O

Given VBN O
the DT O
extent NN O
of IN O
her PRP$ O
disease NN O
, , O
she PRP O
was VBD O
planned VBN O
for IN O
neoadjuvant JJ O
chemotherapy NN B-Medication
followed VBN O
by IN O
surgery NN B-Therapeutic_procedure
if IN O
a DT O
good JJ O
response NN O
was VBD O
achieved VBN O
. . O

She PRP O
was VBD O
started VBN O
on IN O
a DT O
regimen NN O
of IN O
carboplatin NN B-Medication
and CC O
paclitaxel NN B-Medication
, , O
which WDT O
she PRP O
received VBD O
for IN O
3 CD B-Dosage
cycles NNS I-Dosage
. . O

She PRP O
also RB O
had VBD O
palliative JJ O
radiation NN B-Therapeutic_procedure
to TO O
the DT O
uterus NN B-Biological_structure
to TO O
control VB O
bleeding NN B-Sign_symptom
. . O

However RB O
, , O
her PRP$ O
disease NN O
failed VBD O
to TO O
respond VB O
significantly RB O
to TO O
chemotherapy VB O
, , O
and CC O
she PRP O
ultimately RB O
died VBD O
from IN O
complications NNS B-Disease_disorder
of IN I-Disease_disorder
malignancy NN I-Disease_disorder
. . O

-DOCSTART- NN -X-

A DT O
67 CD B-Age
- : I-Age
year NN I-Age
- : I-Age
old JJ I-Age
woman NN O
was VBD O
sent VBN O
to TO O
emergency NN B-Nonbiological_location
department NN I-Nonbiological_location
because IN O
of IN O
fever NN B-Sign_symptom
and CC O
sore NN B-Sign_symptom
throat NN B-Biological_structure
. . O

Her PRP$ O
medical JJ O
history NN O
included VBD O
ESRD NNP B-Disease_disorder
with IN O
regular JJ O
hemodialysis NN B-Therapeutic_procedure
3 CD B-Frequency
times NNS I-Frequency
per IN I-Frequency
week NN I-Frequency
for IN O
15 CD B-Duration
years NNS I-Duration
, , O
hyperuricemia NN O
and CC O
gout NN O
. . O

She PRP O
also RB O
had VBD O
comorbidity NN O
such JJ O
as IN O
dyslipidemia NN O
, , O
hypertension NN O
, , O
secondary JJ B-Detailed_description
hyperparathyroidism NN O
, , O
and CC O
diabetes NNS O
. . O

The DT O
hemogram NN B-Diagnostic_procedure
revealed VBD O
a DT O
white JJ B-Diagnostic_procedure
blood NN I-Diagnostic_procedure
cell NN I-Diagnostic_procedure
count NN I-Diagnostic_procedure
( ( O
WBC NNP B-Diagnostic_procedure
) ) O
of IN O
700 CD B-Lab_value
/ JJ I-Lab_value
μL NN I-Lab_value
, , O
with IN O
2 CD B-Lab_value
% NN I-Lab_value
neutrophils NNS B-Diagnostic_procedure
, , O
94 CD B-Lab_value
% NN I-Lab_value
lymphocytes NNS B-Diagnostic_procedure
and CC O
2 CD B-Lab_value
% NN I-Lab_value
monocytes NNS B-Diagnostic_procedure
, , O
hemoglobin VBD B-Diagnostic_procedure
11 CD B-Lab_value
. . I-Lab_value
1 CD I-Lab_value
g JJ I-Lab_value
/ NNP I-Lab_value
dL NN I-Lab_value
, , O
and CC O
platelet NN B-Diagnostic_procedure
count NN I-Diagnostic_procedure
, , O
131,000 CD B-Lab_value
/ NN I-Lab_value
μL NN I-Lab_value
. . O

Under IN O
the DT O
impression NN O
of IN O
febrile JJ B-Detailed_description
neutropenia NN B-Sign_symptom
and CC O
acute NN B-Detailed_description
pharyngitis NN B-Disease_disorder
, , O
she PRP O
was VBD O
admitted VBN O
to TO O
our PRP$ O
hematologic JJ B-Nonbiological_location
ward NN I-Nonbiological_location
for IN O
further JJ O
survey NN O
and CC O
management NN O
. . O

Broad NNP B-Detailed_description
- : I-Detailed_description
spectrum NN I-Detailed_description
antibiotics NNS B-Medication
with IN O
piperacillin NN B-Medication
2 CD B-Dosage
g NN I-Dosage
and CC O
tazobactam $ B-Medication
0 CD B-Dosage
. . I-Dosage
25 CD I-Dosage
gm NN I-Dosage
i NN O
. . O
v NN O
. . O

q8h NN B-Dosage
had VBD O
been VBN O
administered VBN O
and CC O
her PRP$ O
infection NN B-Sign_symptom
sign NN I-Sign_symptom
resolved VBD O
gradually RB O
. . O

Upon IN O
admission NN O
, , O
we PRP O
reviewed VBD O
her PRP O
oral JJ O
medication NN O
: : O
glipizide NN B-Medication
5 CD B-Dosage
mg NN I-Dosage
tid NN I-Dosage
, , O
saxagliptin VBD B-Medication
2 CD B-Dosage
. . I-Dosage
5 CD I-Dosage
mg NN I-Dosage
qd NN I-Dosage
, , O
fenofibrate VBP B-Medication
600 CD B-Dosage
mg NN I-Dosage
qd NN I-Dosage
, , O
aluminum NN B-Medication
hydroxide NN I-Medication
324 CD B-Dosage
mg NN I-Dosage
tid NN I-Dosage
, , O
folic JJ B-Medication
acid VBP I-Medication
5 CD B-Dosage
mg NN I-Dosage
qd NN I-Dosage
, , O
calcium NN B-Medication
carbonate NN I-Medication
1000 CD B-Dosage
mg NN I-Dosage
tid NN I-Dosage
, , O
and CC O
febuxostat RB B-Medication
40 CD B-Dosage
mg NN I-Dosage
qd NN I-Dosage
. . O

Besides IN O
, , O
she PRP O
also RB O
received VBD O
epoetin JJ B-Medication
- : I-Medication
beta NN I-Medication
2000 CD B-Dosage
iu NN I-Dosage
i NN O
. . O
v NN O
. . O
tiw NN B-Dosage
. . O

Except IN O
for IN O
febuxostat NN B-Medication
, , O
all PDT O
the DT O
other JJ O
drugs NNS O
had VBD O
been VBN O
used VBN O
for IN O
more JJR B-Duration
than IN I-Duration
1 CD I-Duration
year NN I-Duration
. . O

Febuxostat NNP B-Medication
was VBD O
administered VBN O
2 CD O
1/2 CD O
months NNS O
before IN O
admission NN O
for IN O
inadequate JJ O
serum NN O
uric JJ O
acid NN O
control NN O
by IN O
allopurinol JJ B-Medication
50 CD B-Dosage
mg NN I-Dosage
qd NN I-Dosage
. . O

Two CD O
weeks NNS O
before IN O
febuxostat JJ O
exposure NN O
, , O
routine JJ O
laboratory NN B-Diagnostic_procedure
test NN I-Diagnostic_procedure
revealed VBD O
WBC NNP B-Diagnostic_procedure
6000 CD B-Lab_value
/ NNP I-Lab_value
μL NNP I-Lab_value
and CC O
serum VB B-Detailed_description
uric JJ B-Diagnostic_procedure
acid NNS I-Diagnostic_procedure
level VBP O
9 CD B-Lab_value
. . I-Lab_value
8 CD I-Lab_value
mg JJ I-Lab_value
/ NNP I-Lab_value
dL NN I-Lab_value
. . O

Febuxostat NNP B-Medication
was VBD O
discontinued VBN O
thereafter RB O
due JJ O
to TO O
the DT O
causal NN O
relationship NN O
of IN O
agranulocytosis NN B-Disease_disorder
can MD O
not RB O
be VB O
excluded VBN O
. . O

Besides IN O
, , O
we PRP O
also RB O
surveyed VBD O
viral JJ O
infection NN O
and CC O
autoimmune JJ O
disorder NN O
. . O

There EX O
were VBD O
no DT O
clinical JJ O
or CC O
laboratory JJ O
evidence NN O
of IN O
Epstein NNP B-Detailed_description
- : I-Detailed_description
Barr NNP I-Detailed_description
virus NN I-Detailed_description
, , O
cytomegalovirus NN B-Detailed_description
, , O
or CC O
human JJ B-Detailed_description
immunodeficiency NN I-Detailed_description
virus NN I-Detailed_description
infections NNS B-Disease_disorder
; : O
antinuclear VB B-Diagnostic_procedure
antibody NN I-Diagnostic_procedure
( ( O
ANA NNP B-Diagnostic_procedure
) ) O
and CC O
antiextractable JJ B-Diagnostic_procedure
nuclear JJ I-Diagnostic_procedure
antigen NN I-Diagnostic_procedure
( ( O
anti JJ B-Diagnostic_procedure
- : I-Diagnostic_procedure
ENA NN I-Diagnostic_procedure
) ) O
were VBD O
both DT O
negative JJ B-Lab_value
. . O

Bone NNP B-Diagnostic_procedure
marrow NN I-Diagnostic_procedure
examination NN I-Diagnostic_procedure
during IN O
hospitalization NN O
showed VBD O
hypocellular JJ B-Sign_symptom
marrow NN B-Biological_structure
with IN O
a DT O
marked JJ O
decrease NN B-Lab_value
in IN O
myeloid JJ B-Diagnostic_procedure
component NN I-Diagnostic_procedure
but CC O
no DT O
evidence NN O
of IN O
hematologic JJ B-Biological_structure
neoplasms NNS B-Sign_symptom
. . O

Chromosome NNP B-Diagnostic_procedure
analysis NN I-Diagnostic_procedure
of IN O
bone NN B-Biological_structure
marrow NN I-Biological_structure
was VBD O
normal JJ B-Lab_value
karyotype NN I-Lab_value
. . O

The DT O
patient NN O
denied VBD O
history NN O
of IN O
radiation NN O
or CC O
chemicals NNS O
exposure NN O
. . O

After IN O
stopping VBG O
febuxostat NN B-Medication
for IN O
17 CD B-Duration
days NNS I-Duration
, , O
her PRP$ O
neutropenia NN B-Sign_symptom
improved VBN O
significantly RB O
( ( O
WBC JJ B-Diagnostic_procedure
2100 CD B-Lab_value
/ NNP I-Lab_value
μL NNP I-Lab_value
, , O
and CC O
neutrophil RB B-Diagnostic_procedure
66 CD B-Lab_value
% NN I-Lab_value
) ) O
, , O
without IN O
any DT O
granulocyte NN B-Medication
colony NN I-Medication
- : I-Medication
stimulating NN I-Medication
factor NN I-Medication
( ( O
G NNP O
- : O
CSF NN O
) ) O
support NN O
. . O

After IN O
discharge NN O
, , O
her PRP$ O
WBC NNP B-Diagnostic_procedure
and CC O
differential JJ B-Diagnostic_procedure
count NN I-Diagnostic_procedure
was VBD O
completely RB O
normal JJ B-Lab_value
during IN O
follow JJ O
- : O
up RB O
( ( O
Fig NNP O
. . O
1 CD O
) ) O
. . O

This DT O
study NN O
was VBD O
approved VBN O
by IN O
our PRP$ O
institutional JJ O
review NN O
board NN O
. . O

-DOCSTART- NN -X-

A DT O
52 CD B-Age
- : I-Age
year NN I-Age
- : I-Age
old JJ I-Age
man NN O
( ( O
body JJ O
surface NN O
area NN O
: : O
1 CD O
. . O
3 CD O
m2 NN O
) ) O
known VBN O
to TO O
have VB O
dilated VBN O
cardiomyopathy NN O
( ( O
DCM NNP B-Disease_disorder
) ) O
, , O
was VBD O
admitted VBN O
for IN O
worsening VBG O
heart NN B-Disease_disorder
failure NN I-Disease_disorder
( ( O
NYHA NNP B-Lab_value
class NN I-Lab_value
IV NNP I-Lab_value
) ) O
. . O

He PRP O
presented VBD O
with IN O
a DT O
5 CD B-Duration
- : I-Duration
month NN I-Duration
history NN O
of IN O
cough NN B-Sign_symptom
, , O
progressive JJ B-Detailed_description
dyspnoea NN B-Sign_symptom
, , O
orthopnea NN B-Sign_symptom
and CC O
recurrent NN B-Detailed_description
upper JJ B-Biological_structure
abdominal JJ I-Biological_structure
pain NN B-Sign_symptom
started VBD O
from IN B-Duration
2 CD I-Duration
months NNS I-Duration
ago RB I-Duration
. . O

On IN O
examination NN B-Diagnostic_procedure
his PRP$ O
vital JJ B-Diagnostic_procedure
signs NNS I-Diagnostic_procedure
were VBD O
body JJ B-Diagnostic_procedure
temperature JJ I-Diagnostic_procedure
37 CD B-Lab_value
°C NN I-Lab_value
, , O
blood NN B-Diagnostic_procedure
pressure NN I-Diagnostic_procedure
80 CD B-Lab_value
/ NN I-Lab_value
40 CD I-Lab_value
mmHg NN I-Lab_value
, , O
respiratory NN B-Diagnostic_procedure
rate NN I-Diagnostic_procedure
24 CD B-Lab_value
breaths NNS I-Lab_value
per IN I-Lab_value
minute NN I-Lab_value
, , O
and CC O
electrocardiogram NN B-Diagnostic_procedure
showed VBD O
atrial JJ B-Disease_disorder
fibrillation NN I-Disease_disorder
with IN O
heart NN B-Diagnostic_procedure
rate NN I-Diagnostic_procedure
50 CD B-Lab_value
beats NNS I-Lab_value
per IN I-Lab_value
minute NN I-Lab_value
. . O

Physical JJ B-Diagnostic_procedure
examination NN I-Diagnostic_procedure
revealed VBD O
the DT O
jugular NN B-Biological_structure
venous JJ I-Biological_structure
distension NN B-Sign_symptom
, , O
significant JJ B-Severity
tender NN B-Detailed_description
hepatomegaly NN B-Sign_symptom
and CC O
bilateral JJ B-Detailed_description
pitting NN B-Detailed_description
edema NN B-Sign_symptom
at IN O
lower JJR B-Biological_structure
limbs NN I-Biological_structure
. . O

Laboratory NN B-Diagnostic_procedure
tests NNS I-Diagnostic_procedure
showed VBD O
elevated JJ B-Lab_value
pro JJ B-Diagnostic_procedure
- : I-Diagnostic_procedure
NT NN I-Diagnostic_procedure
brain NN I-Diagnostic_procedure
natriuretic JJ I-Diagnostic_procedure
peptide NN I-Diagnostic_procedure
of IN O
22145 CD B-Lab_value
pg NNS I-Lab_value
/ JJ I-Lab_value
ml NN I-Lab_value
( ( O
normal JJ O
0 CD O
to TO O
227 CD O
pg NNS O
/ NNP O
ml NN O
) ) O
and CC O
unremarkable JJ B-Lab_value
D NNP B-Diagnostic_procedure
- : I-Diagnostic_procedure
dimer NN I-Diagnostic_procedure
. . O

X LS B-Diagnostic_procedure
- : I-Diagnostic_procedure
ray NN I-Diagnostic_procedure
and CC O
computed VBD B-Diagnostic_procedure
tomography NN I-Diagnostic_procedure
of IN O
the DT O
chest NN B-Biological_structure
demonstrated VBD O
consolidation NN B-Sign_symptom
of IN O
bilateral JJ B-Biological_structure
lower JJR I-Biological_structure
lobes NN I-Biological_structure
with IN O
pleural JJ B-Sign_symptom
effusion NN I-Sign_symptom
, , O
while IN O
his PRP$ O
venous JJ B-Biological_structure
Doppler NNP B-Diagnostic_procedure
of IN O
lower JJR B-Biological_structure
extremities NNS I-Biological_structure
was VBD O
normal JJ B-Lab_value
. . O

Based VBN O
on IN O
his PRP$ O
clinical JJ O
condition NN O
, , O
echocardiography NN B-Diagnostic_procedure
was VBD O
immediately RB O
inserted VBN O
. . O

There EX O
were VBD O
severe RB B-Severity
dilated VBN B-Sign_symptom
cardiac JJ I-Sign_symptom
chambers NNS I-Sign_symptom
, , O
especially RB O
enlargement NN B-Sign_symptom
of IN O
the DT O
left JJ B-Biological_structure
ventricle NN I-Biological_structure
( ( O
LV NNP B-Biological_structure
) ) O
( ( O
58 CD B-Lab_value
mm NN I-Lab_value
/ NNP I-Lab_value
m2 NN I-Lab_value
) ) O
with IN O
spherical JJ B-Sign_symptom
shape NN I-Sign_symptom
, , O
decreased VBD B-Sign_symptom
wall NN I-Sign_symptom
thickness NN I-Sign_symptom
, , O
impaired JJ B-Lab_value
ejection NN B-Diagnostic_procedure
fraction NN I-Diagnostic_procedure
22 CD B-Lab_value
% NN I-Lab_value
and CC O
severe JJ B-Severity
mitral JJ B-Sign_symptom
regurgitation NN I-Sign_symptom
on IN O
two CD B-Diagnostic_procedure
- : I-Diagnostic_procedure
dimensional JJ I-Diagnostic_procedure
transthoracic NN I-Diagnostic_procedure
echocardiography NN I-Diagnostic_procedure
( ( O
2DTTE CD B-Diagnostic_procedure
) ) O
. . O

Parasternal NNP O
short JJ O
axis NN O
and CC O
subxyphoid JJ O
view NN O
( ( O
Figure NNP O
1 CD O
) ) O
showed VBD O
the DT O
mobile JJ B-Detailed_description
right JJ B-Biological_structure
atrial JJ I-Biological_structure
mass NN B-Sign_symptom
highly RB O
suspicious JJ O
of IN O
a DT O
thrombus NN B-Disease_disorder
traversing VBG O
the DT O
right JJ B-Biological_structure
atrial JJ I-Biological_structure
cavity NN I-Biological_structure
during IN O
the DT O
cardiac JJ O
cycle NN O
accompanying VBG O
with IN O
free JJ B-Detailed_description
- : I-Detailed_description
floating VBG I-Detailed_description
small JJ B-Detailed_description
parts NNS I-Detailed_description
of IN O
the DT O
thrombi NN B-Disease_disorder
. . O

Real JJ B-Diagnostic_procedure
- : I-Diagnostic_procedure
time NN I-Diagnostic_procedure
three CD I-Diagnostic_procedure
dimensional JJ I-Diagnostic_procedure
transthoracic NN I-Diagnostic_procedure
echocardiography NN I-Diagnostic_procedure
( ( O
RT NNP B-Diagnostic_procedure
- : I-Diagnostic_procedure
3DTTE CD I-Diagnostic_procedure
) ) O
was VBD O
performed VBN O
to TO O
further RBR O
confirm VB O
the DT O
nature NN O
of IN O
mass NN B-Sign_symptom
. . O

It PRP O
showed VBD O
a DT O
highly RB B-Detailed_description
mobile JJ I-Detailed_description
thrombus NN B-Disease_disorder
, , O
irregular NN B-Shape
in IN I-Shape
contour NN I-Shape
, , O
measured VBD O
2 CD B-Area
. . I-Area
6 CD I-Area
× JJ I-Area
1 CD I-Area
. . I-Area
0 CD I-Area
cm NN I-Area
which WDT O
floating VBG O
around IN O
the DT O
orifice NN B-Biological_structure
of IN I-Biological_structure
inferior JJ I-Biological_structure
vena NN I-Biological_structure
cava NN I-Biological_structure
and CC O
protruding VBG B-Biological_structure
into IN I-Biological_structure
the DT I-Biological_structure
right JJ I-Biological_structure
atrial JJ I-Biological_structure
cavity NN I-Biological_structure
( ( O
Figure NNP O
2 CD O
) ) O
. . O

In IN O
addition NN O
, , O
RT NNP B-Diagnostic_procedure
- : I-Diagnostic_procedure
3DTTE CD I-Diagnostic_procedure
evaluated VBD O
right JJ B-Biological_structure
ventricle NN I-Biological_structure
( ( O
RV NNP B-Biological_structure
) ) O
systolic JJ B-Sign_symptom
dysfunction NN I-Sign_symptom
with IN O
ejection NN B-Diagnostic_procedure
fraction NN I-Diagnostic_procedure
15 CD B-Lab_value
. . I-Lab_value
7 CD I-Lab_value
% NN I-Lab_value
( ( O
Figure NNP O
3 CD O
) ) O
. . O

He PRP O
was VBD O
maintained VBN O
on IN O
digoxin NN B-Medication
, , O
spironolactone NN B-Medication
, , O
furosemide RB B-Medication
, , O
sotalol NN B-Medication
and CC O
dopamine NN B-Medication
. . O

At IN O
the DT O
same JJ O
time NN O
therapeutic JJ B-Therapeutic_procedure
anticoagulation NN I-Therapeutic_procedure
was VBD O
started VBN O
with IN O
low JJ B-Detailed_description
- : I-Detailed_description
molecular JJ I-Detailed_description
- : I-Detailed_description
weight NN I-Detailed_description
heparin NN B-Medication
and CC O
warfarin NN B-Medication
. . O

The DT O
patient NN O
had VBD O
an DT O
uneventful JJ B-Lab_value
hospital NN B-Therapeutic_procedure
course NN I-Therapeutic_procedure
and CC O
one CD O
week NN O
follow SYM O
- : O
up RB O
echocardiography NN B-Diagnostic_procedure
confirmed VBD O
adequate JJ O
removal NN O
of IN O
the DT O
thrombus NN B-Disease_disorder
( ( O
Figures NNS O
4A CD O
and CC O
4B CD O
) ) O
. . O

-DOCSTART- NN -X-

A DT O
75 CD B-Age
- : I-Age
year NN I-Age
- : I-Age
old JJ I-Age
female NN O
presented VBN O
in IN O
the DT O
Emergency NNP B-Nonbiological_location
Department NNP I-Nonbiological_location
of IN I-Nonbiological_location
Ilfov NNP I-Nonbiological_location
Clinical NNP I-Nonbiological_location
Hospital NNP I-Nonbiological_location
, , I-Nonbiological_location
Bucharest NNP I-Nonbiological_location
, , I-Nonbiological_location
Romania NNP I-Nonbiological_location
, , O
with IN O
dyspnea NN B-Sign_symptom
, , O
orthopnea NN B-Sign_symptom
, , O
lower JJR B-Biological_structure
extremities NNS I-Biological_structure
swelling VBG B-Sign_symptom
, , O
palpitations NNS B-Sign_symptom
. . O

She PRP O
had VBD O
a DT O
3 CD B-Duration
years NNS I-Duration
history NN O
of IN O
atrial JJ B-Sign_symptom
fibrillation NN I-Sign_symptom
diagnosed VBN O
by IN O
her PRP$ O
family NN O
doctor NN O
and CC O
one CD B-Duration
- : I-Duration
year NN I-Duration
history NN O
of IN O
cardiac JJ B-Disease_disorder
failure NN I-Disease_disorder
NYHA NNP B-Lab_value
( ( I-Lab_value
New NNP I-Lab_value
York NNP I-Lab_value
Heart NNP I-Lab_value
Association NNP I-Lab_value
) ) I-Lab_value
class NN I-Lab_value
Ⅱ NN I-Lab_value
. . O

Physical JJ B-Diagnostic_procedure
examination NN I-Diagnostic_procedure
revealed VBD O
an DT O
irregular JJ B-Sign_symptom
pulse NN I-Sign_symptom
80 CD B-Lab_value
beats NNS I-Lab_value
/ JJ I-Lab_value
min NN I-Lab_value
, , O
blood NN B-Diagnostic_procedure
pressure NN I-Diagnostic_procedure
of IN O
100 CD B-Lab_value
/ JJ I-Lab_value
60 CD I-Lab_value
mmHg NN I-Lab_value
, , O
bi SYM B-Sign_symptom
- : I-Sign_symptom
basal NN I-Sign_symptom
crackles NNS I-Sign_symptom
on IN O
chest JJS B-Biological_structure
auscultation NN B-Diagnostic_procedure
, , O
lower JJR B-Biological_structure
extremities NNS I-Biological_structure
swelling VBG O
. . O

Heart NNP B-Diagnostic_procedure
sounds VBZ I-Diagnostic_procedure
examination NN I-Diagnostic_procedure
revealed VBD O
a DT O
IVth NNP B-Lab_value
degree NN I-Lab_value
pansystolic NN B-Sign_symptom
murmur NN I-Sign_symptom
at IN O
the DT O
left JJ B-Biological_structure
border NN I-Biological_structure
of IN I-Biological_structure
the DT I-Biological_structure
stern NN I-Biological_structure
. . O

The DT O
jugular NN B-Biological_structure
veins NNS I-Biological_structure
were VBD O
dilated VBN B-Sign_symptom
. . O

The DT O
patient NN O
complained VBD O
of IN O
pain NN B-Sign_symptom
in IN O
the DT O
upper JJ B-Biological_structure
right JJ I-Biological_structure
abdominal JJ I-Biological_structure
region NN I-Biological_structure
, , O
enhanced VBN B-Detailed_description
by IN I-Detailed_description
palpation NN I-Detailed_description
. . O

The DT O
liver NN B-Diagnostic_procedure
margin NN I-Diagnostic_procedure
was VBD O
tender NN B-Texture
, , O
round NN B-Shape
, , O
of IN O
6 CD B-Distance
cm NN I-Distance
below IN I-Distance
the DT I-Distance
costal JJ I-Distance
rib NN I-Distance
, , O
with IN O
a DT O
smooth JJ B-Texture
liver NN B-Diagnostic_procedure
surface NN I-Diagnostic_procedure
. . O

The DT O
spleen NN O
could MD O
not RB O
be VB O
felt VBN O
. . O

EKG NN B-Diagnostic_procedure
: : O
atrial JJ B-Sign_symptom
fibrillation NN I-Sign_symptom
of IN O
80 CD B-Lab_value
/ JJ I-Lab_value
min NN I-Lab_value
, , O
right JJ B-Sign_symptom
bundle NN I-Sign_symptom
branch NN I-Sign_symptom
block NN I-Sign_symptom
, , O
infero NN B-Biological_structure
- : I-Biological_structure
lateral JJ I-Biological_structure
ischemia NN B-Sign_symptom
. . O

Transabdominal NNP B-Biological_structure
ultrasound NN B-Diagnostic_procedure
showed VBD O
a DT O
homogenous JJ B-Detailed_description
, , O
enlarged VBD B-Sign_symptom
liver NN I-Sign_symptom
. . O

The DT O
suprahepatic JJ B-Biological_structure
veins NNS I-Biological_structure
were VBD O
dilated VBN B-Sign_symptom
, , O
as RB O
well RB O
as IN O
the DT O
inferior JJ B-Biological_structure
vena NN I-Biological_structure
cava NN I-Biological_structure
( ( O
30 CD B-Lab_value
mm NN I-Lab_value
, , O
without IN O
respiratory JJ O
variations NNS O
) ) O
. . O

Transthoracic NNP B-Diagnostic_procedure
echocardiography NN I-Diagnostic_procedure
revealed VBD O
a DT O
dilated JJ B-Sign_symptom
right JJ B-Biological_structure
atrium NN I-Biological_structure
of IN O
74,2 CD B-Lab_value
mm NNS I-Lab_value
( ( O
Figure NNP O
1 CD O
) ) O
, , O
dilated VBN B-Sign_symptom
left VBD B-Biological_structure
atrium NN I-Biological_structure
of IN O
55,2 CD B-Lab_value
mm NNS I-Lab_value
, , O
dilated VBN B-Sign_symptom
left VBD B-Biological_structure
ventricle NN I-Biological_structure
of IN O
64 CD B-Lab_value
/ JJ I-Lab_value
72,3 CD I-Lab_value
mm NN I-Lab_value
, , O
dilated VBD B-Sign_symptom
right JJ B-Biological_structure
ventricle NN I-Biological_structure
of IN O
44,4 CD B-Lab_value
mm NN I-Lab_value
. . O

Atrial JJ B-Disease_disorder
septal JJ I-Disease_disorder
defect NN I-Disease_disorder
ostium NN B-Detailed_description
secundum NN I-Detailed_description
type NN I-Detailed_description
, , O
of IN O
6 CD B-Distance
cm NN I-Distance
( ( O
Figure NNP O
2 CD O
) ) O
, , O
with IN O
left JJ B-Sign_symptom
- : I-Sign_symptom
to TO I-Sign_symptom
- : I-Sign_symptom
right JJ I-Sign_symptom
shunt NN I-Sign_symptom
. . O

Severe NNP B-Severity
tricuspid JJ B-Disease_disorder
insufficiency NN I-Disease_disorder
with IN O
maximum JJ O
gradient NN O
of IN O
55,4 CD B-Lab_value
mm NN I-Lab_value
Hg NNP I-Lab_value
. . O

4th CD B-Lab_value
degree JJ I-Lab_value
mitral JJ B-Disease_disorder
insufficiency NN I-Disease_disorder
. . O

Severe NNP B-Severity
pulmonary JJ B-Biological_structure
hypertension NN B-Sign_symptom
of IN O
75 CD B-Lab_value
mm NN I-Lab_value
Hg NNP I-Lab_value
. . O

The DT O
ejection NN B-Diagnostic_procedure
fraction NN I-Diagnostic_procedure
of IN O
29 CD B-Lab_value
% NN I-Lab_value
. . O

Atrial JJ B-Sign_symptom
fibrillation NN I-Sign_symptom
. . O

Interventricular JJ B-Biological_structure
sept NN I-Biological_structure
with IN O
paradoxical JJ B-Sign_symptom
motion NN I-Sign_symptom
. . O

Flattening VBG B-Sign_symptom
of IN O
the DT O
interventricular JJ B-Biological_structure
septum NN I-Biological_structure
( ( O
Figure NNP O
3 CD O
) ) O
. . O

The DT O
diagnosis NN O
was VBD O
IVth NNP B-Lab_value
degree JJ I-Lab_value
chronic JJ B-Disease_disorder
heart NN I-Disease_disorder
failure NN I-Disease_disorder
NYHA NNP O
. . O

Atrial JJ O
septal JJ O
defect NN O
ostium NN O
secundum NN O
type NN O
with IN O
left JJ O
- : O
to TO O
- : O
right JJ O
shunt NN O
. . O

Severe NNP O
tricuspid JJ O
insufficiency NN O
. . O

4th CD O
degree JJ O
mitral JJ O
insufficiency NN O
. . O

Severe NNP O
pulmonary JJ O
hypertension NN O
of IN O
75 CD O
mm NN O
Hg NNP O
. . O

Chronic NNP O
atrial JJ O
fibrillation NN O
. . O

Right RB O
bundle JJ O
branch NN O
block NN O
. . O

-DOCSTART- NN -X-

A DT O
34 CD B-Age
- : I-Age
year NN I-Age
- : I-Age
old JJ I-Age
woman NN O
, , O
1 CD O
week NN O
postpartum NN O
, , O
presented VBN O
to TO O
our PRP$ O
dermatology NN B-Nonbiological_location
clinic NN I-Nonbiological_location
with IN O
an DT O
intensely RB B-Severity
pruritic JJ B-Detailed_description
generalized JJ B-Detailed_description
rash NN B-Sign_symptom
. . O

Two CD O
days NNS O
after IN O
delivery NN O
of IN O
her PRP$ O
child NN O
, , O
the DT O
patient NN O
developed VBD O
an DT O
itchy JJ B-Detailed_description
rash NN B-Sign_symptom
on IN O
the DT O
abdomen NNS B-Biological_structure
. . O

On IN O
discharge NN O
, , O
she PRP O
was VBD O
instructed VBN O
to TO O
follow VB O
up RP O
with IN O
the DT O
dermatology NN O
department NN O
if IN O
the DT O
rash NN O
did VBD O
not RB O
resolve VB O
. . O

After IN O
leaving VBG O
the DT O
hospital NN O
, , O
she PRP O
reported VBD O
that IN O
the DT O
eruption NN B-Sign_symptom
had VBD O
progressively RB B-Detailed_description
spread VBN I-Detailed_description
to TO O
the DT O
buttocks NNS B-Biological_structure
and CC O
legs NNS B-Biological_structure
and CC O
the DT O
itching NN B-Sign_symptom
seemed VBD O
to TO O
be VB O
worse JJR O
. . O

The DT O
patient NN O
` `` O
s JJ O
prenatal JJ B-Sign_symptom
course NN I-Sign_symptom
was VBD O
uneventful JJ B-Lab_value
. . O

She PRP O
gained VBD B-Sign_symptom
13 CD B-Lab_value
kg NN I-Lab_value
during IN B-Detailed_description
pregnancy NN I-Detailed_description
, , O
with IN O
a DT O
prepregnancy NN B-Detailed_description
weight NN O
of IN O
72 CD B-Weight
kg NNS I-Weight
. . O

A DT O
healthy JJ B-Detailed_description
male NN B-Detailed_description
neonate NN O
was VBD O
delivered VBN O
by IN O
caesarean JJ B-Therapeutic_procedure
section NN I-Therapeutic_procedure
at IN B-Lab_value
38 CD I-Lab_value
weeks NNS I-Lab_value
` `` I-Lab_value
gestation NN I-Lab_value
without IN O
complication NN B-Sign_symptom
. . O

The DT O
patient NN O
` `` O
s JJ O
medical JJ O
history NN O
was VBD O
unremarkable JJ O
. . O

She PRP O
was VBD O
currently RB O
not RB O
taking VBG O
any DT O
medications NNS B-Medication
, , O
and CC O
she PRP O
reported VBD O
no DT O
known VBN O
drug NN B-Sign_symptom
allergies NNS I-Sign_symptom
. . O

On IN O
physical JJ B-Diagnostic_procedure
examination NN I-Diagnostic_procedure
, , O
the DT O
patient NN O
was VBD O
afebrile JJ B-Sign_symptom
and CC O
her PRP$ O
blood NN B-Diagnostic_procedure
pressure NN I-Diagnostic_procedure
was VBD O
normal JJ B-Lab_value
. . O

Examination NN B-Diagnostic_procedure
of IN I-Diagnostic_procedure
the DT I-Diagnostic_procedure
skin NN I-Diagnostic_procedure
revealed VBD O
erythematous JJ B-Detailed_description
papules NNS B-Sign_symptom
and CC O
urticarial JJ B-Detailed_description
plaques NNS B-Sign_symptom
involving VBG O
the DT O
abdominal JJ B-Biological_structure
striae NN I-Biological_structure
with IN O
periumbilical JJ B-Biological_structure
sparing NN I-Biological_structure
. . O

Similar JJ O
lesions NNS B-Sign_symptom
were VBD O
noted VBN O
on IN O
the DT O
legs NN B-Biological_structure
and CC O
buttocks NNS B-Biological_structure
( ( O
Fig NNP O
. . O
1a CD O
) ) O
. . O

The DT O
face NN B-Biological_structure
, , O
palms NNS B-Biological_structure
, , O
and CC O
soles NNS B-Biological_structure
were VBD O
uninvolved JJ B-Sign_symptom
. . O

No DT O
vesicles NNS B-Sign_symptom
or CC O
pustules NNS B-Sign_symptom
were VBD O
noted VBN O
. . O

Based VBN O
on IN O
the DT O
characteristic JJ O
clinical JJ O
presentation NN O
and CC O
disease NN O
course NN O
, , O
she PRP O
was VBD O
diagnosed VBN O
with IN O
PUPPP NNP B-Disease_disorder
. . O

She PRP O
was VBD O
informed VBN O
of IN O
the DT O
safety NN O
profile NN O
and CC O
potential JJ O
benefits NNS O
of IN O
medications NNS O
but CC O
remained VBD O
reluctant JJ O
to TO O
use VB O
medications NNS B-Medication
during IN O
lactation NN O
, , O
despite IN O
her PRP$ O
severe JJ O
symptoms NNS O
. . O

AWB NNP B-Therapeutic_procedure
injection NN I-Therapeutic_procedure
was VBD O
then RB O
considered VBN O
for IN O
her PRP$ O
treatment NN O
. . O

Venous JJ B-Biological_structure
blood NN I-Biological_structure
of IN O
10 CD B-Volume
mL NN I-Volume
was VBD O
drawn VBN B-Therapeutic_procedure
from IN O
the DT O
patient NN O
, , O
followed VBN O
by IN O
intramuscular JJ O
injection NN B-Therapeutic_procedure
of IN O
5 CD B-Volume
mL NN I-Volume
of IN O
the DT O
blood NN B-Biological_structure
on IN O
each DT B-Biological_structure
side NN I-Biological_structure
of IN I-Biological_structure
her PRP$ I-Biological_structure
buttock NN I-Biological_structure
. . O

Seven NNP O
days NNS O
later RB O
, , O
both DT O
subjective JJ O
and CC O
objective JJ O
improvements NNS B-Lab_value
of IN O
symptoms NNS B-Sign_symptom
were VBD O
noticed VBN O
and CC O
she PRP O
received VBD O
1 CD B-Lab_value
more JJR I-Lab_value
session NN I-Lab_value
of IN O
AWB NNP B-Therapeutic_procedure
injection NN I-Therapeutic_procedure
( ( O
Fig NNP O
. . O
1b CD O
) ) O
. . O

On IN O
follow SYM O
- : O
up RB O
after IN O
12 CD O
days NNS O
, , O
all DT O
subjective JJ O
symptoms NNS B-Sign_symptom
had VBD O
improved VBN B-Lab_value
, , O
leaving VBG O
only RB O
postinflammatory JJ B-Detailed_description
hyperpigmentation NN B-Sign_symptom
( ( O
Fig NNP O
. . O
1c CD O
) ) O
. . O

No DT O
complications NNS O
such JJ O
as IN O
infection NN B-Sign_symptom
, , O
abscess JJ B-Sign_symptom
formation NN O
, , O
or CC O
hematoma NN B-Sign_symptom
were VBD O
observed VBN O
at IN O
the DT B-Biological_structure
injection NN I-Biological_structure
site NN I-Biological_structure
. . O

-DOCSTART- NN -X-

A DT O
78 CD B-Age
- : I-Age
year NN I-Age
- : I-Age
old JJ I-Age
previously RB O
healthy JJ O
male NN O
heavy JJ O
smoker NN O
presented VBN O
at IN O
the DT O
Emergency NNP B-Nonbiological_location
Department NNP I-Nonbiological_location
with IN O
generalized JJ B-Detailed_description
jaundice NN B-Sign_symptom
( ( O
sclera NN B-Biological_structure
and CC O
skin NN B-Biological_structure
) ) O
, , O
ascites VBZ B-Sign_symptom
, , O
and CC O
hepatic JJ B-Disease_disorder
coma NN I-Disease_disorder
. . O

The DT O
relatives NNS O
declared VBD O
that IN O
he PRP O
was VBD O
known VBN O
to TO O
have VB O
a DT O
urinary JJ O
bladder NN O
carcinoma NN O
that WDT O
was VBD O
diagnosed VBN O
at IN O
a DT O
routine JJ O
control NN O
performed VBD O
3 CD O
months NNS O
before IN O
but CC O
no DT O
medical JJ O
papers NNS O
to TO O
prove VB O
this DT O
diagnosis NN O
were VBD O
shown VBN O
. . O

They PRP O
also RB O
mentioned VBD O
a DT O
2 CD B-Duration
- : I-Duration
month NN I-Duration
history NN O
of IN O
progressive JJ B-Detailed_description
jaundice NN B-Sign_symptom
, , O
somnolence NN O
, , O
and CC O
temporary JJ B-Detailed_description
loss NN B-Sign_symptom
of IN I-Sign_symptom
consciousness NN I-Sign_symptom
. . O

No DT O
weight JJ B-Sign_symptom
loss NN I-Sign_symptom
or CC O
other JJ O
clinical JJ O
signs NNS O
were VBD O
mentioned VBN O
. . O

No DT O
previously RB O
viral JJ B-Disease_disorder
hepatitis NN I-Disease_disorder
or CC O
drug NN O
excess NN O
was VBD O
reported VBN O
. . O

No DT O
family NN O
history NN O
of IN O
cancer NN O
was VBD O
declared VBN O
. . O

At IN O
the DT O
present JJ O
admission NN O
, , O
the DT O
abdominal JJ B-Biological_structure
CT NNP B-Diagnostic_procedure
scan NN I-Diagnostic_procedure
showed VBD O
marked JJ O
hepatomegaly NN B-Sign_symptom
with IN O
multiple JJ B-Detailed_description
small JJ B-Detailed_description
nodules NNS B-Sign_symptom
( ( O
2 CD B-Distance
- : I-Distance
10 CD I-Distance
mm NN I-Distance
in IN O
diameter NN O
) ) O
that WDT O
was VBD O
supposed VBN O
to TO O
be VB O
hepatic JJ B-Biological_structure
metastases NNS B-Sign_symptom
from IN O
the DT O
bladder NN B-Disease_disorder
carcinoma NN I-Disease_disorder
. . O

The DT O
thoracic NN B-Biological_structure
x NNP B-Diagnostic_procedure
- : I-Diagnostic_procedure
ray NN I-Diagnostic_procedure
showed VBD O
a DT O
bilateral JJ B-Detailed_description
bronchopneumonia NN B-Sign_symptom
without IN O
abnormal JJ B-Lab_value
opacities NNS B-Sign_symptom
. . O

The DT O
patient NN O
died VBD O
with IN O
hepatic JJ B-Disease_disorder
encephalopathy NN I-Disease_disorder
at IN O
7 CD B-Time
hours NNS I-Time
after IN I-Time
admission NN O
. . O

Prior RB O
to TO O
the DT O
autopsy NN B-Diagnostic_procedure
, , O
signed VBD O
informed JJ O
consent NN O
of IN O
the DT O
relatives NNS O
was VBD O
obtained VBN O
for IN O
the DT O
case NN O
publication NN O
. . O

Being VBG O
about IN O
a DT O
case NN O
report NN O
, , O
no DT O
Ethical NNP O
Committee NNP O
approval NN O
was VBD O
necessary JJ O
. . O

At IN O
autopsy NN O
, , O
the DT O
macroscopic NN B-Diagnostic_procedure
examination NN I-Diagnostic_procedure
showed VBD O
a DT O
huge JJ B-Lab_value
liver NN B-Diagnostic_procedure
( ( O
6 CD O
. . O
5 CD O
kg NN O
) ) O
with IN O
widely RB B-Detailed_description
distributed VBN I-Detailed_description
white JJ B-Color
nodules NNS B-Sign_symptom
of IN O
varying VBG B-Detailed_description
sizes NNS I-Detailed_description
( ( O
Fig NNP O
. . O
1 CD O
) ) O
. . O

The DT O
urinary JJ B-Diagnostic_procedure
bladder NN I-Diagnostic_procedure
was VBD O
not RB B-Lab_value
modified VBN I-Lab_value
, , O
but CC O
a DT O
30 CD B-Volume
× NN I-Volume
30 CD I-Volume
× NN I-Volume
50 CD I-Volume
mm NN I-Volume
prostate NN B-Biological_structure
nodule NN B-Sign_symptom
with IN O
infiltrative JJ B-Detailed_description
aspect NN I-Detailed_description
was VBD O
observed VBN O
( ( O
Fig NNP O
. . O
2 CD O
) ) O
. . O

The DT O
bilateral JJ B-Detailed_description
bronchopneumonia NN B-Sign_symptom
was VBD O
confirmed VBN O
, , O
without IN O
any DT O
central JJ B-Detailed_description
tumor NN B-Sign_symptom
mass NN I-Sign_symptom
. . O

A DT O
10 CD B-Distance
- : I-Distance
mm NN I-Distance
white JJ B-Color
nodule NN B-Sign_symptom
was VBD O
identified VBN O
encasing VBG O
a DT O
small JJ B-Biological_structure
bronchus NN I-Biological_structure
from IN O
the DT O
middle JJ B-Biological_structure
lobe NN I-Biological_structure
of IN I-Biological_structure
the DT I-Biological_structure
right NN I-Biological_structure
lung NN I-Biological_structure
, , O
without IN O
peripheral JJ B-Sign_symptom
nodules NNS I-Sign_symptom
( ( O
Fig NNP O
. . O
3 CD O
) ) O
. . O

Except IN O
for IN O
moderate JJ B-Severity
edema NN B-Sign_symptom
, , O
no DT O
other JJ O
brain NN B-Biological_structure
lesions NNS B-Sign_symptom
were VBD O
identified VBN O
. . O

The DT O
other JJ B-Biological_structure
organs NNS I-Biological_structure
did VBD O
not RB O
show VB O
modifications NNS B-Sign_symptom
. . O

The DT O
tissues NNS O
were VBD O
fixed VBN O
in IN O
10 CD O
% NN O
neutral JJ O
formalin NN O
and CC O
embedded VBN O
in IN O
paraffin NN O
together RB O
with IN O
iliac JJ O
crest NN O
bone NN O
grafting NN O
. . O

Microscopic NNP B-Diagnostic_procedure
examination NN I-Diagnostic_procedure
of IN O
the DT O
prostate NN B-Biological_structure
showed VBD O
a DT O
3 CD B-Diagnostic_procedure
+3 NN I-Diagnostic_procedure
Gleason NNP I-Diagnostic_procedure
` `` I-Diagnostic_procedure
s RB I-Diagnostic_procedure
grade VB I-Diagnostic_procedure
2 CD B-Lab_value
occult NN B-Detailed_description
adenocarcinoma NN B-Disease_disorder
( ( O
Fig NNP O
. . O
2 CD O
) ) O
. . O

Clusters NNS O
and CC O
sheets NNS O
of IN O
small JJ O
round NN O
cells NNS O
were VBD O
seen VBN O
in IN O
the DT O
liver NN O
parenchyma NN O
( ( O
Fig NNP O
. . O
1 CD O
) ) O
and CC O
the DT O
lymph NN O
nodes NNS O
from IN O
the DT O
hepatic JJ O
hilum NN O
. . O

Examination NN O
of IN O
the DT O
lung NN O
parenchyma NN O
showed VBD O
a DT O
peribronchial JJ B-Biological_structure
SCLC NNP B-Disease_disorder
with IN O
multiple JJ B-Detailed_description
tumor NN B-Sign_symptom
emboli NN I-Sign_symptom
in IN O
both DT O
veins NNS B-Biological_structure
and CC O
lymphatic JJ B-Biological_structure
vessels NNS I-Biological_structure
and CC O
multiple JJ O
` `` O
coin NN B-Shape
- : I-Shape
shaped JJ I-Shape
` `` O
tumor NN B-Sign_symptom
nodules NNS O
of IN O
1 CD B-Distance
to TO I-Distance
2 CD I-Distance
mm NNS I-Distance
in IN O
diameter NN O
below IN B-Biological_structure
the DT I-Biological_structure
pleura NN I-Biological_structure
( ( O
Fig NNP O
. . O
3 CD O
) ) O
. . O

The DT O
small JJ O
round NN O
tumor NN O
cells NNS O
were VBD O
also RB O
seen VBN O
in IN O
bone NN O
marrow NN O
from IN O
the DT O
iliac JJ O
crest NN O
bone NN O
( ( O
Fig NNP O
. . O
3 CD O
) ) O
. . O

No DT O
brain NN B-Biological_structure
metastases NNS B-Sign_symptom
have VBP O
been VBN O
detected VBN O
. . O

Based VBN O
on IN O
the DT O
macro NN O
- : O
and CC O
microscopic NN O
features NNS O
and CC O
clinical JJ O
picture NN O
, , O
the DT O
final JJ O
diagnosis NN O
was VBD O
` `` O
peribronchial JJ B-Biological_structure
and CC O
coin JJ B-Shape
- : I-Shape
like IN I-Shape
peripheral JJ B-Detailed_description
SCLC NNP B-Disease_disorder
with IN O
massive JJ B-Severity
angiolymphatic JJ B-Biological_structure
invasion NN B-Disease_disorder
and CC O
metastases NNS B-Sign_symptom
in IN O
the DT O
lymph NN B-Biological_structure
nodes NNS I-Biological_structure
, , O
liver NN B-Biological_structure
and CC O
bone NN B-Biological_structure
, , O
associated VBN O
with IN O
encephalopathy JJ B-Disease_disorder
and CC O
synchronous JJ B-Detailed_description
occult NN B-Detailed_description
adenocarcinoma NN B-Disease_disorder
of IN O
the DT O
prostate NN B-Biological_structure
. . O
` `` O

-DOCSTART- NN -X-

This DT O
16 CD B-Age
- : I-Age
year NN I-Age
- : I-Age
old JJ I-Age
boy NN O
was VBD O
the DT O
first JJ O
child NN O
to TO O
non VB O
- : O
consanguineous JJ O
parents NNS O
. . O

His PRP$ O
parents NNS O
and CC O
two CD O
younger JJR O
siblings NNS O
were VBD O
healthy JJ O
. . O

He PRP O
was VBD O
well RB O
until IN O
starting VBG O
school NN O
at IN O
7 CD O
years NNS O
of IN O
age NN O
when WRB O
he PRP O
was VBD O
found VBN O
to TO O
be VB O
short JJ B-Sign_symptom
in IN I-Sign_symptom
height NN I-Sign_symptom
, , O
slightly RB B-Sign_symptom
myopic NN I-Sign_symptom
, , O
astigmatic JJ B-Sign_symptom
and CC O
to TO O
have VB O
subnormal JJ B-Sign_symptom
visual JJ I-Sign_symptom
acuity NN I-Sign_symptom
. . O

Endocrinological JJ B-Diagnostic_procedure
investigations NNS I-Diagnostic_procedure
were VBD O
performed VBN O
that IN O
initially RB O
revealed VBD O
borderline NN B-Lab_value
values NNS I-Lab_value
for IN O
growth NN B-Sign_symptom
hormone NN I-Sign_symptom
( ( I-Sign_symptom
GH NNP I-Sign_symptom
) ) I-Sign_symptom
deficiency NN I-Sign_symptom
and CC O
he PRP O
was VBD O
therefore RB O
treated VBN O
for IN O
a DT O
period NN O
with IN O
GH NNP B-Medication
without IN O
any DT O
beneficiary JJ B-Sign_symptom
effect NN I-Sign_symptom
on IN I-Sign_symptom
his PRP$ I-Sign_symptom
growth NN I-Sign_symptom
. . O

At IN O
age NN O
16 CD O
years NNS O
, , O
height NN B-Sign_symptom
and CC I-Sign_symptom
weight NN I-Sign_symptom
was VBD I-Sign_symptom
− JJ I-Sign_symptom
3 CD I-Sign_symptom
SD NNP I-Sign_symptom
below IN I-Sign_symptom
the DT I-Sign_symptom
mean NN I-Sign_symptom
compared VBN O
with IN O
a DT O
standardized JJ O
Swedish JJ O
growth NN O
chart NN O
. . O

Ophthalmological JJ B-Diagnostic_procedure
investigations NNS I-Diagnostic_procedure
at IN O
10 CD O
years NNS O
of IN O
age NN O
showed VBD O
pigmentary JJ B-Sign_symptom
retinopathy NN I-Sign_symptom
and CC O
optic JJ B-Sign_symptom
atrophy NN I-Sign_symptom
. . O

An DT O
electroretinogram NN B-Diagnostic_procedure
was VBD O
performed VBN O
and CC O
showed VBD O
a DT O
severe JJ B-Severity
rod NN B-Sign_symptom
cone NN I-Sign_symptom
dystrophy NN I-Sign_symptom
. . O

He PRP O
had VBD O
decreased VBN B-Lab_value
visual JJ B-Sign_symptom
acuity NN I-Sign_symptom
, , O
visual JJ B-Sign_symptom
fields NNS I-Sign_symptom
, , O
color NN B-Sign_symptom
vision NN I-Sign_symptom
, , O
and CC O
dark JJ B-Sign_symptom
adaption NN I-Sign_symptom
. . O

Nystagmus NNP B-Sign_symptom
has VBZ O
been VBN O
noted VBN O
since IN O
14 CD O
years NNS O
of IN O
age NN O
. . O

A DT O
year NN O
later RB O
, , O
photophobia NNS B-Sign_symptom
and CC O
bilateral JJ B-Sign_symptom
cataracts NNS I-Sign_symptom
were VBD O
developed VBN O
. . O

The DT O
cataracts NNS B-Therapeutic_procedure
were VBD I-Therapeutic_procedure
operated VBN I-Therapeutic_procedure
on IN I-Therapeutic_procedure
at IN O
16 CD O
years NNS O
of IN O
age NN O
. . O

He PRP O
is VBZ O
now RB O
blind RB B-Sign_symptom
. . O

At IN O
14 CD O
years NNS O
of IN O
age NN O
, , O
he PRP O
was VBD O
referred VBN O
for IN O
neurological JJ B-Diagnostic_procedure
investigations NNS I-Diagnostic_procedure
. . O

A DT O
clinical JJ B-Diagnostic_procedure
examination NN I-Diagnostic_procedure
showed VBD O
mild JJ B-Severity
ataxia NN B-Sign_symptom
with IN I-Sign_symptom
tremor NN I-Sign_symptom
, , O
dysmetria NN B-Sign_symptom
and CC O
gait NN B-Sign_symptom
instability NN I-Sign_symptom
together RB O
with IN O
mild NN B-Severity
to TO I-Severity
moderate VB I-Severity
muscle NN B-Sign_symptom
weakness NN I-Sign_symptom
, , O
weak JJ B-Severity
to TO I-Severity
absent VB I-Severity
tendon NN B-Sign_symptom
reflexes NNS I-Sign_symptom
in IN O
the DT O
lower JJR B-Biological_structure
extremities NNS I-Biological_structure
, , O
and CC O
exercise NN B-Sign_symptom
intolerance NN I-Sign_symptom
. . O

Audiometric JJ B-Diagnostic_procedure
investigations NNS I-Diagnostic_procedure
revealed VBD O
a DT O
mild JJ B-Severity
bilateral JJ B-Detailed_description
sensorineural JJ B-Sign_symptom
hearing NN I-Sign_symptom
impairment NN I-Sign_symptom
. . O

At IN O
15 CD O
years NNS O
of IN O
age NN O
, , O
he PRP O
had VBD O
an DT O
unprovoked JJ B-Detailed_description
epileptic JJ B-Sign_symptom
seizure NN I-Sign_symptom
and CC O
he PRP O
has VBZ O
since IN O
then RB O
been VBN O
treated VBN O
with IN O
levetiracetam NN B-Medication
. . O

Decreased VBN B-Sign_symptom
renal JJ I-Sign_symptom
function NN I-Sign_symptom
was VBD O
identified VBN O
at IN O
15 CD O
years NNS O
of IN O
age NN O
, , O
with IN O
increased VBN B-Lab_value
serum NN B-Diagnostic_procedure
creatinine NN I-Diagnostic_procedure
to TO O
145 CD B-Lab_value
μmol NNS I-Lab_value
/ JJ I-Lab_value
l NN I-Lab_value
( ( O
reference NN O
interval NN O
30 CD O
- : O
90 CD O
μmol JJ O
/ NNP O
l NN O
) ) O
, , O
proteinuria NN B-Sign_symptom
with IN O
urine JJ B-Diagnostic_procedure
albumine NN I-Diagnostic_procedure
at IN O
244 CD B-Lab_value
- : I-Lab_value
538 CD I-Lab_value
mg NN I-Lab_value
/ NN I-Lab_value
l NN I-Lab_value
( ( O
reference NN O
interval NN O
< VBD O
20 CD O
mg NN O
/ NNP O
l NN O
) ) O
, , O
and CC O
urine JJ B-Diagnostic_procedure
albumine NN I-Diagnostic_procedure
/ NNP I-Diagnostic_procedure
creatinine NN I-Diagnostic_procedure
ratio NN O
at IN O
44 CD B-Lab_value
- : I-Lab_value
59 CD I-Lab_value
g NN I-Lab_value
/ NN I-Lab_value
mol NN I-Lab_value
( ( O
reference NN O
interval NN O
< VBD O
3 CD O
g NN O
/ NNP O
mol NN O
) ) O
. . O

A DT O
renal JJ B-Biological_structure
scintigraphy NN B-Diagnostic_procedure
demonstrated VBD O
reduced JJ B-Sign_symptom
kidney NN I-Sign_symptom
size NN I-Sign_symptom
. . O

Cr51 NNP B-Diagnostic_procedure
- : I-Diagnostic_procedure
EDTA NN I-Diagnostic_procedure
clearance NN I-Diagnostic_procedure
showed VBD O
a DT O
decreased JJ B-Lab_value
glomerular JJ B-Diagnostic_procedure
filtration NN I-Diagnostic_procedure
rate NN I-Diagnostic_procedure
of IN O
42 CD B-Lab_value
% NN I-Lab_value
of IN I-Lab_value
normal JJ I-Lab_value
. . I-Lab_value

The DT O
filtration NN O
rate NN O
decreased VBN B-Lab_value
over IN O
time NN O
to TO O
29 CD B-Lab_value
% NN I-Lab_value
of IN I-Lab_value
normal JJ I-Lab_value
at IN O
16 CD O
years NNS O
of IN O
age NN O
. . O

Since IN O
14 CD O
years NNS O
of IN O
age NN O
, , O
cardiac JJ B-Diagnostic_procedure
investigations NNS I-Diagnostic_procedure
have VBP O
demonstrated VBN O
hypertrophy NN B-Sign_symptom
of IN O
the DT O
walls NNS B-Biological_structure
of IN I-Biological_structure
the DT I-Biological_structure
left JJ I-Biological_structure
ventricle NN I-Biological_structure
( ( O
+3 JJ O
SD NNP O
compared VBN O
with IN O
normal JJ O
) ) O
with IN O
normal JJ B-Severity
systolic JJ B-Sign_symptom
and CC I-Sign_symptom
diastolic JJ I-Sign_symptom
function NN I-Sign_symptom
and CC O
without IN O
obstruction NN B-Sign_symptom
of IN I-Sign_symptom
the DT I-Sign_symptom
outflow NN I-Sign_symptom
. . O

Mitochondrial JJ B-Diagnostic_procedure
investigations NNS I-Diagnostic_procedure
were VBD O
performed VBN O
at IN O
14 CD O
years NNS O
of IN O
age NN O
. . O

Blood NN B-Diagnostic_procedure
levels NNS I-Diagnostic_procedure
of IN O
lactate NN B-Diagnostic_procedure
and CC O
pyruvate NN B-Diagnostic_procedure
were VBD O
1 CD B-Lab_value
. . I-Lab_value
6 CD I-Lab_value
and CC O
0 CD B-Lab_value
. . I-Lab_value
096 CD I-Lab_value
mmol JJ I-Lab_value
/ NNP I-Lab_value
l NN I-Lab_value
, , O
respectively RB O
, , O
leading VBG O
to TO O
a DT O
ratio NN B-Diagnostic_procedure
of IN O
33 CD B-Lab_value
( ( O
reference NN O
interval NN O
< NNP O
20 CD O
) ) O
, , O
while IN O
cerebrospinal JJ B-Diagnostic_procedure
fluid NN I-Diagnostic_procedure
( ( O
CSF NNP B-Diagnostic_procedure
) ) O
levels NNS O
of IN O
lactate NN B-Diagnostic_procedure
and CC O
pyruvate NN B-Diagnostic_procedure
were VBD O
3 CD B-Lab_value
. . I-Lab_value
6 CD I-Lab_value
and CC O
0 CD B-Lab_value
. . I-Lab_value
137 CD I-Lab_value
mmol JJ I-Lab_value
/ NNP I-Lab_value
l NN I-Lab_value
, , I-Lab_value
respectively RB O
, , O
leading VBG O
to TO O
a DT O
lactate NN B-Diagnostic_procedure
to TO I-Diagnostic_procedure
pyruvate VB I-Diagnostic_procedure
ratio NN I-Diagnostic_procedure
of IN O
26 CD B-Lab_value
. . O

The DT O
urinary JJ B-Diagnostic_procedure
lactate NN I-Diagnostic_procedure
excretion NN I-Diagnostic_procedure
was VBD O
normal JJ B-Lab_value
. . O

The DT O
CSF NNP B-Diagnostic_procedure
albumin NN I-Diagnostic_procedure
was VBD O
increased VBN B-Lab_value
to TO O
258 CD B-Lab_value
mg NNS I-Lab_value
/ JJ I-Lab_value
l NN I-Lab_value
( ( O
reference NN O
level NN O
< VBD O
225 CD O
mg NN O
/ NNP O
l NN O
) ) O
and CC O
he PRP O
also RB O
had VBD O
an DT O
increased VBN B-Lab_value
CSF NNP B-Diagnostic_procedure
/ NNP I-Diagnostic_procedure
plasma NN I-Diagnostic_procedure
albumin NN I-Diagnostic_procedure
ratio NN I-Diagnostic_procedure
of IN O
7 CD B-Lab_value
. . I-Lab_value
4 CD I-Lab_value
( ( O
reference NN O
level NN O
< NNP O
5 CD O
) ) O
. . O

The DT O
serum NN B-Diagnostic_procedure
acyl NN I-Diagnostic_procedure
carnitine NN I-Diagnostic_procedure
profile NN I-Diagnostic_procedure
and CC O
muscle NN B-Diagnostic_procedure
carnitine NN I-Diagnostic_procedure
levels NNS I-Diagnostic_procedure
were VBD O
normal JJ B-Lab_value
. . O

The DT O
serum NN B-Diagnostic_procedure
creatine JJ I-Diagnostic_procedure
kinase NN I-Diagnostic_procedure
activity NN I-Diagnostic_procedure
was VBD O
mildly RB B-Lab_value
increased VBN I-Lab_value
to TO O
5 CD B-Lab_value
. . I-Lab_value
4 CD I-Lab_value
μkat JJ I-Lab_value
/ NN I-Lab_value
l NN I-Lab_value
( ( O
reference NN O
interval NN O
< VBD O
3 CD O
. . O
5 CD O
μkat JJ O
/ NNP O
l NN O
) ) O
. . O

-DOCSTART- NN -X-

A DT O
61 CD B-Age
- : I-Age
year NN I-Age
- : I-Age
old JJ I-Age
male NN O
was VBD O
referred VBN O
to TO O
the DT O
emergency NN B-Nonbiological_location
department NN I-Nonbiological_location
by IN O
his PRP$ O
general JJ O
practitioner NN O
in IN O
April NNP O
2010 CD O
for IN O
investigation NN O
of IN O
loose JJ B-Sign_symptom
bowel JJ I-Sign_symptom
motions NNS I-Sign_symptom
and CC O
an DT O
episode NN O
of IN O
black JJ B-Sign_symptom
stool NN I-Sign_symptom
. . O

The DT O
patient NN O
had VBD O
a DT O
history NN O
of IN O
insulin NN O
- : O
dependent NN O
type NN O
II NNP O
diabetes VBZ O
mellitus NN O
, , O
hypertension NN O
, , O
ischaemic JJ O
heart NN O
disease NN O
with IN O
two CD O
previous JJ O
ischaemic JJ O
events NNS O
, , O
obstructive JJ O
sleep NN O
apnoea NN O
, , O
depression NN O
, , O
schizophrenia NN O
and CC O
a DT O
previous JJ O
incisional JJ O
hernia NN O
repair NN O
. . O

On IN O
examination NN O
, , O
he PRP O
was VBD O
morbidly RB B-Disease_disorder
obese JJ I-Disease_disorder
( ( O
BMI NNP B-Diagnostic_procedure
45 CD B-Lab_value
) ) O
and CC O
was VBD O
noted VBN O
to TO O
have VB O
marked VBN O
hepatomegaly NN B-Disease_disorder
. . O

This DT O
was VBD O
not RB O
associated VBN O
with IN O
any DT O
recent JJ O
weight NN B-Sign_symptom
loss NN I-Sign_symptom
, , O
haematemesis NN B-Sign_symptom
, , O
jaundice NN B-Sign_symptom
or CC O
abdominal JJ B-Biological_structure
pain NN B-Sign_symptom
. . O

The DT O
patient NN O
denied VBD O
previous JJ O
blood NN O
transfusions NNS O
, , O
usage NN O
of IN O
intravenous JJ O
drugs NNS O
and CC O
did VBD O
not RB O
drink VB O
alcohol NN O
. . O

A DT O
faecal JJ B-Diagnostic_procedure
occult NN I-Diagnostic_procedure
blood NN I-Diagnostic_procedure
test NN I-Diagnostic_procedure
was VBD O
negative JJ B-Lab_value
, , O
and CC O
the DT O
patient NN O
` `` O
s NN O
last JJ O
colonoscopy NN B-Diagnostic_procedure
2 CD O
years NNS O
prior RB O
was VBD O
unremarkable JJ B-Lab_value
. . O

He PRP O
was VBD O
referred VBN O
to TO O
our PRP$ O
tertiary JJ B-Nonbiological_location
centre NN I-Nonbiological_location
for IN O
further JJ O
management NN O
after IN O
an DT O
ultrasound JJ B-Diagnostic_procedure
scan NN I-Diagnostic_procedure
( ( O
USS NNP B-Diagnostic_procedure
) ) O
displayed VBD O
an DT O
ovoid JJ B-Shape
mass NN B-Sign_symptom
of IN O
mixed JJ B-Detailed_description
echogenicity NN I-Detailed_description
arising VBG O
from IN O
the DT O
liver NN B-Biological_structure
, , O
measuring VBG O
12 CD B-Area
× JJ I-Area
9 CD I-Area
cm NN I-Area
. . O

A DT O
computed JJ B-Diagnostic_procedure
tomography NN I-Diagnostic_procedure
( ( O
CT NNP B-Diagnostic_procedure
) ) O
scan NN O
confirmed VBD O
a DT O
malignant NN B-Detailed_description
appearing NN I-Detailed_description
, , O
pedunculated VBN B-Detailed_description
lesion NN B-Sign_symptom
attached VBN O
to TO O
segment NN B-Biological_structure
IV NNP I-Biological_structure
( ( O
Fig NNP O
. . O
1 CD O
) ) O
. . O

A DT O
subsequent JJ O
magnetic JJ B-Diagnostic_procedure
resonance NN I-Diagnostic_procedure
imaging NN I-Diagnostic_procedure
( ( O
MRI NNP B-Diagnostic_procedure
) ) O
confirmed VBD O
that IN O
on IN O
T2 NNP B-Detailed_description
weighted VBD B-Diagnostic_procedure
imaging NN I-Diagnostic_procedure
( ( O
WI NNP B-Diagnostic_procedure
) ) O
, , O
the DT O
lesion NN B-Sign_symptom
was VBD O
isointense JJ B-Detailed_description
to TO O
the DT O
liver NN B-Biological_structure
peripherally RB O
with IN O
central JJ B-Detailed_description
branching VBG I-Detailed_description
hyperintensities NNS I-Detailed_description
( ( O
Fig NNP O
. . O
2a CD O
) ) O
which WDT O
corresponded VBD O
to TO O
the DT O
hypointensities NNS B-Sign_symptom
seen VBN O
on IN O
T1WI NNP B-Diagnostic_procedure
( ( O
Fig NNP O
. . O
2b CD O
) ) O
. . O

Enhancement NN B-Detailed_description
of IN O
the DT O
lesion NN B-Sign_symptom
was VBD O
noted VBN O
in IN O
arterial JJ B-Detailed_description
phase NN I-Detailed_description
( ( O
Fig NNP O
. . O
3a CD O
) ) O
, , O
during IN O
portal JJ B-Detailed_description
venous JJ I-Detailed_description
phase NN I-Detailed_description
( ( O
Fig NNP O
. . O
3b CD O
) ) O
and CC O
at IN B-Detailed_description
2 CD I-Detailed_description
min NN I-Detailed_description
( ( O
Fig NNP O
. . O
3c CD O
) ) O
, , O
with IN O
some DT O
central JJ B-Detailed_description
areas NNS I-Detailed_description
of IN I-Detailed_description
non JJ I-Detailed_description
- : I-Detailed_description
enhancement NN I-Detailed_description
. . O

The DT O
lesion NN B-Sign_symptom
becomes VBZ O
slightly RB B-Detailed_description
hypointense VBN I-Detailed_description
on IN O
delayed JJ B-Detailed_description
images NNS I-Detailed_description
at IN O
10 CD B-Detailed_description
( ( O
Fig NNP O
. . O
3d CD O
) ) O
and CC O
20 CD B-Detailed_description
min NNS I-Detailed_description
compared VBN O
to TO O
the DT O
surrounding VBG O
liver NN B-Biological_structure
. . O

Laboratory JJ B-Diagnostic_procedure
investigations NNS I-Diagnostic_procedure
revealed VBD O
a DT O
mildly RB B-Lab_value
elevated VBN I-Lab_value
gamma NN B-Diagnostic_procedure
- : I-Diagnostic_procedure
glutamyl JJ I-Diagnostic_procedure
transpeptidase NN I-Diagnostic_procedure
of IN O
137 CD B-Lab_value
IU NNP I-Lab_value
/ NNP I-Lab_value
L NNP I-Lab_value
( ( O
normal JJ O
5 CD O
- : O
50 CD O
IU NNP O
/ NNP O
L NNP O
) ) O
. . O

Hepatitis NNP B-Diagnostic_procedure
screen NN I-Diagnostic_procedure
, , O
alpha SYM B-Diagnostic_procedure
- : I-Diagnostic_procedure
fetoprotein NN I-Diagnostic_procedure
, , O
carcinoembryonic JJ B-Diagnostic_procedure
antigen NN I-Diagnostic_procedure
and CC O
cancer NN B-Diagnostic_procedure
antigen NN I-Diagnostic_procedure
19 CD I-Diagnostic_procedure
- : I-Diagnostic_procedure
9 CD I-Diagnostic_procedure
were VBD O
all DT O
unremarkable JJ B-Lab_value
. . O

The DT O
patient NN O
underwent NN O
a DT O
subsegmental JJ B-Detailed_description
resection NN B-Therapeutic_procedure
of IN O
the DT O
15 CD B-Distance
cm NN I-Distance
segment NN B-Biological_structure
IVb NNP I-Biological_structure
mass NN B-Sign_symptom
in IN O
June NNP O
2010 CD O
. . O

There EX O
was VBD O
severe JJ B-Severity
hepatic JJ B-Disease_disorder
steatosis NN I-Disease_disorder
, , O
but CC O
no DT O
cirrhosis NN B-Disease_disorder
. . O

The DT O
patient NN O
was VBD O
discharged VBN O
postoperative JJ O
day NN O
seven CD O
without IN O
complications NNS B-Sign_symptom
. . O

Pathology NN B-Diagnostic_procedure
of IN O
the DT O
resection NN B-Biological_structure
specimen NNS I-Biological_structure
confirmed VBD O
SFTL NNP B-Disease_disorder
. . O

The DT O
specimen NNS O
displayed VBD O
a DT O
pale JJ B-Color
tan NN I-Color
nodular JJ B-Shape
appearance NN I-Shape
with IN O
a DT O
firm NN B-Texture
and CC I-Texture
rubbery NN I-Texture
cut NN I-Texture
surface NN I-Texture
. . O

Histological JJ B-Diagnostic_procedure
examination NN I-Diagnostic_procedure
revealed VBD O
fascicles NNS B-Lab_value
of IN I-Lab_value
spindle JJ I-Lab_value
cells NNS I-Lab_value
in IN O
storiform NN B-Detailed_description
arrangement NN I-Detailed_description
with IN O
a DT O
pushing VBG B-Detailed_description
margin NN I-Detailed_description
. . O

There EX O
was VBD O
evidence NN B-Lab_value
of IN I-Lab_value
extracellular JJ I-Lab_value
collagen NN I-Lab_value
deposition NN I-Lab_value
, , O
areas NNS B-Lab_value
of IN I-Lab_value
myxoid NN I-Lab_value
stroma NN I-Lab_value
and CC O
branching NN B-Lab_value
vessels NNS I-Lab_value
with IN I-Lab_value
hyalinisation NN I-Lab_value
. . O

The DT O
specimen NNS B-Biological_structure
displayed VBD O
a DT O
high JJ B-Lab_value
mitotic JJ B-Diagnostic_procedure
rate NN I-Diagnostic_procedure
of IN O
up IN O
to TO O
9 CD B-Lab_value
per IN I-Lab_value
10 CD I-Lab_value
high JJ I-Lab_value
- : I-Lab_value
power NN I-Lab_value
fields NNS I-Lab_value
( ( O
HPF NNP O
) ) O
with IN O
no DT B-Lab_value
necrotic JJ I-Lab_value
or CC I-Lab_value
haemorrhagic JJ I-Lab_value
features NNS I-Lab_value
. . O

Immunohistochemistry NN B-Diagnostic_procedure
showed VBD O
positive JJ B-Lab_value
staining NN O
for IN O
CD34 NNP B-Diagnostic_procedure
, , O
CD99 NNP B-Diagnostic_procedure
and CC O
BCL NNP B-Diagnostic_procedure
- : I-Diagnostic_procedure
2 CD I-Diagnostic_procedure
. . O

The DT O
tumour NN O
was VBD O
negative JJ B-Lab_value
for IN O
c SYM B-Diagnostic_procedure
- : I-Diagnostic_procedure
Kit NNP I-Diagnostic_procedure
, , O
CD31 NNP B-Diagnostic_procedure
, , O
SMA NNP B-Diagnostic_procedure
, , O
desmin NN B-Diagnostic_procedure
, , O
cytokeratins NNS B-Diagnostic_procedure
( ( O
AE1 NNP B-Detailed_description
/ NNP I-Detailed_description
AE3 NNP I-Detailed_description
, , I-Detailed_description
MNF116 NNP I-Detailed_description
and CC I-Detailed_description
Cam NNP I-Detailed_description
5 CD I-Detailed_description
. . I-Detailed_description
2 CD I-Detailed_description
) ) O
, , O
EMA NNP B-Diagnostic_procedure
and CC O
S100 NNP B-Diagnostic_procedure
. . O

The DT O
margins NNS B-Diagnostic_procedure
were VBD O
clear JJ B-Lab_value
. . O

The DT O
non JJ O
- : O
neoplastic JJ O
remainder NN B-Biological_structure
of IN I-Biological_structure
the DT I-Biological_structure
liver NN I-Biological_structure
displayed VBD O
pericellular JJ B-Detailed_description
fibrosis NN B-Sign_symptom
indicative NN O
of IN O
steatohepatitis NN B-Disease_disorder
. . O

The DT O
patient NN O
was VBD O
followed VBN O
- : O
up RB O
regularly RB O
every DT B-Frequency
4 CD I-Frequency
to TO I-Frequency
6 CD I-Frequency
months NNS I-Frequency
with IN O
CT NNP B-Diagnostic_procedure
scans NNS O
by IN O
the DT O
local JJ B-Nonbiological_location
general JJ I-Nonbiological_location
practitioner NN I-Nonbiological_location
who WP O
liaised VBD O
with IN O
the DT O
consultant NN B-Nonbiological_location
surgeon NN I-Nonbiological_location
. . O

There EX O
were VBD O
two CD B-Lab_value
episodes NNS O
of IN O
re NN O
- : O
admissions NNS O
for IN O
further JJ O
investigation NN O
of IN O
recurrent NN B-Detailed_description
right JJ B-Biological_structure
upper JJ I-Biological_structure
quadrant NN I-Biological_structure
pain NN B-Sign_symptom
between IN O
2011 CD O
and CC O
2013 CD O
. . O

Multiple NNP B-Detailed_description
MRI NNP B-Diagnostic_procedure
scans NNS O
performed VBD O
during IN O
this DT O
period NN O
revealed VBD O
expected JJ B-Sign_symptom
postsurgical JJ I-Sign_symptom
changes NNS I-Sign_symptom
with IN O
no DT O
tumour JJ B-Sign_symptom
recurrence NN I-Sign_symptom
. . O

However RB O
, , O
in IN O
May NNP O
2016 CD O
, , O
the DT O
patient NN O
presented VBD O
to TO O
his PRP$ O
local JJ B-Nonbiological_location
emergency NN I-Nonbiological_location
department NN I-Nonbiological_location
with IN O
progressively RB O
worsening VBG O
right JJ B-Biological_structure
upper JJ I-Biological_structure
quadrant NN I-Biological_structure
pain NN B-Sign_symptom
and CC O
increasing VBG O
dyspnoea NN B-Sign_symptom
with IN O
an DT O
oxygen NN B-Therapeutic_procedure
demand NN I-Therapeutic_procedure
. . O

CT NN B-Diagnostic_procedure
of IN O
his PRP$ O
chest NN B-Biological_structure
, , O
abdomen NNS B-Biological_structure
and CC O
pelvis NN B-Biological_structure
revealed VBD O
extensive JJ B-Detailed_description
tumour NN B-Sign_symptom
recurrence NN I-Sign_symptom
adjacent NN B-Biological_structure
to TO I-Biological_structure
the DT I-Biological_structure
previous JJ I-Biological_structure
resection NN I-Biological_structure
site NN I-Biological_structure
( ( O
Fig NNP O
. . O
4 CD O
) ) O
. . O

In IN O
addition NN O
, , O
there EX O
was VBD O
a DT O
clinically RB O
significant JJ O
right JJ B-Detailed_description
- : I-Detailed_description
sided VBD I-Detailed_description
pleural JJ B-Disease_disorder
effusion NN I-Disease_disorder
and CC O
a DT O
pleural JJ B-Biological_structure
mass NN B-Sign_symptom
at IN O
the DT O
right JJ B-Biological_structure
lung NN I-Biological_structure
base NN I-Biological_structure
measuring VBG O
3 CD O
. . O
8 CD O
cm NN O
( ( O
Fig NNP O
. . O
5 CD O
) ) O
. . O

Pleurocentesis NN B-Therapeutic_procedure
was VBD O
performed VBN O
, , O
draining VBG O
1400 CD B-Volume
ml NN I-Volume
of IN O
serosanguineous JJ B-Biological_structure
fluid NN I-Biological_structure
. . O

Cytology NNP B-Diagnostic_procedure
was VBD O
negative JJ B-Lab_value
for IN O
malignant JJ B-Diagnostic_procedure
cells NNS I-Diagnostic_procedure
. . O

The DT O
case NN O
was VBD O
discussed VBN O
extensively RB O
in IN O
a DT O
multi NN B-Nonbiological_location
- : I-Nonbiological_location
disciplinary JJ I-Nonbiological_location
setting NN I-Nonbiological_location
, , O
and CC O
it PRP O
was VBD O
decided VBN O
given VBN O
the DT O
patient NN O
` `` O
s JJ O
two CD O
sites NNS O
of IN O
disease NN O
and CC O
significant JJ O
perioperative JJ O
risk NN O
that IN O
he PRP O
was VBD O
not RB O
a DT O
candidate NN O
for IN O
radical JJ O
reoperation NN B-Therapeutic_procedure
. . O

There EX O
were VBD O
also RB O
no DT O
suitable JJ O
chemo NN B-Medication
- : O
or CC O
radiotherapeutic JJ B-Therapeutic_procedure
therapies NNS I-Therapeutic_procedure
available JJ O
. . O

The DT O
patient NN O
was VBD O
subsequently RB O
referred VBN O
to TO O
the DT O
palliative JJ B-Nonbiological_location
team NN I-Nonbiological_location
for IN O
management NN O
of IN O
his PRP$ O
symptoms NNS O
and CC O
discharged VBD O
back RB O
to TO O
the DT O
community NN B-Nonbiological_location
. . O

He PRP O
was VBD O
still RB O
alive JJ B-Sign_symptom
1 CD O
month NN O
after IN O
discharge NN O
. . O

-DOCSTART- NN -X-

A DT O
51 CD B-Age
- : I-Age
year NN I-Age
- : I-Age
old JJ I-Age
man NN O
was VBD O
referred VBN O
to TO O
our PRP$ O
hospital NN B-Biological_structure
due JJ O
to TO O
severe JJ B-Severity
congestive JJ B-Detailed_description
heart NN B-Disease_disorder
failure NN I-Disease_disorder
and CC O
ventricular JJ B-Biological_structure
arrhythmias NN B-Disease_disorder
in IN O
March NNP O
2008 CD O
. . O

He PRP O
had VBD O
been VBN O
suffering VBG O
from IN O
heart NN B-Disease_disorder
failure NN I-Disease_disorder
and CC O
ventricular JJ B-Biological_structure
tachycardia NN B-Sign_symptom
for IN B-Duration
years NNS I-Duration
despite IN O
receiving VBG O
the DT O
conventional JJ B-Therapeutic_procedure
treatment NN I-Therapeutic_procedure
( ( O
ie JJ O
, , O
furosemide RB B-Medication
, , O
lisinopril JJ B-Medication
hydrate NN I-Medication
, , O
pimobendan NN B-Medication
, , O
warfarin JJ B-Medication
potassium NN I-Medication
, , O
carvedilol NN B-Medication
, , O
metildigoxin NN B-Medication
and CC O
amiodarone NN B-Medication
hydrochloride NN I-Medication
) ) O
. . O

His PRP$ O
height NN O
was VBD O
161 CD B-Height
cm NN I-Height
and CC O
body NN O
weight NN O
was VBD O
83 CD B-Weight
kg NN I-Weight
. . O

Blood NNP B-Diagnostic_procedure
pressure NN I-Diagnostic_procedure
was VBD O
110 CD B-Lab_value
/ JJ I-Lab_value
60 CD I-Lab_value
mm NN I-Lab_value
Hg NNP I-Lab_value
. . O

The DT O
fasting NN B-Diagnostic_procedure
blood NN I-Diagnostic_procedure
glucose NN I-Diagnostic_procedure
was VBD O
107 CD B-Lab_value
mg NN I-Lab_value
/ NNP I-Lab_value
dl NN I-Lab_value
and CC O
HbA1c NNP B-Diagnostic_procedure
was VBD O
6 CD B-Lab_value
. . I-Lab_value
3 CD I-Lab_value
% NN I-Lab_value
. . O

The DT O
chest JJS B-Biological_structure
x JJ B-Diagnostic_procedure
- : I-Diagnostic_procedure
ray NN I-Diagnostic_procedure
showed VBD O
cardiomegaly NN B-Sign_symptom
with IN O
a DT O
cardiothoracic NN B-Diagnostic_procedure
ratio NN I-Diagnostic_procedure
of IN O
0 CD B-Lab_value
. . I-Lab_value
67 CD I-Lab_value
( ( O
figure NN O
1A CD O
) ) O
. . O

ECG NNP B-Diagnostic_procedure
, , O
as IN O
shown VBN O
in IN O
video NN O
1 CD O
, , O
revealed VBD O
a DT O
diffused JJ B-Detailed_description
hypokinetic JJ B-Sign_symptom
left VBD I-Sign_symptom
ventricle NN I-Sign_symptom
with IN O
markedly RB B-Lab_value
dilated VBN I-Lab_value
left JJ B-Diagnostic_procedure
ventricle NN I-Diagnostic_procedure
dimension NN I-Diagnostic_procedure
( ( O
end VB B-Diagnostic_procedure
- : I-Diagnostic_procedure
diastole NN I-Diagnostic_procedure
: : O
95 CD B-Lab_value
mm NN I-Lab_value
) ) O
and CC O
reduced VBN B-Lab_value
EF NNP B-Diagnostic_procedure
( ( O
0 CD B-Lab_value
. . I-Lab_value
11 CD I-Lab_value
) ) O
. . O

The DT O
coronary JJ B-Biological_structure
angiogram NN B-Diagnostic_procedure
was VBD O
normal JJ B-Lab_value
. . O

A DT O
myocardial JJ B-Biological_structure
biopsy NN B-Diagnostic_procedure
revealed VBD O
that IN O
over IN B-Lab_value
50 CD I-Lab_value
% NN I-Lab_value
of IN I-Lab_value
cardiomyocytes NNS I-Lab_value
were VBD O
replaced VBN O
by IN O
fibrosis NN B-Sign_symptom
( ( O
figure JJ O
2 CD O
) ) O
. . O

An DT O
implantable JJ B-Detailed_description
cardioverter NN B-Therapeutic_procedure
- : I-Therapeutic_procedure
defibrillator NN I-Therapeutic_procedure
was VBD O
implanted VBN O
. . O

Due JJ O
to TO O
the DT O
typical JJ B-Lab_value
facial JJ B-Diagnostic_procedure
appearance NN I-Diagnostic_procedure
and CC O
thickening NN B-Sign_symptom
of IN I-Sign_symptom
hands NNS I-Sign_symptom
, , O
he PRP O
was VBD O
referred VBN O
to TO O
the DT O
endocrinology NN B-Nonbiological_location
department NN I-Nonbiological_location
. . O

The DT O
plasma JJ B-Diagnostic_procedure
level NN I-Diagnostic_procedure
of IN I-Diagnostic_procedure
GH NNP I-Diagnostic_procedure
was VBD O
8 CD B-Lab_value
. . I-Lab_value
2 CD I-Lab_value
ng JJ I-Lab_value
/ NNP I-Lab_value
ml NN I-Lab_value
and CC O
IGF NNP B-Diagnostic_procedure
- : I-Diagnostic_procedure
1 CD I-Diagnostic_procedure
was VBD O
504 CD B-Lab_value
ng JJ I-Lab_value
/ NNP I-Lab_value
ml NN I-Lab_value
. . O

MRI NNP B-Diagnostic_procedure
demonstrated VBD O
a DT O
macroadenoma NN B-Disease_disorder
in IN O
the DT O
pituitary NN B-Biological_structure
. . O

Thus RB O
, , O
he PRP O
was VBD O
diagnosed VBN O
as IN O
acromegaly NN B-Disease_disorder
. . O

He PRP O
was VBD O
treated VBN O
with IN O
octreotide NN B-Medication
long RB B-Detailed_description
- : I-Detailed_description
acting VBG I-Detailed_description
- : I-Detailed_description
release NN I-Detailed_description
( ( O
LAR NNP B-Detailed_description
) ) O
for IN O
8 CD B-Duration
months NNS I-Duration
. . O

Thereafter RB O
, , O
he PRP O
underwent VBD O
trans NNS B-Therapeutic_procedure
- : I-Therapeutic_procedure
sphenoidal NN I-Therapeutic_procedure
surgery NN I-Therapeutic_procedure
in IN O
January NNP O
2009 CD O
( ( O
figure NN O
3 CD O
) ) O
. . O

The DT O
plasma NN B-Diagnostic_procedure
levels NNS I-Diagnostic_procedure
of IN I-Diagnostic_procedure
GH NNP I-Diagnostic_procedure
and CC O
IGF NNP B-Diagnostic_procedure
- : I-Diagnostic_procedure
1 CD I-Diagnostic_procedure
were VBD O
decreased VBN B-Lab_value
with IN O
octreotide JJ B-Medication
LAR NNP B-Detailed_description
, , O
but CC O
basal VBP B-Diagnostic_procedure
plasma JJ I-Diagnostic_procedure
levels NNS I-Diagnostic_procedure
of IN I-Diagnostic_procedure
GH NNP I-Diagnostic_procedure
were VBD O
always RB O
more JJR B-Lab_value
than IN I-Lab_value
4 CD I-Lab_value
ng JJ I-Lab_value
/ NNP I-Lab_value
ml NN I-Lab_value
and CC O
plasma NN B-Diagnostic_procedure
IGF NNP I-Diagnostic_procedure
- : I-Diagnostic_procedure
1 CD I-Diagnostic_procedure
levels NNS I-Diagnostic_procedure
were VBD O
above IN B-Lab_value
the DT I-Lab_value
appropriate JJ I-Lab_value
age NN I-Lab_value
range NN I-Lab_value
( ( O
figure JJ O
3 CD O
) ) O
. . O

After IN O
surgery NN O
, , O
both DT O
plasma JJ B-Diagnostic_procedure
levels NNS I-Diagnostic_procedure
of IN I-Diagnostic_procedure
GH NNP I-Diagnostic_procedure
and CC O
IGF NNP B-Diagnostic_procedure
- : I-Diagnostic_procedure
1 CD I-Diagnostic_procedure
further RB B-Lab_value
decreased VBN I-Lab_value
. . O

Basal NNP B-Diagnostic_procedure
plasma NN I-Diagnostic_procedure
levels NNS I-Diagnostic_procedure
of IN I-Diagnostic_procedure
GH NNP I-Diagnostic_procedure
were VBD O
mostly RB B-Lab_value
less JJR I-Lab_value
than IN I-Lab_value
0 CD I-Lab_value
. . I-Lab_value
5 CD I-Lab_value
ng JJ I-Lab_value
/ NNP I-Lab_value
ml NN I-Lab_value
and CC O
IGF NNP B-Diagnostic_procedure
- : I-Diagnostic_procedure
1 CD I-Diagnostic_procedure
levels NNS O
were VBD O
within IN B-Lab_value
normal JJ I-Lab_value
ranges NNS I-Lab_value
( ( O
figure NN O
3 CD O
) ) O
. . O

With IN O
the DT O
treatment NN O
of IN O
LAR NNP O
, , O
the DT O
cardiac JJ B-Diagnostic_procedure
function NN I-Diagnostic_procedure
improved VBN B-Lab_value
partially RB I-Lab_value
( ( O
cardiothoracic JJ B-Diagnostic_procedure
ratio NN I-Diagnostic_procedure
= VBD O
0 CD B-Lab_value
. . I-Lab_value
58 CD I-Lab_value
; : O
EF NNP B-Diagnostic_procedure
= VBD O
0 CD B-Lab_value
. . I-Lab_value
20 CD I-Lab_value
in IN O
September NNP O
2008 CD O
) ) O
. . O

After IN O
surgery NN O
, , O
the DT O
cardiac JJ B-Diagnostic_procedure
function NN I-Diagnostic_procedure
improved VBN B-Lab_value
drastically RB I-Lab_value
( ( O
cardiothoracic JJ B-Diagnostic_procedure
ratio NN I-Diagnostic_procedure
= VBD O
0 CD B-Lab_value
. . I-Lab_value
47 CD I-Lab_value
; : O
EF NNP B-Diagnostic_procedure
= VBD O
0 CD B-Lab_value
. . I-Lab_value
55 CD I-Lab_value
in IN O
April NNP O
2009 CD O
; : O
figures NNS O
1B CD O
and CC O
and2B NN O
) ) O
. . O
2B CD O
) ) O
. . O

Frequency NN B-Lab_value
of IN I-Lab_value
ventricular JJ B-Biological_structure
arrhythmias NNS B-Disease_disorder
decreased VBN I-Lab_value
and CC O
pimobendan NN B-Medication
was VBD O
tapered VBN O
off RP O
. . O

-DOCSTART- NN -X-

A DT O
69 CD B-Age
- : I-Age
year NN I-Age
- : I-Age
old JJ I-Age
male JJ O
diabetic JJ O
patient NN O
was VBD O
admitted VBN O
with IN O
acute JJ B-Detailed_description
left VBD B-Disease_disorder
ventricular JJ I-Disease_disorder
( ( I-Disease_disorder
LV NNP I-Disease_disorder
) ) I-Disease_disorder
failure NN I-Disease_disorder
and CC O
was VBD O
treated VBN O
with IN O
intensive JJ B-Detailed_description
decongestive JJ B-Therapeutic_procedure
therapy NN I-Therapeutic_procedure
. . O

He PRP O
had VBD O
severe JJ B-Severity
peripheral JJ B-Biological_structure
edema NN B-Sign_symptom
and CC O
bilateral JJ B-Detailed_description
basal NN B-Detailed_description
crepitations NNS B-Sign_symptom
. . O

Initial JJ O
workup NN B-Diagnostic_procedure
revealed VBD O
normal JJ B-Lab_value
levels NNS O
of IN O
troponine NN B-Diagnostic_procedure
( ( O
< JJ B-Lab_value
0 CD I-Lab_value
. . I-Lab_value
01 CD I-Lab_value
ng JJ I-Lab_value
/ NNP I-Lab_value
ml NN I-Lab_value
) ) O
and CC O
CPK NNP B-Diagnostic_procedure
- : I-Diagnostic_procedure
MB NNP I-Diagnostic_procedure
( ( O
4 CD B-Lab_value
. . I-Lab_value
6 CD I-Lab_value
ng JJ I-Lab_value
/ NNP I-Lab_value
ml NN I-Lab_value
) ) O
, , O
thereby RB O
ruling VBG O
out RP O
acute JJ B-Disease_disorder
coronary JJ I-Disease_disorder
syndrome NN I-Disease_disorder
. . O

The DT O
level NN O
of IN O
BNP NNP B-Diagnostic_procedure
was VBD O
1230 CD B-Lab_value
pg NN I-Lab_value
/ NNP I-Lab_value
ml NN I-Lab_value
confirming VBG O
the DT O
diagnosis NN O
of IN O
heart NN B-Disease_disorder
failure NN I-Disease_disorder
. . O

Echocardiographic JJ B-Diagnostic_procedure
assessment NN I-Diagnostic_procedure
revealed VBD O
LVEF NNP B-Diagnostic_procedure
of IN O
10 CD B-Lab_value
% NN I-Lab_value
with IN O
dilated JJ B-Sign_symptom
cardiac JJ I-Sign_symptom
chambers NNS I-Sign_symptom
, , O
and CC O
estimated VBD O
pulmonary JJ B-Diagnostic_procedure
artery NN I-Diagnostic_procedure
systolic JJ I-Diagnostic_procedure
pressure NN I-Diagnostic_procedure
( ( O
PASP NNP B-Diagnostic_procedure
) ) O
was VBD O
70 CD B-Lab_value
mm NN I-Lab_value
of IN I-Lab_value
Hg NNP I-Lab_value
with IN O
features NNS B-Lab_value
of IN I-Lab_value
raised VBN I-Lab_value
LV NNP I-Lab_value
diastolic JJ I-Lab_value
pressure NN I-Lab_value
. . O

Angiography NNP B-Diagnostic_procedure
was VBD O
performed VBN O
after IN B-Duration
3 CD I-Duration
days NNS I-Duration
of IN O
decongestive JJ B-Therapeutic_procedure
therapy NN I-Therapeutic_procedure
which WDT O
revealed VBD O
critical JJ B-Severity
triple JJ B-Disease_disorder
vessel NN I-Disease_disorder
disease NN I-Disease_disorder
with IN O
left JJ B-Biological_structure
main JJ I-Biological_structure
coronary JJ B-Disease_disorder
artery NN I-Disease_disorder
disease NN I-Disease_disorder
( ( O
Fig NNP O
. . O
1 CD O
) ) O
. . O

He PRP O
was VBD O
referred VBN O
for IN O
CABG NNP B-Therapeutic_procedure
. . O

The DT O
patient NN O
was VBD O
put VBN O
on IN O
frusemide JJ B-Medication
infusion NN O
with IN O
oral JJ O
ramipril NN B-Medication
and CC O
aldactone NN B-Medication
. . O

He PRP O
was VBD O
taken VBN O
up RP O
for IN O
elective JJ O
OPCAB NNP B-Therapeutic_procedure
1 CD O
week NN O
after IN O
angiography NN O
. . O

Renal JJ B-Diagnostic_procedure
function NN I-Diagnostic_procedure
was VBD O
monitored VBN O
regularly RB O
to TO B-Detailed_description
adjust VB I-Detailed_description
diuretic JJ I-Detailed_description
dose NN I-Detailed_description
. . O

There EX O
was VBD O
no DT O
feature NN O
of IN O
end NN B-Disease_disorder
organ JJ I-Disease_disorder
dysfunction NN I-Disease_disorder
. . O

STS NNP B-Diagnostic_procedure
risk NN I-Diagnostic_procedure
of IN I-Diagnostic_procedure
mortality NN I-Diagnostic_procedure
was VBD O
2 CD B-Lab_value
. . I-Lab_value
4 CD I-Lab_value
% NN I-Lab_value
. . O

Repeat NNP O
echocardiographic JJ B-Diagnostic_procedure
assessment NN I-Diagnostic_procedure
revealed VBD O
improvement NN B-Lab_value
of IN O
LVEF NNP B-Diagnostic_procedure
to TO O
15 CD B-Lab_value
% NN I-Lab_value
and CC O
decrease NN B-Lab_value
in IN O
PASP NNP B-Diagnostic_procedure
to TO O
30 CD B-Lab_value
mm NNS I-Lab_value
Hg NNP I-Lab_value
and CC O
decrease NN B-Lab_value
in IN O
LV NNP B-Diagnostic_procedure
filling JJ I-Diagnostic_procedure
pressure NN I-Diagnostic_procedure
. . O

OPCAB NNP B-Therapeutic_procedure
was VBD O
performed VBN O
through IN O
median JJ B-Therapeutic_procedure
sternotomy NN I-Therapeutic_procedure
. . O

Left NNP B-Biological_structure
ITA NNP I-Biological_structure
was VBD O
used VBN O
for IN O
grafting VBG B-Therapeutic_procedure
left JJ B-Biological_structure
anterior JJ I-Biological_structure
descending VBG I-Biological_structure
artery NN I-Biological_structure
( ( O
LAD NNP B-Biological_structure
) ) O
. . O

After IN O
revascularizing VBG B-Therapeutic_procedure
LAD NNP B-Biological_structure
, , O
right JJ B-Biological_structure
ITA NNP I-Biological_structure
( ( O
RITA NNP B-Biological_structure
) ) O
and CC O
RA NNP B-Biological_structure
composite JJ O
, , O
graft NN B-Therapeutic_procedure
was VBD O
prepared VBN O
. . O

The DT O
distal JJ B-Biological_structure
end NN I-Biological_structure
of IN I-Biological_structure
RITA NNP I-Biological_structure
was VBD O
used VBN O
for IN O
revascularizing VBG B-Therapeutic_procedure
the DT O
diagonal JJ B-Biological_structure
artery NN I-Biological_structure
. . O

There EX O
was VBD O
significant JJ B-Detailed_description
improvement NN B-Lab_value
in IN O
systolic JJ B-Detailed_description
blood NN B-Diagnostic_procedure
pressure NN I-Diagnostic_procedure
after IN O
this DT O
distal JJ B-Detailed_description
anastomosis NN B-Therapeutic_procedure
. . O

After IN O
these DT O
two CD O
grafts NNS O
, , O
heart NN B-Biological_structure
was VBD O
lifted VBN B-Therapeutic_procedure
for IN I-Therapeutic_procedure
lateral JJ I-Therapeutic_procedure
and CC I-Therapeutic_procedure
posterior JJ I-Therapeutic_procedure
wall NN I-Therapeutic_procedure
vessels NNS I-Therapeutic_procedure
. . O

We PRP O
make VBP O
a DT O
longer JJR O
skin JJ B-Therapeutic_procedure
incision NN I-Therapeutic_procedure
, , O
open VB B-Therapeutic_procedure
the DT I-Therapeutic_procedure
sternum NN I-Therapeutic_procedure
widely RB O
, , O
and CC O
release NN B-Therapeutic_procedure
pericardium NN I-Therapeutic_procedure
on IN O
the DT O
right JJ O
side NN O
to TO O
displace VB O
the DT O
heart NN O
gradually RB O
. . O

This DT O
was VBD O
supplemented VBN O
with IN O
headlow NN B-Detailed_description
and CC O
lateral JJ B-Detailed_description
tilt JJ I-Detailed_description
position NN B-Therapeutic_procedure
. . O

Liberal JJ B-Dosage
doses NNS I-Dosage
of IN O
inotropic JJ B-Medication
support NN I-Medication
were VBD O
used VBN O
. . O

RA NNP B-Biological_structure
was VBD O
used VBN O
for IN O
sequential JJ B-Detailed_description
grafting NN B-Therapeutic_procedure
of IN O
obtuse NN B-Biological_structure
marginal JJ I-Biological_structure
, , O
posterior JJ B-Biological_structure
LV NNP I-Biological_structure
branch NN I-Biological_structure
, , O
and CC O
posterior JJ B-Biological_structure
descending NN I-Biological_structure
artery NN I-Biological_structure
. . O

All PDT O
these DT O
five CD B-Lab_value
distal NN B-Detailed_description
anastamoses NNS B-Therapeutic_procedure
were VBD O
performed VBN O
uneventfully RB O
. . O

The DT O
patient NN O
was VBD O
electively RB O
ventilated VBN B-Therapeutic_procedure
for IN O
2 CD B-Duration
days NNS I-Duration
. . O

Echocardiography NN B-Diagnostic_procedure
on IN O
1st CD O
POD NNP O
revealed VBD O
improvement NN B-Lab_value
in IN O
LVEF NNP B-Diagnostic_procedure
to TO O
20 CD B-Lab_value
% NN I-Lab_value
. . O

He PRP O
was VBD O
started VBN O
on IN O
low JJ B-Dosage
dose JJ I-Dosage
beta NN B-Medication
blockers NNS I-Medication
after IN O
inotropic NN B-Medication
supports NNS I-Medication
were VBD O
weaned VBN O
off RP O
. . O

He PRP O
had VBD O
slow JJ B-Lab_value
and CC O
uneventful JJ B-Lab_value
recovery NN O
. . O

Echocardiography NN B-Diagnostic_procedure
on IN O
4th CD O
POD NNP O
revealed VBD O
improvement NN B-Lab_value
in IN O
LVEF NNP B-Diagnostic_procedure
to TO O
30 CD B-Lab_value
% NN I-Lab_value
( ( O
Table JJ O
1 CD O
) ) O
. . O

He PRP O
had VBD O
persistent JJ B-Detailed_description
pleural JJ B-Sign_symptom
drainage NN I-Sign_symptom
requiring VBG O
prolonged VBD O
intensive JJ B-Nonbiological_location
care NN I-Nonbiological_location
unit NN I-Nonbiological_location
stay NN O
. . O

After IN O
pleural JJ B-Sign_symptom
drainage NN I-Sign_symptom
subsided VBD O
and CC O
drains NNS O
were VBD O
removed VBN O
, , O
he PRP O
was VBD O
discharged VBN O
on IN O
diuretics NNS B-Medication
, , O
low JJ B-Dosage
dose NN I-Dosage
beta NN B-Medication
blocker NN I-Medication
, , O
and CC O
ramipril NN B-Medication
. . O

-DOCSTART- NN -X-

An DT O
8 CD B-Age
- : I-Age
year NN I-Age
- : I-Age
old JJ I-Age
boy NN O
with IN O
S549R NNP O
/ NN O
1717 CD O
- : O
1G CD O
> IN O
A NNP O
genotype NN O
was VBD O
started VBN O
on IN O
ivacaftor NN B-Medication
( ( O
150 CD B-Dosage
mg NN I-Dosage
b NN I-Dosage
. . I-Dosage
i NN I-Dosage
. . I-Dosage
d NN I-Dosage
. . I-Dosage
) ) O
on IN O
compassionate NN O
use NN O
. . O

At IN O
the DT O
age NN O
of IN O
9 CD O
months NNS O
he PRP O
was VBD O
diagnosed VBN O
with IN O
CF NNP B-Disease_disorder
due JJ O
to TO O
failure VB B-Disease_disorder
to TO I-Disease_disorder
thrive VB I-Disease_disorder
. . O

His PRP$ O
previous JJ O
history NN O
was VBD O
remarkable JJ O
for IN O
recurring VBG O
nasal JJ O
polyposis NN O
requiring VBG O
endoscopic CC O
surgery NN O
and CC O
exocrine VB O
pancreatic JJ O
insufficiency NN O
necessitating VBG O
enzyme JJ O
replacement NN O
therapy NN O
. . O

He PRP O
grew VBD O
with IN O
body NN O
weight NN O
and CC O
height NN O
along IN O
the DT O
10th CD O
percentile NN O
. . O

He PRP O
suffered VBD O
from IN O
rather RB O
mild JJ B-Severity
respiratory NN B-Sign_symptom
symptoms NNS I-Sign_symptom
, , O
primarily RB O
intermittent JJ B-Detailed_description
productive JJ B-Detailed_description
cough NN B-Sign_symptom
, , O
and CC O
had VBD O
close JJ B-Lab_value
to TO I-Lab_value
normal JJ I-Lab_value
lung NN B-Diagnostic_procedure
function NN I-Diagnostic_procedure
parameters NNS O
in IN O
previous JJ O
years NNS O
as IN O
measured VBN O
by IN O
body NN B-Diagnostic_procedure
plethysmography NN I-Diagnostic_procedure
and CC O
spirometry NN B-Diagnostic_procedure
( ( O
minimal JJ B-Lab_value
z SYM I-Lab_value
- : I-Lab_value
score NN I-Lab_value
of IN I-Lab_value
FEV1 NNP I-Lab_value
: : I-Lab_value
− NN I-Lab_value
1 CD I-Lab_value
. . I-Lab_value
2 CD I-Lab_value
) ) O
. . O

Sputum NNP B-Diagnostic_procedure
cultures VBZ I-Diagnostic_procedure
grew VBD O
Haemophilus NNP B-Lab_value
influenzae NN I-Lab_value
and CC O
Staphylococcus NNP B-Lab_value
aureus VBP I-Lab_value
on IN O
several JJ B-Detailed_description
occasions NNS I-Detailed_description
. . O

After IN O
6 CD B-Duration
weeks NNS I-Duration
of IN O
ivacaftor NN B-Medication
treatment NN O
, , O
the DT O
patient NN O
reported VBD O
clinical JJ B-Lab_value
improvements NNS I-Lab_value
in IN O
cough JJ B-Sign_symptom
frequency NN O
, , O
sputum NN B-Sign_symptom
production NN I-Sign_symptom
, , O
physical JJ B-Diagnostic_procedure
performance NN I-Diagnostic_procedure
, , O
and CC O
less JJR O
salt JJ B-Sign_symptom
cravings NNS I-Sign_symptom
. . O

He PRP O
gained VBD B-Lab_value
1 CD I-Lab_value
. . I-Lab_value
4 CD I-Lab_value
kg NN I-Lab_value
in IN O
body NN B-Diagnostic_procedure
weight NN I-Diagnostic_procedure
without IN O
changing VBG O
the DT O
dose NN O
of IN O
his PRP$ O
pancreatic JJ B-Medication
enzyme NN I-Medication
replacement NN I-Medication
therapy NN O
. . O

His PRP$ O
sweat NN B-Diagnostic_procedure
chloride NN I-Diagnostic_procedure
level NN I-Diagnostic_procedure
( ( O
Macroduct NNP O
® NNP O
) ) O
decreased VBD O
from IN O
115 CD B-Lab_value
mmol NNS I-Lab_value
/ JJ I-Lab_value
l NN I-Lab_value
before IN B-Detailed_description
ivacaftor NN I-Detailed_description
to TO O
40 CD B-Lab_value
mmol NNS I-Lab_value
/ JJ I-Lab_value
l NN I-Lab_value
after IN O
6 CD O
weeks NNS O
and CC O
52 CD B-Lab_value
mmol NN I-Lab_value
/ NNP I-Lab_value
l NN I-Lab_value
after IN O
41 CD O
weeks NNS O
( ( O
normal JJ O
< $ O
30 CD O
mmol NN O
/ NNP O
l NN O
[ VBD O
11 CD O
] NNP O
) ) O
of IN O
treatment NN O
. . O

His PRP$ O
FEV1 NNP B-Diagnostic_procedure
increased VBD O
from IN O
1 CD B-Lab_value
. . I-Lab_value
25 CD I-Lab_value
L NNP I-Lab_value
( ( O
− JJ B-Lab_value
1 CD I-Lab_value
. . I-Lab_value
2 CD I-Lab_value
z SYM I-Lab_value
- : I-Lab_value
score NN I-Lab_value
) ) O
to TO O
1 CD B-Lab_value
. . I-Lab_value
65 CD I-Lab_value
L NNP I-Lab_value
( ( O
+0 NNP B-Lab_value
. . I-Lab_value
5 CD I-Lab_value
z SYM I-Lab_value
- : I-Lab_value
score NN I-Lab_value
) ) O
after IN O
41 CD O
weeks NNS O
of IN O
ivacaftor NN B-Medication
therapy NN O
. . O

The DT O
LCI NNP B-Diagnostic_procedure
( ( O
normal JJ O
< NNP O
8 CD O
) ) O
measured VBN B-Detailed_description
by IN I-Detailed_description
N2 NNP I-Detailed_description
- : I-Detailed_description
MBW NN I-Detailed_description
decreased VBD O
from IN O
14 CD B-Lab_value
. . I-Lab_value
5 CD I-Lab_value
to TO O
8 CD B-Lab_value
. . I-Lab_value
3 CD I-Lab_value
after IN O
6 CD O
weeks NNS O
and CC O
7 CD B-Lab_value
. . I-Lab_value
8 CD I-Lab_value
after IN O
41 CD O
weeks NNS O
of IN O
ivacaftor NN B-Medication
treatment NN O
( ( O
Table JJ O
1 CD O
and CC O
Fig NNP O
. . O
1 CD O
) ) O
. . O

-DOCSTART- NN -X-

This DT O
73 CD B-Age
- : I-Age
year NN I-Age
- : I-Age
old JJ I-Age
female NN O
, , O
with IN O
a DT O
history NN O
of IN O
coronary JJ O
artery NN O
disease NN O
and CC O
situs NN O
inversus NN O
, , O
had VBD O
recently RB O
noticed VBN O
left JJ B-Biological_structure
arm NN I-Biological_structure
exercise NN B-Detailed_description
weakness NN B-Sign_symptom
. . O

The DT O
magnetic JJ B-Diagnostic_procedure
resonance NN I-Diagnostic_procedure
angiogram NN I-Diagnostic_procedure
and CC O
computer NN B-Diagnostic_procedure
tomography NN I-Diagnostic_procedure
of IN O
the DT O
upper JJ B-Biological_structure
limb NN I-Biological_structure
vessels NNS I-Biological_structure
showed VBD O
critical JJ B-Severity
stenosis NN B-Sign_symptom
of IN O
the DT O
left JJ B-Biological_structure
- : I-Biological_structure
side NN I-Biological_structure
SCA NNP I-Biological_structure
with IN O
calcification NN B-Sign_symptom
near IN O
the DT O
orifice NN B-Biological_structure
( ( O
Fig NNP O
. . O
1 CD O
) ) O
. . O

Percutaneous JJ B-Detailed_description
revascularization NN B-Therapeutic_procedure
was VBD O
done VBN O
via IN O
right JJ B-Detailed_description
femoral JJ I-Detailed_description
artery NN I-Detailed_description
approach NN I-Detailed_description
, , O
and CC O
severe JJ B-Severity
left VBN B-Biological_structure
SCA NNP I-Biological_structure
stenosis NN B-Sign_symptom
was VBD O
confirmed VBN O
( ( O
Fig NNP O
. . O
2A CD O
) ) O
( ( O
Supplementary JJ O
Video NNP O
1 CD O
, , O
only RB O
online NN O
) ) O
. . O

Direct JJ B-Detailed_description
stenting NN B-Therapeutic_procedure
in IN O
the DT O
left NN B-Biological_structure
SCA NNP I-Biological_structure
was VBD O
carried VBN O
out RP O
with IN O
a DT O
balloon NN B-Detailed_description
- : I-Detailed_description
expansible JJ I-Detailed_description
Express NNP I-Detailed_description
LD NNP I-Detailed_description
10 CD I-Detailed_description
× VBD I-Detailed_description
25 CD I-Detailed_description
mm NN I-Detailed_description
stent NN I-Detailed_description
( ( O
Boston NNP B-Detailed_description
Scientific NNP I-Detailed_description
Corporation NNP I-Detailed_description
, , I-Detailed_description
Natick NNP I-Detailed_description
, , I-Detailed_description
MA NNP I-Detailed_description
, , I-Detailed_description
USA NNP I-Detailed_description
) ) O
( ( O
Fig NNP O
. . O
2B CD O
) ) O
up RB O
to TO O
8 CD B-Lab_value
atmospheres NNS I-Lab_value
for IN I-Lab_value
13 CD I-Lab_value
seconds NNS I-Lab_value
. . O

However RB O
, , O
severe JJ B-Severity
shortness NN B-Sign_symptom
of IN I-Sign_symptom
breath NN I-Sign_symptom
and CC O
hypotension NN B-Sign_symptom
developed VBD O
after IN O
stenting VBG O
. . O

The DT O
blood NN B-Diagnostic_procedure
pressure NN I-Diagnostic_procedure
was VBD O
down RB O
to TO O
88 CD B-Lab_value
/ NNS I-Lab_value
56 CD I-Lab_value
, , O
and CC O
the DT O
heart NN B-Diagnostic_procedure
rate NN I-Diagnostic_procedure
was VBD O
up RB O
to TO O
90 CD B-Lab_value
. . O

The DT O
oxygen NN B-Diagnostic_procedure
saturation NN I-Diagnostic_procedure
was VBD O
down RB O
to TO O
74 CD B-Lab_value
% NN I-Lab_value
. . O

Emergent JJ B-Detailed_description
intubation NN B-Therapeutic_procedure
, , O
fluid NN B-Therapeutic_procedure
infusion NN I-Therapeutic_procedure
, , O
inotropic JJ B-Medication
agent NN I-Medication
with IN O
norepinephrine NN B-Medication
were VBD O
given VBN O
. . O

The DT O
immediate JJ B-Detailed_description
angiography NN B-Diagnostic_procedure
showed VBD O
vascular JJ B-Sign_symptom
perforation NN I-Sign_symptom
in IN O
the DT O
stented JJ B-Biological_structure
segment NN I-Biological_structure
of IN I-Biological_structure
left JJ I-Biological_structure
SCA NNP I-Biological_structure
( ( O
Fig NNP O
. . O
2C CD O
) ) O
( ( O
Supplementary JJ O
Video NNP O
2 CD O
, , O
only RB O
online NN O
) ) O
. . O

Emergency NNP O
balloon NN B-Therapeutic_procedure
inflation NN I-Therapeutic_procedure
within IN B-Biological_structure
the DT I-Biological_structure
stent NN I-Biological_structure
was VBD O
done VBN O
with IN O
an DT O
8 CD B-Detailed_description
× NN I-Detailed_description
40 CD I-Detailed_description
mm NN I-Detailed_description
balloon NN I-Detailed_description
. . O

The DT O
cardiovascular JJ B-Nonbiological_location
surgeon NN I-Nonbiological_location
was VBD O
also RB O
consulted VBN O
. . O

However RB O
, , O
due JJ O
to TO O
the DT O
high JJ O
surgical JJ O
risk NN O
of IN O
bypass NN O
, , O
endovascular JJ B-Therapeutic_procedure
treatment NN I-Therapeutic_procedure
was VBD O
suggested VBN O
. . O

We PRP O
decided VBD O
to TO O
do VB O
a DT O
retrograde NN B-Therapeutic_procedure
approach NN I-Therapeutic_procedure
through IN O
the DT O
left JJ B-Biological_structure
brachial JJ I-Biological_structure
artery NN I-Biological_structure
by IN B-Detailed_description
surgical JJ I-Detailed_description
cut NN I-Detailed_description
- : I-Detailed_description
down RB I-Detailed_description
. . O

Since IN O
there EX O
was VBD O
no DT O
suitable JJ O
graft NN O
stent NN O
in IN O
our PRP$ O
cath NN O
lab NN O
, , O
we PRP O
modified VBD B-Detailed_description
and CC I-Detailed_description
cut VBD I-Detailed_description
the DT I-Detailed_description
iliac JJ I-Detailed_description
extension NN I-Detailed_description
of IN O
self NN B-Detailed_description
- : I-Detailed_description
expanding VBG I-Detailed_description
Endurant NNP B-Detailed_description
II NNP I-Detailed_description
graft NN I-Detailed_description
stent NN I-Detailed_description
10 CD B-Area
× NN I-Area
82 CD I-Area
mm NN I-Area
( ( O
Medtronic NNP B-Detailed_description
, , I-Detailed_description
Inc NNP I-Detailed_description
. . I-Detailed_description
, , I-Detailed_description
Minneapolis NNP I-Detailed_description
, , I-Detailed_description
MN NNP I-Detailed_description
, , I-Detailed_description
USA NNP I-Detailed_description
) ) O
, , O
which WDT O
was VBD O
originally RB O
designed VBN O
to TO O
treat VB O
abdominal JJ O
aortic JJ O
aneurysms NNS O
( ( O
AAA NNP O
) ) O
, , O
to TO O
a DT O
suitable JJ O
length NN O
( ( O
around IN B-Detailed_description
30 CD I-Detailed_description
mm NN I-Detailed_description
) ) O
( ( O
Fig NNP O
. . O
3 CD O
) ) O
. . O

After IN O
retrograde NN O
wiring NN O
, , O
an DT O
operator NN O
- : O
modified VBN O
Endurant NNP O
II NNP O
graft NN B-Therapeutic_procedure
stent NN I-Therapeutic_procedure
was VBD O
deployed VBN O
in IN O
the DT O
stent NN O
segment NN O
( ( O
Fig NNP O
. . O
2D CD O
) ) O
and CC O
the DT O
perforation NN B-Therapeutic_procedure
was VBD I-Therapeutic_procedure
sealed VBN I-Therapeutic_procedure
successfully RB O
. . O

After IN O
stenting VBG O
of IN O
the DT O
graft NN O
stent NN O
, , O
however RB O
, , O
slow JJ B-Lab_value
flow NN B-Diagnostic_procedure
of IN O
left JJ B-Biological_structure
common JJ I-Biological_structure
carotid NN I-Biological_structure
artery NN I-Biological_structure
( ( O
LCCA NNP B-Biological_structure
) ) O
was VBD O
noted VBN O
, , O
and CC O
angiography NN B-Diagnostic_procedure
confirmed VBD O
the DT O
near JJ B-Severity
total JJ I-Severity
occlusion NN B-Sign_symptom
of IN O
the DT O
LCCA NNP B-Biological_structure
, , O
occluded VBN B-Detailed_description
by IN I-Detailed_description
the DT I-Detailed_description
SCA NNP I-Detailed_description
graft NN I-Detailed_description
stent NN I-Detailed_description
( ( O
Fig NNP O
. . O
2E CD O
) ) O
( ( O
Supplementary JJ O
Video NNP O
3 CD O
, , O
only RB O
online NN O
) ) O
. . O

A DT O
firm NN B-Therapeutic_procedure
wire NN I-Therapeutic_procedure
( ( O
Conquest NNP O
pro RB O
, , O
Asahi NNP O
Inc NNP O
, , O
Seto NNP O
, , O
Japan NNP O
) ) O
was VBD O
successfully RB O
advanced JJ B-Detailed_description
outside IN B-Biological_structure
the DT I-Biological_structure
graft NN I-Biological_structure
stent NN I-Biological_structure
and CC O
into IN O
the DT O
LCCA NNP B-Biological_structure
. . O

Despite IN O
sequent JJ O
balloon NN B-Therapeutic_procedure
dilations NNS I-Therapeutic_procedure
at IN O
the DT O
bifurcation NN B-Biological_structure
site NN I-Biological_structure
, , O
the DT O
flow NN B-Diagnostic_procedure
to TO O
the DT O
LCCA NNP B-Biological_structure
was VBD O
still RB O
poor JJ B-Lab_value
. . O

Intravascular JJ B-Detailed_description
ultrasound NN B-Diagnostic_procedure
also RB O
confirmed VBD O
the DT O
severe JJ B-Severity
compromise NN B-Sign_symptom
of IN O
the DT O
LCCA NNP B-Biological_structure
ostium NN I-Biological_structure
which WDT O
was VBD O
caused VBN B-Detailed_description
by IN I-Detailed_description
the DT I-Detailed_description
graft NN I-Detailed_description
stent NN I-Detailed_description
( ( O
Fig NNP O
. . O
2F CD O
) ) O
. . O

Therefore RB O
, , O
we PRP O
put VBD O
a DT O
balloon NN B-Detailed_description
- : I-Detailed_description
expansible JJ I-Detailed_description
carotid NN B-Therapeutic_procedure
stent NN I-Therapeutic_procedure
, , O
Express NNP B-Detailed_description
7 CD I-Detailed_description
× NN I-Detailed_description
37 CD I-Detailed_description
mm NN I-Detailed_description
( ( O
Boston NNP B-Detailed_description
Scientific NNP I-Detailed_description
Corporation NNP I-Detailed_description
) ) O
, , O
from IN B-Biological_structure
the DT I-Biological_structure
LCCA NNP I-Biological_structure
to TO O
the DT O
left VBN B-Biological_structure
brachiocephalic JJ I-Biological_structure
artery NN I-Biological_structure
( ( O
Fig NNP O
. . O
4A CD O
) ) O
. . O

TIMI NNP B-Diagnostic_procedure
III NNP I-Diagnostic_procedure
flow NN I-Diagnostic_procedure
of IN O
the DT O
LCCA NNP B-Biological_structure
was VBD O
restored VBN B-Lab_value
after IN O
stenting VBG O
( ( O
Fig NNP O
. . O
4B CD O
- : O
E NN O
) ) O
( ( O
Supplementary JJ O
Video NNP O
4 CD O
, , O
only RB O
online NN O
) ) O
. . O

Intravascular JJ B-Detailed_description
ultrasound NN B-Diagnostic_procedure
also RB O
confirmed VBD O
proper JJ B-Lab_value
expansion NN B-Sign_symptom
of IN O
the DT O
LCCA NNP B-Biological_structure
stent NN I-Biological_structure
( ( O
Fig NNP O
. . O
4F CD O
) ) O
. . O

The DT O
follow NN O
- : O
up RB O
chest JJS B-Biological_structure
radiography NN B-Diagnostic_procedure
revealed VBD O
left VBD B-Detailed_description
- : I-Detailed_description
side NN I-Detailed_description
hemothorax NN B-Sign_symptom
. . O

After IN O
thoracocentesis NN B-Therapeutic_procedure
with IN O
drainage NN B-Detailed_description
and CC O
proper JJ B-Therapeutic_procedure
care NN I-Therapeutic_procedure
, , O
the DT O
patient NN O
was VBD O
discharged VBN O
. . O

Till NNP O
now RB O
, , O
the DT O
patient NN O
has VBZ O
been VBN O
free JJ O
from IN O
symptoms NNS B-Sign_symptom
for IN O
six CD B-Duration
months NNS I-Duration
. . O

-DOCSTART- NN -X-

A DT O
20 CD B-Age
- : I-Age
year NN I-Age
- : I-Age
old JJ I-Age
previously RB O
healthy JJ O
Bengali NNP O
man NN O
presented VBD O
to TO O
our PRP$ O
hospital NN B-Nonbiological_location
with IN O
anuria NNS B-Sign_symptom
and CC O
features NNS O
of IN O
uremic JJ B-Detailed_description
encephalopathy NN B-Disease_disorder
. . O

Ten CD O
days NNS O
prior RB O
to TO O
this DT O
presentation NN O
, , O
he PRP O
had VBD O
experienced VBN O
severe JJ B-Severity
upper JJ B-Biological_structure
abdominal JJ I-Biological_structure
pain NN B-Sign_symptom
and CC O
vomiting NN B-Sign_symptom
, , O
and CC O
he PRP O
had VBD O
been VBN O
treated VBN B-Therapeutic_procedure
in IN O
a DT O
primary JJ B-Nonbiological_location
care NN I-Nonbiological_location
facility NN I-Nonbiological_location
for IN O
having VBG O
a DT O
case NN O
of IN O
acute NN B-Detailed_description
pancreatitis NN B-Disease_disorder
. . O

His PRP$ O
initial JJ B-Sign_symptom
symptoms NNS I-Sign_symptom
improved VBN O
; : O
however RB O
, , O
he PRP O
gradually RB O
became VBD O
anuric JJ B-Sign_symptom
and CC O
disoriented VBN B-Sign_symptom
. . O

Then RB O
he PRP O
was VBD O
transferred VBN O
to TO O
our PRP$ O
hospital NN B-Nonbiological_location
for IN O
further JJ O
management NN O
. . O

At IN O
presentation NN O
to TO O
our PRP$ O
hospital NN O
, , O
he PRP O
was VBD O
severely RB B-Severity
agitated VBN B-Sign_symptom
, , O
restless NN B-Sign_symptom
, , O
and CC O
disoriented VBD B-Sign_symptom
. . O

He PRP O
was VBD O
tachypneic JJ B-Sign_symptom
with IN O
acidotic JJ B-Sign_symptom
breath NN I-Sign_symptom
. . O

Mild NNP B-Severity
pedal JJ B-Biological_structure
edema NN B-Sign_symptom
was VBD O
present JJ O
; : O
however RB O
, , O
his PRP$ O
jugular JJ B-Diagnostic_procedure
venous JJ I-Diagnostic_procedure
pressure NN I-Diagnostic_procedure
was VBD O
not RB B-Lab_value
raised VBN I-Lab_value
. . O

His PRP$ O
pulse NN B-Diagnostic_procedure
was VBD O
112 CD B-Lab_value
beats NNS I-Lab_value
/ VBP I-Lab_value
minute NN I-Lab_value
, , O
his PRP$ O
blood NN B-Diagnostic_procedure
pressure NN I-Diagnostic_procedure
was VBD O
140 CD B-Lab_value
/ JJ I-Lab_value
90 CD I-Lab_value
mmHg NN I-Lab_value
, , O
and CC O
his PRP$ O
body NN B-Diagnostic_procedure
temperature NN I-Diagnostic_procedure
was VBD O
98 CD B-Lab_value
°F NN I-Lab_value
. . O

Signs NNS O
of IN O
meningeal JJ B-Biological_structure
irritation NN B-Sign_symptom
were VBD O
absent JJ O
, , O
and CC O
his PRP$ O
plantar NN B-Diagnostic_procedure
response NN I-Diagnostic_procedure
was VBD O
bilaterally RB B-Lab_value
extensor JJ I-Lab_value
. . O

His PRP$ O
fundus NN B-Diagnostic_procedure
could MD B-Lab_value
not RB I-Lab_value
be VB I-Lab_value
evaluated VBN I-Lab_value
, , O
and CC O
examination NN B-Diagnostic_procedure
of IN O
his PRP$ O
other JJ B-Biological_structure
systems NNS I-Biological_structure
was VBD O
unremarkable JJ B-Lab_value
. . O

His PRP$ O
laboratory NN B-Diagnostic_procedure
parameters NNS I-Diagnostic_procedure
showed VBD O
features NNS O
of IN O
renal JJ B-Disease_disorder
dysfunction NN I-Disease_disorder
( ( O
serum JJ B-Diagnostic_procedure
creatinine NN I-Diagnostic_procedure
13 CD B-Lab_value
mg NN I-Lab_value
/ NNP I-Lab_value
dl NN I-Lab_value
, , O
serum JJ B-Diagnostic_procedure
urea JJ I-Diagnostic_procedure
293 CD B-Lab_value
mg NN I-Lab_value
/ NNP I-Lab_value
dl NN I-Lab_value
) ) O
, , O
raised VBD B-Lab_value
pancreatic JJ B-Diagnostic_procedure
enzymes NNS I-Diagnostic_procedure
( ( O
serum JJ B-Diagnostic_procedure
amylase NN I-Diagnostic_procedure
249 CD B-Lab_value
U NNP I-Lab_value
/ NNP I-Lab_value
L NNP I-Lab_value
[ NNP O
reference NN O
up RB O
to TO O
100 CD O
U NNP O
/ NNP O
L NNP O
] NNP O
, , O
serum VBD B-Diagnostic_procedure
lipase JJ I-Diagnostic_procedure
227 CD B-Lab_value
U NNP I-Lab_value
/ NNP I-Lab_value
L NNP I-Lab_value
[ NNP O
reference NN O
13 CD O
- : O
60 CD O
U NNP O
/ NNP O
L NNP O
) ) O
, , O
normal JJ B-Lab_value
liver NN B-Diagnostic_procedure
function NN I-Diagnostic_procedure
tests NNS O
( ( O
serum JJ B-Diagnostic_procedure
bilirubin NN I-Diagnostic_procedure
0 CD B-Lab_value
. . I-Lab_value
9 CD I-Lab_value
mg JJ I-Lab_value
/ NNP I-Lab_value
dl NN I-Lab_value
, , O
alanine JJ B-Diagnostic_procedure
aminotransferase NN I-Diagnostic_procedure
38 CD B-Lab_value
U NNP I-Lab_value
/ NNP I-Lab_value
L NNP I-Lab_value
, , O
aspartate JJ B-Diagnostic_procedure
aminotransferase NN I-Diagnostic_procedure
35 CD B-Lab_value
U NNP I-Lab_value
/ NNP I-Lab_value
L NNP I-Lab_value
, , O
alkaline JJ B-Diagnostic_procedure
phosphatase NN I-Diagnostic_procedure
122 CD B-Lab_value
U NNP I-Lab_value
/ NNP I-Lab_value
L NNP I-Lab_value
, , O
serum VBD B-Diagnostic_procedure
albumin RB I-Diagnostic_procedure
37 CD B-Lab_value
g NNS I-Lab_value
/ NNP I-Lab_value
L NNP I-Lab_value
) ) O
, , O
normal JJ B-Lab_value
potassium NN B-Diagnostic_procedure
( ( O
5 CD B-Lab_value
. . I-Lab_value
1 CD I-Lab_value
mmol JJ I-Lab_value
/ NNP I-Lab_value
L NNP I-Lab_value
) ) O
, , O
normal JJ B-Lab_value
bicarbonate NN B-Diagnostic_procedure
( ( O
19 CD B-Lab_value
mmol NN I-Lab_value
/ NNP I-Lab_value
L NNP I-Lab_value
) ) O
, , O
and CC O
normal JJ B-Lab_value
triglycerides NNS B-Diagnostic_procedure
( ( O
173 CD B-Lab_value
mg NN I-Lab_value
/ NNP I-Lab_value
dl NN I-Lab_value
) ) O
. . O

His PRP$ O
serological JJ B-Diagnostic_procedure
markers NNS I-Diagnostic_procedure
, , O
including VBG O
antinuclear JJ B-Diagnostic_procedure
antibodies NNS I-Diagnostic_procedure
, , O
cytoplasmic JJ B-Diagnostic_procedure
antineutrophil NN I-Diagnostic_procedure
cytoplasmic JJ I-Diagnostic_procedure
antibodies NNS I-Diagnostic_procedure
, , O
perinuclear VBP B-Diagnostic_procedure
antineutrophil JJ I-Diagnostic_procedure
cytoplasmic JJ I-Diagnostic_procedure
antibodies NNS I-Diagnostic_procedure
, , O
C3 NNP B-Diagnostic_procedure
, , O
and CC O
C4 NNP B-Diagnostic_procedure
, , O
were VBD O
within IN B-Lab_value
normal JJ I-Lab_value
limits NNS I-Lab_value
. . O

An DT O
ultrasonogram NN B-Diagnostic_procedure
of IN O
his PRP$ O
whole JJ O
abdomen NNS B-Biological_structure
was VBD O
unremarkable JJ B-Lab_value
, , O
but CC O
non SYM B-Detailed_description
- : I-Detailed_description
contrast NN I-Detailed_description
- : I-Detailed_description
enhanced VBN I-Detailed_description
computed JJ B-Diagnostic_procedure
tomography NN I-Diagnostic_procedure
( ( O
CT NNP B-Diagnostic_procedure
) ) O
findings NNS O
were VBD O
suggestive JJ O
of IN O
acute JJ B-Detailed_description
pancreatitis NN B-Disease_disorder
( ( O
Fig NNP O
. . O
1 CD O
) ) O
. . O

His PRP$ O
kidneys NNS B-Diagnostic_procedure
were VBD O
unremarkable JJ B-Lab_value
, , O
however RB O
. . O

The DT O
patient NN O
was VBD O
managed VBN O
as IN O
having VBG O
a DT O
case NN O
of IN O
AKI NNP B-Disease_disorder
and CC O
acute JJ B-Detailed_description
pancreatitis NN B-Disease_disorder
. . O

Urgent JJ B-Detailed_description
hemodialysis NN B-Therapeutic_procedure
was VBD O
initiated VBN O
. . O

After IN O
he PRP O
had VBD O
received VBN O
two CD B-Detailed_description
sessions NNS I-Detailed_description
of IN O
hemodialysis NN B-Therapeutic_procedure
, , O
his PRP$ O
level NN B-Diagnostic_procedure
of IN I-Diagnostic_procedure
consciousness NN I-Diagnostic_procedure
improved VBN B-Lab_value
, , O
but CC O
he PRP O
complained VBD O
of IN O
profound JJ B-Severity
visual JJ B-Disease_disorder
loss NN I-Disease_disorder
. . O

An DT O
assessment NN O
revealed VBD O
only RB O
perception NN B-Sign_symptom
of IN I-Sign_symptom
light NN I-Sign_symptom
. . O

A DT O
funduscopic NN B-Diagnostic_procedure
examination NN I-Diagnostic_procedure
showed VBD O
retinal JJ B-Sign_symptom
whitening NN I-Sign_symptom
and CC O
extensive JJ B-Severity
cotton NN B-Sign_symptom
wool NN I-Sign_symptom
exudates VBZ I-Sign_symptom
as RB O
well RB O
as IN O
Purtscher NNP B-Sign_symptom
` `` I-Sign_symptom
s RB I-Sign_symptom
flecken VBN I-Sign_symptom
( ( O
Fig NNP O
. . O
2 CD O
) ) O
compatible NN O
with IN O
Purtscher NNP B-Disease_disorder
` `` I-Disease_disorder
s RB I-Disease_disorder
retinopathy NN I-Disease_disorder
. . O

High JJ B-Dosage
- : I-Dosage
dose JJ I-Dosage
parenteral JJ O
methylprednisolone NN B-Medication
( ( O
1 CD B-Dosage
g NN I-Dosage
intravenously RB O
once RB B-Dosage
daily JJ I-Dosage
for IN O
3 CD B-Duration
days NNS I-Duration
) ) O
was VBD O
administered VBN O
. . O

For IN O
evaluation NN B-Diagnostic_procedure
of IN I-Diagnostic_procedure
renal JJ I-Diagnostic_procedure
dysfunction NN I-Diagnostic_procedure
, , O
a DT O
renal JJ B-Biological_structure
biopsy NN B-Diagnostic_procedure
was VBD O
done VBN O
; : O
the DT O
histopathological JJ B-Diagnostic_procedure
findings NNS I-Diagnostic_procedure
were VBD O
compatible JJ O
with IN O
renal JJ B-Disease_disorder
cortical JJ I-Disease_disorder
necrosis NN I-Disease_disorder
( ( O
Fig NNP O
. . O
3 CD O
) ) O
. . O

The DT O
patient NN O
denied VBD O
substance NN O
abuse NN O
or CC O
alcohol NN O
ingestion NN O
. . O

He PRP O
did VBD O
not RB O
consume VB O
any DT O
nephrotoxic JJ O
drugs NNS O
or CC O
herbal JJ O
products NNS O
in IN O
the DT O
recent JJ O
past NN O
. . O

No DT O
history NN O
suggesting VBG O
connective JJ O
tissue NN O
diseases NNS O
was VBD O
available JJ O
, , O
nor CC O
did VBD O
he PRP O
have VB O
a DT O
history NN O
of IN O
hypotension NN B-Sign_symptom
throughout IN O
the DT O
course NN O
of IN O
his PRP$ O
current JJ O
illness NN O
. . O

The DT O
patient NN O
was VBD O
finally RB O
diagnosed VBN O
with IN O
acute JJ B-Detailed_description
pancreatitis NN B-Disease_disorder
complicated VBN O
with IN O
renal JJ B-Disease_disorder
cortical JJ I-Disease_disorder
necrosis NN I-Disease_disorder
leading VBG O
to TO O
AKI NNP B-Disease_disorder
and CC O
Purtscher NNP B-Disease_disorder
` `` I-Disease_disorder
s RB I-Disease_disorder
retinopathy JJ I-Disease_disorder
leading VBG O
to TO O
complete VB B-Severity
bilateral JJ B-Detailed_description
blindness NN B-Disease_disorder
. . O

He PRP O
died VBD O
16 CD O
months NNS O
after IN O
his PRP$ O
initial JJ O
presentation NN O
as IN O
a DT O
result NN O
of IN O
a DT O
recurrent JJ B-Detailed_description
attack NN O
of IN O
acute JJ B-Detailed_description
pancreatitis NN B-Disease_disorder
. . O

Before IN O
that DT O
, , O
he PRP O
had VBD O
been VBN O
undergoing JJ O
maintenance NN B-Detailed_description
hemodialysis NN B-Therapeutic_procedure
; : O
however RB O
, , O
his PRP$ O
renal JJ B-Diagnostic_procedure
function NN I-Diagnostic_procedure
did VBD B-Lab_value
not RB I-Lab_value
recover VB I-Lab_value
, , O
though IN O
his PRP$ O
vision NN B-Diagnostic_procedure
was VBD O
improved VBN B-Lab_value
to TO O
finger VB B-Diagnostic_procedure
- : I-Diagnostic_procedure
counting NN I-Diagnostic_procedure
at IN O
2 CD B-Lab_value
feet NNS I-Lab_value
. . O

-DOCSTART- NN -X-

Here RB O
, , O
we PRP O
describe VBP O
another DT O
case NN O
in IN O
a DT O
60 CD B-Age
- : I-Age
year NN I-Age
- : I-Age
old JJ I-Age
man NN O
from IN O
San NNP O
Francisco NNP O
who WP O
had VBD O
consumed VBN B-Activity
raw JJ I-Activity
pork NN I-Activity
while IN O
traveling VBG B-Activity
in IN O
the DT O
Philippines NNPS B-Nonbiological_location
. . O

In IN O
June NNP O
2003 CD O
, , O
this DT O
man NN O
became VBD O
ill JJ B-Sign_symptom
with IN O
fever NN B-Sign_symptom
, , O
diaphoresis NN B-Sign_symptom
, , O
headache NN B-Sign_symptom
, , O
nausea NN B-Sign_symptom
, , O
and CC O
anorexia NN B-Sign_symptom
. . O

He PRP O
had VBD O
just RB O
returned VBN B-Activity
from IN O
a DT O
7 CD B-Duration
- : I-Duration
month NN I-Duration
vacation NN B-Activity
in IN O
the DT O
Philippines NNPS B-Nonbiological_location
. . O

Three CD O
days NNS O
after IN O
symptoms JJ O
onset NN O
, , O
his PRP$ O
physician JJ O
prescribed JJ O
doxycycline NN B-Medication
. . O

Symptoms NNP B-Sign_symptom
continued VBD I-Sign_symptom
and CC O
he PRP O
was VBD O
admitted VBN O
to TO O
a DT O
local JJ B-Nonbiological_location
hospital NN I-Nonbiological_location
5 CD O
days NNS O
later RB O
with IN O
a DT O
fever NN B-Sign_symptom
of IN O
38 CD B-Lab_value
. . I-Lab_value
9 CD I-Lab_value
°C NN I-Lab_value
, , O
nuchal JJ B-Sign_symptom
rigidity NN I-Sign_symptom
, , O
headache NN B-Sign_symptom
, , O
and CC O
general JJ O
malaise NN B-Sign_symptom
. . O

The DT O
patient NN O
described VBD O
no DT O
recent JJ O
contact NN O
with IN O
sick JJ O
persons NNS O
; : O
past JJ O
medical JJ O
history NN O
was VBD O
unremarkable JJ O
. . O

On IN O
physical JJ B-Diagnostic_procedure
examination NN I-Diagnostic_procedure
, , O
he PRP O
was VBD O
somnolent JJ B-Sign_symptom
but CC O
fully RB B-Sign_symptom
oriented VBN I-Sign_symptom
, , O
with IN O
no DT O
focal JJ B-Sign_symptom
findings NNS I-Sign_symptom
on IN O
neurologic JJ B-Diagnostic_procedure
examination NN I-Diagnostic_procedure
and CC O
only RB O
slight JJ B-Severity
nuchal JJ B-Sign_symptom
rigidity NN I-Sign_symptom
. . O

He PRP O
had VBD O
a DT O
leukocyte JJ B-Diagnostic_procedure
count NN I-Diagnostic_procedure
of IN O
21,000 CD B-Lab_value
/ JJ I-Lab_value
mm3 NN I-Lab_value
, , O
including VBG O
16,400 CD B-Lab_value
/ JJ I-Lab_value
mm3 NN I-Lab_value
neutrophils NNS B-Diagnostic_procedure
. . O

Cerebrospinal JJ B-Biological_structure
fluid NN I-Biological_structure
( ( O
CSF NNP B-Biological_structure
) ) O
showed VBD O
leukocyte JJ B-Diagnostic_procedure
count NN I-Diagnostic_procedure
of IN O
487 CD B-Lab_value
/ NNS I-Lab_value
μL VBP I-Lab_value
with IN O
80 CD B-Lab_value
% NN I-Lab_value
polymorphonuclear JJ I-Lab_value
cells NNS I-Lab_value
and CC O
18 CD B-Lab_value
% NN I-Lab_value
lymphocytes NNS I-Lab_value
, , O
and CC O
glucose NN B-Diagnostic_procedure
and CC O
protein NN B-Diagnostic_procedure
levels NNS O
< VBP B-Lab_value
20 CD I-Lab_value
mg NN I-Lab_value
/ NNP I-Lab_value
dL NN I-Lab_value
and CC O
< $ B-Lab_value
167 CD I-Lab_value
mg NN I-Lab_value
/ NNP I-Lab_value
dL NN I-Lab_value
, , O
respectively RB O
. . O

Gram NNP B-Diagnostic_procedure
stain NN I-Diagnostic_procedure
of IN O
CSF NNP B-Biological_structure
showed VBD O
gram JJ B-Sign_symptom
- : I-Sign_symptom
positive JJ I-Sign_symptom
cocci NN I-Sign_symptom
in IN I-Sign_symptom
pairs NNS I-Sign_symptom
( ( O
Figure NNP O
) ) O
. . O

Empiric JJ O
therapy NN O
( ( O
ceftriaxone NN B-Medication
, , O
vancomycin NN B-Medication
, , O
and CC O
ampicillin NN B-Medication
) ) O
for IN O
bacterial JJ B-Disease_disorder
meningitis NN I-Disease_disorder
was VBD O
begun VBN O
. . O

Computed VBN B-Diagnostic_procedure
tomographic JJ I-Diagnostic_procedure
scan NN I-Diagnostic_procedure
of IN O
the DT O
head NN B-Biological_structure
showed VBD O
only RB O
sinusitis NN B-Sign_symptom
; : O
findings NNS O
of IN O
chest NN B-Biological_structure
radiograph NN B-Diagnostic_procedure
and CC O
transesophageal JJ B-Diagnostic_procedure
echocardiogram NNS I-Diagnostic_procedure
were VBD O
negative JJ B-Lab_value
. . O

On IN O
hospital JJ O
day NN O
2 CD O
, , O
blood NN B-Diagnostic_procedure
cultures NNS I-Diagnostic_procedure
grew VBD O
gram JJ B-Sign_symptom
- : I-Sign_symptom
positive JJ I-Sign_symptom
cocci NN I-Sign_symptom
in IN O
pairs NNS B-Detailed_description
and CC O
chains NNS B-Detailed_description
. . O

The DT O
organism NN B-Sign_symptom
was VBD O
catalase JJ B-Diagnostic_procedure
- : O
negative JJ B-Lab_value
, , O
bile JJ B-Diagnostic_procedure
esculin SYM I-Diagnostic_procedure
- : O
negative JJ B-Lab_value
, , O
and CC O
pyrrolidonyl JJ B-Diagnostic_procedure
aminopeptidase NN I-Diagnostic_procedure
- : O
negative JJ B-Lab_value
, , O
consistent JJ O
with IN O
Streptococcus NNP B-Sign_symptom
spp NN I-Sign_symptom
. . O

A DT O
latex JJ B-Diagnostic_procedure
agglutination NN I-Diagnostic_procedure
test NN I-Diagnostic_procedure
did VBD O
not RB O
detect VB O
Streptococcus NNP B-Sign_symptom
pneumoniae NN I-Sign_symptom
antigen NN I-Sign_symptom
. . O

Antimicrobial JJ B-Diagnostic_procedure
susceptibility NN I-Diagnostic_procedure
testing VBG I-Diagnostic_procedure
showed VBD O
that IN O
the DT O
isolate NN O
was VBD O
sensitive JJ B-Sign_symptom
to TO I-Sign_symptom
penicillin VB I-Sign_symptom
( ( I-Sign_symptom
MIC NNP I-Sign_symptom
= NNP I-Sign_symptom
0 CD I-Sign_symptom
. . I-Sign_symptom
03 CD I-Sign_symptom
) ) I-Sign_symptom
, , I-Sign_symptom
ceftriaxone NN I-Sign_symptom
, , I-Sign_symptom
and CC I-Sign_symptom
vancomycin NNS I-Sign_symptom
but CC O
resistant JJ B-Sign_symptom
to TO I-Sign_symptom
tetracycline VB I-Sign_symptom
and CC I-Sign_symptom
clindamycin VB I-Sign_symptom
. . O

Antimicrobial JJ B-Medication
therapy NN I-Medication
was VBD O
changed VBN O
to TO O
penicillin VB B-Medication
G NNP I-Medication
, , O
24 CD B-Dosage
million CD I-Dosage
units NNS I-Dosage
intravenously RB O
per IN B-Frequency
day NN I-Frequency
. . O

On IN O
hospital JJ O
day NN O
5 CD O
, , O
the DT O
patient NN O
complained VBD O
of IN O
hearing VBG B-Sign_symptom
loss NN I-Sign_symptom
in IN O
his PRP$ O
left JJ B-Biological_structure
ear NN I-Biological_structure
. . O

Results NNS O
of IN O
nasopharyngeal JJ B-Diagnostic_procedure
endoscopy NNS I-Diagnostic_procedure
were VBD O
negative JJ B-Lab_value
. . O

By IN O
hospital JJ O
day NN O
7 CD O
, , O
the DT O
organism NN O
was VBD O
identified VBN O
by IN O
the DT O
API NNP B-Diagnostic_procedure
20 CD I-Diagnostic_procedure
Strep NNP I-Diagnostic_procedure
System NNP I-Diagnostic_procedure
( ( O
bioMerieux NN O
, , O
Marcy NNP O
l`Etoile NN O
, , O
France NNP O
) ) O
, , O
as IN O
S NNP B-Sign_symptom
. . I-Sign_symptom
suis NN I-Sign_symptom
serotype NN I-Sign_symptom
2 CD I-Sign_symptom
. . O

The DT O
patient NN O
subsequently RB O
stated VBD O
that IN O
he PRP O
was VBD O
a DT O
butcher NN B-Occupation
with IN O
a DT O
culinary JJ B-Detailed_description
preference NN I-Detailed_description
for IN I-Detailed_description
partially RB B-Other_entity
cooked VBN I-Other_entity
pork NN I-Other_entity
, , I-Detailed_description
which WDT O
he PRP O
had VBD O
eaten VBN B-Activity
in IN O
the DT O
Philippines NNPS B-Nonbiological_location
until IN O
the DT O
week NN O
prior RB O
to TO O
onset VB O
of IN O
symptoms NNS O
. . O

On IN O
hospital JJ O
day NN O
9 CD O
, , O
a DT O
formal JJ B-Diagnostic_procedure
audiology NN I-Diagnostic_procedure
evaluation NN I-Diagnostic_procedure
showed VBD O
severe JJ B-Severity
bilateral JJ B-Sign_symptom
sensorineural JJ I-Sign_symptom
high JJ I-Sign_symptom
- : I-Sign_symptom
frequency NN I-Sign_symptom
hearing NN I-Sign_symptom
loss NN I-Sign_symptom
( ( O
- : B-Lab_value
70 CD I-Lab_value
dB NN I-Lab_value
) ) O
. . O

The DT O
patient NN O
completed VBD O
a DT O
10 CD B-Duration
- : I-Duration
day NN I-Duration
course NN I-Duration
of IN O
parenteral JJ B-Medication
antimicrobial JJ I-Medication
drugs NNS I-Medication
and CC O
was VBD O
discharged VBN O
on IN O
continued JJ B-Detailed_description
oral JJ B-Medication
therapy NN I-Medication
with IN O
close JJ O
followup NNS O
. . O

Two CD O
months NNS O
after IN O
discharge NN O
, , O
the DT O
patient NN O
reported VBD O
much RB B-Sign_symptom
improved VBN I-Sign_symptom
hearing NN I-Sign_symptom
without IN O
other JJ O
sequelae NN B-Sign_symptom
. . O

-DOCSTART- NN -X-

A DT O
76 CD B-Age
- : I-Age
year NN I-Age
old JJ I-Age
woman NN O
presented VBN O
with IN O
a DT O
24 CD B-Duration
- : I-Duration
month NN I-Duration
history NN I-Duration
of IN O
enlarging VBG B-Lab_value
mass NN B-Sign_symptom
involving VBG O
the DT O
back JJ B-Biological_structure
history NN O
of IN O
trauma NN O
. . O

Physical JJ B-Diagnostic_procedure
examination NN I-Diagnostic_procedure
showed VBD O
a DT O
mass NN B-Sign_symptom
of IN O
an DT O
3x4 CD B-Area
cm NN I-Area
in IN O
diameter NN O
, , O
localized VBN O
in IN O
the DT O
right JJ B-Biological_structure
inter NN I-Biological_structure
- : I-Biological_structure
scapular JJ I-Biological_structure
region NN I-Biological_structure
. . O

The DT O
mass NN O
was VBD O
ulcerative JJ B-Detailed_description
helophytic JJ B-Detailed_description
, , O
grayish JJ B-Color
in IN O
colour NN O
, , O
hard RB B-Texture
in IN O
consistency NN O
and CC O
easily RB O
bleeding VBG B-Detailed_description
on IN I-Detailed_description
manipulation NN I-Detailed_description
. . O

The DT O
remainder NN O
of IN O
the DT O
examination NN O
was VBD O
unremarkable JJ O
; : O
no DT O
lymphadenopathy NN B-Sign_symptom
and CC O
no DT O
abdominal JJ B-Biological_structure
masses NNS B-Sign_symptom
were VBD O
felt VBN O
. . O

After IN O
resection NN B-Therapeutic_procedure
, , O
the DT O
histological JJ B-Diagnostic_procedure
examinations NNS I-Diagnostic_procedure
of IN O
the DT O
specimens NNS O
have VBP O
concluded VBN O
for IN O
basal NN B-Disease_disorder
cell NN I-Disease_disorder
carcinoma NN I-Disease_disorder
. . O

A DT O
local JJ B-Detailed_description
recurrence NN B-Sign_symptom
was VBD O
observed VBN O
18 CD O
months NNS O
later RB O
; : O
the DT O
patient NN O
was VBD O
admitted VBN O
to TO O
our PRP$ O
institution NN B-Nonbiological_location
for IN O
Lumpectomy NNP B-Therapeutic_procedure
( ( O
Figure NNP O
1 CD O
) ) O
. . O

Histopathological JJ B-Diagnostic_procedure
examination NN I-Diagnostic_procedure
revealed VBD O
a DT O
syringomatous JJ B-Sign_symptom
pattern NN I-Sign_symptom
infiltrating VBG O
the DT O
dermis NN B-Biological_structure
( ( O
Figure NNP O
2 CD O
, , O
Figure NNP O
3 CD O
) ) O
, , O
subcutis NN B-Biological_structure
and CC O
skeletal JJ B-Biological_structure
muscle NN I-Biological_structure
. . O

The DT O
neoplastic JJ O
epithelial JJ O
cells NNS O
were VBD O
arranged VBN B-Detailed_description
in IN I-Detailed_description
interconnecting VBG I-Detailed_description
cords NNS I-Detailed_description
with IN O
microcystic JJ B-Detailed_description
areas NNS I-Detailed_description
. . O

Nests NNS O
, , O
cords NNS O
, , O
and CC O
tubules NNS O
of IN O
the DT O
tumour NN B-Sign_symptom
extended VBD O
into IN O
the DT O
dermis NN B-Biological_structure
and CC O
into IN O
the DT O
adjacent JJ B-Biological_structure
muscle NN I-Biological_structure
. . O

Many JJ O
lobules NNS B-Sign_symptom
showed VBD O
squamous JJ B-Detailed_description
differentiation NN I-Detailed_description
. . O

Sclerosis NN B-Sign_symptom
of IN O
stroma NN B-Biological_structure
around IN I-Biological_structure
the DT I-Biological_structure
cords NNS I-Biological_structure
was VBD O
present JJ O
. . O

Tumour CD B-Sign_symptom
cells NNS I-Sign_symptom
were VBD O
not RB O
connected VBN O
to TO O
the DT O
epidermis NN B-Biological_structure
. . O

The DT O
immunohistochemical JJ B-Diagnostic_procedure
analysis NN I-Diagnostic_procedure
showed VBD O
positivity NN B-Lab_value
for IN O
anti JJ B-Diagnostic_procedure
- : I-Diagnostic_procedure
CK7 NNP I-Diagnostic_procedure
( ( O
Figure NNP O
4 CD O
) ) O
, , O
AE1 NNP B-Diagnostic_procedure
/ NNP I-Diagnostic_procedure
AE3 NNP I-Diagnostic_procedure
and CC O
negativity NN B-Lab_value
for IN O
anti JJ B-Diagnostic_procedure
CEA NNP I-Diagnostic_procedure
and CC O
anti JJ B-Diagnostic_procedure
CK20 NNP I-Diagnostic_procedure
. . O

Based VBN O
upon IN O
her PRP$ O
histological JJ O
and CC O
immunohistochemical JJ O
presentation NN O
, , O
the DT O
diagnosis NN O
of IN O
syringomatous JJ B-Disease_disorder
eccrine NN I-Disease_disorder
carcinoma NN I-Disease_disorder
was VBD O
established VBN O
. . O

Radiotherapy NN B-Therapeutic_procedure
of IN O
the DT O
involved JJ O
area NN O
was VBD O
performed VBN O
( ( O
70 CD B-Dosage
Gy NNP I-Dosage
, , I-Dosage
35 CD I-Dosage
sessions NNS I-Dosage
) ) O

-DOCSTART- NN -X-

This DT O
case NN O
report NN O
was VBD O
approved VBN O
by IN O
the DT O
Review NNP O
Board NNP O
of IN O
Shandong NNP O
Power NNP O
Central NNP O
Hospital NNP O
and CC O
the DT O
patient NN O
` `` O
s JJ O
parents NNS O
signed VBD O
informed JJ O
consent NN O
for IN O
publication NN O
of IN O
the DT O
case NN O
report NN O
and CC O
any DT O
accompanying JJ O
images NNS O
. . O

A DT O
4 CD B-Age
- : I-Age
year NN I-Age
- : I-Age
old JJ I-Age
female JJ O
child NN O
presented VBN O
at IN O
the DT O
outpatients NNS B-Nonbiological_location
department NN I-Nonbiological_location
with IN O
slowly RB B-Detailed_description
enlarging VBG I-Detailed_description
, , O
painless NN B-Detailed_description
, , O
symmetrical JJ B-Detailed_description
swelling NN B-Sign_symptom
of IN O
both DT B-Biological_structure
cheeks NNS I-Biological_structure
. . O

When WRB O
the DT O
girl NN O
was VBD O
approximately RB O
2 CD O
years NNS O
old JJ O
, , O
the DT O
parents NNS O
noticed VBD O
a DT O
change NN B-Sign_symptom
in IN I-Sign_symptom
her PRP$ I-Sign_symptom
facial JJ I-Sign_symptom
symmetry NN I-Sign_symptom
, , O
which WDT O
later RB O
became VBD O
more RBR O
obvious JJ O
. . O

On IN O
palpation NN B-Diagnostic_procedure
, , O
the DT O
swellings NNS B-Sign_symptom
were VBD O
bony JJ B-Detailed_description
and CC O
hard JJ B-Detailed_description
in IN O
consistency NN O
. . O

The DT O
skin NN B-Biological_structure
over IN O
the DT O
swelling NN B-Sign_symptom
was VBD O
smooth JJ B-Texture
and CC O
freely RB B-Detailed_description
movable JJ I-Detailed_description
, , O
with IN O
no DT B-Lab_value
increase NN I-Lab_value
in IN O
temperature NN B-Diagnostic_procedure
( ( O
Fig NNP O
. . O
1 CD O
) ) O
. . O

There EX O
was VBD O
no DT O
history NN O
of IN O
any DT O
trauma NN O
, , O
pain NN O
, , O
pus NN O
discharge NN O
, , O
blood NN O
discharge NN O
, , O
fever NN O
, , O
paresthesia NN O
, , O
anorexia NN O
, , O
or CC O
weight JJ O
loss NN O
. . O

No DT O
significant JJ O
family NN O
history NN O
was VBD O
reported VBN O
. . O

Panoramic NNP B-Detailed_description
radiography NN B-Diagnostic_procedure
revealed VBD O
involvement NN B-Sign_symptom
of IN O
both CC O
the DT O
mandible NN B-Biological_structure
and CC O
the DT O
maxilla NN B-Biological_structure
, , O
and CC O
showed VBD O
a DT O
soap NN B-Shape
bubble JJ I-Shape
- : I-Shape
like IN I-Shape
multilocular JJ B-Detailed_description
radiolucency NN B-Sign_symptom
with IN O
thin JJ B-Detailed_description
and CC I-Detailed_description
expanded JJ I-Detailed_description
cortices NNS I-Detailed_description
. . O

Unerupted VBN B-Sign_symptom
teeth NNS I-Sign_symptom
included VBD O
: : O
15 CD B-Biological_structure
, , I-Biological_structure
25 CD I-Biological_structure
, , I-Biological_structure
35 CD I-Biological_structure
, , I-Biological_structure
37 CD I-Biological_structure
, , I-Biological_structure
45 CD I-Biological_structure
, , O
and CC O
47 CD B-Biological_structure
was VBD O
impacted VBN B-Sign_symptom
( ( O
Fig NNP O
. . O
2 CD O
) ) O
. . O

Multislice NNP B-Detailed_description
computed VBD B-Diagnostic_procedure
tomography NN I-Diagnostic_procedure
showed VBD O
the DT O
presence NN O
of IN O
multilocular JJ B-Detailed_description
cystic JJ B-Detailed_description
lesions NNS B-Sign_symptom
filled VBN O
with IN O
soft JJ B-Detailed_description
- : I-Detailed_description
tissue NN I-Detailed_description
density NN I-Detailed_description
material NN I-Detailed_description
and CC O
dental JJ B-Biological_structure
anomalies NNS B-Sign_symptom
affecting VBG O
the DT O
body NN B-Biological_structure
and CC I-Biological_structure
the DT I-Biological_structure
sides NNS I-Biological_structure
of IN I-Biological_structure
the DT I-Biological_structure
mandible JJ I-Biological_structure
. . O

Similar JJ O
lesions NNS B-Sign_symptom
were VBD O
also RB O
observed VBN O
in IN O
the DT O
maxilla NN B-Biological_structure
( ( O
Fig NNP O
. . O
3 CD O
) ) O
. . O

A DT O
biopsy NN B-Diagnostic_procedure
was VBD O
obtained VBN O
from IN O
the DT O
central JJ B-Biological_structure
area NN I-Biological_structure
of IN I-Biological_structure
the DT I-Biological_structure
left NN I-Biological_structure
rami NN I-Biological_structure
. . O

Histologic NNP B-Diagnostic_procedure
examination NN I-Diagnostic_procedure
showed VBD O
many JJ B-Detailed_description
large JJ B-Detailed_description
multinucleated VBN B-Detailed_description
giant JJ B-Sign_symptom
cells NNS I-Sign_symptom
in IN O
a DT O
loose JJ B-Detailed_description
, , O
delicate JJ B-Detailed_description
fibrillar JJ B-Detailed_description
connective JJ B-Biological_structure
tissue NN I-Biological_structure
stroma NN I-Biological_structure
containing VBG O
large JJ B-Biological_structure
numbers NNS I-Biological_structure
of IN I-Biological_structure
fibroblasts NNS I-Biological_structure
and CC O
many JJ B-Biological_structure
small JJ I-Biological_structure
blood NN I-Biological_structure
vessels NNS I-Biological_structure
( ( O
Fig NNP O
. . O
4 CD O
) ) O
. . O

As IN O
the DT O
child NN O
grows VBZ O
older JJR O
, , O
the DT O
lesions NNS O
often RB O
become VBP O
static JJ O
and CC O
may MD O
show VB O
regression NN O
at IN O
puberty NN O
. . O

In IN O
the DT O
current JJ O
case NN O
, , O
no DT O
surgical JJ B-Therapeutic_procedure
intervention NN I-Therapeutic_procedure
was VBD O
under IN O
taken VBN O
and CC O
the DT O
patient NN O
was VBD O
followed VBN O
up RP O
at IN O
regular JJ B-Detailed_description
intervals NNS I-Detailed_description
. . O

-DOCSTART- NN -X-

A DT O
28 CD B-Age
- : I-Age
year NN I-Age
- : I-Age
old JJ I-Age
woman NN O
was VBD O
referred VBN O
with IN O
a DT O
4 CD B-Duration
- : I-Duration
week NN I-Duration
history NN O
of IN O
continuous JJ B-Detailed_description
, , O
moderate JJ B-Severity
right NN B-Biological_structure
upper NN I-Biological_structure
quadrant NN I-Biological_structure
pain NN B-Sign_symptom
associated VBN O
with IN O
jaundice NN B-Sign_symptom
, , O
as RB O
well RB O
as IN O
weight JJ B-Sign_symptom
loss NN I-Sign_symptom
( ( O
10 CD B-Lab_value
kg NN I-Lab_value
over IN O
3 CD B-Duration
months NNS I-Duration
) ) O
and CC O
a DT O
liver JJ B-Biological_structure
mass NN B-Sign_symptom
identified VBN O
by IN O
ultrasonography NN B-Diagnostic_procedure
. . O

The DT O
pain NN O
sensation NN O
seemed VBD O
different JJ B-Lab_value
from IN O
previous JJ O
colicky NN B-Sign_symptom
attacks VBZ I-Sign_symptom
the DT O
patient NN O
had VBD O
experienced VBN O
before IN O
she PRP O
underwent JJ O
laparoscopic JJ B-Detailed_description
cholecystectomy NN B-Therapeutic_procedure
7 CD O
years NNS O
previously RB O
. . O

On IN O
physical JJ B-Diagnostic_procedure
examination NN I-Diagnostic_procedure
, , O
she PRP O
was VBD O
obese JJ B-Sign_symptom
( ( O
body JJ B-Diagnostic_procedure
mass NN I-Diagnostic_procedure
index NN I-Diagnostic_procedure
37 CD B-Lab_value
. . I-Lab_value
8 CD I-Lab_value
) ) O
, , O
with IN O
icterus NN B-Sign_symptom
noted VBN O
over IN O
the DT O
conjunctivae NN B-Biological_structure
, , O
oral JJ B-Biological_structure
mucosa NN I-Biological_structure
and CC O
skin NN B-Biological_structure
. . O

Imaging VBG O
modalities NNS O
included VBD O
computed VBN B-Diagnostic_procedure
tomography NN I-Diagnostic_procedure
( ( O
CT NNP B-Diagnostic_procedure
) ) O
, , O
positron JJ B-Diagnostic_procedure
emission NN I-Diagnostic_procedure
tomography NN I-Diagnostic_procedure
( ( O
PET NNP B-Diagnostic_procedure
) ) O
and CC O
endoscopic $ B-Diagnostic_procedure
cholangiopancreatography NN I-Diagnostic_procedure
( ( O
ERCP NNP B-Diagnostic_procedure
) ) O
( ( O
Fig NNP O
. . O
1 CD O
) ) O
. . O

The DT O
patient JJ O
underwent JJ O
exploratory JJ B-Detailed_description
laparotomy NN B-Diagnostic_procedure
. . O

Intraoperative JJ B-Detailed_description
ultrasonography NN B-Diagnostic_procedure
revealed VBD O
a DT O
cystic JJ B-Detailed_description
lesion NN B-Sign_symptom
measuring VBG O
3 CD B-Area
. . I-Area
5 CD I-Area
2 CD I-Area
. . I-Area
5 CD I-Area
cm NN I-Area
within IN O
the DT O
central JJ B-Biological_structure
portion NN I-Biological_structure
of IN I-Biological_structure
the DT I-Biological_structure
liver NN I-Biological_structure
, , O
anterior RB B-Biological_structure
to TO I-Biological_structure
the DT I-Biological_structure
porta NN I-Biological_structure
hepatis NN I-Biological_structure
. . O

Intraoperative JJ B-Detailed_description
cholangiography NN B-Diagnostic_procedure
demonstrated VBD O
an DT O
extensive JJ B-Severity
stricture NN B-Sign_symptom
obliterating VBG O
the DT O
left JJ B-Biological_structure
hepatic JJ I-Biological_structure
duct NN I-Biological_structure
, , O
with IN O
partial JJ B-Severity
occlusion NN B-Sign_symptom
of IN O
the DT O
right JJ B-Biological_structure
hepatic JJ I-Biological_structure
duct NN I-Biological_structure
. . O

An DT O
extended JJ B-Detailed_description
left NN B-Detailed_description
lobectomy NN B-Therapeutic_procedure
was VBD O
done VBN O
en JJ B-Detailed_description
bloc NN I-Detailed_description
with IN I-Detailed_description
the DT I-Detailed_description
biliary JJ I-Detailed_description
confluence NN I-Detailed_description
. . O

On IN O
frozen JJ B-Diagnostic_procedure
- : I-Diagnostic_procedure
section NN I-Diagnostic_procedure
examination NN I-Diagnostic_procedure
, , O
all DT O
margins NNS B-Diagnostic_procedure
of IN I-Diagnostic_procedure
the DT I-Diagnostic_procedure
excised JJ I-Diagnostic_procedure
specimen NNS I-Diagnostic_procedure
were VBD O
free JJ B-Lab_value
of IN I-Lab_value
malignant JJ I-Lab_value
cells NNS I-Lab_value
. . O

Reconstruction NN B-Therapeutic_procedure
was VBD O
performed VBN O
with IN O
a DT O
Roux NNP B-Detailed_description
- : I-Detailed_description
en SYM I-Detailed_description
- : I-Detailed_description
Y PRP$ I-Detailed_description
cholangiojejunostomy NN B-Therapeutic_procedure
to TO O
3 CD B-Biological_structure
second JJ I-Biological_structure
bile NN I-Biological_structure
duct NN I-Biological_structure
radicals NNS I-Biological_structure
in IN O
the DT O
right JJ B-Detailed_description
side NN I-Detailed_description
. . O

Intraoperatively RB O
, , O
radiotherapy NN B-Therapeutic_procedure
was VBD O
applied VBN O
to TO O
the DT O
surgical JJ B-Biological_structure
margins NNS I-Biological_structure
. . O

After IN O
this DT O
, , O
the DT O
patient JJ O
underwent JJ O
6 CD B-Duration
weeks NNS I-Duration
of IN O
image NN B-Detailed_description
- : I-Detailed_description
guided VBD I-Detailed_description
external JJ B-Detailed_description
beam NN I-Detailed_description
radiation NN B-Therapeutic_procedure
centred VBD O
on IN O
the DT O
resection NN B-Biological_structure
field NN I-Biological_structure
labelled VBD O
at IN O
surgery NN O
. . O

The DT O
final JJ O
pathology NN O
described VBD O
this DT O
tumour NN O
as IN O
an DT O
infiltrating NN B-Detailed_description
, , O
moderately RB B-Lab_value
differentiated VBD B-Detailed_description
squamous JJ B-Disease_disorder
cell NN I-Disease_disorder
carcinoma NN I-Disease_disorder
associated VBN O
with IN O
severe JJ B-Severity
dysplasia NN B-Disease_disorder
of IN O
the DT O
bile NN B-Biological_structure
- : I-Biological_structure
duct NN I-Biological_structure
epithelium NN I-Biological_structure
( ( O
Fig NNP O
. . O
2 CD O
) ) O
. . O

The DT O
patient NN O
recovered VBD B-Sign_symptom
without IN O
complications NNS B-Sign_symptom
and CC O
was VBD O
doing VBG B-Sign_symptom
well RB I-Sign_symptom
18 CD O
months NNS O
after IN O
the DT O
initial JJ O
surgical JJ O
procedure NN O
, , O
with IN O
an DT O
unremarkable JJ B-Lab_value
CT NNP B-Diagnostic_procedure
scan NN I-Diagnostic_procedure
. . O

-DOCSTART- NN -X-

A DT O
28 CD B-Age
- : I-Age
year NN I-Age
- : I-Age
old JJ I-Age
African JJ O
American NNP O
woman NN O
presented VBD O
to TO O
the DT O
R NNP B-Nonbiological_location
Adams NNP I-Nonbiological_location
Cowley NNP I-Nonbiological_location
Shock NNP I-Nonbiological_location
Trauma NNP I-Nonbiological_location
Center NNP I-Nonbiological_location
in IN O
Baltimore NNP B-Nonbiological_location
, , I-Nonbiological_location
Maryland NNP I-Nonbiological_location
, , O
for IN O
evaluation NN B-Diagnostic_procedure
of IN O
right JJ B-Detailed_description
- : I-Detailed_description
sided VBN I-Detailed_description
paralysis NN B-Disease_disorder
and CC O
left VBD B-Detailed_description
- : I-Detailed_description
sided VBN I-Detailed_description
paresthesias NN B-Sign_symptom
after IN O
being VBG O
found VBD O
down RB B-Detailed_description
in IN O
her PRP$ O
home NN B-Nonbiological_location
between IN B-Detailed_description
her PRP$ I-Detailed_description
nightstand NN I-Detailed_description
and CC I-Detailed_description
her PRP$ I-Detailed_description
bed NN I-Detailed_description
. . O

The DT O
symptoms NNS O
began VBD O
after IN O
eating VBG B-Activity
at IN O
a DT O
local JJ B-Nonbiological_location
restaurant NN I-Nonbiological_location
chain NN I-Nonbiological_location
, , O
consuming VBG B-Activity
alcohol NN I-Activity
, , O
and CC O
smoking VBG B-Activity
one CD O
cigarette NN B-Detailed_description
dipped VBD O
in IN O
liquid JJ B-Detailed_description
phencyclidine NN B-Detailed_description
( ( O
PCP NNP B-Detailed_description
) ) O
. . O

She PRP O
was VBD O
asymptomatic JJ B-Sign_symptom
that IN B-Time
night NN I-Time
and CC O
went VBD B-Activity
to TO I-Activity
bed VB I-Activity
without IN O
complications NNS B-Sign_symptom
. . O

She PRP O
was VBD O
found VBN O
down RB B-Detailed_description
next JJ B-Nonbiological_location
to TO I-Nonbiological_location
the DT I-Nonbiological_location
bed NN I-Nonbiological_location
the DT B-Time
following JJ I-Time
morning NN I-Time
unable JJ B-Sign_symptom
to TO I-Sign_symptom
move VB I-Sign_symptom
. . O

The DT O
patient NN O
denied VBD O
any DT O
physical JJ B-Disease_disorder
trauma NN I-Disease_disorder
other JJ O
than IN O
falling VBG B-Sign_symptom
from IN O
the DT O
bed NN O
. . O

She PRP O
had VBD O
no DT O
history NN O
of IN O
seizures NNS O
, , O
sickle NN O
cell NN O
anemia NN O
, , O
fever NN O
, , O
urinary JJ O
or CC O
bowel JJ O
incontinence NN O
, , O
or CC O
pain NN O
. . O

The DT O
patient NN O
had VBD O
a DT O
history NN O
of IN O
viral JJ B-Disease_disorder
meningitis NN I-Disease_disorder
without IN B-Detailed_description
residual JJ I-Detailed_description
deficits NNS I-Detailed_description
eight CD O
years NNS O
prior RB O
, , O
gastric JJ O
bypass NN O
surgery NN O
, , O
and CC O
cholecystectomy NN O
, , O
and CC O
she PRP O
was VBD O
treated VBN B-Therapeutic_procedure
for IN O
a DT O
presumed JJ O
urinary JJ B-Disease_disorder
tract NN I-Disease_disorder
infection NN I-Disease_disorder
five CD O
days NNS O
prior RB O
to TO O
admission NN O
at IN O
an DT O
outside JJ B-Nonbiological_location
institution NN I-Nonbiological_location
. . O

Her PRP$ O
triage NN O
vital JJ B-Diagnostic_procedure
signs NNS I-Diagnostic_procedure
were VBD O
as IN O
follows VBZ O
: : O
temperature NN B-Diagnostic_procedure
36 CD B-Lab_value
. . I-Lab_value
8 CD I-Lab_value
°C NN I-Lab_value
, , O
blood NN B-Diagnostic_procedure
pressure NN I-Diagnostic_procedure
155 CD B-Lab_value
/ NN I-Lab_value
100 CD I-Lab_value
mm NN I-Lab_value
Hg NNP I-Lab_value
, , O
heart NN B-Diagnostic_procedure
rate NN I-Diagnostic_procedure
90 CD B-Lab_value
beats NNS I-Lab_value
per IN I-Lab_value
minute NN I-Lab_value
, , O
respiratory NN B-Diagnostic_procedure
rate NN I-Diagnostic_procedure
16 CD B-Lab_value
breaths NNS I-Lab_value
per IN I-Lab_value
minute NN I-Lab_value
, , O
and CC O
an DT O
oxygen NN B-Diagnostic_procedure
saturation NN I-Diagnostic_procedure
of IN O
95 CD B-Lab_value
% NN I-Lab_value
on IN O
room NN B-Detailed_description
air NN I-Detailed_description
. . O

On IN O
physical JJ B-Diagnostic_procedure
exam NN I-Diagnostic_procedure
, , O
the DT O
patient NN O
was VBD O
alert JJ B-Sign_symptom
and CC O
oriented VBN B-Sign_symptom
to TO O
person NN B-Detailed_description
, , O
place NN B-Detailed_description
, , O
and CC O
time NN B-Detailed_description
. . O

Her PRP$ O
cranial JJ B-Diagnostic_procedure
nerves NNS I-Diagnostic_procedure
II NNP I-Diagnostic_procedure
- : I-Diagnostic_procedure
XII NN I-Diagnostic_procedure
were VBD O
grossly RB B-Lab_value
intact JJ I-Lab_value
. . O

She PRP O
had VBD O
2 CD B-Lab_value
/ JJ I-Lab_value
5 CD I-Lab_value
strength NN B-Diagnostic_procedure
in IN O
her PRP$ O
right JJ B-Biological_structure
lower JJR I-Biological_structure
extremity NN I-Biological_structure
, , O
3 CD B-Lab_value
/ NN I-Lab_value
5 CD I-Lab_value
in IN O
her PRP$ O
left JJ B-Biological_structure
lower JJR I-Biological_structure
extremity NN I-Biological_structure
, , O
and CC O
4 CD B-Lab_value
/ NNS I-Lab_value
5 CD I-Lab_value
bilaterally RB B-Biological_structure
in IN I-Biological_structure
her PRP$ I-Biological_structure
upper JJ I-Biological_structure
extremities NNS I-Biological_structure
. . O

Her PRP$ O
sensation NN B-Diagnostic_procedure
was VBD O
intact JJ B-Lab_value
. . O

She PRP O
opened VBD B-Lab_value
her PRP O
eyes NNS B-Diagnostic_procedure
spontaneously RB B-Detailed_description
, , O
her PRP O
verbal JJ B-Diagnostic_procedure
response NN I-Diagnostic_procedure
was VBD O
oriented VBN B-Lab_value
and CC O
appropriate JJ B-Lab_value
, , O
and CC O
she PRP O
obeyed VBD B-Lab_value
commands NNS B-Diagnostic_procedure
, , O
resulting VBG O
in IN O
a DT O
Glasgow NNP B-Diagnostic_procedure
Coma NNP I-Diagnostic_procedure
Scale NNP I-Diagnostic_procedure
score NN O
of IN O
15 CD B-Lab_value
. . O

Pupils NNS B-Diagnostic_procedure
were VBD O
equal JJ B-Detailed_description
, , O
round NN B-Shape
, , O
and CC O
reactive JJ B-Lab_value
to TO I-Lab_value
light NN I-Lab_value
. . O

She PRP O
had VBD O
tenderness NN B-Sign_symptom
to TO O
palpation NN B-Detailed_description
over IN O
the DT O
cervical JJ B-Biological_structure
, , O
thoracic NN B-Biological_structure
, , O
and CC O
lumbar NN B-Biological_structure
spine NN B-Biological_structure
without IN O
obvious JJ O
external JJ O
signs NNS B-Sign_symptom
of IN I-Sign_symptom
trauma NN I-Sign_symptom
. . O

Her PRP$ O
anal JJ B-Diagnostic_procedure
sphincter NN I-Diagnostic_procedure
tone NN I-Diagnostic_procedure
was VBD O
intact JJ B-Lab_value
. . O

Multiple JJ O
laboratory NN B-Diagnostic_procedure
abnormalities NNS B-Lab_value
were VBD O
noted VBN O
on IN O
admission NN O
, , O
including VBG O
hyperlactemia NN B-Sign_symptom
, , O
elevated VBD B-Lab_value
liver JJ B-Diagnostic_procedure
function NN I-Diagnostic_procedure
tests NNS O
, , O
and CC O
electrolyte JJ B-Sign_symptom
derangements NNS I-Sign_symptom
. . O

Her PRP$ O
complete JJ B-Diagnostic_procedure
blood NN I-Diagnostic_procedure
count NN I-Diagnostic_procedure
and CC O
remainder NN O
of IN O
her PRP$ O
complete JJ B-Diagnostic_procedure
metabolic JJ I-Diagnostic_procedure
panel NN I-Diagnostic_procedure
were VBD O
within IN B-Lab_value
normal JJ I-Lab_value
limits NNS I-Lab_value
. . O

These DT B-Other_entity
values NNS I-Other_entity
are VBP I-Other_entity
summarized VBN I-Other_entity
along IN I-Other_entity
with IN I-Other_entity
reference NN I-Other_entity
ranges NNS I-Other_entity
in IN I-Other_entity
Table JJ I-Other_entity
1 CD I-Other_entity
. . O

Her PRP$ O
toxicology NN B-Diagnostic_procedure
screen NN I-Diagnostic_procedure
was VBD O
positive JJ B-Lab_value
for IN O
PCP NNP B-Diagnostic_procedure
. . O

Blood NN B-Diagnostic_procedure
cultures NNS I-Diagnostic_procedure
drawn VBN O
on IN O
admission NN O
grew VBD O
the DT O
aerobic JJ B-Detailed_description
bacteria NNS I-Detailed_description
Salmonella NNP B-Disease_disorder
enterica VBD I-Disease_disorder
serotype JJ B-Detailed_description
4,12 CD I-Detailed_description
: : I-Detailed_description
i NN I-Detailed_description
, , O
and CC O
then RB O
repeat NN B-Diagnostic_procedure
cultures NNS I-Diagnostic_procedure
drawn VBN O
two CD O
days NNS O
later RB O
grew VBD O
group NN B-Detailed_description
B NNP I-Detailed_description
streptococcus NN B-Disease_disorder
( ( O
aerobic JJ B-Detailed_description
and CC O
non JJ B-Detailed_description
- : I-Detailed_description
aerobic NN I-Detailed_description
) ) O
. . O

Subsequent JJ O
blood NN B-Diagnostic_procedure
cultures NNS I-Diagnostic_procedure
were VBD O
negative JJ B-Lab_value
, , O
as IN O
were VBD O
stool JJ B-Diagnostic_procedure
cultures NNS I-Diagnostic_procedure
. . O

Metronidazole NNP B-Medication
and CC O
vancomycin JJ B-Medication
therapy NN O
was VBD O
initiated VBN O
empirically RB O
, , O
with IN O
transition NN O
to TO O
ceftriaxone VB B-Medication
upon IN O
learning NN O
of IN O
the DT O
culture NN O
results NNS O
. . O

In IN O
addition NN O
, , O
she PRP O
had VBD O
a DT O
detailed JJ O
autoimmunity NN B-Diagnostic_procedure
workup NN I-Diagnostic_procedure
including VBG O
anti JJ B-Diagnostic_procedure
- : I-Diagnostic_procedure
nuclear JJ I-Diagnostic_procedure
antibody NN I-Diagnostic_procedure
( ( O
ANA NNP B-Diagnostic_procedure
) ) O
and CC O
HLA NNP B-Diagnostic_procedure
- : I-Diagnostic_procedure
B27 NNP I-Diagnostic_procedure
, , O
all DT O
of IN O
which WDT O
returned VBD O
within IN B-Lab_value
normal JJ I-Lab_value
limits NNS I-Lab_value
. . O

Admission NNP O
computerized VBD B-Diagnostic_procedure
tomography JJ I-Diagnostic_procedure
scan NN O
of IN O
her PRP$ O
cervical JJ B-Biological_structure
, , O
thoracic NN B-Biological_structure
, , O
and CC O
lumbar JJS B-Biological_structure
spine NN B-Biological_structure
revealed VBD O
no DT O
spinal JJ B-Biological_structure
fractures NNS B-Disease_disorder
. . O

Magnetic JJ B-Diagnostic_procedure
resonance NN I-Diagnostic_procedure
imaging NN I-Diagnostic_procedure
( ( O
MRI NNP B-Diagnostic_procedure
) ) O
revealed VBD O
no DT O
acute JJ O
intracranial JJ B-Biological_structure
abnormalities NNS B-Sign_symptom
, , O
but CC O
enhancement NN B-Diagnostic_procedure
within IN I-Diagnostic_procedure
the DT I-Diagnostic_procedure
central JJ I-Diagnostic_procedure
aspect NN I-Diagnostic_procedure
of IN I-Diagnostic_procedure
C3 NNP I-Diagnostic_procedure
- : I-Diagnostic_procedure
T2 NN I-Diagnostic_procedure
suggested VBD O
spinal JJ B-Biological_structure
cord NN I-Biological_structure
edema NN B-Sign_symptom
, , O
disc JJ B-Sign_symptom
protrusions NNS I-Sign_symptom
at IN O
C3 NNP B-Biological_structure
- : I-Biological_structure
4 CD I-Biological_structure
, , O
C4 NNP B-Biological_structure
- : I-Biological_structure
5 CD I-Biological_structure
, , O
and CC O
C5 NNP B-Biological_structure
- : I-Biological_structure
6 CD I-Biological_structure
, , O
and CC O
bilateral JJ B-Biological_structure
posterior JJ I-Biological_structure
neck NN I-Biological_structure
muscle NN I-Biological_structure
edema NN B-Sign_symptom
. . O

A DT O
lumbar NN B-Therapeutic_procedure
puncture NN I-Therapeutic_procedure
was VBD O
not RB O
initially RB O
performed VBN O
upon IN O
patient JJ O
admission NN O
due JJ O
to TO O
concerns NNS O
about IN O
raised VBN O
intracranial JJ O
pressure NN O
from IN O
suspected VBN O
trauma NN O
. . O

Four CD B-Time
hours NNS I-Time
after IN I-Time
presentation NN O
, , O
her PRP$ O
strength NN B-Diagnostic_procedure
had VBD O
progressively RB O
deteriorated VBN B-Lab_value
to TO O
1 CD B-Lab_value
/ NNS I-Lab_value
5 CD I-Lab_value
in IN O
all DT B-Biological_structure
extremities NNS I-Biological_structure
. . O

She PRP O
lost VBD B-Lab_value
proprioception NN B-Diagnostic_procedure
in IN O
her PRP$ O
toes NNS B-Biological_structure
bilaterally RB B-Detailed_description
and CC O
developed VBD O
absent JJ B-Lab_value
anal JJ B-Diagnostic_procedure
sphincter NN I-Diagnostic_procedure
tone NN I-Diagnostic_procedure
. . O

The DT O
patient NN O
was VBD O
admitted VBN O
to TO O
the DT O
neurotrauma JJ B-Nonbiological_location
intensive JJ I-Nonbiological_location
care NN I-Nonbiological_location
unit NN I-Nonbiological_location
with IN O
further JJ O
deterioration NN O
ultimately RB O
requiring VBG O
endotracheal JJ B-Detailed_description
intubation NN B-Therapeutic_procedure
due JJ O
to TO O
respiratory JJ B-Disease_disorder
failure NN I-Disease_disorder
. . O

Upon IN O
her PRP$ O
positive JJ O
blood NN O
culture NN O
results NNS O
, , O
lumbar JJ B-Therapeutic_procedure
puncture NN I-Therapeutic_procedure
was VBD O
performed VBN O
, , O
which WDT O
demonstrated VBD O
a DT O
pattern NN O
consistent JJ O
with IN O
ATM NNP B-Disease_disorder
, , O
the DT O
results NNS O
of IN O
which WDT O
are VBP O
summarized VBN O
in IN O
Table JJ O
2 CD O
. . O

An DT O
extensive JJ O
workup NN B-Diagnostic_procedure
for IN I-Diagnostic_procedure
infectious JJ I-Diagnostic_procedure
etiologies NNS I-Diagnostic_procedure
was VBD O
also RB O
completed VBN O
, , O
with IN O
the DT O
results NNS O
summarized VBD O
in IN O
Table JJ O
3 CD O
. . O

Plasma NNP B-Therapeutic_procedure
exchange NN I-Therapeutic_procedure
therapy NN I-Therapeutic_procedure
was VBD O
initiated VBN O
with IN O
a DT O
suspected JJ O
diagnosis NN O
of IN O
ATM NNP B-Disease_disorder
. . O

Despite IN O
maximal JJ B-Detailed_description
medical JJ O
therapy NN B-Therapeutic_procedure
, , O
the DT O
patient NN O
remains VBZ O
quadriplegic JJ B-Disease_disorder
, , O
is VBZ O
experiencing VBG O
neurologic JJ B-Biological_structure
pain NN B-Sign_symptom
, , O
received VBD O
a DT O
tracheostomy NN B-Therapeutic_procedure
due JJ O
to TO O
prolonged JJ B-Detailed_description
respiratory NN B-Disease_disorder
failure NN I-Disease_disorder
, , O
and CC O
required VBD O
a DT O
feeding JJ O
jejunostomy NN B-Therapeutic_procedure
tube NN I-Therapeutic_procedure
placement NN O
at IN O
the DT O
time NN O
of IN O
this DT O
report NN O
. . O

-DOCSTART- NN -X-

A DT O
46 CD B-Age
- : I-Age
year NN I-Age
- : I-Age
old JJ I-Age
woman NN O
with IN O
a DT O
history NN O
of IN O
Graves NNP O
` `` O
disease NN O
( ( O
GD NNP O
) ) O
was VBD O
transferred VBN O
to TO O
our PRP$ O
emergency NN B-Nonbiological_location
department NN I-Nonbiological_location
on IN O
suspicion NN O
of IN O
DKA NNP B-Disease_disorder
. . O

She PRP O
had VBD O
noticed VBN O
polydipsia NN B-Sign_symptom
, , O
polyuria NN B-Sign_symptom
, , O
and CC O
fatigue VB B-Sign_symptom
approximately RB O
four CD B-Duration
months NNS I-Duration
prior RB I-Duration
to TO I-Duration
admission NN I-Duration
. . O

She PRP O
had VBD O
also RB O
been VBN O
suffering VBG O
from IN O
a DT O
1 CD B-Duration
- : I-Duration
month NN I-Duration
complaint NN O
of IN O
appetite JJ B-Sign_symptom
loss NN I-Sign_symptom
, , O
approximately RB O
7 CD B-Lab_value
kg NNS I-Lab_value
weight JJ B-Sign_symptom
loss NN I-Sign_symptom
, , O
fatigue NN B-Sign_symptom
, , O
nausea NN B-Sign_symptom
, , O
and CC O
sweating NN B-Sign_symptom
. . O

Her PRP$ O
medical JJ O
history NN O
included VBD O
GD NNP B-Disease_disorder
, , O
diagnosed VBD O
at IN O
42 CD O
years NNS O
of IN O
age NN O
and CC O
managed VBD O
with IN O
methimazole NN B-Medication
. . O

However RB O
, , O
she PRP O
had VBD O
poor JJ B-Lab_value
compliance NN I-Lab_value
with IN O
anti JJ B-Medication
- : I-Medication
thyroid NN I-Medication
drugs NNS I-Medication
. . O

She PRP O
denied VBD O
a DT O
family NN O
history NN O
of IN O
thyroid JJ O
diseases NNS O
or CC O
diabetes NNS O
. . O

Three CD O
days NNS O
before IN O
admission NN O
, , O
she PRP O
was VBD O
also RB O
diagnosed VBN O
with IN O
influenza NN B-Disease_disorder
A NNP I-Disease_disorder
at IN O
a DT O
nearby JJ B-Nonbiological_location
hospital NN I-Nonbiological_location
, , O
and CC O
oseltamivir JJ B-Medication
phosphate NN I-Medication
was VBD O
prescribed VBN O
. . O

At IN O
the DT O
emergency NN B-Nonbiological_location
department NN I-Nonbiological_location
, , O
she PRP O
presented VBD O
with IN O
drowsiness NN B-Sign_symptom
and CC O
a DT O
body NN B-Diagnostic_procedure
temperature NN I-Diagnostic_procedure
of IN O
37 CD B-Lab_value
. . I-Lab_value
0 CD I-Lab_value
℃ NN I-Lab_value
, , O
blood NN B-Diagnostic_procedure
pressure NN I-Diagnostic_procedure
of IN O
90 CD B-Lab_value
/ JJ I-Lab_value
60 CD I-Lab_value
mmHg NN I-Lab_value
, , O
heart NN B-Diagnostic_procedure
rate NN I-Diagnostic_procedure
of IN O
200 CD B-Lab_value
bpm NN I-Lab_value
, , O
respiratory JJ B-Diagnostic_procedure
rate NN I-Diagnostic_procedure
of IN O
32 CD B-Lab_value
breaths NNS I-Lab_value
/ JJ I-Lab_value
min NN I-Lab_value
, , O
oxygen JJ B-Diagnostic_procedure
saturation NN I-Diagnostic_procedure
of IN O
99 CD B-Lab_value
% NN I-Lab_value
in IN O
5 CD B-Lab_value
L NNP I-Lab_value
nasal NN I-Lab_value
air NN I-Lab_value
, , O
and CC O
a DT O
Glasgow NNP B-Diagnostic_procedure
coma NN I-Diagnostic_procedure
scale NN I-Diagnostic_procedure
( ( O
GCS NNP B-Diagnostic_procedure
) ) O
score NN O
of IN O
14 CD B-Lab_value
. . O

Her PRP$ O
clinical JJ B-Diagnostic_procedure
examination NN I-Diagnostic_procedure
revealed VBD O
a DT O
diffuse NN B-Detailed_description
goiter NN B-Sign_symptom
with IN O
bilateral JJ B-Detailed_description
exophthalmoses NNS I-Detailed_description
. . O

Her PRP$ O
lungs NNS B-Biological_structure
were VBD O
clear JJ B-Lab_value
when WRB O
auscultated VBN B-Diagnostic_procedure
. . O

Her PRP$ O
abdomen NNS B-Biological_structure
was VBD O
soft JJ B-Lab_value
and CC O
non JJ O
- : O
tender NN B-Sign_symptom
. . O

Her PRP$ O
skin NN B-Biological_structure
was VBD O
warm JJ B-Lab_value
and CC O
wet NN B-Lab_value
. . O

She PRP O
had VBD O
no DT O
lower JJR B-Biological_structure
extremity NN I-Biological_structure
edema NN B-Sign_symptom
. . O

The DT O
electrocardiogram NN B-Diagnostic_procedure
showed VBD O
marked JJ B-Detailed_description
tachycardia NN B-Sign_symptom
with IN O
atrial JJ B-Disease_disorder
fibrillation NN I-Disease_disorder
, , O
and CC O
a DT O
chest NN B-Biological_structure
radiograph NN B-Diagnostic_procedure
was VBD O
normal JJ B-Lab_value
. . O

The DT O
laboratory NN B-Diagnostic_procedure
data NNS I-Diagnostic_procedure
are VBP O
shown VBN O
in IN O
Table JJ O
1 CD O
. . O

Her PRP$ O
initial JJ O
laboratory NN B-Diagnostic_procedure
data NNS I-Diagnostic_procedure
demonstrated VBD O
marked JJ O
metabolic JJ B-Sign_symptom
acidosis NN I-Sign_symptom
, , O
an DT O
increased VBN B-Lab_value
plasma NN B-Diagnostic_procedure
glucose JJ I-Diagnostic_procedure
level NN O
of IN O
472 CD B-Lab_value
mg NNS I-Lab_value
/ JJ I-Lab_value
dL NN I-Lab_value
, , O
an DT O
increased VBN B-Lab_value
HbA1c NNP B-Diagnostic_procedure
level NN O
of IN O
13 CD B-Lab_value
. . I-Lab_value
7 CD I-Lab_value
% NN I-Lab_value
, , O
an DT O
increased VBN B-Lab_value
free JJ B-Diagnostic_procedure
triiodothyronine NN I-Diagnostic_procedure
level NN O
of IN O
6 CD B-Lab_value
. . I-Lab_value
440 CD I-Lab_value
pg JJ I-Lab_value
/ NNP I-Lab_value
mL NN I-Lab_value
, , O
and CC O
a DT O
free JJ B-Diagnostic_procedure
thyroxine NN I-Diagnostic_procedure
level NN O
of IN O
2 CD B-Lab_value
. . I-Lab_value
830 CD I-Lab_value
ng JJ I-Lab_value
/ NNP I-Lab_value
dL NN I-Lab_value
, , O
with IN O
a DT O
suppressed JJ B-Diagnostic_procedure
thyrotropin NN I-Diagnostic_procedure
( ( O
TSH NNP O
) ) O
level NN O
of IN O
0 CD B-Lab_value
. . I-Lab_value
005 CD I-Lab_value
μIU JJ I-Lab_value
/ NNP I-Lab_value
mL NN I-Lab_value
. . O

She PRP O
scored VBD O
55 CD B-Lab_value
on IN O
the DT O
diagnostic JJ B-Diagnostic_procedure
criteria NNS I-Diagnostic_procedure
of IN I-Diagnostic_procedure
Burch NNP I-Diagnostic_procedure
& CC I-Diagnostic_procedure
Wartofsky NNP I-Diagnostic_procedure
for IN I-Diagnostic_procedure
thyroid JJ I-Diagnostic_procedure
storm NN I-Diagnostic_procedure
, , O
and CC O
the DT O
diagnostic JJ B-Diagnostic_procedure
criteria NNS I-Diagnostic_procedure
of IN I-Diagnostic_procedure
the DT I-Diagnostic_procedure
Japan NNP I-Diagnostic_procedure
Thyroid NNP I-Diagnostic_procedure
Association NNP I-Diagnostic_procedure
for IN I-Diagnostic_procedure
thyroid JJ I-Diagnostic_procedure
storm NN I-Diagnostic_procedure
were VBD O
also RB O
satisfied VBN B-Lab_value
, , O
since IN O
she PRP O
had VBD O
thyrotoxicosis NN B-Disease_disorder
, , O
symptoms NNS B-Sign_symptom
involving VBG I-Sign_symptom
the DT I-Sign_symptom
central JJ I-Sign_symptom
nervous JJ I-Sign_symptom
system NN I-Sign_symptom
, , O
tachycardia NN B-Sign_symptom
, , O
and CC O
gastrointestinal JJ B-Sign_symptom
symptoms NNS I-Sign_symptom
( ( O
4 CD O
) ) O
. . O

Accordingly RB O
, , O
she PRP O
was VBD O
diagnosed VBN O
with IN O
DKA NNP B-Disease_disorder
and CC O
thyroid JJ B-Disease_disorder
storm NN I-Disease_disorder
and CC O
admitted VBN O
to TO O
the DT O
medical JJ B-Nonbiological_location
intensive JJ I-Nonbiological_location
care NN I-Nonbiological_location
unit NN I-Nonbiological_location
for IN O
further JJ O
monitoring NN B-Diagnostic_procedure
and CC O
treatment NN B-Therapeutic_procedure
. . O

The DT O
clinical JJ O
course NN O
is VBZ O
shown VBN O
in IN O
Figure NNP O
. . O

She PRP O
was VBD O
treated VBN O
with IN O
an DT O
intravenous JJ O
insulin NN B-Medication
drip NN O
and CC O
aggressive JJ B-Detailed_description
intravenous JJ O
fluid NN B-Therapeutic_procedure
therapy NN I-Therapeutic_procedure
. . O

The DT O
thyroid JJ B-Disease_disorder
storm NN I-Disease_disorder
with IN O
GD NNP B-Disease_disorder
was VBD O
treated VBN O
with IN O
intravenous JJ O
hydrocortisone NN B-Medication
100 CD B-Dosage
mg NN I-Dosage
every DT I-Dosage
8 CD I-Dosage
hours NNS I-Dosage
, , O
oral JJ O
potassium NN B-Medication
iodine NN I-Medication
50 CD B-Dosage
mg NN I-Dosage
every DT I-Dosage
6 CD I-Dosage
hours NNS I-Dosage
, , O
and CC O
oral JJ O
methimazole NN B-Medication
20 CD B-Dosage
mg NN I-Dosage
every DT I-Dosage
6 CD I-Dosage
hours NNS I-Dosage
. . O

Since IN O
she PRP O
had VBD O
a DT O
history NN O
of IN O
asthma NN O
, , O
landiolol JJ B-Medication
hydrochloride NN I-Medication
, , O
a DT O
short JJ O
- : O
acting VBG O
beta SYM O
- : O
adrenoceptor NN O
blocker NN O
, , O
was VBD O
used VBN O
at IN O
4 CD B-Dosage
- : I-Dosage
12 CD I-Dosage
μg JJ I-Dosage
/ NNP I-Dosage
kg NN I-Dosage
/ NNP I-Dosage
min NN I-Dosage
to TO O
control VB O
her PRP$ O
heart NN O
rate NN O
. . O

By IN O
Day NNP O
3 CD O
, , O
her PRP$ O
tachycardia NN B-Sign_symptom
had VBD O
resolved VBN O
, , O
and CC O
landiolol JJ B-Medication
hydrochloride NN I-Medication
was VBD O
discontinued VBN O
. . O

On IN O
Day NNP O
6 CD O
, , O
the DT O
white JJ B-Diagnostic_procedure
blood NN I-Diagnostic_procedure
cell NN I-Diagnostic_procedure
count NN I-Diagnostic_procedure
had VBD O
decreased VBN O
to TO O
2,800 CD B-Lab_value
cells NNS I-Lab_value
/ JJ I-Lab_value
mm3 JJ I-Lab_value
[ NN O
neutrophils NNS B-Lab_value
, , I-Lab_value
44 CD I-Lab_value
. . I-Lab_value
2 CD I-Lab_value
% NN I-Lab_value
( ( I-Lab_value
1,238 CD I-Lab_value
cells NNS I-Lab_value
/ JJ I-Lab_value
mm3 NN I-Lab_value
) ) I-Lab_value
] NN O
. . O

Methimazole NNP B-Medication
was VBD O
discontinued VBN O
because IN O
methimazole JJ B-Detailed_description
- : I-Detailed_description
induced JJ I-Detailed_description
neutropenia NN B-Sign_symptom
was VBD O
suspected VBN O
. . O

The DT O
patient NN O
was VBD O
referred VBN O
to TO O
an DT O
endocrine NN B-Nonbiological_location
surgeon NN I-Nonbiological_location
, , O
and CC O
thyroidectomy NN B-Therapeutic_procedure
was VBD O
performed VBN O
on IN O
Day NNP O
32 CD O
. . O

She PRP O
was VBD O
discharged VBN O
from IN O
the DT O
hospital NN B-Nonbiological_location
on IN O
Day NNP O
37 CD O
and CC O
maintained VBD O
on IN O
multiple JJ B-Dosage
daily JJ I-Dosage
insulin NN B-Medication
infusion NN O
and CC O
levothyroxine JJ B-Medication
sodium NN I-Medication
hydrate NN I-Medication
. . O

Further RB O
immunological JJ B-Diagnostic_procedure
investigation NN I-Diagnostic_procedure
revealed VBD O
elevated JJ B-Lab_value
levels NNS I-Lab_value
of IN O
anti JJ B-Diagnostic_procedure
- : I-Diagnostic_procedure
glutamic JJ I-Diagnostic_procedure
acid JJ I-Diagnostic_procedure
decarboxylase NN I-Diagnostic_procedure
( ( I-Diagnostic_procedure
GAD NNP I-Diagnostic_procedure
) ) I-Diagnostic_procedure
antibody NN I-Diagnostic_procedure
, , O
anti SYM B-Diagnostic_procedure
- : I-Diagnostic_procedure
insulinoma NN I-Diagnostic_procedure
antigen NN I-Diagnostic_procedure
2 CD I-Diagnostic_procedure
( ( I-Diagnostic_procedure
IA NNP I-Diagnostic_procedure
- : I-Diagnostic_procedure
2 CD I-Diagnostic_procedure
) ) I-Diagnostic_procedure
antibody NN I-Diagnostic_procedure
, , O
and CC O
insulin NN B-Diagnostic_procedure
autoantibody NN I-Diagnostic_procedure
, , O
consistent JJ O
with IN O
T1D NNP B-Disease_disorder
. . O

The DT O
intravenous JJ B-Diagnostic_procedure
glucagon NN I-Diagnostic_procedure
stimulation NN I-Diagnostic_procedure
test NN I-Diagnostic_procedure
was VBD O
performed VBN O
with IN O
blood NN B-Biological_structure
samples NNS I-Biological_structure
for IN B-Detailed_description
glucose NN I-Detailed_description
and CC I-Detailed_description
C NNP I-Detailed_description
- : I-Detailed_description
peptide NN I-Detailed_description
taken VBN I-Detailed_description
at IN I-Detailed_description
baseline NN I-Detailed_description
and CC I-Detailed_description
6 CD I-Detailed_description
minutes NNS I-Detailed_description
. . O

Her PRP$ O
plasma NN B-Diagnostic_procedure
glucose NN I-Diagnostic_procedure
levels NNS O
were VBD O
139 CD B-Lab_value
and CC O
152 CD B-Lab_value
mg NN I-Lab_value
/ NN I-Lab_value
dL NN I-Lab_value
at IN O
baseline NN B-Detailed_description
and CC O
6 CD B-Detailed_description
minutes NNS I-Detailed_description
, , O
respectively RB O
. . O

The DT O
corresponding JJ O
serum NN B-Diagnostic_procedure
C NNP I-Diagnostic_procedure
- : I-Diagnostic_procedure
peptide NN I-Diagnostic_procedure
levels NNS O
were VBD O
0 CD B-Lab_value
. . I-Lab_value
8 CD I-Lab_value
and CC O
1 CD B-Lab_value
. . I-Lab_value
3 CD I-Lab_value
ng JJ I-Lab_value
/ NN I-Lab_value
mL NN I-Lab_value
at IN O
baseline NN B-Detailed_description
and CC O
6 CD B-Detailed_description
minutes NNS I-Detailed_description
, , O
respectively RB O
. . O

-DOCSTART- NN -X-

A DT O
60 CD B-Age
- : I-Age
year NN I-Age
- : I-Age
old JJ I-Age
man NN O
presented VBN O
with IN O
a DT O
retroperitoneal JJ B-Biological_structure
metastatic JJ B-Sign_symptom
lymph NN B-Biological_structure
node NN I-Biological_structure
in IN O
magnetic JJ B-Diagnostic_procedure
resonance NN I-Diagnostic_procedure
( ( O
MR NNP B-Diagnostic_procedure
) ) O
imaging VBG O
with IN O
a DT O
history NN O
of IN O
right JJ B-Biological_structure
liver NN I-Biological_structure
resection NN B-Therapeutic_procedure
in IN O
2010 CD O
, , O
pulmonary JJ B-Biological_structure
wedge NN I-Biological_structure
resection NN B-Therapeutic_procedure
in IN O
2012 CD O
, , O
and CC O
transarterial JJ B-Therapeutic_procedure
chemoembolization NN I-Therapeutic_procedure
twice RB B-Detailed_description
in IN O
2014 CD O
, , O
in IN O
which WDT O
the DT O
postoperative NN O
pathology NN B-Diagnostic_procedure
suggested VBD O
the DT O
mixed JJ B-Detailed_description
liver NN B-Disease_disorder
cancer NN I-Disease_disorder
, , O
and CC O
poorly RB B-Detailed_description
differentiated VBN I-Detailed_description
lung NN B-Disease_disorder
cancer NN I-Disease_disorder
from IN O
liver JJ B-Biological_structure
metastasis NN B-Sign_symptom
. . O

At IN O
examination NN B-Diagnostic_procedure
, , O
the DT O
tumor NN O
was VBD O
very RB O
close RB O
to TO O
the DT O
duodenum NN B-Biological_structure
, , O
pancreas NNS B-Biological_structure
, , O
stomach NN B-Biological_structure
, , O
and CC O
hepatic JJ B-Biological_structure
portal NN I-Biological_structure
vein NN I-Biological_structure
. . O

The DT O
patient NN O
with IN O
unresectable JJ B-Detailed_description
masses NNS B-Sign_symptom
had VBD O
hypertension NN B-Sign_symptom
over IN O
10 CD B-Duration
years NNS I-Duration
and CC O
chronic JJ B-Detailed_description
HBV NNP B-Disease_disorder
- : I-Disease_disorder
related JJ I-Disease_disorder
cirrhosis NN I-Disease_disorder
for IN O
30 CD B-Duration
years NNS I-Duration
when WRB O
he PRP O
was VBD O
treated VBN O
with IN O
lamivudine JJ B-Medication
100 CD B-Dosage
mg NN I-Dosage
qd NN I-Dosage
, , O
and CC O
adefovir RB B-Medication
dipivoxil VB I-Medication
10 CD B-Dosage
mg NNS I-Dosage
qd NN I-Dosage
for IN O
6 CD B-Duration
years NNS I-Duration
. . O

He PRP O
kept VBD O
a DT O
constant JJ B-Lab_value
body NN B-Diagnostic_procedure
temperature NN I-Diagnostic_procedure
of IN O
37 CD B-Lab_value
°C NNS I-Lab_value
, , O
the DT O
blood NN B-Diagnostic_procedure
pressure NN I-Diagnostic_procedure
of IN O
148 CD B-Lab_value
/ JJ I-Lab_value
96 CD I-Lab_value
mm NN I-Lab_value
Hg NNP I-Lab_value
, , O
and CC O
the DT O
pulse NN B-Diagnostic_procedure
of IN O
77 CD B-Lab_value
beats NNS I-Lab_value
every DT I-Lab_value
minute NN I-Lab_value
. . O

The DT O
patient NN O
had VBD O
no DT O
obvious JJ O
sense NN O
of IN O
abdominal JJ B-Biological_structure
pain NN B-Sign_symptom
, , O
abdominal JJ B-Biological_structure
distention NN B-Sign_symptom
, , O
nausea NN B-Sign_symptom
, , O
and CC O
vomiting NN B-Sign_symptom
. . O

On IN O
a DT O
test NN O
of IN O
tumor NN B-Diagnostic_procedure
markers NNS I-Diagnostic_procedure
levels NNS O
, , O
the DT O
results NNS O
were VBD O
normal JJ B-Lab_value
, , O
which WDT O
showed VBD O
carcinoembryonic JJ B-Diagnostic_procedure
antigen NN I-Diagnostic_procedure
3 CD B-Lab_value
. . I-Lab_value
7 CD I-Lab_value
ng JJ I-Lab_value
/ NNP I-Lab_value
mL NN I-Lab_value
, , O
alpha JJ B-Diagnostic_procedure
fetoprotein NN I-Diagnostic_procedure
17 CD B-Lab_value
. . I-Lab_value
3 CD I-Lab_value
ng JJ I-Lab_value
/ NNP I-Lab_value
mL NN I-Lab_value
, , O
and CC O
carbohydrate VB B-Diagnostic_procedure
antigen NN I-Diagnostic_procedure
19 CD I-Diagnostic_procedure
- : I-Diagnostic_procedure
9 CD I-Diagnostic_procedure
levels NNS O
6 CD B-Lab_value
. . I-Lab_value
1 CD I-Lab_value
U NNP I-Lab_value
/ NNP I-Lab_value
mL NN I-Lab_value
. . O

In IN O
this DT O
study NN O
, , O
the DT O
procedure NN O
was VBD O
approved VBN O
by IN O
the DT O
ethics NNS O
committee NN O
of IN O
the DT O
First NNP O
Affiliated NNP O
Hospital NNP O
of IN O
Zhejiang NNP O
University NNP O
. . O

The DT O
efficacy NN O
of IN O
local JJ B-Detailed_description
ablation NN B-Therapeutic_procedure
was VBD O
estimated VBN O
with IN O
Choi NNP B-Diagnostic_procedure
criteria NNS I-Diagnostic_procedure
, , O
which WDT O
appraised VBD O
the DT O
variations NNS O
both DT O
in IN O
tumor NN O
size NN O
and CC O
lesion NN O
density NN O
on IN O
computed VBN B-Diagnostic_procedure
tomography NN I-Diagnostic_procedure
( ( O
CT NNP B-Diagnostic_procedure
) ) O
imaging NN O
: : O
complete JJ B-Other_entity
response NN I-Other_entity
, , I-Other_entity
disappearance NN I-Other_entity
of IN I-Other_entity
all DT I-Other_entity
lesions NNS I-Other_entity
and CC I-Other_entity
no DT I-Other_entity
new JJ I-Other_entity
lesions NNS I-Other_entity
; : I-Other_entity
partial JJ I-Other_entity
response NN I-Other_entity
( ( I-Other_entity
PR NNP I-Other_entity
) ) I-Other_entity
, , I-Other_entity
a DT I-Other_entity
decrease NN I-Other_entity
in IN I-Other_entity
size NN I-Other_entity
of IN I-Other_entity
10 CD I-Other_entity
% NN I-Other_entity
or CC I-Other_entity
a DT I-Other_entity
decrease NN I-Other_entity
in IN I-Other_entity
tumor NN I-Other_entity
density NN I-Other_entity
over IN I-Other_entity
15 CD I-Other_entity
% NN I-Other_entity
on IN I-Other_entity
CT NNP I-Other_entity
and CC I-Other_entity
no DT I-Other_entity
new JJ I-Other_entity
lesions NNS I-Other_entity
; : I-Other_entity
stable JJ I-Other_entity
disease NN I-Other_entity
, , I-Other_entity
not RB I-Other_entity
fit VB I-Other_entity
for IN I-Other_entity
complete JJ I-Other_entity
response NN I-Other_entity
, , I-Other_entity
PR NNP I-Other_entity
, , I-Other_entity
or CC I-Other_entity
progressive JJ I-Other_entity
disease NN I-Other_entity
; : I-Other_entity
and CC I-Other_entity
progressive JJ I-Other_entity
disease NN I-Other_entity
, , I-Other_entity
an DT I-Other_entity
increase NN I-Other_entity
in IN I-Other_entity
tumor NN I-Other_entity
size NN I-Other_entity
over IN I-Other_entity
10 CD I-Other_entity
% NN I-Other_entity
and CC I-Other_entity
not RB I-Other_entity
fit VB I-Other_entity
for IN I-Other_entity
PR NNP I-Other_entity
by IN I-Other_entity
tumor NN I-Other_entity
density NN I-Other_entity
on IN I-Other_entity
CT NNP I-Other_entity
or CC I-Other_entity
new JJ I-Other_entity
lesions NNS I-Other_entity
. . O
[ $ O
19 CD O
] NN O

Preoperative JJ O
MR NNP B-Diagnostic_procedure
imaging NN O
scan NN O
showed VBD O
a DT O
mass NN B-Sign_symptom
of IN O
2 CD B-Area
. . I-Area
8 CD I-Area
× JJ I-Area
3 CD I-Area
. . I-Area
5 CD I-Area
cm NN I-Area
in IN O
size NN O
close NN O
to TO O
the DT O
duodenum NN B-Biological_structure
, , O
pancreas NNS B-Biological_structure
, , O
and CC O
blood NN B-Biological_structure
vessels NNS I-Biological_structure
( ( O
Fig NNP O
. . O
1A CD O
) ) O
. . O

During IN O
substance NN B-Detailed_description
phase NN I-Detailed_description
, , O
MR NNP B-Diagnostic_procedure
images VBZ O
indicated VBN O
mildly RB B-Severity
high JJ I-Severity
signal JJ B-Sign_symptom
intensity NN I-Sign_symptom
around IN O
the DT O
tumor NN O
and CC O
intermediate JJ B-Severity
low JJ I-Severity
signal NN B-Sign_symptom
intensity NN I-Sign_symptom
in IN O
the DT O
solid JJ B-Biological_structure
component NN I-Biological_structure
and CC O
in IN O
the DT O
walls NNS B-Biological_structure
( ( O
Fig NNP O
. . O
1B CD O
) ) O
. . O

Before IN O
the DT O
initial JJ O
ablation NN B-Therapeutic_procedure
, , O
there EX O
was VBD O
a DT O
retroperitoneal JJ B-Biological_structure
mild JJ B-Severity
hyperechoic JJ B-Sign_symptom
area NN I-Sign_symptom
on IN O
axial JJ B-Detailed_description
US NNP B-Diagnostic_procedure
image NN O
( ( O
Fig NNP O
. . O
1C CD O
) ) O
. . O

In IN O
this DT O
study NN O
, , O
the DT O
inpatient JJ O
underwent JJ O
percutaneous JJ B-Detailed_description
transhepatic JJ B-Biological_structure
biopsies NNS B-Diagnostic_procedure
and CC O
ablations NNS B-Therapeutic_procedure
to TO O
avoid VB O
the DT O
nearby JJ O
blood NN O
vessels NNS O
, , O
the DT O
procedure NN O
of IN O
which WDT O
was VBD O
performed VBN O
about IN B-Duration
40 CD I-Duration
minutes NNS I-Duration
under IN O
local JJ B-Medication
anesthesia NN I-Medication
and CC O
mild JJ O
sedation NN B-Medication
. . O

We PRP O
used VBD O
ultrasonography NN B-Diagnostic_procedure
to TO O
real JJ B-Detailed_description
- : I-Detailed_description
timely RB I-Detailed_description
guide IN O
the DT O
inserting NN O
of IN O
2 CD B-Detailed_description
Nd NN I-Detailed_description
: : I-Detailed_description
YAG NNP I-Detailed_description
laser NN B-Therapeutic_procedure
fibers NNS I-Therapeutic_procedure
( ( O
Echolaser NNP B-Detailed_description
X4 NNP I-Detailed_description
, , I-Detailed_description
ESAOTE NNP I-Detailed_description
, , I-Detailed_description
Italy NNP I-Detailed_description
) ) O
in IN O
0 CD B-Detailed_description
. . I-Detailed_description
3 CD I-Detailed_description
mm NN I-Detailed_description
diameter NN I-Detailed_description
through IN B-Detailed_description
a DT I-Detailed_description
21 CD I-Detailed_description
- : I-Detailed_description
gauge NN I-Detailed_description
Chiba NNP I-Detailed_description
needle CC I-Detailed_description
into IN O
the DT O
lesions NNS B-Sign_symptom
( ( O
Fig NNP O
. . O
1D CD O
) ) O
. . O

Although IN O
part NN O
of IN O
the DT O
heat NN O
ran VBD O
off RP O
by IN O
blood NN O
flow NN O
, , O
[ JJ O
20 CD O
] JJ O
ablation NN B-Therapeutic_procedure
could MD O
keep VB O
valid JJ O
area NN B-Detailed_description
from IN I-Detailed_description
12 CD I-Detailed_description
to TO I-Detailed_description
15 CD I-Detailed_description
mm NN I-Detailed_description
with IN O
the DT O
power NN B-Detailed_description
of IN I-Detailed_description
5 CD I-Detailed_description
W NNP I-Detailed_description
in IN O
5 CD B-Detailed_description
to TO I-Detailed_description
6 CD I-Detailed_description
minutes NNS I-Detailed_description
. . O

Subsequently RB O
, , O
immediate JJ O
ultrasonography NN B-Diagnostic_procedure
showed VBD O
that IN O
the DT O
whole JJ O
lesion NN B-Sign_symptom
was VBD O
covered VBN O
with IN O
hyperechoic JJ B-Sign_symptom
zone NN I-Sign_symptom
( ( O
Fig NNP O
. . O
( ( O
Fig NNP O
. . O
1E CD O
and CC O
F NNP O
) ) O
. . O

However RB O
, , O
the DT O
next JJ O
day NN O
contrast VBD B-Diagnostic_procedure
- : I-Diagnostic_procedure
enhanced VBN I-Diagnostic_procedure
ultrasound IN I-Diagnostic_procedure
( ( O
CEUS NNP B-Diagnostic_procedure
) ) O
revealed VBD O
an DT O
abnormal JJ B-Sign_symptom
residual NN I-Sign_symptom
of IN O
proximal JJ B-Biological_structure
part NN I-Biological_structure
of IN I-Biological_structure
the DT I-Biological_structure
pancreatic JJ I-Biological_structure
head NN I-Biological_structure
( ( O
Fig NNP O
. . O
2A CD O
) ) O
. . O

At IN O
5 CD O
- : O
day NN O
follow VB O
- : O
up IN O
contrast NN B-Detailed_description
- : I-Detailed_description
enhanced VBN I-Detailed_description
CT NNP B-Diagnostic_procedure
images NNS I-Diagnostic_procedure
, , O
the DT O
lower JJR B-Detailed_description
mass NN B-Sign_symptom
had VBD O
low JJ B-Severity
signal JJ B-Sign_symptom
intensity NN I-Sign_symptom
and CC O
upper JJ B-Detailed_description
tumor NN B-Sign_symptom
revealed VBD O
intermediate JJ B-Severity
high JJ I-Severity
signal JJ B-Sign_symptom
intensity NN I-Sign_symptom
of IN O
residual JJ B-Detailed_description
in IN I-Detailed_description
substance NN I-Detailed_description
phase NN I-Detailed_description
( ( O
Fig NNP O
. . O
2B CD O
and CC O
C NNP O
) ) O
. . O

Surprizingly RB O
, , O
1 CD O
- : O
week NN O
follow VBP O
- : O
up RB O
CEUS NNP B-Diagnostic_procedure
image NN O
showed VBD O
an DT O
enlarged JJ B-Sign_symptom
retroperitoneal NN B-Biological_structure
lymph NN B-Biological_structure
node NN I-Biological_structure
located VBN O
near IN B-Biological_structure
the DT I-Biological_structure
pancreatic JJ I-Biological_structure
head NN I-Biological_structure
, , O
which WDT O
could MD O
be VB O
fusion NN O
of IN O
these DT O
residuary JJ O
small JJ O
nodules NNS O
( ( O
Fig NNP O
. . O
2D CD O
) ) O
. . O

Then RB O
the DT O
patient NN O
undergoing VBG O
the DT O
2nd CD B-Detailed_description
ablation NN B-Therapeutic_procedure
with IN O
2 CD B-Detailed_description
laser NN B-Therapeutic_procedure
fibers NNS I-Therapeutic_procedure
showed VBD O
the DT O
lesions NNS B-Sign_symptom
well RB O
- : O
defined VBN O
hyperechoic NN B-Sign_symptom
zone NN I-Sign_symptom
( ( O
Fig NNP O
. . O
2E CD O
and CC O
F NNP O
) ) O
. . O

On IN O
the DT O
2nd CD O
day NN O
, , O
postoperative JJ O
CEUS NNP B-Diagnostic_procedure
images NNS O
showed VBD O
they PRP O
were VBD O
still RB O
remanent JJ O
( ( O
Fig NNP O
. . O
2G CD O
and CC O
I PRP O
) ) O
. . O

At IN O
the DT O
corresponding JJ O
MR NNP B-Diagnostic_procedure
imaging NN O
, , O
it PRP O
also RB O
showed VBD O
this DT O
in IN O
left NN O
of IN O
tumor NN B-Sign_symptom
( ( O
Fig NNP O
. . O
2H CD O
) ) O
. . O

Thus RB O
, , O
the DT O
3rd CD B-Detailed_description
laser NN B-Detailed_description
ablation NN B-Therapeutic_procedure
was VBD O
performed VBN O
( ( O
Fig NNP O
. . O
2J CD O
) ) O
2J CD O
) ) O
and CC O
3 CD O
days NNS O
later RB O
CEUS NNP B-Diagnostic_procedure
found VBD O
that IN O
there EX O
was VBD O
still RB O
a DT O
minor JJ B-Severity
lesion NN B-Sign_symptom
located VBN O
in IN O
the DT O
separation NN O
gap NN O
of IN O
last JJ O
2 CD O
needles NNS O
( ( O
Fig NNP O
. . O
3A CD O
) ) O
. . O

Subsequently RB O
the DT O
patient NN O
had VBD O
the DT O
4th JJ B-Detailed_description
ablation NN B-Therapeutic_procedure
along IN O
this DT O
separation NN O
gap NN O
until IN O
hyperechoic JJ O
overlay NN O
( ( O
Fig NNP O
. . O
3B CD O
- : O
D NN O
) ) O
, , O
then RB O
3 CD O
days NNS O
later RB O
, , O
based VBN O
on IN O
these DT O
4 CD O
treatments NNS O
, , O
enhanced VBD O
CT NNP B-Diagnostic_procedure
image NN O
of IN O
the DT O
retroperitoneal JJ B-Biological_structure
mass NN B-Sign_symptom
suggested VBD O
complete JJ O
necrosis NN B-Sign_symptom
( ( O
Fig NNP O
. . O
3E CD O
- : O
G NN O
) ) O
. . O
3E CD O
- : O
G NN O
) ) O
. . O

After IN O
the DT O
following JJ O
1 CD O
month NN O
, , O
substance NN O
phase NN O
MR NNP B-Diagnostic_procedure
revealed VBD O
low JJ O
- : O
intensity NN O
signal NN B-Sign_symptom
of IN I-Sign_symptom
tumor NN I-Sign_symptom
necrosis NN I-Sign_symptom
with IN O
resolution NN O
of IN O
his PRP$ O
problems NNS B-Sign_symptom
( ( O
Fig NNP O
. . O
3H CD O
) ) O
. . O

Until IN O
5 CD O
months NNS O
after IN O
4 CD O
ablations NNS O
, , O
CT NNP B-Diagnostic_procedure
showed VBD O
the DT O
tumor NN B-Sign_symptom
PR NNP O
with IN O
little JJ O
enhanced JJ O
recurrence NN B-Sign_symptom
( ( O
yellow JJ O
arrows NNS O
) ) O
, , O
which WDT O
located VBN O
in IN O
the DT O
left NN O
lower JJR O
edge NN O
of IN O
original JJ O
lesions NNS O
( ( O
Fig NNP O
. . O
4A CD O
and CC O
B NNP O
) ) O
. . O

On IN O
laboratory JJ O
test NN O
of IN O
tumor NN B-Diagnostic_procedure
markers NNS I-Diagnostic_procedure
, , O
the DT O
levels NNS O
of IN O
carcinoembryonic JJ B-Diagnostic_procedure
antigen NN I-Diagnostic_procedure
, , O
alpha JJ B-Diagnostic_procedure
fetoprotein NN I-Diagnostic_procedure
, , O
and CC O
carbohydrate VB B-Diagnostic_procedure
antigen NN I-Diagnostic_procedure
19 CD I-Diagnostic_procedure
- : I-Diagnostic_procedure
9 CD I-Diagnostic_procedure
indicated VBD O
3 CD B-Lab_value
. . I-Lab_value
6 CD I-Lab_value
ng JJ I-Lab_value
/ NNP I-Lab_value
mL NN I-Lab_value
, , O
26 CD B-Lab_value
. . I-Lab_value
7 CD I-Lab_value
ng JJ I-Lab_value
/ NNP I-Lab_value
mL NN I-Lab_value
, , O
and CC O
8 CD B-Lab_value
. . I-Lab_value
1 CD I-Lab_value
U NNP I-Lab_value
/ NNP I-Lab_value
mL NN I-Lab_value
, , O
respectively RB O
. . O

No DT O
obvious JJ O
side NN B-Sign_symptom
effects NNS I-Sign_symptom
were VBD O
discovered VBN O
in IN O
this DT O
case NN O
during IN O
these DT O
procedures NNS O
. . O

-DOCSTART- NN -X-

A DT O
65 CD B-Age
- : I-Age
year NN I-Age
- : I-Age
old JJ I-Age
man NN O
was VBD O
admitted VBN O
to TO O
the DT O
China NNP B-Nonbiological_location
- : I-Nonbiological_location
Japan NNP I-Nonbiological_location
Friendship NNP I-Nonbiological_location
hospital NN I-Nonbiological_location
with IN O
a DT O
chief JJ O
complaint NN O
of IN O
progressive JJ B-Detailed_description
dysphagia NN B-Sign_symptom
for IN O
3 CD B-Duration
mo NN I-Duration
. . O

He PRP O
also RB O
complained VBD O
of IN O
a DT O
drastic JJ B-Severity
weight NN B-Sign_symptom
loss NN I-Sign_symptom
of IN O
8 CD B-Lab_value
kg NNS I-Lab_value
in IN O
the DT O
past JJ B-Duration
2 CD I-Duration
mo NN I-Duration
. . O

He PRP O
denied VBD O
a DT O
history NN O
of IN O
smoking NN O
, , O
alcohol NN O
intake NN O
and CC O
substance NN O
abuse NN O
, , O
but CC O
had VBD O
a DT O
chronic JJ B-Detailed_description
atrophic JJ B-Detailed_description
gastritis NN B-Disease_disorder
for IN O
nearly RB B-Duration
10 CD I-Duration
years NNS I-Duration
. . O

Also RB O
, , O
there EX O
was VBD O
no DT O
family NN O
history NN O
of IN O
genetic JJ O
defect NN O
or CC O
malignancy NN O
. . O

Physical JJ B-Diagnostic_procedure
examination NN I-Diagnostic_procedure
showed VBD O
no DT B-Lab_value
palpable JJ I-Lab_value
findings NNS I-Lab_value
. . O

Admission NNP O
blood NN B-Diagnostic_procedure
test NN I-Diagnostic_procedure
showed VBD O
a DT O
slight JJ B-Lab_value
decrease NN I-Lab_value
in IN O
hemoglobin NN B-Diagnostic_procedure
( ( O
106 CD B-Lab_value
g NN I-Lab_value
/ NNP I-Lab_value
L NNP I-Lab_value
) ) O
. . O

Upper NNP B-Biological_structure
gastrointestinal NN I-Biological_structure
( ( O
GI NNP B-Biological_structure
) ) O
examination NN B-Diagnostic_procedure
using VBG O
barium NN B-Detailed_description
contrasts NNS I-Detailed_description
showed VBD O
a DT O
large JJ B-Severity
tumor NN B-Sign_symptom
blocking VBG B-Sign_symptom
the DT O
esophago JJ B-Biological_structure
- : I-Biological_structure
gastric JJ I-Biological_structure
junction NN I-Biological_structure
( ( O
Figure NNP O
1 CD O
) ) O
. . O

Computed VBN B-Diagnostic_procedure
tomography NN I-Diagnostic_procedure
( ( O
CT NNP B-Diagnostic_procedure
) ) O
scan VBP O
revealed VBD O
a DT O
soft JJ B-Texture
mass NN B-Sign_symptom
in IN O
the DT O
esophago JJ B-Biological_structure
- : I-Biological_structure
gastric JJ I-Biological_structure
junction NN I-Biological_structure
with IN O
lymph JJ B-Biological_structure
node JJ I-Biological_structure
metastasis NN B-Sign_symptom
in IN O
the DT O
lesser JJR B-Biological_structure
curvature NN I-Biological_structure
of IN I-Biological_structure
the DT I-Biological_structure
stomach NN I-Biological_structure
( ( O
Figure NNP O
2 CD O
) ) O
. . O

Endoscopic NNP B-Diagnostic_procedure
examination NN I-Diagnostic_procedure
showed VBD O
a DT O
black JJ B-Color
spot NN B-Sign_symptom
in IN O
the DT O
lower JJR B-Biological_structure
esophagus NN I-Biological_structure
and CC O
a DT O
bulky JJ B-Detailed_description
black JJ B-Color
mass NN B-Sign_symptom
blocking VBG B-Sign_symptom
the DT O
esophago JJ B-Biological_structure
- : I-Biological_structure
gastric JJ I-Biological_structure
junction NN I-Biological_structure
, , O
as RB O
well RB O
as IN O
two CD B-Detailed_description
black JJ B-Color
crater NN B-Shape
- : I-Shape
like IN I-Shape
ulcers NNS B-Sign_symptom
in IN O
the DT O
fundus NN B-Biological_structure
of IN I-Biological_structure
the DT I-Biological_structure
stomach NN I-Biological_structure
( ( O
Figure NNP O
3 CD O
) ) O
. . O

Biopsy NNP B-Diagnostic_procedure
specimens VBZ O
taken VBN O
from IN O
the DT O
tumor NN B-Sign_symptom
were VBD O
identified VBN O
as IN O
poorly RB B-Detailed_description
differentiated VBN I-Detailed_description
adenocarcinoma NN B-Disease_disorder
. . O

Preoperative JJ O
nutrition NN B-Diagnostic_procedure
status NN I-Diagnostic_procedure
of IN O
this DT O
case NN O
was VBD O
scored VBN O
2 CD B-Lab_value
based VBN O
on IN O
the DT O
Nutrition NNP B-Detailed_description
Risk NNP I-Detailed_description
Screening NNP I-Detailed_description
2002 CD I-Detailed_description
( ( O
NRS NNP O
2002 CD O
) ) O
[ VBD O
6 CD O
] NN O
. . O

Because IN O
of IN O
the DT O
obstructive JJ O
symptom NN O
caused VBN O
by IN O
the DT O
tumor NN O
, , O
a DT O
debulking VBG B-Therapeutic_procedure
surgery NN I-Therapeutic_procedure
of IN O
distal JJ B-Detailed_description
esophagectomy NN B-Therapeutic_procedure
and CC O
proximal JJ B-Detailed_description
gastrectomy NN B-Therapeutic_procedure
was VBD O
performed VBN O
. . O

Esophagogastric JJ B-Biological_structure
anastomosis NN B-Therapeutic_procedure
and CC O
reconstruction NN B-Therapeutic_procedure
was VBD O
then RB O
completed VBN O
with IN O
stapling VBG B-Therapeutic_procedure
device NN I-Therapeutic_procedure
. . O

Intraoperatively RB O
, , O
the DT O
tumor NN B-Sign_symptom
was VBD O
found VBN O
located VBN O
at IN O
the DT O
esophago JJ B-Biological_structure
- : I-Biological_structure
gastric JJ I-Biological_structure
junction NN I-Biological_structure
and CC O
the DT O
tumor NN O
infiltrated VBD B-Sign_symptom
the DT O
whole JJ B-Biological_structure
layer NN I-Biological_structure
with IN O
lymph JJ B-Biological_structure
node JJ I-Biological_structure
metastasis NN B-Sign_symptom
at IN O
station NN B-Biological_structure
four CD I-Biological_structure
. . O

No DT O
ascites NNS B-Sign_symptom
or CC O
dissemination NN B-Sign_symptom
of IN I-Sign_symptom
the DT I-Sign_symptom
tumor NN I-Sign_symptom
was VBD O
observed VBN O
in IN O
the DT O
peritoneal JJ B-Biological_structure
cavity NN I-Biological_structure
. . O

The DT O
tumor NN B-Sign_symptom
measured VBD O
3 CD B-Area
cm NN I-Area
× VBD I-Area
6 CD I-Area
cm NN I-Area
in IN O
size NN O
with IN O
black JJ B-Color
pigmentation NN I-Color
( ( O
Figure NNP O
4 CD O
) ) O
. . O

There EX O
were VBD O
several JJ B-Detailed_description
pigmented VBN B-Color
satellite JJ B-Detailed_description
nodules NNS B-Sign_symptom
beside IN O
the DT O
main JJ O
tumor NN O
lesion NN O
, , O
the DT O
largest JJS O
one CD O
being VBG O
1 CD B-Area
cm NN I-Area
× VBD I-Area
1 CD I-Area
cm NN I-Area
in IN O
diameter NN O
. . O

Moreover RB O
, , O
two CD O
ulceration NN B-Detailed_description
lesions NNS B-Sign_symptom
were VBD O
found VBN O
at IN O
the DT O
fundus NN B-Biological_structure
of IN I-Biological_structure
the DT I-Biological_structure
stomach NN I-Biological_structure
. . O

Microscopically RB B-Diagnostic_procedure
, , O
the DT O
excised JJ O
tumor NN B-Biological_structure
tissue NN I-Biological_structure
was VBD O
composed VBN O
of IN O
non JJ B-Lab_value
- : I-Lab_value
organized VBN I-Lab_value
and CC O
pleomorphic JJ B-Lab_value
cells NNS B-Diagnostic_procedure
exhibiting VBG O
atypical JJ B-Lab_value
nuclei NN B-Diagnostic_procedure
, , O
and CC O
abundant JJ B-Lab_value
melanin NN B-Diagnostic_procedure
granules NNS I-Diagnostic_procedure
( ( O
Figure NNP O
5 CD O
) ) O
. . O

Pathological JJ B-Diagnostic_procedure
examination NN I-Diagnostic_procedure
identified VBD O
this DT O
case NN O
at IN O
a DT O
stage NN B-Diagnostic_procedure
of IN O
IVA NNP B-Lab_value
( ( O
T4aN1M0 NNP B-Lab_value
) ) O
. . O

Immunohistochemical JJ B-Diagnostic_procedure
staining NN I-Diagnostic_procedure
showed VBD O
that IN O
the DT O
tumor NN O
was VBD O
positive JJ B-Lab_value
for IN O
S NNP B-Diagnostic_procedure
- : I-Diagnostic_procedure
100 CD I-Diagnostic_procedure
, , O
HMB NNP B-Diagnostic_procedure
- : I-Diagnostic_procedure
45 CD I-Diagnostic_procedure
, , O
mclean SYM B-Diagnostic_procedure
- : I-Diagnostic_procedure
A DT I-Diagnostic_procedure
and CC O
Vimentin NNP B-Diagnostic_procedure
, , O
but CC O
negative JJ B-Lab_value
for IN O
cytokeratin NN B-Diagnostic_procedure
7 CD I-Diagnostic_procedure
and CC O
cytokeratin VB B-Diagnostic_procedure
20 CD I-Diagnostic_procedure
( ( O
Figure NNP O
6 CD O
) ) O
. . O

Based VBN O
on IN O
these DT O
results NNS O
, , O
a DT O
diagnosis NN O
of IN O
primary JJ B-Detailed_description
advanced JJ B-Severity
esophago IN B-Detailed_description
- : I-Detailed_description
gastric JJ I-Detailed_description
melanoma NN B-Disease_disorder
was VBD O
established VBN O
. . O

The DT O
postoperative JJ B-Therapeutic_procedure
course NN I-Therapeutic_procedure
was VBD O
smooth JJ B-Lab_value
and CC O
without IN O
complications NNS B-Sign_symptom
. . O

The DT O
patient NN O
gradually RB O
recovered VBD B-Sign_symptom
and CC O
was VBD O
discharged VBN O
14 CD O
d NN O
after IN O
surgery NN O
. . O

As IN O
the DT O
patient NN O
denied VBD O
a DT O
postoperative JJ O
adjuvant NN B-Medication
therapy NN I-Medication
, , O
abdominal JJ B-Biological_structure
recurrence NN B-Sign_symptom
and CC O
hepatic JJ B-Biological_structure
metastases NNS B-Sign_symptom
were VBD O
found VBN O
within IN O
one CD O
month NN O
by IN O
a DT O
postoperative JJ O
follow NN O
- : O
up RB O
CT NNP B-Diagnostic_procedure
. . O

No DT O
other JJ B-Therapeutic_procedure
effective JJ I-Therapeutic_procedure
treatment NN I-Therapeutic_procedure
was VBD O
administered VBN O
afterwards NNS O
. . O

The DT O
patient NN O
died VBD O
of IN O
diffuse NN B-Detailed_description
metastatic JJ B-Disease_disorder
disease NN I-Disease_disorder
2 CD O
mo NN O
later RB O
. . O

-DOCSTART- NN -X-

The DT O
patient NN O
was VBD O
a DT O
3 CD B-Age
- : I-Age
year NN I-Age
- : I-Age
old JJ I-Age
girl NN O
with IN O
the DT O
following JJ O
features NNS O
of IN O
VACTERL NNP B-Diagnostic_procedure
association NN I-Diagnostic_procedure
: : O
absent NN B-Detailed_description
C1 NNP B-Biological_structure
vertebra NN I-Biological_structure
, , O
supernumerary JJ B-Detailed_description
lumbar NN B-Biological_structure
vertebrae NN I-Biological_structure
, , O
hypoplastic JJ B-Detailed_description
sacrum NN B-Biological_structure
/ NNP O
coccyx NN B-Biological_structure
, , O
fatty JJ B-Detailed_description
filum NN B-Biological_structure
terminale NN I-Biological_structure
with IN O
tethered JJ B-Detailed_description
spinal JJ B-Biological_structure
cord NN I-Biological_structure
, , O
and CC O
three CD B-Lab_value
fused JJ B-Detailed_description
ribs NN B-Biological_structure
; : O
an DT O
anorectal JJ B-Disease_disorder
malformation NN I-Disease_disorder
including VBG O
a DT O
cloaca NN B-Biological_structure
consisting NN O
of IN O
a DT O
common JJ B-Detailed_description
urogenital JJ B-Biological_structure
sinus NN I-Biological_structure
and CC O
a DT O
duplex JJ B-Detailed_description
vagina NN B-Biological_structure
with IN O
midline JJ B-Detailed_description
septum NN I-Detailed_description
; : O
type CC B-Detailed_description
C NNP I-Detailed_description
TE NNP B-Disease_disorder
fistula NN I-Disease_disorder
; : O
right JJ B-Biological_structure
renal JJ I-Biological_structure
agenesis NN B-Disease_disorder
with IN O
moderate JJ B-Severity
left VBN B-Detailed_description
hydronephrosis NN B-Disease_disorder
and CC O
vesicoureteral JJ B-Disease_disorder
reflux NN I-Disease_disorder
. . O

She PRP O
had VBD O
no DT O
cardiac NN B-Disease_disorder
or CC I-Disease_disorder
limb NN B-Disease_disorder
malformations NNS I-Disease_disorder
, , O
and CC O
no DT O
other JJ B-Disease_disorder
major JJ I-Disease_disorder
organ JJ I-Disease_disorder
anomalies NNS I-Disease_disorder
. . O

Both DT O
she PRP B-Other_entity
and CC O
her PRP$ O
father NN O
were VBD O
additionally RB O
clinically RB O
diagnosed VBN O
with IN O
hypermobile JJ B-Detailed_description
type NN I-Detailed_description
Ehlers NNP O
- : O
Danlos NNP O
syndrome NN O
, , O
but CC O
family NN O
history NN O
was VBD O
otherwise RB O
noncontributory JJ O
. . O

The DT O
diagnosis NN O
of IN O
hypermobile JJ B-Detailed_description
type NN I-Detailed_description
Ehlers NNP B-Disease_disorder
- : I-Disease_disorder
Danlos NNP I-Disease_disorder
was VBD O
based VBN O
on IN O
the DT O
patient NN O
` `` O
s JJ O
hypermobility NN B-Disease_disorder
( ( O
9 CD B-Lab_value
/ RB I-Lab_value
9 CD I-Lab_value
on IN O
the DT O
Beighton NNP B-Diagnostic_procedure
hypermobility NN I-Diagnostic_procedure
scale NN I-Diagnostic_procedure
) ) O
, , O
very RB B-Lab_value
soft JJ B-Texture
, , O
fragile JJ B-Texture
skin NN B-Biological_structure
with IN O
unusual JJ B-Detailed_description
scarring NN I-Detailed_description
, , O
and CC O
poor JJ B-Lab_value
skin NN B-Detailed_description
healing NN I-Detailed_description
. . O

Skin NNP B-Biological_structure
biopsy NN B-Diagnostic_procedure
was VBD O
not RB O
performed VBN O
, , O
but CC O
testing VBG B-Diagnostic_procedure
on IN O
peripheral JJ B-Biological_structure
blood NN I-Biological_structure
did VBD O
not RB O
reveal VB O
mutations NNS B-Diagnostic_procedure
associated VBN O
with IN O
other JJ B-Detailed_description
forms NNS I-Detailed_description
of IN O
Ehlers NNP B-Disease_disorder
- : I-Disease_disorder
Danlos NNP I-Disease_disorder
syndrome NN I-Disease_disorder
. . O

Microarray NNP B-Diagnostic_procedure
analysis NN I-Diagnostic_procedure
initially RB O
showed VBD O
a DT O
maternally RB B-Detailed_description
- : I-Detailed_description
inherited VBN I-Detailed_description
deletion NN B-Diagnostic_procedure
at IN O
4q35 CD B-Biological_structure
. . I-Biological_structure
1 CD I-Biological_structure
detected VBD O
with IN O
one CD B-Diagnostic_procedure
clone NN I-Diagnostic_procedure
and CC O
confirmed VBN O
by IN O
FISH NNP B-Diagnostic_procedure
( ( B-Diagnostic_procedure
RP11 NNP I-Diagnostic_procedure
- : I-Diagnostic_procedure
173M11 CD I-Diagnostic_procedure
) ) I-Diagnostic_procedure
. . O

Subsequent JJ O
performance NN O
of IN O
an DT O
180K CD B-Diagnostic_procedure
custom NN I-Diagnostic_procedure
oligonucleotide IN I-Diagnostic_procedure
microarray NN I-Diagnostic_procedure
( ( O
Baylor NNP B-Nonbiological_location
College NNP I-Nonbiological_location
of IN I-Nonbiological_location
Medicine NNP I-Nonbiological_location
Medical NNP I-Nonbiological_location
Genetics NNP I-Nonbiological_location
Laboratories NNPS I-Nonbiological_location
) ) O
refined VBD O
the DT O
deleted JJ B-Diagnostic_procedure
region NN I-Diagnostic_procedure
deletion NN I-Diagnostic_procedure
to TO O
a DT O
maximum JJ B-Lab_value
size NN I-Lab_value
of IN I-Lab_value
1 CD I-Lab_value
. . I-Lab_value
37 CD I-Lab_value
Mb NNP I-Lab_value
, , O
with IN O
karyotype NN B-Diagnostic_procedure
revised VBN O
to TO O
46 CD B-Detailed_description
, , I-Detailed_description
XX NNP I-Detailed_description
, , I-Detailed_description
arr VBD I-Detailed_description
cgh JJ I-Detailed_description
4q35 CD I-Detailed_description
. . I-Detailed_description
1q35 CD I-Detailed_description
. . I-Detailed_description
2 CD I-Detailed_description
( ( I-Detailed_description
187,321 CD I-Detailed_description
- : I-Detailed_description
768 CD I-Detailed_description
- : I-Detailed_description
188,694 CD I-Detailed_description
- : I-Detailed_description
589 CD I-Detailed_description
) ) I-Detailed_description
3 CD I-Detailed_description
1 CD I-Detailed_description
. . O

Genes NNS B-Diagnostic_procedure
in IN O
the DT O
deleted JJ B-Detailed_description
region NN I-Detailed_description
, , O
which WDT O
contains VBZ O
a DT O
number NN O
of IN O
much JJ O
smaller JJR O
copy NN O
number NN O
variations NNS O
( ( O
CNVs NNP O
) ) O
identified VBN O
in IN O
normal JJ O
controls NNS O
, , O
include VBP O
CYP4V2 NNP B-Diagnostic_procedure
, , O
KLKB2 NNP B-Diagnostic_procedure
, , O
F11 NNP B-Diagnostic_procedure
, , O
MTRNR1A NNP B-Diagnostic_procedure
, , O
and CC O
FAT1 NNP B-Diagnostic_procedure
, , O
none NN O
of IN O
which WDT O
can MD O
be VB O
clearly RB O
related JJ O
to TO O
her PRP$ O
phenotype NN O
, , O
especially RB O
as IN O
her PRP$ O
mother NN O
, , O
from IN B-Detailed_description
whom WP I-Detailed_description
the DT I-Detailed_description
deletion NN I-Detailed_description
was VBD I-Detailed_description
inherited VBN I-Detailed_description
, , O
is VBZ O
unaffected JJ O
. . O

Evidence NN O
for IN O
mitochondrial JJ B-Disease_disorder
dysfunction NN I-Disease_disorder
began VBD O
at IN O
13 CD B-Age
months NNS I-Age
of IN I-Age
age NN I-Age
with IN O
progressive JJ B-Detailed_description
muscle NN B-Sign_symptom
weakness NN I-Sign_symptom
, , O
autonomic JJ B-Disease_disorder
dysregulation NN I-Disease_disorder
, , O
hypoglycemic JJ B-Disease_disorder
episodes NNS I-Disease_disorder
, , O
exocrine VBP B-Disease_disorder
pancreatic JJ I-Disease_disorder
dysfunction NN I-Disease_disorder
, , O
and CC O
decline NN B-Detailed_description
of IN O
gastrointestinal JJ B-Diagnostic_procedure
function NN I-Diagnostic_procedure
, , O
eventually RB O
leading VBG O
to TO O
total JJ B-Severity
parenteral JJ B-Detailed_description
nutrition NN B-Disease_disorder
dependency NN I-Disease_disorder
due JJ O
to TO O
visceral JJ B-Biological_structure
hyperalgesia NN B-Disease_disorder
, , O
dysmotility NN B-Disease_disorder
, , O
and CC O
malabsorption NN B-Disease_disorder
. . O

Muscle NNP B-Biological_structure
biopsy NN B-Diagnostic_procedure
showed VBD O
a DT O
mild JJ B-Severity
increase NN B-Lab_value
in IN O
fiber JJ B-Diagnostic_procedure
size NN I-Diagnostic_procedure
variability NN I-Diagnostic_procedure
but CC O
no DT O
other JJ B-Diagnostic_procedure
findings NNS I-Diagnostic_procedure
consistent JJ B-Detailed_description
with IN I-Detailed_description
mitochondrial JJ I-Detailed_description
disease NN I-Detailed_description
, , O
including VBG O
via IN O
electron NN B-Diagnostic_procedure
microscopy NN I-Diagnostic_procedure
. . O

However RB O
, , O
analysis NN O
of IN O
electron NN B-Diagnostic_procedure
transport NN I-Diagnostic_procedure
chain NN I-Diagnostic_procedure
( ( B-Diagnostic_procedure
ETC NNP I-Diagnostic_procedure
) ) I-Diagnostic_procedure
activity NN I-Diagnostic_procedure
showed VBD O
normal JJ B-Lab_value
activity NN O
of IN O
complexes NNS B-Diagnostic_procedure
I PRP I-Diagnostic_procedure
, , I-Diagnostic_procedure
II NNP I-Diagnostic_procedure
, , I-Diagnostic_procedure
and CC I-Diagnostic_procedure
III NNP I-Diagnostic_procedure
, , O
but CC O
complex JJ B-Diagnostic_procedure
IV NNP I-Diagnostic_procedure
, , O
or CC O
cytochrome VB B-Diagnostic_procedure
c JJ I-Diagnostic_procedure
oxidase NN I-Diagnostic_procedure
, , O
activity NN O
was VBD O
45 CD B-Lab_value
. . I-Lab_value
4 CD I-Lab_value
lmol JJ I-Lab_value
/ NNP I-Lab_value
min NN I-Lab_value
/ NNP I-Lab_value
g NN I-Lab_value
weight NN I-Lab_value
, , O
well RB B-Detailed_description
below IN I-Detailed_description
the DT I-Detailed_description
control NN I-Detailed_description
range NN I-Detailed_description
( ( O
148 CD O
. . O
9 CD O
+ JJ O
/ NNP O
− NNP O
67 CD O
. . O
2 CD O
lmol JJ O
/ NNP O
min NN O
/ NNP O
g NN O
weight NN O
) ) O
. . O

Repeat NNP B-Detailed_description
ETC NNP B-Diagnostic_procedure
analysis NN I-Diagnostic_procedure
in IN O
isolated JJ B-Detailed_description
mitochondria NN B-Biological_structure
confirmed VBD O
a DT O
profound NN B-Severity
and CC O
reproducible JJ B-Detailed_description
complex JJ B-Disease_disorder
IV NNP I-Disease_disorder
deficiency NN I-Disease_disorder
. . O

Citrate NNP B-Diagnostic_procedure
synthase NN I-Diagnostic_procedure
activity NN I-Diagnostic_procedure
and CC I-Diagnostic_procedure
content NN I-Diagnostic_procedure
in IN O
both DT O
ETC NNP O
analyses NNS O
were VBD O
normal JJ B-Lab_value
, , O
confirming VBG O
good JJ B-Lab_value
sample NN B-Diagnostic_procedure
quality NN I-Diagnostic_procedure
and CC O
normal JJ B-Lab_value
mitochondrial JJ B-Diagnostic_procedure
content NN I-Diagnostic_procedure
. . O

Whole JJ B-Detailed_description
mitochondrial JJ B-Biological_structure
genome NN B-Diagnostic_procedure
sequencing NN I-Diagnostic_procedure
, , O
and CC O
sequencing NN B-Diagnostic_procedure
of IN O
DNA NNP B-Diagnostic_procedure
Polymerase NNP I-Diagnostic_procedure
Gamma NNP I-Diagnostic_procedure
1 CD I-Diagnostic_procedure
and CC I-Diagnostic_procedure
2 CD I-Diagnostic_procedure
( ( O
POLG1 NNP B-Diagnostic_procedure
and CC O
POLG2 NNP B-Diagnostic_procedure
) ) O
and CC O
Thymidine NNP B-Diagnostic_procedure
Phosphorylase NNP I-Diagnostic_procedure
did VBD O
not RB O
reveal VB O
abnormalities NNS O
. . O

-DOCSTART- NN -X-

A DT O
newborn JJ B-Age
boy NN O
of IN O
healthy JJ O
nonconsanguineous JJ O
parents NNS O
was VBD O
delivered VBN O
at IN O
37 CD O
weeks NNS O
` `` O
gestation NN O
by IN O
cesarean JJ B-Therapeutic_procedure
section NN I-Therapeutic_procedure
. . O

His PRP$ O
mother NN O
( ( O
primipara NN O
, , O
32 CD O
years NNS O
old JJ O
) ) O
had VBD O
been VBN O
admitted VBN O
to TO O
our PRP$ O
hospital JJ B-Nonbiological_location
2 CD O
weeks NNS O
previously RB O
because IN O
of IN O
reduced JJ B-Lab_value
fetal JJ B-Sign_symptom
intrauterine NN I-Sign_symptom
movements NNS I-Sign_symptom
and CC O
polyhydramnios NNS B-Sign_symptom
. . O

The DT O
child NN O
` `` O
s JJ O
birthweight NN B-Diagnostic_procedure
was VBD O
2,330 CD B-Lab_value
g NN I-Lab_value
( ( O
< JJ B-Lab_value
10th CD I-Lab_value
percentile NN I-Lab_value
) ) O
, , O
length $ B-Diagnostic_procedure
47 CD B-Lab_value
cm NN I-Lab_value
, , O
and CC O
head NN B-Diagnostic_procedure
circumference NN I-Diagnostic_procedure
33 CD B-Lab_value
. . I-Lab_value
2 CD I-Lab_value
cm NN I-Lab_value
( ( O
25th CD O
percentile NN O
) ) O
. . O

He PRP O
had VBD O
low JJ B-Sign_symptom
- : I-Sign_symptom
set NN I-Sign_symptom
ears NNS I-Sign_symptom
and CC O
bilateral JJ B-Sign_symptom
clubfoot NN I-Sign_symptom
. . O

Apgar NNP B-Diagnostic_procedure
scores NNS I-Diagnostic_procedure
were VBD O
2 CD B-Lab_value
, , O
6 CD B-Lab_value
, , O
and CC O
7 CD B-Lab_value
at IN O
1 CD B-Time
, , I-Time
5 CD B-Time
, , I-Time
and CC I-Time
10 CD B-Time
minutes NNS I-Time
. . O

The DT O
child NN O
presented VBN O
with IN O
severe JJ B-Severity
hypotonia NN B-Sign_symptom
and CC O
generalized JJ B-Sign_symptom
muscle NN I-Sign_symptom
weakness NN I-Sign_symptom
, , O
requiring VBG O
ventilatory NN B-Therapeutic_procedure
assistance NN I-Therapeutic_procedure
and CC O
total JJ B-Therapeutic_procedure
parenteral JJ I-Therapeutic_procedure
nutrition NN I-Therapeutic_procedure
. . O

Weaning VBG O
failed VBD O
because IN O
of IN O
inadequate JJ O
pulmonary JJ O
ventilation NN O
and CC O
respiratory JJ B-Disease_disorder
acidosis NN I-Disease_disorder
. . O

Hearing VBG B-Sign_symptom
loss NN I-Sign_symptom
was VBD O
detected VBN O
by IN O
auditory NN B-Diagnostic_procedure
evoked VBN I-Diagnostic_procedure
potentials NNS I-Diagnostic_procedure
, , O
while IN O
cranial JJ B-Biological_structure
MRI NNP B-Diagnostic_procedure
showed VBD O
mildly RB B-Lab_value
enlarged VBN I-Lab_value
ventricles NNS B-Biological_structure
and CC O
liquor NN B-Biological_structure
spaces NNS I-Biological_structure
. . O

Two CD O
days NNS O
after IN O
birth NN O
, , O
the DT O
infant NN O
presented VBN O
with IN O
severe JJ B-Severity
abdominal JJ B-Sign_symptom
distension NN I-Sign_symptom
with IN O
a DT O
hypoactive JJ B-Sign_symptom
bowel NN I-Sign_symptom
. . O

MRI NNP B-Diagnostic_procedure
revealed VBD O
marked JJ B-Severity
intestinal JJ B-Sign_symptom
dilation NN I-Sign_symptom
without IN O
mechanical JJ B-Sign_symptom
obstruction NN I-Sign_symptom
. . O

Laboratory NN B-Diagnostic_procedure
investigations NNS I-Diagnostic_procedure
showed VBD O
hypoglycemia NN B-Sign_symptom
( ( O
27 CD B-Lab_value
mg NN I-Lab_value
/ NNP I-Lab_value
dL NN I-Lab_value
) ) O
, , O
hypomagnesemia NN B-Sign_symptom
( ( O
0 CD B-Lab_value
. . I-Lab_value
58 CD I-Lab_value
mmol JJ I-Lab_value
/ NNP I-Lab_value
L NNP I-Lab_value
) ) O
, , O
and CC O
hypokalemia NN B-Sign_symptom
( ( O
2 CD B-Lab_value
. . I-Lab_value
4 CD I-Lab_value
mmol JJ I-Lab_value
/ NNP I-Lab_value
L NNP I-Lab_value
) ) O
. . O

Blood NNP B-Diagnostic_procedure
lactate NN I-Diagnostic_procedure
was VBD O
normal JJ B-Lab_value
( ( O
1 CD B-Lab_value
. . I-Lab_value
3 CD I-Lab_value
mmol JJ I-Lab_value
/ NNP I-Lab_value
L NNP I-Lab_value
, , O
normal JJ B-Detailed_description
range NN I-Detailed_description
0 CD I-Detailed_description
. . I-Detailed_description
5 CD I-Detailed_description
- : I-Detailed_description
2 CD I-Detailed_description
. . I-Detailed_description
2 CD I-Detailed_description
mmol JJ I-Detailed_description
/ NNP I-Detailed_description
L NNP I-Detailed_description
) ) O
and CC O
liver $ B-Diagnostic_procedure
enzymes NNS I-Diagnostic_procedure
were VBD O
unremarkable JJ B-Lab_value
. . O

A DT O
skeletal JJ B-Biological_structure
muscle NN I-Biological_structure
biopsy NN B-Diagnostic_procedure
was VBD O
performed VBN O
and CC O
showed VBN O
scattered JJ B-Detailed_description
, , O
hypertrophic JJ B-Detailed_description
cytochrome NN B-Diagnostic_procedure
c NN I-Diagnostic_procedure
oxidase NN I-Diagnostic_procedure
( ( O
COX NNP B-Diagnostic_procedure
) ) O
- : O
deficient NN B-Lab_value
and CC O
succinate NN B-Diagnostic_procedure
dehydrogenase NN I-Diagnostic_procedure
- : O
positive JJ B-Lab_value
muscle NN B-Biological_structure
fibers NNS I-Biological_structure
( ( O
figure NN O
) ) O
, , O
suggesting VBG O
a DT O
mitochondrial JJ B-Disease_disorder
disorder NN I-Disease_disorder
. . O

Molecular JJ B-Diagnostic_procedure
genetic JJ I-Diagnostic_procedure
studies NNS I-Diagnostic_procedure
revealed VBD O
marked JJ B-Severity
mtDNA NN B-Sign_symptom
depletion NN I-Sign_symptom
in IN O
muscle NN O
( ( O
93 CD B-Lab_value
% NN I-Lab_value
decrease NN I-Lab_value
as IN O
compared VBN B-Detailed_description
to TO I-Detailed_description
age NN I-Detailed_description
- : I-Detailed_description
matched VBN I-Detailed_description
controls NNS I-Detailed_description
) ) O
, , O
while IN O
a DT O
screen NN B-Diagnostic_procedure
for IN I-Diagnostic_procedure
mtDNA NN I-Diagnostic_procedure
rearrangements NNS I-Diagnostic_procedure
within IN O
individual JJ B-Biological_structure
COX NNP I-Biological_structure
- : I-Biological_structure
positive JJ I-Biological_structure
and CC I-Biological_structure
COX NNP B-Biological_structure
- : I-Biological_structure
deficient NN I-Biological_structure
fibers4 NN I-Biological_structure
was VBD O
negative JJ B-Lab_value
. . O

We PRP O
sequenced VBD B-Diagnostic_procedure
the DT O
entire JJ B-Detailed_description
coding NN I-Detailed_description
region NN I-Detailed_description
and CC I-Detailed_description
intron NN I-Detailed_description
- : I-Detailed_description
exon JJ I-Detailed_description
boundaries NNS I-Detailed_description
of IN O
the DT O
POLG1 NNP B-Biological_structure
gene NN I-Biological_structure
, , O
identifying VBG O
two CD B-Lab_value
reported VBD O
heterozygous JJ B-Sign_symptom
missense NN I-Sign_symptom
mutations NNS I-Sign_symptom
in IN O
compound NN O
c NN B-Sign_symptom
. . I-Sign_symptom
679C CD I-Sign_symptom
> JJ I-Sign_symptom
T NNP I-Sign_symptom
predicting VBG I-Sign_symptom
p NN I-Sign_symptom
. . I-Sign_symptom
R227W NNP I-Sign_symptom
and CC O
c NN B-Sign_symptom
. . I-Sign_symptom
2542G CD I-Sign_symptom
> VBD I-Sign_symptom
A NNP I-Sign_symptom
predicting VBG I-Sign_symptom
p NN I-Sign_symptom
. . I-Sign_symptom
G848S NNP I-Sign_symptom
. . O

Sequencing VBG B-Diagnostic_procedure
of IN I-Diagnostic_procedure
parental JJ I-Diagnostic_procedure
samples NNS I-Diagnostic_procedure
confirmed VBD O
recessive JJ B-Sign_symptom
inheritance NN I-Sign_symptom
. . O

The DT O
infant NN O
died VBD O
at IN O
20 CD O
days NNS O
of IN O
respiratory JJ B-Disease_disorder
failure NN I-Disease_disorder
. . O

At IN O
autopsy NN B-Diagnostic_procedure
, , O
the DT O
brain NN B-Biological_structure
did VBD O
not RB O
show VB O
remarkable JJ B-Sign_symptom
changes NNS I-Sign_symptom
on IN O
gross JJ B-Diagnostic_procedure
examination NN I-Diagnostic_procedure
. . O

Histology NNP B-Diagnostic_procedure
was VBD O
not RB O
informative JJ O
due JJ O
to TO O
poor JJ O
preservation NN O
of IN O
tissue NN O
; : O
there EX O
was VBD O
no DT O
evidence NN O
of IN O
neuronal JJ B-Sign_symptom
damage NN I-Sign_symptom
in IN O
the DT O
spinal JJ B-Biological_structure
cord NN I-Biological_structure
. . O

The DT O
liver NN B-Biological_structure
showed VBD O
diffuse IN B-Detailed_description
cholestasis NN B-Sign_symptom
, , O
consistent NN O
with IN O
total JJ O
parenteral JJ O
nutrition NN O
; : O
hepatocyte JJ B-Biological_structure
steatosis NN B-Sign_symptom
, , O
necrosis NN B-Sign_symptom
, , O
or CC O
liver RB B-Biological_structure
fibrosis NN B-Sign_symptom
were VBD O
not RB O
observed VBN O
. . O

The DT O
testicles NNS O
were VBD O
undescended JJ O
, , O
while IN O
remaining VBG O
visceral JJ O
organs NNS O
were VBD O
normal JJ O
except IN O
for IN O
a DT O
marked JJ O
dilation NN B-Sign_symptom
and CC O
thinning NN B-Sign_symptom
of IN O
the DT O
bowel NN B-Biological_structure
wall NN I-Biological_structure
. . O

Despite IN O
normal JJ O
histology NN O
, , O
analysis NN O
of IN O
stomach NN B-Biological_structure
, , I-Biological_structure
ileum NN B-Biological_structure
, , I-Biological_structure
and CC I-Biological_structure
colon NN B-Biological_structure
homogenates NNS I-Biological_structure
revealed VBD O
severe JJ B-Severity
mtDNA NN B-Sign_symptom
depletion NN I-Sign_symptom
( ( O
up IN B-Lab_value
to TO I-Lab_value
94 CD I-Lab_value
% NN I-Lab_value
decrease NN I-Lab_value
; : O
table JJ O
e NN O
- : O
1 CD O
on IN O
the DT O
Neurology NNP O
® NNP O
Web NNP O
site NN O
at IN O
www NN O
. . O
neurology NN O
. . O
org NN O
) ) O
. . O

Laser NNP B-Diagnostic_procedure
capture NN I-Diagnostic_procedure
microdissection NN I-Diagnostic_procedure
analysis5 NN I-Diagnostic_procedure
revealed VBD O
that IN O
the DT O
mtDNA NN O
depletion NN O
was VBD O
confined VBN O
to TO O
the DT O
muscularis NN B-Biological_structure
propria NN I-Biological_structure
, , O
being VBG O
most JJS O
prominent JJ O
in IN O
its PRP$ O
external JJ B-Detailed_description
layer NN I-Detailed_description
( ( O
figure NN O
) ) O
. . O

Ganglion NNP B-Biological_structure
cells NNS I-Biological_structure
from IN O
the DT O
myenteric NN B-Biological_structure
plexus NN I-Biological_structure
showed VBD O
milder JJR B-Severity
mtDNA NN O
depletion NN O
, , O
restricted VBN O
to TO O
the DT O
small JJ B-Biological_structure
intestine NN I-Biological_structure
( ( O
figure NN O
) ) O
. . O

There EX O
was VBD O
no DT O
mtDNA NN B-Sign_symptom
depletion NN I-Sign_symptom
in IN O
liver NN B-Biological_structure
( ( O
not RB O
shown VBN O
) ) O
. . O

-DOCSTART- NN -X-

A DT O
60 CD B-Age
- : I-Age
year NN I-Age
- : I-Age
old JJ I-Age
woman NN O
patient NN O
was VBD O
admitted VBN O
to TO O
our PRP$ O
hospital NN B-Nonbiological_location
on IN O
Feb NNP O
. . O
18 CD O
, , O
2016 CD O
because IN O
of IN O
frequent JJ B-Frequency
episodes NNS O
of IN O
hemoptysis NN B-Sign_symptom
for IN O
2 CD B-Duration
weeks NNS I-Duration
. . O

In IN O
the DT O
previous JJ O
decade NN O
, , O
the DT O
patient NN O
had VBD O
frequent JJ B-Frequency
but CC O
less RBR B-Severity
severe JJ I-Severity
episodes NNS O
of IN O
hemoptysis NN B-Sign_symptom
, , O
which WDT O
typically RB O
ensued VBD O
following VBG O
an DT O
upper JJ B-Biological_structure
respiratory NN I-Biological_structure
tract JJ I-Biological_structure
infection NN B-Disease_disorder
. . O

Ear NNP B-Diagnostic_procedure
, , I-Diagnostic_procedure
nose RB I-Diagnostic_procedure
, , I-Diagnostic_procedure
and CC I-Diagnostic_procedure
throat NN I-Diagnostic_procedure
examination NN I-Diagnostic_procedure
and CC O
laryngoscope NN B-Diagnostic_procedure
failed VBD O
to TO O
identify VB O
an DT O
apparent JJ O
source NN B-Sign_symptom
of IN I-Sign_symptom
bleeding NN I-Sign_symptom
. . O

CT NNP B-Diagnostic_procedure
chest JJS B-Biological_structure
scan NN O
revealed VBD O
no DT O
abnormality NN B-Sign_symptom
. . O

The DT O
most RBS O
recent JJ O
episode NN O
occurred VBD O
after IN O
an DT O
upper JJ B-Biological_structure
respiratory NN I-Biological_structure
tract JJ I-Biological_structure
infection NN B-Disease_disorder
2 CD O
weeks NNS O
ago RB O
. . O

The DT O
patient NN O
coughed VBD B-Sign_symptom
up RP O
as RB O
much RB O
as IN O
about RB O
500 CD B-Volume
mL NNS I-Volume
of IN O
fresh JJ B-Sign_symptom
blood NN I-Sign_symptom
in IN O
an DT O
episode NN O
of IN O
hemoptysis NN B-Sign_symptom
, , O
which WDT O
was VBD O
alleviated VBN O
by IN O
anti JJ B-Medication
- : I-Medication
tussive JJ I-Medication
therapy NN I-Medication
. . O

The DT O
patient NN O
denied VBD O
a DT O
history NN O
of IN O
smoking NN O
and CC O
illicit JJ O
drug NN O
use NN O
. . O

Diagnostic NNP B-Diagnostic_procedure
workup NN I-Diagnostic_procedure
revealed VBD O
no DT O
evidence NN O
of IN O
coagulopathy NN B-Disease_disorder
. . O

Upon IN O
admission NN O
, , O
physical JJ B-Diagnostic_procedure
examination NN I-Diagnostic_procedure
revealed VBD O
signs NNS O
of IN O
rhonchi NN B-Sign_symptom
and CC O
reduced JJ B-Lab_value
breath NN B-Diagnostic_procedure
sounds NNS I-Diagnostic_procedure
. . O

Bronchoscopy NNP B-Diagnostic_procedure
showed VBD O
a DT O
1 CD B-Distance
- : I-Distance
cm NN I-Distance
lesion NN B-Sign_symptom
at IN O
the DT O
membranous JJ B-Biological_structure
trachea NN I-Biological_structure
2 CD B-Distance
cm NN I-Distance
to TO O
the DT O
carina NN B-Biological_structure
. . O

Tortuous JJ B-Sign_symptom
blood NN I-Sign_symptom
vessels NNS I-Sign_symptom
were VBD O
observed VBN O
running VBG O
in IN O
the DT O
submucosa NN B-Biological_structure
of IN I-Biological_structure
the DT I-Biological_structure
trachea NN I-Biological_structure
( ( O
Fig NNP O
. . O
1 CD O
) ) O
. . O

CT NNP B-Diagnostic_procedure
angiography NN I-Diagnostic_procedure
was VBD O
performed VBN O
, , O
demonstrating VBG O
an DT O
artery NN B-Sign_symptom
extending VBG I-Sign_symptom
into IN O
the DT O
submucosa NN B-Biological_structure
from IN O
the DT O
descending VBG B-Biological_structure
aorta NN I-Biological_structure
( ( O
Fig NNP O
. . O
2 CD O
) ) O
. . O

A DT O
diagnosis NN O
of IN O
Dieulafoy NNP B-Therapeutic_procedure
disease NN I-Therapeutic_procedure
of IN O
the DT O
trachea NN B-Biological_structure
was VBD O
entertained VBN O
. . O

Since IN O
the DT O
blood NN O
vessel NN O
was VBD O
considered VBN O
to TO O
be VB O
the DT O
culprit NN O
of IN O
hemoptysis NN B-Sign_symptom
, , O
selective JJ B-Detailed_description
arterial JJ B-Therapeutic_procedure
embolization NN I-Therapeutic_procedure
was VBD O
performed VBN O
1 CD O
week NN O
later RB O
. . O

No DT O
fresh JJ O
episode NN O
of IN O
acute JJ B-Detailed_description
hemoptysis NN B-Sign_symptom
was VBD O
observed VBN O
and CC O
the DT O
patient NN O
was VBD O
still RB O
being VBG O
followed VBN O
up RP O
at IN O
the DT O
time NN O
of IN O
writing VBG O
this DT O
report NN O
. . O

This DT O
study NN O
was VBD O
approved VBN O
by IN O
Ethics NNP O
Committee NNP O
of IN O
Shanghai NNP O
Jiao NNP O
Tong NNP O
University NNP O
Affiliated NNP O
Sixth NNP O
People NNP O
` `` O
s JJ O
Hospital NN O
, , O
and CC O
also RB O
got VBD O
an DT O
informed JJ O
written VBN O
consent NN O
from IN O
the DT O
patient NN O
. . O

-DOCSTART- NN -X-

A DT O
16 CD B-Age
- : I-Age
year NN I-Age
- : I-Age
old JJ I-Age
female NN O
suffered VBD O
from IN O
an DT O
abdominal JJ B-Biological_structure
pain NN B-Sign_symptom
at IN O
right JJ B-Biological_structure
upper JJ I-Biological_structure
quadrant NN I-Biological_structure
, , O
lasting VBG O
for IN O
more JJR B-Duration
than IN I-Duration
10 CD I-Duration
days NNS I-Duration
. . O

Shortly RB O
ahead RB O
of IN O
her PRP$ O
medical JJ O
consultation NN O
, , O
4 CD B-Lab_value
ascaris SYM B-Detailed_description
- : I-Detailed_description
like IN I-Detailed_description
worms NNS I-Detailed_description
were VBD O
vomited VBN B-Sign_symptom
out RP O
, , O
individually RB O
with IN O
a DT O
length NN O
of IN O
about IN O
10 CD B-Distance
cm NN I-Distance
. . O

She PRP O
had VBD O
a DT O
previous JJ B-Detailed_description
onset NN I-Detailed_description
of IN O
ascariasis NN B-Disease_disorder
, , O
during IN O
which WDT O
low JJ B-Lab_value
- : I-Lab_value
grade NN I-Lab_value
fever NN B-Sign_symptom
( ( O
38 CD B-Lab_value
. . I-Lab_value
4 CD I-Lab_value
°C NN I-Lab_value
) ) O
occurred VBD O
without IN O
apparent JJ O
jaundice NN B-Sign_symptom
, , O
diarrhea NN B-Sign_symptom
, , O
or CC O
anemia NN B-Sign_symptom
. . O

Physical JJ B-Diagnostic_procedure
examination NN I-Diagnostic_procedure
revealed VBD O
tenderness NN B-Sign_symptom
at IN O
right JJ B-Biological_structure
upper JJ I-Biological_structure
quadrant NN I-Biological_structure
. . O

Her PRP$ O
total JJ B-Diagnostic_procedure
leukocyte NN I-Diagnostic_procedure
count NN I-Diagnostic_procedure
was VBD O
11 CD B-Lab_value
. . I-Lab_value
2 CD I-Lab_value
G NNP I-Lab_value
/ NNP I-Lab_value
L NNP I-Lab_value
consisting VBG O
of IN O
5 CD B-Lab_value
. . I-Lab_value
2 CD I-Lab_value
% NN I-Lab_value
eosinophils NNS I-Lab_value
. . O

Serum NNP B-Biological_structure
and CC O
urine JJ B-Biological_structure
amylase NN B-Diagnostic_procedure
were VBD O
386 CD B-Lab_value
and CC I-Lab_value
928 CD B-Lab_value
U NNP I-Lab_value
/ NNP I-Lab_value
L NNP I-Lab_value
, , O
respectively RB O
. . O

In IN O
terms NNS O
of IN O
liver NN B-Diagnostic_procedure
functionality NN I-Diagnostic_procedure
, , O
the DT O
level NN O
of IN O
total JJ B-Diagnostic_procedure
bilirubin NN I-Diagnostic_procedure
rose VBD B-Lab_value
up RB I-Lab_value
to TO O
23 CD B-Lab_value
. . I-Lab_value
2 CD I-Lab_value
μm JJ I-Lab_value
/ NNP I-Lab_value
L NNP I-Lab_value
, , O
meanwhile RB O
the DT O
hepatic JJ B-Diagnostic_procedure
enzymes NNS I-Diagnostic_procedure
were VBD O
similarly RB O
elevated VBN B-Lab_value
( ( O
alanine JJ B-Diagnostic_procedure
aminotransferase NN I-Diagnostic_procedure
163 CD B-Lab_value
U NNP I-Lab_value
/ NNP I-Lab_value
L NNP I-Lab_value
; : O
aspartate JJ B-Diagnostic_procedure
aminotransferase NN I-Diagnostic_procedure
96 CD B-Lab_value
U NNP I-Lab_value
/ NNP I-Lab_value
L NNP I-Lab_value
) ) O
. . O

Abdominal NNP B-Biological_structure
ultrasound NN B-Diagnostic_procedure
described VBD O
the DT O
enlargement NN B-Sign_symptom
of IN O
the DT O
gallbladder NN B-Biological_structure
, , O
upper JJ B-Biological_structure
segment NN I-Biological_structure
of IN I-Biological_structure
common JJ I-Biological_structure
bile NN I-Biological_structure
duct NN I-Biological_structure
( ( O
1 CD B-Distance
. . I-Distance
5 CD I-Distance
cm NN I-Distance
in IN I-Distance
diameter NN I-Distance
) ) O
and CC O
intrahepatic JJ B-Biological_structure
bile NN I-Biological_structure
duct NN I-Biological_structure
( ( O
1 CD B-Distance
. . I-Distance
3 CD I-Distance
cm NN I-Distance
in IN I-Distance
diameter NN I-Distance
) ) O
. . O

Furthermore RB O
, , O
the DT O
intrahepatic JJ B-Biological_structure
bile NN I-Biological_structure
duct NN I-Biological_structure
was VBD O
also RB O
discovered VBN O
to TO O
be VB O
filled VBN O
with IN O
echogenic JJ B-Sign_symptom
and CC O
banded VBD B-Sign_symptom
substances NNS I-Sign_symptom
. . O

Based VBN O
on IN O
such JJ O
evidences NNS O
, , O
she PRP O
was VBD O
clinically RB O
diagnosed VBN O
as IN O
biliary JJ B-Biological_structure
ascariasis NN B-Disease_disorder
with IN O
a DT O
concomitant JJ O
manifestation NN O
of IN O
biliary JJ B-Biological_structure
duct NN I-Biological_structure
infection NN B-Disease_disorder
. . O

Through IN O
a DT O
laparoscopic NN B-Diagnostic_procedure
exploration NN I-Diagnostic_procedure
, , O
the DT O
enlarged JJ B-Sign_symptom
gallbladder NN B-Biological_structure
and CC O
common JJ B-Biological_structure
bile NN I-Biological_structure
duct NN I-Biological_structure
were VBD O
visually RB O
confirmed VBN O
, , O
as RB O
well RB O
as IN O
the DT O
massive JJ B-Severity
storage NN I-Severity
of IN O
worms NNS B-Sign_symptom
within IN O
the DT O
biliary JJ B-Biological_structure
tract NN I-Biological_structure
. . O

Subsequently RB O
, , O
a DT O
1 CD B-Distance
cm NN I-Distance
incision NN B-Therapeutic_procedure
was VBD O
made VBN O
on IN O
the DT O
common JJ B-Biological_structure
bile NN I-Biological_structure
duct NN I-Biological_structure
in IN O
order NN O
to TO O
facilitate VB O
the DT O
extraction NN B-Therapeutic_procedure
of IN O
the DT O
pathogenic JJ O
worms NNS B-Sign_symptom
, , O
which WDT O
were VBD O
then RB O
placed VBN B-Therapeutic_procedure
into IN I-Therapeutic_procedure
a DT I-Therapeutic_procedure
specimen JJ I-Therapeutic_procedure
bag NN I-Therapeutic_procedure
laparoscopically RB B-Detailed_description
( ( O
Fig NNP O
. . O
1 CD O
) ) O
. . O

Once RB O
the DT O
contained VBN O
worms NNS B-Sign_symptom
were VBD O
virtually RB O
cleared VBN O
out RP O
under IN O
laparoscope NN B-Diagnostic_procedure
, , O
chodedochoscopy NN B-Diagnostic_procedure
was VBD O
employed VBN O
to TO O
seek VB O
for IN O
more JJR O
hidden JJ B-Detailed_description
worms NNS B-Sign_symptom
inside IN O
the DT O
biliary JJ B-Biological_structure
system NN I-Biological_structure
( ( O
Fig NNP O
. . O
2 CD O
) ) O
. . O

After IN O
finishing VBG O
the DT O
removal NN B-Therapeutic_procedure
of IN O
ascarides NNS O
, , O
the DT O
biliary JJ B-Biological_structure
duct NN I-Biological_structure
incision NN B-Therapeutic_procedure
was VBD I-Therapeutic_procedure
well RB I-Therapeutic_procedure
sutured VBN I-Therapeutic_procedure
, , O
with IN O
a DT O
T NNP B-Therapeutic_procedure
- : I-Therapeutic_procedure
tube NN I-Therapeutic_procedure
placed VBN I-Therapeutic_procedure
in IN O
situ NN O
( ( O
Fig NNP O
. . O
3 CD O
) ) O
. . O

Eventually RB O
, , O
a DT O
standard JJ O
laparoscopic NN B-Detailed_description
cholecystectomy NN B-Therapeutic_procedure
was VBD O
performed VBN O
, , O
followed VBN O
by IN O
the DT O
removal NN B-Therapeutic_procedure
of IN I-Therapeutic_procedure
specimen NNS I-Therapeutic_procedure
bags NNS I-Therapeutic_procedure
and CC O
drainage NN B-Therapeutic_procedure
tube NN I-Therapeutic_procedure
placement NN I-Therapeutic_procedure
( ( O
Fig NNP O
. . O
4 CD O
) ) O
. . O

The DT O
total JJ O
amount NN O
of IN O
worms NNS B-Sign_symptom
inside IN O
the DT O
common JJ B-Biological_structure
bile NN I-Biological_structure
duct NN I-Biological_structure
summed VBD O
up RB O
to TO O
more JJR B-Lab_value
than IN I-Lab_value
100 CD I-Lab_value
( ( O
Fig NNP O
. . O
5 CD O
) ) O
. . O

Postoperatively RB O
, , O
she PRP O
was VBD O
treated VBN O
with IN O
oral JJ O
antihelminthic JJ B-Medication
drugs NNS I-Medication
for IN O
3 CD B-Duration
days NNS I-Duration
. . O

The DT O
T NNP B-Therapeutic_procedure
- : I-Therapeutic_procedure
tube NN I-Therapeutic_procedure
was VBD I-Therapeutic_procedure
rinsed VBN I-Therapeutic_procedure
with IN I-Therapeutic_procedure
saline JJ I-Therapeutic_procedure
every DT O
day NN O
, , O
and CC O
during IN B-Duration
the DT I-Duration
first JJ I-Duration
3 CD I-Duration
days NNS I-Duration
, , O
6 CD B-Lab_value
more JJR O
worms NNS B-Sign_symptom
were VBD O
additionally RB O
washed VBN O
out RP O
. . O

The DT O
patient NN O
experienced VBD O
a DT O
smooth JJ B-Lab_value
postoperative JJ B-Therapeutic_procedure
recovery NN I-Therapeutic_procedure
and CC O
was VBD O
finally RB O
discharged VBN O
from IN B-Nonbiological_location
hospital NN I-Nonbiological_location
without IN O
any DT O
complications NNS B-Sign_symptom
. . O

-DOCSTART- NN -X-

An DT O
18 CD B-Age
- : I-Age
year NN I-Age
- : I-Age
old JJ I-Age
lady NN O
presented VBN O
with IN O
history NN O
of IN O
progressive JJ O
swaying VBG B-Sign_symptom
while IN O
walking VBG O
, , O
worse JJR B-Lab_value
in IN O
night NN B-Time
since IN O
5 CD B-Duration
years NNS I-Duration
. . O

Speech NNP B-Diagnostic_procedure
was VBD O
normal JJ B-Lab_value
and CC O
there EX O
was VBD O
not RB O
any DT O
tremulousness NN B-Sign_symptom
of IN O
upper JJ B-Biological_structure
limbs NNS I-Biological_structure
. . O

Also RB O
, , O
there EX O
was VBD O
no DT O
history NN O
of IN O
weakness NN B-Sign_symptom
or CC O
numbness NN B-Sign_symptom
. . O

The DT O
family NN O
history NN O
was VBD O
significant JJ O
as IN O
her PRP$ O
elder NN O
sister NN O
had VBD O
similar JJ O
difficulty NN B-Sign_symptom
in IN I-Sign_symptom
walking NN I-Sign_symptom
of IN O
7 CD B-Duration
- : I-Duration
year NN I-Duration
duration NN O
and CC O
died VBD O
because IN O
of IN O
poorly RB B-Lab_value
controlled VBN I-Lab_value
diabetes VBZ B-Disease_disorder
mellitus NN I-Disease_disorder
at IN O
an DT O
age NN O
of IN O
20 CD B-Age
years NNS I-Age
. . O

No DT O
other JJ O
members NNS O
of IN O
the DT O
kin NN O
were VBD O
affected JJ O
and CC O
there EX O
was VBD O
no DT O
history NN O
of IN O
consanguinity NN O
in IN O
the DT O
parents NNS O
. . O

The DT O
cognitive JJ B-Diagnostic_procedure
function NN I-Diagnostic_procedure
was VBD O
normal JJ B-Lab_value
and CC O
her PRP$ O
Mini NNP B-Diagnostic_procedure
Mental NNP I-Diagnostic_procedure
Status NNP I-Diagnostic_procedure
Score NNP I-Diagnostic_procedure
was VBD O
30 CD B-Lab_value
/ JJ I-Lab_value
30 CD I-Lab_value
. . O

Visual JJ B-Diagnostic_procedure
acuity NN I-Diagnostic_procedure
and CC O
fundus JJ B-Diagnostic_procedure
examination NN I-Diagnostic_procedure
were VBD O
normal JJ B-Lab_value
. . O

The DT O
extraocular JJ B-Diagnostic_procedure
movements NNS I-Diagnostic_procedure
including VBG O
saccades NNS B-Diagnostic_procedure
, , O
pursuits NNS B-Diagnostic_procedure
were VBD O
normal JJ B-Lab_value
, , O
and CC O
no DT O
saccadic JJ B-Disease_disorder
intrusions NNS I-Disease_disorder
or CC O
nystagmus NNS B-Disease_disorder
were VBD O
noticed VBN O
. . O

The DT O
tone NN B-Diagnostic_procedure
and CC O
power NN B-Diagnostic_procedure
were VBD O
normal JJ B-Lab_value
in IN O
all DT B-Biological_structure
four CD I-Biological_structure
limbs NNS I-Biological_structure
; : O
however RB O
, , O
there EX O
was VBD O
generalised VBN O
exaggeration NN B-Lab_value
of IN O
myotatic JJ B-Diagnostic_procedure
reflexes NNS I-Diagnostic_procedure
along IN O
with IN O
bilateral JJ B-Sign_symptom
extensor NN I-Sign_symptom
plantar NN I-Sign_symptom
response NN I-Sign_symptom
. . O

Vibration NN B-Diagnostic_procedure
and CC O
joint JJ B-Diagnostic_procedure
position NN I-Diagnostic_procedure
sense NN I-Diagnostic_procedure
were VBD O
intact JJ B-Lab_value
but CC O
Romberg NNP B-Diagnostic_procedure
` `` I-Diagnostic_procedure
s NN I-Diagnostic_procedure
was VBD O
positive JJ B-Lab_value
. . O

Patient NNP O
swayed VBD B-Sign_symptom
to TO B-Detailed_description
either DT I-Detailed_description
side NN I-Detailed_description
while IN O
performing VBG B-Activity
tandem JJ I-Activity
walk NN I-Activity
. . O

Fasting VBG B-Detailed_description
and CC O
postprandial JJ B-Detailed_description
blood NN B-Diagnostic_procedure
glucose NN I-Diagnostic_procedure
levels NNS O
were VBD O
normal JJ B-Lab_value
. . O

Haemogram NNP B-Diagnostic_procedure
, , O
renal JJ B-Diagnostic_procedure
, , O
liver RB B-Diagnostic_procedure
and CC O
thyroid JJ B-Diagnostic_procedure
function NN I-Diagnostic_procedure
tests NNS I-Diagnostic_procedure
were VBD O
normal JJ B-Lab_value
. . O

Serum NNP B-Diagnostic_procedure
vitamin NN I-Diagnostic_procedure
B12 NNP I-Diagnostic_procedure
and CC O
folic JJ B-Diagnostic_procedure
acid NN I-Diagnostic_procedure
levels NNS O
were VBD O
within IN O
normal JJ B-Lab_value
limits NNS O
. . O

Nerve NNP B-Diagnostic_procedure
conduction NN I-Diagnostic_procedure
study NN I-Diagnostic_procedure
showed VBD O
absent JJ B-Lab_value
sensory JJ B-Diagnostic_procedure
nerve NN I-Diagnostic_procedure
action NN I-Diagnostic_procedure
potential NN I-Diagnostic_procedure
with IN O
normal JJ B-Lab_value
distal JJ B-Diagnostic_procedure
latency NN I-Diagnostic_procedure
, , O
conduction NN B-Diagnostic_procedure
velocity NN I-Diagnostic_procedure
and CC O
amplitude NN B-Diagnostic_procedure
of IN I-Diagnostic_procedure
compound NN I-Diagnostic_procedure
muscle NN I-Diagnostic_procedure
action NN I-Diagnostic_procedure
potential NN I-Diagnostic_procedure
( ( O
CMAP NNP B-Diagnostic_procedure
) ) O
in IN O
all DT O
nerves NNS B-Biological_structure
trunks NNS I-Biological_structure
. . O

MRI NNP B-Diagnostic_procedure
showed VBD O
marked JJ B-Severity
atrophy NN B-Sign_symptom
of IN O
the DT O
cervical JJ B-Biological_structure
cord NN I-Biological_structure
as IN O
compared VBN O
to TO O
cerebellum VB B-Biological_structure
which WDT O
was VBD O
normal JJ B-Lab_value
( ( O
figure JJ O
1 CD O
) ) O
. . O

The DT O
genetic JJ B-Diagnostic_procedure
testing NN I-Diagnostic_procedure
using VBG O
PCR NNP B-Diagnostic_procedure
disclosed VBD O
expansion NN B-Sign_symptom
of IN I-Sign_symptom
GAA NNP I-Sign_symptom
repeat NN I-Sign_symptom
in IN O
both DT B-Detailed_description
alleles NNS I-Detailed_description
( ( I-Detailed_description
254 CD I-Detailed_description
and CC I-Detailed_description
298 CD I-Detailed_description
) ) I-Detailed_description
of IN I-Detailed_description
FXN NNP I-Detailed_description
gene NN I-Detailed_description
. . O

A DT O
variety NN O
of IN O
causes NNS O
of IN O
autosomal JJ B-Disease_disorder
recessive JJ I-Disease_disorder
ataxias NNS I-Disease_disorder
need VBP O
to TO O
be VB O
considered VBN O
in IN O
the DT O
differential JJ O
diagnosis NN O
of IN O
FRDA NNP B-Disease_disorder
. . O

These DT O
were VBD O
systemically RB O
excluded VBN O
here RB O
. . O

Ataxia NNP B-Disease_disorder
with IN I-Disease_disorder
vitamin NNP I-Disease_disorder
E NNP I-Disease_disorder
deficiency NN I-Disease_disorder
( ( O
AVED NNP B-Disease_disorder
) ) O
has VBZ O
a DT O
phenotype NN O
quite RB O
similar JJ O
to TO O
FRDA NNP O
, , O
though IN O
titubation NN B-Sign_symptom
and CC O
hyperkinesia NN B-Sign_symptom
are VBP O
more RBR O
common JJ O
in IN O
AVED NNP O
. . O
4 CD O
A NNP O
strong JJ O
family NN O
history NN O
of IN O
ataxia NN O
and CC O
diabetes VBZ O
mellitus NNS O
in IN O
elder NN O
sister NN O
favoured VBD O
FRDA NNP O
. . O

Ataxia NNP B-Disease_disorder
with IN I-Disease_disorder
oculomotor NN I-Disease_disorder
apraxia NN I-Disease_disorder
( ( O
AOA NNP B-Disease_disorder
) ) O
types VBZ B-Detailed_description
1 CD I-Detailed_description
and CC I-Detailed_description
2 CD I-Detailed_description
were VBD O
not RB O
considered VBN O
owing VBG O
to TO O
lack VB O
of IN O
apraxia NN B-Sign_symptom
of IN I-Sign_symptom
ocular JJ I-Sign_symptom
movements NNS I-Sign_symptom
, , O
distal JJ B-Sign_symptom
amyotrophy NN I-Sign_symptom
( ( O
severe JJ B-Severity
axonal JJ B-Sign_symptom
sensorimotor NN I-Sign_symptom
polyneuropathy NN I-Sign_symptom
) ) O
, , O
atrophy NN B-Sign_symptom
of IN O
cerebellum NN B-Biological_structure
and CC O
involuntary JJ B-Sign_symptom
movements NNS I-Sign_symptom
. . O
5 CD O
Ataxia NNP B-Disease_disorder
telengiectesia NN I-Disease_disorder
has VBZ O
presentation NN O
very RB O
similar JJ O
to TO O
AOA NNP O
types NNS O
1 CD O
and CC O
2 CD O
. . O

Muco NNP B-Sign_symptom
- : I-Sign_symptom
cutaneous JJ I-Sign_symptom
markers NNS I-Sign_symptom
, , O
sino NN B-Biological_structure
- : I-Biological_structure
pulmonary JJ I-Biological_structure
infections NNS B-Sign_symptom
, , O
hypogammaglobulinaemia NN B-Sign_symptom
and CC O
radiosensitivity NN B-Sign_symptom
along IN O
with IN O
predisposition NN O
to TO O
development NN O
of IN O
a DT O
variety NN O
of IN O
neoplasms NNS B-Sign_symptom
are VBP O
features NNS O
of IN O
ataxia NN O
telengiectasia NN O
not RB O
seen VBN O
in IN O
AOAs NNP O
and CC O
FRDA NNP O
. . O

The DT O
other JJ O
important JJ O
causes NNS O
of IN O
autosomal JJ B-Disease_disorder
recessive JJ I-Disease_disorder
spastic JJ I-Disease_disorder
ataxia NNS I-Disease_disorder
apart RB O
from IN O
FRDA NNP O
would MD O
be VB O
autosomal JJ B-Disease_disorder
recessive JJ I-Disease_disorder
spastic JJ I-Disease_disorder
ataxia NN I-Disease_disorder
of IN I-Disease_disorder
Charlevoix NNP I-Disease_disorder
- : I-Disease_disorder
Saguenay NN I-Disease_disorder
and CC O
Marinesco NNP B-Disease_disorder
- : I-Disease_disorder
Sjögren NNP I-Disease_disorder
syndrome NN I-Disease_disorder
. . O

Charcot NNP B-Disease_disorder
- : I-Disease_disorder
Marie NNP I-Disease_disorder
- : I-Disease_disorder
Tooth DT I-Disease_disorder
disease NN I-Disease_disorder
, , O
an DT O
inherited VBN B-Detailed_description
polyneuropathy NN B-Disease_disorder
has VBZ O
gait VBN B-Sign_symptom
ataxia NNS I-Sign_symptom
in IN O
common JJ O
with IN O
FRDA NNP O
; : O
however RB O
, , O
in IN O
this DT O
case NN O
, , O
CMT NNP B-Disease_disorder
was VBD O
improbable JJ O
due JJ O
to TO O
following VBG O
features NNS O
in IN O
this DT O
case NN O
: : O
lack NN O
of IN O
motor NN B-Sign_symptom
weakness NN I-Sign_symptom
, , O
retained VBD B-Sign_symptom
reflexes NNS I-Sign_symptom
, , O
bilaterally RB B-Sign_symptom
extensor JJ I-Sign_symptom
plantar NN I-Sign_symptom
and CC O
pure NN B-Sign_symptom
sensory NN I-Sign_symptom
neuropathy NN I-Sign_symptom
on IN O
nerve NN B-Diagnostic_procedure
conduction NN I-Diagnostic_procedure
study NN I-Diagnostic_procedure
. . O

Idebenone NN B-Medication
was VBD O
started VBN O
at IN O
a DT O
dose NN O
of IN O
450 CD B-Dosage
mg NN I-Dosage
twice RB I-Dosage
a DT I-Dosage
day NN I-Dosage
for IN O
its PRP$ O
antioxidant JJ B-Detailed_description
properties NNS I-Detailed_description
. . O

For IN O
gait NN O
ataxia NN O
, , O
physiotherapy SYM B-Therapeutic_procedure
- : O
Frenkel NNP B-Therapeutic_procedure
` `` I-Therapeutic_procedure
s NN I-Therapeutic_procedure
exercise NN I-Therapeutic_procedure
- : O
was VBD O
initiated VBN O
. . O

Blood NNP B-Diagnostic_procedure
glucose NN I-Diagnostic_procedure
is VBZ O
monitored VBN O
regularly RB B-Frequency
. . O

At IN O
4 CD O
months NNS O
, , O
there EX O
was VBD O
no DT B-Severity
significant JJ I-Severity
change NN I-Severity
in IN O
the DT O
gait NN B-Diagnostic_procedure
difficulty NN I-Diagnostic_procedure
. . O

-DOCSTART- NN -X-

A DT O
69 CD B-Age
- : I-Age
year NN I-Age
- : I-Age
old JJ I-Age
man NN O
became VBD O
aware JJ O
of IN O
the DT O
onset NN O
of IN O
exertional JJ B-Detailed_description
dyspnea NN B-Sign_symptom
in IN O
July NNP O
2010 CD O
. . O

He PRP O
had VBD O
a DT O
history NN O
of IN O
smoking VBG O
for IN O
more JJR O
than IN O
40 CD O
years NNS O
, , O
20 CD O
cigarettes NNS O
per IN O
day NN O
. . O

His PRP$ O
parents NNS O
and CC O
1 CD O
brother NN O
had VBD O
lung NN O
cancer NN O
. . O

His PRP$ O
past JJ O
medical JJ O
history NN O
was VBD O
unremarkable JJ O
. . O

He PRP O
had VBD O
no DT O
occupational JJ O
exposure NN O
. . O

Due JJ O
to TO O
the DT O
exertional JJ B-Detailed_description
dyspnea NN B-Sign_symptom
, , O
he PRP O
was VBD O
admitted VBN O
to TO O
the DT O
People NNP B-Nonbiological_location
` `` I-Nonbiological_location
s JJ I-Nonbiological_location
Hospital NN I-Nonbiological_location
of IN I-Nonbiological_location
Shunde NNP I-Nonbiological_location
District NNP I-Nonbiological_location
for IN O
echocardiography NN B-Diagnostic_procedure
and CC O
computed VBD B-Diagnostic_procedure
tomography NN I-Diagnostic_procedure
pulmonary JJ I-Diagnostic_procedure
angiography NN I-Diagnostic_procedure
( ( O
CTPA NNP B-Diagnostic_procedure
) ) O
. . O

Echocardiography NN B-Diagnostic_procedure
indicated VBD O
that IN O
he PRP O
had VBD O
severe JJ B-Severity
PAH NNP B-Disease_disorder
, , O
because IN O
his PRP$ O
pulmonary JJ B-Diagnostic_procedure
arterial JJ I-Diagnostic_procedure
pressure NN I-Diagnostic_procedure
( ( O
PAP NNP B-Diagnostic_procedure
) ) O
was VBD O
104 CD B-Lab_value
mmHg NN I-Lab_value
, , O
and CC O
his PRP$ O
right JJ B-Biological_structure
heart NN I-Biological_structure
was VBD O
enlarged VBN B-Sign_symptom
( ( O
the DT O
right NN B-Diagnostic_procedure
ventricle NN I-Diagnostic_procedure
diameter NN I-Diagnostic_procedure
: : O
57 CD B-Lab_value
mm NN I-Lab_value
) ) O
. . O

CTPA NNP B-Diagnostic_procedure
showed VBD O
that IN O
he PRP O
had VBD O
not RB O
only RB O
PAH NNP B-Disease_disorder
, , O
but CC O
also RB O
a DT O
thrombus NN B-Disease_disorder
in IN O
the DT O
upper JJ B-Biological_structure
lobe NN I-Biological_structure
artery NN I-Biological_structure
of IN I-Biological_structure
the DT I-Biological_structure
right JJ I-Biological_structure
lung NN I-Biological_structure
. . O

However RB O
, , O
the DT O
region NN B-Biological_structure
in IN I-Biological_structure
the DT I-Biological_structure
lung NN I-Biological_structure
affected VBN O
by IN O
this DT O
PE NNP O
was VBD O
considered VBN O
too RB O
small JJ O
to TO O
induce VB O
such PDT O
a DT O
severe JJ O
PAH NNP O
. . O

In IN O
addition NN O
, , O
he PRP O
did VBD O
not RB O
have VB O
connective JJ O
tissue NN O
disease NN O
, , O
drug NN O
use NN O
, , O
history NN O
of IN O
chemotherapy NN O
, , O
or CC O
HIV NNP O
test NN O
( ( O
+ NN O
) ) O
, , O
so IN O
he PRP O
was VBD O
diagnosed VBN O
as IN O
IPAH NNP B-Disease_disorder
combined VBD O
with IN O
PE NNP B-Disease_disorder
. . O

He PRP O
was VBD O
treated VBN O
with IN O
warfarin NN B-Medication
( ( O
2 CD B-Dosage
. . I-Dosage
5 CD I-Dosage
mg JJ I-Dosage
per IN I-Dosage
day NN I-Dosage
with IN O
a DT O
target NN O
of IN O
the DT O
international JJ B-Diagnostic_procedure
normalized JJ I-Diagnostic_procedure
ratio NN I-Diagnostic_procedure
[ NNP O
INR NNP B-Diagnostic_procedure
] NNP O
between IN O
1 CD B-Lab_value
. . I-Lab_value
5 CD I-Lab_value
and CC I-Lab_value
2 CD I-Lab_value
. . I-Lab_value
5 CD I-Lab_value
) ) O
and CC O
slidenafil $ B-Medication
targeted VBN O
PAH NNP O
therapy NN O
( ( O
20 CD B-Dosage
mg NN I-Dosage
twice RB I-Dosage
per IN I-Dosage
day NN I-Dosage
) ) O
. . O

The DT O
patient NN O
` `` O
s JJ O
dyspnea NN B-Sign_symptom
was VBD O
relieved VBN O
slightly RB O
after IN O
the DT O
use NN O
of IN O
these DT O
medications NNS B-Medication
for IN O
1 CD B-Duration
month NN I-Duration
and CC O
the DT O
retested VBN O
PAP NNP B-Diagnostic_procedure
by IN O
echocardiography NN B-Detailed_description
was VBD O
decreased VBN B-Lab_value
to TO O
72 CD B-Lab_value
mmHg NN I-Lab_value
, , O
but CC O
all PDT O
the DT O
other JJ B-Sign_symptom
symptoms NNS I-Sign_symptom
and CC I-Sign_symptom
signs NNS I-Sign_symptom
failed VBD B-Lab_value
to TO I-Lab_value
further RBR I-Lab_value
improve VB I-Lab_value
after IN O
taking VBG O
these DT O
medications NNS B-Medication
for IN O
6 CD B-Duration
months NNS I-Duration
. . O

In IN O
March NNP O
2011 CD O
, , O
he PRP O
went VBD O
to TO O
the DT O
Kyorin NNP B-Nonbiological_location
University NNP I-Nonbiological_location
affiliated VBD I-Nonbiological_location
hospital NN I-Nonbiological_location
in IN O
Japan NNP B-Nonbiological_location
for IN O
further JJ O
treatment NN O
. . O

Right JJ B-Biological_structure
heart NN I-Biological_structure
catheterization NN B-Diagnostic_procedure
revealed VBD O
PAP NNP B-Diagnostic_procedure
72 CD B-Lab_value
/ VBD I-Lab_value
34 CD I-Lab_value
/ JJ I-Lab_value
47 CD I-Lab_value
mmHg NN I-Lab_value
, , O
pulmonary JJ B-Diagnostic_procedure
capillary JJ I-Diagnostic_procedure
wedge NN I-Diagnostic_procedure
pressure NN I-Diagnostic_procedure
( ( O
PCWP NNP B-Diagnostic_procedure
) ) O
17 CD B-Lab_value
/ $ I-Lab_value
5 CD I-Lab_value
/ $ I-Lab_value
10 CD I-Lab_value
mmHg NN I-Lab_value
, , O
cardiac JJ B-Diagnostic_procedure
output NN I-Diagnostic_procedure
4 CD B-Lab_value
. . I-Lab_value
3 CD I-Lab_value
L NNP I-Lab_value
/ NNP I-Lab_value
min NN I-Lab_value
, , O
cardiac JJ B-Diagnostic_procedure
ejection NN I-Diagnostic_procedure
index NN I-Diagnostic_procedure
2 CD B-Lab_value
. . I-Lab_value
36 CD I-Lab_value
L NNP I-Lab_value
/ NNP I-Lab_value
min NNP I-Lab_value
/ NNP I-Lab_value
m2 NN I-Lab_value
, , O
and CC O
pulmonary JJ B-Diagnostic_procedure
vascular NN I-Diagnostic_procedure
resistance NN I-Diagnostic_procedure
7 CD B-Lab_value
. . I-Lab_value
3 CD I-Lab_value
Wood NNP I-Lab_value
units NNS I-Lab_value
. . O

He PRP O
was VBD O
retested VBN O
for IN O
CTPA NNP B-Diagnostic_procedure
that WDT O
showed VBD O
that IN O
the DT O
thrombus NN B-Disease_disorder
in IN O
the DT O
upper JJ B-Biological_structure
lobe NN I-Biological_structure
artery NN I-Biological_structure
of IN I-Biological_structure
the DT I-Biological_structure
right JJ I-Biological_structure
lung NN I-Biological_structure
disappeared VBD O
. . O

He PRP O
was VBD O
still RB O
diagnosed VBN O
as IN O
having VBG O
IPAH NNP B-Disease_disorder
, , O
so RB O
treated JJ O
with IN O
sildenafil NN B-Medication
( ( O
20 CD B-Dosage
mg RB I-Dosage
3 CD I-Dosage
times NNS I-Dosage
a DT I-Dosage
day NN I-Dosage
) ) O
and CC O
sorafenib NN B-Medication
( ( O
400 CD B-Dosage
mg NN I-Dosage
once RB I-Dosage
a DT I-Dosage
day NN I-Dosage
) ) O
targeted VBD O
PAH NNP B-Therapeutic_procedure
therapy NN I-Therapeutic_procedure
and CC O
oral JJ O
warfarin NN B-Medication
anticoagulation NN B-Therapeutic_procedure
therapy NN I-Therapeutic_procedure
( ( O
2 CD B-Dosage
. . I-Dosage
5 CD I-Dosage
- : I-Dosage
3 CD I-Dosage
. . I-Dosage
75 CD I-Dosage
mg JJ I-Dosage
per IN I-Dosage
day NN I-Dosage
, , O
but CC O
the DT O
daily JJ O
dose NN O
was VBD O
adjusted VBN O
by IN O
INR NNP B-Diagnostic_procedure
that WDT O
was VBD O
between IN O
2 CD B-Lab_value
and CC I-Lab_value
3 CD I-Lab_value
) ) O
. . O

Disappointingly RB O
, , O
his PRP$ O
dyspnea NN B-Sign_symptom
was VBD O
not RB O
relieved VBN O
and CC O
the DT O
PAP NNP B-Diagnostic_procedure
tested VBN O
by IN O
the DT O
echocardiography NN B-Detailed_description
was VBD O
around IN B-Lab_value
95 CD I-Lab_value
mmHg NN I-Lab_value
. . O

In IN O
September NNP O
2011 CD O
, , O
he PRP O
visited VBD O
the DT O
Shanghai NNP B-Nonbiological_location
Pulmonary NNP I-Nonbiological_location
hospital NN I-Nonbiological_location
in IN O
China NNP B-Nonbiological_location
because IN O
of IN O
no DT O
relief NN O
of IN O
dyspnea NN B-Sign_symptom
. . O

Arterial NNP B-Diagnostic_procedure
blood NN I-Diagnostic_procedure
gas NN I-Diagnostic_procedure
analysis NN I-Diagnostic_procedure
showed VBD O
that IN O
PaO2 NNP B-Diagnostic_procedure
was VBD O
63 CD B-Lab_value
mmHg NN I-Lab_value
with IN O
oxygen NN B-Diagnostic_procedure
saturation NN I-Diagnostic_procedure
93 CD B-Lab_value
% NN I-Lab_value
; : O
lung CC B-Diagnostic_procedure
function NN I-Diagnostic_procedure
test NN I-Diagnostic_procedure
revealed VBD O
a DT O
mild JJ B-Severity
obstructive JJ B-Disease_disorder
dysfunction NN I-Disease_disorder
of IN O
the DT O
pulmonary JJ B-Detailed_description
ventilation NN I-Detailed_description
( ( O
FEV1 NNP B-Diagnostic_procedure
/ NNP I-Diagnostic_procedure
FVC NNP I-Diagnostic_procedure
62 CD B-Lab_value
. . I-Lab_value
06 CD I-Lab_value
% NN I-Lab_value
, , O
FEV1 NNP B-Diagnostic_procedure
% NN I-Diagnostic_procedure
Prediction NNP B-Detailed_description
80 CD B-Lab_value
. . I-Lab_value
9 CD I-Lab_value
% NN I-Lab_value
) ) O
and CC O
a DT O
severe JJ O
reduction NN B-Lab_value
in IN O
the DT O
diffusing NN B-Diagnostic_procedure
capacity NN I-Diagnostic_procedure
of IN I-Diagnostic_procedure
the DT I-Diagnostic_procedure
lungs NNS I-Diagnostic_procedure
for IN I-Diagnostic_procedure
carbon NN I-Diagnostic_procedure
monoxide NN I-Diagnostic_procedure
( ( O
DLCO NNP B-Diagnostic_procedure
42 CD B-Lab_value
% NN I-Lab_value
) ) O
; : O
6 CD B-Detailed_description
- : I-Detailed_description
minute NN I-Detailed_description
walk VBP B-Diagnostic_procedure
test NN I-Diagnostic_procedure
was VBD O
385 CD B-Lab_value
m NN I-Lab_value
. . O

Chest NNP B-Biological_structure
high JJ B-Diagnostic_procedure
- : I-Diagnostic_procedure
resolution NN I-Diagnostic_procedure
computed VBD I-Diagnostic_procedure
tomography NN I-Diagnostic_procedure
( ( O
HRCT NNP B-Diagnostic_procedure
) ) O
( ( O
Fig NNP O
. . O
1A CD O
and CC O
B NNP O
) ) O
showed VBD O
smooth JJ B-Texture
thickening NN B-Sign_symptom
of IN O
interlobular JJ B-Biological_structure
septa NN I-Biological_structure
, , O
diffuse IN B-Detailed_description
centrilobular JJ B-Biological_structure
nodules NNS B-Sign_symptom
, , O
and CC O
the DT O
enlargement NN B-Sign_symptom
of IN O
mediastinal JJ B-Biological_structure
lymph NN I-Biological_structure
nodes NNS I-Biological_structure
. . O

The DT O
right JJ B-Biological_structure
heart NN I-Biological_structure
catheterization NN B-Diagnostic_procedure
revealed VBD O
that IN O
PAP NNP B-Diagnostic_procedure
was VBD O
83 CD B-Lab_value
/ JJ I-Lab_value
34 CD I-Lab_value
/ JJ I-Lab_value
53 CD I-Lab_value
mmHg NN I-Lab_value
and CC O
PCWP NNP B-Diagnostic_procedure
was VBD O
14 CD B-Lab_value
/ JJ I-Lab_value
6 CD I-Lab_value
/ JJ I-Lab_value
11 CD I-Lab_value
mmHg NN I-Lab_value
. . O

Acute NNP B-Diagnostic_procedure
vasodilator NN I-Diagnostic_procedure
testing NN I-Diagnostic_procedure
was VBD O
negative JJ B-Lab_value
. . O

Coronary JJ B-Diagnostic_procedure
angiography NN I-Diagnostic_procedure
and CC O
CTPA NNP B-Diagnostic_procedure
were VBD O
both DT O
normal JJ B-Lab_value
; : O
pulmonary JJ B-Biological_structure
ventilation NN B-Diagnostic_procedure
/ NNP I-Diagnostic_procedure
perfusion NN I-Diagnostic_procedure
( ( O
V NNP B-Diagnostic_procedure
` `` I-Diagnostic_procedure
/ RB I-Diagnostic_procedure
Q NNP I-Diagnostic_procedure
` `` I-Diagnostic_procedure
) ) O
lung NN B-Biological_structure
scan JJ O
showed VBD O
a DT O
matched VBN B-Sign_symptom
ventilation NN I-Sign_symptom
and CC I-Sign_symptom
perfusion NN I-Sign_symptom
defects NNS I-Sign_symptom
. . O

Bronchoalveolar JJ B-Diagnostic_procedure
lavage NN I-Diagnostic_procedure
showed VBD O
an DT O
elevated JJ B-Lab_value
percentage NN O
( ( O
65 CD B-Lab_value
% NN I-Lab_value
) ) O
of IN O
hemosiderin NN B-Biological_structure
- : I-Biological_structure
laden JJ I-Biological_structure
macrophages NNS I-Biological_structure
with IN O
the DT O
Golde NNP B-Diagnostic_procedure
score NN I-Diagnostic_procedure
80 CD B-Lab_value
( ( O
the DT O
normal JJ O
range NN O
: : O
0 CD O
- : O
20 CD O
) ) O
. . O

He PRP O
was VBD O
still RB O
diagnosed VBN O
as IN O
having VBG O
IPAH NNP B-Disease_disorder
, , O
but CC O
he PRP O
was VBD O
suspected VBN O
as IN O
actually RB O
having VBG O
PVOD NNP B-Disease_disorder
. . O

He PRP O
was VBD O
continuously RB O
treated VBN O
with IN O
the DT O
targeted JJ O
PAH NNP B-Therapeutic_procedure
therapy NN I-Therapeutic_procedure
, , O
and CC O
he PRP O
was VBD O
asked VBN O
to TO O
continue VB O
his PRP$ O
anticoagulation NN B-Therapeutic_procedure
treatment NN I-Therapeutic_procedure
, , O
but CC O
he PRP O
stopped VBD O
warfarin JJ B-Medication
anticoagulation NN O
treatment NN O
by IN B-Detailed_description
himself PRP I-Detailed_description
sometime RB O
in IN O
2014 CD O
( ( O
he PRP O
failed VBD O
to TO O
recall VB O
the DT O
exact JJ O
date NN O
. . O
) ) O
because IN O
he PRP O
felt VBD O
that IN O
it PRP O
was VBD O
too RB O
cumbersome JJ O
to TO O
frequently RB O
test VB O
the DT O
INR NNP O
for IN O
blood NN O
coagulation NN O
monitoring NN O
. . O

Furthermore RB O
, , O
after IN O
he PRP O
discontinued VBD O
his PRP$ O
warfarin NN O
therapy NN O
, , O
he PRP O
also RB O
failed VBD O
to TO O
monitor VB B-Diagnostic_procedure
D NNP I-Diagnostic_procedure
- : I-Diagnostic_procedure
Dimer NN I-Diagnostic_procedure
to TO O
prevent VB O
PE NNP O
recurrence NN O
. . O

His PRP$ O
dyspnea NN B-Sign_symptom
was VBD O
relatively RB O
stable JJ B-Lab_value
, , O
but CC O
he PRP O
developed VBD O
many JJ B-Detailed_description
, , O
but CC O
not RB B-Severity
fatal JJ I-Severity
, , O
episodes NNS O
of IN O
pulmonary JJ B-Disease_disorder
edema NN I-Disease_disorder
during IN O
the DT O
therapy NN O
. . O

In IN O
January NNP O
2015 CD O
, , O
he PRP O
was VBD O
rushed VBN O
to TO O
hospital VB B-Nonbiological_location
because IN O
his PRP$ O
dyspnea NN B-Sign_symptom
was VBD O
suddenly RB O
exacerbated VBN B-Detailed_description
. . O

CTPA NNP B-Diagnostic_procedure
showed VBD O
a DT O
thrombus NN B-Disease_disorder
in IN O
the DT O
right NN B-Biological_structure
main JJ I-Biological_structure
pulmonary JJ I-Biological_structure
artery NN I-Biological_structure
( ( O
Fig NNP O
. . O
1C CD O
) ) O
. . O

Rivaroxaban NNP B-Medication
was VBD O
administered VBN O
for IN O
anticoagulation NN B-Therapeutic_procedure
treatment NN I-Therapeutic_procedure
, , O
but CC O
this DT O
medication NN O
did VBD O
not RB O
relieve VB O
his PRP$ O
dyspnea NN B-Sign_symptom
, , O
therefore RB O
, , O
he PRP O
was VBD O
too RB B-Sign_symptom
ill JJ I-Sign_symptom
to TO I-Sign_symptom
walk VB I-Sign_symptom
. . O

Instead RB O
, , O
he PRP O
was VBD O
bound VBN B-Activity
to TO I-Activity
his PRP$ I-Activity
wheelchair NN I-Activity
for IN O
half PDT B-Duration
a DT I-Duration
year NN I-Duration
. . O

The DT O
severe JJ O
PAH NNP B-Disease_disorder
( ( O
suspected VBN O
as IN O
PVOD NNP B-Disease_disorder
) ) O
combined VBD O
with IN O
a DT O
life NN B-Severity
- : I-Severity
threatening VBG I-Severity
PE NNP B-Disease_disorder
mandates VBZ O
a DT O
lung NN B-Therapeutic_procedure
transplantation NN I-Therapeutic_procedure
for IN O
his PRP$ O
survival NN O
. . O

Six CD O
months NNS O
later RB O
, , O
he PRP O
was VBD O
undergone RB O
a DT O
bilateral JJ B-Detailed_description
sequential JJ B-Detailed_description
allogenic NN B-Detailed_description
lung NN B-Therapeutic_procedure
transplantation NN I-Therapeutic_procedure
assisted VBN O
by IN O
veno JJ B-Therapeutic_procedure
- : I-Therapeutic_procedure
arterial JJ I-Therapeutic_procedure
extra JJ I-Therapeutic_procedure
- : I-Therapeutic_procedure
corporeal NN I-Therapeutic_procedure
membrane NN I-Therapeutic_procedure
oxygenation NN I-Therapeutic_procedure
( ( O
VA NNP B-Therapeutic_procedure
- : I-Therapeutic_procedure
ECMO NN I-Therapeutic_procedure
) ) O
after IN O
he PRP O
signed VBD O
the DT O
written VBN O
consent NN O
on IN O
July NNP O
29 CD O
, , O
2015 CD O
. . O

Histology NN B-Diagnostic_procedure
of IN O
the DT O
explanted JJ B-Biological_structure
lung NN I-Biological_structure
specimen NNS I-Biological_structure
showed VBD O
pulmonary JJ B-Biological_structure
vein NN I-Biological_structure
occlusion NN B-Lab_value
( ( O
Fig NNP O
. . O
1D CD O
- : O
F NN O
) ) O
and CC O
the DT O
pulmonary JJ B-Biological_structure
embolism NN B-Lab_value
in IN O
the DT O
right JJ B-Biological_structure
pulmonary JJ I-Biological_structure
artery NN I-Biological_structure
. . O

Until IN O
then RB O
, , O
he PRP O
was VBD O
confirmed VBN O
as IN O
having VBG O
PVOD NNP B-Disease_disorder
combined VBN O
with IN O
PE NNP B-Disease_disorder
, , O
instead RB O
of IN O
IPAH NNP B-Disease_disorder
. . O

He PRP O
has VBZ O
been VBN O
living VBG O
well RB B-Sign_symptom
without IN O
dyspnea NN B-Sign_symptom
for IN O
more JJR B-Duration
than IN I-Duration
1 CD I-Duration
year NN I-Duration
after IN O
the DT O
lung NN O
transplantation NN O
and CC O
the DT O
echocardiography NN B-Diagnostic_procedure
showed VBD O
the DT O
normalizations NNS B-Lab_value
of IN O
PAP NNP B-Diagnostic_procedure
and CC O
the DT O
once RB O
enlarged VBN B-Sign_symptom
right JJ B-Biological_structure
ventricle NN I-Biological_structure
of IN I-Biological_structure
his PRP$ I-Biological_structure
heart NN I-Biological_structure
. . O

This DT O
study NN O
was VBD O
approved VBN O
by IN O
the DT O
Ethics NNP O
Committee NNP O
of IN O
The DT O
People NNP O
` `` O
s JJ O
Hospital NN O
of IN O
Zhongshan NNP O
City NNP O
. . O

The DT O
written VBN O
informed JJ O
consent NN O
was VBD O
obtained VBN O
from IN O
the DT O
patient NN O
. . O

-DOCSTART- NN -X-

A DT O
52 CD B-Age
- : I-Age
year NN I-Age
- : I-Age
old JJ I-Age
man NN O
with IN O
a DT O
30 CD O
- : O
year NN O
history NN O
of IN O
smoking VBG O
presented VBN O
with IN O
an DT O
abnormal JJ B-Detailed_description
nodule NN B-Sign_symptom
measuring VBG O
0 CD B-Area
. . I-Area
8 CD I-Area
× JJ I-Area
1 CD I-Area
. . I-Area
5 CD I-Area
cm NN I-Area
in IN O
the DT O
left NN B-Biological_structure
upper JJ I-Biological_structure
lung NN I-Biological_structure
lobe NN I-Biological_structure
imaged VBD O
through IN O
chest NN B-Biological_structure
computed VBN B-Diagnostic_procedure
tomography NN I-Diagnostic_procedure
( ( O
CT NNP B-Diagnostic_procedure
) ) O
scanning NN O
in IN O
March NNP O
2012 CD O
in IN O
a DT O
community NN B-Nonbiological_location
hospital NN I-Nonbiological_location
. . O

He PRP O
had VBD O
previously RB O
been VBN O
well RB O
without IN O
any DT O
additional JJ O
relevant NN O
or CC O
abnormal JJ O
symptoms NNS O
. . O

Physical JJ B-Diagnostic_procedure
examination NN I-Diagnostic_procedure
suggested VBD O
no DT O
significant JJ O
abnormalities NNS B-Sign_symptom
. . O

Laboratory JJ B-Diagnostic_procedure
findings NNS I-Diagnostic_procedure
were VBD O
within IN B-Lab_value
normal JJ I-Lab_value
range NN I-Lab_value
, , O
except IN O
for IN O
a DT O
carcinoembryonic JJ B-Diagnostic_procedure
antigen NN I-Diagnostic_procedure
( ( O
CEA NNP B-Diagnostic_procedure
) ) O
level NN O
of IN O
30 CD B-Lab_value
. . I-Lab_value
25 CD I-Lab_value
ng JJ I-Lab_value
/ NN I-Lab_value
mL NN I-Lab_value
( ( O
normal JJ O
range NN O
, , O
0 CD O
- : O
5 CD O
ng JJ O
/ NNP O
mL NN O
) ) O
found VBD O
in IN O
the DT O
serum NN B-Biological_structure
. . O

Subsequently RB O
, , O
a DT O
positron NN B-Diagnostic_procedure
emission NN I-Diagnostic_procedure
tomography NN I-Diagnostic_procedure
( ( O
PET NNP B-Diagnostic_procedure
) ) O
/ VBP O
CT NNP B-Diagnostic_procedure
scan JJ O
showed VBD O
a DT O
lung NN B-Biological_structure
lesion NN B-Sign_symptom
with IN O
a DT O
standardized JJ B-Diagnostic_procedure
uptake JJ I-Diagnostic_procedure
value NN I-Diagnostic_procedure
of IN O
7 CD B-Lab_value
. . I-Lab_value
94 CD I-Lab_value
, , O
which WDT O
was VBD O
highly RB O
suspected VBN O
to TO O
be VB O
a DT O
malignant JJ B-Disease_disorder
tumor NN I-Disease_disorder
( ( O
Fig NNP O
. . O
1 CD O
) ) O
. . O

Subsequently RB O
, , O
he PRP O
underwent JJ O
left VBD B-Biological_structure
upper JJ I-Biological_structure
lung NN I-Biological_structure
lobectomy NN B-Therapeutic_procedure
and CC O
lymph NN B-Therapeutic_procedure
node JJ I-Therapeutic_procedure
dissection NN I-Therapeutic_procedure
. . O

Postoperative JJ O
pathological JJ B-Diagnostic_procedure
examination NN I-Diagnostic_procedure
revealed VBD O
an DT O
adenocarcinoma NN B-Disease_disorder
( ( O
ADC NNP B-Disease_disorder
) ) O
( ( O
Fig NNP O
. . O
2A CD O
) ) O
. . O

Immunohistochemistry NNP B-Diagnostic_procedure
( ( O
IHC NNP B-Diagnostic_procedure
) ) O
staining VBG O
results NNS O
were VBD O
positive JJ B-Lab_value
for IN O
CK7 NNP B-Diagnostic_procedure
, , O
TTF NNP B-Diagnostic_procedure
- : I-Diagnostic_procedure
1 CD I-Diagnostic_procedure
, , O
p63 NN B-Diagnostic_procedure
, , O
and CC O
NapsinA NNP B-Diagnostic_procedure
and CC O
negative JJ B-Lab_value
for IN O
CK NNP B-Diagnostic_procedure
5 CD I-Diagnostic_procedure
/ NNP I-Diagnostic_procedure
6 CD I-Diagnostic_procedure
, , O
Syn NNP B-Diagnostic_procedure
, , O
cgA NN B-Diagnostic_procedure
, , O
and CC O
Ki NNP B-Diagnostic_procedure
- : I-Diagnostic_procedure
67 CD I-Diagnostic_procedure
( ( O
20 CD O
% NN O
- : O
30 CD O
% NN O
) ) O
. . O

The DT O
clinical JJ B-Diagnostic_procedure
stage NN I-Diagnostic_procedure
was VBD O
classified VBN O
as IN O
IA2 NNP B-Lab_value
( ( O
pT1bN0M0 NN B-Lab_value
) ) O
. . O

Because IN O
the DT O
tumor NN O
was VBD O
still RB O
in IN O
an DT O
early JJ B-Detailed_description
stage NN I-Detailed_description
, , O
the DT O
patient NN O
did VBD O
not RB O
receive VB O
adjuvant JJ B-Medication
treatment NN I-Medication
but CC O
continued VBD O
to TO O
be VB O
monitored VBN B-Therapeutic_procedure
through IN O
regular JJ O
hospital NN B-Nonbiological_location
visits NNS O
every DT B-Frequency
3 CD I-Frequency
months NNS I-Frequency
. . O

The DT O
patient NN O
` `` O
s JJ O
condition NN B-Diagnostic_procedure
had VBD O
been VBN O
stable JJ B-Lab_value
until IN O
the DT O
onset NN O
of IN O
left JJ B-Biological_structure
chest NN I-Biological_structure
pain NN B-Sign_symptom
in IN O
April NNP O
2015 CD O
. . O

The DT O
patient NN O
was VBD O
transferred VBN O
to TO O
our PRP$ O
hospital NN B-Nonbiological_location
( ( O
a DT O
tertiary NN B-Nonbiological_location
care NN I-Nonbiological_location
hospital NN I-Nonbiological_location
) ) O
for IN O
further JJ O
treatment NN O
. . O

Physical JJ B-Diagnostic_procedure
examination NN I-Diagnostic_procedure
suggested VBD O
a DT O
significant JJ B-Severity
tender NN B-Sign_symptom
point NN I-Sign_symptom
in IN O
the DT O
left NN B-Biological_structure
chest NN I-Biological_structure
wall NN I-Biological_structure
. . O

Laboratory NN B-Diagnostic_procedure
findings NNS I-Diagnostic_procedure
showed VBD O
only RB O
a DT O
single JJ O
parameter NN O
outside IN O
the DT O
normal JJ O
range NN O
: : O
the DT O
cytokeratin19 NN B-Diagnostic_procedure
fragment NN I-Diagnostic_procedure
antigen NN I-Diagnostic_procedure
21 CD I-Diagnostic_procedure
- : I-Diagnostic_procedure
1 CD I-Diagnostic_procedure
( ( O
CYFRA21 NNP B-Diagnostic_procedure
- : I-Diagnostic_procedure
1 CD I-Diagnostic_procedure
) ) O
level NN O
was VBD O
17 CD B-Lab_value
. . I-Lab_value
45 CD I-Lab_value
ng JJ I-Lab_value
/ NNP I-Lab_value
mL NN I-Lab_value
in IN O
the DT O
serum NN B-Biological_structure
( ( O
normal JJ O
range NN O
= VBD O
0 CD O
- : O
3 CD O
. . O
3 CD O
ng JJ O
/ NNP O
mL NN O
) ) O
. . O

CT NNP B-Diagnostic_procedure
and CC O
PET NNP B-Diagnostic_procedure
/ NNP O
CT NNP B-Diagnostic_procedure
scans NNS O
highlighted VBD O
the DT O
serious JJ B-Severity
involvement NN B-Sign_symptom
of IN O
left JJ B-Biological_structure
pleura NN I-Biological_structure
, , O
showing VBG O
bilateral JJ B-Detailed_description
lung NN B-Biological_structure
lesions NNS B-Sign_symptom
( ( O
Fig NNP O
. . O
3A CD O
and CC O
E NNP O
) ) O
. . O

At IN O
that DT O
point NN O
, , O
the DT O
clinical JJ B-Diagnostic_procedure
stage NN I-Diagnostic_procedure
was VBD O
upgraded VBN B-Lab_value
to TO O
IVB NNP B-Lab_value
. . O

After IN O
the DT O
CT NNP B-Detailed_description
- : I-Detailed_description
guided VBD I-Detailed_description
left JJ B-Biological_structure
pleura NN I-Biological_structure
puncture NN B-Therapeutic_procedure
, , O
pathological JJ O
IHC NNP B-Diagnostic_procedure
analysis NN I-Diagnostic_procedure
showed VBD O
positive JJ B-Lab_value
staining NN O
for IN O
p63 NN B-Diagnostic_procedure
, , O
p40 NN B-Diagnostic_procedure
, , O
CK NNP B-Diagnostic_procedure
7 CD I-Diagnostic_procedure
, , O
and CC O
CK NNP B-Diagnostic_procedure
5 CD I-Diagnostic_procedure
/ NNP I-Diagnostic_procedure
6 CD I-Diagnostic_procedure
, , O
while IN O
TTF NNP B-Diagnostic_procedure
- : I-Diagnostic_procedure
1 CD I-Diagnostic_procedure
and CC O
NapsinA NNP B-Diagnostic_procedure
staining VBG O
were VBD O
absent JJ B-Lab_value
, , O
supporting VBG O
a DT O
diagnosis NN O
of IN O
squamous JJ B-Disease_disorder
cell NN I-Disease_disorder
carcinoma NN I-Disease_disorder
( ( O
SCC NNP B-Disease_disorder
) ) O
( ( O
Fig NNP O
. . O
2B CD O
) ) O
. . O

Meanwhile RB O
, , O
molecular JJ B-Diagnostic_procedure
evaluation NN I-Diagnostic_procedure
confirmed VBD O
an DT O
L858R NNP B-Sign_symptom
mutation NN I-Sign_symptom
in IN O
exon CC B-Detailed_description
21 CD I-Detailed_description
and CC O
a DT O
T790M NNP B-Sign_symptom
mutation NN I-Sign_symptom
in IN O
exon JJ B-Detailed_description
20 CD I-Detailed_description
( ( O
Fig NNP O
. . O
4B CD O
and CC O
C NNP O
) ) O
. . O

Considering VBG B-Other_entity
the DT I-Other_entity
pathology NN I-Other_entity
of IN I-Other_entity
the DT I-Other_entity
SCC NNP I-Other_entity
was VBD I-Other_entity
quite RB I-Other_entity
distinct JJ I-Other_entity
compared VBN I-Other_entity
with IN I-Other_entity
that DT I-Other_entity
of IN I-Other_entity
the DT I-Other_entity
originally RB I-Other_entity
resected VBN I-Other_entity
NSCLC NNP I-Other_entity
specimen NNS I-Other_entity
, , I-Other_entity
we PRP I-Other_entity
retrospectively RB I-Other_entity
reassessed VBD I-Other_entity
the DT I-Other_entity
surgery NN I-Other_entity
specimen NNS I-Other_entity
to TO I-Other_entity
verify VB I-Other_entity
our PRP$ I-Other_entity
primary JJ I-Other_entity
diagnosis NN I-Other_entity
. . O

The DT B-Other_entity
morphologic NN I-Other_entity
and CC I-Other_entity
IHC NNP I-Other_entity
results NNS I-Other_entity
were VBD I-Other_entity
in IN I-Other_entity
complete JJ I-Other_entity
agreement NN I-Other_entity
with IN I-Other_entity
the DT I-Other_entity
initial JJ I-Other_entity
diagnoses NNS I-Other_entity
, , I-Other_entity
but CC I-Other_entity
an DT I-Other_entity
L858R NNP I-Other_entity
mutation NN I-Other_entity
was VBD I-Other_entity
identified VBN I-Other_entity
using VBG I-Other_entity
the DT I-Other_entity
newly RB I-Other_entity
added VBN I-Other_entity
molecular JJ I-Other_entity
evaluation NN I-Other_entity
( ( O
Fig NNP O
. . O
4A CD O
) ) O
. . O

To TO O
relieve VB O
the DT O
acute NN O
pain NN O
in IN O
the DT O
left NN O
pleura NN O
as RB O
quickly RB O
as IN O
possible JJ O
, , O
palliative JJ B-Detailed_description
three CD B-Therapeutic_procedure
- : I-Therapeutic_procedure
dimensional JJ I-Therapeutic_procedure
conformal JJ I-Therapeutic_procedure
radiotherapy NN I-Therapeutic_procedure
( ( O
3D CD B-Therapeutic_procedure
- : I-Therapeutic_procedure
CRT NN I-Therapeutic_procedure
) ) O
for IN O
the DT O
chest JJS B-Biological_structure
lesion NN B-Sign_symptom
was VBD O
delivered VBN O
at IN O
a DT O
total JJ O
dose NN O
of IN O
42 CD B-Dosage
Gy NNP I-Dosage
/ VBD I-Dosage
14 CD I-Dosage
fractions NNS I-Dosage
( ( O
f NN O
) ) O
, , O
once RB B-Frequency
daily JJ I-Frequency
and CC O
5f CD B-Dosage
/ NN I-Dosage
week NN I-Dosage
( ( O
Fig NNP O
. . O
5 CD O
) ) O
. . O

The DT O
volume NN B-Diagnostic_procedure
over IN I-Diagnostic_procedure
radiation NN I-Diagnostic_procedure
dose RB I-Diagnostic_procedure
5 CD I-Diagnostic_procedure
Gy NNP I-Diagnostic_procedure
( ( O
V5 NNP O
) ) O
values NNS O
of IN O
the DT O
left NN B-Biological_structure
, , O
right JJ B-Biological_structure
, , O
and CC O
total JJ B-Biological_structure
lungs NNS I-Biological_structure
were VBD O
20 CD B-Lab_value
% NN I-Lab_value
, , O
0 CD B-Lab_value
% NN I-Lab_value
, , O
and CC O
7 CD B-Lab_value
. . I-Lab_value
8 CD I-Lab_value
% NN I-Lab_value
, , O
respectively RB O
; : O
the DT O
volume NN B-Diagnostic_procedure
over IN I-Diagnostic_procedure
radiation NN I-Diagnostic_procedure
dose RB I-Diagnostic_procedure
20 CD I-Diagnostic_procedure
Gy NNP I-Diagnostic_procedure
( ( O
V20 NNP O
) ) O
values NNS O
were VBD O
10 CD B-Lab_value
% NN I-Lab_value
, , O
0 CD B-Lab_value
% NN I-Lab_value
, , O
and CC O
5 CD B-Lab_value
% NN I-Lab_value
, , O
respectively RB O
; : O
the DT O
mean NN B-Diagnostic_procedure
lung NN I-Diagnostic_procedure
dose NN I-Diagnostic_procedure
( ( O
MLD NNP B-Diagnostic_procedure
) ) O
was VBD O
5 CD B-Lab_value
Gy NNP I-Lab_value
. . O

Meanwhile RB O
, , O
considering VBG O
the DT O
MST NNP O
pathology NN O
was VBD O
that IN O
of IN O
SCC NNP O
, , O
the DT O
patient NN O
received VBD O
GP NNP B-Medication
chemotherapy NN I-Medication
( ( O
cisplatin JJ B-Medication
75 CD B-Dosage
mg NN I-Dosage
/ NNP I-Dosage
m2 NN I-Dosage
d1 NN I-Dosage
, , O
gemcitabine NN B-Medication
1250 CD B-Dosage
mg NN I-Dosage
/ NNP I-Dosage
m2 NN I-Dosage
d1 NN I-Dosage
, , I-Dosage
d8 NN I-Dosage
, , O
for IN O
21 CD B-Detailed_description
days NNS I-Detailed_description
as IN I-Detailed_description
a DT I-Detailed_description
cycle NN I-Detailed_description
) ) O
for IN O
4 CD B-Lab_value
cycles NNS I-Lab_value
, , O
and CC O
the DT O
patient NN O
achieved VBD O
partial JJ B-Detailed_description
remission NN B-Sign_symptom
( ( O
PR NNP O
) ) O
after IN O
2 CD O
cycles NNS O
, , O
followed VBN O
by IN O
stable JJ B-Disease_disorder
disease NN I-Disease_disorder
( ( O
SD NNP B-Disease_disorder
) ) O
after IN O
4 CD O
cycles NNS O
( ( O
Fig NNP O
. . O
3 CD O
[ JJ O
B3 NNP O
[ NNP O
B NNP O
and CC O
F NNP O
] NNP O
and CC O
[ NNP O
C NNP O
and CC O
G NNP O
] NNP O
) ) O
according VBG O
to TO O
response NN B-Diagnostic_procedure
evaluation NN I-Diagnostic_procedure
criteria NNS I-Diagnostic_procedure
in IN I-Diagnostic_procedure
solid JJ I-Diagnostic_procedure
tumors NNS I-Diagnostic_procedure
( ( O
RECIST NNP B-Diagnostic_procedure
) ) O
1 CD B-Detailed_description
. . I-Detailed_description
1 CD I-Detailed_description
. . O

Then RB O
, , O
gefitinib NN B-Medication
( ( O
150 CD B-Dosage
mg RB I-Dosage
qd NN I-Dosage
) ) O
was VBD O
used VBN O
as IN O
maintenance NN O
treatment NN O
from IN O
November NNP O
2015 CD O
onward NN O
. . O

During IN O
the DT O
treatment NN O
, , O
Ibandronate NNP B-Medication
sodium NN I-Medication
was VBD O
given VBN O
monthly RB B-Frequency
for IN O
skeletal JJ B-Sign_symptom
- : I-Sign_symptom
related JJ I-Sign_symptom
events NNS I-Sign_symptom
. . O

The DT O
patient NN O
is VBZ O
currently RB O
under IN O
surveillance NN O
with IN O
SD NNP B-Diagnostic_procedure
( ( O
Fig NNP O
. . O
3D CD O
and CC O
H NNP O
) ) O
and CC O
with IN O
PS NNP B-Diagnostic_procedure
scores NNS O
of IN O
0 CD B-Lab_value
. . O

-DOCSTART- NN -X-

A DT O
65 CD B-Age
- : I-Age
year NN I-Age
- : I-Age
old JJ I-Age
man NN O
with IN O
a DT O
45 CD B-Duration
- : I-Duration
year NN I-Duration
history NN O
of IN O
cigarette NN B-Activity
smoking NN I-Activity
visited VBD O
our PRP$ O
hospital NN B-Nonbiological_location
for IN O
the DT O
diagnosis NN O
of IN O
an DT O
abnormal JJ B-Detailed_description
chest NN B-Biological_structure
shadow NN B-Sign_symptom
on IN O
X NNP B-Diagnostic_procedure
- : I-Diagnostic_procedure
ray NN I-Diagnostic_procedure
. . O

He PRP O
did VBD O
not RB O
have VB O
any DT O
remarkable JJ O
medical JJ O
history NN O
and CC O
had VBD O
not RB O
been VBN O
prescribed VBN O
anticoagulants NNS B-Medication
or CC O
antiplatelet NN B-Medication
agents NNS I-Medication
. . O

A DT O
computed JJ B-Diagnostic_procedure
tomography NN I-Diagnostic_procedure
( ( O
CT NNP B-Diagnostic_procedure
) ) O
scan VBP O
revealed VBD O
a DT O
huge JJ B-Detailed_description
mass NN B-Sign_symptom
in IN O
the DT O
left JJ B-Biological_structure
upper JJ I-Biological_structure
lobe NN I-Biological_structure
( ( O
maximum JJ O
size NN O
: : O
11 CD B-Distance
. . I-Distance
0 CD I-Distance
cm NN I-Distance
in IN O
diameter NN O
) ) O
that WDT O
subsequently RB O
expanded VBD O
to TO O
the DT O
left NN B-Biological_structure
hilum NN I-Biological_structure
and CC O
mediastinum NN B-Biological_structure
, , O
as RB O
well RB O
as IN O
an DT O
intrapulmonary JJ B-Biological_structure
metastasis NN B-Sign_symptom
located VBN O
in IN O
the DT O
left NN B-Biological_structure
lower JJR I-Biological_structure
lobe NN I-Biological_structure
, , O
pleural JJ B-Disease_disorder
effusion NN I-Disease_disorder
on IN O
the DT O
left JJ B-Detailed_description
side NN I-Detailed_description
, , O
and CC O
multiple JJ B-Detailed_description
liver NN B-Biological_structure
tumors NNS B-Sign_symptom
ranging VBG O
from IN O
0 CD B-Distance
. . I-Distance
5 CD I-Distance
to TO I-Distance
4 CD I-Distance
. . I-Distance
7 CD I-Distance
cm NN I-Distance
in IN O
diameter NN O
( ( O
Fig NNP O
. . O
1 CD O
) ) O
. . O

Of IN O
note NN O
, , O
some DT B-Detailed_description
of IN O
the DT O
liver NN B-Biological_structure
metastases NNS O
were VBD O
located VBN B-Detailed_description
subcapsularly RB I-Detailed_description
, , O
and CC O
the DT O
liver NN B-Biological_structure
surface NN I-Biological_structure
was VBD O
irregularly RB B-Detailed_description
distorted VBN B-Sign_symptom
. . O

The DT O
laboratory NN B-Diagnostic_procedure
findings NNS I-Diagnostic_procedure
were VBD O
as IN O
follows VBZ O
: : O
white JJ B-Diagnostic_procedure
blood NN I-Diagnostic_procedure
cell NN I-Diagnostic_procedure
count NN I-Diagnostic_procedure
11,900 CD B-Lab_value
/ NN I-Lab_value
mm3 NN I-Lab_value
, , O
hemoglobin VBZ B-Diagnostic_procedure
14 CD B-Lab_value
. . I-Lab_value
8 CD I-Lab_value
g JJ I-Lab_value
/ NNP I-Lab_value
dL NN I-Lab_value
, , O
platelet NN B-Diagnostic_procedure
count NN I-Diagnostic_procedure
214,000 CD B-Lab_value
/ NN I-Lab_value
mm3 NN I-Lab_value
, , O
aspartate JJ B-Diagnostic_procedure
transaminase NN I-Diagnostic_procedure
31 CD B-Lab_value
IU NNP I-Lab_value
/ NNP I-Lab_value
L NNP I-Lab_value
, , O
alanine JJ B-Diagnostic_procedure
transaminase NN I-Diagnostic_procedure
19 CD B-Lab_value
IU NNP I-Lab_value
/ NNP I-Lab_value
L NNP I-Lab_value
, , O
and CC O
lactate JJ B-Diagnostic_procedure
dehydrogenase NN I-Diagnostic_procedure
( ( O
LDH NNP B-Diagnostic_procedure
) ) O
749 CD B-Lab_value
IU NNP I-Lab_value
/ NNP I-Lab_value
L NNP I-Lab_value
. . O

No DT O
coagulation NN B-Sign_symptom
abnormalities NNS I-Sign_symptom
were VBD O
found VBN O
. . O

A DT O
subsequent JJ O
histological JJ B-Diagnostic_procedure
examination NN I-Diagnostic_procedure
of IN O
a DT O
tumor NN B-Sign_symptom
specimen NNS O
obtained VBN O
by IN O
bronchoscopy NN B-Diagnostic_procedure
confirmed VBD O
the DT O
diagnosis NN O
of IN O
small JJ B-Disease_disorder
cell NN I-Disease_disorder
carcinoma NN I-Disease_disorder
. . O

On IN O
considering VBG O
the DT O
clinical JJ O
diagnosis NN O
, , O
performance NN O
status NN O
, , O
and CC O
age NN O
of IN O
the DT O
patient NN O
, , O
we PRP O
decided VBD O
on IN O
a DT O
regimen NN O
of IN O
antitumor NN B-Detailed_description
chemotherapy NN B-Medication
consisting VBG O
of IN O
cisplatin NN B-Medication
( ( O
60 CD B-Dosage
mg NN I-Dosage
/ NNP I-Dosage
m2 NN I-Dosage
body NN I-Dosage
surface JJ I-Dosage
area NN I-Dosage
on IN O
Day NNP O
1 CD O
) ) O
and CC O
etoposide $ B-Medication
( ( O
100 CD B-Dosage
mg NN I-Dosage
/ NNP I-Dosage
m2 NN I-Dosage
body NN I-Dosage
surface JJ I-Dosage
area NN I-Dosage
on IN O
Days NNS O
1 CD O
- : O
3 CD O
) ) O
. . O

On IN O
a DT O
day NN O
after IN O
2 CD O
weeks NNS O
from IN O
the DT O
initial JJ O
CT NNP B-Diagnostic_procedure
scan NN O
, , O
he PRP O
started VBD O
his PRP$ O
first JJ O
chemotherapy NN B-Medication
session NN O
. . O

On IN O
Day NNP O
3 CD O
after IN O
initiating VBG O
chemotherapy NN O
, , O
he PRP O
complained VBD O
of IN O
abdominal JJ B-Biological_structure
discomfort NN B-Sign_symptom
, , O
and CC O
his PRP$ O
vital JJ B-Diagnostic_procedure
signs NNS I-Diagnostic_procedure
showed VBD O
tachycardia NN B-Sign_symptom
( ( O
120 CD B-Lab_value
beats NNS I-Lab_value
per IN I-Lab_value
minute NN I-Lab_value
) ) O
and CC O
hypotension NN B-Sign_symptom
( ( O
85 CD B-Lab_value
/ RB I-Lab_value
55 CD I-Lab_value
mmHg NN I-Lab_value
) ) O
. . O

A DT O
hematological JJ B-Diagnostic_procedure
examination NN I-Diagnostic_procedure
showed VBD O
severe JJ B-Severity
anemia NN B-Sign_symptom
( ( O
hemoglobin JJ B-Diagnostic_procedure
6 CD B-Lab_value
. . I-Lab_value
7 CD I-Lab_value
g JJ I-Lab_value
/ NNP I-Lab_value
dL NN I-Lab_value
) ) O
that WDT O
had VBD O
dramatically RB O
dropped VBN B-Lab_value
from IN O
14 CD B-Lab_value
. . I-Lab_value
8 CD I-Lab_value
g JJ I-Lab_value
/ NNP I-Lab_value
dL NN I-Lab_value
over IN B-Duration
10 CD I-Duration
days NNS I-Duration
. . O

We PRP O
attempted VBD O
to TO O
identify VB O
the DT O
bleeding NN O
site NN O
on IN O
gastrointestinal JJ B-Biological_structure
endoscopy NN B-Diagnostic_procedure
, , O
to TO O
no DT O
avail NN O
, , O
but CC O
a DT O
CT NNP B-Diagnostic_procedure
scan NN O
revealed VBD O
the DT O
rapid JJ B-Detailed_description
enlargement NN B-Sign_symptom
of IN O
a DT O
liver JJ B-Biological_structure
tumor NN B-Sign_symptom
in IN O
the DT O
left NN B-Biological_structure
lobe NN I-Biological_structure
, , O
which WDT O
contained VBD O
partial JJ B-Detailed_description
high JJ B-Sign_symptom
- : I-Sign_symptom
density NN I-Sign_symptom
areas NNS I-Sign_symptom
on IN O
the DT O
plain NN B-Diagnostic_procedure
scan JJ I-Diagnostic_procedure
, , O
and CC O
also RB O
a DT O
novel JJ O
finding NN O
of IN O
ascites NNS B-Sign_symptom
showing VBG O
higher JJR B-Detailed_description
density NN I-Detailed_description
than IN I-Detailed_description
usual JJ I-Detailed_description
, , O
all DT O
suggesting VBG O
a DT O
ruptured VBN B-Detailed_description
liver NN B-Biological_structure
metastasis NN B-Sign_symptom
and CC O
associated VBN O
hemorrhagic NN B-Detailed_description
ascites NNS B-Sign_symptom
( ( O
Fig NNP O
. . O
2 CD O
) ) O
. . O

A DT O
subsequent JJ O
contrast NN B-Detailed_description
- : I-Detailed_description
enhanced VBN I-Detailed_description
CT NNP B-Diagnostic_procedure
image NN O
was VBD O
negative JJ O
for IN O
extravasation NN B-Sign_symptom
. . O

He PRP O
underwent JJ O
angiography NN B-Diagnostic_procedure
for IN O
the DT O
left NN B-Biological_structure
and CC I-Biological_structure
right JJ I-Biological_structure
hepatic JJ I-Biological_structure
arteries NNS I-Biological_structure
, , O
but CC O
we PRP O
only RB O
observed VBD O
obscure JJ B-Detailed_description
tumor NN B-Sign_symptom
vessels NNS I-Sign_symptom
in IN O
the DT O
left JJ B-Biological_structure
hepatic JJ I-Biological_structure
lobe NN I-Biological_structure
without IN O
extravasation NN B-Sign_symptom
( ( O
Fig NNP O
. . O
3A CD O
) ) O
. . O

We PRP O
suspected VBD O
this DT O
might MD O
be VB O
due JJ O
to TO O
the DT O
hypovascularity NN O
of IN O
the DT O
metastatic JJ O
tumors NNS O
and CC O
inactive JJ O
bleeding NN O
at IN O
the DT O
time NN O
. . O

Although IN O
the DT O
benefit NN O
of IN O
therapeutic JJ O
embolization NN O
of IN O
the DT O
hepatic JJ O
artery NN O
was VBD O
uncertain JJ O
based VBN O
on IN O
the DT O
findings NNS O
on IN O
angiography NN O
, , O
we PRP O
performed VBD O
transcatheter JJ B-Therapeutic_procedure
arterial JJ I-Therapeutic_procedure
embolization NN I-Therapeutic_procedure
( ( O
TAE NNP B-Therapeutic_procedure
) ) O
of IN O
the DT O
left NN B-Biological_structure
main JJ I-Biological_structure
hepatic JJ I-Biological_structure
artery NN I-Biological_structure
using VBG O
gelform NN B-Therapeutic_procedure
particles NNS I-Therapeutic_procedure
to TO O
prevent VB O
future JJ O
re SYM O
- : O
bleeding NN O
. . O

Post NNP O
- : O
embolization NN O
angiography NN B-Diagnostic_procedure
revealed VBD O
a DT O
slowed JJ B-Lab_value
blood NN B-Diagnostic_procedure
flow NN I-Diagnostic_procedure
in IN O
the DT O
left JJ B-Biological_structure
hepatic JJ I-Biological_structure
artery NN I-Biological_structure
, , O
and CC O
the DT O
peripheral JJ O
vessels NNS O
were VBD O
weakly JJ O
visualized VBN O
( ( O
Fig NNP O
. . O
3B CD O
) ) O
. . O

After IN O
the DT O
embolization NN O
concomitant NN O
with IN O
supportive JJ B-Therapeutic_procedure
therapies NNS I-Therapeutic_procedure
, , O
including VBG O
RBC NNP B-Medication
transfusions NNS O
of IN O
6 CD B-Dosage
U NNP I-Dosage
in IN O
total JJ O
, , O
the DT O
clinical JJ B-Diagnostic_procedure
course NN I-Diagnostic_procedure
of IN O
the DT O
patient NN O
stabilized VBN B-Lab_value
. . O

His PRP$ O
blood NN B-Diagnostic_procedure
pressure NN I-Diagnostic_procedure
remained VBD O
around IN O
120 CD B-Lab_value
/ $ I-Lab_value
70 CD I-Lab_value
mmHg NN I-Lab_value
, , O
tachycardia NN B-Sign_symptom
disappeared VBD O
, , O
and CC O
the DT O
anemia NN B-Sign_symptom
was VBD O
improved VBN O
after IN O
transfusion NN O
and CC O
did VBD O
not RB O
progress VB O
again RB O
. . O

Liver NNP B-Biological_structure
dysfunction NN B-Sign_symptom
did VBD O
not RB O
appear VB O
. . O

A DT O
month NN O
after IN O
the DT O
embolization NN O
, , O
he PRP O
was VBD O
in IN O
relatively RB B-Lab_value
good JJ I-Lab_value
health NN B-Diagnostic_procedure
and CC O
re VB O
- : O
started VBD O
his PRP$ O
antitumor NN B-Detailed_description
chemotherapy NN B-Medication
, , O
which WDT O
he PRP O
continued VBD O
( ( O
first JJ O
- : O
line NN O
regimen NNS O
) ) O
for IN O
six CD B-Dosage
courses NNS I-Dosage
. . O

A DT O
good JJ B-Lab_value
partial JJ B-Lab_value
response NN B-Diagnostic_procedure
was VBD O
gained VBN O
after IN O
chemotherapy NN B-Medication
for IN O
both DT O
the DT O
lung NN B-Biological_structure
and CC O
liver NN B-Biological_structure
lesions NNS B-Sign_symptom
. . O

-DOCSTART- NN -X-

An DT O
82 CD B-Age
- : I-Age
year NN I-Age
- : I-Age
old JJ I-Age
woman NN O
was VBD O
transferred VBN O
to TO O
our PRP$ O
hospital NN B-Nonbiological_location
because IN O
of IN O
dyspnea NN B-Sign_symptom
and CC O
massive JJ B-Severity
hemoptysis NN B-Sign_symptom
. . O

The DT O
patient NN O
had VBD O
a DT O
history NN O
of IN O
bronchial JJ O
asthma NN O
that WDT O
was VBD O
well RB O
- : O
controlled VBN O
with IN O
bronchodilator NN O
medications NNS O
. . O

She PRP O
had VBD O
no DT O
history NN O
of IN O
tuberculosis NN O
, , O
nontuberculous JJ O
mycobacterial JJ O
infection NN O
, , O
or CC O
smoking NN O
. . O

The DT O
physical JJ B-Diagnostic_procedure
examination NN I-Diagnostic_procedure
revealed VBD O
diffuse RB B-Detailed_description
bilateral JJ B-Detailed_description
crackles NNS B-Sign_symptom
. . O

She PRP O
suffered VBD O
from IN O
severe JJ B-Severity
hypoxemia NN B-Sign_symptom
( ( O
pH JJ B-Diagnostic_procedure
7 CD B-Lab_value
. . I-Lab_value
362 CD I-Lab_value
, , O
PCO2 NNP B-Diagnostic_procedure
35 CD B-Lab_value
. . I-Lab_value
1 CD I-Lab_value
mmHg NN I-Lab_value
, , O
PO2 NNP B-Diagnostic_procedure
61 CD B-Lab_value
. . I-Lab_value
0 CD I-Lab_value
mmHg NN I-Lab_value
, , O
HCO3 NNP B-Diagnostic_procedure
- : I-Diagnostic_procedure
20 CD B-Lab_value
. . I-Lab_value
1 CD I-Lab_value
mmHg NN I-Lab_value
, , O
BE NNP B-Diagnostic_procedure
- : B-Lab_value
5 CD I-Lab_value
. . I-Lab_value
5 CD I-Lab_value
mmHg NN I-Lab_value
, , O
SpO2 NNP B-Diagnostic_procedure
90 CD B-Lab_value
. . I-Lab_value
5 CD I-Lab_value
% NN I-Lab_value
, , O
under IN B-Lab_value
10 CD I-Lab_value
L NNP I-Lab_value
O2 NNP I-Lab_value
/ NNP I-Lab_value
min NN I-Lab_value
, , O
reservoir VB B-Detailed_description
mask NN I-Detailed_description
) ) O
. . O

After IN O
the DT O
tracheal JJ B-Biological_structure
intubation NN B-Therapeutic_procedure
, , O
100 CD B-Volume
mL NN I-Volume
of IN O
bright JJ B-Color
- : I-Color
red JJ I-Color
blood NN B-Biological_structure
was VBD O
aspirated VBN B-Sign_symptom
. . O

A DT O
chest NN B-Biological_structure
radiograph NN B-Diagnostic_procedure
showed VBD O
bilateral JJ B-Detailed_description
infiltrates NNS B-Sign_symptom
( ( O
Fig NNP O
. . O
1 CD O
) ) O
. . O

A DT O
chest NN B-Biological_structure
CT NNP B-Diagnostic_procedure
further RB O
demonstrated VBD O
multiple JJ B-Detailed_description
consolidations NNS B-Sign_symptom
and CC O
ground NN B-Texture
glass NN I-Texture
opacity NN B-Sign_symptom
and CC O
focal JJ B-Detailed_description
bronchiectasis NN B-Disease_disorder
in IN O
right JJ B-Biological_structure
segment NN I-Biological_structure
4 CD I-Biological_structure
( ( O
S4 NNP B-Biological_structure
) ) O
( ( O
Fig NNP O
. . O
2 CD O
) ) O
. . O

There EX O
were VBD O
no DT O
space NN B-Detailed_description
- : I-Detailed_description
occupying NN I-Detailed_description
lesions NNS B-Sign_symptom
. . O

Four CD O
days NNS O
after IN O
admission NN O
, , O
her PRP$ O
respiratory JJ B-Diagnostic_procedure
condition NN I-Diagnostic_procedure
was VBD O
improved VBN B-Lab_value
. . O

Since IN O
there EX O
was VBD O
no DT O
active JJ B-Detailed_description
hemorrhaging NN B-Sign_symptom
from IN O
the DT O
tracheal NN B-Therapeutic_procedure
tube NN I-Therapeutic_procedure
, , O
she PRP O
was VBD O
then RB O
extubated VBN B-Therapeutic_procedure
. . O

After IN O
that DT O
, , O
only RB O
a DT O
small JJ B-Severity
amount NN I-Severity
of IN O
bloody NN B-Detailed_description
sputum NN B-Sign_symptom
was VBD O
coughed VBN O
up RP O
. . O

To TO O
determine VB O
the DT O
origin NN O
of IN O
bleeding NN O
, , O
she PRP O
underwent VBD O
contrast NN B-Detailed_description
- : I-Detailed_description
enhanced JJ I-Detailed_description
CT NNP B-Diagnostic_procedure
, , O
which WDT O
showed VBD O
bronchiectasis NN B-Disease_disorder
in IN O
right JJ B-Biological_structure
S4 NNP I-Biological_structure
and CC O
regression NN O
of IN O
the DT O
infiltration NN B-Sign_symptom
. . O

CTA NNP B-Diagnostic_procedure
revealed VBD O
an DT O
abnormal JJ B-Detailed_description
vascular JJ B-Biological_structure
anastomosis NN B-Disease_disorder
between IN O
the DT O
right JJ B-Biological_structure
inferior NN I-Biological_structure
phrenic JJ I-Biological_structure
artery NN I-Biological_structure
and CC O
right JJ B-Biological_structure
pulmonary JJ I-Biological_structure
artery NN I-Biological_structure
beside IN O
the DT O
focal JJ B-Detailed_description
bronchiectasis NN B-Disease_disorder
at IN O
the DT O
right JJ B-Biological_structure
middle NN I-Biological_structure
lobe NN I-Biological_structure
( ( O
Fig NNP O
. . O
3 CD O
) ) O
, , O
which WDT O
led VBD O
us PRP O
to TO O
suspect VB O
it PRP O
as IN O
the DT O
possible JJ O
source NN O
of IN O
the DT O
massive JJ B-Severity
hemoptysis NN B-Sign_symptom
. . O

We PRP O
therefore RB O
performed VBD O
embolization NN B-Therapeutic_procedure
by IN O
superselecting VBG B-Therapeutic_procedure
the DT O
right JJ B-Biological_structure
inferior NN I-Biological_structure
phrenic JJ I-Biological_structure
artery NN I-Biological_structure
with IN O
a DT O
2 CD B-Detailed_description
. . I-Detailed_description
2 CD I-Detailed_description
- : I-Detailed_description
Fr NN I-Detailed_description
. . I-Detailed_description
microcatheter NN I-Detailed_description
( ( O
Fig NNP O
. . O
4 CD O
) ) O
. . O

An DT O
angiogram NN B-Diagnostic_procedure
of IN O
the DT O
right JJ B-Biological_structure
bronchial NN I-Biological_structure
artery NN I-Biological_structure
showed VBD O
no DT O
obvious JJ O
active JJ B-Detailed_description
bleeding NN B-Sign_symptom
. . O

Three CD O
weeks NNS O
after IN O
the DT O
embolization NN O
, , O
she PRP O
was VBD O
successfully RB O
discharged VBN O
and CC O
has VBZ O
been VBN O
free JJ O
from IN O
recurrent JJ B-Detailed_description
hemoptysis NN B-Sign_symptom
for IN O
three CD B-Duration
years NNS I-Duration
. . O

-DOCSTART- NN -X-

A DT O
65 CD B-Age
- : I-Age
year NN I-Age
- : I-Age
old JJ I-Age
woman NN O
reported VBD O
persistent JJ B-Detailed_description
back RB B-Biological_structure
pain NN B-Sign_symptom
for IN O
almost RB B-Duration
3 CD I-Duration
months NNS I-Duration
. . O

The DT O
symptoms NNS O
would MD O
be VB O
severe JJ B-Severity
after IN O
walking VBG B-Activity
or CC O
changing VBG B-Activity
positions NNS I-Activity
and CC O
would MD O
be VB O
slightly RB O
relieve VBP B-Sign_symptom
after IN O
taking VBG O
painkillers NNS B-Medication
. . O

The DT O
patient NN O
described VBD O
no DT O
pain NN B-Sign_symptom
or CC O
numbness NN B-Sign_symptom
in IN O
her PRP$ O
legs NNS B-Biological_structure
. . O

She PRP O
also RB O
described VBD O
no DT O
bowel NN B-Biological_structure
or CC O
bladder NN B-Biological_structure
voiding NN B-Sign_symptom
difficulties NNS I-Sign_symptom
. . O

The DT O
patient NN O
reported VBD O
past JJ O
medical JJ O
history NN O
of IN O
hypertension NN O
, , O
coronary JJ O
heart NN O
disease NN O
, , O
cerebral JJ O
infarction NN O
, , O
and CC O
asthma NN O
, , O
all DT O
of IN O
which WDT O
were VBD O
well RB O
controlled VBN O
. . O

Physical JJ B-Diagnostic_procedure
exam NN I-Diagnostic_procedure
demonstrated VBD O
kyphosis NN B-Disease_disorder
of IN O
the DT O
thoracic JJ B-Biological_structure
spine NN I-Biological_structure
in IN B-Detailed_description
standing VBG I-Detailed_description
position NN I-Detailed_description
and CC O
lumbar NN B-Detailed_description
vertebra NN I-Detailed_description
bend VBP I-Detailed_description
forward RB I-Detailed_description
and CC I-Detailed_description
backward RB I-Detailed_description
straight JJ O
activities NNS O
were VBD O
limited VBN O
. . O

There EX O
is VBZ O
obvious JJ O
rap NN B-Detailed_description
pain NN B-Sign_symptom
in IN O
back NN B-Biological_structure
about IN O
T12 NNP B-Biological_structure
level NN O
. . O

The DT O
patient NN O
` `` O
s RB O
general JJ B-Diagnostic_procedure
medical JJ I-Diagnostic_procedure
examination NN I-Diagnostic_procedure
was VBD O
unremarkable JJ B-Lab_value
in IN O
upper JJ B-Biological_structure
and CC I-Biological_structure
lower JJR I-Biological_structure
extremity NN I-Biological_structure
motor NN I-Biological_structure
, , O
stretch NN B-Detailed_description
reflex NN I-Detailed_description
, , O
and CC O
sensory JJ B-Biological_structure
examinations NNS B-Diagnostic_procedure
. . O

X LS B-Diagnostic_procedure
- : I-Diagnostic_procedure
ray NN I-Diagnostic_procedure
, , O
computed VBN B-Diagnostic_procedure
tomography NN I-Diagnostic_procedure
( ( O
CT NNP B-Diagnostic_procedure
) ) O
, , O
and CC O
magnetic JJ B-Diagnostic_procedure
resonance NN I-Diagnostic_procedure
imaging NN I-Diagnostic_procedure
( ( O
MRI NNP B-Diagnostic_procedure
) ) O
exams NNS O
were VBD O
performed VBN O
after IN O
the DT O
patient NN O
in IN O
hospital NN B-Nonbiological_location
( ( O
Fig NNP O
. . O
1 CD O
) ) O
. . O

The DT O
lateral JJ B-Detailed_description
X NNP B-Diagnostic_procedure
- : I-Diagnostic_procedure
ray NN I-Diagnostic_procedure
showed VBD O
T12 NNP B-Biological_structure
fracture NN B-Disease_disorder
with IN O
40 CD B-Lab_value
° NNS I-Lab_value
kyphotic JJ I-Lab_value
cobb NN B-Diagnostic_procedure
angle NN I-Diagnostic_procedure
. . O

CT NNP B-Diagnostic_procedure
showed VBD O
an DT O
intravertebral JJ B-Sign_symptom
vacuum NN I-Sign_symptom
sign NN I-Sign_symptom
. . O

Sagittal JJ B-Detailed_description
T1 NNP I-Detailed_description
- : I-Detailed_description
weighted VBD I-Detailed_description
MRI NNP B-Diagnostic_procedure
showed VBD O
a DT O
decreased JJ B-Detailed_description
signal JJ I-Detailed_description
intravertebral JJ B-Sign_symptom
vacuum NN I-Sign_symptom
cleft NN I-Sign_symptom
and CC O
posterior JJ B-Biological_structure
cortex NN I-Biological_structure
breakage NN B-Disease_disorder
with IN O
cord NN B-Sign_symptom
compression NN I-Sign_symptom
in IN O
T12 NNP B-Biological_structure
. . O

Sagittal JJ B-Detailed_description
T2 NNP I-Detailed_description
- : I-Detailed_description
weighted VBD I-Detailed_description
MRI NNP B-Diagnostic_procedure
showed VBD O
an DT O
increased VBN B-Detailed_description
signal NN I-Detailed_description
in IN O
the DT O
intravertebral JJ B-Sign_symptom
vacuum NN I-Sign_symptom
cleft NN I-Sign_symptom
. . O

The DT O
patient NN O
was VBD O
diagnosed VBN O
with IN O
Kümmell NNP B-Disease_disorder
disease NN I-Disease_disorder
( ( O
Stage NNP B-Lab_value
III NNP I-Lab_value
) ) O
. . O
[ $ O
9 CD O
] NN O

The DT O
operation NN B-Therapeutic_procedure
was VBD O
performed VBN O
under IN O
general JJ B-Medication
anesthesia NN I-Medication
and CC O
prone NN B-Detailed_description
position NN I-Detailed_description
. . O

A DT O
standard JJ B-Detailed_description
posterior NN B-Therapeutic_procedure
exposure NN I-Therapeutic_procedure
of IN O
the DT O
spine NN B-Biological_structure
was VBD O
given VBN O
, , O
pedicle NN B-Therapeutic_procedure
screws NNS I-Therapeutic_procedure
were VBD O
inserted VBN O
in IN O
target NN O
vertebrae NN B-Biological_structure
T10 NNP B-Biological_structure
, , O
T11 NNP B-Biological_structure
, , O
L1 NNP B-Biological_structure
, , O
and CC O
L2 NNP B-Biological_structure
under IN O
C NNP B-Detailed_description
- : I-Detailed_description
arm NN I-Detailed_description
guidance NN I-Detailed_description
. . O
[ CC O
10 CD O
] IN O
The DT O
screws NNS O
were VBD O
connected VBN B-Detailed_description
on IN I-Detailed_description
the DT I-Detailed_description
left JJ I-Detailed_description
side NN I-Detailed_description
with IN I-Detailed_description
a DT I-Detailed_description
temporary JJ I-Detailed_description
stabilizing NN I-Detailed_description
rod NN I-Detailed_description
. . O

Laminectomy NNP B-Therapeutic_procedure
was VBD O
performed VBN O
to TO O
decompress VB O
and CC O
fully RB O
visualize VB O
the DT O
spinal JJ O
cord NN O
. . O
[ CC O
10 CD O
] JJ O
Careful NNP O
subperiosteal NN B-Therapeutic_procedure
dissection NN I-Therapeutic_procedure
was VBD O
carried VBN O
out RP O
on IN O
the DT O
right JJ B-Detailed_description
side NN I-Detailed_description
to TO O
exposure VB O
the DT O
lateral JJ B-Biological_structure
wall NN I-Biological_structure
of IN I-Biological_structure
the DT I-Biological_structure
T12 NNP I-Biological_structure
vertebral JJ I-Biological_structure
body NN I-Biological_structure
until IN O
the DT O
anterior JJ O
aspect NN O
was VBD O
reached VBN O
. . O

The DT O
right JJ B-Biological_structure
side NN I-Biological_structure
pedicle NN I-Biological_structure
and CC O
articular JJ B-Biological_structure
process NN I-Biological_structure
of IN O
the DT O
T12 NNP B-Biological_structure
vertebral JJ I-Biological_structure
body NN I-Biological_structure
were VBD O
removed VBN B-Therapeutic_procedure
. . O

T11 NNP B-Biological_structure
/ NNP I-Biological_structure
T12 NNP I-Biological_structure
and CC O
T12 NNP B-Biological_structure
/ NNP I-Biological_structure
L1 NNP I-Biological_structure
intervertebral JJ B-Biological_structure
disks NNS I-Biological_structure
were VBD O
also RB O
removed VBN B-Therapeutic_procedure
. . O

Then RB O
, , O
the DT O
temporary JJ B-Detailed_description
stabilizing NN I-Detailed_description
rod NN B-Therapeutic_procedure
was VBD O
replaced VBN O
by IN O
rod NN B-Therapeutic_procedure
bended VBN B-Detailed_description
to TO I-Detailed_description
the DT I-Detailed_description
desired VBN I-Detailed_description
contour NN I-Detailed_description
. . O

Autologous JJ B-Detailed_description
bone NN B-Therapeutic_procedure
graft NN I-Therapeutic_procedure
and CC O
titanium NN B-Therapeutic_procedure
mesh NNS I-Therapeutic_procedure
were VBD O
placed VBN O
in IN O
the DT O
intervertebral JJ B-Biological_structure
space NN I-Biological_structure
. . O

Another DT B-Detailed_description
rod NN B-Therapeutic_procedure
with IN B-Detailed_description
the DT I-Detailed_description
desired JJ I-Detailed_description
contour NN I-Detailed_description
was VBD O
connected VBN O
on IN O
the DT O
right JJ B-Detailed_description
side NN I-Detailed_description
. . O

Adequate JJ O
hemostasis NN B-Therapeutic_procedure
was VBD O
ensured VBN O
and CC O
wound NN B-Biological_structure
was VBD O
thoroughly RB O
irrigated VBN B-Therapeutic_procedure
with IN I-Therapeutic_procedure
saline NN I-Therapeutic_procedure
. . O

Drainage NN B-Therapeutic_procedure
tube NN I-Therapeutic_procedure
was VBD O
inserted VBN O
and CC O
the DT O
surgical JJ B-Biological_structure
wound NN I-Biological_structure
was VBD O
closed VBN B-Therapeutic_procedure
layer NN B-Detailed_description
- : I-Detailed_description
by IN I-Detailed_description
- : I-Detailed_description
layer NN I-Detailed_description
. . O
[ CC O
10 CD O
] JJ O
Time NNP O
from IN O
skin JJ O
incision NN O
to TO O
completion NN O
of IN O
wound JJ O
closure NN O
lasted VBD O
150 CD B-Duration
minutes NNS I-Duration
, , O
and CC O
estimated VBD O
blood NN B-Disease_disorder
loss NN I-Disease_disorder
totaled VBD O
600 CD B-Volume
mL NN I-Volume
. . O

Postoperatively RB O
, , O
the DT O
patient NN O
was VBD O
given VBN O
preventive JJ O
antibiotic JJ B-Medication
treatment NN O
for IN O
1 CD B-Duration
day NN I-Duration
, , O
pain NN B-Medication
treatment NN I-Medication
for IN O
3 CD B-Duration
days NNS I-Duration
, , O
and CC O
anticoagulant JJ B-Medication
therapy NN O
for IN O
1 CD B-Duration
week NN I-Duration
. . O

The DT O
drainage NN B-Therapeutic_procedure
tube NN I-Therapeutic_procedure
was VBD O
removed VBN O
at IN O
3 CD O
days NNS O
postoperative JJ O
when WRB O
volume NN B-Diagnostic_procedure
of IN I-Diagnostic_procedure
drainage NN I-Diagnostic_procedure
was VBD O
less JJR B-Lab_value
than IN I-Lab_value
50 CD I-Lab_value
mL NNS I-Lab_value
per IN I-Lab_value
24 CD I-Lab_value
hours NNS I-Lab_value
. . O

Patient NN O
was VBD O
allowed VBN O
out IN O
of IN O
bed NN B-Nonbiological_location
with IN O
a DT O
custom NN B-Detailed_description
- : I-Detailed_description
made VBN I-Detailed_description
plastic JJ B-Detailed_description
orthosis NN B-Therapeutic_procedure
at IN O
1 CD O
week NN O
after IN O
operation NN O
. . O

The DT O
plastic JJ O
orthosis NN O
was VBD O
kept VBN O
for IN O
at IN B-Duration
least JJS I-Duration
3 CD I-Duration
months NNS I-Duration
. . O

The DT O
patient NN O
was VBD O
allowed VBN O
out IN O
of IN O
hospital NN B-Nonbiological_location
at IN O
12 CD O
days NNS O
after IN O
operation NN O
when WRB O
surgical JJ B-Therapeutic_procedure
suture NN I-Therapeutic_procedure
had VBD O
been VBN O
removed VBN O
. . O

Pain NN B-Diagnostic_procedure
assessments NNS I-Diagnostic_procedure
were VBD O
conducted VBN O
using VBG O
the DT O
visual JJ B-Diagnostic_procedure
analogue NN I-Diagnostic_procedure
scale NN I-Diagnostic_procedure
( ( O
VAS NNP B-Diagnostic_procedure
) ) O
. . O

VAS NNP O
for IN O
preoperative NN O
, , O
1 CD O
week NN O
after IN O
operation NN O
, , O
and CC O
1 CD O
year NN O
after IN O
operation NN O
were VBD O
9 CD B-Lab_value
score NN I-Lab_value
, , O
3 CD B-Lab_value
score NN I-Lab_value
, , O
and CC O
2 CD B-Lab_value
score NN I-Lab_value
, , O
respectively RB O
, , O
which WDT O
demonstrated VBD O
significant JJ O
improvement NN B-Lab_value
. . O

The DT O
patient NN O
resumed VBD O
normal JJ B-Activity
activities NNS I-Activity
and CC O
returned VBN B-Activity
to TO I-Activity
work VB I-Activity
at IN O
3 CD O
months NNS O
after IN O
operation NN O
. . O

Kyphotic NNP B-Lab_value
Cobb NNP B-Diagnostic_procedure
angle NN I-Diagnostic_procedure
for IN O
preoperative JJ O
, , O
1 CD O
week NN O
after IN O
operation NN O
, , O
and CC O
1 CD O
year NN O
after IN O
operation NN O
were VBD O
40 CD B-Lab_value
° NNS I-Lab_value
, , O
8 CD B-Lab_value
° NN I-Lab_value
, , O
and CC O
17 CD B-Lab_value
° NN I-Lab_value
, , O
respectively RB O
, , O
which WDT O
demonstrated VBD O
significant JJ O
improvement NN B-Lab_value
( ( O
Fig NNP O
. . O
2 CD O
) ) O
. . O

-DOCSTART- NN -X-

A DT O
57 CD B-Age
- : I-Age
year NN I-Age
- : I-Age
old JJ I-Age
male NN O
was VBD O
admitted VBN O
to TO O
our PRP$ O
hospital NN B-Nonbiological_location
with IN O
5 CD B-Duration
months NNS I-Duration
` `` O
history NN O
of IN O
massive JJ B-Severity
rectal NN B-Biological_structure
bleeding NN B-Sign_symptom
( ( O
rectorrhagia NN O
) ) O
. . O

He PRP O
had VBD O
past JJ O
history NN O
of IN O
passage NN B-Sign_symptom
of IN I-Sign_symptom
fresh JJ I-Sign_symptom
blood NN I-Sign_symptom
mixed JJ I-Sign_symptom
stool NN I-Sign_symptom
since IN O
last JJ B-Duration
55 CD I-Duration
years NNS I-Duration
. . O

He PRP O
first RB O
complained VBD O
of IN O
rectal JJ B-Biological_structure
bleeding NN B-Sign_symptom
at IN O
the DT O
age NN O
of IN O
2 CD O
. . O

He PRP O
went VBD O
hospital NN B-Nonbiological_location
numerous JJ O
times NNS O
for IN O
this DT O
symptom NN O
; : O
multiple JJ O
interventions NNS B-Therapeutic_procedure
were VBD O
done VBN O
but CC O
disease NN O
was VBD O
not RB O
cured VBN O
completely RB O
. . O

During IN O
one CD O
of IN O
his PRP$ O
hospital NN O
visit NN O
in IN O
the DT O
past JJ O
( ( O
patient JJ O
forgot VBD O
the DT O
date NN O
) ) O
, , O
he PRP O
was VBD O
diagnosed VBN O
and CC O
treated VBN O
as IN O
hemorrhoids NNS O
. . O

The DT O
symptom NN B-Sign_symptom
was VBD O
relieved VBN O
for IN O
a DT B-Duration
while NN I-Duration
and CC O
then RB O
recurred VBD B-Sign_symptom
again RB O
. . O

Thirty CD O
years NNS O
ago RB O
, , O
he PRP O
was VBD O
diagnosed VBN O
as IN O
rectal JJ B-Biological_structure
hemangioma NN B-Disease_disorder
and CC O
managed VBD O
with IN O
cryotherapy NN B-Therapeutic_procedure
in IN O
our PRP$ O
hospital NN B-Nonbiological_location
. . O

That DT O
could MD O
also RB O
just RB O
relieve VB O
the DT O
symptom NN B-Sign_symptom
for IN O
few JJ B-Duration
years NNS I-Duration
and CC O
it PRP O
recurred VBD B-Sign_symptom
again RB O
. . O

Then RB O
, , O
he PRP O
consulted VBD O
many JJ B-Nonbiological_location
other JJ I-Nonbiological_location
hospitals NNS I-Nonbiological_location
, , O
but CC O
could MD O
only RB O
get VB O
short JJ B-Detailed_description
- : I-Detailed_description
term NN I-Detailed_description
symptomatic JJ B-Sign_symptom
relief NN I-Sign_symptom
without IN O
proper JJ O
treatment NN O
of IN O
the DT O
cause NN O
. . O

Since IN B-Duration
5 CD I-Duration
months NNS I-Duration
, , O
the DT O
severity NN O
of IN O
rectal JJ B-Biological_structure
bleeding NN B-Sign_symptom
increased VBD O
. . O

He PRP O
then RB O
went VBD O
to TO O
local JJ B-Nonbiological_location
hospital NN I-Nonbiological_location
where WRB O
intervention NN B-Therapeutic_procedure
was VBD O
done VBN O
to TO O
control VB O
bleeding NN B-Sign_symptom
and CC O
symptomatic JJ B-Therapeutic_procedure
treatment NN I-Therapeutic_procedure
was VBD O
done VBN O
with IN O
intravenous JJ O
fluid NNS B-Medication
and CC O
blood NN B-Therapeutic_procedure
transfusion NN I-Therapeutic_procedure
. . O

He PRP O
finally RB O
referred VBD O
to TO O
our PRP$ O
hospital NN B-Nonbiological_location
for IN O
further JJ O
evaluation NN O
. . O

Intermediate NNP B-Severity
rectal JJ B-Biological_structure
bleeding NN B-Sign_symptom
of IN O
fresh JJ B-Detailed_description
blood NN I-Detailed_description
was VBD O
presented VBN O
on IN O
admission NN O
. . O

Patient NNP O
complained VBD O
of IN O
dizziness NN B-Sign_symptom
on IN O
standing NN B-Detailed_description
, , O
shortness NN B-Sign_symptom
of IN I-Sign_symptom
breath NN I-Sign_symptom
, , O
and CC O
palpitation NN B-Sign_symptom
on IN O
walking VBG B-Detailed_description
a DT I-Detailed_description
short JJ I-Detailed_description
distance NN I-Detailed_description
. . O

There EX O
was VBD O
no DT O
history NN O
of IN O
similar JJ O
illness NN O
in IN O
family NN O
. . O

On IN O
general JJ B-Diagnostic_procedure
examination NN I-Diagnostic_procedure
, , O
patient NN O
appeared VBD O
pale JJ B-Sign_symptom
, , O
but CC O
his PRP$ O
heart NN B-Diagnostic_procedure
rate NN I-Diagnostic_procedure
and CC O
blood NN B-Diagnostic_procedure
pressure NN I-Diagnostic_procedure
were VBD O
within IN B-Lab_value
normal JJ I-Lab_value
limit NN I-Lab_value
during IN O
rest NN O
. . O

He PRP O
lost VBD B-Lab_value
5 CD I-Lab_value
kg NN I-Lab_value
of IN O
his PRP$ O
body NN B-Diagnostic_procedure
weight NN I-Diagnostic_procedure
during IN B-Duration
last JJ I-Duration
5 CD I-Duration
months NNS I-Duration
. . O

On IN O
rectal JJ B-Diagnostic_procedure
examination NN I-Diagnostic_procedure
, , O
fresh JJ B-Sign_symptom
blood NN I-Sign_symptom
was VBD O
seen VBN O
around IN B-Biological_structure
anal JJ I-Biological_structure
region NN I-Biological_structure
and CC O
soft JJ B-Texture
mass NN B-Sign_symptom
was VBD O
felt VBN O
on IN O
digital JJ B-Diagnostic_procedure
rectal JJ I-Diagnostic_procedure
examination NN I-Diagnostic_procedure
. . O

On IN O
proctoscopy NN B-Diagnostic_procedure
, , O
anal JJ B-Biological_structure
cavity NN I-Biological_structure
and CC O
rectum NN B-Biological_structure
were VBD O
seen VBN O
filled VBN O
with IN O
fresh JJ B-Sign_symptom
blood NN I-Sign_symptom
, , O
but CC O
active JJ B-Sign_symptom
site NN I-Sign_symptom
of IN I-Sign_symptom
bleeding NN I-Sign_symptom
, , O
polyp NN B-Sign_symptom
, , O
or CC O
ulcer NN B-Sign_symptom
was VBD O
not RB O
detected VBN O
. . O

On IN O
laboratory NN B-Diagnostic_procedure
examination NN I-Diagnostic_procedure
, , O
red JJ B-Diagnostic_procedure
blood NN I-Diagnostic_procedure
cell NN I-Diagnostic_procedure
count NN I-Diagnostic_procedure
was VBD O
3 CD B-Lab_value
. . I-Lab_value
09 CD I-Lab_value
× JJ I-Lab_value
1012 CD I-Lab_value
/ NN I-Lab_value
L NNP I-Lab_value
( ( O
Normal NNP O
: : O
4 CD O
. . O
32 CD O
- : O
5 CD O
. . O
72 CD O
× JJ O
1012 CD O
/ NNP O
L NNP O
) ) O
and CC O
hemoglobin NN B-Diagnostic_procedure
was VBD O
86 CD B-Lab_value
g JJ I-Lab_value
/ NN I-Lab_value
L NNP I-Lab_value
( ( O
Normal NNP O
: : O
135 CD O
- : O
175 CD O
g NN O
/ NNP O
L NNP O
) ) O
. . O

All DT B-Diagnostic_procedure
other JJ I-Diagnostic_procedure
parameters NNS I-Diagnostic_procedure
were VBD O
within IN B-Lab_value
normal JJ I-Lab_value
limit NN I-Lab_value
. . O

None NN B-Detailed_description
enhanced VBD I-Detailed_description
CT NNP B-Diagnostic_procedure
showed VBD O
isodense NN B-Detailed_description
( ( O
35 CD B-Lab_value
HU NNP I-Lab_value
) ) O
homogenous JJ B-Detailed_description
bowel NN B-Biological_structure
wall NN I-Biological_structure
thickening VBG B-Sign_symptom
that IN O
on IN O
contrast NN B-Detailed_description
- : I-Detailed_description
enhanced VBN I-Detailed_description
CT NNP B-Diagnostic_procedure
venous JJ B-Detailed_description
phase NN I-Detailed_description
enhances VBZ B-Sign_symptom
heterogeneously RB B-Detailed_description
. . O

Multiple JJ B-Detailed_description
calcifications NNS B-Sign_symptom
were VBD O
seen VBN O
in IN O
the DT O
thickened JJ B-Biological_structure
bowel NN I-Biological_structure
wall NN I-Biological_structure
and CC O
around IN O
the DT O
peri NN B-Biological_structure
- : I-Biological_structure
rectal JJ I-Biological_structure
area NN I-Biological_structure
. . O

Lesion NN B-Sign_symptom
was VBD O
seen VBN O
extending VBG O
from IN O
distal JJ B-Biological_structure
sigmoid NN I-Biological_structure
to TO O
whole VB B-Biological_structure
of IN I-Biological_structure
the DT I-Biological_structure
rectum NN I-Biological_structure
( ( O
Fig NNP O
. . O
1 CD O
) ) O
. . O

Multiple JJ B-Detailed_description
hypodense NN B-Detailed_description
lesions NNS B-Sign_symptom
were VBD O
also RB O
seen VBN O
in IN O
spleen JJ B-Biological_structure
( ( O
Fig NNP O
. . O
2 CD O
) ) O
. . O

After IN O
initial JJ O
management NN B-Therapeutic_procedure
of IN O
anemia NN B-Sign_symptom
, , O
the DT O
patient JJ O
underwent JJ O
abdominal JJ B-Biological_structure
laparotomy NN B-Therapeutic_procedure
followed VBN O
by IN O
surgical JJ B-Therapeutic_procedure
excision NN I-Therapeutic_procedure
. . O

During IN O
surgery NN O
, , O
25 CD B-Distance
cm NN I-Distance
long JJ O
lesion NN B-Sign_symptom
was VBD O
found VBN O
extending VBG O
from IN O
distal JJ B-Biological_structure
sigmoid NN I-Biological_structure
to TO O
whole VB B-Biological_structure
of IN I-Biological_structure
the DT I-Biological_structure
rectum NN I-Biological_structure
. . O

Whole NNP B-Biological_structure
of IN I-Biological_structure
the DT I-Biological_structure
rectum NN I-Biological_structure
and CC O
part NN B-Biological_structure
of IN I-Biological_structure
the DT I-Biological_structure
sigmoid JJ I-Biological_structure
colon NN I-Biological_structure
were VBD O
excised VBN B-Therapeutic_procedure
and CC O
sigmoid JJ B-Detailed_description
- : I-Detailed_description
anus NN I-Detailed_description
anastomosis NN B-Therapeutic_procedure
was VBD O
done VBN O
. . O

Postsurgical JJ O
histopathological JJ B-Diagnostic_procedure
examination NN I-Diagnostic_procedure
of IN O
excised JJ B-Detailed_description
specimen NNS I-Detailed_description
showed VBD O
submucosal JJ B-Detailed_description
multiple NNS I-Detailed_description
thin JJ I-Detailed_description
- : I-Detailed_description
walled JJ I-Detailed_description
vessel NN I-Detailed_description
of IN O
varying VBG B-Lab_value
size NN I-Lab_value
with IN O
interposed JJ B-Lab_value
stroma NN I-Lab_value
. . O

Some DT B-Lab_value
vessels NNS I-Lab_value
lumen NNS I-Lab_value
consisted VBD I-Lab_value
of IN I-Lab_value
blood NN I-Lab_value
cells NNS I-Lab_value
( ( O
consistent JJ O
with IN O
blood NN O
vessel NN O
) ) O
, , O
whereas IN O
other JJ B-Lab_value
consisted VBN I-Lab_value
of IN I-Lab_value
clear JJ I-Lab_value
fluid NN I-Lab_value
( ( O
consistent JJ O
with IN O
lymph JJ O
vessel NN O
) ) O
. . O

Immunohistochemistry NN B-Diagnostic_procedure
of IN O
specimen NNS O
showed VBD O
endothelial JJ B-Biological_structure
cells NNS I-Biological_structure
positive JJ B-Lab_value
for IN O
CD NN B-Diagnostic_procedure
31 CD I-Diagnostic_procedure
and CC O
CD NNP B-Diagnostic_procedure
34 CD I-Diagnostic_procedure
. . O

Some DT B-Biological_structure
cells NNS I-Biological_structure
were VBD O
positive JJ B-Lab_value
for IN O
D2 NNP B-Diagnostic_procedure
- : I-Diagnostic_procedure
40 CD I-Diagnostic_procedure
, , O
while IN O
others NNS B-Biological_structure
were VBD O
negative JJ B-Lab_value
for IN O
D2 NNP B-Diagnostic_procedure
- : I-Diagnostic_procedure
40 CD I-Diagnostic_procedure
( ( O
Fig NNP O
. . O
3 CD O
) ) O
. . O

On IN O
the DT O
basis NN O
of IN O
histopathological JJ O
report NN O
and CC O
immunohistochemistry NN O
, , O
hemolymphangioma NN B-Disease_disorder
was VBD O
diagnosed VBN O
. . O

The DT O
surgery NN O
, , O
which WDT O
followed VBN O
by IN O
complication NN O
( ( O
intestinal JJ B-Biological_structure
infection NN B-Disease_disorder
) ) O
, , O
was VBD O
well RB O
managed VBN B-Therapeutic_procedure
and CC O
the DT O
patient NN O
was VBD O
discharged VBN O
from IN O
hospital NN B-Nonbiological_location
on IN O
the DT O
23rd CD O
day NN O
of IN O
surgery NN O
. . O

Then RB O
after IN O
, , O
no DT O
further JJ O
complication NN B-Sign_symptom
or CC O
recurrence NN B-Sign_symptom
was VBD O
noticed VBN O
during IN O
6 CD B-Duration
months NNS I-Duration
` `` I-Duration
follow VB O
- : O
up RB O
. . O

This DT O
study NN O
was VBD O
approved VBN O
by IN O
the DT O
First NNP O
Affiliated NNP O
Hospital NNP O
of IN O
Sun NNP O
Yat NNP O
- : O
Sen NNP O
University NNP O
Institutional NNP O
Review NNP O
Board NNP O
. . O

Written NNP O
consent NN O
for IN O
this DT O
case NN O
report NN O
was VBD O
obtained VBN O
from IN O
the DT O
patient NN O
. . O

-DOCSTART- NN -X-

The DT O
21 CD B-Age
- : I-Age
year NN I-Age
- : I-Age
old JJ I-Age
patient NN O
presented VBN O
to TO O
the DT O
closest JJS B-Nonbiological_location
emergency NN I-Nonbiological_location
department NN I-Nonbiological_location
at IN O
8 CD B-Time
PM NNP I-Time
for IN O
nausea NN B-Sign_symptom
, , O
numbness NN B-Sign_symptom
of IN O
the DT O
left NN B-Biological_structure
limbs NN I-Biological_structure
, , O
incoordination NN B-Sign_symptom
of IN I-Sign_symptom
walking NN I-Sign_symptom
and CC O
dysarthria NN B-Sign_symptom
, , O
with IN O
the DT O
symptomatology NN B-Sign_symptom
installed VBN O
in IN O
a DT O
progressive JJ B-Detailed_description
mode NN O
4 CD B-Time
hours NNS I-Time
before IN I-Time
presentation NN O
. . O

The DT O
nausea NN B-Sign_symptom
was VBD O
the DT O
initial JJ O
symptom NN O
, , O
starting VBG O
at IN O
4 CD B-Time
PM NNP I-Time
( ( O
without IN O
headache NN B-Sign_symptom
, , O
nuchal JJ B-Biological_structure
pain NN B-Sign_symptom
, , O
or CC O
vomit NN B-Sign_symptom
) ) O
and CC O
then RB O
, , O
after IN B-Time
5 CD I-Time
. . I-Time
30 CD I-Time
PM NNP I-Time
, , O
the DT O
numbness NN B-Sign_symptom
of IN O
the DT O
left NN B-Biological_structure
limbs NN I-Biological_structure
and CC O
the DT O
incoordination NN B-Sign_symptom
of IN I-Sign_symptom
walking NN I-Sign_symptom
and CC O
by IN O
7 CD B-Time
PM NNP I-Time
dysarthria NN B-Sign_symptom
was VBD O
added VBN O
to TO O
the DT O
entire JJ O
clinical JJ O
constellation NN O
. . O

The DT O
patient NN O
did VBD O
not RB O
have VB O
a DT O
medical JJ O
history NN O
or CC O
a DT O
current JJ O
medication NN O
. . O

He PRP O
was VBD O
a DT O
student NN B-Occupation
. . O

He PRP O
did VBD O
not RB O
smoke VB O
and CC O
did VBD O
not RB O
use VB O
recreational JJ O
drugs NNS O
. . O

He PRP O
only RB O
drank VBD O
alcohol NN O
occasionally RB O
. . O

There EX O
was VBD O
no DT O
family NN O
history NN O
of IN O
thromboembolism NN O
, , O
cardiovascular JJ O
problems NNS O
, , O
or CC O
hematologic JJ O
diseases NNS O
. . O

He PRP O
was VBD O
first RB O
evaluated VBN B-Diagnostic_procedure
by IN O
a DT O
neurosurgeon NN B-Nonbiological_location
in IN O
the DT O
emergency NN B-Nonbiological_location
unit NN I-Nonbiological_location
and CC O
had VBD O
a DT O
brain NN B-Biological_structure
CT NNP B-Diagnostic_procedure
scan VBD O
that IN O
highlighted VBD O
infracentimetric JJ B-Detailed_description
hypodensity NN B-Sign_symptom
in IN O
the DT O
thalamic JJ B-Biological_structure
nucleus NN I-Biological_structure
, , O
on IN O
the DT O
left JJ B-Detailed_description
side NN I-Detailed_description
and CC O
at IN O
the DT O
level NN B-Biological_structure
of IN I-Biological_structure
the DT I-Biological_structure
right JJ I-Biological_structure
cerebellar NN I-Biological_structure
hemisphere RB I-Biological_structure
in IN O
the DT O
PICA NNP B-Biological_structure
territory NN I-Biological_structure
, , O
and CC O
also RB O
a DT O
chest NN B-Biological_structure
X SYM B-Diagnostic_procedure
- : I-Diagnostic_procedure
ray NN I-Diagnostic_procedure
that WDT O
revealed VBD O
a DT O
widened JJ B-Sign_symptom
projection NN I-Sign_symptom
area NN I-Sign_symptom
of IN O
the DT O
right JJ B-Biological_structure
side NN I-Biological_structure
hilum NN I-Biological_structure
, , O
without IN O
any DT O
other JJ B-Sign_symptom
pathological JJ I-Sign_symptom
findings NNS I-Sign_symptom
. . O

Following VBG O
this DT O
evaluation NN O
, , O
he PRP O
was VBD O
sent VBN O
to TO O
the DT O
National NNP B-Nonbiological_location
Institute NNP I-Nonbiological_location
of IN I-Nonbiological_location
Neurology NNP I-Nonbiological_location
and CC I-Nonbiological_location
Cerebrovascular NNP I-Nonbiological_location
Diseases NNP I-Nonbiological_location
for IN O
consultation NN O
and CC O
special JJ B-Therapeutic_procedure
treatment NN I-Therapeutic_procedure
. . O

During IN O
the DT O
ambulance NN B-Detailed_description
transportation NN O
, , O
he PRP O
had VBD O
repeated VBN B-Detailed_description
episodes NNS O
of IN O
vomiting VBG B-Sign_symptom
. . O

The DT O
initial JJ O
physical JJ B-Diagnostic_procedure
examination NN I-Diagnostic_procedure
( ( O
at IN O
10 CD B-Time
P NNP I-Time
. . I-Time
M NNP I-Time
) ) O
showed VBD O
normal JJ B-Lab_value
vital JJ B-Diagnostic_procedure
signs NNS I-Diagnostic_procedure
: : O
blood NN B-Diagnostic_procedure
pressure NN I-Diagnostic_procedure
130 CD B-Lab_value
/ NN I-Lab_value
80mmHg CD I-Lab_value
, , O
heart NN B-Diagnostic_procedure
rate NN I-Diagnostic_procedure
100 CD B-Lab_value
beats NNS I-Lab_value
per IN I-Lab_value
minute NN I-Lab_value
and CC O
normal JJ B-Lab_value
body NN B-Diagnostic_procedure
temperature NN I-Diagnostic_procedure
36,8 CD B-Lab_value
°C NN I-Lab_value
. . O

The DT O
cardiopulmonary JJ B-Diagnostic_procedure
exam NN I-Diagnostic_procedure
was VBD O
normal JJ B-Lab_value
. . O

No DT O
carotid NN B-Sign_symptom
bruits NNS I-Sign_symptom
were VBD O
registered VBN O
. . O

The DT O
neurological JJ B-Diagnostic_procedure
examination NN I-Diagnostic_procedure
was VBD O
notable JJ O
for IN O
normal JJ B-Lab_value
orientation NN I-Lab_value
. . O

The DT O
patient NN O
had VBD O
equal JJ B-Lab_value
, , O
reactive JJ B-Lab_value
pupils NNS B-Diagnostic_procedure
, , O
divergent NN B-Detailed_description
strabismus NN B-Sign_symptom
to TO O
the DT O
left NN B-Biological_structure
eye NN I-Biological_structure
, , O
horizontal JJ B-Detailed_description
nystagmus RB B-Sign_symptom
, , O
normal JJ B-Lab_value
deglutition NN B-Diagnostic_procedure
, , O
mild JJ B-Severity
paresis NN B-Disease_disorder
of IN O
the DT O
left NN B-Biological_structure
arm NN I-Biological_structure
, , O
ataxia NN B-Disease_disorder
of IN O
all DT B-Biological_structure
limbs NNS I-Biological_structure
, , O
with IN O
an DT O
accent NN B-Biological_structure
on IN I-Biological_structure
the DT I-Biological_structure
left NN I-Biological_structure
extremities VBZ I-Biological_structure
, , O
numbness NN B-Sign_symptom
of IN O
the DT O
left NN B-Biological_structure
limbs NN I-Biological_structure
, , O
bilateral JJ B-Lab_value
response NN I-Lab_value
present NN O
at IN O
all DT B-Biological_structure
deep JJ I-Biological_structure
tendons NNS I-Biological_structure
reflex VBP B-Diagnostic_procedure
, , O
Babinski NNP B-Sign_symptom
sign NN I-Sign_symptom
on IN O
the DT O
left JJ B-Detailed_description
side NN I-Detailed_description
, , O
stereotypical JJ B-Lab_value
language NN B-Diagnostic_procedure
. . O

The DT O
patient NN O
was VBD O
able JJ B-Detailed_description
to TO I-Detailed_description
repeat VB I-Detailed_description
a DT I-Detailed_description
few JJ I-Detailed_description
words NNS I-Detailed_description
and CC I-Detailed_description
fragment NN I-Detailed_description
of IN I-Detailed_description
phrases NNS I-Detailed_description
and CC O
to TO O
perform VB B-Detailed_description
simple JJ I-Detailed_description
commands NNS I-Detailed_description
of IN I-Detailed_description
medium NN I-Detailed_description
complexity NN I-Detailed_description
. . O

The DT O
laboratory NN B-Diagnostic_procedure
analysis NN I-Diagnostic_procedure
highlighted VBD O
a DT O
normal JJ B-Lab_value
hemoleucogram NN B-Diagnostic_procedure
, , O
normal JJ B-Lab_value
blood NN B-Diagnostic_procedure
glucose JJ I-Diagnostic_procedure
level NN O
9,11 CD B-Lab_value
mmol NN I-Lab_value
/ NN I-Lab_value
L NNP I-Lab_value
( ( O
normal JJ O
range NN O
3,9 CD O
- : O
5,8 CD O
mmol NN O
/ NNP O
L NNP O
) ) O
, , O
serum JJ B-Diagnostic_procedure
creatinine NN I-Diagnostic_procedure
0,69 CD B-Lab_value
mmol NN I-Lab_value
/ NN I-Lab_value
L NNP I-Lab_value
( ( O
range VBP O
0,5 CD O
- : O
0,9 CD O
mmol NN O
/ NNP O
L NNP O
) ) O
, , O
total JJ B-Diagnostic_procedure
serum NN I-Diagnostic_procedure
cholesterol NN I-Diagnostic_procedure
5,2 CD B-Lab_value
mmol NN I-Lab_value
/ NN I-Lab_value
L NNP I-Lab_value
( ( O
normal JJ O
range NN O
< VBD O
5,2 CD O
mmol NN O
/ NNP O
L NNP O
) ) O
. . O

The DT O
tests NNS O
for IN O
thrombophilia NNS B-Diagnostic_procedure
were VBD O
negative JJ B-Lab_value
. . O

He PRP O
also RB O
presented VBD O
a DT O
normal JJ B-Lab_value
sinus NN B-Diagnostic_procedure
rhythm NN I-Diagnostic_procedure
on IN O
the DT O
ECG NNP B-Detailed_description
. . O

The DT O
brain NN B-Biological_structure
CT NNP B-Diagnostic_procedure
performed VBD O
at IN O
the DT O
first JJ O
emergency NN O
unit NN O
, , O
as IN O
mentioned VBN O
above IN O
, , O
revealed VBD O
a DT O
infracentimetric JJ B-Detailed_description
hypodensity NN B-Sign_symptom
at IN O
the DT O
level NN B-Biological_structure
of IN I-Biological_structure
the DT I-Biological_structure
left JJ I-Biological_structure
thalamic JJ I-Biological_structure
nucleus NN I-Biological_structure
and CC O
at IN O
the DT O
level NN B-Biological_structure
of IN I-Biological_structure
the DT I-Biological_structure
right JJ I-Biological_structure
cerebellar NN I-Biological_structure
hemisphere RB I-Biological_structure
in IN O
the DT O
PICA NNP B-Biological_structure
territory NN I-Biological_structure
. . O

Doppler NNP B-Detailed_description
ultrasound NN B-Diagnostic_procedure
for IN O
cerebral JJ B-Biological_structure
and CC I-Biological_structure
cervical JJ I-Biological_structure
blood NN I-Biological_structure
vessels NNS I-Biological_structure
highlighted VBD O
the DT O
marked JJ O
frena NN B-Lab_value
in IN O
the DT O
flow JJ B-Diagnostic_procedure
velocities NNS I-Diagnostic_procedure
of IN O
the DT O
V2 NNP B-Biological_structure
segment NN I-Biological_structure
of IN I-Biological_structure
the DT I-Biological_structure
right JJ I-Biological_structure
vertebral JJ I-Biological_structure
artery NN I-Biological_structure
, , O
an DT O
accentuated JJ B-Sign_symptom
aspect NN I-Sign_symptom
in IN O
the DT O
high JJ B-Biological_structure
V2 NNP I-Biological_structure
segments NNS I-Biological_structure
with IN O
the DT O
complete JJ B-Lab_value
disappearance NN I-Lab_value
of IN O
the DT O
flow NN B-Diagnostic_procedure
in IN O
the DT O
V3 NNP B-Biological_structure
segment NN I-Biological_structure
, , O
without IN O
carotid NN B-Biological_structure
atheromatous JJ B-Detailed_description
lesions NNS B-Sign_symptom
or CC O
modifications NNS B-Sign_symptom
of IN I-Sign_symptom
the DT I-Sign_symptom
trajectories NNS I-Sign_symptom
or CC I-Sign_symptom
the DT I-Sign_symptom
arterial JJ I-Sign_symptom
caliber NN I-Sign_symptom
. . O

Overall JJ O
, , O
there EX O
was VBD O
a DT O
possibility NN O
of IN O
a DT O
dissection NN B-Disease_disorder
of IN O
the DT O
right JJ B-Biological_structure
vertebral JJ I-Biological_structure
artery NN I-Biological_structure
in IN O
the DT O
higher JJR B-Detailed_description
segments NNS I-Detailed_description
with IN O
indication NN O
of IN O
cerebral JJ B-Biological_structure
and CC O
angio JJ B-Biological_structure
MRI NNP B-Diagnostic_procedure
. . O

Cerebral NNP O
and CC O
angio VB O
MRI NNP O
showed VBD O
: : O
areas NNS O
with IN O
T2 NNP B-Detailed_description
, , O
FLAIR NNP B-Diagnostic_procedure
hypersignal NN B-Lab_value
, , O
with IN O
an DT O
important JJ O
restriction NN B-Sign_symptom
of IN I-Sign_symptom
diffusion NN I-Sign_symptom
and CC O
low JJ B-Lab_value
ADC NNP B-Diagnostic_procedure
, , O
situated VBN O
in IN O
the DT O
right JJ B-Biological_structure
cerebellar JJ I-Biological_structure
area NN I-Biological_structure
of IN I-Biological_structure
the DT I-Biological_structure
postero NN I-Biological_structure
- : I-Biological_structure
inferior JJ I-Biological_structure
territory NN I-Biological_structure
, , O
anterior JJ B-Biological_structure
bilateral JJ I-Biological_structure
cerebellar JJ I-Biological_structure
territory NN I-Biological_structure
, , O
left VBD B-Biological_structure
cerebellar JJ I-Biological_structure
peduncle NN I-Biological_structure
, , O
both DT B-Biological_structure
right JJ I-Biological_structure
> NN I-Biological_structure
left VBD I-Biological_structure
thalamic JJ I-Biological_structure
nuclei NN I-Biological_structure
, , O
as RB O
well RB O
as IN O
subcortical JJ B-Biological_structure
occipital JJ I-Biological_structure
bilateral NN I-Biological_structure
, , O
with IN O
an DT O
ischemic JJ B-Sign_symptom
aspect NN I-Sign_symptom
that WDT O
was VBD O
recently RB O
constituted VBN O
in IN B-Biological_structure
the DT I-Biological_structure
vertebrobasilar JJ I-Biological_structure
territory NN I-Biological_structure
. . O

T1 NNP B-Diagnostic_procedure
FS NNP I-Diagnostic_procedure
hypersignal NN B-Lab_value
was VBD O
present JJ O
on IN O
the DT O
entire JJ B-Biological_structure
intracranial JJ I-Biological_structure
segment NN I-Biological_structure
of IN I-Biological_structure
the DT I-Biological_structure
right JJ I-Biological_structure
vertebral JJ I-Biological_structure
artery NN I-Biological_structure
and CC O
the DT O
cranio NN B-Biological_structure
- : I-Biological_structure
spinal JJ I-Biological_structure
junction NN I-Biological_structure
. . O

On IN O
the DT O
angiographic JJ B-Diagnostic_procedure
arterial JJ B-Detailed_description
3D CD B-Detailed_description
TOF NNP B-Detailed_description
sequence NN O
, , O
the DT O
presence NN O
of IN O
the DT O
rapid JJ B-Lab_value
flow NN B-Diagnostic_procedure
of IN O
the DT O
right JJ B-Biological_structure
vertebral JJ I-Biological_structure
artery NN I-Biological_structure
could MD O
be VB O
viewed VBN O
, , O
up RB B-Biological_structure
to TO I-Biological_structure
the DT I-Biological_structure
C2 NNP I-Biological_structure
segment NN I-Biological_structure
, , O
where WRB O
there EX O
was VBD O
a DT O
progressive JJ B-Detailed_description
pinch NN B-Sign_symptom
out RP I-Sign_symptom
with IN O
an DT O
aspect NN O
of IN O
flute NN B-Shape
beak NN I-Shape
shape NN I-Shape
. . O

Distal NN B-Biological_structure
of IN I-Biological_structure
this DT I-Biological_structure
level NN I-Biological_structure
, , O
there EX O
was VBD O
an DT O
absence NN B-Lab_value
of IN O
the DT O
rapid JJ B-Diagnostic_procedure
flow JJ I-Diagnostic_procedure
signal NN O
and CC O
also RB O
a DT O
lack NN B-Lab_value
of IN O
right NN B-Biological_structure
PICA NNP I-Biological_structure
visualization NN B-Diagnostic_procedure
. . O

The DT O
MRI NNP B-Diagnostic_procedure
aspect NN O
suggested VBD O
a DT O
subacute JJ B-Detailed_description
dissection NN B-Disease_disorder
of IN O
the DT O
right JJ B-Biological_structure
vertebral JJ I-Biological_structure
artery NN I-Biological_structure
. . O

The DT O
cerebral JJ B-Biological_structure
ventricular NN I-Biological_structure
system NN I-Biological_structure
had VBD O
normal JJ B-Lab_value
dimensions NNS B-Diagnostic_procedure
, , O
shape NN B-Diagnostic_procedure
, , O
and CC O
topography NN B-Diagnostic_procedure
. . O

The DT O
pericerebral JJ B-Diagnostic_procedure
fluid NN I-Diagnostic_procedure
spaces NNS I-Diagnostic_procedure
and CC O
the DT O
basal NN B-Diagnostic_procedure
cisterns NNS I-Diagnostic_procedure
were VBD O
normal JJ B-Lab_value
. . O

Conclusions NNS O
: : O
there EX O
were VBD O
some DT O
ischemic JJ B-Detailed_description
lesions NNS B-Sign_symptom
recently RB O
constituted VBD O
in IN O
the DT O
vertebrobasilar JJ B-Biological_structure
territory NN I-Biological_structure
and CC O
also RB O
a DT O
subacute JJ B-Detailed_description
dissection NN B-Disease_disorder
of IN O
the DT O
right JJ B-Biological_structure
vertebral JJ I-Biological_structure
artery NN I-Biological_structure
. . O

Heparin NNP B-Medication
administration NN O
was VBD O
started VBN O
immediately RB O
in IN O
the DT O
process NN O
of IN O
hospitalization NN O
because IN O
of IN O
the DT O
dissection NN O
. . O

The DT O
APTT NNP B-Diagnostic_procedure
value NN I-Diagnostic_procedure
was VBD O
kept VBN O
in IN O
the DT O
range NN B-Lab_value
of IN I-Lab_value
50 CD I-Lab_value
- : I-Lab_value
70 CD I-Lab_value
seconds NNS I-Lab_value
. . O

Also RB O
, , O
the DT O
prophylactic JJ B-Therapeutic_procedure
therapy NN I-Therapeutic_procedure
for IN O
stress NN B-Detailed_description
ulcer NN I-Detailed_description
was VBD O
performed VBN O
. . O

After IN O
7 CD O
days NNS O
from IN O
the DT O
debut NN O
, , O
the DT O
patient NN O
was VBD O
transitioned VBN O
to TO O
acenocumarol VB B-Medication
for IN O
long JJ O
- : O
term NN O
anticoagulation NN O
. . O

The DT O
treatment NN O
with IN O
acenocumarol NN B-Medication
was VBD O
instituted VBN O
with IN O
the DT O
heparin NN B-Medication
overlap NN O
until IN O
getting VBG O
the DT O
INR NNP B-Diagnostic_procedure
therapeutic NN B-Lab_value
in IN O
the DT O
2 CD B-Detailed_description
- : I-Detailed_description
3 CD I-Detailed_description
intervals NNS I-Detailed_description
. . O

The DT O
evolution NN B-Diagnostic_procedure
was VBD O
favorable JJ B-Lab_value
, , O
the DT O
patient NN O
regaining VBG B-Lab_value
the DT O
verbal JJ B-Diagnostic_procedure
fluency NN I-Diagnostic_procedure
and CC O
the DT O
capacity NN O
for IN O
autonomy NN B-Sign_symptom
in IN I-Sign_symptom
movement NN I-Sign_symptom
. . O

The DT O
ataxia NN B-Disease_disorder
was VBD O
remitted VBN B-Detailed_description
at IN I-Detailed_description
the DT I-Detailed_description
right JJ I-Detailed_description
limbs NNS I-Detailed_description
and CC O
persisted VBN B-Detailed_description
at IN I-Detailed_description
the DT I-Detailed_description
left NN I-Detailed_description
extremities VBZ I-Detailed_description
, , O
but CC O
registered VBD O
a DT O
lot NN O
of IN O
improvement NN B-Lab_value
. . O

The DT O
patient NN O
was VBD O
discharged VBN O
home NN B-Nonbiological_location
with IN O
the DT O
recommendation NN B-Other_entity
to TO I-Other_entity
continue VB I-Other_entity
the DT I-Other_entity
treatment NN I-Other_entity
with IN I-Other_entity
Acenocumarol NNP I-Other_entity
for IN I-Other_entity
6 CD I-Other_entity
months NNS I-Other_entity
with IN I-Other_entity
clinical JJ I-Other_entity
, , I-Other_entity
paraclinical JJ I-Other_entity
and CC I-Other_entity
treatment NN I-Other_entity
reevaluation NN I-Other_entity
at IN I-Other_entity
6 CD I-Other_entity
months NNS I-Other_entity
. . O

The DT O
follow NN O
up RP O
was VBD O
not RB O
possible JJ O
because IN O
the DT O
patient NN O
did VBD O
not RB O
return VB O
to TO O
the DT O
hospital NN B-Nonbiological_location
after IN O
6 CD O
months NNS O
. . O

-DOCSTART- NN -X-

A DT O
33 CD B-Age
- : I-Age
year NN I-Age
old JJ I-Age
woman NN O
presented VBD O
to TO O
our PRP$ O
cardiology NN O
service NN O
with IN O
signs NNS O
and CC O
symptoms NNS O
of IN O
congestive JJ B-Sign_symptom
heart NN I-Sign_symptom
failure NN I-Sign_symptom
. . O

Her PRP$ O
medical JJ O
history NN O
was VBD O
unremarkable JJ B-Detailed_description
, , O
however RB O
a DT O
year NN O
ago RB O
and CC O
soon RB O
after IN O
her PRP$ O
third JJ O
child JJ B-Other_event
delivery NN I-Other_event
, , O
she PRP O
had VBD O
been VBN O
admitted VBN O
in IN O
another DT O
hospital NN B-Nonbiological_location
for IN O
acute JJ B-Disease_disorder
pulmonary JJ I-Disease_disorder
oedema NN I-Disease_disorder
after IN O
labor NN O
. . O

Cor NNP B-Disease_disorder
triatriatum NN I-Disease_disorder
with IN O
obstructive JJ O
behavior NN O
causing VBG O
pulmonary JJ B-Sign_symptom
hypertension NN I-Sign_symptom
had VBD O
bee NNS O
diagnosed VBN O
, , O
while IN O
the DT O
left JJ B-Biological_structure
ventricle NN I-Biological_structure
was VBD O
structurally RB B-Detailed_description
and CC I-Detailed_description
functionally RB I-Detailed_description
intact JJ I-Detailed_description
. . O

The DT O
patient NN O
at IN O
that DT O
time NN O
denied VBD O
surgey NN O
and CC O
had VBD O
been VBN O
discharged VBN O
on IN O
medical JJ B-Detailed_description
therapy NN B-Therapeutic_procedure
. . O

At IN O
present JJ O
admission NN O
the DT O
patient NN O
presented VBN O
with IN O
NYHA NNP B-Disease_disorder
functional JJ I-Disease_disorder
class NN I-Disease_disorder
III NNP I-Disease_disorder
, , O
symptoms NNS O
of IN O
heart NN B-Sign_symptom
failure NN I-Sign_symptom
and CC I-Sign_symptom
palpittions NNS I-Sign_symptom
as IN O
a DT O
result NN O
of IN O
persistent JJ B-Sign_symptom
atrial JJ I-Sign_symptom
flutter NN I-Sign_symptom
. . O

On IN O
physical JJ B-Diagnostic_procedure
examination NN I-Diagnostic_procedure
a DT O
loud JJ O
pulmonary JJ O
component NN O
of IN O
the DT O
2nd CD O
heart NN O
sound NN O
and CC O
a DT O
diastolic JJ O
murmur NN O
was VBD O
heard VBN O
in IN O
the DT O
mitral JJ B-Biological_structure
area NN I-Biological_structure
. . O

Signs NNS O
of IN O
right JJ B-Detailed_description
- : I-Detailed_description
sided VBD I-Detailed_description
heart NN B-Disease_disorder
failure NN I-Disease_disorder
were VBD O
absent JJ O
. . O

A DT O
transthoracic NN B-Diagnostic_procedure
echocardiography NN I-Diagnostic_procedure
revealed VBD O
a DT O
moderately RB B-Detailed_description
dilated JJ I-Detailed_description
left VBD B-Biological_structure
ventricle NN I-Biological_structure
( ( O
LV NNP B-Biological_structure
) ) O
, , O
globally RB B-Detailed_description
hypokinetic JJ B-Disease_disorder
, , O
with IN O
severely RB B-Detailed_description
impaired JJ I-Detailed_description
systolic JJ B-Disease_disorder
function NN I-Disease_disorder
( ( O
EF NNP O
estimated VBN O
≥ RB O
30 CD B-Lab_value
% NN I-Lab_value
) ) O
. . O

Left NNP B-Biological_structure
atrium NN I-Biological_structure
( ( O
LA NNP B-Biological_structure
) ) O
was VBD O
dilated VBN B-Shape
, , O
with IN O
a DT O
mobile JJ B-Detailed_description
, , I-Detailed_description
membrane JJ I-Detailed_description
- : I-Detailed_description
like IN I-Detailed_description
echogenic JJ B-Biological_structure
structure NN I-Biological_structure
into IN O
it PRP O
. . O

Transesophageal NNP B-Diagnostic_procedure
echocardiogram NN I-Diagnostic_procedure
( ( O
TEE NNP B-Diagnostic_procedure
) ) O
documented VBD O
a DT O
fibromuscular JJ B-Biological_structure
membrane NN I-Biological_structure
across IN O
the DT O
LA NNP B-Biological_structure
, , O
dividing VBG O
it PRP O
into IN O
two CD O
compartments NNS O
, , O
a DT O
proximal JJ O
one CD O
receiving VBG O
the DT O
pulmonary JJ O
venous JJ O
flow NN O
and CC O
a DT O
distal JJ O
one CD O
containing VBG O
the DT O
left JJ B-Biological_structure
atrial JJ I-Biological_structure
appendage NN I-Biological_structure
( ( O
LAA NNP B-Biological_structure
) ) O
. . O

The DT O
two CD O
chambers NNS B-Biological_structure
communicated VBD O
via IN O
a DT O
non JJ B-Detailed_description
- : I-Detailed_description
restrictive JJ I-Detailed_description
orifice NN B-Biological_structure
, , O
but CC O
the DT O
membrane NN B-Biological_structure
prolapsed VBD O
towards IN O
the DT O
mitral JJ B-Biological_structure
valve NN I-Biological_structure
inflow NN O
causing VBG O
severe JJ O
obstruction NN O
. . O

Mitral JJ B-Biological_structure
valve NN I-Biological_structure
appeared VBD O
normal JJ O
, , O
with IN O
mild JJ O
regurgitation NN O
. . O

Patent NNP B-Disease_disorder
foramen NNS I-Disease_disorder
ovale NN I-Disease_disorder
( ( O
PFO NNP B-Disease_disorder
) ) O
, , O
atrial JJ B-Disease_disorder
septal NN I-Disease_disorder
defect NN I-Disease_disorder
( ( O
ASD NNP B-Disease_disorder
) ) O
and CC O
anomalous JJ O
venous JJ O
connections NNS O
were VBD O
ruled VBN O
out RP O
and CC O
the DT O
diagnosis NN O
of IN O
cor NN B-Disease_disorder
triatriatum NN I-Disease_disorder
was VBD O
reconfirmed VBN O
. . O

Magnetic JJ B-Diagnostic_procedure
resonance NN I-Diagnostic_procedure
imaging NN I-Diagnostic_procedure
( ( O
MRI NNP B-Diagnostic_procedure
) ) O
of IN O
the DT O
heart NN O
also RB O
revealed VBD O
the DT O
fibromuscular JJ B-Biological_structure
septum NN I-Biological_structure
into IN O
the DT O
left JJ B-Biological_structure
atrium NN I-Biological_structure
and CC O
the DT O
low JJ O
left VBD O
ventricular JJ B-Lab_value
ejection NN I-Lab_value
fraction NN I-Lab_value
[ NNP O
( ( O
LVEF NNP B-Lab_value
) ) O
30 CD B-Lab_value
% NN I-Lab_value
, , O
cardiac JJ B-Lab_value
index NN I-Lab_value
1,6 CD B-Lab_value
L NNP I-Lab_value
/ NNP I-Lab_value
min NNP I-Lab_value
/ NNP I-Lab_value
m2 NN I-Lab_value
, , O
cardiac JJ B-Lab_value
output NN I-Lab_value
2,7 CD B-Lab_value
L NNP I-Lab_value
/ NNP I-Lab_value
min NN I-Lab_value
] NNP O
( ( O
figure NN O
1 CD O
) ) O
. . O

Coronary JJ B-Diagnostic_procedure
angiography NN I-Diagnostic_procedure
showed VBD O
normal JJ O
coronary JJ B-Biological_structure
arteries NNS I-Biological_structure
. . O

With IN O
these DT O
findings NNS O
the DT O
patient NN O
was VBD O
scheduled VBN O
for IN O
surgery NN O
. . O

Anesthetic JJ O
induction NN O
was VBD O
achieved VBN O
with IN O
standard JJ O
technique NN O
including VBG O
administration NN O
of IN O
sodium NN B-Medication
pentothal NN I-Medication
, , O
sevofluorane NN B-Medication
, , O
fentanyl NN B-Medication
and CC O
muscle NN B-Medication
relaxant NN I-Medication
. . O

Invasive JJ O
monitoring NN O
included VBD O
the DT O
use NN O
of IN O
right JJ B-Other_entity
radial JJ I-Other_entity
arterial JJ I-Other_entity
lines NNS I-Other_entity
, , O
a DT O
pulmonary JJ B-Other_entity
artery NN I-Other_entity
catheter NN I-Other_entity
and CC O
a DT O
foley JJ B-Other_entity
catheter NN I-Other_entity
with IN O
temperature NN B-Other_entity
probe NN I-Other_entity
to TO O
measure VB O
bladder JJR O
temperature NN O
as IN O
an DT O
indicator NN O
of IN O
core NN O
body NN O
temperature NN O
. . O

Transesophageal NNP B-Diagnostic_procedure
echocardiography NN I-Diagnostic_procedure
( ( O
TEE NNP B-Diagnostic_procedure
) ) O
was VBD O
also RB O
instituted VBN O
. . O

Surgery NN O
was VBD O
performed VBN O
through IN O
a DT O
median JJ B-Therapeutic_procedure
sternotomy NN I-Therapeutic_procedure
. . O

Connection NN O
to TO O
cardiopulmonary JJ O
bypass NN O
( ( O
CPB NNP O
) ) O
was VBD O
achieved VBN O
by IN O
standard JJ O
ascending VBG O
aorta NN O
and CC O
bicaval JJ O
cannulation NN O
. . O

Mildly RB O
hypothermic JJ B-Sign_symptom
( ( O
32 CD B-Lab_value
°C NN I-Lab_value
) ) O
CPB NNP O
was VBD O
established VBN O
. . O

Cold NNP O
blood NN O
cardioplegia NN O
was VBD O
administered VBN O
in IN O
an DT O
antegrade JJ O
fashion NN O
through IN O
the DT O
aortic JJ O
root NN O
after IN O
clamping VBG O
the DT O
aorta NN O
. . O

The DT O
interatrial JJ O
groove NN O
was VBD O
developed VBN O
and CC O
the DT O
common JJ O
pulmonary JJ O
venous JJ O
chamber NN O
of IN O
the DT O
left JJ O
atrium NN O
was VBD O
opened VBN O
through IN O
a DT O
vertical JJ O
incision NN O
anterior NN O
to TO O
the DT O
right JJ O
pulmonary NN O
veins NNS O
, , O
exactly RB O
as IN O
for IN O
mitral JJ B-Therapeutic_procedure
valve NN I-Therapeutic_procedure
surgery NN I-Therapeutic_procedure
. . O

After IN O
insertion NN O
of IN O
a DT O
self NN O
- : O
retaining VBG O
retractor NN O
to TO O
facilitate VB O
exposure NN O
, , O
the DT O
diaphragm NN B-Biological_structure
was VBD O
exposed VBN O
and CC O
the DT O
central JJ O
hole NN O
in IN O
it PRP O
was VBD O
identified VBN O
. . O

A DT O
preliminary JJ O
incision NN O
out IN O
from IN O
the DT O
hole NN O
improved VBD O
exposure NN O
for IN O
the DT O
definitive JJ O
excision NN O
. . O

Orifices NNS O
of IN O
the DT O
pulmonary JJ B-Biological_structure
veins NNS I-Biological_structure
on IN O
both DT O
sides NNS O
were VBD O
located VBN O
. . O

Position NN O
of IN O
the DT O
atrial JJ B-Disease_disorder
septum NN I-Disease_disorder
was VBD O
also RB O
identified VBN O
by IN O
a DT O
small JJ O
opening NN O
in IN O
the DT O
right JJ B-Biological_structure
atrium NN I-Biological_structure
and CC O
by IN O
inserting VBG O
a DT O
curved JJ B-Other_entity
clamp NN I-Other_entity
to TO O
displace VB O
the DT O
septum NN O
into IN O
the DT O
common JJ O
pulmonary JJ O
venous JJ O
chamber NN O
of IN O
the DT O
left JJ B-Biological_structure
atrium NN I-Biological_structure
. . O

There EX O
was VBD O
no DT O
atrial JJ B-Disease_disorder
septal NN I-Disease_disorder
defect NN I-Disease_disorder
or CC O
patent NN B-Disease_disorder
foramen NNS I-Disease_disorder
ovale VBP I-Disease_disorder
. . O

The DT O
diaphragm NN B-Biological_structure
was VBD O
then RB O
easily RB O
completely RB O
excised VBN O
exposing VBG O
the DT O
mitral JJ B-Biological_structure
valve NN I-Biological_structure
( ( O
figure JJ O
2 CD O
) ) O
. . O

The DT O
left JJ O
atrial JJ O
appendage NN O
was VBD O
closed VBN O
from IN O
inside IN O
the DT O
left JJ O
atrium NN O
using VBG O
a DT O
running VBG O
3 CD O
- : O
0 CD O
polypropylene JJ O
suture NN O
to TO O
prevent VB O
future JJ O
thrombus NN B-Sign_symptom
formation NN I-Sign_symptom
. . O

The DT O
atriotomy JJ B-Therapeutic_procedure
incisions NNS I-Therapeutic_procedure
were VBD O
closed VBN O
, , O
the DT O
heart NN O
having VBG O
been VBN O
filled VBN O
with IN O
blood NN O
before IN O
the DT O
last JJ O
few JJ O
sutures NNS O
were VBD O
placed VBN O
. . O

The DT O
patient NN O
was VBD O
rewarmed VBN O
, , O
the DT O
aortic JJ B-Other_entity
cross NN I-Other_entity
- : I-Other_entity
clamp NN I-Other_entity
was VBD O
removed VBN O
and CC O
additional JJ O
de FW O
- : O
airing NN O
was VBD O
carried VBN O
out RP O
in IN O
the DT O
usual JJ O
manner NN O
. . O

CPB NNP O
was VBD O
terminated VBN O
with IN O
minimal JJ O
inotropic NN O
support NN O
, , O
involving VBG O
milrinone NN O
and CC O
levophed VBN O
with IN O
good JJ O
hemodynamics NNS O
. . O

The DT O
postoperative JJ O
course NN O
was VBD O
uneventful JJ O
and CC O
the DT O
patient NN O
was VBD O
extubated VBN O
after IN O
12 CD O
hours NNS O
and CC O
discharged VBN O
from IN O
the DT O
hospital NN O
on IN O
the DT O
fifth JJ O
postoperative JJ O
day NN O
. . O

At IN O
3 CD O
months NNS O
follow VBP O
- : O
up RB O
, , O
the DT O
patient NN O
was VBD O
asymptomatic JJ O
( ( O
NYHA NNP O
class NN O
I PRP O
) ) O
, , O
in IN O
sinus NN O
rhythm NN O
. . O

TTE NNP B-Diagnostic_procedure
and CC O
MRI NNP B-Diagnostic_procedure
revealed VBD O
a DT O
mildly RB O
dilated VBN O
LV NNP O
with IN O
great JJ O
improvement NN O
in IN O
systolic JJ O
function NN O
and CC O
an DT O
estimated JJ O
LVEF NNP B-Lab_value
of IN O
50 CD B-Lab_value
% NN I-Lab_value
. . O

-DOCSTART- NN -X-

A DT O
42 CD B-Age
- : I-Age
year NN I-Age
- : I-Age
old JJ I-Age
woman NN O
presented VBN O
with IN O
a DT O
right JJ B-Biological_structure
breast NN I-Biological_structure
lump NN B-Sign_symptom
, , O
lower JJR B-Biological_structure
back RB I-Biological_structure
pain NN B-Sign_symptom
, , O
loss NN B-Sign_symptom
of IN I-Sign_symptom
height NN I-Sign_symptom
, , O
marked VBN O
kyphosis NN B-Sign_symptom
and CC O
hepatomegaly NN B-Sign_symptom
. . O

Core NN O
biopsies NNS B-Diagnostic_procedure
from IN O
the DT O
breast NN B-Biological_structure
lump NN I-Biological_structure
showed VBD O
ductal JJ B-Disease_disorder
carcinoma NN I-Disease_disorder
in IN O
situ NN O
( ( O
sample NN O
labelled VBN O
P1 NNP O
. . O
1 CD O
; : O
Supplementary NNP O
Fig NNP O
. . O
1 CD O
and CC O
Supplementary NNP O
Table NNP O
1 CD O
) ) O
. . O

An DT O
additional JJ O
biopsy NN B-Diagnostic_procedure
from IN O
an DT O
ipsilateral JJ B-Biological_structure
axillary JJ I-Biological_structure
lymph NN I-Biological_structure
node NN I-Biological_structure
( ( O
P1 NNP O
. . O
2 CD O
) ) O
revealed VBD O
metastatic JJ B-Detailed_description
ductal JJ B-Disease_disorder
adenocarcinoma NN I-Disease_disorder
( ( O
ER NNP O
+ NNP O
( ( O
8 CD O
/ RB O
8 CD O
) ) O
and CC O
HER2 NNP O
+ NNP O
( ( O
3 CD O
+ NNP O
) ) O
) ) O
. . O

Computed VBN B-Diagnostic_procedure
tomography NN I-Diagnostic_procedure
scan JJ O
revealed VBD O
widespread JJ B-Detailed_description
metastatic JJ B-Disease_disorder
disease NN I-Disease_disorder
in IN O
bones NNS B-Biological_structure
, , O
pleura NN B-Biological_structure
and CC O
liver NN B-Biological_structure
( ( O
Supplementary JJ O
Fig NNP O
. . O
2 CD O
and CC O
Supplementary NNP O
Table NNP O
2 CD O
) ) O
. . O

The DT O
patient NN O
was VBD O
started VBN O
on IN O
treatment NN O
with IN O
trastuzumab NN B-Medication
and CC O
taxane NN B-Medication
- : I-Medication
based VBN I-Medication
chemotherapy NN I-Medication
, , O
with IN O
a DT O
significant JJ B-Detailed_description
partial JJ B-Detailed_description
response NN B-Sign_symptom
( ( O
Supplementary JJ O
Fig NNP O
. . O
3 CD O
) ) O
. . O

After IN O
induction NN B-Detailed_description
chemotherapy NN B-Medication
, , O
she PRP O
was VBD O
maintained VBN O
on IN O
tamoxifen NN B-Medication
and CC O
trastuzumab NN B-Medication
. . O

After IN O
19 CD B-Duration
months NNS I-Duration
on IN O
treatment NN O
, , O
she PRP O
presented VBD O
with IN O
seizures NNS B-Sign_symptom
and CC O
head NN B-Biological_structure
computed VBD B-Diagnostic_procedure
tomography NN I-Diagnostic_procedure
revealed VBD O
a DT O
large JJ O
metastasis NN B-Sign_symptom
in IN O
the DT O
left JJ B-Biological_structure
frontal JJ I-Biological_structure
lobe NN I-Biological_structure
( ( O
Supplementary JJ O
Fig NNP O
. . O
4 CD O
) ) O
, , O
which WDT O
was VBD O
resected VBN B-Therapeutic_procedure
( ( O
M2 NNP O
. . O
1 CD O
) ) O
. . O

Therapy NN O
with IN O
tamoxifen NN B-Medication
and CC O
trastuzumab NN B-Medication
was VBD O
continued VBN O
and CC O
collection NN O
of IN O
plasma NN B-Diagnostic_procedure
samples NNS I-Diagnostic_procedure
was VBD O
initiated VBN O
( ( O
samples NNS O
T1 NNP O
- : O
T9 NN O
) ) O
. . O

Four CD O
months NNS O
after IN O
surgery NN O
, , O
she PRP O
had VBD O
enlarging VBG B-Detailed_description
liver JJ B-Biological_structure
lesions NNS B-Sign_symptom
and CC O
a DT O
new JJ O
metastatic JJ B-Sign_symptom
deposit NN I-Sign_symptom
in IN O
the DT O
left NN B-Biological_structure
ovary JJ I-Biological_structure
( ( O
Supplementary JJ O
Fig NNP O
. . O
5 CD O
) ) O
. . O

Treatment NN O
was VBD O
switched VBN O
to TO O
a DT O
combination NN O
of IN O
lapatinib NN B-Medication
and CC O
capecitabine NN B-Medication
, , O
resulting VBG O
in IN O
stable JJ B-Sign_symptom
disease NN I-Sign_symptom
for IN O
12 CD B-Duration
months NNS I-Duration
( ( O
Supplementary NNP O
Fig NNP O
. . O
6 CD O
) ) O
. . O

General NNP B-Sign_symptom
deterioration NN I-Sign_symptom
then RB O
occurred VBD O
, , O
with IN O
disease JJ B-Sign_symptom
progression NN I-Sign_symptom
in IN O
the DT O
chest NN B-Biological_structure
( ( O
new JJ O
pulmonary JJ B-Biological_structure
nodules NNS B-Sign_symptom
, , O
bilateral JJ B-Detailed_description
pleural JJ B-Disease_disorder
effusions NNS I-Disease_disorder
and CC O
posterior JJ B-Biological_structure
chest NN I-Biological_structure
wall NN I-Biological_structure
mass NN B-Sign_symptom
, , O
Supplementary NNP O
Fig NNP O
. . O
7 CD O
; : O
Eastern NNP B-Diagnostic_procedure
Cooperative NNP I-Diagnostic_procedure
Oncology NNP I-Diagnostic_procedure
Group NNP I-Diagnostic_procedure
performance NN I-Diagnostic_procedure
status NN I-Diagnostic_procedure
2 CD B-Lab_value
- : I-Lab_value
3 CD I-Lab_value
) ) O
. . O

Treatment NN B-Therapeutic_procedure
was VBD O
stopped VBN O
and CC O
the DT O
patient NN O
died VBD O
∼ JJ O
4 CD O
months NNS O
later RB O
. . O

Tumour CD O
samples NNS O
were VBD O
obtained VBN O
at IN O
diagnosis NN O
from IN O
the DT O
primary JJ O
breast NN O
site NN O
( ( O
P1 NNP O
. . O
1 CD O
) ) O
and CC O
an DT O
axillary JJ O
lymph NN O
node NN O
( ( O
P1 NNP O
. . O
2 CD O
) ) O
; : O
after IN O
19 CD O
months NNS O
from IN O
the DT O
brain NN O
metastasis NN O
area NN O
( ( O
M2 NNP O
. . O
1 CD O
) ) O
; : O
and CC O
at IN O
autopsy NN O
after IN O
3 CD O
years NNS O
on IN O
treatment NN O
( ( O
from IN O
the DT O
primary JJ O
breast NN O
site NN O
, , O
and CC O
from IN O
metastatic JJ O
deposits NNS O
in IN O
the DT O
chest NN O
, , O
liver RB O
, , O
ovary JJ O
and CC O
vertebrae NN O
, , O
labelled VBD O
P3 NNP O
. . O
1 CD O
and CC O
M3 NNP O
. . O
1 CD O
- : O
M3 NN O
. . O
4 CD O
, , O
respectively RB O
) ) O
. . O

Serial JJ O
plasma NN O
samples NNS O
were VBD O
obtained VBN O
over IN O
the DT O
last JJ O
500 CD O
days NNS O
of IN O
clinical JJ O
follow NN O
- : O
up RB O
( ( O
T1 NNP O
- : O
T9 NN O
) ) O
. . O

Tumour CD O
and CC O
plasma VB O
samples NNS O
collected VBN O
and CC O
the DT O
clinical JJ O
course NN O
are VBP O
summarized VBN O
in IN O
Fig NNP O
. . O
1a CD O
, , O
b NN O
. . O

-DOCSTART- NN -X-

Our PRP$ O
patient NN O
was VBD O
a DT O
68 CD B-Age
- : I-Age
year NN I-Age
- : I-Age
old JJ I-Age
woman NN O
with IN O
chronic JJ O
obstructive JJ O
pulmonary JJ O
disease NN O
. . O

She PRP O
had VBD O
no DT O
history NN O
of IN O
gastroesophageal NN O
reflux JJ O
disease NN O
or CC O
esophageal NN O
disorders NNS O
but CC O
was VBD O
found VBN O
to TO O
have VB O
a DT O
progressive JJ B-Detailed_description
solitary JJ B-Detailed_description
pulmonary JJ B-Biological_structure
nodule NN B-Sign_symptom
( ( O
1 CD B-Area
× RB I-Area
1 CD I-Area
. . I-Area
3 CD I-Area
cm NN I-Area
) ) O
. . O

A DT O
right JJ B-Detailed_description
lower JJR I-Detailed_description
wedge NN I-Detailed_description
resection NN B-Therapeutic_procedure
was VBD O
performed VBN O
in IN O
December NNP O
2011 CD O
and CC O
the DT O
University NNP B-Nonbiological_location
of IN I-Nonbiological_location
Iowa NNP I-Nonbiological_location
pathology NN I-Nonbiological_location
department NN I-Nonbiological_location
identified VBD O
the DT O
tumor NN O
as IN O
a DT O
LCNEC NNP B-Disease_disorder
. . O

Approximately RB O
six CD O
months NNS O
after IN O
her PRP$ O
operation NN O
, , O
our PRP$ O
patient NN O
started VBD O
having VBG O
slowly RB B-Detailed_description
progressing VBG I-Detailed_description
dysphagia NN B-Sign_symptom
for IN B-Detailed_description
both DT I-Detailed_description
solids NNS I-Detailed_description
and CC I-Detailed_description
liquids NNS I-Detailed_description
. . O

A DT O
positron NN B-Diagnostic_procedure
emission NN I-Diagnostic_procedure
tomography NN I-Diagnostic_procedure
( ( O
PET NNP B-Diagnostic_procedure
) ) O
scan NN O
performed VBN O
in IN O
2012 CD O
, , O
one CD O
year NN O
post NN O
surgery NN O
, , O
was VBD O
unremarkable JJ B-Lab_value
for IN O
recurrence NN O
or CC O
metastasis NN O
. . O

Repeat NN O
computed VBN B-Diagnostic_procedure
tomography NN I-Diagnostic_procedure
( ( O
CT NNP B-Diagnostic_procedure
) ) O
in IN O
June NNP O
2013 CD O
( ( O
18 CD O
months NNS O
post RB O
surgery NN O
) ) O
did VBD O
not RB O
show VB O
any DT O
recurrence NN B-Sign_symptom
( ( O
Figure NNP O
1 CD O
) ) O
. . O

Our PRP$ O
patient NN O
had VBD O
an DT O
esophagogastroduodenoscopy NN B-Diagnostic_procedure
( ( O
EGD NNP B-Diagnostic_procedure
) ) O
and CC O
barium NN B-Diagnostic_procedure
swallow NN I-Diagnostic_procedure
that WDT O
revealed VBD O
no DT O
stricture NN B-Sign_symptom
of IN O
her PRP$ O
esophagus NN B-Biological_structure
but CC O
failure NN B-Sign_symptom
of IN O
primary JJ B-Biological_structure
and CC I-Biological_structure
secondary JJ I-Biological_structure
peristaltic JJ I-Biological_structure
waves NNS I-Biological_structure
and CC O
reflux NN B-Biological_structure
. . O

In IN O
July NNP O
2013 CD O
, , O
esophageal JJ B-Diagnostic_procedure
manometry NN I-Diagnostic_procedure
found VBD O
failure NN B-Sign_symptom
of IN O
the DT O
lower JJR B-Detailed_description
esophageal NN I-Detailed_description
sphincter NN I-Detailed_description
to TO I-Detailed_description
relax VB I-Detailed_description
, , O
with IN O
a DT O
residual JJ B-Diagnostic_procedure
pressure NN I-Diagnostic_procedure
of IN O
32mmHg CD B-Lab_value
. . O

Our PRP$ O
patient NN O
was VBD O
treated VBN O
with IN O
calcium NN B-Medication
channel NN I-Medication
blockers NNS I-Medication
with IN O
partial JJ O
relief NN B-Sign_symptom
. . O

Thus RB O
far RB O
, , O
up RB B-Duration
to TO I-Duration
18 CD I-Duration
months NNS I-Duration
post VBN I-Duration
resection NN O
, , O
our PRP$ O
patient NN O
had VBD O
been VBN O
able JJ O
to TO O
maintain VB B-Lab_value
her PRP$ O
weight NN B-Diagnostic_procedure
and CC O
her PRP$ O
basic JJ B-Diagnostic_procedure
laboratory NN I-Diagnostic_procedure
parameters NNS I-Diagnostic_procedure
, , O
including VBG O
hemoglobin NN B-Diagnostic_procedure
, , O
albumin NN B-Diagnostic_procedure
and CC O
cholesterol NN B-Diagnostic_procedure
levels NNS O
. . O

However RB O
, , O
in IN O
January NNP O
2014 CD O
, , O
she PRP O
reported VBD O
worsening VBG O
dysphagia NN B-Sign_symptom
and CC O
weight JJ B-Sign_symptom
loss NN I-Sign_symptom
of IN O
10 CD B-Lab_value
lbs NN I-Lab_value
over IN B-Duration
a DT I-Duration
period NN I-Duration
of IN I-Duration
one CD I-Duration
month NN I-Duration
. . O

She PRP O
was VBD O
referred VBN O
to TO O
our PRP$ O
center NN B-Nonbiological_location
for IN O
further JJ O
treatment NN B-Therapeutic_procedure
of IN O
her PRP$ O
achalasia NN B-Disease_disorder
. . O

A DT O
repeat NN O
esophageal NN B-Diagnostic_procedure
manometry NN I-Diagnostic_procedure
showed VBD O
an DT O
elevated VBN B-Lab_value
lower JJR B-Diagnostic_procedure
esophageal JJ I-Diagnostic_procedure
sphincter JJR I-Diagnostic_procedure
pressure NN I-Diagnostic_procedure
of IN O
50mmHg CD B-Lab_value
as IN O
well RB O
non IN B-Detailed_description
- : I-Detailed_description
propagative NN I-Detailed_description
, , O
non SYM B-Detailed_description
- : I-Detailed_description
peristaltic JJ I-Detailed_description
contractions NNS B-Sign_symptom
throughout IN O
her PRP$ O
esophageal JJ B-Biological_structure
musculature NN I-Biological_structure
( ( O
Figure NNP O
2 CD O
) ) O
. . O

A DT O
repeat NN O
EGD NNP B-Diagnostic_procedure
with IN O
an DT O
intention NN O
to TO O
perform VB O
therapeutic JJ O
pneumatic JJ B-Therapeutic_procedure
dilation NN I-Therapeutic_procedure
showed VBD O
a DT O
nearly RB B-Detailed_description
circumferential JJ I-Detailed_description
ulcerated JJ B-Detailed_description
, , O
fungating VBG B-Detailed_description
mass NN B-Sign_symptom
from IN O
approximately RB B-Distance
36 CD I-Distance
cm NNS I-Distance
that WDT O
extended VBD O
to TO O
her PRP$ O
gastroesophageal JJ B-Biological_structure
junction NN I-Biological_structure
at IN B-Distance
39 CD I-Distance
cm NN I-Distance
. . O

Biopsies NNS B-Diagnostic_procedure
revealed VBD O
a DT O
LCNEC NNP B-Disease_disorder
with IN O
similar JJ B-Detailed_description
features NNS I-Detailed_description
to TO I-Detailed_description
the DT I-Detailed_description
primary JJ I-Detailed_description
tumor NN I-Detailed_description
resected VBD I-Detailed_description
in IN I-Detailed_description
2011 CD I-Detailed_description
, , O
and CC O
was VBD O
concluded VBN O
to TO O
be VB O
a DT O
metastasis NN B-Sign_symptom
. . O

Subsequently RB O
, , O
a DT O
repeat NN O
CT NNP B-Diagnostic_procedure
scan NN I-Diagnostic_procedure
revealed VBD O
progressive JJ B-Detailed_description
diffuse NN B-Detailed_description
metastatic JJ B-Disease_disorder
disease NN I-Disease_disorder
. . O

Our PRP$ O
patient JJ O
underwent JJ O
two CD B-Detailed_description
courses NNS I-Detailed_description
of IN O
chemotherapy NN B-Medication
but CC O
died VBD O
from IN O
the DT O
disease NN O
after IN O
six CD O
months NNS O
. . O

-DOCSTART- NN -X-

A DT O
55 CD B-Age
- : I-Age
year NN I-Age
- : I-Age
old JJ I-Age
woman NN O
was VBD O
referred VBN O
to TO O
our PRP$ O
hospital NN B-Nonbiological_location
because IN O
of IN O
a DT O
suspicion NN O
of IN O
mediastinal JJ B-Biological_structure
tumor NN B-Sign_symptom
incidentally RB O
found VBN O
through IN O
a DT O
medical JJ O
- : O
checkup NN O
plain NN O
X NNP B-Diagnostic_procedure
- : I-Diagnostic_procedure
ray NN I-Diagnostic_procedure
photography NN I-Diagnostic_procedure
( ( O
X NNP B-Diagnostic_procedure
- : I-Diagnostic_procedure
P NN I-Diagnostic_procedure
) ) O
( ( O
Figure NNP O
( ( O
Figure1A NNP O
) ) O
. . O
1A CD O
) ) O
. . O

Chest NNP B-Biological_structure
MRI NNP B-Diagnostic_procedure
revealed VBD O
a DT O
3 CD B-Distance
cm NN I-Distance
diameter NN O
tumor NN B-Sign_symptom
which WDT O
seemed VBD O
to TO O
connect VB O
to TO O
the DT O
right JJ B-Biological_structure
lobe NN I-Biological_structure
of IN I-Biological_structure
thyroid NN I-Biological_structure
and CC O
projected VBN O
into IN O
the DT O
mediastinum NN B-Biological_structure
( ( O
Figure NNP O
1B CD O
) ) O
. . O

By IN O
123I CD B-Diagnostic_procedure
- : I-Diagnostic_procedure
RI NN I-Diagnostic_procedure
, , O
no DT B-Lab_value
unusual JJ I-Lab_value
accumulation NN I-Lab_value
was VBD O
detected VBN O
( ( O
Figure NNP O
1C CD O
) ) O
. . O

A DT O
fine JJ B-Detailed_description
needle JJ I-Detailed_description
aspiration NN I-Detailed_description
biopsy NN B-Diagnostic_procedure
, , O
which WDT O
is VBZ O
viewed VBN O
as IN O
the DT O
` `` O
gold JJ O
standard NN O
` `` O
for IN O
diagnosis NN O
in IN O
most JJS O
cases NNS O
, , O
was VBD O
tried VBN O
but CC O
could MD B-Lab_value
not RB I-Lab_value
reach VB I-Lab_value
a DT I-Lab_value
conclusive JJ I-Lab_value
diagnosis NN I-Lab_value
. . O

Thereby RB O
, , O
18F CD B-Diagnostic_procedure
- : I-Diagnostic_procedure
FDG NNP I-Diagnostic_procedure
- : I-Diagnostic_procedure
PET NN I-Diagnostic_procedure
was VBD O
performed VBN O
and CC O
a DT O
high JJ B-Lab_value
accumulation NN I-Lab_value
was VBD O
revealed VBN O
with IN O
standardized JJ B-Diagnostic_procedure
uptake JJ I-Diagnostic_procedure
value NN I-Diagnostic_procedure
( ( O
SUV NNP B-Diagnostic_procedure
) ) O
of IN O
3 CD B-Lab_value
. . I-Lab_value
8 CD I-Lab_value
( ( O
Figure NNP O
1D CD O
) ) O
. . O

Thus RB O
, , O
as IN O
a DT O
possibility NN O
of IN O
malignancy NN B-Disease_disorder
could MD O
not RB O
be VB O
excluded VBN O
, , O
the DT O
right JJ B-Biological_structure
lobe NN I-Biological_structure
excision NN B-Therapeutic_procedure
procedure NN O
for IN O
thyroid JJ B-Biological_structure
gland NN I-Biological_structure
was VBD O
enforced VBN O
. . O

The DT O
obtained JJ O
tumor NN B-Sign_symptom
was VBD O
continuous JJ O
to TO O
the DT O
right JJ B-Biological_structure
lobe NN I-Biological_structure
as IN O
expected VBN O
. . O

The DT O
surface NN O
was VBD O
flat JJ B-Texture
and CC O
smooth JJ B-Texture
and CC O
the DT O
exfoliation NN O
from IN O
the DT O
circumference NN O
organization NN O
was VBD O
easy JJ O
( ( O
Figure NNP O
2A CD O
) ) O
. . O

Microscopically RB B-Diagnostic_procedure
, , O
the DT O
encapsulated JJ O
tumor NN O
consisted VBD O
of IN O
atypical JJ B-Sign_symptom
large JJ B-Detailed_description
- : I-Detailed_description
sized JJ I-Detailed_description
follicles NNS B-Biological_structure
without IN O
malignant JJ B-Sign_symptom
characteristics NNS I-Sign_symptom
, , O
the DT O
background NN O
thyroid JJ B-Biological_structure
tissue NN I-Biological_structure
showing VBG O
no DT O
remarkable JJ O
change NN B-Sign_symptom
( ( O
Figure NNP O
2B CD O
) ) O
. . O

Thus RB O
, , O
histological JJ B-Diagnostic_procedure
diagnosis NN I-Diagnostic_procedure
was VBD O
follicular JJ B-Disease_disorder
thyroid JJ I-Disease_disorder
adenoma NN I-Disease_disorder
. . O

Ethical JJ O
approval NN O
was VBD O
not RB O
thought VBN O
to TO O
be VB O
necessary JJ O
because IN O
all PDT O
the DT O
clinical JJ O
course NN O
of IN O
the DT O
case NN O
was VBD O
completely RB O
within IN O
usual JJ O
medical JJ O
cares NNS O
. . O

Informed NNP O
consent NN O
was VBD O
given VBN O
from IN O
the DT O
case NN O
on IN O
each DT O
occasion NN O
of IN O
diagnostic JJ O
examinations NNS O
and CC O
therapeutic JJ O
procedures NNS O
. . O

-DOCSTART- NN -X-

We PRP O
present VBP O
the DT O
case NN O
of IN O
a DT O
16 CD B-Age
- : I-Age
year NN I-Age
- : I-Age
old JJ I-Age
girl NN O
, , O
admitted VBN O
to TO O
our PRP$ O
clinic NN B-Nonbiological_location
with IN O
severe JJ B-Severity
abdominal JJ B-Biological_structure
pain NN B-Sign_symptom
, , O
loss NN B-Sign_symptom
of IN I-Sign_symptom
appetite NN I-Sign_symptom
, , O
nausea NN B-Sign_symptom
, , O
and CC O
vomiting NN B-Sign_symptom
. . O

The DT O
anamnesis NN B-Diagnostic_procedure
revealed VBD O
that IN O
the DT O
girl NN O
comes VBZ O
from IN O
a DT O
family NN O
of IN O
potters NNS O
, , O
and CC O
that IN O
she PRP O
also RB O
participated VBD B-Occupation
in IN I-Occupation
the DT I-Occupation
process NN I-Occupation
of IN I-Occupation
pottery NN I-Occupation
, , O
her PRP$ O
father NN O
being VBG O
diagnosed VBN O
with IN O
lead JJ O
poisoning VBG O
2 CD O
years NNS O
before RB O
. . O

The DT O
patient NN O
` `` O
s JJ O
personal JJ O
history NN O
underlined VBD O
that IN O
approximately RB O
1 CD O
year NN O
ago IN O
she PRP O
presented VBD O
with IN O
severe JJ B-Severity
abdominal JJ B-Biological_structure
pain NN B-Sign_symptom
, , O
being VBG O
diagnosed VBN O
with IN O
acute JJ B-Detailed_description
appendicitis NN B-Disease_disorder
and CC O
she PRP O
underwent JJ O
appendectomy NN B-Therapeutic_procedure
, , O
but CC O
the DT O
pain NN B-Sign_symptom
persisted VBD B-Detailed_description
, , O
thus RB O
due JJ O
to TO O
family NN O
history NN O
of IN O
lead NN O
poisoning NN O
, , O
the DT O
suspicion NN O
of IN O
saturnine JJ B-Disease_disorder
colic NN I-Disease_disorder
rose VBD O
, , O
and CC O
she PRP O
was VBD O
diagnosed VBN O
with IN O
lead JJ B-Disease_disorder
poisoning NN I-Disease_disorder
( ( O
urinary JJ B-Diagnostic_procedure
lead NN I-Diagnostic_procedure
: : O
219 CD B-Lab_value
μg NN I-Lab_value
/ NNP I-Lab_value
L NNP I-Lab_value
) ) O
, , O
but CC O
she PRP O
received VBD O
only RB O
symptomatic JJ B-Therapeutic_procedure
treatment NN I-Therapeutic_procedure
. . O

Approximately RB O
3 CD O
weeks NNS O
before IN O
admission NN O
to TO O
our PRP$ O
clinic NN O
, , O
she PRP O
was VBD O
admitted VBN O
to TO O
the DT O
regional JJ B-Nonbiological_location
hospital NN I-Nonbiological_location
with IN O
another DT O
episode NN O
of IN O
saturnine JJ B-Disease_disorder
colic NN I-Disease_disorder
( ( O
blood JJ B-Diagnostic_procedure
lead NN I-Diagnostic_procedure
: : O
113 CD B-Lab_value
. . I-Lab_value
2 CD I-Lab_value
μg JJ I-Lab_value
/ NNP I-Lab_value
dL NN I-Lab_value
) ) O
, , O
and CC O
chelation NN B-Medication
therapy NN I-Medication
with IN O
EDTA NNP B-Medication
( ( O
4 CD O
days NNS O
before IN O
the DT O
admission NN O
in IN O
our PRP$ O
clinic NN O
) ) O
was VBD O
initiated VBN O
, , O
with IN O
a DT O
dose NN O
of IN O
2 CD B-Dosage
tablets NNS I-Dosage
daily RB I-Dosage
, , O
one CD B-Dosage
in IN I-Dosage
the DT I-Dosage
morning NN I-Dosage
and CC I-Dosage
one CD I-Dosage
in IN I-Dosage
the DT I-Dosage
evening NN I-Dosage
associated VBN O
with IN O
calcium NN B-Medication
supplements NNS I-Medication
. . O

The DT O
clinical JJ B-Diagnostic_procedure
examination NN I-Diagnostic_procedure
performed VBN O
at IN O
the DT O
time NN O
of IN O
admission NN O
revealed VBD O
the DT O
following JJ O
pathological JJ O
elements NNS O
: : O
influenced VBN B-Sign_symptom
general JJ I-Sign_symptom
status NN I-Sign_symptom
, , O
ailing VBG B-Sign_symptom
face NN I-Sign_symptom
, , O
jaundice NN B-Sign_symptom
of IN O
the DT O
sclera NN B-Biological_structure
, , O
blue JJ B-Color
pigmentation NN B-Sign_symptom
of IN O
the DT O
nails NNS B-Biological_structure
, , O
painful JJ B-Sign_symptom
abdomen NNS B-Biological_structure
at IN O
palpation NN B-Detailed_description
, , O
and CC O
weight NN B-Diagnostic_procedure
: : O
45 CD B-Lab_value
kg NN I-Lab_value
. . O

The DT O
laboratory NN B-Diagnostic_procedure
test NN I-Diagnostic_procedure
performed VBN O
upon IN O
admission NN O
revealed VBD O
hypochromic JJ B-Detailed_description
anemia NN B-Sign_symptom
( ( O
hemoglobin NN B-Diagnostic_procedure
( ( O
Hb NNP B-Diagnostic_procedure
) ) O
: : O
10 CD B-Lab_value
. . I-Lab_value
9 CD I-Lab_value
g JJ I-Lab_value
/ NNP I-Lab_value
dl NN I-Lab_value
, , O
hematocrit NN B-Diagnostic_procedure
( ( O
Htc NNP B-Diagnostic_procedure
) ) O
: : O
31 CD B-Lab_value
. . I-Lab_value
6 CD I-Lab_value
% NN I-Lab_value
, , O
medium NN B-Diagnostic_procedure
cellular JJ I-Diagnostic_procedure
volume NN I-Diagnostic_procedure
( ( O
MCV NNP B-Diagnostic_procedure
) ) O
: : O
77 CD B-Lab_value
. . I-Lab_value
6 CD I-Lab_value
fL NN I-Lab_value
) ) O
, , O
increased VBD B-Lab_value
level NN O
of IN O
liver NN B-Diagnostic_procedure
transaminases NNS I-Diagnostic_procedure
( ( O
alanine JJ B-Diagnostic_procedure
- : I-Diagnostic_procedure
aminotransferase NN I-Diagnostic_procedure
( ( O
ALAT NNP B-Diagnostic_procedure
) ) O
: : O
158 CD B-Lab_value
. . I-Lab_value
9 CD I-Lab_value
U NNP I-Lab_value
/ NNP I-Lab_value
L NNP I-Lab_value
, , O
aspartate VBP B-Diagnostic_procedure
- : I-Diagnostic_procedure
aminotransferase NN I-Diagnostic_procedure
( ( O
ASAT NNP B-Diagnostic_procedure
) ) O
: : O
63 CD B-Lab_value
U NNP I-Lab_value
/ NNP I-Lab_value
L NNP I-Lab_value
, , O
gamma SYM B-Diagnostic_procedure
- : I-Diagnostic_procedure
glutamyl NN I-Diagnostic_procedure
- : I-Diagnostic_procedure
transferase NN I-Diagnostic_procedure
( ( O
GGT NNP B-Diagnostic_procedure
) ) O
: : O
128 CD B-Lab_value
U NNP I-Lab_value
/ NNP I-Lab_value
L NNP I-Lab_value
) ) O
, , O
conjugated VBN B-Sign_symptom
hyperbilirubinemia NN I-Sign_symptom
( ( O
direct JJ B-Diagnostic_procedure
bilirubin NN I-Diagnostic_procedure
( ( O
DBi NNP B-Diagnostic_procedure
) ) O
: : O
1 CD B-Lab_value
. . I-Lab_value
432 CD I-Lab_value
mg JJ I-Lab_value
/ NNP I-Lab_value
dL NN I-Lab_value
) ) O
, , O
hyponatremia NN B-Sign_symptom
( ( O
Na NNP B-Diagnostic_procedure
: : O
132 CD B-Lab_value
mmol NN I-Lab_value
/ NNP I-Lab_value
L NNP I-Lab_value
) ) O
, , O
and CC O
hypopotassemia NN B-Sign_symptom
( ( O
K NNP B-Diagnostic_procedure
: : O
2 CD B-Lab_value
. . I-Lab_value
85 CD I-Lab_value
mmol JJ I-Lab_value
/ NNP I-Lab_value
L NNP I-Lab_value
) ) O
. . O

The DT O
systolic JJ B-Detailed_description
arterial JJ B-Diagnostic_procedure
pressure NN I-Diagnostic_procedure
was VBD O
156 CD B-Lab_value
mm NN I-Lab_value
Hg NNP I-Lab_value
, , O
and CC O
the DT O
diastolic NN B-Detailed_description
was VBD O
96 CD B-Lab_value
mm JJ I-Lab_value
Hg NNP I-Lab_value
. . O

The DT O
blood NN B-Biological_structure
lead JJ B-Diagnostic_procedure
level NN O
was VBD O
66 CD B-Lab_value
. . I-Lab_value
28 CD I-Lab_value
μg JJ I-Lab_value
/ NNP I-Lab_value
dL NN I-Lab_value
, , O
the DT O
urinary JJ B-Biological_structure
one NN O
was VBD O
419 CD B-Lab_value
. . I-Lab_value
7 CD I-Lab_value
μg JJ I-Lab_value
/ NN I-Lab_value
L NNP I-Lab_value
( ( O
normal JJ O
< $ O
50 CD O
μg NNP O
/ NNP O
L NNP O
) ) O
and CC O
the DT O
value NN O
of IN O
delta JJ B-Diagnostic_procedure
- : I-Diagnostic_procedure
aminolevulinic JJ I-Diagnostic_procedure
acid NN I-Diagnostic_procedure
was VBD O
7 CD B-Lab_value
. . I-Lab_value
66 CD I-Lab_value
mg JJ I-Lab_value
/ NN I-Lab_value
L NNP I-Lab_value
( ( O
normal JJ O
< $ O
4 CD O
. . O
5 CD O
mg JJ O
/ NNP O
L NNP O
) ) O
. . O

We PRP O
also RB O
performed VBD O
abdominal JJ B-Biological_structure
ultrasound NN B-Diagnostic_procedure
which WDT O
revealed VBD O
a DT O
disappearance NN B-Sign_symptom
of IN O
the DT O
delimitation NN B-Detailed_description
between IN I-Detailed_description
the DT I-Detailed_description
cortical JJ I-Detailed_description
and CC I-Detailed_description
medullar JJ I-Detailed_description
parts NNS I-Detailed_description
in IN O
both DT B-Biological_structure
kidneys NNS I-Biological_structure
. . O

We PRP O
requested VBD O
consultation NN O
from IN O
an DT O
occupational JJ B-Nonbiological_location
healthcare NN I-Nonbiological_location
specialist NN I-Nonbiological_location
, , O
who WP O
recommended VBD O
the DT O
continuation NN O
of IN O
chelation NN B-Medication
therapy NN I-Medication
with IN O
EDTA NNP B-Medication
, , O
increasing VBG O
the DT O
dose NN O
at IN O
4 CD B-Dosage
tablets NNS I-Dosage
/ JJ I-Dosage
day NN I-Dosage
. . O

We PRP O
also RB O
required VBD O
a DT O
neurological JJ B-Detailed_description
consultation NN O
, , O
and CC O
the DT O
specialist NN O
established VBD O
the DT O
diagnosis NN O
of IN O
behavioral JJ B-Disease_disorder
disorders NNS I-Disease_disorder
with IN O
depressive JJ B-Disease_disorder
elements NNS O
, , O
and CC O
recommended VBD O
psychotherapy NN B-Diagnostic_procedure
. . O

Based VBN O
on IN O
all PDT O
these DT O
clinical JJ O
and CC O
laboratory JJ O
findings NNS O
, , O
we PRP O
established VBD O
the DT O
diagnosis NN O
of IN O
lead JJ B-Disease_disorder
poisoning NN I-Disease_disorder
. . O

We PRP O
initiated VBD O
an DT O
intense JJ O
i NN O
. . O
v NN O
. . O
hydration NN B-Medication
in IN O
order NN O
to TO O
favor VB O
lead JJ O
elimination NN O
, , O
approximately RB O
3 CD B-Dosage
liters NNS I-Dosage
per IN I-Dosage
24 CD I-Dosage
hours NNS I-Dosage
initially RB O
, , O
and CC O
we PRP O
decreased VBD O
progressively RB O
the DT O
quantity NN O
once RB O
she PRP O
ceased VBD O
to TO O
vomit VB B-Sign_symptom
, , O
and CC O
she PRP O
was VBD O
able JJ B-Sign_symptom
to TO I-Sign_symptom
consume VB I-Sign_symptom
liquids NNS I-Sign_symptom
. . O

We PRP O
associated VBD O
diuretics NNS B-Medication
, , O
initially RB O
furosemide JJ B-Medication
by IN O
vein NN O
, , O
but CC O
the DT O
values NNS O
of IN O
the DT O
arterial JJ B-Diagnostic_procedure
pressure NN I-Diagnostic_procedure
persisted VBN O
above IN B-Lab_value
the DT I-Lab_value
upper JJ I-Lab_value
limit NN I-Lab_value
, , O
therefore IN O
we PRP O
were VBD O
forced VBN O
to TO O
introduce VB O
also RB O
an DT O
angiotensin NN B-Medication
- : I-Medication
converting VBG I-Medication
enzyme JJ I-Medication
inhibitor NN I-Medication
, , O
with IN O
the DT O
remission NN O
of IN O
arterial JJ B-Sign_symptom
hypertension NN I-Sign_symptom
. . O

Regarding VBG O
the DT O
liver NN O
function NN O
, , O
we PRP O
administered VBD O
amino JJ B-Medication
acids NNS I-Medication
intravenously RB O
, , O
associated VBN O
with IN O
liver NN B-Medication
protectors NNS I-Medication
by IN O
mouth NN O
. . O

We PRP O
also RB O
administered VBD O
vitamins NNS B-Medication
of IN I-Medication
the DT I-Medication
B NNP I-Medication
complex NN I-Medication
in IN O
order NN O
to TO O
improve VB O
the DT O
neurological JJ O
impairment NN O
. . O

The DT O
evolution NN B-Diagnostic_procedure
was VBD O
slightly RB B-Lab_value
favorable JJ I-Lab_value
, , O
in IN O
the DT O
first JJ O
3 CD O
days NNS O
after IN O
the DT O
admission NN O
, , O
the DT O
patient NN O
continued VBD O
to TO O
present VB O
severe JJ B-Severity
abdominal JJ B-Biological_structure
pain NN B-Sign_symptom
, , O
vomiting NN B-Sign_symptom
, , O
and CC O
she PRP O
also RB O
complained VBD O
of IN O
pain NN B-Sign_symptom
in IN O
the DT O
lumbar NN B-Biological_structure
area NN I-Biological_structure
. . O

All PDT O
the DT O
laboratory NN B-Diagnostic_procedure
parameters NNS I-Diagnostic_procedure
presented VBD O
normalization NN B-Lab_value
of IN O
the DT O
values NNS O
after IN O
approximately RB B-Duration
10 CD I-Duration
days NNS I-Duration
of IN O
treatment NN B-Therapeutic_procedure
. . O

On IN O
the DT O
6th CD O
day NN O
of IN O
admission NN O
, , O
we PRP O
ceased VBD O
the DT O
chelation NN B-Medication
therapy NN I-Medication
with IN O
EDTA NNP B-Medication
. . O

We PRP O
also RB O
repeated VBD O
the DT O
blood NN B-Biological_structure
and CC O
urinary JJ B-Biological_structure
lead NN B-Diagnostic_procedure
levels NNS O
. . O

The DT O
blood NN B-Biological_structure
level NN O
was VBD O
45 CD B-Lab_value
. . I-Lab_value
57 CD I-Lab_value
μg JJ I-Lab_value
/ NNP I-Lab_value
dL NN I-Lab_value
, , O
and CC O
the DT O
urinary JJ B-Biological_structure
one NN O
was VBD O
836 CD B-Lab_value
. . I-Lab_value
4 CD I-Lab_value
μg JJ I-Lab_value
/ NNP I-Lab_value
L NNP I-Lab_value
before IN O
discharging VBG O
the DT O
patient NN O
. . O

The DT O
abdominal JJ B-Biological_structure
ultrasound JJ B-Diagnostic_procedure
reevaluation NN O
revealed VBD O
no DT O
pathological JJ B-Sign_symptom
modifications NNS I-Sign_symptom
. . O

After IN O
14 CD O
days NNS O
of IN O
admission NN O
, , O
the DT O
patient NN O
was VBD O
discharged VBN O
without IN O
any DT O
complaints NNS B-Sign_symptom
, , O
and CC O
we PRP O
recommended VBD O
no DT O
further JJ O
exposure NN O
to TO O
lead VB O
, , O
avoiding VBG O
the DT O
contact NN O
and CC O
the DT O
working NN O
in IN O
the DT O
pottery NN O
process NN O
. . O

The DT O
long JJ O
- : O
term NN O
outcome NN O
of IN O
this DT O
case NN O
depends VBZ O
on IN O
further JJ O
exposure NN O
to TO O
this DT O
heavy JJ O
metal NN O
. . O

Nevertheless RB B-Other_entity
, , I-Other_entity
we PRP I-Other_entity
intend VBP I-Other_entity
to TO I-Other_entity
repeat VB I-Other_entity
the DT I-Other_entity
blood NN I-Other_entity
lead NN I-Other_entity
levels NNS I-Other_entity
after IN I-Other_entity
12 CD I-Other_entity
and CC I-Other_entity
24 CD I-Other_entity
months NNS I-Other_entity
, , I-Other_entity
assessing VBG I-Other_entity
also RB I-Other_entity
the DT I-Other_entity
renal NN I-Other_entity
( ( I-Other_entity
urea JJ I-Other_entity
, , I-Other_entity
creatinine NN I-Other_entity
, , I-Other_entity
urinary JJ I-Other_entity
exam NN I-Other_entity
) ) I-Other_entity
and CC I-Other_entity
hepatic JJ I-Other_entity
functions NNS I-Other_entity
( ( I-Other_entity
ASAT NNP I-Other_entity
, , I-Other_entity
ALAT NNP I-Other_entity
, , I-Other_entity
GGT NNP I-Other_entity
, , I-Other_entity
bilirubin NN I-Other_entity
) ) I-Other_entity
. . O

-DOCSTART- NN -X-

A DT O
29 CD B-Age
- : I-Age
year NN I-Age
- : I-Age
old JJ I-Age
primipara NN O
presented VBN O
with IN O
complaints NNS O
of IN O
persistent NN B-Detailed_description
, , O
severe RB B-Severity
right JJ B-Detailed_description
- : I-Detailed_description
sided VBN I-Detailed_description
upper JJ B-Biological_structure
abdominal JJ I-Biological_structure
pain NN B-Sign_symptom
during IN B-Detailed_description
deep JJ I-Detailed_description
inspiration NN I-Detailed_description
, , O
physical JJ B-Activity
exercise NN I-Activity
and CC O
on IN B-Detailed_description
local JJ I-Detailed_description
pressure NN I-Detailed_description
. . O

These DT O
complaints NNS O
had VBD O
developed VBN B-Detailed_description
gradually RB I-Detailed_description
after IN O
giving VBG O
birth NN O
one CD O
year NN O
earlier RBR O
. . O

This DT O
pregnancy NN O
had VBD O
been VBN O
complicated VBN O
by IN O
HELLP NNP B-Disease_disorder
syndrome NN I-Disease_disorder
with IN O
a DT O
subcapsular JJ B-Detailed_description
liver NN B-Biological_structure
hematoma NN B-Sign_symptom
sized VBD O
20 CD B-Area
cm NN I-Area
× VBD I-Area
5 CD I-Area
cm NN I-Area
, , O
which WDT O
had VBD O
resolved VBN B-Detailed_description
spontaneously RB I-Detailed_description
. . O

At IN O
current JJ O
presentation NN O
, , O
liver JJ B-Diagnostic_procedure
function NN I-Diagnostic_procedure
tests NNS I-Diagnostic_procedure
were VBD O
normal JJ B-Lab_value
. . O

She PRP O
assured VBD O
having VBG O
never RB O
experienced VBN O
signs NNS O
suggestive JJ O
of IN O
sexually RB B-Disease_disorder
transmitted VBN I-Disease_disorder
diseases NNS I-Disease_disorder
or CC O
pelvic JJ B-Disease_disorder
inflammatory JJ I-Disease_disorder
disease NN I-Disease_disorder
( ( B-Disease_disorder
PID NNP I-Disease_disorder
) ) I-Disease_disorder
. . O

She PRP O
had VBD O
never RB O
undergone JJ O
intra JJ B-Biological_structure
- : I-Biological_structure
abdominal JJ I-Biological_structure
interventions NNS B-Therapeutic_procedure
. . O

An DT O
upper JJ B-Biological_structure
- : I-Biological_structure
abdominal JJ I-Biological_structure
magnetic JJ B-Diagnostic_procedure
resonance NN I-Diagnostic_procedure
imaging NN I-Diagnostic_procedure
revealed VBD O
a DT O
density NN B-Sign_symptom
between IN B-Biological_structure
liver NN I-Biological_structure
and CC I-Biological_structure
diaphragm NN I-Biological_structure
at IN O
the DT O
site NN B-Biological_structure
of IN I-Biological_structure
the DT I-Biological_structure
former JJ I-Biological_structure
subcapsular NN I-Biological_structure
hematoma NN I-Biological_structure
, , O
suspect NN O
of IN O
perihepatic JJ B-Sign_symptom
adhesions NNS I-Sign_symptom
( ( O
Figure NNP O
1 CD O
) ) O
. . O

She PRP O
was VBD O
referred VBN O
to TO O
the DT O
hepatobiliary JJ B-Nonbiological_location
surgeon NN I-Nonbiological_location
, , O
who WP O
performed VBD O
a DT O
laparoscopy NN B-Diagnostic_procedure
and CC O
confirmed VBD O
the DT O
presence NN O
of IN O
a DT O
thick JJ B-Detailed_description
adhesion NN B-Sign_symptom
between IN B-Biological_structure
liver NN I-Biological_structure
segment NN I-Biological_structure
V NNP I-Biological_structure
/ NNP I-Biological_structure
VIII NNP I-Biological_structure
and CC I-Biological_structure
the DT I-Biological_structure
diaphragm NN I-Biological_structure
( ( O
Figure NNP O
2 CD O
) ) O
. . O

Adhesiolysis NN B-Therapeutic_procedure
was VBD O
performed VBN O
in IN O
the DT O
same JJ O
session NN O
by IN O
monopolar JJ B-Therapeutic_procedure
diathermia NN I-Therapeutic_procedure
and CC O
sharp JJ B-Therapeutic_procedure
dissection NN I-Therapeutic_procedure
, , O
followed VBN O
by IN O
the DT O
instillation NN O
of IN O
1 CD B-Dosage
. . I-Dosage
5 CD I-Dosage
L NNP I-Dosage
Adept NNP B-Medication
( ( O
4 CD B-Medication
% NN I-Medication
icodextrin JJ I-Medication
solution NN I-Medication
) ) O
into IN O
the DT O
peritoneal JJ B-Biological_structure
cavity NN I-Biological_structure
to TO O
prevent VB O
the DT O
formation NN O
of IN O
new JJ O
adhesions NNS O
. . O

On IN O
follow SYM O
- : O
up RB O
until IN B-Duration
three CD I-Duration
years NNS I-Duration
post SYM I-Duration
- : I-Duration
surgery NN I-Duration
, , O
she PRP O
was VBD O
free JJ O
of IN O
symptoms NNS B-Sign_symptom
. . O

-DOCSTART- NN -X-

A DT O
68 CD B-Age
- : I-Age
year NN I-Age
- : I-Age
old JJ I-Age
female JJ O
smoker NN O
with IN O
a DT O
history NN O
of IN O
pulmonary JJ O
embolism NN O
and CC O
diabetes VBZ O
mellitus NN O
was VBD O
diagnosed VBN O
with IN O
Stage NNP B-Detailed_description
IIIB NNP I-Detailed_description
( ( O
T4N2M0 NNP B-Detailed_description
) ) O
squamous JJ B-Detailed_description
NSCLC NNP B-Disease_disorder
. . O

She PRP O
was VBD O
treated VBN O
by IN O
definitive JJ B-Detailed_description
chemoradiotherapy NN B-Therapeutic_procedure
with IN O
cisplatin NN B-Medication
and CC O
vinorelbine NN B-Medication
until IN O
September NNP O
2014 CD O
. . O

In IN O
October NNP O
2014 CD O
, , O
positron CC B-Diagnostic_procedure
emission NN I-Diagnostic_procedure
tomography NN I-Diagnostic_procedure
- : I-Diagnostic_procedure
computed VBN I-Diagnostic_procedure
tomography NN I-Diagnostic_procedure
( ( B-Diagnostic_procedure
PET NNP I-Diagnostic_procedure
- : I-Diagnostic_procedure
CT NN I-Diagnostic_procedure
) ) I-Diagnostic_procedure
scan NN O
demonstrated VBD O
a DT O
good JJ B-Lab_value
response NN I-Lab_value
in IN O
the DT O
primary JJ B-Biological_structure
lesion NN I-Biological_structure
; : O
however RB O
, , O
new JJ O
metastases NNS B-Sign_symptom
in IN O
the DT O
right JJ B-Biological_structure
adrenal JJ I-Biological_structure
gland NN I-Biological_structure
and CC O
right JJ B-Biological_structure
femur NN I-Biological_structure
developed VBD O
and CC O
were VBD O
irradiated VBN B-Therapeutic_procedure
in IN O
November NNP O
2014 CD O
. . O

A DT O
month NN O
later RB O
the DT O
disease NN O
progressed VBD O
with IN O
development NN O
of IN O
multiple JJ B-Detailed_description
bone NN B-Biological_structure
and CC O
subcutaneous JJ B-Biological_structure
metastases NNS B-Sign_symptom
. . O

At IN O
that DT O
point NN O
, , O
the DT O
patient NN O
suffered VBD O
from IN O
severe JJ B-Severity
dyspnea NN B-Sign_symptom
and CC O
was VBD O
oxygen VBN B-Therapeutic_procedure
- : I-Therapeutic_procedure
dependent NN I-Therapeutic_procedure
. . O

She PRP O
received VBD O
one CD B-Dosage
cycle NN I-Dosage
of IN O
carboplatin NN B-Medication
and CC O
gemcitabine NN B-Medication
followed VBN O
by IN O
severe JJ B-Severity
pancytopenia NN B-Sign_symptom
, , O
and CC O
treatment NN O
was VBD O
switched VBN O
to TO O
nivolumab VB B-Medication
3 CD B-Dosage
mg NN I-Dosage
/ NNP I-Dosage
kg VBZ I-Dosage
q14 JJ I-Dosage
days NNS I-Dosage
in IN O
January NNP O
2015 CD O
. . O

One CD O
week NN O
after IN O
the DT O
first JJ O
cycle NN O
of IN O
nivolumab NN B-Medication
, , O
a DT O
subcutaneous JJ B-Biological_structure
lesion NN B-Sign_symptom
in IN O
her PRP$ O
upper JJ B-Biological_structure
back NN I-Biological_structure
grew VBD B-Detailed_description
substantially RB I-Detailed_description
, , O
accompanied VBN O
by IN O
severe JJ B-Severity
pain NN B-Sign_symptom
and CC O
significant JJ B-Severity
inflammatory JJ B-Sign_symptom
reaction NN I-Sign_symptom
( ( O
Fig NNP O
. . O
1 CD O
) ) O
. . O

Other JJ O
subcutaneous JJ B-Biological_structure
metastases NNS B-Sign_symptom
grew VBD B-Detailed_description
slightly RB I-Detailed_description
as RB O
well RB O
. . O

After IN O
the DT O
second JJ O
cycle NN O
of IN O
treatment NN O
marked VBN O
symptomatic JJ B-Sign_symptom
improvement NN I-Sign_symptom
was VBD O
observed VBN O
, , O
including VBG O
improvement NN B-Sign_symptom
in IN I-Sign_symptom
general JJ I-Sign_symptom
appearance NN I-Sign_symptom
and CC O
dyspnea NN B-Sign_symptom
and CC O
reduction NN O
of IN O
the DT O
bone NN B-Biological_structure
pain NN B-Sign_symptom
. . O

The DT O
patient NN O
no RB O
longer RB O
required VBN O
oxygen NN B-Therapeutic_procedure
supplementation NN I-Therapeutic_procedure
. . O

The DT O
subcutaneous JJ B-Biological_structure
lesions NNS B-Sign_symptom
started VBD O
to TO O
regress VB O
too RB O
, , O
with IN O
complete JJ B-Lab_value
resolution NN I-Lab_value
by IN O
the DT O
12th CD O
week NN O
as RB O
well RB O
as IN O
improvement NN O
in IN O
all DT O
bone NN B-Biological_structure
lesions NNS B-Sign_symptom
( ( O
Figs NNP O
. . O
1 CD O
and CC O
2 CD O
) ) O
. . O

The DT O
patient NN O
continued VBD O
on IN O
nivolumab NN B-Medication
until IN O
June NNP O
2015 CD O
, , O
and CC O
tolerated VBD O
the DT O
treatment NN O
well RB O
. . O

Unfortunately RB O
, , O
she PRP O
developed VBD O
bacterial JJ B-Detailed_description
aspiration NN I-Detailed_description
pneumonia NN B-Sign_symptom
and CC O
passed VBD O
away RB O
in IN O
June NNP O
2015 CD O
. . O

-DOCSTART- NN -X-

A DT O
60 CD B-Age
- : I-Age
year NN I-Age
- : I-Age
old JJ I-Age
white JJ O
Brazilian JJ O
man NN O
, , O
with IN O
controlled VBN O
hypertension NN O
and CC O
stage NN O
2 CD O
obesity NN O
presented VBN O
to TO O
our PRP$ O
institution NN B-Nonbiological_location
with IN O
a DT O
complaint NN O
of IN O
progressive JJ B-Detailed_description
fatigue NN B-Sign_symptom
with IN O
moderate JJ B-Detailed_description
to TO I-Detailed_description
light JJ I-Detailed_description
exertion NN I-Detailed_description
of IN O
approximately RB B-Duration
1 CD I-Duration
year NN I-Duration
` `` O
s JJ O
duration NN O
. . O

During IN O
that DT O
period NN O
, , O
he PRP O
had VBD O
undergone JJ O
myocardial JJ B-Detailed_description
perfusion NN I-Detailed_description
scintigraphy NN B-Diagnostic_procedure
without IN O
evidence NN O
of IN O
obstructive JJ B-Disease_disorder
ischemic JJ I-Disease_disorder
disease NN I-Disease_disorder
. . O

He PRP O
had VBD O
no DT O
clinical JJ O
evidence NN O
of IN O
systolic JJ B-Detailed_description
heart NN B-Disease_disorder
failure NN I-Disease_disorder
. . O

He PRP O
had VBD O
undergone JJ O
biological JJ B-Detailed_description
mitral JJ B-Therapeutic_procedure
valve NN I-Therapeutic_procedure
replacement NN I-Therapeutic_procedure
3 CD O
years NNS O
previously RB O
for IN O
mitral JJ B-Disease_disorder
valve NN I-Disease_disorder
stenosis NN I-Disease_disorder
and CC O
had VBD O
undergone JJ O
ablation NN B-Therapeutic_procedure
of IN O
atrioventricular JJ B-Biological_structure
nodal JJ I-Biological_structure
reentry NN I-Biological_structure
tachycardia VBD B-Sign_symptom
18 CD O
months NNS O
previously RB O
. . O

At IN O
the DT O
time NN O
of IN O
valve JJ O
replacement NN O
, , O
there EX O
was VBD O
no DT O
reported JJ O
evidence NN O
of IN O
pulmonary JJ B-Disease_disorder
arterial JJ I-Disease_disorder
hypertension NN I-Disease_disorder
. . O

The DT O
patient NN O
` `` O
s JJ O
medication NN O
list NN O
included VBD O
aspirin JJ B-Medication
100 CD B-Dosage
mg JJ I-Dosage
/ NNP I-Dosage
day NN I-Dosage
, , O
carvedilol VBP B-Medication
50 CD B-Dosage
mg JJ I-Dosage
/ NNP I-Dosage
day NN I-Dosage
, , O
atorvastatin RB B-Medication
10 CD B-Dosage
mg NNS I-Dosage
/ JJ I-Dosage
day NN I-Dosage
, , O
and CC O
losartan VBZ B-Medication
25 CD B-Dosage
mg NN I-Dosage
/ NNP I-Dosage
day NN I-Dosage
. . O

His PRP$ O
echocardiogram NN B-Diagnostic_procedure
showed VBD O
normal JJ B-Lab_value
function NN I-Lab_value
of IN O
a DT O
mitral JJ B-Biological_structure
prosthesis NN I-Biological_structure
, , O
global JJ B-Diagnostic_procedure
left VBD I-Diagnostic_procedure
ventricular JJ I-Diagnostic_procedure
systolic JJ I-Diagnostic_procedure
function NN I-Diagnostic_procedure
within IN B-Lab_value
normal JJ I-Lab_value
limits NNS I-Lab_value
( ( O
left VBD B-Diagnostic_procedure
ventricular JJ I-Diagnostic_procedure
ejection NN I-Diagnostic_procedure
fraction NN I-Diagnostic_procedure
62 CD B-Lab_value
% NN I-Lab_value
measured VBN O
using VBG B-Detailed_description
the DT I-Detailed_description
Teichholz NNP I-Detailed_description
method NN I-Detailed_description
) ) O
, , O
stage NN B-Lab_value
I PRP I-Lab_value
diastolic JJ B-Disease_disorder
dysfunction NN I-Disease_disorder
, , O
and CC O
mean JJ B-Detailed_description
pulmonary JJ B-Biological_structure
arterial JJ I-Biological_structure
systolic JJ B-Detailed_description
blood NN B-Diagnostic_procedure
pressure NN I-Diagnostic_procedure
of IN O
50 CD B-Lab_value
mmHg NN I-Lab_value
. . O

In IN O
the DT O
6 CD B-Detailed_description
- : I-Detailed_description
minute NN I-Detailed_description
walk NN B-Diagnostic_procedure
test NN I-Diagnostic_procedure
, , O
the DT O
patient NN O
walked VBD O
104 CD B-Lab_value
meters NNS I-Lab_value
( ( O
Table JJ O
1 CD O
) ) O
. . O

Catheterization NN B-Diagnostic_procedure
of IN O
his PRP$ O
right JJ B-Biological_structure
heart NN I-Biological_structure
chambers NNS I-Biological_structure
and CC O
pulmonary JJ B-Biological_structure
arteries NNS I-Biological_structure
confirmed VBD O
the DT O
diagnosis NN O
of IN O
pulmonary JJ B-Disease_disorder
hypertension NN I-Disease_disorder
( ( O
Table JJ O
2 CD O
) ) O
. . O

During IN O
the DT O
follow JJ O
- : O
up RB O
period NN O
, , O
therapy NN O
with IN O
nifedipine NN B-Medication
and CC O
sildenafil NN B-Medication
was VBD O
not RB O
tolerated VBN O
secondary JJ O
to TO O
orthostatic JJ B-Detailed_description
hypotension NN B-Sign_symptom
. . O

The DT O
patient NN O
was VBD O
referred VBN O
for IN O
radiofrequency NN B-Detailed_description
ablation NN B-Therapeutic_procedure
of IN O
the DT O
pulmonary JJ B-Biological_structure
artery NN I-Biological_structure
trunk NN I-Biological_structure
for IN O
the DT O
treatment NN O
of IN O
refractory NN B-Detailed_description
pulmonary JJ B-Disease_disorder
hypertension NN I-Disease_disorder
. . O

The DT O
procedure NN O
was VBD O
performed VBN O
in IN O
the DT O
catheterization NN B-Nonbiological_location
laboratory NN I-Nonbiological_location
with IN O
direct JJ B-Detailed_description
visualization NN I-Detailed_description
using VBG I-Detailed_description
fluoroscopy NN I-Detailed_description
and CC I-Detailed_description
radiopaque NN I-Detailed_description
contrast NN I-Detailed_description
dye NN I-Detailed_description
. . O

The DT O
patient NN O
remained VBD O
under IN O
unconscious JJ O
sedation NN B-Therapeutic_procedure
. . O

Catheterization NN B-Diagnostic_procedure
of IN O
the DT O
right JJ B-Biological_structure
femoral JJ I-Biological_structure
artery NN I-Biological_structure
via IN O
the DT O
standard JJ B-Detailed_description
Seldinger NNP I-Detailed_description
technique NN I-Detailed_description
was VBD O
performed VBN O
using VBG B-Detailed_description
an DT I-Detailed_description
8 CD I-Detailed_description
- : I-Detailed_description
French JJ I-Detailed_description
valved VBN I-Detailed_description
short JJ I-Detailed_description
sheath NN I-Detailed_description
after IN O
subcutaneous JJ O
injection NN O
of IN O
a DT O
local JJ B-Medication
anesthetic NN I-Medication
. . O

Subsequently RB O
, , O
this DT O
sheath NN B-Detailed_description
was VBD I-Detailed_description
replaced VBN I-Detailed_description
with IN I-Detailed_description
a DT I-Detailed_description
steerable JJ I-Detailed_description
long JJ I-Detailed_description
sheath NN I-Detailed_description
( ( O
Agilis NNP B-Detailed_description
® NNP I-Detailed_description
; : I-Detailed_description
St NNP I-Detailed_description
. . I-Detailed_description
Jude NNP I-Detailed_description
Medical NNP I-Detailed_description
, , I-Detailed_description
St NNP I-Detailed_description
. . I-Detailed_description
Paul NNP I-Detailed_description
, , I-Detailed_description
MN NNP I-Detailed_description
, , I-Detailed_description
USA NNP I-Detailed_description
) ) O
using VBG B-Detailed_description
the DT I-Detailed_description
standard NN I-Detailed_description
over IN I-Detailed_description
- : I-Detailed_description
the DT I-Detailed_description
- : I-Detailed_description
wire NN I-Detailed_description
technique NN I-Detailed_description
. . O

Unfractionated VBN B-Medication
heparin NN I-Medication
was VBD O
administered VBN O
intravenously RB O
, , O
targeting VBG O
an DT O
activated VBN B-Diagnostic_procedure
coagulation NN I-Diagnostic_procedure
time NN I-Diagnostic_procedure
between IN B-Lab_value
250 CD I-Lab_value
and CC I-Lab_value
350 CD I-Lab_value
seconds NNS I-Lab_value
. . O

Electroanatomic JJ B-Diagnostic_procedure
reconstruction NN I-Diagnostic_procedure
of IN O
both CC O
the DT O
right NN B-Biological_structure
ventricular NN I-Biological_structure
outflow IN I-Biological_structure
tract NN I-Biological_structure
and CC O
pulmonary JJ B-Biological_structure
artery NN I-Biological_structure
was VBD O
performed VBN O
using VBG O
the DT O
EnSite NNP B-Detailed_description
Velocity NNP I-Detailed_description
Cardiac NNP I-Detailed_description
Mapping NNP I-Detailed_description
System NNP I-Detailed_description
( ( O
St NNP B-Detailed_description
. . I-Detailed_description
Jude NNP I-Detailed_description
Medical NNP I-Detailed_description
) ) O
under IN O
direct JJ B-Detailed_description
fluoroscopic NN I-Detailed_description
visualization NN I-Detailed_description
, , O
and CC O
a DT O
merger NN O
was VBD O
made VBN O
with IN O
the DT O
formatted JJ O
image NN O
obtained VBN O
by IN O
performing VBG O
cardiac JJ B-Biological_structure
computed VBN B-Diagnostic_procedure
tomography NN I-Diagnostic_procedure
angiography NN I-Diagnostic_procedure
( ( O
Fig NNP O
. . O
1 CD O
) ) O
. . O

The DT O
Agilis NNP B-Detailed_description
® NNP I-Detailed_description
sheath NN B-Diagnostic_procedure
was VBD I-Diagnostic_procedure
advanced VBN I-Diagnostic_procedure
into IN O
the DT O
right JJ B-Biological_structure
ventricular NN I-Biological_structure
outflow IN I-Biological_structure
tract NN I-Biological_structure
just RB O
before IN B-Biological_structure
reaching VBG I-Biological_structure
the DT I-Biological_structure
pulmonary JJ I-Biological_structure
valve NN I-Biological_structure
. . O

Through IN O
this DT O
long JJ O
sheath NN O
, , O
we PRP O
introduced VBD O
an DT O
ablation NN B-Therapeutic_procedure
catheter NN I-Therapeutic_procedure
with IN O
an DT O
open JJ B-Detailed_description
irrigated VBN I-Detailed_description
tip NN I-Detailed_description
( ( O
St NNP B-Detailed_description
. . I-Detailed_description
Jude NNP I-Detailed_description
Medical NNP I-Detailed_description
) ) O
. . O

The DT O
parameters NNS O
used VBN O
for IN O
each DT O
application NN O
according VBG O
to TO O
our PRP$ O
protocol NN O
were VBD O
as IN O
follows VBZ O
: : O
power NN B-Lab_value
of IN I-Lab_value
5 CD I-Lab_value
W NNP I-Lab_value
, , O
maximum JJ B-Lab_value
temperature NN I-Lab_value
of IN I-Lab_value
48 CD I-Lab_value
°C NNS I-Lab_value
, , O
60 CD B-Lab_value
- : I-Lab_value
second JJ I-Lab_value
duration NN I-Lab_value
in IN I-Lab_value
each DT I-Lab_value
spot NN I-Lab_value
, , O
maximum JJ B-Lab_value
impedance NN I-Lab_value
variation NN I-Lab_value
of IN I-Lab_value
10 CD I-Lab_value
% NN I-Lab_value
from IN I-Lab_value
baseline NN I-Lab_value
values NNS I-Lab_value
, , O
and CC O
an DT O
irrigation NN B-Lab_value
flow NN I-Lab_value
rate NN I-Lab_value
of IN I-Lab_value
17 CD I-Lab_value
ml NNS I-Lab_value
/ JJ I-Lab_value
minute NN I-Lab_value
, , O
which WDT O
created VBD B-Therapeutic_procedure
a DT I-Therapeutic_procedure
circle NN I-Therapeutic_procedure
in IN O
the DT O
pulmonary JJ B-Biological_structure
artery NN I-Biological_structure
trunk NN I-Biological_structure
. . O

The DT O
patient NN O
was VBD O
discharged VBN O
the DT O
next JJ B-Time
morning NN I-Time
. . O

No DT O
noteworthy JJ O
changes NNS B-Sign_symptom
before IN O
or CC O
after IN O
the DT O
procedure NN O
or CC O
before IN O
discharge NN O
in IN O
the DT O
patient NN O
` `` O
s JJ O
radiographic NN B-Detailed_description
or CC I-Detailed_description
echocardiographic JJ I-Detailed_description
laboratory NN I-Detailed_description
parameters NNS I-Detailed_description
were VBD O
seen VBN O
. . O

The DT O
patient NN O
` `` O
s JJ O
blood NN B-Diagnostic_procedure
pressure NN I-Diagnostic_procedure
in IN O
both CC B-Biological_structure
the DT I-Biological_structure
right JJ I-Biological_structure
heart NN I-Biological_structure
chambers NNS I-Biological_structure
and CC O
the DT O
pulmonary JJ B-Biological_structure
artery NN I-Biological_structure
were VBD O
determined VBN O
using VBG B-Detailed_description
catheterization NN I-Detailed_description
before IN O
and CC O
at IN O
3 CD O
and CC O
6 CD O
months NNS O
after IN O
the DT O
procedure NN O
. . O

The DT O
results NNS O
are VBP O
shown VBN O
in IN O
Table JJ O
2 CD O
. . O

At IN O
the DT O
patient NN O
` `` O
s RB O
3 CD O
- : O
month NN O
follow SYM O
- : O
up IN O
examination NN O
, , O
he PRP O
showed VBD O
an DT O
improvement NN B-Lab_value
in IN O
functional JJ B-Diagnostic_procedure
class NN I-Diagnostic_procedure
for IN I-Diagnostic_procedure
fatigue NN I-Diagnostic_procedure
with IN I-Diagnostic_procedure
major JJ I-Diagnostic_procedure
exertion NN I-Diagnostic_procedure
. . O

He PRP O
also RB O
demonstrated VBD O
an DT O
increased VBN B-Lab_value
distance NN I-Lab_value
walked VBN O
in IN O
the DT O
6 CD B-Detailed_description
- : I-Detailed_description
minute NN I-Detailed_description
walk VBP B-Diagnostic_procedure
test NN I-Diagnostic_procedure
and CC O
reduction NN B-Lab_value
of IN O
the DT O
pressures NNS B-Diagnostic_procedure
in IN O
both DT O
the DT O
right JJ B-Biological_structure
cavities NNS I-Biological_structure
and CC O
the DT O
pulmonary JJ B-Biological_structure
artery NN I-Biological_structure
. . O

Currently RB O
, , O
with IN O
6 CD B-Duration
months NNS I-Duration
of IN O
clinical JJ O
follow NN O
- : O
up RB O
, , O
he PRP O
has VBZ O
maintained VBN O
his PRP$ O
improvement NN B-Lab_value
in IN O
functional JJ B-Diagnostic_procedure
classification NN I-Diagnostic_procedure
and CC O
is VBZ O
pedaling VBG B-Activity
his PRP$ I-Activity
bicycle NN I-Activity
. . O

-DOCSTART- NN -X-

A DT O
31 CD B-Age
- : I-Age
year NN I-Age
- : I-Age
old JJ I-Age
man NN O
developed VBD O
diabetes NNS B-Disease_disorder
insipidus VBP I-Disease_disorder
with IN O
urine NN B-Diagnostic_procedure
volume NN I-Diagnostic_procedure
up RB O
to TO O
10 CD B-Volume
to TO I-Volume
20 CD I-Volume
L NNP I-Volume
every DT B-Frequency
24 CD I-Frequency
hours NNS I-Frequency
in IN O
2003 CD O
. . O

Four CD O
years NNS O
later RB O
, , O
he PRP O
complained VBD O
of IN O
fatigue NN B-Sign_symptom
, , O
anorexia NN B-Sign_symptom
, , O
jaundice NN B-Sign_symptom
and CC O
pruritus NN B-Sign_symptom
, , O
and CC O
a DT O
symptomatic JJ B-Detailed_description
occipital JJ B-Biological_structure
mass NN B-Sign_symptom
. . O

Laboratory NN B-Diagnostic_procedure
tests NNS I-Diagnostic_procedure
showed VBD O
an DT O
abnormal JJ B-Lab_value
liver NN B-Diagnostic_procedure
enzyme NN I-Diagnostic_procedure
( ( O
Table JJ O
1 CD O
) ) O
, , O
the DT O
patient NN O
was VBD O
negative JJ B-Lab_value
for IN O
hepatitis NN B-Diagnostic_procedure
viruses NNS I-Diagnostic_procedure
. . O

As IN O
shown VBN O
in IN O
Fig NNP O
. . O
1 CD O
, , O
abdominal JJ B-Biological_structure
MRI NNP B-Diagnostic_procedure
showed VBD O
multiple JJ B-Detailed_description
low JJ B-Detailed_description
- : I-Detailed_description
density NN I-Detailed_description
lesions NNS B-Sign_symptom
in IN O
the DT O
liver NN B-Biological_structure
on IN O
the DT O
T1 NNP B-Diagnostic_procedure
- : I-Diagnostic_procedure
weighted JJ I-Diagnostic_procedure
image NN I-Diagnostic_procedure
and CC O
obvious JJ B-Severity
expansion NN B-Sign_symptom
of IN O
the DT O
intrahepatic JJ B-Biological_structure
bile NN I-Biological_structure
duct NN I-Biological_structure
on IN O
the DT O
T2 NNP B-Diagnostic_procedure
- : I-Diagnostic_procedure
weighted JJ I-Diagnostic_procedure
image NN I-Diagnostic_procedure
. . O

Magnetic JJ B-Diagnostic_procedure
resonance NN I-Diagnostic_procedure
cholangiopancreatography NN I-Diagnostic_procedure
revealed VBD O
multifocal JJ B-Detailed_description
intrahepatic JJ B-Biological_structure
bile NN I-Biological_structure
duct NN I-Biological_structure
strictures NNS B-Sign_symptom
and CC O
dilatation NN B-Sign_symptom
, , O
but CC O
the DT O
common JJ B-Diagnostic_procedure
hepatic JJ I-Diagnostic_procedure
duct NN I-Diagnostic_procedure
was VBD O
normal JJ B-Lab_value
, , O
it PRP O
was VBD O
highly RB O
suggestive JJ O
of IN O
SC NNP B-Disease_disorder
. . O

The DT O
neurohypophyseal JJ B-Biological_structure
area NN I-Biological_structure
MRI NNP B-Diagnostic_procedure
showed VBD O
the DT O
thickened JJ B-Sign_symptom
hypothalamic JJ B-Biological_structure
nuclei NN I-Biological_structure
and CC O
a DT O
low JJ B-Detailed_description
- : I-Detailed_description
density NN I-Detailed_description
signal NN B-Sign_symptom
of IN O
4 CD B-Area
. . I-Area
9 CD I-Area
× JJ I-Area
5 CD I-Area
. . I-Area
6 CD I-Area
mm NN I-Area
in IN O
size NN O
in IN O
the DT O
hypothalamic JJ B-Biological_structure
- : I-Biological_structure
pituitary JJ I-Biological_structure
area NN I-Biological_structure
. . O

A DT O
multisystem NN B-Detailed_description
, , O
high JJ B-Severity
- : I-Severity
risk NN I-Severity
organ IN B-Detailed_description
LCH NNP B-Disease_disorder
was VBD O
confirmed VBN O
after IN O
occipital JJ B-Biological_structure
mass NN B-Sign_symptom
was VBD O
biopsied VBN B-Diagnostic_procedure
in IN O
the DT O
local JJ B-Nonbiological_location
hospital NN I-Nonbiological_location
, , O
the DT O
patient NN O
was VBD O
given VBN O
ursodeoxycholic JJ B-Medication
acid RB I-Medication
150 CD B-Dosage
mg NN I-Dosage
3 CD I-Dosage
times NNS I-Dosage
a DT I-Dosage
day NN I-Dosage
. . O

Then RB O
, , O
he PRP O
began VBD O
to TO O
receive VB O
a DT O
course NN O
of IN O
COEP NNP B-Medication
chemotherapy NN I-Medication
( ( O
cyclophosphamide NN B-Medication
, , O
1000 CD B-Dosage
mg NN I-Dosage
; : O
vincristine NN B-Medication
, , O
2 CD B-Dosage
mg NN I-Dosage
; : O
epirubicin CC B-Medication
, , O
90 CD B-Dosage
mg NN I-Dosage
; : O
and CC O
prednisone NN B-Medication
, , O
90 CD B-Dosage
mg NN I-Dosage
) ) O
in IN O
2009 CD O
. . O

However RB O
, , O
on IN O
the DT O
5th JJ O
day NN O
of IN O
the DT O
1st CD O
COEP NNP B-Medication
chemotherapy NN I-Medication
, , O
the DT O
patient NN O
appeared VBD O
to TO O
severe VB B-Severity
liver JJ B-Biological_structure
function NN B-Disease_disorder
injury NN I-Disease_disorder
with IN O
an DT O
obvious JJ B-Severity
increase NN B-Lab_value
of IN O
serum JJ B-Diagnostic_procedure
bilirubin NN I-Diagnostic_procedure
( ( O
Table JJ O
1 CD O
) ) O
. . O

He PRP O
refused VBD O
further JJ O
chemotherapy NN B-Medication
. . O

One CD O
year NN O
later RB O
, , O
the DT O
patient NN O
developed VBD O
liver JJ B-Biological_structure
decompensation NN B-Disease_disorder
with IN O
bleeding VBG B-Detailed_description
esophageal JJ B-Biological_structure
varices NNS B-Sign_symptom
, , O
ascites NNS B-Sign_symptom
, , O
and CC O
splenomegaly NN B-Sign_symptom
, , O
and CC O
he PRP O
was VBD O
referred VBN O
to TO O
LT NNP B-Therapeutic_procedure
( ( O
Model NNP B-Diagnostic_procedure
for IN I-Diagnostic_procedure
End NNP I-Diagnostic_procedure
Stage NNP I-Diagnostic_procedure
Liver NNP I-Diagnostic_procedure
Disease NNP I-Diagnostic_procedure
score VBD O
17 CD B-Lab_value
) ) O
. . O

He PRP O
underwent JJ O
successful JJ O
orthotopic NN B-Detailed_description
LT NNP B-Therapeutic_procedure
in IN O
November NNP O
2011 CD O
in IN O
our PRP$ O
center NN B-Nonbiological_location
, , O
and CC O
the DT O
donor NN O
came VBD O
from IN O
voluntary JJ B-Detailed_description
deceased VBN I-Detailed_description
citizen NN I-Detailed_description
organ JJ O
donation NN O
in IN O
China NNP B-Nonbiological_location
. . O

Liver NNP B-Diagnostic_procedure
histopathology NN I-Diagnostic_procedure
after IN O
LT NNP B-Therapeutic_procedure
revealed VBD O
micronodular JJ B-Detailed_description
cirrhosis NN B-Disease_disorder
with IN O
SC NNP B-Disease_disorder
and CC O
positive JJ B-Lab_value
immunostaining NN B-Diagnostic_procedure
( ( O
CD1a NNP B-Diagnostic_procedure
and CC O
S100 NNP B-Diagnostic_procedure
) ) O
, , O
suggestive JJ O
of IN O
LCH NNP B-Disease_disorder
involving VBG O
in IN O
the DT O
liver NN B-Biological_structure
( ( O
Fig NNP O
. . O
2 CD O
) ) O
. . O

Postoperatively RB O
, , O
the DT O
man NN O
continued VBD O
to TO O
be VB O
immunosuppressed VBN B-Disease_disorder
with IN O
tacrolimus NN B-Medication
and CC O
mycofenolate NN B-Medication
mofetil NN I-Medication
. . O

The DT O
patient NN O
is VBZ O
currently RB O
well RB B-Sign_symptom
with IN O
normal JJ B-Lab_value
liver NN B-Diagnostic_procedure
function NN I-Diagnostic_procedure
and CC O
no DT O
evidence NN O
of IN O
recurrence NN B-Sign_symptom
of IN O
LCH NNP B-Disease_disorder
for IN O
4 CD O
and CC O
a DT O
half JJ O
years NNS O
follow VBP O
- : O
up RB O
. . O

-DOCSTART- NN -X-

A DT O
13 CD B-Age
year NN I-Age
- : I-Age
old JJ I-Age
boy NN O
presented VBN O
with IN O
a DT O
1 CD B-Duration
month NN I-Duration
history NN O
of IN O
intermittent JJ B-Biological_structure
episodes NNS O
of IN O
small JJ B-Detailed_description
volume NN I-Detailed_description
epistaxis NN B-Sign_symptom
. . O

There EX O
was VBD O
no DT O
significant JJ O
past JJ O
medical JJ O
, , O
surgical JJ O
or CC O
family NN O
history NN O
. . O

Physical JJ B-Diagnostic_procedure
examination NN I-Diagnostic_procedure
revealed VBD O
a DT O
left JJ B-Biological_structure
palatal JJ I-Biological_structure
fleshy JJ B-Detailed_description
mass NN B-Sign_symptom
centered VBD O
at IN O
left JJ B-Biological_structure
posterior JJ I-Biological_structure
molars NNS I-Biological_structure
. . O

A DT O
nasoendoscopic JJ B-Diagnostic_procedure
examination NN I-Diagnostic_procedure
demonstrated VBD O
a DT O
large JJ B-Severity
swelling VBG B-Sign_symptom
on IN O
the DT O
floor NN B-Biological_structure
of IN I-Biological_structure
left JJ I-Biological_structure
anterior JJ I-Biological_structure
nasal JJ I-Biological_structure
space NN I-Biological_structure
, , O
involving VBG O
the DT O
left NN B-Biological_structure
inferior JJ I-Biological_structure
meatus NN I-Biological_structure
and CC O
abutting VBG O
the DT O
inferior JJ B-Biological_structure
turbinate NN I-Biological_structure
. . O

Computed VBN B-Diagnostic_procedure
Tomography NNP I-Diagnostic_procedure
( ( O
CT NNP B-Diagnostic_procedure
) ) O
of IN O
the DT O
paranasal NN B-Biological_structure
sinuses VBZ I-Biological_structure
showed VBD O
a DT O
lobulated VBN B-Detailed_description
, , O
expansile JJ B-Detailed_description
lytic JJ B-Detailed_description
lesion NN B-Sign_symptom
of IN O
left JJ B-Biological_structure
maxilla NN I-Biological_structure
[ NNP O
Fig NNP O
1 CD O
] NN O
with IN O
a DT O
lucent NN B-Detailed_description
center NN I-Detailed_description
and CC O
peripheral JJ B-Detailed_description
calcifications NNS I-Detailed_description
. . O

The DT O
lesion NN O
was VBD O
associated VBN O
with IN O
a DT O
large JJ B-Detailed_description
soft JJ I-Detailed_description
tissue NN I-Detailed_description
component NN I-Detailed_description
that WDT O
demonstrated VBD O
mild RB B-Severity
heterogeneous JJ B-Detailed_description
contrast NN B-Sign_symptom
enhancement NN I-Sign_symptom
. . O

The DT O
lesion NN O
was VBD O
centered VBN O
at IN O
the DT O
left JJ B-Biological_structure
maxillary JJ I-Biological_structure
alveolus NN I-Biological_structure
, , O
involving VBG O
the DT O
left JJS B-Biological_structure
hard JJ I-Biological_structure
palate NN I-Biological_structure
, , O
inferior JJ B-Biological_structure
part NN I-Biological_structure
of IN I-Biological_structure
the DT I-Biological_structure
anterior JJ I-Biological_structure
left VBD I-Biological_structure
maxillary JJ I-Biological_structure
wall NN I-Biological_structure
and CC O
medial JJ B-Biological_structure
left VBD I-Biological_structure
maxillary JJ I-Biological_structure
wall NN I-Biological_structure
. . O

The DT O
lesion NN O
also RB O
involved VBD O
the DT O
roots NNS B-Biological_structure
of IN I-Biological_structure
the DT I-Biological_structure
left JJ I-Biological_structure
maxillary JJ I-Biological_structure
molars NNS I-Biological_structure
and CC I-Biological_structure
pre VB I-Biological_structure
- : I-Biological_structure
molars NNS I-Biological_structure
and CC O
was VBD O
abutting VBG O
the DT O
left JJ B-Biological_structure
orbital JJ I-Biological_structure
floor NN I-Biological_structure
, , O
with IN O
no DT O
gross JJ O
orbital JJ B-Biological_structure
invasion NN B-Sign_symptom
. . O

The DT O
patient NN O
subsequently RB O
underwent JJ O
18 CD B-Diagnostic_procedure
- : I-Diagnostic_procedure
FDG NN I-Diagnostic_procedure
PET NNP I-Diagnostic_procedure
- : I-Diagnostic_procedure
CT NN I-Diagnostic_procedure
study NN I-Diagnostic_procedure
. . O

The DT O
mass NN O
centered VBN O
in IN O
left JJ B-Biological_structure
maxilla NN I-Biological_structure
was VBD O
hypermetabolic JJ B-Detailed_description
, , O
with IN O
index NN B-Lab_value
SUVmax NNP I-Lab_value
9 CD I-Lab_value
. . I-Lab_value
7 CD I-Lab_value
[ JJ O
Fig NNP O
2 CD O
] NN O
. . O

There EX O
was VBD O
no DT O
FDG NNP B-Detailed_description
- : I-Detailed_description
avid NN I-Detailed_description
metastatic JJ B-Disease_disorder
disease NN I-Disease_disorder
. . O

A DT O
trans JJ B-Detailed_description
- : I-Detailed_description
oral JJ I-Detailed_description
incisional JJ B-Diagnostic_procedure
biopsy NN I-Diagnostic_procedure
of IN O
the DT O
left JJ B-Biological_structure
palatal JJ I-Biological_structure
mass NN B-Sign_symptom
was VBD O
performed VBN O
and CC O
was VBD O
suggestive NN O
of IN O
a DT O
preliminary JJ O
diagnosis NN O
of IN O
mesenchymal JJ B-Disease_disorder
chondrosarcoma NN I-Disease_disorder
, , O
as IN O
evidenced VBN O
by IN O
a DT O
biphasic JJ B-Detailed_description
pattern NN I-Detailed_description
featuring VBG O
sheets NNS B-Detailed_description
of IN I-Detailed_description
small JJ I-Detailed_description
round NN I-Detailed_description
cells NNS I-Detailed_description
with IN O
hemangiopericytoma JJ B-Detailed_description
- : I-Detailed_description
like IN I-Detailed_description
vascular JJ I-Detailed_description
pattern NN I-Detailed_description
and CC O
mature NN B-Detailed_description
cartilaginous JJ I-Detailed_description
islands NNS I-Detailed_description
. . O

The DT O
patient JJ O
underwent NN O
left VBD B-Detailed_description
subtotal JJ I-Detailed_description
maxillectomy NN B-Therapeutic_procedure
via IN O
lateral JJ B-Detailed_description
rhinotomy NN B-Therapeutic_procedure
and CC O
translabial JJ B-Detailed_description
approach NN I-Detailed_description
. . O

The DT O
final JJ O
histology NN B-Diagnostic_procedure
was VBD O
conclusive JJ O
of IN O
a DT O
5 CD B-Distance
cm NN I-Distance
high JJ B-Lab_value
- : I-Lab_value
grade NN I-Lab_value
( ( O
Grade NNP B-Lab_value
3 CD I-Lab_value
) ) O
mesenchymal NN B-Disease_disorder
chondrosarcoma NN I-Disease_disorder
. . O

One CD O
of IN O
the DT O
resection NN B-Biological_structure
margins NNS I-Biological_structure
was VBD O
positive JJ O
for IN O
tumor NN B-Sign_symptom
involvement NN I-Sign_symptom
and CC O
the DT O
patient NN O
was VBD O
planned VBN O
for IN O
adjuvant JJ B-Detailed_description
chemotherapy NN B-Medication
. . O

-DOCSTART- NN -X-

A DT O
woman NN O
in IN O
her PRP$ O
60s CD B-Age
was VBD O
found VBN O
to TO O
have VB O
screen NN B-Diagnostic_procedure
detected VBN O
invasive JJ B-Detailed_description
lobular JJ B-Detailed_description
breast NN B-Disease_disorder
carcinoma NN I-Disease_disorder
of IN O
the DT O
right JJ B-Biological_structure
breast NN I-Biological_structure
and CC O
invasive JJ B-Detailed_description
ductal NN B-Disease_disorder
carcinoma NN I-Disease_disorder
, , O
no DT B-Detailed_description
special JJ I-Detailed_description
type NN I-Detailed_description
, , O
of IN O
the DT O
left NN B-Biological_structure
breast NN I-Biological_structure
. . O

Staging VBG O
CT NNP B-Diagnostic_procedure
imaging VBG I-Diagnostic_procedure
prior RB O
to TO O
mastectomy VB B-Therapeutic_procedure
showed VBD O
a DT O
12 CD B-Distance
cm NN I-Distance
pelvic NN B-Biological_structure
mass NN B-Sign_symptom
which WDT O
on IN O
initial JJ O
impression NN O
was VBD O
thought VBN O
to TO O
be VB O
a DT O
fibroid JJ B-Sign_symptom
uterus NN B-Biological_structure
. . O

Associated VBN O
postmenopausal NN B-Detailed_description
bleeding VBG B-Sign_symptom
led VBN O
to TO O
pelvic VB B-Biological_structure
ultrasound NN B-Diagnostic_procedure
, , O
hysteroscopy NN B-Diagnostic_procedure
and CC O
biopsy NN B-Diagnostic_procedure
. . O

The DT O
biopsy NN B-Diagnostic_procedure
showed VBD O
undifferentiated JJ B-Detailed_description
sarcoma NN B-Disease_disorder
, , O
unclassifiable JJ B-Lab_value
with IN O
immunohistochemistry NN B-Diagnostic_procedure
. . O

Following VBG O
discussion NN O
at IN O
a DT O
multidisciplinary JJ O
team NN O
meeting NN O
it PRP O
was VBD O
felt VBN O
that IN O
the DT O
uterine JJ B-Biological_structure
tumour NN B-Sign_symptom
was VBD O
a DT O
separate JJ O
primary JJ B-Detailed_description
malignancy NN I-Detailed_description
rather RB O
than IN O
metastasis NN B-Disease_disorder
from IN O
the DT O
breast NN B-Biological_structure
. . O

Hysterectomy NNP B-Therapeutic_procedure
and CC O
bilateral JJ B-Detailed_description
salpingo NN B-Therapeutic_procedure
- : I-Therapeutic_procedure
oophorectomy NN I-Therapeutic_procedure
was VBD O
performed VBN O
for IN O
both DT O
treatment NN O
purposes NNS O
and CC O
to TO O
fully RB O
categorise VB O
the DT O
malignancy NN O
to TO O
guide VB O
further JJ O
adjuvant JJ B-Therapeutic_procedure
therapy NN I-Therapeutic_procedure
. . O

Histological JJ B-Diagnostic_procedure
examination NN I-Diagnostic_procedure
of IN O
the DT O
resection NN O
specimen NNS O
showed VBD O
a DT O
partially RB B-Detailed_description
necrotic JJ I-Detailed_description
tumour NN B-Sign_symptom
with IN O
a DT O
discrete JJ B-Detailed_description
outline NN I-Detailed_description
located VBN O
within IN O
and CC O
extending VBG O
throughout IN O
the DT O
myometrium NN B-Biological_structure
. . O

The DT O
tumour NN O
was VBD O
composed VBN O
of IN O
malignant JJ B-Detailed_description
spindle JJ I-Detailed_description
cells NNS I-Detailed_description
( ( O
figure NN O
1A CD O
) ) O
, , O
with IN O
an DT O
intermittent JJ O
component NN O
of IN O
pleomorphic JJ B-Detailed_description
cells NNS I-Detailed_description
with IN O
abundant JJ O
eosinophilic JJ B-Detailed_description
cytoplasm NN I-Detailed_description
. . O

Plentiful NNP B-Detailed_description
osteoclast MD B-Detailed_description
- : I-Detailed_description
like VB I-Detailed_description
giant JJ B-Sign_symptom
cells NNS I-Sign_symptom
were VBD O
present JJ O
( ( O
figure JJ O
1B CD O
) ) O
. . O

Mitoses NNS B-Diagnostic_procedure
were VBD O
numerous JJ B-Lab_value
and CC O
structurally RB B-Sign_symptom
abnormal JJ I-Sign_symptom
forms NNS I-Sign_symptom
were VBD O
common JJ O
. . O

Neoplastic JJ O
cells NNS O
were VBD O
surrounded VBN O
by IN O
hyaline NN O
osteoid NN O
matrix NN O
and CC O
foci NN O
of IN O
coarse JJ O
neoplastic JJ O
woven NN O
bone NN O
( ( O
figure JJ O
1C CD O
) ) O
. . O

Generous JJ O
sampling NN O
of IN O
the DT O
tumour NN O
showed VBD O
no DT O
admixed JJ O
neoplastic JJ B-Sign_symptom
epithelial JJ I-Sign_symptom
elements NNS I-Sign_symptom
, , O
thus RB O
ruling VBG O
out RP O
the DT O
more JJR O
common JJ O
carcinosarcoma NN O
( ( O
malignant JJ B-Disease_disorder
mixed JJ I-Disease_disorder
Müllerian NNP I-Disease_disorder
tumour NN I-Disease_disorder
) ) O
. . O

Tumour NNP O
cells NNS O
showed VBD O
immunohistochemical JJ B-Diagnostic_procedure
expression NN B-Lab_value
for IN O
vimentin NN B-Diagnostic_procedure
, , O
smooth JJ B-Diagnostic_procedure
muscle NN I-Diagnostic_procedure
actin NN I-Diagnostic_procedure
( ( O
SMA NNP B-Diagnostic_procedure
) ) O
, , O
desmin FW B-Diagnostic_procedure
( ( O
focally RB B-Lab_value
) ) O
and CC O
CD99 NNP B-Diagnostic_procedure
. . O

Epithelial JJ B-Diagnostic_procedure
markers NNS I-Diagnostic_procedure
were VBD O
not RB B-Lab_value
expressed VBN I-Lab_value
. . O

The DT O
morphological JJ O
and CC O
immunohistochemical JJ O
appearances NNS O
were VBD O
in IN O
keeping VBG O
with IN O
primary JJ B-Detailed_description
uterine JJ I-Detailed_description
osteoblastic JJ I-Detailed_description
variant NN I-Detailed_description
of IN O
osteosarcoma NN B-Disease_disorder
. . O

Unfortunately RB O
, , O
despite IN O
treatment NN O
, , O
further JJ O
CT NNP B-Diagnostic_procedure
imaging NN I-Diagnostic_procedure
showed VBD O
the DT O
development NN O
of IN O
multiple JJ B-Detailed_description
peritoneal NN B-Biological_structure
and CC O
pulmonary JJ B-Biological_structure
deposits NNS B-Sign_symptom
, , O
confirmed VBN O
on IN O
biopsy NN B-Diagnostic_procedure
to TO O
be VB O
metastatic JJ B-Detailed_description
osteosarcoma NN B-Disease_disorder
. . O

The DT O
patient NN O
received VBD O
palliative JJ B-Detailed_description
chemotherapy NN B-Therapeutic_procedure
and CC O
died VBD O
several JJ O
months NNS O
later RB O
. . O

-DOCSTART- NN -X-

A DT O
68 CD B-Age
- : I-Age
year NN I-Age
- : I-Age
old JJ I-Age
female NN O
nonsmoker NN O
, , O
nondrinker NN O
with IN O
a DT O
medical JJ O
history NN O
of IN O
hypertension NN O
presented VBN O
with IN O
new JJ B-Detailed_description
- : I-Detailed_description
onset NN I-Detailed_description
painless NN B-Detailed_description
jaundice NN B-Sign_symptom
and CC O
pruritus NN B-Sign_symptom
, , O
a DT O
three CD B-Duration
- : I-Duration
month NN I-Duration
history NN O
of IN O
9 CD B-Lab_value
. . I-Lab_value
9 CD I-Lab_value
kg JJ I-Lab_value
weight JJ B-Sign_symptom
loss NN I-Sign_symptom
and CC O
chronic JJ B-Detailed_description
diarrhea NN B-Sign_symptom
with IN O
four CD B-Lab_value
to TO I-Lab_value
five CD I-Lab_value
loose JJ B-Lab_value
bowel NN B-Diagnostic_procedure
movements NNS I-Diagnostic_procedure
per IN B-Detailed_description
day NN I-Detailed_description
. . O

Medications NNS B-Medication
included VBD O
vitamin NN B-Medication
D NNP I-Medication
, , O
amlodipine NN B-Medication
and CC O
eprosartan NN B-Medication
. . O

Physical JJ B-Diagnostic_procedure
examination NN I-Diagnostic_procedure
was VBD O
normal JJ B-Lab_value
except IN O
for IN O
jaundice NN B-Sign_symptom
and CC O
muscle NN B-Disease_disorder
wasting NN I-Disease_disorder
. . O

Recent JJ O
colonoscopy NN B-Diagnostic_procedure
had VBD O
been VBN O
normal JJ B-Lab_value
. . O

Total JJ B-Detailed_description
and CC O
direct JJ B-Detailed_description
bilirubin NN B-Diagnostic_procedure
levels NNS O
were VBD O
6 CD B-Lab_value
. . I-Lab_value
84 CD I-Lab_value
mg JJ I-Lab_value
/ NN I-Lab_value
dL NN I-Lab_value
( ( O
116 CD B-Lab_value
. . I-Lab_value
96 CD I-Lab_value
μmol JJ I-Lab_value
/ NNP I-Lab_value
L NNP I-Lab_value
) ) O
and CC O
9 CD B-Lab_value
. . I-Lab_value
18 CD I-Lab_value
mg JJ I-Lab_value
/ NN I-Lab_value
dL NN I-Lab_value
( ( O
156 CD B-Lab_value
. . I-Lab_value
98 CD I-Lab_value
μmol JJ I-Lab_value
/ NNP I-Lab_value
L NNP I-Lab_value
) ) O
, , O
respectively RB O
. . O

Other JJ O
results NNS O
included VBD O
an DT O
international JJ B-Diagnostic_procedure
normalized JJ I-Diagnostic_procedure
ratio NN I-Diagnostic_procedure
of IN O
1 CD B-Lab_value
. . I-Lab_value
0 CD I-Lab_value
, , O
alanine JJ B-Diagnostic_procedure
aminotransferase NN I-Diagnostic_procedure
level NN O
247 CD B-Lab_value
U NNP I-Lab_value
/ NNP I-Lab_value
L NNP I-Lab_value
( ( O
normal JJ O
< $ O
33 CD O
U NNP O
/ NNP O
L NNP O
) ) O
, , O
aspartate JJ B-Diagnostic_procedure
aminotransferase NN I-Diagnostic_procedure
level NN O
139 CD B-Lab_value
U NNP I-Lab_value
/ NNP I-Lab_value
L NNP I-Lab_value
( ( O
normal JJ O
< $ O
32 CD O
U NNP O
/ NNP O
L NNP O
) ) O
and CC O
alkaline JJ B-Diagnostic_procedure
phosphatase NN I-Diagnostic_procedure
level NN O
524 CD B-Lab_value
U NNP I-Lab_value
/ NNP I-Lab_value
L NNP I-Lab_value
( ( O
normal JJ O
35 CD O
to TO O
104 CD O
U NNP O
/ NNP O
L NNP O
) ) O
. . O

Viral NNP B-Diagnostic_procedure
hepatitis NN I-Diagnostic_procedure
serologies NNS I-Diagnostic_procedure
, , O
and CC O
antimitochondrial JJ B-Diagnostic_procedure
antibody NN I-Diagnostic_procedure
and CC O
anti JJ B-Diagnostic_procedure
- : I-Diagnostic_procedure
smooth JJ I-Diagnostic_procedure
muscle NN I-Diagnostic_procedure
antibody NN I-Diagnostic_procedure
tests NNS O
were VBD O
negative JJ B-Lab_value
. . O

Her PRP$ O
alpha JJ B-Diagnostic_procedure
- : I-Diagnostic_procedure
fetoprotein NN I-Diagnostic_procedure
level NN O
was VBD O
2 CD B-Lab_value
. . I-Lab_value
4 CD I-Lab_value
ng JJ I-Lab_value
/ NN I-Lab_value
mL NN I-Lab_value
( ( O
normal JJ O
< $ O
5 CD O
ng JJ O
/ NNP O
mL NN O
) ) O
, , O
total JJ B-Diagnostic_procedure
immunoglobulin NN I-Diagnostic_procedure
( ( I-Diagnostic_procedure
Ig NNP I-Diagnostic_procedure
) ) I-Diagnostic_procedure
G NNP I-Diagnostic_procedure
was VBD O
1880 CD B-Lab_value
mg NN I-Lab_value
/ NNP I-Lab_value
dL NN I-Lab_value
( ( O
normal JJ O
< $ O
640 CD O
mg NN O
/ NNP O
dL NN O
) ) O
, , O
carbohydrate VBP B-Diagnostic_procedure
antigen NN I-Diagnostic_procedure
19 CD I-Diagnostic_procedure
- : I-Diagnostic_procedure
9 CD I-Diagnostic_procedure
was VBD O
856 CD B-Lab_value
U NNP I-Lab_value
/ NNP I-Lab_value
mL NN I-Lab_value
( ( O
normal JJ O
< $ O
33 CD O
U NNP O
/ NNP O
mL NN O
) ) O
and CC O
IgG4 NNP B-Diagnostic_procedure
was VBD O
890 CD B-Lab_value
g JJ I-Lab_value
/ NN I-Lab_value
L NNP I-Lab_value
( ( O
normal JJ O
< $ O
3 CD O
g NN O
/ NNP O
L NNP O
) ) O
. . O

Doppler NNP B-Detailed_description
ultrasound NN B-Diagnostic_procedure
, , O
magnetic JJ B-Diagnostic_procedure
resonance NN I-Diagnostic_procedure
cholangiopancreatography NN I-Diagnostic_procedure
and CC O
magnetic JJ B-Diagnostic_procedure
resonance NN I-Diagnostic_procedure
imaging NN I-Diagnostic_procedure
of IN O
the DT O
liver NN B-Biological_structure
were VBD O
suspicious JJ O
for IN O
a DT O
subtly RB B-Detailed_description
enhancing VBG I-Detailed_description
mass NN B-Sign_symptom
( ( O
2 CD B-Distance
. . I-Distance
8 CD I-Distance
cm NN I-Distance
to TO I-Distance
4 CD I-Distance
. . I-Distance
2 CD I-Distance
cm NN I-Distance
in IN O
diameter NN O
) ) O
in IN O
the DT O
region NN O
of IN O
the DT O
hilum NN B-Biological_structure
and CC O
porta NN B-Biological_structure
hepatis NN I-Biological_structure
, , O
obstructing VBG B-Sign_symptom
both PDT O
the DT O
right NN B-Biological_structure
and CC I-Biological_structure
left VBD I-Biological_structure
hepatic JJ I-Biological_structure
ducts NNS I-Biological_structure
. . O

Endoscopic NNP B-Detailed_description
retrograde VBD B-Detailed_description
cholangiopancreatography NN B-Diagnostic_procedure
identified VBN O
strictures NNS B-Sign_symptom
in IN O
the DT O
central JJ B-Biological_structure
portions NNS I-Biological_structure
of IN I-Biological_structure
the DT I-Biological_structure
right NN I-Biological_structure
and CC I-Biological_structure
left VBD I-Biological_structure
hepatic JJ I-Biological_structure
duct NN I-Biological_structure
, , O
which WDT O
was VBD O
concerning VBG O
for IN O
cholangiocarcinoma NN B-Disease_disorder
( ( O
Figure NNP O
1 CD O
) ) O
. . O

Biliary JJ B-Diagnostic_procedure
brushings NNS I-Diagnostic_procedure
were VBD O
negative JJ B-Lab_value
for IN I-Lab_value
malignancy NN I-Lab_value
. . O

Esophagogastroduodenoscopy NNP B-Diagnostic_procedure
was VBD O
normal JJ B-Lab_value
. . O

Biopsies NNS B-Diagnostic_procedure
of IN O
the DT O
ampulla NN B-Biological_structure
of IN I-Biological_structure
Vater NNP I-Biological_structure
revealed VBD O
chronic JJ B-Detailed_description
active JJ B-Detailed_description
duodenitis NN B-Disease_disorder
( ( O
Figures NNS O
2 CD O
and CC O
and3 NN O
) ) O
; : O
3 CD O
) ) O
; : O
an DT O
ancillary JJ B-Diagnostic_procedure
test NN I-Diagnostic_procedure
confirmed VBD B-Lab_value
the DT I-Lab_value
diagnosis NN I-Lab_value
( ( O
Figure NNP O
4 CD O
) ) O
. . O

Treatment NN O
with IN O
corticosteroids NNS B-Medication
normalized VBD O
the DT O
patient NN O
` `` O
s JJ O
biochemical NN B-Detailed_description
and CC O
radiological JJ B-Detailed_description
abnormalities NNS B-Disease_disorder
within IN O
three CD O
months NNS O
. . O

-DOCSTART- NN -X-

This DT O
is VBZ O
the DT O
case NN O
of IN O
a DT O
58 CD B-Age
- : I-Age
year NN I-Age
- : I-Age
old JJ I-Age
white JJ O
Hispanic NNP O
woman NN O
with IN O
a DT O
history NN O
of IN O
uveal JJ O
melanoma NN O
in IN O
her PRP$ O
right JJ O
eye NN O
( ( O
Fig NNP O
. . O
1 CD O
) ) O
. . O

She PRP O
was VBD O
admitted VBN O
to TO O
the DT O
hospital NN O
with IN O
jaundice NN B-Sign_symptom
and CC O
abdominal JJ B-Biological_structure
pain NN B-Sign_symptom
for IN O
10 CD B-Duration
days NNS I-Duration
. . O

On IN O
admission NN O
, , O
laboratory NN B-Diagnostic_procedure
tests NNS I-Diagnostic_procedure
were VBD O
obtained VBN O
( ( O
a DT O
complete JJ B-Diagnostic_procedure
blood NN I-Diagnostic_procedure
count NN I-Diagnostic_procedure
was VBD O
within IN B-Lab_value
normal JJ I-Lab_value
limits NNS I-Lab_value
, , O
amylase NN B-Diagnostic_procedure
: : O
136 CD B-Lab_value
U NNP I-Lab_value
/ NNP I-Lab_value
L NNP I-Lab_value
, , O
total JJ B-Diagnostic_procedure
bilirubin NN I-Diagnostic_procedure
: : O
6 CD B-Lab_value
. . I-Lab_value
37 CD I-Lab_value
mg JJ I-Lab_value
/ NNP I-Lab_value
dL NN I-Lab_value
with IN O
a DT O
direct JJ B-Diagnostic_procedure
fraction NN I-Diagnostic_procedure
of IN O
5 CD B-Lab_value
. . I-Lab_value
30 CD I-Lab_value
mg JJ I-Lab_value
/ NNP I-Lab_value
dL NN I-Lab_value
) ) O
. . O

Cross NNP B-Detailed_description
- : I-Detailed_description
sectional NN I-Detailed_description
, , O
abdominal JJ B-Biological_structure
computed VBN B-Diagnostic_procedure
tomography NN I-Diagnostic_procedure
( ( O
CT NNP B-Diagnostic_procedure
) ) O
with IN B-Detailed_description
contrast NN I-Detailed_description
, , O
showed VBD O
a DT O
low JJ B-Detailed_description
- : I-Detailed_description
attenuating VBG I-Detailed_description
lesion NN B-Sign_symptom
localized VBN O
in IN O
the DT O
pancreatic JJ B-Biological_structure
head NN I-Biological_structure
( ( O
measuring VBG O
4 CD B-Area
× JJ I-Area
3 CD I-Area
cm NN I-Area
) ) O
and CC O
a DT O
thinner JJR B-Biological_structure
section NN I-Biological_structure
of IN I-Biological_structure
the DT I-Biological_structure
distal JJ I-Biological_structure
bile NN I-Biological_structure
duct NN I-Biological_structure
suspicious JJ O
for IN O
compression NN O
) ) O
. . O

After IN O
a DT O
multidisciplinary JJ O
meeting NN O
, , O
our PRP$ O
patient NN O
was VBD O
scheduled VBN O
for IN O
EUS NNP B-Diagnostic_procedure
- : I-Diagnostic_procedure
FNA NN I-Diagnostic_procedure
. . O

EUS NNP O
showed VBD O
a DT O
solid JJ B-Detailed_description
, , O
heteroechoic JJ B-Detailed_description
with IN O
predominantly RB B-Detailed_description
hypoechoic JJ I-Detailed_description
areas NNS I-Detailed_description
, , O
well RB B-Detailed_description
- : I-Detailed_description
defined VBN I-Detailed_description
lesion NN B-Sign_symptom
with IN O
regular JJ B-Texture
contours NNS I-Texture
( ( O
measuring VBG O
3 CD B-Area
. . I-Area
1 CD I-Area
× JJ I-Area
2 CD I-Area
. . I-Area
6 CD I-Area
cm NN I-Area
) ) O
, , O
localized VBN O
between IN B-Biological_structure
the DT I-Biological_structure
head NN I-Biological_structure
and CC I-Biological_structure
neck NN I-Biological_structure
of IN I-Biological_structure
the DT I-Biological_structure
pancreas NNS I-Biological_structure
( ( O
Fig NNP O
. . O
2 CD O
) ) O
. . O

There EX O
was VBD O
no DT O
vascular NN B-Sign_symptom
or CC I-Sign_symptom
lymph NN I-Sign_symptom
node JJ I-Sign_symptom
invasion NN I-Sign_symptom
identified VBN O
. . O

EUS NNP O
- : O
FNA NN O
was VBD O
performed VBN O
with IN B-Detailed_description
a DT I-Detailed_description
22G CD I-Detailed_description
needle JJ I-Detailed_description
using VBG B-Detailed_description
the DT I-Detailed_description
fanning NN I-Detailed_description
technique NN I-Detailed_description
. . O

In IN O
the DT O
cytology NN B-Diagnostic_procedure
specimens NNS I-Diagnostic_procedure
( ( O
Fig NNP O
. . O
3 CD O
) ) O
, , O
the DT O
cells NNS B-Biological_structure
presented VBN O
have VBP O
a DT O
discohesive JJ B-Lab_value
dispersed JJ I-Lab_value
pattern NN I-Lab_value
, , O
with IN O
marked JJ O
variation NN B-Lab_value
in IN I-Lab_value
size NN I-Lab_value
and CC I-Lab_value
shape NN I-Lab_value
including VBG O
epithelioid NN B-Shape
and CC O
spindle JJ B-Shape
- : I-Shape
shaped VBD I-Shape
cells NNS B-Biological_structure
with IN O
plasmacytoid NN B-Shape
and CC O
round NN B-Shape
nuclei NN B-Biological_structure
. . O

The DT O
nuclear JJ B-Diagnostic_procedure
chromatin NN I-Diagnostic_procedure
is VBZ O
clumping VBG B-Lab_value
and CC O
irregular JJ B-Lab_value
with IN O
excessive JJ B-Lab_value
parachromatin NN I-Lab_value
clearing NN I-Lab_value
, , O
there EX O
are VBP O
single JJ B-Detailed_description
or CC O
multiple JJ B-Detailed_description
macronucleoli NN B-Biological_structure
, , O
and CC O
abundant JJ B-Detailed_description
cytoplasm NN B-Biological_structure
with IN O
deep JJ B-Lab_value
brownish JJ I-Lab_value
- : I-Lab_value
black JJ I-Lab_value
granules NNS I-Lab_value
obscuring VBG O
the DT O
cell NN O
details NNS O
. . O

The DT O
background NN B-Diagnostic_procedure
shows VBZ O
necrosis NN B-Sign_symptom
and CC O
hemorrhage NN B-Sign_symptom
. . O

Our PRP$ O
patient JJ O
underwent JJ O
right JJ B-Biological_structure
orbital JJ I-Biological_structure
exenteration NN B-Therapeutic_procedure
and CC O
followed VBN O
by IN O
duodenopancreatectomy NN B-Therapeutic_procedure
( ( O
the DT O
Whipple NNP B-Detailed_description
procedure NN I-Detailed_description
) ) O
, , O
without IN O
any DT O
complications NNS B-Sign_symptom
( ( O
Fig NNP O
. . O
4 CD O
) ) O
. . O

The DT O
surgical JJ B-Diagnostic_procedure
specimen NNS I-Diagnostic_procedure
showed VBD O
undifferentiated JJ B-Detailed_description
cells NNS B-Biological_structure
, , O
with IN O
extended JJ B-Lab_value
disposition NN I-Lab_value
of IN I-Lab_value
brown JJ I-Lab_value
pigment NN I-Lab_value
, , O
infiltrating VBG B-Sign_symptom
the DT O
pancreas NN B-Biological_structure
and CC O
the DT O
serosa NN B-Biological_structure
of IN I-Biological_structure
the DT I-Biological_structure
duodenal JJ I-Biological_structure
wall NN I-Biological_structure
. . O

Immunohistochemistry NN B-Diagnostic_procedure
was VBD O
positive JJ B-Lab_value
for IN O
Melan NNP B-Diagnostic_procedure
- : I-Diagnostic_procedure
A NN I-Diagnostic_procedure
, , O
HMB45 NNP B-Diagnostic_procedure
, , O
vimentin NN B-Diagnostic_procedure
, , O
S NNP B-Diagnostic_procedure
- : I-Diagnostic_procedure
100 CD I-Diagnostic_procedure
protein NN I-Diagnostic_procedure
and CC O
negative JJ B-Lab_value
for IN O
cytokeratin NN B-Diagnostic_procedure
, , O
all DT O
consistent JJ O
with IN O
metastatic JJ B-Detailed_description
malignant JJ B-Detailed_description
melanoma NN B-Disease_disorder
. . O

At IN O
the DT O
moment NN O
, , O
our PRP$ O
patient NN O
is VBZ O
receiving VBG O
adjuvant JJ B-Detailed_description
chemotherapy NN B-Medication
at IN O
an DT O
outside JJ B-Nonbiological_location
oncology NN I-Nonbiological_location
clinic NN I-Nonbiological_location
. . O

-DOCSTART- NN -X-

A DT O
4 CD B-Age
and CC I-Age
a DT I-Age
half JJ I-Age
years NNS I-Age
old JJ I-Age
male JJ O
child NN O
presented VBN O
to TO O
our PRP$ O
hospital NN B-Nonbiological_location
for IN O
abdominal JJ B-Biological_structure
swelling NN B-Sign_symptom
. . O

The DT O
child NN O
occasionally RB B-Detailed_description
felt VBD O
stomach NN B-Sign_symptom
ache NN I-Sign_symptom
that WDT O
was VBD O
relieved VBN B-Detailed_description
for IN I-Detailed_description
no DT I-Detailed_description
reason NN I-Detailed_description
. . O

The DT O
child NN O
showed VBD O
no DT O
obvious JJ O
tenderness NN B-Sign_symptom
and CC O
rebound NN B-Sign_symptom
. . O

He PRP O
was VBD O
born VBN O
as IN O
a DT O
premature NN O
baby NN O
in IN O
the DT O
32nd CD O
week NN O
of IN O
his PRP$ O
mother NN O
` `` O
s JJ O
pregnancy NN O
. . O

His PRP$ O
medical JJ O
history NN O
included VBD O
inguinal JJ O
hernia NN O
on IN O
2 CD O
sides NNS O
, , O
but CC O
he PRP O
had VBD O
only RB O
received VBN O
an DT O
operation NN O
for IN O
the DT O
left JJ O
inguinal JJ O
hernia NN O
. . O

No DT O
family NN O
or CC O
genetic JJ O
history NN O
was VBD O
found VBN O
. . O

Physical JJ B-Diagnostic_procedure
examination NN I-Diagnostic_procedure
of IN O
this DT O
child NN O
showed VBD O
that IN O
the DT O
abdomen NNS B-Biological_structure
was VBD O
obviously RB B-Detailed_description
bulging VBG B-Sign_symptom
. . O

The DT O
mass NN B-Sign_symptom
could MD O
be VB O
touched VBN O
below IN B-Biological_structure
umbilicus NN I-Biological_structure
about IN B-Distance
3 CD I-Distance
fingers NNS I-Distance
. . O

There EX O
were VBD O
no DT O
other JJ O
positive JJ O
signs NNS O
. . O

The DT O
results NNS O
of IN O
laboratory JJ B-Diagnostic_procedure
tests NNS I-Diagnostic_procedure
were VBD O
almost RB B-Lab_value
normal JJ I-Lab_value
, , O
including VBG O
alpha SYM B-Diagnostic_procedure
- : I-Diagnostic_procedure
fetoprotein NN I-Diagnostic_procedure
( ( O
AFP NNP B-Diagnostic_procedure
) ) O
level NN O
. . O

The DT O
Child NNP B-Diagnostic_procedure
- : I-Diagnostic_procedure
Pugh NNP I-Diagnostic_procedure
score NN I-Diagnostic_procedure
was VBD O
less JJR B-Lab_value
than IN I-Lab_value
5 CD I-Lab_value
. . O

Abdominal NNP B-Biological_structure
ultrasonography NN B-Diagnostic_procedure
showed VBD O
an DT O
uneven JJ B-Detailed_description
lesion NN B-Sign_symptom
in IN O
the DT O
liver NN B-Biological_structure
and CC O
a DT O
diagnosis NN O
of IN O
HB NNP B-Disease_disorder
was VBD O
considered VBN O
. . O

Enhancement NN B-Detailed_description
computed VBN B-Diagnostic_procedure
tomography NN I-Diagnostic_procedure
( ( O
CT NNP B-Diagnostic_procedure
) ) O
scanning NN O
showed VBD O
a DT O
large JJ B-Detailed_description
mass NN B-Sign_symptom
in IN O
the DT O
left JJ B-Biological_structure
upper JJ I-Biological_structure
abdomen NNS I-Biological_structure
and CC O
left VBD B-Biological_structure
lobe NN I-Biological_structure
of IN I-Biological_structure
the DT I-Biological_structure
liver NN I-Biological_structure
with IN O
an DT O
irregular JJ B-Shape
edge NN I-Shape
. . O

The DT O
size NN O
of IN O
the DT O
mass NN O
was VBD O
12 CD B-Volume
. . I-Volume
3 CD I-Volume
× JJ I-Volume
10 CD I-Volume
. . I-Volume
2 CD I-Volume
× JJ I-Volume
7 CD I-Volume
. . I-Volume
2 CD I-Volume
cm NN I-Volume
( ( O
Fig NNP O
. . O
1 CD O
) ) O
. . O

There EX O
was VBD O
an DT O
uneven JJ B-Detailed_description
nodular JJ I-Detailed_description
shadow NN I-Detailed_description
and CC O
the DT O
edge NN B-Detailed_description
was VBD I-Detailed_description
obvious JJ I-Detailed_description
when WRB O
the DT O
mass NN O
was VBD O
enhanced VBN O
. . O

Calcification NN B-Sign_symptom
and CC O
an DT O
expanded VBN B-Sign_symptom
bile NN I-Sign_symptom
duct NN I-Sign_symptom
were VBD O
not RB O
observed VBN O
. . O

The DT O
left JJ B-Biological_structure
branch NN I-Biological_structure
of IN I-Biological_structure
the DT I-Biological_structure
portal NN I-Biological_structure
was VBD O
pressed VBN B-Detailed_description
and CC O
the DT O
distant JJ B-Detailed_description
part NN I-Detailed_description
was VBD I-Detailed_description
shown VBN I-Detailed_description
to TO I-Detailed_description
be VB I-Detailed_description
unclear JJ I-Detailed_description
. . O

Abnormal NNP B-Sign_symptom
was VBD O
not RB O
observed VBN O
in IN O
the DT O
right JJ B-Biological_structure
branch NN I-Biological_structure
. . O

According VBG O
to TO O
the DT O
medical JJ O
history NN O
, , O
the DT O
diagnosis NN O
of IN O
HB NNP B-Disease_disorder
was VBD O
considered VBN O
. . O

We PRP O
did VBD O
not RB O
recommend VB O
a DT O
biopsy NN B-Diagnostic_procedure
to TO O
the DT O
patient NN O
because IN O
it PRP O
might MD O
cause VB O
bleeding NN O
and CC O
tumor NN O
diffusion NN O
. . O

An DT O
operation NN B-Therapeutic_procedure
was VBD O
necessary JJ O
. . O

The DT O
patient JJ O
underwent JJ O
DVSS NNP B-Therapeutic_procedure
surgery NN I-Therapeutic_procedure
with IN B-Detailed_description
sufficient JJ I-Detailed_description
preparation NN I-Detailed_description
. . O

Exploration NN B-Diagnostic_procedure
showed VBD O
an DT O
extrahepatic JJ B-Detailed_description
12 CD B-Area
× JJ I-Area
10 CD I-Area
cm JJ I-Area
mass NN B-Sign_symptom
in IN O
the DT O
left JJ B-Biological_structure
lobe NN I-Biological_structure
of IN I-Biological_structure
the DT I-Biological_structure
liver NN I-Biological_structure
( ( O
Fig NNP O
. . O
2 CD O
) ) O
. . O

After IN O
the DT O
operation NN O
, , O
the DT O
sample NN O
was VBD O
split VBN B-Detailed_description
. . O

The DT O
edge NN B-Shape
of IN I-Shape
the DT I-Shape
tumor NN I-Shape
was VBD I-Shape
clear JJ I-Shape
but CC O
no DT B-Detailed_description
envelope NN I-Detailed_description
. . O

Tremelloid NNP B-Detailed_description
mesenchyme NN B-Biological_structure
was VBD O
seen VBN O
on IN O
the DT O
section NN O
( ( O
Fig NNP O
. . O
2C CD O
) ) O
. . O

The DT O
pathological JJ O
examination NN O
showed VBD O
that IN O
the DT O
sample NN O
was VBD O
grey JJ B-Color
red JJ I-Color
and CC O
14 CD B-Volume
× NNS I-Volume
13 CD I-Volume
× $ I-Volume
7 CD I-Volume
cm NN I-Volume
in IN O
size NN O
. . O

The DT O
color NN O
of IN O
the DT O
section NN O
was VBD O
grey VBN B-Color
red JJ I-Color
and CC O
grey JJ B-Color
white JJ I-Color
. . O

MHL NNP B-Disease_disorder
was VBD O
diagnosed VBN O
( ( O
Fig NNP O
. . O
3 CD O
) ) O
. . O

Immunohistochemistry NN B-Diagnostic_procedure
results NNS I-Diagnostic_procedure
( ( O
Fig NNP O
. . O
4 CD O
) ) O
were VBD O
the DT O
following JJ O
: : O
mesenchymal JJ B-Diagnostic_procedure
CD34 NNP I-Diagnostic_procedure
( ( O
+ NNP B-Lab_value
) ) O
, , O
D2 NNP B-Diagnostic_procedure
- : I-Diagnostic_procedure
40 CD I-Diagnostic_procedure
( ( O
+ NN B-Lab_value
) ) O
, , O
S NNP B-Diagnostic_procedure
- : I-Diagnostic_procedure
100 CD I-Diagnostic_procedure
( ( O
- : B-Lab_value
) ) O
, , O
SMA NNP B-Diagnostic_procedure
( ( O
+ NNP B-Lab_value
) ) O
, , O
CD7 NNP B-Diagnostic_procedure
( ( O
- : B-Lab_value
) ) O
, , O
epithelium JJ B-Diagnostic_procedure
CK19 NNP I-Diagnostic_procedure
( ( O
+ NNP B-Lab_value
) ) O
, , O
AFP NNP B-Diagnostic_procedure
( ( O
- : B-Lab_value
) ) O
, , O
HCG NNP B-Diagnostic_procedure
( ( O
- : B-Lab_value
) ) O
. . O

After IN O
9 CD B-Duration
days NNS I-Duration
of IN O
recovery NN B-Therapeutic_procedure
, , O
the DT O
patient NN O
returned VBD O
home NN B-Nonbiological_location
without IN O
complications NNS B-Sign_symptom
. . O

A DT O
follow NN O
- : O
up IN O
examination NN O
, , O
which WDT O
included VBD O
blood NN B-Diagnostic_procedure
routine NN I-Diagnostic_procedure
, , O
liver WP B-Diagnostic_procedure
renal JJ I-Diagnostic_procedure
function NN I-Diagnostic_procedure
, , O
coagulation NN B-Diagnostic_procedure
routine NN I-Diagnostic_procedure
, , O
and CC O
ultrasound JJ B-Diagnostic_procedure
scan NN I-Diagnostic_procedure
at IN O
30 CD O
days NNS O
, , O
did VBD O
not RB O
show VB O
any DT O
abnormality NN B-Sign_symptom
. . O

No DT O
adverse JJ B-Sign_symptom
or CC I-Sign_symptom
unanticipated JJ I-Sign_symptom
event NN I-Sign_symptom
was VBD O
presented VBN O
. . O

-DOCSTART- NN -X-

CASE NN O
: : O
A DT O
28 CD B-Age
- : I-Age
year NN I-Age
- : I-Age
old JJ I-Age
previously RB O
healthy JJ B-Sign_symptom
man NN O
presented VBN O
with IN O
a DT O
6 CD B-Duration
- : I-Duration
week NN I-Duration
history NN O
of IN O
palpitations NNS B-Sign_symptom
. . O

The DT O
symptoms NNS O
occurred VBD O
during IN O
rest NN O
, , O
2 CD B-Frequency
- : I-Frequency
3 CD I-Frequency
times NNS I-Frequency
per IN I-Frequency
week NN I-Frequency
, , O
lasted VBD O
up RB B-Detailed_description
to TO I-Detailed_description
30 CD I-Detailed_description
minutes NNS I-Detailed_description
at IN I-Detailed_description
a DT I-Detailed_description
time NN I-Detailed_description
and CC O
were VBD O
associated VBN O
with IN O
dyspnea NN B-Sign_symptom
. . O

Except IN O
for IN O
a DT O
grade NN B-Lab_value
2 CD I-Lab_value
/ NN I-Lab_value
6 CD I-Lab_value
holosystolic JJ B-Detailed_description
tricuspid JJ B-Biological_structure
regurgitation NN B-Sign_symptom
murmur NN I-Sign_symptom
( ( O
best JJS O
heard NN O
at IN O
the DT O
left JJ B-Biological_structure
sternal JJ I-Biological_structure
border NN I-Biological_structure
with IN O
inspiratory JJ B-Detailed_description
accentuation NN I-Detailed_description
) ) O
, , O
physical JJ B-Diagnostic_procedure
examination NN I-Diagnostic_procedure
yielded VBN O
unremarkable JJ B-Lab_value
findings NNS O
. . O

An DT O
electrocardiogram NN B-Diagnostic_procedure
( ( O
ECG NNP B-Diagnostic_procedure
) ) O
revealed VBD O
normal JJ B-Lab_value
sinus NN B-Diagnostic_procedure
rhythm NN I-Diagnostic_procedure
and CC O
a DT O
Wolff NNP B-Sign_symptom
- : I-Sign_symptom
Parkinson NNP I-Sign_symptom
- : I-Sign_symptom
White NNP I-Sign_symptom
pre SYM I-Sign_symptom
- : I-Sign_symptom
excitation NN I-Sign_symptom
pattern NN I-Sign_symptom
( ( O
Fig NNP O
. . O
1 CD O
: : O
Top NN O
) ) O
, , O
produced VBN O
by IN O
a DT O
right JJ B-Detailed_description
- : I-Detailed_description
sided VBD I-Detailed_description
accessory JJ B-Disease_disorder
pathway NN I-Disease_disorder
. . O

Transthoracic NNP B-Biological_structure
echocardiography NN B-Diagnostic_procedure
demonstrated VBD O
the DT O
presence NN O
of IN O
Ebstein NNP B-Disease_disorder
` `` I-Disease_disorder
s JJ I-Disease_disorder
anomaly NN I-Disease_disorder
of IN O
the DT O
tricuspid JJ B-Biological_structure
valve NN I-Biological_structure
, , O
with IN O
apical JJ B-Sign_symptom
displacement NN I-Sign_symptom
of IN O
the DT O
valve NN O
and CC O
formation NN O
of IN O
an DT O
` `` O
atrialized JJ B-Disease_disorder
` `` O
right JJ B-Biological_structure
ventricle NN I-Biological_structure
( ( O
a DT O
functional JJ O
unit NN O
between IN O
the DT O
right JJ B-Biological_structure
atrium NN I-Biological_structure
and CC O
the DT O
inlet NN B-Biological_structure
[ NNP O
inflow NN O
] NNP O
portion NN O
of IN O
the DT O
right JJ B-Biological_structure
ventricle NN I-Biological_structure
) ) O
( ( O
Fig NNP O
. . O
2 CD O
) ) O
. . O

The DT O
anterior JJ B-Biological_structure
tricuspid JJ I-Biological_structure
valve NN I-Biological_structure
leaflet NN I-Biological_structure
was VBD O
elongated VBN B-Sign_symptom
( ( O
Fig NNP O
. . O
2C CD O
, , O
arrow NN O
) ) O
, , O
whereas IN O
the DT O
septal JJ B-Biological_structure
leaflet NN I-Biological_structure
was VBD O
rudimentary JJ B-Sign_symptom
( ( O
Fig NNP O
. . O
2C CD O
, , O
arrowhead NN O
) ) O
. . O

Contrast NNP B-Detailed_description
echocardiography NN B-Diagnostic_procedure
using VBG B-Detailed_description
saline NN I-Detailed_description
revealed VBD O
a DT O
patent NN B-Disease_disorder
foramen NNS I-Disease_disorder
ovale VBP I-Disease_disorder
with IN O
right JJ B-Sign_symptom
- : I-Sign_symptom
to TO I-Sign_symptom
- : I-Sign_symptom
left NN I-Sign_symptom
shunting NN I-Sign_symptom
and CC O
bubbles NNS B-Sign_symptom
in IN O
the DT O
left JJ B-Biological_structure
atrium NN I-Biological_structure
( ( O
Fig NNP O
. . O
2D CD O
) ) O
. . O

The DT O
patient NN O
underwent VBD O
an DT O
electrophysiologic NN B-Diagnostic_procedure
study NN I-Diagnostic_procedure
with IN O
mapping NN B-Diagnostic_procedure
of IN O
the DT O
accessory JJ B-Biological_structure
pathway NN I-Biological_structure
, , O
followed VBN O
by IN O
radiofrequency NN B-Detailed_description
ablation NN B-Therapeutic_procedure
( ( O
interruption NN O
of IN O
the DT O
pathway NN O
using VBG O
the DT O
heat NN O
generated VBN O
by IN O
electromagnetic JJ O
waves NNS O
at IN O
the DT O
tip NN O
of IN O
an DT O
ablation NN B-Therapeutic_procedure
catheter NN I-Therapeutic_procedure
) ) O
. . O

His PRP$ O
post NN O
- : O
ablation NN O
ECG NNP B-Diagnostic_procedure
showed VBD O
a DT O
prolonged JJ B-Lab_value
PR NNP B-Diagnostic_procedure
interval NN I-Diagnostic_procedure
and CC O
an DT O
odd JJ B-Lab_value
` `` B-Lab_value
second JJ I-Lab_value
` `` I-Lab_value
QRS NN B-Diagnostic_procedure
complex NN I-Diagnostic_procedure
in IN O
leads NNS B-Detailed_description
III NNP I-Detailed_description
, , I-Detailed_description
aVF NN I-Detailed_description
and CC I-Detailed_description
V2 NNP I-Detailed_description
- : I-Detailed_description
V4 NNP I-Detailed_description
( ( O
Fig NNP O
. . O
1Bottom CD O
) ) O
, , O
a DT O
consequence NN O
of IN O
abnormal JJ B-Disease_disorder
impulse JJ I-Disease_disorder
conduction NN I-Disease_disorder
in IN O
the DT O
` `` O
atrialized JJ B-Disease_disorder
` `` O
right JJ B-Biological_structure
ventricle NN I-Biological_structure
. . O

The DT O
patient NN O
reported VBD O
no DT O
recurrence NN O
of IN O
palpitations NNS B-Sign_symptom
at IN O
follow JJ O
- : O
up RB O
6 CD O
months NNS O
after IN O
the DT O
ablation NN O
. . O

-DOCSTART- NN -X-

A DT O
47 CD B-Age
- : I-Age
year NN I-Age
- : I-Age
old JJ I-Age
woman NN O
presented VBD O
to TO O
the DT O
hospital NN B-Nonbiological_location
with IN O
a DT O
1 CD B-Duration
- : I-Duration
month NN I-Duration
history NN O
of IN O
abdominal JJ B-Biological_structure
distention NN B-Sign_symptom
. . O

Physical JJ B-Diagnostic_procedure
examination NN I-Diagnostic_procedure
revealed VBD O
a DT O
huge JJ B-Severity
mass NN B-Sign_symptom
in IN O
the DT O
lower JJR B-Biological_structure
abdomen NNS I-Biological_structure
. . O

The DT O
peripheral JJ B-Diagnostic_procedure
blood NN I-Diagnostic_procedure
test NN I-Diagnostic_procedure
showed VBD O
elevated JJ B-Lab_value
levels NNS O
of IN O
carcinoembryonic JJ B-Diagnostic_procedure
antigen NN I-Diagnostic_procedure
( ( O
CEA NNP B-Diagnostic_procedure
, , O
335 CD B-Lab_value
. . I-Lab_value
2 CD I-Lab_value
ng JJ I-Lab_value
/ NNP I-Lab_value
mL NN I-Lab_value
[ NNP O
normal JJ O
, , O
< JJ O
5 CD O
ng JJ O
/ NNP O
mL NNP O
] NNP O
) ) O
and CC O
carbohydrate JJ B-Diagnostic_procedure
antigen NN I-Diagnostic_procedure
( ( O
CA NNP B-Diagnostic_procedure
) ) O
125 CD B-Detailed_description
( ( O
219 CD B-Lab_value
U NNP I-Lab_value
/ NNP I-Lab_value
mL FW I-Lab_value
[ NNP O
normal JJ O
, , O
< JJ O
45 CD O
U NNP O
/ NNP O
mL NNP O
] NNP O
) ) O
but CC O
a DT O
normal JJ B-Lab_value
level NN O
of IN O
CA19 NNP B-Diagnostic_procedure
- : I-Diagnostic_procedure
9 CD I-Diagnostic_procedure
( ( O
9 CD B-Lab_value
U NNP I-Lab_value
/ NNP I-Lab_value
mL FW I-Lab_value
[ NNP O
normal JJ O
, , O
< JJ O
37 CD O
U NNP O
/ NNP O
mL NNP O
] NNP O
) ) O
. . O

Computed VBN B-Diagnostic_procedure
tomography NN I-Diagnostic_procedure
( ( O
CT NNP B-Diagnostic_procedure
) ) O
demonstrated VBD O
a DT O
large JJ B-Severity
, , O
round JJ B-Shape
mass NN B-Sign_symptom
with IN O
a DT O
maximum JJ O
diameter NN O
of IN O
15 CD B-Distance
cm NN I-Distance
in IN O
the DT O
pelvic JJ B-Biological_structure
cavity NN I-Biological_structure
without IN O
the DT O
presence NN O
of IN O
ascites NNS B-Sign_symptom
or CC O
pleural JJ B-Sign_symptom
effusion NN I-Sign_symptom
( ( O
Fig NNP O
. . O
1a CD O
, , O
b NN O
) ) O
. . O

Colonoscopy NNP B-Diagnostic_procedure
identified VBD O
an DT O
elevated JJ B-Lab_value
lesion NN B-Sign_symptom
with IN O
severe JJ B-Severity
stenosis NN B-Sign_symptom
in IN O
the DT O
sigmoid NN B-Biological_structure
colon NN I-Biological_structure
, , O
and CC O
histopathological JJ B-Diagnostic_procedure
examination NN I-Diagnostic_procedure
of IN O
biopsy NN B-Diagnostic_procedure
specimens NNS I-Diagnostic_procedure
from IN O
the DT O
tumor NN O
showed VBD O
moderately RB B-Lab_value
differentiated VBN I-Lab_value
adenocarcinoma NN B-Disease_disorder
. . O

Although IN O
we PRP O
scheduled VBD O
an DT O
early JJ O
operation NN B-Therapeutic_procedure
, , O
the DT O
patient NN O
developed VBD O
acute JJ B-Lab_value
dyspnea NN B-Sign_symptom
and CC O
general JJ B-Lab_value
edema NN B-Sign_symptom
2 CD O
weeks NNS O
after IN O
the DT O
first JJ O
CT NNP O
scan NN O
. . O

The DT O
second JJ O
CT NNP B-Diagnostic_procedure
scan JJ O
examination NN O
demonstrated VBD O
massive JJ B-Severity
bilateral JJ B-Detailed_description
pleural JJ B-Sign_symptom
effusion NN I-Sign_symptom
with IN O
atelectasis NN B-Sign_symptom
and CC O
ascites NNS B-Sign_symptom
( ( O
Fig NNP O
. . O
2a CD O
, , O
b NN O
) ) O
. . O

Thoracic NNP B-Therapeutic_procedure
drainage NN I-Therapeutic_procedure
and CC O
laparotomy NN B-Therapeutic_procedure
were VBD O
emergently RB O
performed VBN O
. . O

Macroscopically RB B-Diagnostic_procedure
, , O
the DT O
tumor NN O
in IN O
the DT O
sigmoid NN B-Biological_structure
colon NN I-Biological_structure
had VBD O
invaded VBN B-Sign_symptom
the DT O
serosa NN B-Biological_structure
, , O
and CC O
the DT O
huge JJ B-Severity
pelvic JJ B-Biological_structure
mass NN B-Sign_symptom
was VBD O
found VBN O
to TO O
contain VB O
a DT O
right JJ B-Detailed_description
ovarian JJ B-Disease_disorder
tumor NN I-Disease_disorder
. . O

Several JJ O
small JJ O
nodules NNS B-Sign_symptom
of IN O
peritoneal JJ B-Biological_structure
dissemination NN B-Sign_symptom
were VBD O
distributed VBN O
over IN O
the DT O
greater JJR B-Biological_structure
omentum NN I-Biological_structure
. . O

Perioperatively RB O
, , O
3800 CD B-Volume
mL NN I-Volume
of IN O
serous JJ B-Lab_value
ascitic JJ B-Sign_symptom
fluid NN I-Sign_symptom
was VBD O
drained VBN B-Therapeutic_procedure
. . O

Cytodiagnosis NN B-Diagnostic_procedure
of IN O
the DT O
fluid NN B-Sign_symptom
drained VBD O
from IN O
the DT O
ascites NNS B-Sign_symptom
and CC O
pleural JJ B-Sign_symptom
effusion NN I-Sign_symptom
revealed VBD O
no DT B-Lab_value
tumor NN B-Diagnostic_procedure
cells NNS I-Diagnostic_procedure
. . O

Bilateral NNP B-Detailed_description
oophorectomy NN B-Therapeutic_procedure
, , O
total JJ B-Detailed_description
hysterectomy NN B-Therapeutic_procedure
, , O
omentectomy NN B-Therapeutic_procedure
, , O
and CC O
sigmoidectomy NN B-Therapeutic_procedure
with IN O
regional JJ B-Detailed_description
node JJ B-Therapeutic_procedure
dissection NN I-Therapeutic_procedure
were VBD O
performed VBN O
( ( O
Fig NNP O
. . O
3a CD O
) ) O
. . O

Histopathological JJ B-Diagnostic_procedure
examination NN I-Diagnostic_procedure
of IN O
the DT O
resected VBN O
specimens NNS O
showed VBD O
moderately RB B-Lab_value
differentiated VBN I-Lab_value
adenocarcinoma NN B-Disease_disorder
in IN O
the DT O
tumors NNS B-Sign_symptom
of IN O
both DT O
the DT O
ovaries NNS B-Biological_structure
and CC O
the DT O
sigmoid NN B-Biological_structure
colon NN I-Biological_structure
( ( O
Fig NNP O
. . O
3b CD O
) ) O
. . O

The DT O
dissected JJ O
paracolic NN B-Biological_structure
nodes NNS I-Biological_structure
showed VBD O
malignant JJ B-Sign_symptom
cells NNS I-Sign_symptom
. . O

Immunohistochemically RB B-Diagnostic_procedure
, , O
tumor NN B-Sign_symptom
cells NNS I-Sign_symptom
from IN O
the DT O
ovaries NNS B-Biological_structure
and CC O
the DT O
colon NN B-Biological_structure
both DT O
showed VBD O
positive JJ B-Lab_value
expression NN I-Lab_value
of IN O
cytokeratin NN B-Diagnostic_procedure
20 CD I-Diagnostic_procedure
( ( O
CK20 NNP B-Diagnostic_procedure
) ) O
but CC O
no DT B-Lab_value
expression NN I-Lab_value
of IN O
cytokeratin NN B-Diagnostic_procedure
7 CD I-Diagnostic_procedure
( ( O
CK7 NNP B-Diagnostic_procedure
) ) O
, , O
confirming VBG O
that IN O
the DT O
ovarian JJ B-Disease_disorder
tumors NNS I-Disease_disorder
were VBD O
metastases NNS B-Sign_symptom
from IN O
primary JJ B-Disease_disorder
colon NN I-Disease_disorder
cancer NN I-Disease_disorder
( ( O
Fig NNP O
. . O
4a CD O
, , O
b NN O
) ) O
. . O

The DT O
postoperative JJ B-Diagnostic_procedure
course NN I-Diagnostic_procedure
was VBD O
uneventful JJ B-Lab_value
, , O
and CC O
both DT O
pleural JJ B-Sign_symptom
effusion NN I-Sign_symptom
and CC O
ascites VBZ B-Sign_symptom
rapidly RB O
resolved VBN O
. . O

Postoperatively RB O
, , O
a DT O
regimen NNS O
of IN O
5 CD B-Medication
- : I-Medication
fluorouracil NN I-Medication
( ( O
5 CD B-Medication
- : I-Medication
FU NN I-Medication
) ) O
, , O
leucovorin UH B-Medication
, , O
and CC O
oxaliplatin NN B-Medication
( ( O
FOLFOX NNP B-Medication
) ) O
was VBD O
administered VBN O
every DT B-Frequency
2 CD I-Frequency
weeks NNS I-Frequency
for IN I-Frequency
5 CD I-Frequency
months NNS I-Frequency
. . O

At IN O
29 CD O
months NNS O
after IN O
the DT O
first JJ O
operation NN O
, , O
the DT O
patient NN O
required VBN O
curative JJ O
hepatic JJ B-Biological_structure
resection NN B-Therapeutic_procedure
for IN O
liver NN B-Biological_structure
metastases NNS B-Sign_symptom
. . O

At IN O
78 CD O
months NNS O
after IN O
the DT O
first JJ O
operation NN O
, , O
the DT O
patient NN O
remains VBZ O
alive JJ B-Sign_symptom
with IN O
no DT O
evidence NN O
of IN O
a DT O
disease NN B-Disease_disorder
. . O

-DOCSTART- NN -X-

We PRP O
present VBP O
the DT O
case NN O
of IN O
a DT O
66 CD B-Age
- : I-Age
year NN I-Age
- : I-Age
old JJ I-Age
female JJ O
patient NN O
with IN O
no DT O
significant JJ O
past JJ O
medical JJ O
history NN O
presenting VBG O
with IN O
chest NN B-Biological_structure
pain NN B-Sign_symptom
that WDT O
was VBD O
treated VBN O
with IN O
antacids NNS B-Medication
by IN O
her PRP$ O
primary JJ B-Nonbiological_location
care NN I-Nonbiological_location
physician NN I-Nonbiological_location
. . O

The DT O
next JJ O
day NN O
she PRP O
presented VBD O
to TO O
the DT O
emergency NN B-Nonbiological_location
room NN I-Nonbiological_location
, , O
where WRB O
an DT O
electrocardiogram NN B-Diagnostic_procedure
revealed VBD O
posterolateral JJ B-Detailed_description
ST NNP B-Detailed_description
elevation NN I-Detailed_description
myocardial JJ B-Disease_disorder
infarction NN I-Disease_disorder
. . O

The DT O
patient NN O
was VBD O
immediately RB O
taken VBN O
to TO O
the DT O
catheterization NN B-Nonbiological_location
lab NN I-Nonbiological_location
. . O

A DT O
successful JJ O
percutaneous JJ B-Therapeutic_procedure
intervention NN I-Therapeutic_procedure
was VBD O
performed VBN O
on IN O
an DT O
acutely RB B-Severity
occluded JJ B-Sign_symptom
large JJ B-Biological_structure
ramus NN I-Biological_structure
intermedius NN I-Biological_structure
vessel NN I-Biological_structure
that WDT O
was VBD O
supplying VBG B-Sign_symptom
a DT O
large JJ O
portion NN O
of IN O
the DT O
lateral JJ B-Biological_structure
wall NN I-Biological_structure
( ( O
Figure NNP O
1 CD O
) ) O
. . O

The DT O
patient NN O
did VBD B-Sign_symptom
well RB I-Sign_symptom
initially RB B-Detailed_description
, , O
but CC O
several JJ B-Time
hours NNS I-Time
later RB I-Time
she PRP O
suddenly RB B-Lab_value
went VBD O
into IN O
cardiogenic JJ B-Disease_disorder
shock NN I-Disease_disorder
. . O

An DT O
intra JJ B-Therapeutic_procedure
- : I-Therapeutic_procedure
aortic JJ I-Therapeutic_procedure
balloon NN I-Therapeutic_procedure
pump NN I-Therapeutic_procedure
was VBD O
placed VBN O
, , O
and CC O
an DT O
echocardiogram NN B-Diagnostic_procedure
demonstrated VBD O
that IN O
she PRP O
had VBD O
severe JJ B-Severity
mitral JJ B-Disease_disorder
regurgitation NN I-Disease_disorder
from IN O
a DT O
ruptured JJ B-Disease_disorder
papillary JJ B-Biological_structure
muscle NN I-Biological_structure
( ( O
Figure NNP O
2 CD O
) ) O
. . O

The DT O
patient NN O
, , O
on IN O
maximal JJ B-Lab_value
support NN B-Therapeutic_procedure
, , O
deteriorated VBD B-Sign_symptom
rapidly RB B-Severity
with IN O
progressive JJ B-Lab_value
acidosis NN B-Sign_symptom
, , O
oliguria NN B-Sign_symptom
, , O
and CC O
florid JJ B-Detailed_description
pulmonary JJ B-Biological_structure
edema NN B-Sign_symptom
. . O

In IN O
spite NN O
of IN O
the DT O
very RB O
high JJ O
risk NN O
, , O
we PRP O
decided VBD O
to TO O
intervene VB O
surgically RB O
. . O

Once RB O
in IN O
the DT O
operating NN B-Nonbiological_location
room NN I-Nonbiological_location
, , O
transesophageal JJ B-Biological_structure
echocardiography NN B-Diagnostic_procedure
confirmed VBD O
severe JJ B-Severity
mitral JJ B-Disease_disorder
regurgitation NN I-Disease_disorder
with IN O
a DT O
ruptured JJ B-Disease_disorder
anterolateral JJ B-Biological_structure
papillary JJ I-Biological_structure
muscle NN I-Biological_structure
and CC O
a DT O
small JJ B-Sign_symptom
left JJ B-Biological_structure
atrium NN I-Biological_structure
. . O

Shortly RB O
after IN O
the DT O
patient NN O
was VBD O
put VBN O
on IN O
cardiopulmonary JJ B-Therapeutic_procedure
bypass NN I-Therapeutic_procedure
, , O
the DT O
acidosis NN B-Sign_symptom
resolved VBD O
and CC O
she PRP O
began VBD O
to TO O
make VB O
urine NN O
. . O

Excellent JJ O
visualization NN B-Diagnostic_procedure
of IN O
the DT O
mitral JJ B-Biological_structure
valve NN I-Biological_structure
was VBD O
obtained VBN O
using VBG O
a DT O
vertical JJ B-Detailed_description
transseptal NN I-Detailed_description
approach NN I-Detailed_description
through IN O
the DT O
right JJ B-Biological_structure
atrium NN I-Biological_structure
. . O

The DT O
valve NN O
was VBD O
carefully RB O
inspected VBN B-Diagnostic_procedure
and CC O
the DT O
necrotic JJ B-Sign_symptom
ruptured JJ B-Disease_disorder
anterolateral JJ B-Biological_structure
papillary JJ I-Biological_structure
muscle NN I-Biological_structure
was VBD O
seen VBN O
( ( O
Figure NNP O
3 CD O
) ) O
. . O

There EX O
was VBD O
a DT O
large JJ B-Severity
chunk NN B-Biological_structure
of IN I-Biological_structure
muscle NN I-Biological_structure
attached VBN B-Sign_symptom
to TO O
the DT O
A1 NNP B-Biological_structure
chordal NN I-Biological_structure
apparatus NN I-Biological_structure
. . O

The DT O
anterior JJ B-Biological_structure
leaflet NN I-Biological_structure
of IN I-Biological_structure
the DT I-Biological_structure
mitral JJ I-Biological_structure
valve NN I-Biological_structure
was VBD O
excised VBN B-Therapeutic_procedure
while IN O
keeping VBG O
the DT O
posterior JJ B-Biological_structure
leaflet NN I-Biological_structure
intact NN B-Sign_symptom
. . O

A DT O
27 CD B-Distance
- : I-Distance
mm NN I-Distance
St NNP B-Detailed_description
Jude NNP I-Detailed_description
Epic NNP I-Detailed_description
bioprosthesis NN B-Therapeutic_procedure
was VBD O
inserted VBN O
( ( O
Figure NNP O
4 CD O
) ) O
. . O

She PRP O
was VBD O
placed VBN O
on IN O
extracorporeal JJ B-Therapeutic_procedure
membrane NN I-Therapeutic_procedure
oxygenation NN I-Therapeutic_procedure
that WDT O
was VBD O
successfully RB O
weaned JJ B-Therapeutic_procedure
3 CD O
days NNS O
later RB O
. . O

Following VBG O
this DT O
, , O
she PRP O
made VBD O
a DT O
remarkable JJ O
early JJ B-Lab_value
recovery NN B-Sign_symptom
. . O

One CD O
month NN O
later RB O
, , O
just RB O
prior RB O
to TO O
discharge VB O
, , O
she PRP O
expired VBD O
after IN O
developing VBG O
pneumonia NN B-Disease_disorder
that WDT O
progressed VBD O
to TO O
sepsis VB B-Disease_disorder
with IN O
multiorgan JJ B-Disease_disorder
failure NN I-Disease_disorder
. . O

-DOCSTART- NN -X-

A DT O
60 CD B-Age
- : I-Age
year NN I-Age
- : I-Age
old JJ I-Age
man NN O
who WP O
underwent VBD O
colonoscopy NN B-Diagnostic_procedure
was VBD O
found VBN O
to TO O
have VB O
a DT O
2 CD B-Distance
cm NN I-Distance
sessile NN B-Sign_symptom
polyp NN I-Sign_symptom
that WDT O
was VBD O
located VBN O
10 CD B-Distance
cm NN I-Distance
from IN O
the DT O
anal JJ B-Biological_structure
verge NN I-Biological_structure
and CC O
successfully RB B-Therapeutic_procedure
removed VBN I-Therapeutic_procedure
. . O

The DT O
polyp NN O
was VBD O
a DT O
tubulovillous JJ B-Disease_disorder
adenoma NN I-Disease_disorder
with IN O
focal JJ O
high JJ B-Sign_symptom
- : I-Sign_symptom
grade NN I-Sign_symptom
dysplasia NN I-Sign_symptom
. . O

A DT O
flexible JJ B-Diagnostic_procedure
sigmoidoscopy NN I-Diagnostic_procedure
performed VBD O
three CD O
months NNS O
later RB O
, , O
as RB O
well RB O
as IN O
a DT O
repeat NN B-Detailed_description
colonoscopy NN B-Diagnostic_procedure
one CD O
year NN O
after IN O
the DT O
initial JJ O
colonoscopy NN O
, , O
were VBD O
both DT O
negative JJ B-Lab_value
for IN O
recurrence NN O
. . O

A DT O
colonoscopy NN B-Diagnostic_procedure
performed VBN O
three CD O
years NNS O
after IN O
the DT O
initial JJ O
colonoscopy NN O
revealed VBD O
a DT O
sessile JJ B-Sign_symptom
polyp NN I-Sign_symptom
, , O
3 CD B-Distance
cm NN I-Distance
in IN O
size NN O
, , O
at IN O
10 CD B-Distance
cm NN I-Distance
from IN O
the DT O
anal JJ B-Biological_structure
verge NN I-Biological_structure
. . O

Biopsies NNS B-Diagnostic_procedure
were VBD O
taken VBN O
and CC O
reported VBN O
to TO O
be VB O
fragments NNS O
of IN O
a DT O
villous JJ B-Disease_disorder
adenoma NN I-Disease_disorder
with IN O
low JJ B-Sign_symptom
- : I-Sign_symptom
grade NN I-Sign_symptom
dysplasia NN I-Sign_symptom
. . O

Due JJ O
to TO O
the DT O
previous JJ O
high JJ O
- : O
grade NN O
dysplasia NN O
, , O
relatively RB O
rapid JJ O
recurrence NN O
and CC O
concern NN O
that IN O
a DT O
cancer NN O
may MD O
have VB O
been VBN O
missed VBN O
by IN O
sampling VBG O
error NN O
, , O
a DT O
pelvic JJ B-Biological_structure
magnetic JJ B-Diagnostic_procedure
resonance NN I-Diagnostic_procedure
imaging NN I-Diagnostic_procedure
( ( O
MRI NNP B-Diagnostic_procedure
) ) O
scan NN O
and CC O
an DT O
endoscopic NN B-Diagnostic_procedure
ultrasound NN I-Diagnostic_procedure
( ( O
EUS NNP B-Diagnostic_procedure
) ) O
were VBD O
performed VBN O
before IN O
definitive JJ O
excision NN O
. . O

The DT O
MRI NNP O
revealed VBD O
an DT O
invasive JJ B-Detailed_description
rectal JJ B-Biological_structure
mass NN B-Sign_symptom
involving VBG O
the DT O
muscularis NN B-Biological_structure
propria NN I-Biological_structure
but CC O
without IN O
breach NN O
of IN O
the DT O
adventitia NN O
, , O
consistent JJ O
with IN O
a DT O
T2 NNP B-Disease_disorder
rectal NN I-Disease_disorder
carcinoma NN I-Disease_disorder
( ( O
Figure NNP O
1 CD O
) ) O
. . O

No DT O
pelvic JJ B-Biological_structure
lymphadenopathy NN B-Sign_symptom
was VBD O
detected VBN O
. . O

The DT O
EUS NNP O
revealed VBD O
a DT O
rectal JJ B-Biological_structure
mass NN B-Sign_symptom
involving VBG O
the DT O
mucosa NN B-Biological_structure
and CC O
submucosa NN B-Biological_structure
, , O
with IN O
no DT O
involvement NN O
of IN O
the DT O
muscularis NN O
propria NN O
( ( O
Figure NNP O
2 CD O
) ) O
. . O

The DT O
results NNS O
of IN O
the DT O
MRI NNP O
and CC O
EUS NNP O
, , O
as RB O
well RB O
as IN O
the DT O
surgical JJ O
versus NN O
endoscopic NN O
resection NN O
treatment NN O
options NNS O
, , O
were VBD O
discussed VBN O
with IN O
the DT O
patient NN O
, , O
who WP O
opted VBD O
for IN O
a DT O
surgical JJ B-Therapeutic_procedure
resection NN I-Therapeutic_procedure
. . O

The DT O
patient NN O
underwent VBD O
a DT O
low JJ B-Therapeutic_procedure
anterior JJ I-Therapeutic_procedure
resection NN I-Therapeutic_procedure
and CC O
end VB B-Therapeutic_procedure
- : I-Therapeutic_procedure
to TO I-Therapeutic_procedure
- : I-Therapeutic_procedure
end VB I-Therapeutic_procedure
anastomosis NN I-Therapeutic_procedure
with IN O
loop JJ B-Therapeutic_procedure
ileostomy NN I-Therapeutic_procedure
. . O

Pathology NNP B-Diagnostic_procedure
review NN I-Diagnostic_procedure
of IN O
the DT O
resected VBN B-Biological_structure
rectosigmoid NN I-Biological_structure
revealed VBD O
a DT O
villous JJ B-Disease_disorder
adenoma NN I-Disease_disorder
with IN O
low JJ B-Sign_symptom
- : I-Sign_symptom
grade NN I-Sign_symptom
dyplasia NN I-Sign_symptom
. . O

There EX O
was VBD O
no DT O
evidence NN O
of IN O
muscularis NN B-Sign_symptom
propria NN I-Sign_symptom
invasion NN I-Sign_symptom
, , O
and CC O
a DT O
total NN O
of IN O
five CD B-Lab_value
pericolic JJ B-Biological_structure
and CC I-Biological_structure
two CD B-Lab_value
mesorectal JJ B-Biological_structure
lymph NN I-Biological_structure
nodes NNS I-Biological_structure
were VBD O
excised VBN B-Therapeutic_procedure
and CC O
deemed VBN O
benign NN B-Sign_symptom
. . O

The DT O
patient JJ O
underwent JJ O
ileostomy NN B-Therapeutic_procedure
reversal VBP I-Therapeutic_procedure
five CD O
months NNS O
later RB O
. . O

He PRP O
remains VBZ O
asymptomatic JJ B-Sign_symptom
with IN O
no DT O
recurrence NN B-Sign_symptom
of IN I-Sign_symptom
tumours NNS I-Sign_symptom
. . O

-DOCSTART- NN -X-

A DT O
46 CD B-Age
- : I-Age
year NN I-Age
- : I-Age
old JJ I-Age
woman NN O
presented VBN O
with IN O
severe JJ B-Severity
acute NN B-Detailed_description
pain NN B-Sign_symptom
in IN O
the DT O
right JJ B-Biological_structure
iliac NN I-Biological_structure
fossa NN I-Biological_structure
and CC O
periumbilical JJ B-Biological_structure
region NN I-Biological_structure
. . O

Ultrasound NN B-Diagnostic_procedure
and CC O
a DT O
computed JJ B-Diagnostic_procedure
tomography NN I-Diagnostic_procedure
scan NN I-Diagnostic_procedure
revealed VBD O
a DT O
mucocele NN B-Sign_symptom
in IN O
the DT O
vermiform NN B-Biological_structure
appendix NN I-Biological_structure
, , O
with IN O
a DT O
well NN B-Detailed_description
defined VBN I-Detailed_description
lesion NN B-Sign_symptom
located VBN O
at IN O
the DT O
mid NN B-Biological_structure
zone NN I-Biological_structure
of IN I-Biological_structure
the DT I-Biological_structure
appendix NN I-Biological_structure
. . O

The DT O
patient NN O
underwent JJ O
right JJ B-Therapeutic_procedure
hemicolectomy NN I-Therapeutic_procedure
, , O
and CC O
her PRP$ O
postoperative JJ O
clinical JJ O
course NN O
was VBD O
uneventful JJ O
. . O

Gross NNP B-Diagnostic_procedure
examination NN I-Diagnostic_procedure
of IN O
the DT O
surgical JJ B-Biological_structure
specimen NN I-Biological_structure
showed VBD O
an DT O
enlarged JJ B-Lab_value
appendix NN B-Biological_structure
, , O
which WDT O
was VBD O
filled VBN O
with IN O
thick JJ B-Texture
mucinous JJ B-Biological_structure
material NN I-Biological_structure
. . O

A DT O
distinct JJ B-Detailed_description
lesion NN O
which WDT O
involved VBD O
the DT O
appendiceal NN B-Biological_structure
wall NN I-Biological_structure
, , O
and CC O
measured VBD O
1 CD B-Distance
. . I-Distance
5 CD I-Distance
cm NN I-Distance
maximally RB O
, , O
was VBD O
identified VBN O
in IN O
the DT O
mid NN B-Biological_structure
- : I-Biological_structure
portion NN I-Biological_structure
of IN I-Biological_structure
the DT I-Biological_structure
appendix NN I-Biological_structure
. . O

There EX O
was VBD O
no DT O
evidence NN O
of IN O
perforation NN B-Sign_symptom
, , O
extravasation NN B-Sign_symptom
of IN O
mucin NN B-Biological_structure
into IN O
the DT O
periappendiceal JJ B-Biological_structure
tissue NN I-Biological_structure
, , O
or CC O
pseudomyxoma NN B-Disease_disorder
peritonei NN I-Disease_disorder
during IN O
surgery NN O
. . O

Histopathological JJ B-Diagnostic_procedure
examination NN I-Diagnostic_procedure
showed VBD O
combined JJ O
GCC NNP B-Disease_disorder
and CC O
MCA NNP B-Disease_disorder
of IN O
the DT O
vermiform NN B-Biological_structure
appendix NN I-Biological_structure
( ( O
Figure NNP O
1A CD O
) ) O
. . O

The DT O
appendiceal JJ B-Biological_structure
lumen NNS I-Biological_structure
was VBD O
dilated VBN B-Sign_symptom
and CC O
lined VBN O
by IN O
mucin SYM B-Sign_symptom
- : I-Sign_symptom
containing VBG I-Sign_symptom
columnar JJ B-Biological_structure
epithelial JJ I-Biological_structure
cells NNS I-Biological_structure
( ( O
Figure NNP O
1B CD O
) ) O
. . O

There EX O
was VBD O
no DT O
significant JJ O
cytologic NN B-Sign_symptom
atypia NN I-Sign_symptom
, , O
and CC O
no DT O
mitotic JJ B-Sign_symptom
figures NNS I-Sign_symptom
were VBD O
identified VBN O
. . O

Focal JJ B-Sign_symptom
papillary JJ I-Sign_symptom
configurations NNS I-Sign_symptom
of IN O
the DT O
lining NN B-Biological_structure
epithelium NN I-Biological_structure
, , O
and CC O
mild JJ B-Severity
epithelial JJ B-Sign_symptom
pseudostratification NN I-Sign_symptom
were VBD O
present JJ O
. . O

In IN O
addition NN O
, , O
the DT O
appendiceal NN B-Biological_structure
wall NN I-Biological_structure
was VBD O
infiltrated VBN O
by IN O
glandular JJ B-Sign_symptom
structures NNS I-Sign_symptom
of IN O
various JJ B-Area
sizes NNS I-Area
which WDT O
were VBD O
arranged VBN O
in IN O
nests NNS B-Shape
and CC O
tubules NNS B-Shape
. . O

These DT O
glandular JJ O
structures NNS O
comprised VBD O
2 CD O
distinct JJ O
types NNS O
of IN O
cells NNS O
: : O
( ( O
1 CD O
) ) O
small JJ B-Area
to TO I-Area
intermediate VB I-Area
sized VBN I-Area
monotonous JJ B-Detailed_description
neuroendocrine JJ B-Biological_structure
cells NNS I-Biological_structure
with IN O
a DT O
small JJ B-Detailed_description
amount NN I-Detailed_description
of IN I-Detailed_description
finely RB I-Detailed_description
granular JJ I-Detailed_description
eosinophilic JJ I-Detailed_description
cytoplasm NN I-Detailed_description
, , O
and CC O
mild JJ B-Severity
cytonuclear JJ B-Sign_symptom
atypia NN I-Sign_symptom
( ( O
Figure NNP O
( ( O
Figure1C NNP O
) ) O
; : O
1C CD O
) ) O
; : O
( ( O
2 CD O
) ) O
mucin SYM B-Detailed_description
- : I-Detailed_description
filled VBN I-Detailed_description
intermediate JJ B-Area
sized VBN I-Area
cells NNS O
( ( O
goblet VB B-Biological_structure
cells NNS I-Biological_structure
) ) O
, , O
with IN O
peripherally RB B-Detailed_description
located VBN I-Detailed_description
small JJ B-Area
, , O
crescent JJ B-Shape
- : I-Shape
like IN I-Shape
hyperchromatic JJ B-Sign_symptom
nuclei NN I-Sign_symptom
, , O
and CC O
indistinct JJ B-Detailed_description
nucleoli NNS B-Biological_structure
( ( O
Figure NNP O
( ( O
Figure1D NNP O
) ) O
. . O
1D CD O
) ) O
. . O

Scattered NNP B-Texture
infiltrating VBG B-Detailed_description
single JJ B-Detailed_description
goblet NN B-Biological_structure
neoplastic JJ I-Biological_structure
cells NNS I-Biological_structure
were VBD O
focally RB B-Sign_symptom
present JJ I-Sign_symptom
. . O

As IN O
previously RB O
described VBN O
[ JJ O
1 CD O
] IN O
the DT O
tumor NN B-Sign_symptom
nests NNS I-Sign_symptom
appeared VBD O
to TO O
arise VB O
from IN O
the DT O
basiglandular JJ B-Biological_structure
region NN I-Biological_structure
of IN O
the DT O
intestinal JJ B-Biological_structure
crypts NNS I-Biological_structure
in IN O
close JJ B-Detailed_description
proximity NN I-Detailed_description
to TO I-Detailed_description
the DT I-Detailed_description
MCA NNP B-Disease_disorder
( ( O
Figure NNP O
( ( O
Figure1E NNP O
) ) O
. . O
1E CD O
) ) O
. . O

There EX O
was VBD O
no DT O
lymphovascular JJ B-Sign_symptom
invasion NN I-Sign_symptom
, , O
although IN O
perineural JJ B-Sign_symptom
and CC I-Sign_symptom
intraneural JJ B-Sign_symptom
invasion NN I-Sign_symptom
was VBD O
present JJ O
. . O

The DT O
tumor NN O
infiltrated VBD O
the DT O
full JJ B-Biological_structure
thickness NN I-Biological_structure
of IN O
the DT O
appendiceal NN B-Biological_structure
wall NN I-Biological_structure
and CC O
extended VBD O
to TO O
the DT O
mesoappendix NN B-Biological_structure
. . O

Ten CD B-Lab_value
lymph JJ B-Biological_structure
nodes NNS I-Biological_structure
were VBD O
histologically RB B-Diagnostic_procedure
identified VBN I-Diagnostic_procedure
, , O
of IN O
which WDT O
all DT O
were VBD O
negative JJ O
for IN O
malignancy NN B-Disease_disorder
. . O

Immunohistochemically RB B-Diagnostic_procedure
( ( O
Table JJ O
1 CD O
) ) O
, , O
the DT O
tumor NN B-Sign_symptom
cells NNS I-Sign_symptom
of IN O
the DT O
GCC NNP B-Disease_disorder
were VBD O
positive JJ B-Lab_value
for IN O
chromogranin NN B-Diagnostic_procedure
, , O
synaptophysin NN B-Diagnostic_procedure
, , O
and CC O
serotonin NN B-Diagnostic_procedure
, , O
which WDT O
are VBP O
neuroendocrine JJ B-Detailed_description
markers NNS I-Detailed_description
. . O

Diffuse NNP B-Lab_value
staining VBG I-Lab_value
for IN O
cytokeratin NN B-Diagnostic_procedure
( ( O
CK NNP O
) ) O
20 CD O
( ( O
Figure NNP O
2 CD O
) ) O
, , O
CK19 NNP B-Diagnostic_procedure
, , I-Diagnostic_procedure
and CC O
CD99 NNP B-Diagnostic_procedure
was VBD O
also RB O
present JJ O
. . O

The DT O
Ki67 NNP B-Diagnostic_procedure
proliferating VBG I-Diagnostic_procedure
index NN I-Diagnostic_procedure
revealed VBD O
nuclear JJ B-Sign_symptom
staining NN I-Sign_symptom
in IN O
approximately RB O
15 CD B-Lab_value
% NN I-Lab_value
of IN O
the DT O
tumor NN B-Sign_symptom
cells NNS I-Sign_symptom
. . O

There EX O
was VBD O
no DT O
staining NN O
for IN O
CK7 NNP B-Diagnostic_procedure
. . I-Diagnostic_procedure

-DOCSTART- NN -X-

A DT O
58 CD B-Age
- : I-Age
year NN I-Age
- : I-Age
old JJ I-Age
white JJ O
American JJ O
male NN O
presented VBN O
to TO O
the DT O
emergency NN B-Nonbiological_location
department NN I-Nonbiological_location
( ( O
ED NNP B-Nonbiological_location
) ) O
with IN O
acute JJ B-Detailed_description
onset NN I-Detailed_description
of IN O
confusion NN B-Sign_symptom
, , O
disorientation NN B-Sign_symptom
, , O
inability NN B-Sign_symptom
to TO I-Sign_symptom
walk VB I-Sign_symptom
steadily RB I-Sign_symptom
, , O
and CC O
dehydration NN B-Sign_symptom
with IN O
associated VBN O
generalized JJ O
weakness NN B-Sign_symptom
, , O
polyuria NN B-Sign_symptom
, , O
and CC O
polydipsia NN B-Sign_symptom
over IN B-Duration
the DT I-Duration
previous JJ I-Duration
week NN I-Duration
. . O

He PRP O
had VBD O
been VBN O
diagnosed VBN O
with IN O
CML NNP B-Disease_disorder
six CD O
years NNS O
earlier RBR O
, , O
with IN O
no DT O
hematological JJ B-Sign_symptom
response NN I-Sign_symptom
to TO O
multiple VB B-Detailed_description
chemotherapy NN B-Medication
regimens NNS B-Detailed_description
; : O
he PRP O
was VBD O
at IN O
that DT O
time NN O
on IN O
treatment NN O
with IN O
allopurinol NN B-Medication
and CC O
awaiting VBG O
allogenic JJ B-Detailed_description
bone NN B-Therapeutic_procedure
marrow NN I-Therapeutic_procedure
transplant NN I-Therapeutic_procedure
. . O

Vital JJ B-Diagnostic_procedure
signs NNS I-Diagnostic_procedure
on IN O
admission NN O
to TO O
the DT O
ED NNP B-Nonbiological_location
included VBD O
heart NN B-Diagnostic_procedure
rate NN I-Diagnostic_procedure
of IN O
104 CD B-Lab_value
bpm NN I-Lab_value
, , O
blood NN B-Diagnostic_procedure
pressure NN I-Diagnostic_procedure
of IN O
122 CD B-Lab_value
/ JJ I-Lab_value
68 CD I-Lab_value
mm NN I-Lab_value
Hg NNP I-Lab_value
and CC O
temperature NN B-Diagnostic_procedure
of IN O
99 CD B-Lab_value
. . I-Lab_value
7 CD I-Lab_value
°F NN I-Lab_value
( ( O
37 CD B-Lab_value
. . I-Lab_value
6 CD I-Lab_value
°C NN I-Lab_value
) ) O
. . O

There EX O
were VBD O
no DT B-Lab_value
remarkable JJ I-Lab_value
findings NNS I-Lab_value
on IN O
physical JJ B-Diagnostic_procedure
examination NN I-Diagnostic_procedure
except IN O
for IN O
altered JJ B-Sign_symptom
mental JJ I-Sign_symptom
status NN I-Sign_symptom
and CC O
dehydration NN B-Sign_symptom
. . O

Laboratory JJ B-Diagnostic_procedure
evaluations NNS I-Diagnostic_procedure
were VBD O
: : O
hemoglobin NN B-Diagnostic_procedure
13 CD B-Lab_value
. . I-Lab_value
3 CD I-Lab_value
g JJ I-Lab_value
/ NNP I-Lab_value
dL NN I-Lab_value
, , O
white JJ B-Diagnostic_procedure
blood NN I-Diagnostic_procedure
cell NN I-Diagnostic_procedure
count NN I-Diagnostic_procedure
18 CD B-Lab_value
. . I-Lab_value
3 CD I-Lab_value
× JJ I-Lab_value
109 CD I-Lab_value
/ JJ I-Lab_value
L NNP I-Lab_value
( ( O
neutrophils JJ B-Lab_value
79 CD I-Lab_value
. . I-Lab_value
6 CD I-Lab_value
% NN I-Lab_value
, , O
lymphocytes VBZ B-Lab_value
7 CD I-Lab_value
. . I-Lab_value
2 CD I-Lab_value
% NN I-Lab_value
, , O
and CC O
monocytes VBZ B-Lab_value
8 CD I-Lab_value
. . I-Lab_value
3 CD I-Lab_value
% NN I-Lab_value
) ) O
, , O
and CC O
platelet NN B-Diagnostic_procedure
count NN I-Diagnostic_procedure
910 CD B-Lab_value
× $ I-Lab_value
109 CD I-Lab_value
/ NNP I-Lab_value
L NNP I-Lab_value
. . O

Serum NN B-Diagnostic_procedure
levels NNS I-Diagnostic_procedure
were VBD O
: : O
calcium NN B-Diagnostic_procedure
18 CD B-Lab_value
. . I-Lab_value
6 CD I-Lab_value
mg JJ I-Lab_value
/ NNP I-Lab_value
dL NN I-Lab_value
, , O
phosphate NN B-Diagnostic_procedure
4 CD B-Lab_value
. . I-Lab_value
6 CD I-Lab_value
mg JJ I-Lab_value
/ NNP I-Lab_value
dL NN I-Lab_value
, , O
sodium NN B-Diagnostic_procedure
135 CD B-Lab_value
mEq NN I-Lab_value
/ NNP I-Lab_value
L NNP I-Lab_value
, , O
potassium NN B-Diagnostic_procedure
2 CD B-Lab_value
. . I-Lab_value
7 CD I-Lab_value
mg JJ I-Lab_value
/ NNP I-Lab_value
dL NN I-Lab_value
, , O
albumin RB B-Diagnostic_procedure
4 CD B-Lab_value
. . I-Lab_value
0 CD I-Lab_value
g JJ I-Lab_value
/ NNP I-Lab_value
dL NN I-Lab_value
, , O
creatinine NN B-Diagnostic_procedure
2 CD B-Lab_value
. . I-Lab_value
2 CD I-Lab_value
mg JJ I-Lab_value
/ NNP I-Lab_value
dL NN I-Lab_value
, , O
total JJ B-Diagnostic_procedure
bilirubin NN I-Diagnostic_procedure
0 CD B-Lab_value
. . I-Lab_value
9 CD I-Lab_value
mg JJ I-Lab_value
/ NNP I-Lab_value
dL NN I-Lab_value
, , O
alkaline JJ B-Diagnostic_procedure
phosphatase NN I-Diagnostic_procedure
125 CD B-Lab_value
IU NNP I-Lab_value
/ NNP I-Lab_value
L NNP I-Lab_value
, , O
aspartate JJ B-Diagnostic_procedure
aminotransferase NN I-Diagnostic_procedure
41 CD B-Lab_value
IU NNP I-Lab_value
/ NNP I-Lab_value
L NNP I-Lab_value
, , O
and CC O
alanine JJ B-Diagnostic_procedure
aminotransferase NN I-Diagnostic_procedure
71 CD B-Lab_value
IU NNP I-Lab_value
/ NNP I-Lab_value
L NNP I-Lab_value
. . O

SPEP NNP B-Diagnostic_procedure
was VBD O
negative JJ B-Lab_value
for IN I-Lab_value
an DT I-Lab_value
M NNP I-Lab_value
spike NN I-Lab_value
. . O

Hormones NNS B-Diagnostic_procedure
and CC I-Diagnostic_procedure
vitamins NNS I-Diagnostic_procedure
levels NNS I-Diagnostic_procedure
were VBD O
: : O
PTH VB B-Diagnostic_procedure
8 CD B-Lab_value
. . I-Lab_value
5 CD I-Lab_value
pg JJ I-Lab_value
/ NN I-Lab_value
L NNP I-Lab_value
( ( O
15 CD O
- : O
65 CD O
pg NN O
/ NNP O
L NNP O
) ) O
, , O
PHTrP NNP B-Diagnostic_procedure
1 CD B-Lab_value
. . I-Lab_value
4 CD I-Lab_value
pg JJ I-Lab_value
/ NN I-Lab_value
L NNP I-Lab_value
( ( O
< $ O
2 CD O
pg NN O
/ NNP O
L NNP O
) ) O
, , O
25 CD B-Diagnostic_procedure
- : I-Diagnostic_procedure
OH NNP I-Diagnostic_procedure
vitamin NNP I-Diagnostic_procedure
D NNP I-Diagnostic_procedure
30 CD B-Lab_value
. . I-Lab_value
4 CD I-Lab_value
ng JJ I-Lab_value
/ NN I-Lab_value
mL NN I-Lab_value
( ( O
20 CD O
- : O
50 CD O
ng JJ O
/ NNP O
mL NN O
) ) O
and CC O
1,25 CD B-Diagnostic_procedure
OH NNP I-Diagnostic_procedure
vitamin NN I-Diagnostic_procedure
D3 NNP I-Diagnostic_procedure
33 CD B-Lab_value
. . I-Lab_value
7 CD I-Lab_value
ng JJ I-Lab_value
/ NN I-Lab_value
mL NN I-Lab_value
( ( O
18 CD O
- : O
64 CD O
) ) O
ng NN O
/ JJ O
mL NN O
. . O

Chest NNP B-Biological_structure
CT NNP B-Diagnostic_procedure
scan JJ I-Diagnostic_procedure
showed VBD O
diffuse IN B-Detailed_description
lytic JJ B-Detailed_description
lesions NNS B-Sign_symptom
and CC O
bone NN B-Sign_symptom
destruction NN I-Sign_symptom
throughout IN O
the DT O
visualized JJ O
thoracic NN B-Biological_structure
skeleton NN I-Biological_structure
, , O
concerning VBG O
for IN O
diffuse NN O
bone NN B-Sign_symptom
marrow NN I-Sign_symptom
involvement NN I-Sign_symptom
. . O

The DT O
clinical JJ O
history NN O
and CC O
biochemical JJ O
findings NNS O
led VBD O
to TO O
a DT O
diagnosis NN O
of IN O
CML NNP B-Disease_disorder
- : O
associated VBN O
hypercalcemia NN B-Sign_symptom
in IN O
the DT O
context NN O
of IN O
a DT O
blast NN B-Sign_symptom
phase NN I-Sign_symptom
. . O

Treatment NN O
with IN O
aggressive JJ B-Detailed_description
hydration NN B-Therapeutic_procedure
with IN O
0 CD B-Lab_value
. . I-Lab_value
9 CD I-Lab_value
% NN I-Lab_value
saline NN B-Medication
and CC O
calcitonin NN B-Medication
400 CD B-Dosage
units NNS I-Dosage
subcutaneous JJ O
was VBD O
administered VBN O
. . O

Additionally RB O
, , O
zoledronic JJ B-Medication
acid NN I-Medication
3 CD B-Dosage
. . I-Dosage
3 CD I-Dosage
mg NN I-Dosage
intravenous JJ O
, , O
adjusted VBN B-Detailed_description
for IN I-Detailed_description
renal JJ I-Detailed_description
insufficiency NN I-Detailed_description
, , O
was VBD O
given VBN O
. . O

After IN B-Duration
five CD I-Duration
days NNS I-Duration
of IN O
treatment NN O
, , O
normalization NN B-Lab_value
of IN O
symptoms NNS B-Sign_symptom
and CC O
serum JJ B-Diagnostic_procedure
calcium NN I-Diagnostic_procedure
levels NNS I-Diagnostic_procedure
were VBD O
achieved VBN O
. . O

After IN O
discharge NN O
from IN O
the DT O
hospital NN B-Nonbiological_location
, , O
the DT O
patient NN O
continued VBD O
with IN O
palliative JJ B-Therapeutic_procedure
treatment NN I-Therapeutic_procedure
with IN O
ponatinib NN B-Medication
and CC O
radiotherapy NN B-Therapeutic_procedure
. . O

Acceptable JJ O
serum NN B-Diagnostic_procedure
calcium NN I-Diagnostic_procedure
levels NNS I-Diagnostic_procedure
were VBD O
maintained VBN B-Lab_value
with IN O
zoledronic JJ B-Medication
acid NN I-Medication
4 CD B-Dosage
mg NN I-Dosage
every DT I-Dosage
eight CD I-Dosage
weeks NNS I-Dosage
. . O

Despite IN O
these DT O
therapies NNS O
, , O
his PRP$ O
cancer NN B-Disease_disorder
progressed VBD O
and CC O
he PRP O
passed VBD O
away RB O
approximately RB O
eight CD O
months NNS O
after IN O
the DT O
initial JJ O
admission NN O
for IN O
hypercalcemia NN O
. . O

-DOCSTART- NN -X-

A DT O
36 CD B-Age
- : I-Age
yr NN I-Age
- : I-Age
old JJ I-Age
previously RB O
healthy JJ O
Sri NNP O
Lankan NNP O
male NN O
who WP O
takes VBZ B-Occupation
care NN I-Occupation
of IN I-Occupation
a DT I-Occupation
horse NN I-Occupation
presented VBN O
to TO O
the DT O
medical JJ B-Nonbiological_location
casualty NN I-Nonbiological_location
ward NN I-Nonbiological_location
with IN O
fever NN B-Sign_symptom
, , O
arthralgia NN B-Sign_symptom
and CC O
myalgia NN B-Sign_symptom
for IN O
one CD B-Duration
day NN I-Duration
. . O

He PRP O
complained VBD O
of IN O
mild JJ B-Severity
dysuria NNS B-Sign_symptom
but CC O
had VBD O
normal JJ B-Lab_value
urine JJ B-Diagnostic_procedure
output NN I-Diagnostic_procedure
. . O

He PRP O
did VBD O
not RB O
have VB O
chest JJS B-Biological_structure
pain NN B-Sign_symptom
or CC O
shortness NN B-Sign_symptom
of IN I-Sign_symptom
breath NN I-Sign_symptom
. . O

Further RB O
inquiry NN O
revealed VBD O
that IN O
he PRP O
was VBD O
treated VBN O
for IN O
leptospirosis NN O
during IN O
a DT O
febrile JJ O
illness NN O
in IN O
the DT O
past NN O
. . O

On IN O
examination NN B-Diagnostic_procedure
, , O
patient NN O
was VBD O
afebrile RB B-Sign_symptom
, , O
anicteric JJ B-Sign_symptom
. . O

His PRP$ O
blood NN B-Diagnostic_procedure
pressure NN I-Diagnostic_procedure
was VBD O
90 CD B-Lab_value
/ JJ I-Lab_value
60 CD I-Lab_value
mmHg NN I-Lab_value
and CC O
pulse JJ B-Diagnostic_procedure
rate NN I-Diagnostic_procedure
76 CD B-Lab_value
bpm NN I-Lab_value
. . O

Rest NNP O
of IN O
the DT O
examination NN B-Diagnostic_procedure
was VBD O
unremarkable JJ B-Lab_value
. . O

Initial JJ O
investigations NNS B-Diagnostic_procedure
performed VBN O
on IN O
the DT O
day NN O
of IN O
admission NN O
revealed VBN O
neutrophil JJ B-Biological_structure
leukocytosis NN B-Sign_symptom
, , O
mild JJ B-Severity
thrombocytopaenia NN B-Sign_symptom
and CC O
microscopic NN B-Detailed_description
haematuria NNS B-Sign_symptom
( ( O
Table JJ O
1 CD O
) ) O
. . O

Renal JJ B-Diagnostic_procedure
function NN I-Diagnostic_procedure
and CC O
liver NN B-Diagnostic_procedure
enzymes NNS I-Diagnostic_procedure
were VBD O
within IN B-Lab_value
normal JJ I-Lab_value
limits NNS I-Lab_value
. . O

Urine JJ B-Diagnostic_procedure
analysis NN I-Diagnostic_procedure
revealed VBD O
pus NN B-Lab_value
cells NNS I-Lab_value
05 CD I-Lab_value
- : I-Lab_value
06 CD I-Lab_value
/ NN I-Lab_value
hpf NN I-Lab_value
, , O
red JJ B-Lab_value
cells NNS I-Lab_value
30 CD I-Lab_value
- : I-Lab_value
35 CD I-Lab_value
/ JJ I-Lab_value
hpf NN I-Lab_value
. . O

CRP NNP B-Diagnostic_procedure
( ( O
C NNP B-Diagnostic_procedure
- : I-Diagnostic_procedure
reactive JJ I-Diagnostic_procedure
protein NN I-Diagnostic_procedure
) ) O
was VBD O
75 CD B-Lab_value
mg NN I-Lab_value
/ NNP I-Lab_value
dl NN I-Lab_value
. . O

A DT O
clinical JJ O
diagnosis NN O
of IN O
leptospirosis NN B-Disease_disorder
was VBD O
made VBN O
and CC O
he PRP O
was VBD O
started VBN O
on IN O
intravenous JJ O
penicillin NN B-Medication
in IN O
addition NN O
to TO O
adequate VB O
hydration NN B-Therapeutic_procedure
. . O

On IN O
the DT O
second JJ O
day NN O
of IN O
illness NN O
, , O
he PRP O
developed VBD O
hypotension NN B-Sign_symptom
with IN O
tachycardia NN B-Sign_symptom
and CC O
dyspnoea NN B-Sign_symptom
. . O

ECG NNP B-Diagnostic_procedure
revealed VBD O
sinus JJ B-Detailed_description
tachycardia NN B-Sign_symptom
with IN O
ST NNP B-Detailed_description
depression NN I-Detailed_description
in IN I-Detailed_description
leads NNS I-Detailed_description
V4 NNP I-Detailed_description
- : I-Detailed_description
V6 NNP I-Detailed_description
[ NNP O
Figure NNP O
1 CD O
] NN O
. . O

His PRP$ O
CXR NNP B-Diagnostic_procedure
( ( O
chest JJS B-Diagnostic_procedure
x RB I-Diagnostic_procedure
ray NN I-Diagnostic_procedure
) ) O
showed VBD O
gross JJ B-Detailed_description
cardiomegaly NN B-Disease_disorder
and CC O
bilateral JJ B-Detailed_description
pulmonary JJ B-Biological_structure
shadows NNS B-Sign_symptom
[ VBP O
Figure NNP O
2 CD O
] NN O
. . O

CVP NNP B-Diagnostic_procedure
( ( O
central JJ B-Diagnostic_procedure
venous JJ I-Diagnostic_procedure
pressure NN I-Diagnostic_procedure
) ) O
was VBD O
16 CD B-Lab_value
cmH2O NN I-Lab_value
and CC O
2D CD B-Detailed_description
echocardiogram NN B-Diagnostic_procedure
revealed VBD O
dilatation NN B-Sign_symptom
of IN O
all DT B-Biological_structure
four CD I-Biological_structure
chambers NNS I-Biological_structure
, , O
severe JJ B-Severity
global JJ B-Detailed_description
hypokinesia NN B-Disease_disorder
and CC O
ejection NN B-Diagnostic_procedure
fraction NN I-Diagnostic_procedure
of IN O
20 CD B-Lab_value
% NN I-Lab_value
. . O

Troponin NN B-Diagnostic_procedure
I PRP I-Diagnostic_procedure
was VBD O
12 CD B-Lab_value
. . I-Lab_value
77 CD I-Lab_value
ng JJ I-Lab_value
/ NN I-Lab_value
ml NN I-Lab_value
( ( O
normal JJ O
range NN O
< VBD O
0 CD O
. . O
40 CD O
) ) O
. . O

He PRP O
was VBD O
diagnosed VBN O
to TO O
have VB O
early JJ B-Detailed_description
and CC O
severe JJ B-Severity
myocarditis NN B-Disease_disorder
. . O

Patient NN O
was VBD O
transferred VBN O
to TO O
ICU NNP B-Nonbiological_location
( ( O
intensive JJ B-Nonbiological_location
care NN I-Nonbiological_location
unit NN I-Nonbiological_location
) ) O
as IN O
he PRP O
needed VBD O
inotropic JJ B-Therapeutic_procedure
support NN I-Therapeutic_procedure
. . O

Intravenous JJ O
antibiotics NNS B-Medication
including VBG O
penicillin NN B-Medication
, , O
meropenem NN B-Medication
and CC O
levofloxacin NN B-Medication
were VBD O
continued VBN O
. . O

Patient NN O
was VBD O
electively RB O
ventilated VBN B-Therapeutic_procedure
on IN O
the DT O
3rd CD O
day NN O
of IN O
illness NN O
due JJ O
to TO O
severe JJ B-Severity
respiratory NN B-Disease_disorder
distress NN I-Disease_disorder
. . O

On IN O
the DT O
same JJ B-Time
day NN I-Time
, , O
he PRP O
developed VBD O
rapid JJ B-Detailed_description
atrial JJ B-Disease_disorder
fibrillation NN I-Disease_disorder
[ NNP O
Figure NNP O
3 CD O
] NNP O
unresponsive JJ O
to TO O
digoxin VB B-Medication
and CC O
intravenous JJ O
amiodarone NN B-Medication
. . O

Platelet NNP B-Diagnostic_procedure
count NN I-Diagnostic_procedure
dropped VBD B-Lab_value
to TO O
10 CD B-Lab_value
× NNS I-Lab_value
103 CD I-Lab_value
μ JJ I-Lab_value
/ NNP I-Lab_value
L NNP I-Lab_value
and CC O
he PRP O
was VBD O
given VBN O
platelet JJ B-Therapeutic_procedure
transfusions NNS I-Therapeutic_procedure
to TO O
prevent VB O
bleeding VBG O
[ NNP O
Table NNP O
1 CD O
] NN O
. . O

We PRP O
started VBD O
intravenous JJ O
methylprednisolone NN B-Medication
based VBN O
on IN O
previous JJ O
studies NNS O
showing VBG O
a DT O
mortality NN O
benefit NN O
in IN O
severe JJ O
leptospirosis NN O
complicated VBN O
with IN O
myocarditis NN O
[ $ O
11 CD O
] NN O
. . O

His PRP$ O
serum JJ B-Biological_structure
creatinine NN B-Diagnostic_procedure
increased VBD B-Lab_value
to TO O
362 CD B-Lab_value
μ NNS I-Lab_value
mol JJ I-Lab_value
/ NNP I-Lab_value
L NNP I-Lab_value
by IN O
the DT O
5th JJ O
day NN O
of IN O
illness NN O
and CC O
ALT NNP B-Diagnostic_procedure
( ( O
alanine JJ B-Diagnostic_procedure
transaminase NN I-Diagnostic_procedure
) ) O
and CC O
AST NNP B-Diagnostic_procedure
( ( O
aspartate JJ B-Diagnostic_procedure
transaminase NN I-Diagnostic_procedure
) ) O
were VBD O
markedly RB O
elevated VBN B-Lab_value
up RP O
to TO O
2726 CD B-Lab_value
U NNP I-Lab_value
/ NNP I-Lab_value
l NN I-Lab_value
and CC O
7438 CD B-Lab_value
U NNP I-Lab_value
/ NNP I-Lab_value
l NN I-Lab_value
respectively RB O
. . O

Dengue NNP B-Detailed_description
and CC O
Mycoplasma NNP B-Detailed_description
infections NNS B-Disease_disorder
were VBD O
excluded VBN O
. . O

Blood NN B-Diagnostic_procedure
cultures NNS I-Diagnostic_procedure
were VBD O
negative JJ B-Lab_value
. . O

Leptospira NNP B-Detailed_description
IgM NNP I-Detailed_description
antibody NN B-Diagnostic_procedure
performed VBD O
on IN O
the DT O
5th JJ O
day NN O
of IN O
illness NN O
was VBD O
positive JJ B-Lab_value
( ( O
IgG NNP B-Diagnostic_procedure
negative RB B-Lab_value
) ) O
. . O

Patient NNP O
developed VBD O
refractory NN B-Disease_disorder
shock NN I-Disease_disorder
and CC O
died VBD O
of IN O
persistent JJ B-Detailed_description
ventricular JJ B-Biological_structure
tachycardia NN B-Sign_symptom
despite IN O
optimal JJ B-Detailed_description
treatment NN B-Therapeutic_procedure
in IN O
the DT O
ICU NNP B-Nonbiological_location
. . O

-DOCSTART- NN -X-

A DT O
50 CD B-Age
- : I-Age
year NN I-Age
old JJ I-Age
man NN O
with IN O
a DT O
history NN O
of IN O
metastatic JJ B-Detailed_description
mucinous JJ B-Detailed_description
appendiceal NN B-Disease_disorder
adenocarcinoma NN I-Disease_disorder
presents NNS O
for IN O
evaluation NN O
of IN O
a DT O
desquamating VBG B-Detailed_description
rash NN B-Sign_symptom
on IN O
his PRP$ O
face NN B-Biological_structure
that WDT O
has VBZ O
spread VBN O
to TO O
his PRP$ O
scalp NN B-Biological_structure
, , O
inguinal JJ B-Biological_structure
region NN I-Biological_structure
, , O
and CC O
perineum NN B-Biological_structure
over IN B-Duration
the DT I-Duration
past JJ I-Duration
4 CD I-Duration
months NNS I-Duration
( ( O
Figure NNP O
1 CD O
) ) O
. . O

The DT O
rash NN B-Sign_symptom
has VBZ O
been VBN O
accompanied VBN O
by IN O
diffuse NN B-Detailed_description
alopecia NN B-Disease_disorder
of IN O
the DT O
face NN B-Biological_structure
, , O
scalp NN B-Biological_structure
, , O
axilla NN B-Biological_structure
, , O
and CC O
groin NN B-Biological_structure
. . O

There EX O
was VBD O
no DT O
improvement NN O
in IN O
the DT O
rash NN B-Sign_symptom
despite IN O
multiple JJ B-Dosage
rounds NNS I-Dosage
of IN O
oral JJ O
fluconazole NN B-Medication
, , O
topical JJ O
antibiotic JJ B-Medication
ointment NN O
, , O
and CC O
intravenous JJ O
antibiotics NNS B-Medication
. . O

Prior RB O
to TO O
the DT O
development NN O
of IN O
his PRP$ O
rash NN O
, , O
he PRP O
completed VBD O
neoadjuvant JJ B-Detailed_description
chemotherapy NN B-Medication
followed VBN O
by IN O
surgical JJ B-Therapeutic_procedure
resection NN I-Therapeutic_procedure
. . O

He PRP O
underwent JJ O
colostomy NN B-Therapeutic_procedure
after IN O
he PRP O
failed VBD O
surgical JJ B-Therapeutic_procedure
correction NN I-Therapeutic_procedure
for IN O
an DT O
enterocutaneous JJ B-Disease_disorder
fistula NN I-Disease_disorder
, , O
and CC O
he PRP O
has VBZ O
required VBN O
total JJ B-Therapeutic_procedure
parenteral JJ I-Therapeutic_procedure
nutrition NN I-Therapeutic_procedure
( ( O
TPN NNP B-Therapeutic_procedure
) ) O
for IN O
the DT O
past JJ B-Duration
year NN I-Duration
. . O

He PRP O
did VBD O
not RB O
notice VB O
any DT O
significant JJ O
changes NNS B-Sign_symptom
in IN I-Sign_symptom
ostomy JJ I-Sign_symptom
output NN I-Sign_symptom
during IN O
this DT O
time NN O
. . O

Dermatological JJ B-Diagnostic_procedure
examination NN I-Diagnostic_procedure
reveals NNS O
widespread VBP B-Detailed_description
erythematous JJ B-Detailed_description
plaques NNS B-Sign_symptom
on IN O
the DT O
face NN B-Biological_structure
, , O
scalp NN B-Biological_structure
, , O
and CC O
medial JJ B-Biological_structure
aspect NN I-Biological_structure
of IN I-Biological_structure
thighs NNS I-Biological_structure
bilaterally RB B-Detailed_description
and CC O
scattered VBD B-Detailed_description
papules NNS B-Sign_symptom
with IN O
scaling VBG B-Detailed_description
on IN O
face NN B-Biological_structure
, , O
scalp NN B-Biological_structure
, , O
chest NN B-Biological_structure
, , O
and CC O
back RB B-Biological_structure
. . O

Diffuse NNP B-Detailed_description
, , O
non SYM B-Detailed_description
- : I-Detailed_description
scarring VBG I-Detailed_description
alopecia NN B-Disease_disorder
is VBZ O
present JJ O
on IN O
the DT O
face NN B-Biological_structure
, , O
scalp NN B-Biological_structure
, , O
axillae NN B-Biological_structure
, , O
and CC O
groin NN B-Biological_structure
. . O

The DT O
patient NN O
had VBD O
acquired VBN O
AE NNP B-Disease_disorder
, , O
a DT O
rare JJ O
dermatologic JJ O
condition NN O
caused VBN O
by IN O
zinc NN B-Disease_disorder
deficiency NN I-Disease_disorder
. . O

This DT O
patient NN O
developed VBD O
acquired VBN B-Detailed_description
zinc NNP B-Disease_disorder
deficiency NN I-Disease_disorder
in IN O
the DT O
setting NN O
of IN O
inadequate JJ B-Lab_value
zinc NN B-Medication
supplementation NN I-Medication
in IN O
TPN NNP B-Therapeutic_procedure
. . O

The DT O
patient NN O
had VBD O
not RB O
received VBN O
trace NN B-Medication
elements NNS I-Medication
for IN O
approximately RB O
one CD B-Duration
year NN I-Duration
due JJ O
to TO O
a DT O
national JJ B-Other_event
shortage NN I-Other_event
. . O

The DT O
key NN O
to TO O
the DT O
correct JJ O
diagnosis NN O
of IN O
acquired VBN O
AE NNP O
is VBZ O
the DT O
combination NN O
of IN O
desquamating VBG O
rash NN O
coupled VBN O
with IN O
alopecia NN O
in IN O
the DT O
setting NN O
of IN O
chronic JJ O
supplemental JJ O
alimentation NN O
. . O

Although IN O
it PRP O
is VBZ O
reasonable JJ O
to TO O
consider VB O
a DT O
skin NN O
biopsy NN O
, , O
a DT O
skin NN O
biopsy NN O
would MD O
not RB O
definitively RB O
establish VB O
the DT O
diagnosis NN O
. . O

A DT O
paraneoplastic JJ O
panel NN O
could MD O
be VB O
considered VBN O
, , O
but CC O
it PRP O
would MD O
delay VB O
diagnosis NN O
, , O
and CC O
the DT O
presentation NN O
is VBZ O
most RBS O
consistent JJ O
with IN O
nutritional JJ O
deficiency NN O
. . O

It PRP O
is VBZ O
not RB O
appropriate JJ O
to TO O
start VB O
a DT O
topical JJ O
steroid NN O
cream NN O
until IN O
a DT O
diagnosis NN O
is VBZ O
determined VBN O
. . O

The DT O
patient NN O
had VBD O
a DT O
zinc JJ B-Diagnostic_procedure
level NN O
of IN O
29 CD B-Lab_value
ug JJ I-Lab_value
/ NN I-Lab_value
dL NN I-Lab_value
( ( O
normal JJ O
range NN O
56 CD O
- : O
134 CD O
ug JJ O
/ NNP O
dL NN O
) ) O
. . O

He PRP O
received VBD O
zinc JJ B-Medication
supplementation NN I-Medication
in IN O
his PRP$ O
TPN NNP B-Therapeutic_procedure
, , O
and CC O
within IN O
one CD O
month NN O
, , O
the DT O
patient NN O
had VBD O
complete JJ O
resolution NN O
of IN O
rash NN B-Sign_symptom
and CC O
fatigue NN B-Sign_symptom
, , O
and CC O
gradual JJ O
return NN O
of IN O
hair NN B-Sign_symptom
growth NN I-Sign_symptom
( ( O
Figure NNP O
2 CD O
) ) O
. . O

Repeat NNP O
zinc NNP B-Diagnostic_procedure
level NN I-Diagnostic_procedure
following VBG O
supplementation NN O
was VBD O
90 CD B-Lab_value
ug JJ I-Lab_value
/ NNP I-Lab_value
dL NN I-Lab_value
. . O

Although IN O
the DT O
patient NN O
recovered VBD O
from IN O
his PRP$ O
zinc NN B-Disease_disorder
deficiency NN I-Disease_disorder
, , O
he PRP O
later RB O
passed VBD O
away RB O
. . O

-DOCSTART- NN -X-

A DT O
77 CD B-Age
- : I-Age
year NN I-Age
- : I-Age
old JJ I-Age
woman NN O
with IN O
dysphagia NN B-Sign_symptom
presented VBN O
with IN O
a DT O
two CD B-Duration
- : I-Duration
week NN I-Duration
history NN I-Duration
of IN O
rash NN B-Sign_symptom
characterized VBN O
by IN O
brown JJ B-Color
plaques NNS B-Sign_symptom
with IN O
erythematous JJ B-Detailed_description
borders NNS I-Detailed_description
and CC O
overlying VBG B-Detailed_description
thick JJ I-Detailed_description
scales NNS I-Detailed_description
involving VBG O
the DT O
face NN B-Biological_structure
and CC O
a DT O
prior RB O
percutaneous JJ B-Diagnostic_procedure
endoscopic NNS I-Diagnostic_procedure
gastrostomy NN I-Diagnostic_procedure
( ( O
PEG NNP B-Diagnostic_procedure
) ) O
tube NN O
site NN B-Biological_structure
( ( O
Fig NNP O
. . O
1a CD O
, , O
c NN O
) ) O
. . O

No DT O
oral JJ B-Biological_structure
or CC O
conjunctival JJ B-Biological_structure
involvement NN B-Sign_symptom
was VBD O
present JJ O
. . O

She PRP O
had VBD O
been VBN O
receiving VBG O
parenteral JJ B-Medication
nutrition NN I-Medication
for IN O
two CD B-Duration
months NNS I-Duration
following VBG O
removal NN O
of IN O
the DT O
PEG NNP B-Diagnostic_procedure
tube NN I-Diagnostic_procedure
due JJ O
to TO O
infection NN B-Disease_disorder
. . O

Although IN O
the DT O
differential JJ O
diagnosis NN O
included VBD O
drug NN B-Disease_disorder
hypersensitivity NN I-Disease_disorder
, , O
autoimmune NN B-Disease_disorder
disorders NNS I-Disease_disorder
and CC O
nutritional JJ B-Disease_disorder
deficiency NN I-Disease_disorder
, , O
the DT O
rash NN B-Sign_symptom
appearance NN O
was VBD O
most RBS O
consistent JJ O
with IN O
acrodermatitis NN B-Disease_disorder
enteropathica SYM I-Disease_disorder
- : O
like IN O
eruption NN B-Sign_symptom
secondary JJ O
to TO O
zinc VB B-Disease_disorder
deficiency NN I-Disease_disorder
. . O

Her PRP$ O
serum NN B-Detailed_description
zinc NN B-Diagnostic_procedure
level NN O
was VBD O
12 CD B-Lab_value
mcg NN I-Lab_value
/ NN I-Lab_value
dL NN I-Lab_value
( ( O
normal JJ O
, , O
55 CD O
- : O
150 CD O
mcg NN O
/ NNP O
dL NN O
) ) O
, , O
and CC O
the DT O
rash NN B-Sign_symptom
resolved VBD O
within IN O
one CD O
week NN O
of IN O
parenteral JJ O
zinc NN B-Medication
supplementation NN I-Medication
( ( O
Fig NNP O
. . O
1b CD O
, , O
d NN O
) ) O
. . O

Zinc NNP O
is VBZ O
essential JJ O
for IN O
protein JJ O
synthesis NN O
and CC O
wound NN O
healing NN O
. . O

Acrodermatitis NNP O
enteropathica NN O
presents NNS O
in IN O
infancy NN O
as IN O
a DT O
periorificial JJ O
desquamative NN O
dermatitis NN O
, , O
resulting VBG O
from IN O
an DT O
autosomal JJ O
recessive JJ O
mutation NN O
that IN O
impairs VBZ O
zinc DT O
absorption NN O
. . O
A DT O
similar JJ O
syndrome NN O
may MD O
occur VB O
due JJ O
to TO O
nutritional JJ O
zinc NN O
deficiency NN O
, , O
and CC O
has VBZ O
been VBN O
reported VBN O
in IN O
the DT O
setting NN O
of IN O
parenteral JJ O
nutrition NN O
that WDT O
fails VBZ O
to TO O
include VB O
zinc JJ O
supplementation NN O
; : O
a DT O
prompt JJ O
response NN O
to TO O
supplementation NN O
helps VBZ O
to TO O
confirm VB O
the DT O
diagnosis NN O
. . O

A DT O
recent JJ O
national JJ O
shortage NN O
of IN O
parenteral JJ O
zinc NN O
in IN O
the DT O
United NNP O
States NNPS O
likely RB O
contributed VBD O
to TO O
this DT O
patient NN O
` `` O
s JJ O
presentation NN O
. . O

-DOCSTART- NN -X-

Our PRP$ O
patient NN O
was VBD O
a DT O
50 CD B-Age
- : I-Age
year NN I-Age
old JJ I-Age
man NN O
with IN O
bicuspid JJ B-Detailed_description
aortic JJ B-Sign_symptom
valve NN I-Sign_symptom
insufficiency NN I-Sign_symptom
and CC O
ascending VBG B-Detailed_description
aorta JJ B-Sign_symptom
dilatation NN I-Sign_symptom
. . O

He PRP O
had VBD O
undergone RP O
a DT O
free JJ B-Detailed_description
- : I-Detailed_description
hand NN I-Detailed_description
aortic JJ B-Biological_structure
homograft NN B-Therapeutic_procedure
implantation NN I-Therapeutic_procedure
with IN O
replacement NN B-Therapeutic_procedure
of IN O
the DT O
non JJ B-Biological_structure
- : I-Biological_structure
coronary JJ I-Biological_structure
sinus NN I-Biological_structure
using VBG O
a DT O
24 CD B-Detailed_description
- : I-Detailed_description
mm NN I-Detailed_description
homograft NN I-Detailed_description
in IN O
2006 CD O
( ( O
at IN O
the DT O
age NN O
of IN O
41 CD O
) ) O
. . O

Follow NNP O
- : O
up RP O
evaluations NNS O
were VBD O
performed VBN O
every DT B-Frequency
6 CD I-Frequency
months NNS I-Frequency
and CC O
showed VBD O
mild JJ B-Severity
aortic JJ B-Sign_symptom
valve NN I-Sign_symptom
insufficiency NN I-Sign_symptom
. . O

After IN O
8 CD B-Duration
years NNS I-Duration
of IN O
follow NN O
- : O
up RB O
, , O
the DT O
patient NN O
presented VBD O
to TO O
hospital VB B-Nonbiological_location
with IN O
fever NN B-Sign_symptom
and CC O
the DT O
echocardiography NN B-Diagnostic_procedure
showed VBD O
severe JJ B-Severity
aortic JJ B-Sign_symptom
insufficiency NN I-Sign_symptom
due JJ O
to TO O
a DT O
rupture NN B-Sign_symptom
of IN O
one CD B-Biological_structure
of IN I-Biological_structure
the DT I-Biological_structure
cusps NN I-Biological_structure
of IN I-Biological_structure
the DT I-Biological_structure
homograft NN I-Biological_structure
, , O
worsening VBG B-Lab_value
of IN O
cardiac JJ B-Diagnostic_procedure
contractility NN I-Diagnostic_procedure
with IN O
left JJ B-Diagnostic_procedure
ventricular JJ I-Diagnostic_procedure
ejection NN I-Diagnostic_procedure
fraction NN I-Diagnostic_procedure
( ( O
LVEF NNP B-Diagnostic_procedure
) ) O
depression NN B-Lab_value
( ( O
40 CD B-Lab_value
- : I-Lab_value
45 CD I-Lab_value
% NN I-Lab_value
) ) O
and CC O
dilatation NN B-Sign_symptom
of IN I-Sign_symptom
the DT I-Sign_symptom
left JJ I-Sign_symptom
ventricle NN I-Sign_symptom
( ( O
telediastolic JJ B-Lab_value
/ NNP I-Lab_value
telesystolic NN I-Lab_value
diameters NNS I-Lab_value
60 CD I-Lab_value
/ $ I-Lab_value
42 CD I-Lab_value
mm NN I-Lab_value
, , O
respectively RB O
) ) O
. . O

The DT O
patient NN O
presented VBD O
orthopnoea JJ B-Sign_symptom
and CC O
hypotension NN B-Sign_symptom
, , O
which WDT O
needed VBD O
infusion NN O
of IN O
dopamine NN B-Medication
and CC O
diuretics NNS B-Medication
. . O

Computed VBN B-Diagnostic_procedure
tomography NN I-Diagnostic_procedure
scan JJ O
showed VBD O
calcifications NNS B-Sign_symptom
on IN O
the DT O
homograft NN B-Biological_structure
, , O
pleural JJ B-Sign_symptom
effusions NNS I-Sign_symptom
and CC O
no DT O
signs NNS O
of IN O
pericardial JJ B-Sign_symptom
effusion NN I-Sign_symptom
( ( O
Fig NNP O
. . O
1 CD O
) ) O
. . O

Since IN O
the DT O
Dukes NNP B-Diagnostic_procedure
criteria NNS I-Diagnostic_procedure
for IN I-Diagnostic_procedure
endocarditis NN I-Diagnostic_procedure
were VBD O
not RB B-Lab_value
satisfied VBN I-Lab_value
, , O
the DT O
final JJ O
diagnosis NN O
was VBD O
an DT O
early JJ O
structural JJ B-Disease_disorder
deterioration NN I-Disease_disorder
of IN O
the DT O
homograft NN B-Biological_structure
, , O
due JJ O
to TO O
a DT O
severe JJ B-Severity
calcification NN B-Sign_symptom
process NN O
. . O

The DT O
operation NN B-Therapeutic_procedure
was VBD O
performed VBN O
through IN O
median JJ B-Detailed_description
resternotomy NN B-Therapeutic_procedure
and CC O
with IN O
standard JJ B-Detailed_description
aorta SYM B-Biological_structure
- : I-Biological_structure
right JJ I-Biological_structure
atrium NN I-Biological_structure
central JJ B-Therapeutic_procedure
cannulation NN I-Therapeutic_procedure
for IN O
the DT O
extracorporeal JJ O
circulation NN O
. . O

The DT O
leaflets NNS B-Biological_structure
and CC O
the DT O
annulus NN B-Biological_structure
of IN O
the DT O
homograft NN B-Biological_structure
presented VBN O
severe JJ B-Severity
calcifications NNS B-Sign_symptom
and CC O
no DT O
signs NNS O
of IN O
endocarditis NN B-Disease_disorder
were VBD O
found VBN O
. . O

An DT O
Edwards NNP B-Detailed_description
Intuity NNP I-Detailed_description
bioprosthesis NN B-Therapeutic_procedure
( ( O
21 CD O
mm NN O
) ) O
was VBD O
then RB O
implanted VBN B-Therapeutic_procedure
( ( O
Fig NNP O
. . O
2 CD O
) ) O
. . O

The DT O
cross NN B-Therapeutic_procedure
- : I-Therapeutic_procedure
clamping NN I-Therapeutic_procedure
time NN O
was VBD O
41 CD B-Duration
min NN I-Duration
, , O
and CC O
the DT O
cardiopulmonary JJ B-Therapeutic_procedure
bypass NN I-Therapeutic_procedure
time NN O
was VBD O
64 CD B-Duration
min NN I-Duration
. . O

The DT O
patient NN O
required VBN O
dopamine NN B-Medication
and CC O
adrenaline NN B-Medication
at IN O
low JJ B-Dosage
doses NNS I-Dosage
for IN O
bypass NN O
weaning NN O
. . O

No DT O
complications NNS B-Sign_symptom
occurred VBD O
during IN O
the DT O
postoperative JJ B-Therapeutic_procedure
period NN I-Therapeutic_procedure
. . O

Echocardiography NN B-Diagnostic_procedure
before IN O
the DT O
discharge NN O
showed VBD O
the DT O
absence NN O
of IN O
paravalvular JJ B-Sign_symptom
leaks NNS I-Sign_symptom
, , O
a DT O
peak JJ B-Diagnostic_procedure
/ JJ I-Diagnostic_procedure
mean NN I-Diagnostic_procedure
aortic JJ I-Diagnostic_procedure
gradient NN I-Diagnostic_procedure
of IN O
34 CD B-Lab_value
/ JJ I-Lab_value
20 CD I-Lab_value
mmHg NN I-Lab_value
and CC O
an DT O
LVEF NNP B-Diagnostic_procedure
of IN O
33 CD B-Lab_value
% NN I-Lab_value
. . O

Follow NNP O
- : O
up RB O
echocardiography NN B-Diagnostic_procedure
after IN O
3 CD O
months NNS O
from IN O
the DT O
operation NN O
showed VBD O
neither DT O
leaks NNS B-Sign_symptom
nor CC O
malfunctions NNS B-Sign_symptom
of IN O
the DT O
Edwards NNP B-Detailed_description
Intuity NNP I-Detailed_description
prosthesis NN B-Biological_structure
, , O
a DT O
peak JJ B-Diagnostic_procedure
/ JJ I-Diagnostic_procedure
mean JJ I-Diagnostic_procedure
gradient NN I-Diagnostic_procedure
of IN O
38 CD B-Lab_value
/ JJ I-Lab_value
22 CD I-Lab_value
mmHg NN I-Lab_value
and CC O
initial JJ B-Lab_value
recovery NN I-Lab_value
of IN O
the DT O
LVEF NNP B-Diagnostic_procedure
( ( O
valued VBN O
47 CD B-Lab_value
% NN I-Lab_value
) ) O
. . O

Patient NN O
was VBD O
asymptomatic JJ B-Sign_symptom
again RB O
. . O

-DOCSTART- NN -X-

A DT O
54 CD B-Age
- : I-Age
year NN I-Age
- : I-Age
old JJ I-Age
Asian JJ O
man NN O
with IN O
IgA NNP O
nephropathy JJ O
underwent NN O
living VBG B-Detailed_description
- : I-Detailed_description
donor NN I-Detailed_description
kidney NN B-Therapeutic_procedure
transplantation NN I-Therapeutic_procedure
14 CD O
years NNS O
previously RB O
. . O

His PRP$ O
medical JJ B-Diagnostic_procedure
condition NN I-Diagnostic_procedure
had VBD O
been VBN O
almost RB B-Lab_value
stable JJ I-Lab_value
for IN O
14 CD B-Duration
years NNS I-Duration
. . O

He PRP O
developed VBD O
multifocal JJ B-Detailed_description
salmon NN B-Color
- : I-Color
pink NN I-Color
skin JJ B-Biological_structure
discoloration NN B-Sign_symptom
, , O
and CC O
swelling VBG B-Sign_symptom
and CC O
spontaneous JJ B-Detailed_description
pain NN B-Sign_symptom
in IN O
the DT O
left NN B-Biological_structure
knee NN I-Biological_structure
and CC O
leg NN B-Biological_structure
. . O

The DT O
symptoms NNS O
had VBD O
gradually RB O
expanded VBN O
across IN O
the DT O
right JJ B-Biological_structure
forearm NN I-Biological_structure
and CC O
outside NN B-Biological_structure
of IN I-Biological_structure
the DT I-Biological_structure
right JJ I-Biological_structure
thigh NN I-Biological_structure
. . O

He PRP O
was VBD O
admitted VBN O
to TO O
our PRP$ O
hospital NN B-Nonbiological_location
for IN O
the DT O
evaluation NN O
of IN O
fever NN B-Sign_symptom
( ( O
39 CD B-Lab_value
°C NN I-Lab_value
) ) O
and CC O
multifocal JJ B-Detailed_description
cellulitis NN B-Disease_disorder
( ( O
Fig NNP O
. . O
1 CD O
) ) O
. . O

Two CD O
months NNS O
before IN O
admission NN O
, , O
he PRP O
had VBD O
developed VBN O
chronic JJ B-Detailed_description
diarrhea NN B-Sign_symptom
. . O

His PRP$ O
serum NN B-Diagnostic_procedure
creatinine NN I-Diagnostic_procedure
level NN O
was VBD O
stabilized VBN B-Lab_value
at IN O
1 CD B-Lab_value
. . I-Lab_value
7 CD I-Lab_value
mg JJ I-Lab_value
/ NNP I-Lab_value
dL NN I-Lab_value
with IN O
maintenance NN O
immunosuppressive JJ B-Therapeutic_procedure
therapy NN I-Therapeutic_procedure
comprising VBG O
tacrolimus NN B-Medication
( ( O
3 CD B-Dosage
mg NNS I-Dosage
/ JJ I-Dosage
day NN I-Dosage
) ) O
, , O
mycophenolate JJ B-Medication
mofetil NN I-Medication
( ( O
1500 CD B-Dosage
mg NN I-Dosage
/ NNP I-Dosage
day NN I-Dosage
) ) O
, , O
and CC O
prednisone NN B-Medication
( ( O
4 CD B-Dosage
mg NN I-Dosage
every DT I-Dosage
other JJ I-Dosage
day NN I-Dosage
) ) O
. . O

The DT O
tacrolimus NN B-Diagnostic_procedure
trough IN I-Diagnostic_procedure
concentration NN I-Diagnostic_procedure
was VBD O
6 CD B-Lab_value
. . I-Lab_value
3 CD I-Lab_value
ng JJ I-Lab_value
/ NNP I-Lab_value
mL NN I-Lab_value
. . O

The DT O
patient NN O
had VBD O
been VBN O
a DT B-Occupation
dog NN I-Occupation
breeder NN I-Occupation
for IN I-Occupation
12 CD I-Occupation
years NNS I-Occupation
. . O

On IN O
admission NN O
, , O
his PRP$ O
white JJ B-Diagnostic_procedure
blood NN I-Diagnostic_procedure
cell NN I-Diagnostic_procedure
count NN I-Diagnostic_procedure
was VBD O
12,400 CD B-Lab_value
/ JJ I-Lab_value
μL NN I-Lab_value
and CC O
his PRP$ O
C NNP B-Diagnostic_procedure
- : I-Diagnostic_procedure
reactive JJ I-Diagnostic_procedure
protein NN I-Diagnostic_procedure
level NN O
was VBD O
3 CD B-Lab_value
. . I-Lab_value
9 CD I-Lab_value
mg JJ I-Lab_value
/ NNP I-Lab_value
dL NN I-Lab_value
. . O

The DT O
patient NN O
was VBD O
initially RB O
treated VBN O
with IN O
ampicillin JJ B-Medication
/ NNS I-Medication
sulbactam NN I-Medication
( ( O
9 CD B-Dosage
g NN I-Dosage
/ NNP I-Dosage
day NN I-Dosage
intravenously RB O
) ) O
. . O

Two CD O
days NNS O
after IN O
the DT O
initiation NN O
of IN O
this DT O
therapy NN O
, , O
he PRP O
was VBD O
afebrile RB B-Sign_symptom
. . O

Four CD O
days NNS O
later RB O
, , O
an DT O
automated VBN O
blood NN B-Diagnostic_procedure
culture NN I-Diagnostic_procedure
( ( O
Bactec NNP B-Detailed_description
FX NNP I-Detailed_description
® NNP I-Detailed_description
; : O
Becton NNP B-Detailed_description
- : I-Detailed_description
Dickinson NN I-Detailed_description
and CC I-Detailed_description
Company NNP I-Detailed_description
, , I-Detailed_description
Sparks NNP I-Detailed_description
, , I-Detailed_description
MD NNP I-Detailed_description
, , I-Detailed_description
USA NNP I-Detailed_description
) ) O
showed VBD O
positivity NN B-Lab_value
for IN O
gram JJ B-Diagnostic_procedure
- : I-Diagnostic_procedure
negative JJ I-Diagnostic_procedure
spiral JJ I-Diagnostic_procedure
bacilli NN I-Diagnostic_procedure
. . O

A DT O
colony NN B-Detailed_description
obtained VBN I-Detailed_description
from IN I-Detailed_description
the DT I-Detailed_description
patient NN I-Detailed_description
` `` I-Detailed_description
s RB I-Detailed_description
blood NN I-Detailed_description
culture NN I-Detailed_description
was VBD O
analyzed VBN O
by IN O
MALDI NNP B-Detailed_description
- : I-Detailed_description
TOF NN I-Detailed_description
MS NNP B-Diagnostic_procedure
( ( O
Biotyper NNP B-Detailed_description
ver RB I-Detailed_description
. . I-Detailed_description
3 CD I-Detailed_description
. . I-Detailed_description
0 CD I-Detailed_description
® NN I-Detailed_description
; : O
Bruker NNP B-Detailed_description
Corporation NNP I-Detailed_description
, , I-Detailed_description
Germany NNP I-Detailed_description
) ) O
. . O

The DT O
identification NN B-Lab_value
score NN I-Lab_value
was VBD I-Lab_value
2 CD I-Lab_value
. . I-Lab_value
064 CD I-Lab_value
( ( O
> JJ O
2 CD O
. . O
0 CD O
) ) O
, , O
indicating VBG O
accurate JJ O
identification NN O
of IN O
H NNP B-Sign_symptom
. . I-Sign_symptom
cinaedi NN I-Sign_symptom
( ( O
Fig NNP O
. . O
2 CD O
) ) O
. . O

Additional JJ O
evaluation NN B-Diagnostic_procedure
of IN O
the DT O
patient NN O
` `` O
s JJ O
blood NN B-Biological_structure
specifically RB O
for IN O
H NNP O
. . O

cinaedi NN O
by IN O
means NNS O
of IN O
gyrase NN B-Detailed_description
subunit NN I-Detailed_description
B NNP I-Detailed_description
( ( I-Detailed_description
gyrB NN I-Detailed_description
) ) I-Detailed_description
- : I-Detailed_description
targeted VBN I-Detailed_description
PCR NNP B-Diagnostic_procedure
assays NNS I-Diagnostic_procedure
( ( O
using VBG B-Detailed_description
the DT I-Detailed_description
forward NN I-Detailed_description
primer NN I-Detailed_description
AGGGATTCCACAAAGTGAGC NNP I-Detailed_description
and CC I-Detailed_description
the DT I-Detailed_description
reverse NN I-Detailed_description
primer NN I-Detailed_description
TCTTGTCCTGTGCGTTCATC NNP I-Detailed_description
to TO I-Detailed_description
amplify VB I-Detailed_description
the DT I-Detailed_description
region NN I-Detailed_description
of IN I-Detailed_description
the DT I-Detailed_description
gyrB JJ I-Detailed_description
gene NN I-Detailed_description
) ) O
yielded VBD O
positive JJ B-Lab_value
results NNS O
. . O

We PRP O
performed VBD O
gyrB JJ B-Detailed_description
- : I-Detailed_description
targeted VBN I-Detailed_description
PCR NNP B-Diagnostic_procedure
using VBG O
a DT O
single JJ B-Detailed_description
colony NN I-Detailed_description
isolated VBN I-Detailed_description
from IN I-Detailed_description
a DT I-Detailed_description
blood NN I-Detailed_description
culture NN I-Detailed_description
. . O

We PRP O
used VBD O
distilled JJ B-Detailed_description
water NN I-Detailed_description
( ( I-Detailed_description
DNA NNP I-Detailed_description
- : I-Detailed_description
and CC I-Detailed_description
DNase NNP I-Detailed_description
- : I-Detailed_description
free JJ I-Detailed_description
water NN I-Detailed_description
) ) I-Detailed_description
as IN I-Detailed_description
a DT I-Detailed_description
negative JJ I-Detailed_description
control NN I-Detailed_description
to TO O
prevent VB O
contamination NN O
of IN O
gyrB JJ O
- : O
targeted VBN O
PCR NNP O
( ( O
Fig NNP O
. . O
3 CD O
) ) O
. . O

In IN O
addition NN O
, , O
we PRP O
performed VBD O
16S CD B-Diagnostic_procedure
rRNA JJ I-Diagnostic_procedure
gene NN I-Diagnostic_procedure
sequencing NN I-Diagnostic_procedure
of IN O
this DT O
strain NN O
, , O
and CC O
the DT O
results NNS O
were VBD O
> JJ O
99 CD O
% NN O
consistent JJ O
with IN O
the DT O
existing VBG O
sequence NN O
( ( O
Fig NNP O
. . O
4 CD O
) ) O
. . O

Given VBN O
these DT O
results NNS O
, , O
we PRP O
diagnosed VBD O
the DT O
patient NN O
with IN O
H NNP O
. . O

cinaedi NN O
bacteremia NN B-Disease_disorder
with IN O
cellulitis NN B-Disease_disorder
. . O

We PRP O
examined VBD B-Diagnostic_procedure
the DT I-Diagnostic_procedure
genomic JJ I-Diagnostic_procedure
heat NN I-Diagnostic_procedure
shock NN I-Diagnostic_procedure
protein NN I-Diagnostic_procedure
( ( I-Diagnostic_procedure
HSP NNP I-Diagnostic_procedure
) ) I-Diagnostic_procedure
60 CD I-Diagnostic_procedure
sequence NN I-Diagnostic_procedure
of IN O
the DT O
blood NN B-Detailed_description
culture NN I-Detailed_description
isolate NN I-Detailed_description
, , O
which WDT O
resulted VBD O
in IN O
identification NN O
of IN O
cluster NN B-Detailed_description
B NNP I-Detailed_description
H NNP B-Sign_symptom
. . I-Sign_symptom
cinaedi NN I-Sign_symptom
. . O

A DT O
blood NN B-Diagnostic_procedure
culture NN I-Diagnostic_procedure
obtained VBN O
at IN O
11 CD O
days NNS O
was VBD O
positive JJ B-Lab_value
for IN O
H NNP O
. . O

cinaedi NN O
, , O
but CC O
a DT O
culture NN B-Diagnostic_procedure
obtained VBN O
at IN O
15 CD O
days NNS O
was VBD O
negative JJ B-Lab_value
. . O

The DT O
patient NN O
` `` O
s JJ O
cellulitis NN B-Disease_disorder
gradually RB O
resolved VBD O
. . O

The DT O
patient NN O
continued VBD O
antibiotic JJ B-Medication
treatment NN O
for IN O
a DT O
total NN O
of IN O
6 CD B-Duration
weeks NNS I-Duration
( ( O
ampicillin SYM B-Medication
- : I-Medication
sulbactam NN I-Medication
in IN O
a DT O
drip NN O
for IN O
2 CD B-Duration
weeks NNS I-Duration
and CC O
oral JJ O
levofloxacin NN B-Medication
for IN O
4 CD B-Duration
weeks NNS I-Duration
) ) O
, , O
and CC O
he PRP O
had VBD O
no DT O
recurrence NN B-Sign_symptom
6 CD O
months NNS O
after IN O
this DT O
therapy NN O
. . O

His PRP$ O
stool JJ B-Diagnostic_procedure
culture NN I-Diagnostic_procedure
was VBD O
negative JJ B-Lab_value
, , O
although IN O
it PRP O
was VBD O
taken VBN B-Detailed_description
after IN I-Detailed_description
treatment NN I-Detailed_description
. . O

We PRP O
did VBD O
not RB O
apply VB O
enteric JJ B-Medication
bacteria NNS I-Medication
elimination NN I-Medication
in IN O
this DT O
case NN O
. . O

-DOCSTART- NN -X-

A DT O
19 CD B-Age
- : I-Age
year NN I-Age
- : I-Age
old JJ I-Age
man NN O
presented VBN O
at IN O
the DT O
emergency NN B-Nonbiological_location
department NN I-Nonbiological_location
, , O
12 CD B-Time
h NN I-Time
after IN I-Time
insertion NN B-Activity
of IN O
a DT O
high JJ B-Detailed_description
pressure NN I-Detailed_description
container NN I-Detailed_description
with IN O
tanning VBG O
spray NN O
into IN O
his PRP$ O
rectum NN B-Biological_structure
. . O

A DT O
plain JJ B-Detailed_description
abdominal JJ B-Biological_structure
radiograph NN B-Diagnostic_procedure
( ( O
Figure NNP O
1 CD O
) ) O
showed VBD O
the DT O
container NN B-Sign_symptom
in IN O
the DT O
rectosigmoid JJ B-Biological_structure
region NN I-Biological_structure
. . O

There EX O
were VBD O
no DT O
signs NNS O
of IN O
perforation NN B-Disease_disorder
. . O

A DT O
flexible JJ B-Detailed_description
sigmoidoscopy NN B-Diagnostic_procedure
was VBD O
performed VBN O
under IN O
conscious JJ B-Medication
sedation NN I-Medication
. . O

The DT O
object NN B-Sign_symptom
was VBD O
located VBN O
just RB O
above IN B-Biological_structure
the DT I-Biological_structure
rectosigmoid JJ I-Biological_structure
junction NN I-Biological_structure
. . O

The DT O
container NN O
could MD O
not RB O
be VB O
extracted VBN B-Therapeutic_procedure
by IN O
bimanual JJ B-Therapeutic_procedure
manipulation NN I-Therapeutic_procedure
. . O

An DT O
attempt NN O
to TO O
remove VB B-Therapeutic_procedure
the DT O
object NN O
with IN O
conventional JJ B-Detailed_description
endoscopic NN I-Detailed_description
instruments NNS I-Detailed_description
, , O
such JJ O
as IN O
polypectomy NN B-Detailed_description
snares NNS I-Detailed_description
, , O
was VBD O
unsuccessful JJ B-Lab_value
. . O

The DT O
sigmoidoscope NN B-Diagnostic_procedure
could MD O
be VB O
passed VBN O
alongside IN O
the DT O
foreign JJ O
body NN O
to TO O
its PRP$ O
proximal JJ O
end NN O
. . O

A DT O
guide NN B-Diagnostic_procedure
wire NN I-Diagnostic_procedure
was VBD O
left VBN O
behind IN O
with IN O
the DT O
sigmoidoscope NN B-Diagnostic_procedure
removed VBD O
. . O

Subsequently RB O
, , O
a DT O
40 CD B-Distance
mm NN I-Distance
pneumatic JJ B-Diagnostic_procedure
dilatation NN I-Diagnostic_procedure
balloon NN I-Diagnostic_procedure
( ( O
Rigiflex NNP O
® NNP O
, , O
Boston NNP O
Scientific NNP O
) ) O
, , O
normally RB O
used VBN O
in IN O
achalasia JJ O
patients NNS O
, , O
was VBD O
inserted VBN O
over IN O
the DT O
guide NN B-Diagnostic_procedure
wire NN I-Diagnostic_procedure
and CC O
inflated JJ O
just RB O
above IN O
the DT O
container NN O
( ( O
Figure NNP O
2 CD O
) ) O
. . O

For IN O
safety NN O
purposes NNS O
, , O
the DT O
sigmoidoscope NN B-Diagnostic_procedure
was VBD O
reintroduced VBN O
alongside IN O
the DT O
catheter NN O
of IN O
the DT O
balloon NN O
to TO O
allow VB O
endoscopic JJ O
visual JJ O
control NN O
of IN O
the DT O
distal JJ O
end NN O
of IN O
the DT O
container NN O
in IN O
the DT O
rectum NN B-Biological_structure
. . O

Gentle NNP O
traction NN O
was VBD O
exerted VBN O
on IN O
the DT O
balloon NN O
catheter NN O
, , O
and CC O
the DT O
container NN O
was VBD O
successfully RB B-Lab_value
removed VBN B-Therapeutic_procedure
under IN O
fluoroscopic NN B-Detailed_description
and CC I-Detailed_description
endoscopic NN I-Detailed_description
control NN I-Detailed_description
( ( O
Figure NNP O
3 CD O
) ) O
. . O

-DOCSTART- NN -X-

A DT O
19 CD B-Age
- : I-Age
year NN I-Age
- : I-Age
old JJ I-Age
woman NN O
presented VBN O
with IN O
a DT O
lump NN B-Sign_symptom
in IN O
her PRP$ O
right JJ B-Biological_structure
breast NN I-Biological_structure
. . O

She PRP O
had VBD O
macrocephaly NNS B-Disease_disorder
and CC O
milimetric JJ B-Biological_attribute
papules NNS B-Sign_symptom
on IN O
the DT O
tongue NN B-Biological_structure
giving VBG O
a DT O
cobble JJ B-Texture
stone NN I-Texture
appearance NN O
. . O

The DT O
breast NN B-Biological_structure
ultrasonography NN B-Diagnostic_procedure
( ( O
US NNP B-Diagnostic_procedure
) ) O
showed VBD O
more JJR B-Lab_value
than IN I-Lab_value
twenty NN I-Lab_value
circumscribed VBN B-Detailed_description
, , O
oval JJ B-Shape
masses NNS B-Disease_disorder
in IN O
each DT O
breast NN B-Biological_structure
. . O

An DT O
US NNP B-Detailed_description
- : I-Detailed_description
guided VBD I-Detailed_description
core NN I-Detailed_description
biopsy NN B-Diagnostic_procedure
was VBD O
performed VBN O
for IN O
the DT O
palpable JJ B-Detailed_description
masses NNS B-Disease_disorder
which WDT O
were VBD O
confirmed VBN O
as IN O
juvenile NN B-Detailed_description
fibroadenomas NN B-Disease_disorder
. . O

After IN O
the DT O
biopsy NN O
, , O
a DT O
breast NN B-Biological_structure
US NNP B-Diagnostic_procedure
was VBD O
done VBN O
as IN O
follow NN O
- : O
up RB O
every DT B-Frequency
6 CD I-Frequency
or CC I-Frequency
12 CD I-Frequency
months NNS I-Frequency
for IN O
3 CD B-Duration
years NNS I-Duration
. . O

During IN O
the DT O
surveillance NN O
period NN O
, , O
core NN B-Detailed_description
biopsies NNS B-Diagnostic_procedure
were VBD O
performed VBN O
six CD B-Quantitative_concept
times NNS I-Quantitative_concept
, , O
followed VBN O
by IN O
US NNP B-Detailed_description
- : I-Detailed_description
guided VBD I-Detailed_description
vacuum NN B-Detailed_description
- : I-Detailed_description
assisted VBN I-Detailed_description
core NN B-Detailed_description
needle JJ B-Diagnostic_procedure
excisions NNS I-Diagnostic_procedure
or CC O
surgical JJ B-Diagnostic_procedure
excisions NNS I-Diagnostic_procedure
of IN O
lesions NNS B-Disease_disorder
with IN O
increased JJ B-Lab_value
sizes NNS I-Lab_value
. . O

Pathologic JJ O
results NNS O
were VBD O
fibroadenoma JJ B-Disease_disorder
, , O
tubular JJ B-Disease_disorder
adenoma NN I-Disease_disorder
or CC O
atypical JJ B-Disease_disorder
ductal JJ I-Disease_disorder
hyperplasia NN I-Disease_disorder
( ( O
ADH NNP B-Disease_disorder
) ) O
involving VBG O
fibroadenoma NN B-Disease_disorder
. . O

At IN O
the DT O
age NN B-Age
of IN I-Age
19 CD I-Age
years NNS I-Age
, , O
the DT O
patient NN O
underwent NN O
a DT O
neck NN B-Biological_structure
US NNP B-Diagnostic_procedure
for IN O
a DT O
palpable JJ B-Detailed_description
mass NN B-Disease_disorder
in IN O
the DT O
left NN B-Biological_structure
neck NN I-Biological_structure
. . O

Several JJ O
indeterminate NN B-Detailed_description
nodules NNS B-Sign_symptom
were VBD O
revealed VBN O
in IN O
both DT B-Lab_value
thyroid JJ B-Biological_structure
glands NNS I-Biological_structure
. . O

A DT O
follow NN B-Detailed_description
- : I-Detailed_description
up IN I-Detailed_description
US NNP B-Diagnostic_procedure
revealed VBD O
that IN O
some DT B-Lab_value
of IN O
those DT O
nodules NNS B-Sign_symptom
increased VBD B-Lab_value
in IN I-Lab_value
size NN I-Lab_value
. . O

The DT O
patient NN O
underwent VBD O
a DT O
total JJ B-Detailed_description
thyroidectomy NN B-Therapeutic_procedure
and CC O
the DT O
pathologic JJ O
result NN O
revealed VBD O
an DT O
invasive JJ B-Detailed_description
follicular NN B-Disease_disorder
carcinoma NN I-Disease_disorder
in IN O
the DT O
left NN B-Biological_structure
thyroid NN I-Biological_structure
and CC O
follicular JJ B-Disease_disorder
adenoma NN I-Disease_disorder
in IN O
the DT O
right JJ B-Biological_structure
thyroid NN I-Biological_structure
( ( O
Fig NNP O
. . O
1A CD O
) ) O
. . O

At IN O
the DT O
age NN O
of IN O
21 CD O
years NNS O
, , O
she PRP O
visited VBD O
the DT O
hospital NN B-Nonbiological_location
due JJ O
to TO O
a DT O
swelling NN B-Sign_symptom
of IN O
her PRP$ O
left JJ B-Biological_structure
cheek NN I-Biological_structure
. . O

Head NN B-Biological_structure
and CC O
neck NN B-Biological_structure
CT NNP B-Diagnostic_procedure
scan NN I-Diagnostic_procedure
revealed VBD O
a DT O
vascular JJ B-Biological_structure
mass NN B-Disease_disorder
in IN O
the DT O
left NN B-Biological_structure
parotid NN I-Biological_structure
gland NN I-Biological_structure
extended VBD O
into IN O
the DT O
left JJ B-Biological_structure
forehead NN I-Biological_structure
. . O

An DT O
external JJ B-Biological_structure
carotid NN I-Biological_structure
angiography NN B-Diagnostic_procedure
confirmed VBD O
the DT O
diagnosis NN O
of IN O
an DT O
AVM NNP B-Disease_disorder
with IN O
feeder JJ B-Biological_structure
vessel NNS I-Biological_structure
arising VBG O
from IN O
the DT O
left VBN B-Biological_structure
internal JJ I-Biological_structure
maxillary JJ I-Biological_structure
artery NN I-Biological_structure
( ( O
Fig NNP O
. . O
1B CD O
) ) O
. . O

A DT O
partial JJ B-Detailed_description
embolization NN B-Therapeutic_procedure
decreased VBD B-Lab_value
the DT O
blood NN B-Diagnostic_procedure
flow NN I-Diagnostic_procedure
through IN O
the DT O
AVM NNP B-Disease_disorder
, , O
alleviating VBG O
the DT O
patient NN O
` `` O
s JJ O
symptom NN O
. . O

She PRP O
was VBD O
referred VBN O
to TO O
genetic JJ B-Therapeutic_procedure
counseling NN I-Therapeutic_procedure
under IN O
the DT O
suggestion NN O
of IN O
a DT O
Cowden NNP B-Disease_disorder
syndrome NN I-Disease_disorder
and CC O
the DT O
PTEN NNP B-Diagnostic_procedure
DNA NNP B-Diagnostic_procedure
sequencing VBG I-Diagnostic_procedure
test NN I-Diagnostic_procedure
of IN O
her PRP$ O
blood NN B-Diagnostic_procedure
sample NN I-Diagnostic_procedure
revealed VBD O
a DT O
frameshift NN B-Diagnostic_procedure
mutation NN I-Diagnostic_procedure
, , O
c NN B-Diagnostic_procedure
. . I-Diagnostic_procedure
301dupA CD I-Diagnostic_procedure
( ( O
p NN B-Diagnostic_procedure
. . I-Diagnostic_procedure
I101NfsX6 NNP I-Diagnostic_procedure
) ) O
. . O

At IN O
the DT O
age NN O
of IN O
22 CD O
years NNS O
, , O
the DT O
patient NN O
presented VBN O
with IN O
a DT O
mass NN B-Disease_disorder
with IN O
increased JJ B-Lab_value
size NN I-Lab_value
and CC O
increased JJ B-Lab_value
vascularity NN I-Lab_value
in IN O
the DT O
left NN B-Biological_structure
breast NN I-Biological_structure
. . O

An DT O
US NNP B-Detailed_description
- : I-Detailed_description
guided VBD I-Detailed_description
vacuum NN B-Detailed_description
- : I-Detailed_description
assisted VBN I-Detailed_description
core NN B-Detailed_description
needle JJ B-Diagnostic_procedure
excision NN I-Diagnostic_procedure
revealed VBD O
a DT O
ductal JJ B-Disease_disorder
carcinoma NN I-Disease_disorder
in IN I-Disease_disorder
situ NN I-Disease_disorder
( ( O
DCIS NNP B-Disease_disorder
) ) O
of IN O
non JJ B-Detailed_description
- : I-Detailed_description
comedo NN I-Detailed_description
type NN I-Detailed_description
and CC O
a DT O
low JJ B-Lab_value
grade NN I-Lab_value
involving VBG O
fibroadenoma NN B-Disease_disorder
( ( O
Fig NNP O
. . O
1C CD O
) ) O
. . O

The DT O
contrast NN B-Detailed_description
- : I-Detailed_description
enhanced VBN I-Detailed_description
breast NN B-Biological_structure
MRI NNP B-Diagnostic_procedure
for IN O
the DT O
preoperative JJ O
evaluation NN O
demonstrated VBD O
multiple NN B-Lab_value
, , O
well RB B-Detailed_description
- : I-Detailed_description
circumscribed NN I-Detailed_description
, , O
enhancing VBG B-Lab_value
masses NNS B-Disease_disorder
in IN O
both DT B-Lab_value
breasts NNS B-Biological_structure
( ( O
Fig NNP O
. . O
1D CD O
) ) O
. . O

All DT B-Lab_value
masses NNS B-Disease_disorder
showed VBD O
high JJ B-Severity
or CC O
intermediate JJ B-Severity
signal JJ B-Diagnostic_procedure
intensity NN I-Diagnostic_procedure
on IN O
T2 NNP B-Diagnostic_procedure
- : I-Diagnostic_procedure
weighted VBD I-Diagnostic_procedure
images NNS I-Diagnostic_procedure
( ( O
Fig NNP O
. . O
1E CD O
) ) O
. . O

Several JJ B-Lab_value
masses NNS B-Disease_disorder
showed VBD O
an DT O
early JJ B-Detailed_description
rapid JJ I-Detailed_description
enhancement NN I-Detailed_description
with IN O
washout NN B-Diagnostic_procedure
kinetic JJ I-Diagnostic_procedure
pattern NN I-Diagnostic_procedure
on IN O
time NN B-Diagnostic_procedure
- : I-Diagnostic_procedure
signal JJ I-Diagnostic_procedure
intensity NN I-Diagnostic_procedure
curve NN I-Diagnostic_procedure
evaluation NN I-Diagnostic_procedure
, , O
which WDT O
tends VBZ O
to TO O
be VB O
associated VBN O
with IN O
malignancy NN B-Disease_disorder
( ( O
Fig NNP O
. . O
1F CD O
) ) O
. . O

A DT O
bilateral JJ B-Detailed_description
prophylactic JJ I-Detailed_description
mastectomy NN B-Therapeutic_procedure
with IN O
immediate JJ B-Detailed_description
breast NN B-Therapeutic_procedure
reconstruction NN I-Therapeutic_procedure
was VBD O
performed VBN O
in IN O
view NN O
of IN O
multiple JJ B-Lab_value
bilateral JJ B-Detailed_description
breast NN B-Biological_structure
masses NNS B-Disease_disorder
with IN O
suspicious JJ B-Detailed_description
kinetic JJ B-Diagnostic_procedure
features NNS I-Diagnostic_procedure
on IN O
breast NN B-Biological_structure
MRI NNP B-Diagnostic_procedure
and CC O
a DT O
high JJ O
risk NN O
for IN O
breast NN B-Disease_disorder
cancer NN I-Disease_disorder
of IN O
Cowden NNP B-Disease_disorder
syndrome NN I-Disease_disorder
. . O

The DT O
surgical JJ B-Diagnostic_procedure
histopathology NN I-Diagnostic_procedure
revealed VBD O
ADH NNP B-Disease_disorder
involving VBG O
tubular JJ B-Disease_disorder
adenoma NN I-Disease_disorder
without IN O
residual JJ B-Detailed_description
carcinoma NN B-Disease_disorder
in IN O
the DT O
left NN B-Biological_structure
breast NN I-Biological_structure
and CC O
multiple JJ B-Lab_value
tubular JJ B-Disease_disorder
adenomas NN I-Disease_disorder
, , O
fibroadenomas NN B-Disease_disorder
and CC O
intraductal JJ B-Disease_disorder
papillomas NN I-Disease_disorder
in IN O
both DT B-Lab_value
breasts NNS B-Biological_structure
. . O

The DT O
patient NN O
had VBD O
no DT O
family NN O
history NN O
of IN O
breast NN O
cancer NN O
or CC O
Cowden NNP O
syndrome NN O
. . O

-DOCSTART- NN -X-

An DT O
11 CD B-Age
- : I-Age
year NN I-Age
- : I-Age
old JJ I-Age
boy NN O
presented VBN O
with IN O
a DT O
history NN O
of IN O
headaches NNS B-Sign_symptom
and CC O
vomiting VBG B-Sign_symptom
that WDT O
had VBD O
been VBN O
present JJ O
for IN O
several JJ B-Duration
months NNS I-Duration
. . O

Physical JJ B-Diagnostic_procedure
examination NN I-Diagnostic_procedure
showed VBD O
papilledema NN B-Disease_disorder
without IN O
the DT O
presence NN O
of IN O
any DT O
other JJ O
neurological JJ B-Disease_disorder
deficits NNS I-Disease_disorder
. . O

Magnetic JJ B-Diagnostic_procedure
resonance NN I-Diagnostic_procedure
imaging NN I-Diagnostic_procedure
( ( O
MRI NNP B-Diagnostic_procedure
) ) O
revealed VBD O
a DT O
large JJ B-Detailed_description
prepontine NN B-Biological_structure
mass NN B-Sign_symptom
with IN O
dorsal JJ B-Detailed_description
displacement NN B-Sign_symptom
of IN O
the DT O
brainstem NN B-Biological_structure
and CC O
a DT O
secondary JJ B-Detailed_description
obstructive JJ B-Detailed_description
hydrocephalus NN B-Disease_disorder
due JJ O
to TO O
compression NN B-Sign_symptom
of IN O
the DT O
aqueduct NN B-Biological_structure
. . O

The DT O
lesion NN O
had VBD O
an DT O
inhomogeneous JJ B-Detailed_description
hypointense NN B-Sign_symptom
aspect NN I-Sign_symptom
on IN O
the DT O
T1 NNP B-Diagnostic_procedure
- : I-Diagnostic_procedure
weighted JJ I-Diagnostic_procedure
image NN I-Diagnostic_procedure
( ( O
T1WI NNP B-Diagnostic_procedure
) ) O
and CC O
an DT O
inhomogeneous JJ B-Detailed_description
hyperintense NN B-Sign_symptom
aspect NN I-Sign_symptom
on IN O
the DT O
T2 NNP B-Diagnostic_procedure
- : I-Diagnostic_procedure
weighted JJ I-Diagnostic_procedure
image NN I-Diagnostic_procedure
( ( O
T2WI NNP B-Diagnostic_procedure
) ) O
. . O

After IN O
administration NN O
of IN O
IV NNP O
gadolinium NN B-Medication
, , O
there EX O
was VBD O
some DT O
inhomogeneous JJ B-Detailed_description
enhancement NN B-Sign_symptom
( ( O
Fig NNP O
. . O
1 CD O
) ) O
. . O

Computed VBN B-Diagnostic_procedure
tomography NN I-Diagnostic_procedure
( ( O
CT NNP B-Diagnostic_procedure
) ) O
imaging NN O
showed VBD O
no DT O
bone NN B-Sign_symptom
involvement NN I-Sign_symptom
. . O

During IN O
the DT O
first JJ O
operation NN O
, , O
a DT O
ventriculoperitoneal NN B-Detailed_description
shunt NN B-Therapeutic_procedure
was VBD O
inserted VBN O
into IN O
the DT O
right JJ B-Biological_structure
lateral JJ I-Biological_structure
ventricle NN I-Biological_structure
to TO O
treat VB O
the DT O
hydrocephalus NN O
. . O

A DT O
careful JJ O
study NN O
of IN O
the DT O
MRI NNP O
suggested VBD O
that IN O
this DT O
infra JJ O
- : O
and CC O
supratentorially RB O
located VBN O
tumour NN O
might MD O
be VB O
resected VBN O
through IN O
a DT O
single JJ O
approach NN O
. . O

A DT O
left JJ B-Detailed_description
frontotemporal JJ B-Detailed_description
transsylvian JJ B-Therapeutic_procedure
approach NN I-Therapeutic_procedure
was VBD O
performed VBN O
to TO O
gain VB O
access NN O
to TO O
the DT O
tumour NN O
. . O

The DT O
tumour NN B-Sign_symptom
had VBD O
well RB B-Detailed_description
- : I-Detailed_description
defined VBN I-Detailed_description
margins NNS I-Detailed_description
and CC O
was VBD O
entirely RB O
located VBN O
in IN O
the DT O
intradural JJ B-Biological_structure
plane NN I-Biological_structure
. . O

There EX O
were VBD O
no DT O
attachments NNS B-Sign_symptom
to TO O
the DT O
cranial JJ B-Biological_structure
nerves NNS I-Biological_structure
or CC O
brainstem NN B-Biological_structure
. . O

A DT O
macroscopic NN B-Detailed_description
complete JJ B-Detailed_description
resection NN B-Therapeutic_procedure
was VBD O
performed VBN O
. . O

Postoperatively RB O
, , O
the DT O
patient NN O
had VBD O
developed VBN O
a DT O
left JJ B-Biological_structure
oculomotor NN I-Biological_structure
nerve NN B-Disease_disorder
palsy NN I-Disease_disorder
, , O
which WDT O
completely RB O
recovered VBD B-Sign_symptom
within IN O
the DT O
next JJ O
4 CD O
weeks NNS O
. . O

The DT O
postoperative JJ O
MRI NNP B-Diagnostic_procedure
showed VBD O
a DT O
complete JJ B-Detailed_description
removal NN I-Detailed_description
of IN O
the DT O
tumour NN B-Sign_symptom
( ( O
Fig NNP O
. . O
2 CD O
) ) O
. . O

After IN O
careful JJ O
consideration NN O
by IN O
a DT O
multidisciplinary JJ O
team NN O
, , O
we PRP O
decided VBD O
that IN O
there EX O
was VBD O
no DT O
indication NN O
for IN O
postoperative JJ O
radiation NN B-Therapeutic_procedure
therapy NN I-Therapeutic_procedure
. . O

At IN O
follow SYM O
- : O
up IN O
one CD O
and CC O
a DT O
half NN O
years NNS O
later RB O
, , O
the DT O
patient NN O
was VBD O
found VBN O
to TO O
have VB O
remained VBN O
asymptomatic JJ B-Sign_symptom
. . O

There EX O
were VBD O
no DT O
signs NNS O
of IN O
tumour JJ B-Sign_symptom
recurrence NN I-Sign_symptom
on IN O
the DT O
MRI NNP B-Diagnostic_procedure
scan NN O
. . O

At IN O
a DT O
follow NN O
- : O
up IN O
of IN O
more JJR O
than IN O
6 CD O
years NNS O
after IN O
treatment NN O
, , O
there EX O
were VBD O
still RB O
no DT O
signs NNS O
of IN O
tumour JJ B-Sign_symptom
recurrence NN I-Sign_symptom
on IN O
the DT O
MRI NNP B-Diagnostic_procedure
scan NN O
. . O

Histological JJ B-Diagnostic_procedure
examination NN I-Diagnostic_procedure
showed VBD O
a DT O
slightly RB B-Shape
lobulated VBN I-Shape
tumour JJ B-Sign_symptom
consisting NN O
of IN O
a DT O
chondromyxoid JJ B-Detailed_description
matrix NN I-Detailed_description
. . O

The DT O
tumour NN O
cells NNS O
showed VBD O
a DT O
vacuolated JJ B-Lab_value
and CC O
pale JJ B-Lab_value
cytoplasm NN B-Diagnostic_procedure
. . O

Moderate JJ B-Severity
nuclear JJ B-Sign_symptom
polymorphism NN I-Sign_symptom
was VBD O
observed VBN O
but CC O
no DT O
obvious JJ O
mitotic JJ B-Sign_symptom
activity NN I-Sign_symptom
( ( O
Fig NNP O
. . O
3 CD O
) ) O
. . O

Some DT O
calcifications NNS B-Sign_symptom
were VBD O
seen VBN O
. . O

The DT O
tumour NN O
cells NNS O
stained VBD O
positive JJ B-Lab_value
for IN O
pan JJ B-Diagnostic_procedure
- : I-Diagnostic_procedure
keratin NN I-Diagnostic_procedure
, , O
S NNP B-Diagnostic_procedure
- : I-Diagnostic_procedure
100 CD I-Diagnostic_procedure
and CC O
epithelial JJ B-Diagnostic_procedure
membrane NN I-Diagnostic_procedure
antigen NN I-Diagnostic_procedure
( ( O
EMA NNP B-Diagnostic_procedure
) ) O
. . O

These DT O
findings NNS O
suggest VBP O
a DT O
histopathological JJ O
diagnosis NN O
of IN O
chordoma NN B-Disease_disorder
. . O

-DOCSTART- NN -X-

A DT O
76 CD B-Age
- : I-Age
year NN I-Age
- : I-Age
old JJ I-Age
Japanese JJ O
man NN O
had VBD O
experienced VBN O
a DT O
decreased JJ B-Sign_symptom
appetite NN I-Sign_symptom
, , O
nausea NN B-Sign_symptom
, , O
and CC O
abdominal JJ B-Biological_structure
distension NN B-Sign_symptom
since IN O
late JJ O
February NNP O
2011 CD O
. . O

The DT O
patient NN O
passed VBD O
loose RB B-Lab_value
, , O
soft JJ B-Lab_value
stools NNS B-Diagnostic_procedure
that WDT O
were VBD O
not RB B-Lab_value
watery JJ I-Lab_value
once RB B-Frequency
daily JJ I-Frequency
. . O

The DT O
results NNS O
of IN O
blood NN B-Diagnostic_procedure
tests NNS I-Diagnostic_procedure
performed VBN O
by IN O
the DT O
primary JJ B-Nonbiological_location
care NN I-Nonbiological_location
physician NN I-Nonbiological_location
( ( O
PCP NNP B-Nonbiological_location
) ) O
between IN O
April NNP O
and CC O
June NNP O
were VBD O
all DT O
normal JJ B-Lab_value
, , O
but CC O
upper JJ B-Detailed_description
and CC I-Detailed_description
lower JJR I-Detailed_description
gastrointestinal NN B-Diagnostic_procedure
endoscopy NN I-Diagnostic_procedure
showed VBD O
atrophic JJ B-Detailed_description
gastritis NN B-Disease_disorder
. . O

Therefore RB O
, , O
we PRP O
assessed VBD O
the DT O
patient NN O
for IN O
Helicobacter NNP B-Diagnostic_procedure
pylori NN I-Diagnostic_procedure
antibodies NNS I-Diagnostic_procedure
and CC O
performed VBD O
the DT O
rapid JJ B-Diagnostic_procedure
urease JJ I-Diagnostic_procedure
test NN I-Diagnostic_procedure
and CC O
a DT O
histopathological JJ B-Diagnostic_procedure
evaluation NN I-Diagnostic_procedure
, , O
all DT O
of IN O
which WDT O
were VBD O
negative JJ B-Lab_value
. . O

In IN O
June NNP O
, , O
the DT O
patient NN O
received VBD O
medication NN B-Medication
from IN O
a DT O
mental JJ B-Nonbiological_location
health NN I-Nonbiological_location
clinic NN I-Nonbiological_location
, , O
but CC O
because IN O
the DT O
symptoms NNS B-Sign_symptom
did VBD O
not RB O
improve VB O
and CC O
his PRP$ O
body NN B-Diagnostic_procedure
weight VBD I-Diagnostic_procedure
further RBR O
decreased VBN B-Lab_value
by IN I-Lab_value
23 CD I-Lab_value
kg NNS I-Lab_value
, , O
he PRP O
stopped VBD O
the DT O
medication NN B-Medication
; : O
he PRP O
was VBD O
referred VBN O
to TO O
our PRP$ O
department NN B-Nonbiological_location
in IN O
November NNP O
. . O

The DT O
patient NN O
had VBD O
been VBN O
suffering VBG O
from IN O
hypertension NN O
since IN O
his PRP$ O
30s CD O
. . O

Amlodipine NNP B-Medication
( ( O
5 CD B-Dosage
mg NNS I-Dosage
/ JJ I-Dosage
day NN I-Dosage
) ) O
administration NN O
was VBD O
initiated VBN O
in IN O
2005 CD O
, , O
and CC O
olmesartan PRP B-Medication
from IN O
May NNP O
2008 CD O
; : O
the DT O
patient NN O
is VBZ O
currently RB O
receiving VBG O
30 CD B-Dosage
mg JJ I-Dosage
/ NNP I-Dosage
day NN I-Dosage
of IN O
olmesartan NN O
. . O

He PRP O
denied VBD O
the DT O
use NN O
of IN O
any DT O
other JJ O
new JJ B-Medication
medications NNS I-Medication
or CC O
nonsteroidal JJ B-Medication
anti SYM I-Medication
- : I-Medication
inflammatory NN I-Medication
drugs NNS I-Medication
. . O

He PRP O
had VBD O
no DT O
history NN O
of IN O
smoking NN O
or CC O
alcohol NN O
consumption NN O
. . O

Physical JJ B-Diagnostic_procedure
examination NN I-Diagnostic_procedure
showed VBD O
that IN O
the DT O
patient NN O
had VBD O
a DT O
height NN O
of IN O
165 CD B-Height
cm NN I-Height
, , O
a DT O
body NN O
weight NN O
of IN O
47 CD B-Weight
kg NNS I-Weight
, , O
and CC O
body NN B-Diagnostic_procedure
mass NN I-Diagnostic_procedure
index NN I-Diagnostic_procedure
of IN O
17 CD B-Lab_value
kg NNS I-Lab_value
/ JJ I-Lab_value
m2 NN I-Lab_value
. . O

His PRP$ O
body NN B-Diagnostic_procedure
temperature NN I-Diagnostic_procedure
was VBD O
36 CD B-Lab_value
. . I-Lab_value
3 CD I-Lab_value
℃ NN I-Lab_value
; : O
pulse JJ B-Diagnostic_procedure
rate NN I-Diagnostic_procedure
, , O
101 CD B-Lab_value
/ JJ I-Lab_value
min NN I-Lab_value
; : O
blood NN B-Diagnostic_procedure
pressure NN I-Diagnostic_procedure
, , O
101 CD B-Lab_value
/ NN I-Lab_value
81 CD I-Lab_value
mmHg NN I-Lab_value
; : O
respiratory NN B-Diagnostic_procedure
rate NN I-Diagnostic_procedure
, , O
12 CD B-Lab_value
breaths NNS I-Lab_value
/ JJ I-Lab_value
min NN I-Lab_value
; : O
and CC O
saturation NN B-Diagnostic_procedure
from IN I-Diagnostic_procedure
pulse JJ I-Diagnostic_procedure
oximetry NN I-Diagnostic_procedure
( ( O
SpO2 NNP B-Diagnostic_procedure
) ) O
was VBD O
98 CD B-Lab_value
% NN I-Lab_value
. . O

The DT O
patient NN O
had VBD O
no DT O
heart NN B-Sign_symptom
murmur NN I-Sign_symptom
, , O
third JJ B-Sign_symptom
heart NN I-Sign_symptom
sound NN I-Sign_symptom
or CC O
jugular JJ B-Biological_structure
venous JJ I-Biological_structure
distension NN B-Sign_symptom
. . O

The DT O
patient NN O
had VBD O
bilateral JJ B-Detailed_description
pitting VBG B-Detailed_description
edema NN B-Sign_symptom
on IN O
his PRP$ O
lower JJR B-Biological_structure
legs NN I-Biological_structure
and CC O
presented VBN O
with IN O
unilateral JJ B-Detailed_description
gaze NNS B-Detailed_description
- : I-Detailed_description
evoked VBD I-Detailed_description
nystagmus JJ B-Sign_symptom
as RB O
well RB O
as IN O
a DT O
mildly RB B-Severity
reduced VBN B-Sign_symptom
tactile JJ I-Sign_symptom
sensation NN I-Sign_symptom
and CC O
thermal JJ B-Detailed_description
nociception NN B-Sign_symptom
in IN O
the DT O
toes NNS B-Biological_structure
and CC O
dorsal JJ B-Biological_structure
regions NNS I-Biological_structure
of IN I-Biological_structure
both DT I-Biological_structure
feet NNS I-Biological_structure
. . O

Moreover RB O
, , O
the DT O
finger NN B-Diagnostic_procedure
- : I-Diagnostic_procedure
to TO I-Diagnostic_procedure
- : I-Diagnostic_procedure
nose JJ I-Diagnostic_procedure
test NN I-Diagnostic_procedure
results NNS O
and CC O
tandem JJ B-Diagnostic_procedure
gait NN I-Diagnostic_procedure
were VBD O
poor JJ B-Lab_value
, , O
and CC O
his PRP$ O
patellar NN B-Biological_structure
and CC O
Achilles NNP B-Biological_structure
tendon VB I-Biological_structure
reflexes NNS B-Diagnostic_procedure
had VBD O
disappeared VBN B-Lab_value
. . O

Confabulation NN B-Sign_symptom
was VBD O
observed VBN O
in IN O
the DT O
patient NN O
, , O
and CC O
the DT O
revised VBN O
Hasegawa NNP B-Diagnostic_procedure
Dementia NNP I-Diagnostic_procedure
Scale NNP I-Diagnostic_procedure
( ( O
HDS NNP B-Diagnostic_procedure
- : I-Diagnostic_procedure
R NN I-Diagnostic_procedure
) ) O
score NN O
was VBD O
17 CD B-Lab_value
/ JJ I-Lab_value
30 CD I-Lab_value
( ( O
cut VBN O
- : O
off IN O
point NN O
: : O
20 CD O
) ) O
. . O

The DT O
hematologic JJ B-Diagnostic_procedure
findings NNS I-Diagnostic_procedure
were VBD O
as IN O
follows VBZ O
: : O
white JJ B-Diagnostic_procedure
blood NN I-Diagnostic_procedure
cell NN I-Diagnostic_procedure
count NN I-Diagnostic_procedure
, , O
6,200 CD B-Lab_value
/ JJ I-Lab_value
μL NN I-Lab_value
; : O
hemoglobin CC B-Diagnostic_procedure
level NN I-Diagnostic_procedure
, , O
12 CD B-Lab_value
. . I-Lab_value
5 CD I-Lab_value
g JJ I-Lab_value
/ NNP I-Lab_value
dL NN I-Lab_value
; : O
mean JJ B-Diagnostic_procedure
corpuscular NN I-Diagnostic_procedure
volume NN I-Diagnostic_procedure
, , O
88 CD B-Lab_value
. . I-Lab_value
4 CD I-Lab_value
; : O
platelet NN B-Diagnostic_procedure
count NN I-Diagnostic_procedure
, , O
230,000 CD B-Lab_value
/ JJ I-Lab_value
μL NN I-Lab_value
; : O
sodium JJ B-Diagnostic_procedure
level NN I-Diagnostic_procedure
, , O
136 CD B-Lab_value
mEq NN I-Lab_value
/ NNP I-Lab_value
L NNP I-Lab_value
; : O
potassium NN B-Diagnostic_procedure
level NN I-Diagnostic_procedure
, , O
3 CD B-Lab_value
. . I-Lab_value
8 CD I-Lab_value
mEq JJ I-Lab_value
/ NNP I-Lab_value
L NNP I-Lab_value
; : O
chlorine JJ B-Diagnostic_procedure
level NN I-Diagnostic_procedure
, , O
103 CD B-Lab_value
mEq NN I-Lab_value
/ NNP I-Lab_value
L NNP I-Lab_value
; : O
iron NN B-Diagnostic_procedure
level NN I-Diagnostic_procedure
, , O
57 CD B-Lab_value
μg NN I-Lab_value
/ NN I-Lab_value
dL NN I-Lab_value
( ( O
reference NN O
value NN O
: : O
64 CD O
- : O
187 CD O
μg JJ O
/ NNP O
dL NN O
) ) O
; : O
ferritin JJ B-Diagnostic_procedure
level NN I-Diagnostic_procedure
, , O
366 CD B-Lab_value
ng JJ I-Lab_value
/ NN I-Lab_value
mL NN I-Lab_value
( ( O
reference NN O
value NN O
: : O
50 CD O
- : O
200 CD O
ng JJ O
/ NNP O
mL NN O
) ) O
; : O
B NNP B-Diagnostic_procedure
- : I-Diagnostic_procedure
type NN I-Diagnostic_procedure
natriuretic JJ I-Diagnostic_procedure
peptide NN I-Diagnostic_procedure
( ( O
BNP NNP B-Diagnostic_procedure
) ) O
level NN O
, , O
125 CD B-Lab_value
. . I-Lab_value
3 CD I-Lab_value
pg JJ I-Lab_value
/ NN I-Lab_value
mL NN I-Lab_value
( ( O
reference NN O
value NN O
: : O
- : O
18 CD O
. . O
4 CD O
pg JJ O
/ NNP O
mL NN O
) ) O
; : O
and CC O
vitamin VB B-Diagnostic_procedure
B1 NNP I-Diagnostic_procedure
level NN I-Diagnostic_procedure
, , O
8 CD B-Lab_value
ng JJ I-Lab_value
/ NN I-Lab_value
mL NN I-Lab_value
( ( O
reference NN O
value NN O
: : O
24 CD O
- : O
66 CD O
ng JJ O
/ NNP O
mL NN O
) ) O
. . O

An DT O
electrocardiogram NN B-Diagnostic_procedure
was VBD O
normal JJ B-Lab_value
and CC O
chest JJS B-Biological_structure
X SYM B-Diagnostic_procedure
- : I-Diagnostic_procedure
rays NNS I-Diagnostic_procedure
showed VBD O
a DT O
normal JJ B-Lab_value
cardiothoracic NN B-Diagnostic_procedure
ratio NN I-Diagnostic_procedure
( ( O
40 CD B-Lab_value
. . I-Lab_value
8 CD I-Lab_value
% NN I-Lab_value
) ) O
without IN O
either DT O
pulmonary JJ B-Sign_symptom
congestion NN I-Sign_symptom
or CC O
pleural JJ B-Disease_disorder
effusion NN I-Disease_disorder
. . O

Cranial NNP B-Biological_structure
fluid NN B-Detailed_description
- : I-Detailed_description
attenuated VBN I-Detailed_description
inversion NN I-Detailed_description
recovery NN I-Detailed_description
- : O
magnetic JJ B-Diagnostic_procedure
resonance NN I-Diagnostic_procedure
imaging NN I-Diagnostic_procedure
findings NNS O
revealed VBD O
periaqueductal JJ B-Biological_structure
hyperintensities NNS B-Sign_symptom
( ( O
Fig NNP O
. . O
1 CD O
) ) O
; : O
therefore RB O
, , O
Wernicke NNP B-Disease_disorder
encephalopathy NN I-Disease_disorder
was VBD O
diagnosed VBN O
. . O

Moreover RB O
, , O
as IN O
sinus JJ B-Detailed_description
tachycardia NN B-Sign_symptom
and CC O
a DT O
tendency NN O
towards IN O
hypotension NN B-Sign_symptom
were VBD O
noted VBN O
, , O
no DT O
clear JJ O
symptoms NNS O
of IN O
heart NN B-Disease_disorder
failure NN I-Disease_disorder
or CC O
dehydration NN B-Sign_symptom
were VBD O
observed VBN O
; : O
it PRP O
was VBD O
thus RB O
inferred VBN O
that IN O
the DT O
vitamin NN B-Disease_disorder
B1 NNP I-Disease_disorder
deficiency NN I-Disease_disorder
had VBD O
likely JJ O
played VBN O
a DT O
role NN O
in IN O
both DT O
of IN O
the DT O
conditions NNS O
. . O

The DT O
antihypertensive JJ B-Medication
agents NNS I-Medication
were VBD O
discontinued VBN O
, , O
and CC O
10 CD O
days NNS O
after IN O
the DT O
intravenous JJ O
administration NN O
of IN O
vitamin JJ B-Medication
B1 NNP I-Medication
, , O
the DT O
patient NN O
` `` O
s JJ O
loss NN B-Sign_symptom
of IN I-Sign_symptom
appetite NN I-Sign_symptom
, , O
nausea NN B-Sign_symptom
, , O
and CC O
gait NN B-Sign_symptom
disturbance NN I-Sign_symptom
disappeared VBD O
, , O
and CC O
his PRP$ O
body NN B-Diagnostic_procedure
weight NN I-Diagnostic_procedure
increased VBN B-Lab_value
by IN I-Lab_value
3 CD I-Lab_value
kg NNS I-Lab_value
. . O

Nystagmus NNP B-Sign_symptom
was VBD O
ameliorated VBN O
on IN O
physical JJ B-Diagnostic_procedure
examination NN I-Diagnostic_procedure
, , O
but CC O
the DT O
patient NN O
still RB O
had VBD O
confabulations NNS B-Sign_symptom
, , O
and CC O
the DT O
HDS NNP B-Diagnostic_procedure
- : I-Diagnostic_procedure
R NN I-Diagnostic_procedure
score NN I-Diagnostic_procedure
and CC O
absence NN B-Lab_value
of IN O
deep JJ B-Biological_structure
tendon NN I-Biological_structure
reflexes NNS B-Diagnostic_procedure
did VBD B-Lab_value
not RB I-Lab_value
improve VB I-Lab_value
. . O

Since IN O
the DT O
gastrointestinal JJ B-Sign_symptom
symptoms NNS I-Sign_symptom
were VBD O
ameliorated VBN O
and CC O
his PRP$ O
blood NN B-Diagnostic_procedure
pressure NN I-Diagnostic_procedure
increased VBD B-Lab_value
to TO O
160 CD B-Lab_value
/ NNS I-Lab_value
90 CD I-Lab_value
mmHg NN I-Lab_value
, , O
the DT O
PCP NNP B-Nonbiological_location
resumed VBD O
the DT O
administration NN O
of IN O
olmesartan NNS B-Medication
on IN O
late JJ O
December NNP O
, , O
2011 CD O
. . O

One CD O
week NN O
later RB O
, , O
the DT O
patient NN O
complained VBD O
of IN O
recurrent NN O
decreased VBN B-Sign_symptom
appetite RB I-Sign_symptom
and CC O
nausea NN B-Sign_symptom
. . O

After IN O
experiencing VBG O
diarrhea NN B-Sign_symptom
( ( O
five CD B-Lab_value
bowel NN I-Lab_value
movements NNS I-Lab_value
during IN I-Lab_value
a DT I-Lab_value
2 CD I-Lab_value
- : I-Lab_value
day NN I-Lab_value
period NN I-Lab_value
) ) O
, , O
he PRP O
passed VBD O
soft JJ B-Lab_value
stools NNS B-Diagnostic_procedure
once RB B-Frequency
daily JJ I-Frequency
, , O
and CC O
his PRP$ O
body NN B-Diagnostic_procedure
weight VBD I-Diagnostic_procedure
decreased VBN B-Lab_value
to TO O
47 CD B-Lab_value
kg NNS I-Lab_value
so RB O
he PRP O
came VBD O
to TO O
our PRP$ O
hospital NN B-Nonbiological_location
again RB O
3 CD O
weeks NNS O
after IN O
the DT O
resumption NN O
of IN O
olmesartan NN B-Medication
for IN O
treatment NN O
. . O

His PRP$ O
vital JJ B-Diagnostic_procedure
signs NNS I-Diagnostic_procedure
were VBD O
as IN O
follows VBZ O
: : O
body NN B-Diagnostic_procedure
temperature NN I-Diagnostic_procedure
, , O
35 CD B-Lab_value
. . I-Lab_value
1 CD I-Lab_value
℃ NN I-Lab_value
; : O
pulse JJ B-Diagnostic_procedure
rate NN I-Diagnostic_procedure
, , O
93 CD B-Lab_value
/ JJ I-Lab_value
min NN I-Lab_value
; : O
and CC O
blood NN B-Diagnostic_procedure
pressure NN I-Diagnostic_procedure
, , O
132 CD B-Lab_value
/ NN I-Lab_value
75 CD I-Lab_value
mmHg NN I-Lab_value
. . O

The DT O
neurologic JJ B-Diagnostic_procedure
findings NNS I-Diagnostic_procedure
showed VBD O
no DT B-Lab_value
worsening NN I-Lab_value
of IN O
his PRP$ O
symptoms NNS O
. . O

The DT O
laboratory NN B-Diagnostic_procedure
findings NNS I-Diagnostic_procedure
were VBD O
as IN O
follows VBZ O
: : O
sodium NN B-Diagnostic_procedure
level NN I-Diagnostic_procedure
, , O
139 CD B-Lab_value
mEq NN I-Lab_value
/ NNP I-Lab_value
L NNP I-Lab_value
; : O
potassium NN B-Diagnostic_procedure
level NN I-Diagnostic_procedure
, , O
2 CD B-Lab_value
. . I-Lab_value
9 CD I-Lab_value
mEq JJ I-Lab_value
/ NNP I-Lab_value
L NNP I-Lab_value
; : O
and CC O
chlorine VB B-Diagnostic_procedure
level NN I-Diagnostic_procedure
, , O
116 CD B-Lab_value
mEq NN I-Lab_value
/ NNP I-Lab_value
L NNP I-Lab_value
. . O

Hyperchloremia NNP B-Sign_symptom
was VBD O
noted VBN O
, , O
and CC O
the DT O
serum NN B-Lab_value
sodium NN I-Lab_value
level NN I-Lab_value
minus NN I-Lab_value
chloride JJ I-Lab_value
level NN I-Lab_value
( ( I-Lab_value
139 CD I-Lab_value
- : I-Lab_value
116 CD I-Lab_value
) ) I-Lab_value
was VBD I-Lab_value
23 CD I-Lab_value
mEq NN I-Lab_value
/ NNP I-Lab_value
L NNP I-Lab_value
; : O
additionally RB O
, , O
the DT O
arterial JJ B-Diagnostic_procedure
blood NN I-Diagnostic_procedure
gas NN I-Diagnostic_procedure
findings NNS I-Diagnostic_procedure
were VBD O
as IN O
follows VBZ O
: : O
pH NN B-Diagnostic_procedure
, , O
7 CD B-Lab_value
. . I-Lab_value
25 CD I-Lab_value
; : O
PCO2 NNP B-Diagnostic_procedure
, , O
25 CD B-Lab_value
mmHg NN I-Lab_value
, , O
and CC O
HCO3 NNP B-Diagnostic_procedure
, , O
11 CD B-Lab_value
mmol NN I-Lab_value
/ NNP I-Lab_value
L NNP I-Lab_value
. . O

The DT O
urinalysis JJ B-Diagnostic_procedure
findings NNS O
were VBD O
as IN O
follows VBZ O
: : O
sodium NN B-Diagnostic_procedure
level NN I-Diagnostic_procedure
, , O
15 CD B-Lab_value
mEq NN I-Lab_value
/ NNP I-Lab_value
L NNP I-Lab_value
; : O
potassium NN B-Diagnostic_procedure
level NN I-Diagnostic_procedure
, , O
13 CD B-Lab_value
mEq NN I-Lab_value
/ NNP I-Lab_value
L NNP I-Lab_value
; : O
chlorine JJ B-Diagnostic_procedure
level NN I-Diagnostic_procedure
, , O
100 CD B-Lab_value
mEq NN I-Lab_value
/ NNP I-Lab_value
L NNP I-Lab_value
; : O
and CC O
urine JJ B-Diagnostic_procedure
anion NN I-Diagnostic_procedure
gap NN I-Diagnostic_procedure
, , O
- : B-Lab_value
72 CD I-Lab_value
mEq NN I-Lab_value
/ NNP I-Lab_value
L NNP I-Lab_value
, , O
and CC O
there EX O
was VBD O
no DT B-Lab_value
apparent JJ I-Lab_value
increase NN I-Lab_value
in IN O
bowel JJ B-Diagnostic_procedure
movements NNS I-Diagnostic_procedure
; : O
however RB O
, , O
this DT O
seemed VBD O
to TO O
be VB O
due JJ O
to TO O
the DT O
absence NN B-Sign_symptom
of IN I-Sign_symptom
HCO3 NNP I-Sign_symptom
- : I-Sign_symptom
from IN O
the DT O
gastrointestinal JJ B-Biological_structure
tract NN I-Biological_structure
( ( O
6 CD O
) ) O
. . O

Plain NNP O
abdominal JJ B-Biological_structure
radiography NN B-Diagnostic_procedure
and CC O
abdominal JJ B-Biological_structure
computed VBN B-Diagnostic_procedure
tomography NN I-Diagnostic_procedure
findings NNS O
revealed VBD O
the DT O
continuous JJ B-Detailed_description
dilation NN B-Sign_symptom
of IN O
the DT O
entire JJ B-Biological_structure
intestinal JJ I-Biological_structure
tract NN I-Biological_structure
( ( O
Fig NNP O
. . O
2 CD O
) ) O
; : O
therefore RB O
, , O
the DT O
patient NN O
was VBD O
diagnosed VBN O
with IN O
intestinal JJ B-Disease_disorder
pseudo NN I-Disease_disorder
- : I-Disease_disorder
obstruction NN I-Disease_disorder
. . O

After IN O
discontinuing VBG O
olmesartan NN B-Medication
, , O
the DT O
nausea NN B-Sign_symptom
and CC O
body NN B-Sign_symptom
weight JJ I-Sign_symptom
decreases NNS I-Sign_symptom
were VBD O
promptly RB O
ameliorated VBN O
. . O

Duodenal NNP B-Biological_structure
biopsy NN B-Diagnostic_procedure
findings NNS O
after IN O
discontinuing VBG O
olmesartan NN B-Medication
showed VBD O
that IN O
the DT O
inflammation NN B-Sign_symptom
observed VBD O
before RB O
discontinuation NN O
as RB O
well RB O
as IN O
the DT O
fold NN B-Sign_symptom
structure NN I-Sign_symptom
had VBD O
both DT O
clearly RB O
ameliorated VBN O
( ( O
Fig NNP O
. . O
3 CD O
) ) O
. . O

-DOCSTART- NN -X-

An DT O
18 CD B-Age
- : I-Age
year NN I-Age
- : I-Age
old JJ I-Age
college NN B-Occupation
student NN I-Occupation
was VBD O
referred VBN O
from IN B-Nonbiological_location
the DT I-Nonbiological_location
University NNP I-Nonbiological_location
Clinic NNP I-Nonbiological_location
for IN O
having VBG O
low JJ B-Lab_value
hemoglobin NN B-Diagnostic_procedure
( ( O
Hg NNP O
4 CD B-Lab_value
. . I-Lab_value
7 CD I-Lab_value
g JJ I-Lab_value
/ NNP I-Lab_value
dl NN I-Lab_value
) ) O
. . O

He PRP O
was VBD O
completely RB O
well RB O
till VB O
one CD O
month NN O
back RB O
when WRB O
he PRP O
presented VBD O
with IN O
easy JJ B-Detailed_description
fatigability NN B-Sign_symptom
, , O
postural JJ B-Detailed_description
dizziness NN B-Sign_symptom
, , O
palpitation NN B-Sign_symptom
and CC O
dyspnea NN B-Sign_symptom
. . O

He PRP O
gave VBD O
history NN O
of IN O
30 CD B-Lab_value
kg NNS I-Lab_value
weight JJ B-Sign_symptom
loss NN I-Sign_symptom
over IN B-Duration
the DT I-Duration
past JJ I-Duration
6 CD I-Duration
months NNS I-Duration
. . O

On IN O
physical JJ B-Diagnostic_procedure
examination NN I-Diagnostic_procedure
, , O
he PRP O
looked VBD O
pale NN B-Sign_symptom
, , O
not RB O
jaundiced VBD B-Sign_symptom
or CC O
cyanosed VBN B-Sign_symptom
. . O

His PRP$ O
vital JJ B-Diagnostic_procedure
signs NNS I-Diagnostic_procedure
were VBD O
all DT O
within IN B-Lab_value
normal JJ I-Lab_value
limits NNS I-Lab_value
, , O
except IN O
for IN O
an DT O
elevated JJ B-Lab_value
heart NN B-Diagnostic_procedure
rate NN I-Diagnostic_procedure
( ( O
98 CD B-Lab_value
/ NNP I-Lab_value
min NN I-Lab_value
) ) O
. . O

Cardiovascular NNP B-Biological_structure
, , O
respiratory NN B-Biological_structure
and CC O
abdominal JJ B-Biological_structure
examinations NNS B-Diagnostic_procedure
were VBD O
unremarkable JJ B-Lab_value
. . O

Primary JJ O
investigations NNS O
in IN O
our PRP$ O
hospital NN B-Nonbiological_location
revealed VBD O
low JJ B-Lab_value
hemoglobin NNS B-Diagnostic_procedure
level NN O
( ( O
5 CD B-Lab_value
. . I-Lab_value
1 CD I-Lab_value
g JJ I-Lab_value
/ NNP I-Lab_value
dl NN I-Lab_value
) ) O
, , O
low JJ B-Lab_value
iron NN B-Diagnostic_procedure
( ( O
< JJ B-Lab_value
10 CD I-Lab_value
ug JJ I-Lab_value
/ NNP I-Lab_value
dl NN I-Lab_value
) ) O
, , O
and CC O
a DT O
positive JJ B-Lab_value
occult NN B-Diagnostic_procedure
blood NN I-Diagnostic_procedure
test NN I-Diagnostic_procedure
. . O

A DT O
provisional JJ O
diagnosis NN O
of IN O
microcytic JJ B-Disease_disorder
hypochromic JJ I-Disease_disorder
anemia NN I-Disease_disorder
for IN O
further JJ O
workup NN O
was VBD O
made VBN O
. . O

Bone NNP B-Diagnostic_procedure
marrow NN I-Diagnostic_procedure
aspirate NN I-Diagnostic_procedure
and CC O
trephine NN B-Diagnostic_procedure
biopsy NN I-Diagnostic_procedure
revealed VBD O
normocellular JJ B-Lab_value
marrow NN I-Lab_value
, , O
depicting VBG O
normal JJ B-Lab_value
trilineage NN I-Lab_value
hematopoiesis NN I-Lab_value
. . O

Upper NNP B-Biological_structure
GI NNP I-Biological_structure
endoscopy NN B-Diagnostic_procedure
showed VBD O
erosive JJ B-Detailed_description
antral JJ B-Biological_structure
gastritis NN B-Disease_disorder
with IN O
patchy JJ B-Detailed_description
ulcerative JJ B-Detailed_description
inflammation NN B-Sign_symptom
. . O

Abdominal NNP B-Biological_structure
ultrasound NN B-Diagnostic_procedure
showed VBD O
a DT O
slightly RB B-Severity
enlarged VBN B-Sign_symptom
liver NN B-Biological_structure
with IN O
a DT O
rounded JJ B-Shape
echogenic JJ B-Detailed_description
lesion NN B-Sign_symptom
in IN O
the DT O
anterior JJ B-Biological_structure
wall NN I-Biological_structure
of IN I-Biological_structure
the DT I-Biological_structure
right JJ I-Biological_structure
lobe NN I-Biological_structure
suggestive NN O
of IN O
hemangioma NN B-Disease_disorder
. . O

The DT O
spleen NN B-Biological_structure
was VBD O
slightly RB B-Severity
enlarged VBN B-Sign_symptom
and CC O
normal JJ B-Lab_value
in IN I-Lab_value
echogenicity NN I-Lab_value
with IN O
no DT O
focal JJ B-Detailed_description
lesions NNS B-Sign_symptom
. . O

Computed VBN B-Diagnostic_procedure
Tomography NNP I-Diagnostic_procedure
( ( O
CT NNP B-Diagnostic_procedure
) ) O
scan NN O
of IN O
the DT O
abdomen NNS B-Biological_structure
and CC O
pelvis NN B-Biological_structure
showed VBD O
a DT O
fairly RB B-Detailed_description
large JJ I-Detailed_description
well RB B-Detailed_description
defined VBN I-Detailed_description
soft JJ B-Detailed_description
tissue NN I-Detailed_description
mass NN B-Sign_symptom
located VBN O
in IN O
the DT O
anterior JJ B-Biological_structure
upper JJ I-Biological_structure
pelvis NN I-Biological_structure
and CC O
engulfing VBG O
jejunal JJ B-Biological_structure
loops NNS I-Biological_structure
causing VBG O
bowel NN B-Biological_structure
wall NN I-Biological_structure
thickening NN B-Sign_symptom
. . O

The DT O
patient NN O
underwent VBD O
an DT O
exploratory JJ O
laparotomy NN B-Diagnostic_procedure
and CC O
excision NN B-Therapeutic_procedure
of IN O
the DT O
jejunal JJ B-Biological_structure
mass NN B-Sign_symptom
. . O

Macroscopic NNP B-Diagnostic_procedure
examination NN I-Diagnostic_procedure
revealed VBD O
an DT O
11 CD B-Volume
× NN I-Volume
8 CD I-Volume
× NN I-Volume
2 CD I-Volume
cm NN I-Volume
annular JJ B-Biological_structure
mass NN B-Sign_symptom
located VBN O
within IN B-Biological_structure
the DT I-Biological_structure
jejunal JJ I-Biological_structure
wall NN I-Biological_structure
ulcerating NN B-Biological_structure
through IN I-Biological_structure
the DT I-Biological_structure
mucosa NN I-Biological_structure
and CC O
extending VBG B-Biological_structure
to TO I-Biological_structure
the DT I-Biological_structure
serosal NN I-Biological_structure
surface NN I-Biological_structure
. . O

Microscopic NNP B-Diagnostic_procedure
examination NN I-Diagnostic_procedure
revealed VBD O
a DT O
tumor NN B-Sign_symptom
situated VBN O
in IN O
the DT O
muscularis NN B-Biological_structure
propria NN I-Biological_structure
and CC O
extending VBG B-Biological_structure
to TO I-Biological_structure
the DT I-Biological_structure
mucosa NN I-Biological_structure
and CC O
the DT O
serosa NN B-Biological_structure
. . O

The DT O
neoplastic JJ O
cells NNS O
were VBD O
arranged VBN O
in IN O
predominantly RB B-Shape
pseudoalveolar JJ I-Shape
pattern NN I-Shape
( ( O
Fig NNP O
. . O
1a CD O
, , O
b NN O
) ) O
. . O

They PRP O
were VBD O
polygonal JJ B-Shape
in IN O
shape NN O
with IN O
variable JJ B-Detailed_description
amount NN I-Detailed_description
of IN I-Detailed_description
eosinophilic JJ I-Detailed_description
to TO I-Detailed_description
clear JJ I-Detailed_description
cytoplasm NN I-Detailed_description
( ( O
Fig NNP O
. . O
1c CD O
) ) O
. . O

The DT O
nuclei NN B-Detailed_description
were VBD I-Detailed_description
oval JJ I-Detailed_description
with IN I-Detailed_description
vesicular JJ I-Detailed_description
chromatin NN I-Detailed_description
and CC I-Detailed_description
inconspicuous JJ I-Detailed_description
nucleoli NNS I-Detailed_description
. . O

Scattered VBN B-Detailed_description
osteoclast SYM B-Detailed_description
- : I-Detailed_description
like IN I-Detailed_description
multinucleated VBN B-Detailed_description
giant JJ B-Sign_symptom
cells NNS I-Sign_symptom
were VBD O
also RB O
identified VBN O
( ( O
Fig NNP O
. . O
1b CD O
, , O
c NN O
) ) O
. . O

Frequent JJ B-Detailed_description
mitotic JJ B-Sign_symptom
figures NNS I-Sign_symptom
and CC O
necrosis NN B-Sign_symptom
were VBD O
noted VBN O
. . O

All DT B-Biological_structure
lymph NN I-Biological_structure
nodes NNS I-Biological_structure
were VBD O
not RB O
involved VBN B-Sign_symptom
by IN I-Sign_symptom
tumor NN I-Sign_symptom
. . O

Immunohistochemically RB B-Diagnostic_procedure
, , O
the DT O
neoplastic JJ O
cells NNS O
were VBD O
strongly RB O
and CC O
diffusely RB O
positive JJ B-Lab_value
for IN O
S NNP B-Diagnostic_procedure
- : I-Diagnostic_procedure
100 CD I-Diagnostic_procedure
protein NN I-Diagnostic_procedure
( ( O
Fig NNP O
. . O
1d CD O
) ) O
. . O

They PRP O
were VBD O
also RB O
positive JJ B-Lab_value
for IN O
vimentin NN B-Diagnostic_procedure
. . O

Melanocytic JJ B-Diagnostic_procedure
markers NNS I-Diagnostic_procedure
( ( O
HMB45 NNP B-Diagnostic_procedure
and CC O
Melan NNP B-Diagnostic_procedure
A NNP I-Diagnostic_procedure
) ) O
, , O
neuroendocrine JJ B-Diagnostic_procedure
markers NNS I-Diagnostic_procedure
( ( O
chromogranin VB B-Diagnostic_procedure
A NNP I-Diagnostic_procedure
, , O
synaptophysin NN B-Diagnostic_procedure
and CC O
CD56 NNP B-Diagnostic_procedure
) ) O
, , O
smooth JJ B-Diagnostic_procedure
muscle NN I-Diagnostic_procedure
actin NN I-Diagnostic_procedure
, , O
desmin NN B-Diagnostic_procedure
, , O
CD34 NNP B-Diagnostic_procedure
, , O
CD117 NNP B-Diagnostic_procedure
, , O
cytokeratin NN B-Diagnostic_procedure
and CC O
LCA NNP B-Diagnostic_procedure
were VBD O
all DT O
negative JJ B-Lab_value
in IN O
the DT O
neoplastic JJ O
cells NNS O
. . O

Fluorescein NNP B-Diagnostic_procedure
in IN I-Diagnostic_procedure
situ JJ I-Diagnostic_procedure
hybridization NN I-Diagnostic_procedure
( ( O
FISH NNP B-Diagnostic_procedure
) ) O
analysis NN O
for IN O
EWSR1 NNP B-Detailed_description
break VBP I-Detailed_description
apart JJ I-Detailed_description
probe NN I-Detailed_description
on IN O
paraffin NN B-Detailed_description
- : I-Detailed_description
embedded VBN I-Detailed_description
tumor NN I-Detailed_description
showed VBD O
evidence NN O
of IN O
a DT O
22q12 CD B-Sign_symptom
rearrangement NN I-Sign_symptom
in IN O
197 CD B-Lab_value
out IN I-Lab_value
of IN I-Lab_value
205 CD I-Lab_value
( ( I-Lab_value
96 CD I-Lab_value
% NN I-Lab_value
) ) I-Lab_value
of IN I-Lab_value
interphase NN I-Lab_value
nuclei NN I-Lab_value
scored VBD O
. . O

The DT O
native JJ O
state NN O
of IN O
EWSR1 NNP O
break VBP O
apart JJ O
probe NN O
will MD O
be VB O
seen VBN O
as IN O
two CD O
adjacent NN O
or CC O
fused VBN O
( ( O
overlapping VBG O
) ) O
red JJ O
/ NN O
green NN O
( ( O
yellow JJ O
) ) O
signals NNS O
. . O

However RB O
, , O
EWSR1 NNP O
gene NN O
rearrangement NN O
presented VBD O
as IN O
one CD O
red JJ O
and CC O
one CD O
green NN O
separated VBN O
signal NN O
( ( O
Fig NNP O
. . O
1e CD O
) ) O
. . O

The DT O
patient NN O
did VBD O
not RB O
receive VB O
chemotherapy NN B-Medication
or CC O
radiotherapy NN B-Therapeutic_procedure
. . O

During IN O
the DT O
clinical JJ O
follow NN O
up RB O
, , O
the DT O
patient NN O
remained VBD O
disease JJ B-Sign_symptom
free JJ I-Sign_symptom
for IN O
3 CD B-Duration
years NNS I-Duration
until IN O
he PRP O
presented VBD O
with IN O
local JJ B-Detailed_description
recurrence NN B-Sign_symptom
. . O

The DT O
treatment NN O
plan NN O
was VBD O
surgical JJ O
resection NN B-Therapeutic_procedure
but CC O
the DT O
patient NN O
sought VBD O
medical JJ O
advice NN O
in IN O
a DT O
different JJ B-Nonbiological_location
institution NN I-Nonbiological_location
where WRB O
he PRP O
died VBD O
of IN O
the DT O
disease NN O
a DT O
year NN O
later RB O
. . O

-DOCSTART- NN -X-

A DT O
54 CD B-Age
year NN I-Age
- : I-Age
old JJ I-Age
diabetic JJ O
woman NN O
complained VBD O
of IN O
blurred JJ B-Sign_symptom
vision NN I-Sign_symptom
in IN O
the DT O
left NN B-Biological_structure
eye NN I-Biological_structure
for IN O
5 CD B-Duration
days NNS I-Duration
without IN O
scalp JJ B-Biological_structure
tenderness NN B-Sign_symptom
or CC O
headache NN B-Sign_symptom
. . O

Visual JJ B-Diagnostic_procedure
acuity NN I-Diagnostic_procedure
( ( O
VA NNP B-Diagnostic_procedure
) ) O
was VBD O
20 CD B-Lab_value
/ JJ I-Lab_value
20 CD I-Lab_value
right JJ B-Biological_structure
eye NN I-Biological_structure
and CC O
20 CD B-Lab_value
/ NN I-Lab_value
30 CD I-Lab_value
left VBD B-Biological_structure
eye NN I-Biological_structure
. . O

Intraocular JJ B-Diagnostic_procedure
pressures NNS I-Diagnostic_procedure
were VBD O
normal JJ B-Lab_value
. . O

Funduscopic NNP B-Diagnostic_procedure
examination NN I-Diagnostic_procedure
revealed VBD O
left VBD B-Biological_structure
optic JJ I-Biological_structure
nerve NN I-Biological_structure
edema NN B-Sign_symptom
and CC O
a DT O
small JJ B-Severity
disc NN B-Biological_structure
margin NN I-Biological_structure
hemorrhage NN B-Sign_symptom
. . O

WBC NNP B-Diagnostic_procedure
count NN I-Diagnostic_procedure
was VBD O
12,700 CD B-Lab_value
, , O
ESR NNP B-Diagnostic_procedure
was VBD O
7 CD B-Lab_value
( ( O
normal JJ O
0 CD O
- : O
20 CD O
mm NN O
/ NNP O
hr NN O
) ) O
and CC O
CRP NNP B-Diagnostic_procedure
was VBD O
2 CD B-Lab_value
. . I-Lab_value
4 CD I-Lab_value
( ( O
normal JJ O
0 CD O
- : O
1 CD O
. . O
0 CD O
mg JJ O
/ NNP O
dL NN O
) ) O
. . O

Three CD O
days NNS O
later RB O
, , O
she PRP O
noted VBD O
new JJ O
left JJ B-Biological_structure
eye NN I-Biological_structure
pain NN B-Sign_symptom
and CC O
her PRP$ O
vision NN B-Diagnostic_procedure
declined VBD O
to TO O
counting VBG B-Lab_value
fingers NNS I-Lab_value
. . O

There EX O
was VBD O
no DT O
pain NN B-Sign_symptom
on IN B-Detailed_description
eye NN I-Detailed_description
movement NN I-Detailed_description
. . O

The DT O
right JJ B-Diagnostic_procedure
pupil NN I-Diagnostic_procedure
was VBD O
4 CD B-Distance
mm NN I-Distance
and CC O
reacted VBD B-Lab_value
to TO I-Lab_value
light NN I-Lab_value
; : O
the DT O
left NN B-Diagnostic_procedure
pupil NN I-Diagnostic_procedure
was VBD O
4 CD B-Distance
mm NN I-Distance
, , O
and CC O
there RB O
was VBD O
a DT O
relative JJ B-Detailed_description
left NN B-Biological_structure
afferent NN I-Biological_structure
pupillary JJ I-Biological_structure
defect NN B-Sign_symptom
. . O

The DT O
left JJ B-Biological_structure
optic JJ I-Biological_structure
nerve NN I-Biological_structure
was VBD O
swollen VBN B-Sign_symptom
with IN O
a DT O
few JJ B-Detailed_description
peripapillary JJ B-Biological_structure
nerve NN I-Biological_structure
fiber NNP I-Biological_structure
layer NN I-Biological_structure
hemorrhages NNS B-Sign_symptom
along IN O
with IN O
a DT O
cherry NN B-Color
red JJ I-Color
spot NN B-Sign_symptom
and CC O
mild VB B-Severity
macular JJ B-Biological_structure
edema NN B-Sign_symptom
consistent NN O
with IN O
central JJ B-Disease_disorder
retinal JJ I-Disease_disorder
artery NN I-Disease_disorder
occlusion NN I-Disease_disorder
; : O
there EX O
were VBD O
no DT O
posterior JJ B-Biological_structure
pole NN I-Biological_structure
or CC O
peripheral JJ B-Biological_structure
retinal JJ I-Biological_structure
hemorrhages NNS B-Sign_symptom
. . O

Trace NN B-Diagnostic_procedure
cells NNS I-Diagnostic_procedure
were VBD O
seen VBN B-Lab_value
in IN O
the DT O
anterior JJ B-Biological_structure
chamber NN I-Biological_structure
, , O
but CC O
not RB B-Lab_value
in IN O
the DT O
vitreous JJ B-Biological_structure
fluid NN I-Biological_structure
. . O

Repeat NNP O
WBC NNP B-Diagnostic_procedure
, , O
ESR NNP B-Diagnostic_procedure
and CC O
CRP NNP B-Diagnostic_procedure
were VBD O
normal JJ B-Lab_value
. . O

Treponemal NNP B-Detailed_description
and CC O
Bartonella NNP B-Detailed_description
antibodies NNS B-Diagnostic_procedure
, , O
the DT O
QuantiFERON NNP B-Diagnostic_procedure
- : I-Diagnostic_procedure
TB NN I-Diagnostic_procedure
test NN I-Diagnostic_procedure
, , O
blood NN B-Diagnostic_procedure
cultures NNS I-Diagnostic_procedure
, , O
EKG NNP B-Diagnostic_procedure
and CC O
carotid VB B-Biological_structure
Doppler NNP B-Detailed_description
ultrasound NN B-Diagnostic_procedure
were VBD O
unremarkable JJ B-Lab_value
. . O

Brain NNP B-Biological_structure
contrast NN B-Detailed_description
MRI NNP B-Diagnostic_procedure
demonstrated VBD O
no DT B-Lab_value
optic JJ B-Biological_structure
nerve NN I-Biological_structure
enhancement NN O
. . O

Twelve NNP O
days NNS O
later RB O
, , O
left VBD B-Biological_structure
eye NN I-Biological_structure
pain NN B-Sign_symptom
and CC O
vision NN B-Diagnostic_procedure
worsened VBN B-Lab_value
, , O
and CC O
the DT O
patient NN O
complained VBD O
of IN O
jaw NN B-Biological_structure
claudication NN B-Sign_symptom
and CC O
scalp NN B-Biological_structure
pain NN B-Sign_symptom
. . O

VA NNP B-Diagnostic_procedure
declined VBD O
to TO O
no DT B-Lab_value
light JJ I-Lab_value
perception NN I-Lab_value
in IN O
the DT O
left NN B-Biological_structure
eye NN I-Biological_structure
with IN O
1 CD B-Lab_value
+ NNS I-Lab_value
cells NNS B-Diagnostic_procedure
and CC I-Diagnostic_procedure
flare NN I-Diagnostic_procedure
in IN O
anterior JJ B-Biological_structure
chamber NN I-Biological_structure
and CC O
2 CD B-Lab_value
+ NNP I-Lab_value
vitreous JJ B-Diagnostic_procedure
cells NNS I-Diagnostic_procedure
and CC I-Diagnostic_procedure
haze NN I-Diagnostic_procedure
. . O

Funduscopic NNP B-Diagnostic_procedure
examination NN I-Diagnostic_procedure
revealed VBD O
extensive JJ B-Severity
retinal JJ B-Biological_structure
necrosis NN B-Sign_symptom
and CC O
diffuse NN B-Detailed_description
hemorrhages NNS B-Sign_symptom
with IN O
multiple JJ B-Detailed_description
areas NNS I-Detailed_description
of IN O
focal JJ B-Detailed_description
venous JJ B-Sign_symptom
beading NN I-Sign_symptom
( ( O
Fig NNP O
. . O
1 CD O
) ) O
, , O
consistent JJ O
with IN O
acute JJ B-Disease_disorder
retinal JJ I-Disease_disorder
necrosis NN I-Disease_disorder
. . O

Vitreous JJ B-Biological_structure
fluid NN I-Biological_structure
was VBD O
examined VBN O
by IN O
PCR NNP B-Diagnostic_procedure
for IN O
amplifiable JJ O
HSV NNP B-Diagnostic_procedure
, , O
VZV NNP B-Diagnostic_procedure
, , O
CMV NNP B-Diagnostic_procedure
and CC O
toxoplasma JJ B-Diagnostic_procedure
sequences NNS O
and CC O
returned VBD O
positive JJ B-Lab_value
for IN O
VZV NNP B-Diagnostic_procedure
DNA NNP B-Detailed_description
. . O

She PRP O
was VBD O
treated VBN O
with IN O
a DT O
one CD B-Frequency
- : I-Frequency
time NN I-Frequency
intravitreal JJ O
injection NN O
of IN O
ganciclovir NN B-Medication
2000 CD B-Dosage
mcg NN I-Dosage
/ VBD I-Dosage
0 CD I-Dosage
. . I-Dosage
5 CD I-Dosage
ml NN I-Dosage
in IN O
the DT O
left NN B-Biological_structure
eye NN I-Biological_structure
, , O
oral JJ O
acyclovir NN B-Medication
800 CD B-Dosage
mg NN I-Dosage
5 CD I-Dosage
times NNS I-Dosage
daily RB I-Dosage
for IN O
14 CD B-Duration
days NNS I-Duration
and CC O
oral JJ O
prednisone NN B-Medication
60 CD B-Dosage
mg JJ I-Dosage
daily RB I-Dosage
for IN O
7 CD B-Duration
days NNS I-Duration
followed VBN O
by IN O
20 CD B-Dosage
mg NNS I-Dosage
for IN O
7 CD B-Duration
days NNS I-Duration
. . O

Eleven NNP O
days NNS O
after IN O
starting VBG O
treatment NN O
, , O
because IN O
she PRP O
had VBD O
recently RB O
developed VBN O
jaw NN B-Biological_structure
claudication NN B-Sign_symptom
and CC O
intermittent JJ B-Frequency
scalp NN B-Biological_structure
pain NN B-Sign_symptom
, , O
a DT O
temporal JJ B-Biological_structure
artery NN I-Biological_structure
biopsy NN B-Therapeutic_procedure
was VBD O
performed VBN O
. . O

Histological JJ B-Diagnostic_procedure
examination NN I-Diagnostic_procedure
was VBD O
normal JJ B-Lab_value
( ( O
Fig NNP O
. . O
2 CD O
) ) O
while IN O
immunohistochemical JJ B-Diagnostic_procedure
analysis NN I-Diagnostic_procedure
demonstrated VBD B-Lab_value
VZV NNP B-Diagnostic_procedure
antigen NN I-Diagnostic_procedure
in IN O
the DT O
arterial JJ B-Biological_structure
adventitia NN I-Biological_structure
; : O
evaluation NN O
of IN O
adjacent JJ O
sections NNS O
for IN O
HSV NNP B-Diagnostic_procedure
- : I-Diagnostic_procedure
1 CD I-Diagnostic_procedure
antigen NN I-Diagnostic_procedure
and CC O
infiltrating NN B-Diagnostic_procedure
leukocytes NNS I-Diagnostic_procedure
( ( O
CD45 NNP O
, , O
not RB O
shown VBN O
) ) O
was VBD O
negative JJ B-Lab_value
( ( O
Fig NNP O
. . O
3 CD O
) ) O
. . O

Antiviral JJ O
therapy NN O
was VBD O
altered VBN O
to TO O
intravenous JJ O
acyclovir NN B-Medication
, , O
10 CD B-Dosage
mg NN I-Dosage
/ NN I-Dosage
kg NN I-Dosage
every DT I-Dosage
8 CD I-Dosage
h NN I-Dosage
for IN O
14 CD B-Duration
days NNS I-Duration
, , O
and CC O
steroids NNS B-Medication
were VBD O
discontinued VBN O
. . O

-DOCSTART- NN -X-

The DT O
patient NN O
, , O
a DT O
4 CD B-Age
- : I-Age
year NN I-Age
- : I-Age
old JJ I-Age
boy NN O
, , O
was VBD O
diagnosed VBN O
as IN O
having VBG O
Blau NNP B-Disease_disorder
syndrome NN I-Disease_disorder
based VBN O
on IN O
the DT O
manifestation NN O
of IN O
typical JJ O
clinical JJ O
features NNS O
( ( O
ankle NN B-Biological_structure
and CC O
wrist NN B-Biological_structure
arthritis NN B-Disease_disorder
/ NNP O
tenosynovitis NN B-Disease_disorder
, , O
diffuse RB B-Detailed_description
eczematous JJ B-Biological_attribute
rash NN B-Sign_symptom
, , O
and CC O
uveitis NN B-Disease_disorder
) ) O
, , O
histologic JJ B-Diagnostic_procedure
evidence NN O
of IN O
noncaseating VBG B-Detailed_description
granulomas NN B-Disease_disorder
, , O
and CC O
a DT O
heterozygous JJ B-Detailed_description
NOD2 NNP B-Diagnostic_procedure
mutation NN I-Diagnostic_procedure
( ( O
p NN B-Diagnostic_procedure
. . I-Diagnostic_procedure
R334W NNP I-Diagnostic_procedure
) ) O
. . O

Ocular JJ B-Disease_disorder
involvement NN I-Disease_disorder
was VBD O
initially RB O
controlled VBN B-Detailed_description
by IN O
topical JJ O
and CC O
oral JJ O
corticosteroids NNS B-Medication
, , O
but CC O
over IN B-Duration
the DT I-Duration
years NNS I-Duration
visual JJ B-Disease_disorder
impairment NN I-Disease_disorder
progressed VBD B-Detailed_description
. . O

Other JJ O
manifestations NNS O
of IN O
Blau NNP B-Disease_disorder
syndrome NN I-Disease_disorder
( ( O
arthritis NN B-Disease_disorder
and CC O
rash NN B-Sign_symptom
) ) O
subsided VBD B-Detailed_description
over IN B-Duration
time NN I-Duration
. . O

Bilateral NNP B-Detailed_description
panuveitis NN B-Disease_disorder
progressed VBD B-Detailed_description
after IN O
age NN O
5 CD O
years NNS O
, , O
and CC O
was VBD O
initially RB O
treated VBN O
with IN O
methotrexate NN B-Medication
. . O

However RB O
, , O
ocular JJ B-Biological_structure
inflammation NN B-Disease_disorder
persisted VBD B-Detailed_description
despite IN O
the DT O
addition NN O
of IN O
local JJ B-Detailed_description
steroid NN B-Medication
injections NNS O
and CC O
repeated VBN B-Detailed_description
intravenous JJ O
( ( O
IV NNP O
) ) O
bolus VBP O
methylprednisolone CD B-Medication
treatment NN I-Medication
; : O
therefore RB O
, , O
when WRB O
the DT O
patient NN O
was VBD O
age NN O
10 CD O
years NNS O
, , O
infliximab NN B-Medication
( ( O
initially RB O
at IN O
5 CD B-Dosage
mg NN I-Dosage
/ NNP I-Dosage
kg NN I-Dosage
increased VBD I-Dosage
to TO I-Dosage
10 CD B-Dosage
mg NNS I-Dosage
/ JJ I-Dosage
kg NNS I-Dosage
IV NNP I-Dosage
every DT I-Dosage
4 CD I-Dosage
to TO I-Dosage
6 CD I-Dosage
weeks NNS I-Dosage
) ) O
was VBD O
initiated VBN O
. . O

Although IN O
there EX O
was VBD O
an DT O
initial JJ O
improvement NN O
, , O
1 CD O
year NN O
after IN O
this DT O
treatment NN O
was VBD O
started VBN O
uveitis NN B-Disease_disorder
worsened VBN B-Severity
, , O
and CC O
at IN O
age NN O
12 CD O
years NNS O
infliximab NN B-Medication
was VBD O
discontinued VBN B-Detailed_description
. . O

Adalimumab NNP B-Medication
( ( O
24 CD B-Dosage
mg NN I-Dosage
/ NN I-Dosage
m2 NN I-Dosage
every DT I-Dosage
2 CD I-Dosage
weeks NNS I-Dosage
) ) O
was VBD O
then RB O
initiated VBN O
and CC O
the DT O
dosage NN O
of IN O
methotrexate NN B-Medication
( ( O
15 CD B-Dosage
mg NN I-Dosage
/ NNP I-Dosage
m2 NN I-Dosage
/ NNP I-Dosage
weekly RB I-Dosage
) ) O
was VBD O
increased VBN B-Lab_value
. . O

However RB O
, , O
ocular JJ B-Disease_disorder
disease NN I-Disease_disorder
remained VBD O
active JJ B-Detailed_description
. . O

Mycophenolate NNP B-Medication
mofetil NN I-Medication
( ( O
750 CD B-Dosage
mg NN I-Dosage
/ NNP I-Dosage
m2 NN I-Dosage
) ) O
and CC O
then RB O
abatacept VB B-Medication
( ( O
10 CD B-Dosage
mg NN I-Dosage
/ NNP I-Dosage
kg NNP I-Dosage
/ NNP I-Dosage
month NN I-Dosage
IV NNP O
) ) O
were VBD O
sequentially RB O
administered VBN O
, , O
without IN B-Diagnostic_procedure
significant JJ I-Diagnostic_procedure
improvement NN I-Diagnostic_procedure
. . O

At IN O
age NN O
16 CD O
years NNS O
the DT O
patient NN O
still RB O
had VBD O
granulomatous JJ B-Disease_disorder
retinal JJ B-Biological_structure
lesions NNS B-Disease_disorder
and CC O
anterior JJ B-Biological_structure
chamber NN I-Biological_structure
inflammation NN B-Disease_disorder
, , O
and CC O
macular JJ B-Biological_structure
edema NN B-Sign_symptom
developed VBD O
, , O
which WDT O
led VBD O
to TO O
retinal JJ B-Disease_disorder
detachment NN I-Disease_disorder
. . O

In IN O
addition NN O
to TO O
the DT O
other JJ O
steroid JJ O
therapy NN O
, , O
corticosteroid JJ B-Medication
pulse NN I-Medication
therapy NN I-Medication
was VBD O
necessary JJ O
to TO O
control VB O
disease NN O
flares NNS O
, , O
with IN O
an DT B-Lab_value
average NN I-Lab_value
of IN I-Lab_value
3 CD B-Dosage
boluses NNS I-Dosage
/ JJ I-Dosage
month NN I-Dosage
for IN O
6 CD B-Duration
consecutive JJ I-Duration
months NNS I-Duration
. . O

Because IN O
of IN O
the DT O
supposed VBN O
autoinflammatory JJ O
nature NN O
of IN O
Blau NNP O
syndrome NN O
, , O
we PRP O
initiated VBD O
a DT O
trial NN O
of IN O
IL NNP B-Medication
- : I-Medication
1 CD I-Medication
antibody NN I-Medication
administration NN I-Medication
( ( O
2 CD B-Dosage
mg NN I-Dosage
/ NNP I-Dosage
kg NNP I-Dosage
/ NNP I-Dosage
month NN I-Dosage
of IN O
canakinumab NN B-Medication
) ) O
. . O

During IN O
the DT O
6 CD O
months NNS O
that WDT O
followed VBD O
, , O
no DT O
ocular JJ B-Disease_disorder
flare NN I-Disease_disorder
occurred VBD O
and CC O
no DT O
steroid JJ B-Medication
pulse NN I-Medication
therapy NN I-Medication
was VBD O
necessary JJ O
. . O

Concomitant JJ O
treatment NN O
with IN O
oral JJ O
methotrexate NN B-Medication
and CC O
low JJ B-Lab_value
- : I-Lab_value
dose NN I-Lab_value
prednisone NN B-Medication
( ( O
0 CD B-Dosage
. . I-Dosage
2 CD I-Dosage
mg JJ I-Dosage
/ NNP I-Dosage
kg NN I-Dosage
/ NNP I-Dosage
day NN I-Dosage
) ) O
remained VBD O
unchanged JJ O
. . O

Figure NN O
1 CD O
shows NNS O
fluorangiograms NNS B-Diagnostic_procedure
before IN O
treatment NN O
and CC O
after IN O
the DT O
first JJ O
6 CD O
injections NNS O
. . O

The DT B-Medication
drug NN I-Medication
was VBD O
well RB B-Detailed_description
tolerated VBN I-Detailed_description
with IN I-Detailed_description
no DT I-Detailed_description
side NN I-Detailed_description
effects NNS I-Detailed_description
, , O
and CC O
findings NNS O
on IN O
laboratory NN B-Diagnostic_procedure
tests NNS I-Diagnostic_procedure
( ( O
performed VBN O
monthly RB B-Frequency
) ) O
were VBD O
normal JJ B-Detailed_description
. . O

-DOCSTART- NN -X-

A DT O
39 CD B-Age
- : I-Age
year NN I-Age
- : I-Age
old JJ I-Age
Korean JJ O
male NN O
come VBN O
to TO O
our PRP$ O
hospital NN B-Nonbiological_location
complaining NN O
of IN O
cough NN B-Sign_symptom
, , O
myalgia NN B-Sign_symptom
, , O
and CC O
fever NN B-Sign_symptom
that WDT O
had VBD O
lasted VBN B-Duration
for IN I-Duration
5 CD I-Duration
days NNS I-Duration
. . O

He PRP O
was VBD O
a DT O
company NN B-Occupation
worker NN I-Occupation
and CC O
denied VBD O
any DT O
previous JJ O
medical JJ O
histories NNS O
. . O

He PRP O
was VBD O
a DT O
current JJ O
smoker NN O
and CC O
drank NN O
alcohol NN O
about IN O
once RB O
a DT O
month NN O
. . O

His PRP$ O
vital JJ B-Diagnostic_procedure
signs NNS I-Diagnostic_procedure
were VBD O
: : O
blood NN B-Diagnostic_procedure
pressure NN I-Diagnostic_procedure
, , O
100 CD B-Lab_value
/ NN I-Lab_value
60 CD I-Lab_value
mmHg NN I-Lab_value
, , O
heart NN B-Diagnostic_procedure
rate NN I-Diagnostic_procedure
, , O
100 CD B-Lab_value
/ NN I-Lab_value
min NN I-Lab_value
, , O
respiratory NN B-Diagnostic_procedure
rate NN I-Diagnostic_procedure
, , O
25 CD B-Lab_value
breaths NNS I-Lab_value
/ JJ I-Lab_value
min NN I-Lab_value
, , O
and CC O
body NN B-Diagnostic_procedure
temperature NN I-Diagnostic_procedure
, , O
39 CD B-Lab_value
°C NN I-Lab_value
. . O

On IN O
the DT O
physical JJ B-Diagnostic_procedure
examination NN I-Diagnostic_procedure
, , O
decreased VBD B-Lab_value
breathing VBG B-Diagnostic_procedure
sound NN I-Diagnostic_procedure
was VBD O
noted VBN O
in IN O
the DT O
right NN B-Biological_structure
lower JJR I-Biological_structure
lung NN I-Biological_structure
. . O

Laboratory NN B-Diagnostic_procedure
tests NNS I-Diagnostic_procedure
revealed VBD O
a DT O
c JJ B-Diagnostic_procedure
- : I-Diagnostic_procedure
reactive JJ I-Diagnostic_procedure
protein NN I-Diagnostic_procedure
( ( O
CRP NNP B-Diagnostic_procedure
) ) O
level NN O
of IN O
119 CD B-Lab_value
mg NNS I-Lab_value
/ JJ I-Lab_value
dL NN I-Lab_value
, , O
a DT O
total JJ B-Diagnostic_procedure
bilirubin JJ I-Diagnostic_procedure
level NN O
of IN O
1 CD B-Lab_value
. . I-Lab_value
8 CD I-Lab_value
mg JJ I-Lab_value
/ NNP I-Lab_value
dL NN I-Lab_value
, , O
and CC O
alanine JJ B-Diagnostic_procedure
transaminase NN I-Diagnostic_procedure
and CC O
aspartate JJ B-Diagnostic_procedure
transaminase NN I-Diagnostic_procedure
levels NNS O
of IN O
250 CD B-Lab_value
and CC O
172 CD B-Lab_value
IU NNP I-Lab_value
/ NNP I-Lab_value
L NNP I-Lab_value
, , O
respectively RB O
. . O

His PRP$ O
platelet NN B-Diagnostic_procedure
count NN I-Diagnostic_procedure
was VBD O
98,000 CD B-Lab_value
/ JJ I-Lab_value
mm3 NNS I-Lab_value
, , O
while IN O
his PRP$ O
white JJ B-Diagnostic_procedure
cell NN I-Diagnostic_procedure
count NN I-Diagnostic_procedure
was VBD O
8150 CD B-Lab_value
/ NNP I-Lab_value
mm3 NN I-Lab_value
( ( O
neutrophil JJ B-Lab_value
: : I-Lab_value
85 CD I-Lab_value
% NN I-Lab_value
) ) O
. . O

In IN O
the DT O
arterial JJ B-Diagnostic_procedure
blood NN I-Diagnostic_procedure
gas NN I-Diagnostic_procedure
analysis NN I-Diagnostic_procedure
checked VBN O
in IN B-Detailed_description
room NN I-Detailed_description
air NN I-Detailed_description
, , O
pH NN B-Diagnostic_procedure
, , O
PaCO2 NNP B-Diagnostic_procedure
, , O
PaO2 NNP B-Diagnostic_procedure
, , O
bicarbonate NN B-Diagnostic_procedure
, , O
and CC O
oxygen NN B-Diagnostic_procedure
saturation NN I-Diagnostic_procedure
levels NNS O
were VBD O
7 CD B-Lab_value
. . I-Lab_value
50 CD I-Lab_value
, , O
34 CD B-Lab_value
mmHg NN I-Lab_value
, , O
67 CD B-Lab_value
mmHg NN I-Lab_value
, , O
26 CD B-Lab_value
. . I-Lab_value
5 CD I-Lab_value
mmol JJ I-Lab_value
/ NNP I-Lab_value
L NNP I-Lab_value
, , O
and CC O
95 CD B-Lab_value
% NN I-Lab_value
, , O
respectively RB O
. . O

A DT O
test NN B-Diagnostic_procedure
for IN I-Diagnostic_procedure
the DT I-Diagnostic_procedure
human JJ I-Diagnostic_procedure
immunodeficiency NN I-Diagnostic_procedure
virus NN I-Diagnostic_procedure
was VBD O
negative JJ B-Lab_value
. . O

Mycoplasma NNP B-Detailed_description
and CC O
Chlamydia NNP B-Detailed_description
antibodies NNS B-Diagnostic_procedure
were VBD O
negative JJ B-Lab_value
. . O

Streptococcal JJ B-Detailed_description
and CC O
Legionella NNP B-Detailed_description
urinary JJ B-Diagnostic_procedure
antigens NNS I-Diagnostic_procedure
were VBD O
negative JJ B-Lab_value
. . O

Anti NNP B-Detailed_description
- : I-Detailed_description
nuclear JJ I-Detailed_description
and CC O
anti JJ B-Detailed_description
- : I-Detailed_description
neutrophilic JJ I-Detailed_description
cytoplasmic JJ B-Diagnostic_procedure
antibodies NNS I-Diagnostic_procedure
were VBD O
also RB O
negative JJ B-Lab_value
. . O

A DT O
chest NN B-Biological_structure
X SYM B-Diagnostic_procedure
- : I-Diagnostic_procedure
ray NN I-Diagnostic_procedure
showed VBD O
consolidation NN B-Sign_symptom
in IN O
the DT O
right NN B-Biological_structure
mid NN I-Biological_structure
to TO I-Biological_structure
lower VB I-Biological_structure
lung NN I-Biological_structure
fields NNS I-Biological_structure
. . O

Chest NNP B-Biological_structure
computed VBD B-Diagnostic_procedure
tomography NN I-Diagnostic_procedure
showed VBD O
consolidation NN B-Sign_symptom
with IN O
surrounding VBG B-Texture
ground NN I-Texture
glass NN I-Texture
opacity NN I-Texture
in IN O
the DT O
right JJ B-Biological_structure
middle NN I-Biological_structure
lobe NN I-Biological_structure
with IN O
a DT O
small JJ B-Severity
amount NN I-Severity
of IN O
pleural JJ B-Disease_disorder
effusion NN I-Disease_disorder
in IN O
the DT O
right JJ B-Biological_structure
hemithorax NN I-Biological_structure
( ( O
Fig NNP O
. . O
1 CD O
) ) O
. . O

Abdominal NNP B-Biological_structure
sonography NN B-Diagnostic_procedure
revealed VBD O
no DT B-Lab_value
abnormal JJ I-Lab_value
finding NN I-Lab_value
in IN O
the DT O
hepatobiliary JJ B-Biological_structure
system NN I-Biological_structure
. . O

We PRP O
began VBD O
to TO O
administer VB O
4 CD B-Dosage
L NNP I-Dosage
/ NNP I-Dosage
min NN I-Dosage
of IN O
oxygen NN B-Medication
nasally RB O
and CC O
empirical JJ O
antibiotics NNS B-Medication
with IN O
third JJ O
generation NN O
cephalosporin NN B-Medication
and CC O
macrolide NN B-Medication
following VBG O
a DT O
diagnosis NN O
of IN O
community NN B-Detailed_description
- : I-Detailed_description
acquired VBN I-Detailed_description
pneumonia NN B-Disease_disorder
. . O

On IN O
the DT O
second JJ O
day NN O
in IN O
the DT O
hospital NN O
, , O
the DT O
patient NN O
` `` O
s JJ O
fever NN B-Sign_symptom
was VBD O
sustained VBN O
and CC O
he PRP O
complained VBD O
of IN O
dyspnea NN B-Sign_symptom
. . O

His PRP$ O
hypoxemia NN B-Sign_symptom
was VBD O
aggravated VBN O
such JJ O
that IN O
he PRP O
required VBD O
7 CD B-Dosage
L NNP I-Dosage
/ NNP I-Dosage
min NN I-Dosage
of IN O
oxygen NN B-Medication
via IN O
a DT O
simple JJ O
mask NN O
and CC O
the DT O
consolidation NN B-Sign_symptom
and CC O
pleural JJ B-Disease_disorder
effusion NN I-Disease_disorder
had VBD O
markedly RB O
progressed VBN O
( ( O
Fig NNP O
. . O
2a CD O
) ) O
. . O

We PRP O
performed VBD O
bronchoscopy NN B-Diagnostic_procedure
and CC O
thoracentesis NN B-Therapeutic_procedure
. . O

Multiplex NNP B-Detailed_description
real JJ B-Diagnostic_procedure
- : I-Diagnostic_procedure
time NN I-Diagnostic_procedure
reverse JJ I-Diagnostic_procedure
transcriptase NN I-Diagnostic_procedure
polymerase NN I-Diagnostic_procedure
chain NN I-Diagnostic_procedure
reaction NN I-Diagnostic_procedure
( ( O
RT NNP B-Diagnostic_procedure
- : I-Diagnostic_procedure
PCR NN I-Diagnostic_procedure
) ) O
for IN B-Detailed_description
respiratory NN I-Detailed_description
viruses NNS I-Detailed_description
using VBG B-Detailed_description
bronchoalveolar JJ I-Detailed_description
lavage NN I-Detailed_description
fluid NN I-Detailed_description
was VBD O
positive JJ B-Lab_value
for IN I-Lab_value
human JJ I-Lab_value
adenovirus NN I-Lab_value
while IN O
other JJ O
microbiological JJ B-Diagnostic_procedure
studies NNS I-Diagnostic_procedure
were VBD O
negative JJ B-Lab_value
. . O

Pleural NNP B-Diagnostic_procedure
fluid NN I-Diagnostic_procedure
was VBD O
lymphocyte JJ B-Lab_value
- : I-Lab_value
dominant JJ I-Lab_value
exudate NN I-Lab_value
and CC O
was VBD O
also RB O
positive JJ B-Lab_value
for IN I-Lab_value
human JJ I-Lab_value
adenovirus NN I-Lab_value
. . O

Under IN O
the DT O
diagnosis NN O
of IN O
adenovirus NN B-Disease_disorder
pneumonia NN I-Disease_disorder
, , O
we PRP O
started VBD O
antiviral JJ B-Medication
therapy NN I-Medication
with IN O
oral JJ O
ribavirin NN B-Medication
400 CD B-Dosage
mg NN I-Dosage
q NN I-Dosage
12 CD I-Dosage
h NN I-Dosage
while IN O
maintaining VBG O
antibiotics NNS B-Medication
. . O

On IN O
hospital JJ O
day NN O
4 CD O
, , O
his PRP$ O
fever NN B-Sign_symptom
had VBD O
subsided VBN O
and CC O
symptoms NNS B-Sign_symptom
were VBD O
much RB O
improved VBN O
. . O

The DT O
transaminase NN B-Diagnostic_procedure
levels NNS O
, , O
CRP NNP B-Diagnostic_procedure
and CC O
platelet NN B-Diagnostic_procedure
counts NNS I-Diagnostic_procedure
gradually RB O
normalized VBN B-Lab_value
( ( O
Fig NNP O
. . O
3 CD O
) ) O
. . O

A DT O
follow NN O
- : O
up RB O
chest JJS B-Biological_structure
X SYM B-Diagnostic_procedure
- : I-Diagnostic_procedure
ray NN I-Diagnostic_procedure
was VBD O
clear JJ B-Lab_value
( ( O
Fig NNP O
. . O
2b CD O
) ) O
and CC O
he PRP O
was VBD O
discharged VBN O
in IN O
hospital JJ O
day NN O
13 CD O
without IN O
any DT O
complications NNS B-Sign_symptom
. . O

-DOCSTART- NN -X-

A DT O
20 CD B-Age
- : I-Age
year NN I-Age
- : I-Age
old JJ I-Age
male NN O
with IN O
cystic JJ O
fibrosis NN O
was VBD O
transferred VBN O
to TO O
Houston NNP B-Nonbiological_location
Methodist NNP I-Nonbiological_location
Hospital NNP I-Nonbiological_location
in IN O
January NNP O
2013 CD O
to TO O
be VB O
evaluated VBN O
for IN O
lung NN B-Biological_structure
and CC O
kidney NN B-Biological_structure
transplant NN B-Therapeutic_procedure
. . O

Patients NNS O
with IN O
cystic JJ O
fibrosis NN O
are VBP O
known VBN O
to TO O
develop VB O
chronic JJ O
lung NN O
infections NNS O
that WDT O
adapt VBP O
over IN O
time NN O
to TO O
this DT O
unique JJ O
anatomic JJ O
niche NN O
( ( O
14 CD O
, , O
15 CD O
) ) O
. . O

His PRP$ O
complicated JJ O
medical JJ O
history NN O
included VBD O
pancreatic JJ O
insufficiency NN O
, , O
liver JJ B-Biological_structure
transplantation NN B-Therapeutic_procedure
in IN O
2004 CD O
, , O
steroid SYM B-Medication
- : O
induced JJ O
diabetes NNS B-Disease_disorder
, , O
end VBP O
- : O
stage NN O
renal JJ O
disease NN O
, , O
and CC O
testicular JJ O
cancer NN O
. . O

He PRP O
had VBD O
a DT O
long JJ O
history NN O
of IN O
respiratory JJ B-Disease_disorder
infections NNS I-Disease_disorder
with IN O
several JJ O
multidrug NNS B-Disease_disorder
- : I-Disease_disorder
resistant NN I-Disease_disorder
bacteria NNS I-Disease_disorder
, , O
including VBG O
MRSA NNP B-Disease_disorder
. . O

He PRP O
was VBD O
treated VBN O
with IN O
ceftaroline NN B-Medication
at IN O
an DT O
outside JJ B-Nonbiological_location
hospital NN I-Nonbiological_location
immediately RB O
prior JJ O
to TO O
transfer VB O
to TO O
Houston NNP B-Nonbiological_location
Methodist NNP I-Nonbiological_location
Hospital NNP I-Nonbiological_location
. . O

The DT O
patient NN O
was VBD O
periodically RB B-Frequency
hospitalized VBN O
from IN O
January NNP B-Duration
to TO I-Duration
July NNP I-Duration
2013 CD I-Duration
and CC O
was VBD O
treated VBN O
for IN O
recurrent JJ O
respiratory NN B-Biological_structure
and CC O
catheter NN B-Detailed_description
- : I-Detailed_description
related JJ I-Detailed_description
infections NNS B-Disease_disorder
caused VBN O
by IN O
MRSA NNP B-Disease_disorder
and CC O
multidrug SYM B-Disease_disorder
- : I-Disease_disorder
resistant JJ I-Disease_disorder
Pseudomonas NNP I-Disease_disorder
aeruginosa NN I-Disease_disorder
. . O

His PRP$ O
antibiotic JJ B-Medication
exposure NN O
included VBD O
long JJ O
treatment NN O
courses NNS O
with IN O
various JJ O
agents NNS O
, , O
including VBG O
meropenem NN B-Medication
, , O
ceftazidime NN B-Medication
, , O
doxycycline NN B-Medication
, , O
vancomycin NN B-Medication
, , O
linezolid JJ B-Medication
, , O
cefepime NN B-Medication
, , O
ciprofloxacin NN B-Medication
, , O
and CC O
inhaled VBD O
and CC O
systemic JJ O
colistin NN B-Medication
and CC O
tobramycin NN B-Medication
. . O

Shortly RB O
after IN O
being VBG O
readmitted VBN O
to TO O
our PRP$ O
hospital NN B-Nonbiological_location
in IN O
June NNP O
2013 CD O
, , O
MRSA NNP B-Disease_disorder
was VBD O
grown VBN O
from IN O
cultures NNS B-Diagnostic_procedure
of IN O
blood NN B-Biological_structure
and CC O
respiratory NN B-Biological_structure
specimens NNS I-Biological_structure
. . O

These DT O
two CD O
isolates NNS O
were VBD O
resistant JJ B-Lab_value
to TO O
clindamycin VB B-Diagnostic_procedure
, , O
linezolid FW B-Diagnostic_procedure
, , O
oxacillin NN B-Diagnostic_procedure
, , O
and CC O
trimethoprim SYM B-Diagnostic_procedure
- : I-Diagnostic_procedure
sulfamethoxazole NN I-Diagnostic_procedure
and CC O
susceptible JJ B-Lab_value
to TO O
minocycline VB B-Diagnostic_procedure
, , O
rifampin NN B-Diagnostic_procedure
, , O
and CC O
vancomycin NN B-Diagnostic_procedure
. . O

His PRP$ O
blood NN B-Biological_structure
isolate NN B-Diagnostic_procedure
grew VBD B-Lab_value
confluently RB I-Lab_value
around IN O
the DT O
ceftaroline NN B-Diagnostic_procedure
Etest NNP I-Diagnostic_procedure
strip NN I-Diagnostic_procedure
, , O
yielding VBG O
an DT O
MIC NNP B-Lab_value
of IN I-Lab_value
> NNP I-Lab_value
32 CD I-Lab_value
mg NN I-Lab_value
/ NN I-Lab_value
liter NN I-Lab_value
. . O

Five CD B-Lab_value
additional JJ O
S NNP B-Disease_disorder
. . I-Disease_disorder
aureus JJ I-Disease_disorder
respiratory NN B-Biological_structure
tract NN I-Biological_structure
isolates NNS B-Diagnostic_procedure
were VBD O
available JJ O
for IN O
further JJ O
study NN O
. . O

All DT O
MRSA NNP O
isolates NNS O
from IN O
this DT O
patient NN O
had VBD O
a DT O
small JJ O
- : O
colony NN O
- : O
variant NN O
( ( O
SCV NNP O
) ) O
phenotype NN O
. . O

-DOCSTART- NN -X-

A DT O
73 CD B-Age
- : I-Age
year NN I-Age
- : I-Age
old JJ I-Age
man NN O
who WP O
had VBD O
been VBN O
diagnosed VBN O
with IN O
type JJ B-Disease_disorder
2 CD I-Disease_disorder
diabetes NNS I-Disease_disorder
mellitus VBP I-Disease_disorder
at IN O
35 CD O
year NN O
of IN O
age NN O
, , O
who WP O
had VBD O
severe JJ B-Severity
diabetic JJ B-Disease_disorder
neuropathy NN I-Disease_disorder
and CC O
diabetic JJ B-Disease_disorder
- : I-Disease_disorder
ESRD NN I-Disease_disorder
complained VBD O
of IN O
respiratory NN B-Sign_symptom
distress NN I-Sign_symptom
and CC O
sudden JJ B-Detailed_description
chest NN B-Biological_structure
pain NN B-Sign_symptom
. . O

On IN O
the DT O
first JJ O
day NN O
of IN O
treatment NN O
, , O
he PRP O
visited VBD O
the DT O
emergency NN B-Nonbiological_location
room NN I-Nonbiological_location
. . O

A DT O
physical JJ B-Diagnostic_procedure
examination NN I-Diagnostic_procedure
revealed VBD O
that IN O
his PRP$ O
body NN B-Diagnostic_procedure
temperature NN I-Diagnostic_procedure
was VBD O
35 CD B-Lab_value
. . I-Lab_value
4 CD I-Lab_value
°C NN I-Lab_value
, , O
his PRP$ O
heart NN B-Diagnostic_procedure
rate NN I-Diagnostic_procedure
was VBD O
90 CD B-Lab_value
beats NNS I-Lab_value
/ VBP I-Lab_value
min NN I-Lab_value
with IN O
a DT O
regular JJ B-Lab_value
rhythm NN I-Lab_value
; : O
and CC O
his PRP$ O
blood NN B-Diagnostic_procedure
pressure NN I-Diagnostic_procedure
was VBD O
130 CD B-Lab_value
/ JJ I-Lab_value
77 CD I-Lab_value
mmHg NN I-Lab_value
. . O

A DT O
physical JJ B-Diagnostic_procedure
examination NN I-Diagnostic_procedure
revealed VBD O
coarse JJ B-Detailed_description
crackles NNS B-Sign_symptom
on IN O
bilateral JJ B-Detailed_description
lung NN B-Diagnostic_procedure
auscultation NN I-Diagnostic_procedure
. . O

The DT O
laboratory NN B-Diagnostic_procedure
data NNS I-Diagnostic_procedure
showed VBD O
a DT O
WBC NNP B-Diagnostic_procedure
count NN O
of IN O
8,800 CD B-Lab_value
/ NNS I-Lab_value
μL VBP I-Lab_value
with IN O
a DT O
shift NN B-Lab_value
to TO I-Lab_value
the DT I-Lab_value
left NN I-Lab_value
( ( O
neutrophils JJ B-Diagnostic_procedure
82 CD B-Lab_value
% NN I-Lab_value
) ) O
, , O
Hb NNP B-Diagnostic_procedure
10 CD B-Lab_value
. . I-Lab_value
2 CD I-Lab_value
g JJ I-Lab_value
/ NNP I-Lab_value
dL NN I-Lab_value
, , O
blood NN B-Diagnostic_procedure
urea JJ I-Diagnostic_procedure
nitrogen NN I-Diagnostic_procedure
( ( O
BUN NNP B-Diagnostic_procedure
) ) O
82 CD B-Lab_value
. . I-Lab_value
2 CD I-Lab_value
mg JJ I-Lab_value
/ NNP I-Lab_value
dL NN I-Lab_value
, , O
creatinine NN B-Diagnostic_procedure
( ( O
Cre NNP B-Diagnostic_procedure
) ) O
6 CD B-Lab_value
. . I-Lab_value
50 CD I-Lab_value
mg JJ I-Lab_value
/ NNP I-Lab_value
dL NN I-Lab_value
, , O
HbA1c NNP B-Diagnostic_procedure
5 CD B-Lab_value
. . I-Lab_value
9 CD I-Lab_value
% NN I-Lab_value
, , O
creatine JJ B-Diagnostic_procedure
kinase NN I-Diagnostic_procedure
( ( O
CK NNP B-Diagnostic_procedure
) ) O
189 CD B-Lab_value
IU NNP I-Lab_value
/ NNP I-Lab_value
L NNP I-Lab_value
, , O
C NNP B-Diagnostic_procedure
- : I-Diagnostic_procedure
reactive JJ I-Diagnostic_procedure
protein NN I-Diagnostic_procedure
( ( O
CRP NNP B-Diagnostic_procedure
) ) O
8 CD B-Lab_value
. . I-Lab_value
51 CD I-Lab_value
mg JJ I-Lab_value
/ NNP I-Lab_value
dL NN I-Lab_value
, , O
brain NN B-Diagnostic_procedure
- : I-Diagnostic_procedure
type NN I-Diagnostic_procedure
natriuretic JJ I-Diagnostic_procedure
peptide NN I-Diagnostic_procedure
( ( O
BNP NNP B-Diagnostic_procedure
) ) O
127 CD B-Lab_value
. . I-Lab_value
4 CD I-Lab_value
pg JJ I-Lab_value
/ NNP I-Lab_value
mL NN I-Lab_value
. . O

A DT O
chest NN B-Biological_structure
radiograph NN B-Diagnostic_procedure
revealed VBD O
perihilar JJ B-Detailed_description
consolidations NNS B-Sign_symptom
and CC O
air NN B-Detailed_description
bronchograms NNS B-Sign_symptom
( ( O
Fig NNP O
. . O
1 CD O
) ) O
. . O

An DT O
electrocardiogram NN B-Diagnostic_procedure
revealed VBD O
ST NNP B-Sign_symptom
- : I-Sign_symptom
segment NN I-Sign_symptom
elevation NN I-Sign_symptom
and CC O
poor JJ B-Sign_symptom
R NNP I-Sign_symptom
- : I-Sign_symptom
wave NN I-Sign_symptom
progression NN I-Sign_symptom
in IN O
leads NNS B-Detailed_description
V1 NNP I-Detailed_description
- : I-Detailed_description
V3 NNP I-Detailed_description
, , O
and CC O
echocardiography NN B-Diagnostic_procedure
revealed VBD O
apical JJ B-Sign_symptom
and CC I-Sign_symptom
ventricular JJ I-Sign_symptom
asynergy NN I-Sign_symptom
. . O

The DT O
patient NN O
was VBD O
therefore RB O
diagnosed VBN O
with IN O
acute JJ B-Detailed_description
myocardial JJ B-Disease_disorder
infarction NN I-Disease_disorder
and CC O
congestive JJ B-Detailed_description
heart NN B-Disease_disorder
failure NN I-Disease_disorder
. . O

Coronary JJ B-Biological_structure
angiography NN B-Diagnostic_procedure
was VBD O
performed VBN O
, , O
revealing VBG O
severe JJ O
angiostenosis NN B-Sign_symptom
in IN O
the DT O
septal JJ B-Biological_structure
branch NN I-Biological_structure
. . O

PCI NNP B-Therapeutic_procedure
was VBD O
therefore RB O
performed VBN O
. . O

The DT O
patient NN O
required VBN O
continuous JJ B-Detailed_description
maintenance NN B-Detailed_description
dialysis NN B-Therapeutic_procedure
. . O

On IN O
the DT O
following JJ O
day NN O
, , O
the DT O
patient NN O
went VBD O
into IN O
cardiorespiratory NN B-Disease_disorder
arrest NN I-Disease_disorder
and CC O
cardiopulmonary JJ B-Therapeutic_procedure
resuscitation NN I-Therapeutic_procedure
was VBD O
performed VBN O
, , O
followed VBN O
by IN O
mechanical JJ B-Detailed_description
ventilation NN B-Therapeutic_procedure
. . O

On IN O
day NN O
8 CD O
, , O
ventilator NN B-Therapeutic_procedure
assistance NN O
was VBD O
discontinued VBN O
. . O

However RB O
, , O
the DT O
patient NN O
produced VBD O
an DT O
increasing VBG B-Lab_value
volume NN I-Lab_value
of IN O
sputum NN B-Sign_symptom
, , O
which WDT O
began VBD O
to TO O
appear VB O
purulent NN B-Lab_value
. . O

Pseudomonas NNP B-Sign_symptom
aeruginosa NN I-Sign_symptom
was VBD O
identified VBN O
from IN O
a DT O
sputum JJ B-Diagnostic_procedure
culture NN I-Diagnostic_procedure
, , O
and CC O
tazobactam JJ B-Medication
/ NNP I-Medication
piperacillin NN I-Medication
( ( O
TAZ NNP B-Medication
/ NNP I-Medication
PIPC NNP I-Medication
) ) O
( ( O
4 CD B-Dosage
. . I-Dosage
5g CD I-Dosage
q12h NN I-Dosage
) ) O
was VBD O
administered VBN O
. . O

Despite IN O
this DT O
therapy NN O
, , O
the DT O
patient NN O
` `` O
s JJ O
respiratory NN B-Diagnostic_procedure
condition NN I-Diagnostic_procedure
worsened VBD B-Lab_value
and CC O
a DT O
chest NN B-Biological_structure
computed VBN B-Diagnostic_procedure
tomography NN I-Diagnostic_procedure
( ( O
CT NNP B-Diagnostic_procedure
) ) O
scan VBP O
on IN O
day NN O
15 CD O
revealed VBD O
bilateral JJ B-Detailed_description
perihilar JJ B-Detailed_description
opacities NNS B-Sign_symptom
, , O
pleural JJ B-Disease_disorder
effusion NN I-Disease_disorder
, , O
and CC O
atelectasis NN B-Disease_disorder
. . O
( ( O
Fig NNP O
. . O
2 CD O
) ) O
. . O

We PRP O
suspected VBD O
the DT O
development NN O
of IN O
complications NNS O
such JJ O
as IN O
microbial JJ B-Disease_disorder
substitution NN I-Disease_disorder
, , O
pneumomycosis NN B-Disease_disorder
and CC O
thus RB O
performed VBN O
sputum NN B-Diagnostic_procedure
culturing NN I-Diagnostic_procedure
and CC O
serum JJ B-Diagnostic_procedure
fungal JJ I-Diagnostic_procedure
antigen NN I-Diagnostic_procedure
tests NNS O
. . O

The DT O
administration NN O
of IN O
TAZ NNP B-Medication
/ NNP I-Medication
PIPC NNP I-Medication
was VBD O
changed VBN O
to TO O
meropenem VB B-Medication
( ( O
0 CD B-Dosage
. . I-Dosage
5 CD I-Dosage
g JJ I-Dosage
/ NNP I-Dosage
day NN I-Dosage
) ) O
. . O

On IN O
day NN O
16 CD O
, , O
the DT O
patient NN O
` `` O
s JJ O
serum NN B-Diagnostic_procedure
tested VBD O
positive JJ B-Lab_value
for IN O
Cryptococcus NNP B-Diagnostic_procedure
antigen NN I-Diagnostic_procedure
. . O

On IN O
day NN O
21 CD O
, , O
cryptococcal JJ B-Sign_symptom
bodies NNS I-Sign_symptom
were VBD O
identified VBN O
in IN O
two CD B-Detailed_description
sets NNS I-Detailed_description
of IN O
blood NN B-Diagnostic_procedure
cultures NNS I-Diagnostic_procedure
and CC O
liposomal JJ B-Medication
amphotericin NN I-Medication
B NNP I-Medication
( ( O
L NNP B-Medication
- : I-Medication
AMB NN I-Medication
) ) O
( ( O
3 CD B-Dosage
mg NN I-Dosage
/ NNP I-Dosage
kg NN I-Dosage
/ NNP I-Dosage
day NN I-Dosage
) ) O
was VBD O
administered VBN O
. . O

On IN O
day NN O
23 CD O
, , O
cryptococcal JJ B-Sign_symptom
bodies NNS I-Sign_symptom
were VBD O
identified VBN O
in IN O
the DT O
sputum NN B-Diagnostic_procedure
, , O
cerebrospinal JJ B-Diagnostic_procedure
fluid NN I-Diagnostic_procedure
, , O
and CC O
bilateral JJ B-Detailed_description
pleural JJ B-Disease_disorder
effusion NN I-Disease_disorder
( ( O
Fig NNP O
. . O
3 CD O
) ) O
. . O

The DT O
patient NN O
was VBD O
therefore RB O
diagnosed VBN O
with IN O
disseminated JJ B-Detailed_description
cryptococcosis NN B-Disease_disorder
. . O

On IN O
day NN O
25 CD O
, , O
brain NN B-Biological_structure
CT NNP B-Diagnostic_procedure
revealed VBD O
the DT O
absence NN O
of IN O
intracranial JJ B-Biological_structure
hypertension NN B-Sign_symptom
and CC O
a DT O
brain NN B-Biological_structure
abscess NN B-Disease_disorder
. . O

The DT O
patient NN O
was VBD O
not RB O
infected VBN O
with IN O
human JJ B-Disease_disorder
immunodeficiency NN I-Disease_disorder
virus NN I-Disease_disorder
( ( O
HIV NNP B-Disease_disorder
) ) O
. . O

The DT O
administration NN O
of IN O
L NNP B-Medication
- : I-Medication
AMB NNP I-Medication
( ( O
3 CD B-Dosage
mg NN I-Dosage
/ NNP I-Dosage
kg NN I-Dosage
/ NNP I-Dosage
day NN I-Dosage
) ) O
was VBD O
continued VBN O
. . O

On IN O
day NN O
31 CD O
, , O
chest JJS B-Biological_structure
CT NNP B-Diagnostic_procedure
revealed VBD O
a DT O
solitary JJ B-Detailed_description
nodule NN B-Sign_symptom
in IN O
the DT O
left JJ B-Biological_structure
lingular JJ I-Biological_structure
segment NN I-Biological_structure
for IN O
the DT O
first JJ O
time NN O
, , O
which WDT O
was VBD O
suspected VBN O
to TO O
be VB O
a DT O
pulmonary JJ B-Biological_structure
cryptococcus NN B-Disease_disorder
lesion NN I-Disease_disorder
( ( O
Fig NNP O
. . O
4a CD O
) ) O
. . O

After IN O
several JJ O
days NNS O
, , O
all DT O
of IN O
the DT O
sputum NN B-Diagnostic_procedure
, , O
blood NN B-Diagnostic_procedure
, , O
bilateral JJ B-Detailed_description
pleural JJ B-Diagnostic_procedure
effusion NN I-Diagnostic_procedure
, , O
and CC O
cerebrospinal JJ B-Diagnostic_procedure
fluid NN B-Diagnostic_procedure
cultures NNS I-Diagnostic_procedure
tested VBD O
negative JJ B-Lab_value
. . O

On IN O
day NN O
52 CD O
, , O
chest JJS B-Biological_structure
CT NNP B-Diagnostic_procedure
revealed VBD O
another DT O
lung NN B-Biological_structure
nodule NN B-Sign_symptom
in IN O
the DT O
right JJ B-Biological_structure
pulmonary JJ I-Biological_structure
apical JJ I-Biological_structure
region NN I-Biological_structure
. . O

These DT O
nodules NNS B-Sign_symptom
gradually RB O
decreased VBN B-Lab_value
in IN I-Lab_value
size NN I-Lab_value
until IN O
day NN O
79 CD O
( ( O
Fig NNP O
. . O
4b CD O
and CC O
c NN O
) ) O
. . O

Although IN O
L NNP B-Medication
- : I-Medication
AMB NN I-Medication
was VBD O
considered VBN O
effective JJ O
, , O
the DT O
C NNP B-Diagnostic_procedure
- : I-Diagnostic_procedure
reactive JJ I-Diagnostic_procedure
protein NN I-Diagnostic_procedure
level NN O
remained VBD O
elevated JJ B-Lab_value
and CC O
the DT O
bilateral JJ B-Detailed_description
pleural JJ B-Disease_disorder
effusion NN I-Disease_disorder
continuously RB O
increased VBD O
. . O

The DT O
patient NN O
lost VBD B-Sign_symptom
consciousness NN I-Sign_symptom
because IN O
of IN O
decreased JJ B-Lab_value
vital JJ B-Diagnostic_procedure
capacity NN I-Diagnostic_procedure
with IN O
increasing VBG O
bilateral JJ B-Detailed_description
pleural JJ B-Disease_disorder
effusion NN I-Disease_disorder
and CC O
was VBD O
diagnosed VBN O
with IN O
CO2 NNP B-Disease_disorder
narcosis NN I-Disease_disorder
. . O

The DT O
patient NN O
` `` O
s JJ O
general JJ B-Diagnostic_procedure
condition NN I-Diagnostic_procedure
deteriorated VBD B-Lab_value
. . O

On IN O
day NN O
87 CD O
, , O
ventricular JJ B-Disease_disorder
fibrillation NN I-Disease_disorder
occurred VBD O
and CC O
the DT O
patient NN O
died VBD O
. . O

Autopsy NNP B-Diagnostic_procedure
was VBD O
not RB O
performed VBN O
. . O

At IN O
a DT O
later JJ O
date NN O
, , O
the DT O
Cryptococcus NNP B-Detailed_description
isolate NN I-Detailed_description
was VBD O
identified VBN O
and CC O
classified VBN O
as IN O
Cryptococcus NNP B-Disease_disorder
neoformans NNPS I-Disease_disorder
var NN I-Disease_disorder
. . I-Disease_disorder
grubii NN I-Disease_disorder
( ( I-Disease_disorder
serotype VB I-Disease_disorder
A DT I-Disease_disorder
) ) I-Disease_disorder
by IN O
a DT O
genetic JJ B-Diagnostic_procedure
analysis NN I-Diagnostic_procedure
. . O

-DOCSTART- NN -X-

A DT O
63 CD B-Age
- : I-Age
year NN I-Age
- : I-Age
old JJ I-Age
male JJ O
patient NN O
without IN O
smoking NN B-Activity
or CC O
drinking NN B-Activity
history NN O
was VBD O
admitted VBN O
on IN O
June NNP O
11 CD O
, , O
2014 CD O
. . O

His PRP$ O
major JJ O
complaints NNS O
were VBD O
gradually RB O
aggravated VBN O
dysphagia NN B-Sign_symptom
and CC O
fatigue NN B-Sign_symptom
, , O
on IN O
suspicion NN O
of IN O
obstructive JJ B-Disease_disorder
disease NN I-Disease_disorder
in IN O
upper JJ B-Biological_structure
digestive JJ I-Biological_structure
tract NN I-Biological_structure
. . O

He PRP O
had VBD B-Occupation
been VBN I-Occupation
an DT I-Occupation
athlete NN I-Occupation
before IN O
, , O
and CC O
then RB O
retired VBD O
in IN O
good JJ O
physical JJ O
status NN O
before IN O
admission NN O
. . O

His PRP$ O
family NN O
and CC O
social JJ O
history NN O
indicated VBD O
nothing NN O
abnormal NN O
. . O

Thorough NNP O
physical JJ B-Diagnostic_procedure
examination NN I-Diagnostic_procedure
of IN O
his PRP$ O
skin NN B-Biological_structure
, , O
oral JJ B-Biological_structure
mucosa NN I-Biological_structure
, , O
eyes NNS B-Biological_structure
, , O
and CC O
genital JJ B-Biological_structure
areas NNS I-Biological_structure
failed VBD O
to TO O
identify VB O
any DT O
superficial JJ O
lesions NNS B-Sign_symptom
. . O

Additionally RB O
, , O
laboratory NN B-Diagnostic_procedure
tests NNS I-Diagnostic_procedure
including VBG O
hepatic JJ B-Diagnostic_procedure
function NN I-Diagnostic_procedure
, , O
renal JJ B-Diagnostic_procedure
function NN I-Diagnostic_procedure
, , O
and CC O
serum JJ B-Diagnostic_procedure
tumor NN I-Diagnostic_procedure
markers NNS I-Diagnostic_procedure
such JJ O
as IN O
carcinoembryonic JJ B-Diagnostic_procedure
antigen NN I-Diagnostic_procedure
, , O
cytokeratin NN B-Diagnostic_procedure
19 CD I-Diagnostic_procedure
fragment NN I-Diagnostic_procedure
, , O
squamous JJ B-Diagnostic_procedure
cell NN I-Diagnostic_procedure
carcinoma NN I-Diagnostic_procedure
, , O
neuron SYM B-Diagnostic_procedure
- : I-Diagnostic_procedure
specific JJ I-Diagnostic_procedure
enolase NN I-Diagnostic_procedure
, , O
and CC O
carbohydrate VB B-Diagnostic_procedure
antigen NN I-Diagnostic_procedure
125 CD I-Diagnostic_procedure
were VBD O
all DT O
in IN B-Lab_value
normal JJ I-Lab_value
range NN I-Lab_value
. . O

Therefore RB O
, , O
further JJ O
endoscopic NN B-Detailed_description
and CC O
radiological JJ B-Detailed_description
examinations NNS B-Diagnostic_procedure
were VBD O
carried VBN O
out RP O
for IN O
accurate JJ O
diagnosis NN O
. . O

Endoscopic NNP B-Diagnostic_procedure
examination NN I-Diagnostic_procedure
revealed VBD O
a DT O
slightly RB B-Color
pigmented VBN I-Color
, , O
irregular JJ B-Detailed_description
mass NN B-Sign_symptom
, , O
which WDT O
was VBD O
located VBN O
in IN O
lower JJR B-Biological_structure
esophagus NN I-Biological_structure
, , O
measuring VBG O
5 CD B-Area
. . I-Area
0 CD I-Area
cm NN I-Area
× VBD I-Area
3 CD I-Area
. . I-Area
0 CD I-Area
cm NN I-Area
in IN O
size NN O
. . O

Fine NNP B-Detailed_description
needle JJ I-Detailed_description
biopsy NN B-Diagnostic_procedure
of IN O
the DT O
lesion NN O
revealed VBD O
esophageal JJ B-Biological_structure
melanoma NN B-Disease_disorder
, , O
which WDT O
was VBD O
confirmed VBN O
by IN O
histopathology NN B-Diagnostic_procedure
. . O

Besides IN O
chest JJS B-Biological_structure
and CC O
abdomen NNS B-Biological_structure
computed VBN B-Diagnostic_procedure
tomography NN I-Diagnostic_procedure
( ( O
CT NNP B-Diagnostic_procedure
) ) O
, , O
enhanced VBD B-Detailed_description
cranial JJ B-Biological_structure
magnetic JJ B-Diagnostic_procedure
resonance NN I-Diagnostic_procedure
image NN I-Diagnostic_procedure
( ( O
MRI NNP B-Diagnostic_procedure
) ) O
and CC O
bone $ B-Biological_structure
emission NN B-Diagnostic_procedure
computed VBN I-Diagnostic_procedure
tomography NN I-Diagnostic_procedure
( ( O
ECT NNP B-Diagnostic_procedure
) ) O
showed VBD O
enlarged JJ B-Sign_symptom
mediastinal NN B-Biological_structure
, , O
nd NN O
also RB O
celiac JJ B-Biological_structure
lymph NN B-Biological_structure
nodes NNS I-Biological_structure
( ( O
Fig NNP O
. . O
1A CD O
) ) O
, , O
without IN O
obvious JJ O
involvement NN B-Sign_symptom
of IN O
supraclavicular JJ B-Biological_structure
lymph NN B-Biological_structure
nodes NNS I-Biological_structure
. . O

Concurrently RB O
, , O
the DT O
CT NNP B-Diagnostic_procedure
showed VBD O
an DT O
isolated JJ B-Detailed_description
, , O
irregular JJ B-Detailed_description
pulmonary JJ B-Biological_structure
tumor NN B-Sign_symptom
( ( O
Fig NNP O
. . O
1B CD O
) ) O
. . O

Positron NNP B-Diagnostic_procedure
emission NN I-Diagnostic_procedure
tomography NN I-Diagnostic_procedure
was VBD O
not RB O
carried VBN O
out RP O
, , O
because IN O
it PRP O
was VBD O
not RB O
covered VBN O
by IN O
health NN O
insurance NN O
of IN O
this DT O
patient NN O
. . O

Therefore RB O
, , O
this DT O
patient NN O
was VBD O
clinically RB B-Diagnostic_procedure
staged VBN I-Diagnostic_procedure
as IN O
cT3NxM1 NN B-Lab_value
according VBG O
to TO O
the DT O
7th JJ B-Detailed_description
edition NN I-Detailed_description
of IN I-Detailed_description
American NNP I-Detailed_description
Joint NNP I-Detailed_description
Committee NNP I-Detailed_description
on IN I-Detailed_description
Cancer NNP I-Detailed_description
TNM NNP I-Detailed_description
staging VBG I-Detailed_description
system NN I-Detailed_description
for IN O
esophageal JJ B-Disease_disorder
cancer NN I-Disease_disorder
. . O

CT NNP B-Detailed_description
- : I-Detailed_description
guided VBD I-Detailed_description
percutaneous JJ B-Detailed_description
pulmonary JJ B-Biological_structure
biopsy NN B-Diagnostic_procedure
was VBD O
avoided VBN O
, , O
with IN O
the DT O
aim NN O
to TO O
diminish VB O
the DT O
risk NN O
of IN O
tumor NN O
dissemination NN O
. . O

Single NNP B-Detailed_description
- : I-Detailed_description
stage NN I-Detailed_description
resection NN B-Therapeutic_procedure
of IN O
the DT O
esophageal NN B-Biological_structure
and CC O
pulmonary JJ B-Biological_structure
lesions NNS B-Sign_symptom
was VBD O
assumed VBN O
to TO O
be VB O
reasonable JJ O
after IN O
multidisciplinary JJ O
consultation NN O
, , O
which WDT O
was VBD O
approved VBN O
by IN O
Ethical NNP O
Committee NNP O
of IN O
Xuzhou NNP O
Central NNP O
Hospital NNP O
. . O

Because IN O
the DT O
prognosis NN O
of IN O
this DT O
patient NN O
probably RB O
was VBD O
extremely RB O
poor JJ O
without IN O
targeted JJ B-Therapeutic_procedure
antibodies NNS I-Therapeutic_procedure
, , O
which WDT O
he PRP O
could MD O
not RB O
afford VB O
for IN O
financial JJ O
reasons NNS O
. . O

After IN O
his PRP$ O
informed JJ O
consent NN O
, , O
simultaneous JJ B-Detailed_description
Ivor NNP B-Detailed_description
- : I-Detailed_description
Lewis NNP I-Detailed_description
esophagectomy NN B-Therapeutic_procedure
and CC O
right JJ B-Detailed_description
upper JJ I-Detailed_description
lobectomy NN B-Therapeutic_procedure
were VBD O
performed VBN O
successfully RB O
, , O
under IN O
general JJ B-Medication
anesthesia NN I-Medication
, , O
after IN O
double JJ B-Detailed_description
- : I-Detailed_description
lumen NNS I-Detailed_description
endotracheal JJ B-Detailed_description
intubation NN B-Therapeutic_procedure
, , O
followed VBN O
by IN O
systemic JJ B-Detailed_description
dissection NN B-Therapeutic_procedure
of IN O
lymph NN B-Biological_structure
nodes NNS I-Biological_structure
located VBN O
in IN O
mediastinum NN B-Biological_structure
and CC O
abdomen NNS B-Biological_structure
, , O
in IN O
accordance NN O
with IN O
the DT O
principles NNS O
of IN O
oncological JJ O
surgery NN O
. . O

The DT O
operation NN O
time NN O
was VBD O
290 CD B-Duration
minutes NNS I-Duration
, , O
without IN O
obvious JJ O
bleeding VBG B-Sign_symptom
during IN O
the DT O
surgery NN O
. . O

Postoperative JJ O
pathological JJ B-Diagnostic_procedure
staining NN I-Diagnostic_procedure
of IN O
the DT O
specimen NNS O
revealed VBD O
pleomorphic JJ B-Sign_symptom
cells NNS I-Sign_symptom
and CC O
abundant JJ O
melanin NN B-Sign_symptom
granules NNS I-Sign_symptom
( ( O
Fig NNP O
. . O
1C CD O
) ) O
, , O
whereas JJ O
immunohistochemical JJ B-Diagnostic_procedure
tests NNS I-Diagnostic_procedure
demonstrated VBD O
positive JJ B-Lab_value
expression NN I-Lab_value
of IN O
human JJ B-Diagnostic_procedure
melanoma NN I-Diagnostic_procedure
black JJ I-Diagnostic_procedure
45 CD I-Diagnostic_procedure
( ( O
HMB45 NNP B-Diagnostic_procedure
) ) O
, , O
microtubule SYM B-Diagnostic_procedure
- : I-Diagnostic_procedure
associated VBN I-Diagnostic_procedure
protein NN I-Diagnostic_procedure
tau VBZ I-Diagnostic_procedure
1 CD I-Diagnostic_procedure
( ( O
MAPT1 NNP B-Diagnostic_procedure
) ) O
, , O
melan VBP B-Diagnostic_procedure
A DT I-Diagnostic_procedure
and CC O
S100 NNP B-Diagnostic_procedure
, , O
and CC O
negative JJ B-Lab_value
expression NN I-Lab_value
of IN O
desmin NN B-Diagnostic_procedure
, , O
synaptophysin NN B-Diagnostic_procedure
, , O
and CC O
epithelial JJ B-Diagnostic_procedure
membrane NN I-Diagnostic_procedure
antigen NN I-Diagnostic_procedure
( ( O
EMA NNP B-Diagnostic_procedure
) ) O
, , O
which WDT O
was VBD O
consistent JJ O
with IN O
melanoma NN B-Disease_disorder
. . O

The DT O
resection NN B-Biological_structure
margin NN I-Biological_structure
and CC O
dissected VBD B-Biological_structure
lymph NN I-Biological_structure
nodes NNS I-Biological_structure
were VBD O
pathologically RB O
tumor JJ B-Sign_symptom
- : O
negative JJ O
. . O

In IN O
addition NN O
, , O
molecular JJ B-Diagnostic_procedure
study NN I-Diagnostic_procedure
of IN O
the DT O
patient NN O
indicated VBD O
mutation NN B-Sign_symptom
of IN I-Sign_symptom
V NNP I-Sign_symptom
- : I-Sign_symptom
raf NN I-Sign_symptom
murine NN I-Sign_symptom
sarcoma NN I-Sign_symptom
viral JJ I-Sign_symptom
oncogene NN I-Sign_symptom
homolog NN I-Sign_symptom
B1 NNP I-Sign_symptom
( ( O
BRAF NNP O
) ) O
V600E NNP O
. . O

Based VBN O
on IN O
these DT O
findings NNS O
, , O
a DT O
diagnosis NN O
of IN O
advanced JJ B-Severity
PMME NNP B-Disease_disorder
was VBD O
tentatively RB O
established VBN O
as IN O
stage NN B-Lab_value
IV NNP I-Lab_value
( ( O
pT3N0M1 NN B-Lab_value
) ) O
, , O
because IN O
there EX O
was VBD O
insufficient JJ O
evidence NN O
to TO O
distinguish VB O
synchronous JJ O
primary JJ O
pulmonary JJ O
melanoma NN O
from IN O
metastasis NN O
for IN O
this DT O
patient NN O
. . O

The DT O
postoperative JJ B-Therapeutic_procedure
recovery NN I-Therapeutic_procedure
was VBD O
mainly RB B-Lab_value
uneventful JJ I-Lab_value
, , O
and CC O
the DT O
patient NN O
was VBD O
discharged VBN O
14 CD O
days NNS O
after IN O
surgery NN O
. . O

Subsequently RB O
, , O
4 CD B-Dosage
cycles NNS I-Dosage
of IN O
adjuvant JJ B-Detailed_description
conventional JJ B-Detailed_description
chemotherapy NN B-Medication
with IN O
an DT B-Dosage
interval NN I-Dosage
of IN I-Dosage
3 CD I-Dosage
weeks NNS I-Dosage
were VBD O
completed VBN O
, , O
with IN O
controlled JJ O
moderate JJ O
toxic NN O
effects NNS O
including VBG O
thrombocytopenia NN B-Sign_symptom
, , O
leukopenia NN B-Sign_symptom
, , O
nausea NN B-Sign_symptom
, , O
vomiting NN B-Sign_symptom
, , O
and CC O
diarrhea NN B-Sign_symptom
. . O

The DT O
detailed JJ O
chemotherapy NN O
regimen NNS O
is VBZ O
as IN O
follows VBZ O
: : O
paclitaxel NN B-Medication
liposome NN I-Medication
for IN O
injection NN O
on IN O
day NN O
1 CD O
and CC O
day NN O
8 CD O
( ( O
135 CD O
mg NN O
per IN O
square JJ O
meter NN O
of IN O
body NN O
surface JJ O
area NN O
; : O
Nanjing NNP O
Luye NNP O
Sike NNP O
Pharmaceutical NNP O
Co NNP O
. . O
, , O
Ltd NNP O
. . O
, , O
Jiangsu NNP O
, , O
China NNP O
. . O
) ) O
, , O
tegafur JJ B-Medication
injection NN O
on IN O
day NN O
2 CD O
to TO O
4 CD O
( ( O
1000 CD O
mg NN O
per IN O
square JJ O
meter NN O
of IN O
body NN O
- : O
surface NN O
area NN O
; : O
Shandong NNP O
Qilu NNP O
Pharmaceutical NNP O
Co NNP O
. . O
, , O
Ltd NNP O
. . O
, , O
Jinan NNP O
, , O
China NNP O
. . O
) ) O
plus CC O
cis JJ B-Medication
- : I-Medication
platinum NN I-Medication
on IN O
day NN O
2 CD O
to TO O
3 CD O
( ( O
75 CD O
mg NN O
per IN O
square JJ O
meter NN O
of IN O
body NN O
- : O
surface NN O
area NN O
; : O
Shandong NNP O
Qilu NNP O
Pharmaceutical NNP O
Co NNP O
. . O
, , O
Ltd NNP O
. . O
, , O
Jinan NNP O
, , O
China NNP O
) ) O
. . O

This DT O
patient NN O
suffered VBD O
from IN O
moderate JJ B-Severity
leukopenia NN B-Sign_symptom
/ NNP O
myelosuppression NN B-Sign_symptom
after IN O
the DT O
second JJ O
cycle NN O
of IN O
TPF NNP O
chemotherapy NN B-Medication
, , O
and CC O
he PRP O
recovered VBD B-Sign_symptom
quickly RB O
after IN O
the DT O
administration NN O
of IN O
granulocyte NN B-Medication
colony NN I-Medication
- : I-Medication
stimulating NN I-Medication
factor NN I-Medication
( ( O
G NNP B-Medication
- : I-Medication
CSF NN I-Medication
) ) O
. . O

Concurrently RB O
, , O
recombinant JJ O
human JJ B-Medication
interferon NN I-Medication
alpha SYM I-Medication
- : I-Medication
2b CD I-Medication
( ( O
Harbin NNP O
pharmaceutical JJ O
group NN O
biological JJ O
engineering NN O
Co NNP O
. . O
, , O
Ltd NNP O
, , O
Harbin NNP O
, , O
China NNP O
) ) O
was VBD O
administrated VBN O
via IN O
hypodermic JJ O
injection NN O
thereafter RB O
( ( O
6000 CD B-Dosage
units NNS I-Dosage
every DT I-Dosage
3 CD I-Dosage
days NNS I-Dosage
; : O
Fig NNP O
. . O
2 CD O
) ) O
, , O
lasting VBG O
for IN B-Duration
1 CD I-Duration
year NN I-Duration
. . O

The DT O
patient NN O
was VBD O
followed VBN O
up RP O
continuously RB O
after IN O
the DT O
surgery NN O
. . O

Chest NNP B-Biological_structure
and CC O
abdomen NNS B-Biological_structure
CT NNP B-Diagnostic_procedure
, , O
cranial JJ B-Biological_structure
MRI NNP B-Diagnostic_procedure
, , O
bone NN B-Biological_structure
ECT NNP B-Diagnostic_procedure
, , O
and CC O
thorough JJ O
physical JJ B-Diagnostic_procedure
examination NN I-Diagnostic_procedure
were VBD O
carried VBN O
out IN O
every DT B-Frequency
3 CD I-Frequency
months NNS I-Frequency
. . O

Encouragingly RB O
, , O
the DT O
patient NN O
survived VBD O
without IN O
loco JJ B-Detailed_description
- : I-Detailed_description
regional JJ I-Detailed_description
recurrence NN B-Sign_symptom
or CC O
remote JJ B-Detailed_description
metastasis NN B-Sign_symptom
during IN O
the DT O
follow JJ O
- : O
up IN O
of IN O
two CD B-Duration
and CC I-Duration
a DT I-Duration
half NN I-Duration
years NNS I-Duration
up IN O
to TO O
now RB O
( ( O
Fig NNP O
. . O
3 CD O
) ) O
. . O

-DOCSTART- NN -X-

Our PRP$ O
24 CD B-Age
- : I-Age
year NN I-Age
- : I-Age
old JJ I-Age
non JJ O
- : O
smoking VBG O
male JJ O
patient NN O
presented VBN O
with IN O
repeated JJ B-Detailed_description
hemoptysis NN B-Sign_symptom
in IN O
May NNP O
2008 CD O
with IN O
4 CD B-Duration
days NNS I-Duration
of IN O
concomitant JJ B-Detailed_description
right JJ B-Biological_structure
thoracic NN I-Biological_structure
pain NN B-Sign_symptom
which WDT B-Detailed_description
intensified VBD I-Detailed_description
while IN I-Detailed_description
breathing VBG I-Detailed_description
. . O

During IN O
holidays NNS O
in IN O
his PRP$ O
home NN O
country NN O
, , O
this DT O
Cuban NNP O
patient NN O
suffered VBD O
from IN O
a DT O
cold JJ B-Sign_symptom
with IN O
fever NN B-Sign_symptom
and CC O
a DT O
strong JJ B-Severity
cough NN B-Sign_symptom
. . O

The DT O
strong JJ B-Severity
dry JJ B-Texture
cough NN O
persisted VBN B-Detailed_description
after IN O
recovery NN O
from IN O
the DT O
cold NN O
. . O

The DT O
patient NN O
did VBD O
not RB O
report VB O
any DT O
loss NN B-Sign_symptom
of IN I-Sign_symptom
weight NN I-Sign_symptom
. . O

The DT O
initial JJ O
CT NNP B-Diagnostic_procedure
scan NN I-Diagnostic_procedure
of IN O
the DT O
thorax NN B-Biological_structure
showed VBD O
a DT O
12 CD B-Area
× NN I-Area
4 CD I-Area
cm NN I-Area
solid JJ B-Detailed_description
mass NN B-Sign_symptom
paravertebral JJ B-Biological_structure
right NN I-Biological_structure
in IN O
the DT O
lower JJR B-Biological_structure
thorax NN I-Biological_structure
without IN O
any DT O
signs NNS O
of IN O
metastases NNS B-Sign_symptom
( ( O
Figure NNP O
1 CD O
) ) O
. . O

The DT O
bronchoscopy NN B-Diagnostic_procedure
( ( O
Figure NNP O
2 CD O
) ) O
with IN O
non JJ B-Detailed_description
- : I-Detailed_description
bleeding NN I-Detailed_description
biopsy NN B-Diagnostic_procedure
revealed VBD O
a DT O
mass NN O
of IN O
the DT O
lower JJR B-Biological_structure
right NN I-Biological_structure
bronchus NN I-Biological_structure
which WDT O
histologically RB B-Diagnostic_procedure
and CC O
immunohistologically RB B-Diagnostic_procedure
provided VBD O
evidence NN O
of IN O
a DT O
granular JJ B-Disease_disorder
cell NN I-Disease_disorder
or CC I-Disease_disorder
Abrikossoff NNP B-Disease_disorder
tumor NN I-Disease_disorder
[ VBD O
1 CD O
] NN O
. . O

The DT O
bronchial JJ B-Diagnostic_procedure
lavage NN I-Diagnostic_procedure
which WDT O
followed VBD O
was VBD O
negative JJ B-Lab_value
for IN O
malignant JJ B-Biological_structure
cells NNS I-Biological_structure
. . O

The DT O
patient NN O
was VBD O
discharged VBN O
and CC O
surgical JJ O
intervention NN O
was VBD O
planned VBN O
. . O

Four CD O
days NNS O
after IN O
discharge NN O
a DT O
spontaneous JJ B-Detailed_description
hemothorax NN B-Sign_symptom
developed VBD O
. . O

The DT O
patient NN O
needed VBD O
to TO O
be VB O
readmitted VBN O
and CC O
the DT O
hemothorax NN O
was VBD O
drained VBN B-Therapeutic_procedure
. . O

No DT O
malignant JJ B-Sign_symptom
cells NNS I-Sign_symptom
were VBD O
detected VBN O
in IN O
the DT O
cytological JJ B-Diagnostic_procedure
examination NN I-Diagnostic_procedure
of IN O
the DT O
drained JJ B-Biological_structure
liquid NN I-Biological_structure
. . O

After IN O
an DT O
uneventful JJ O
course NN O
and CC O
decreasing NN B-Lab_value
of IN O
the DT O
hematoma NN B-Sign_symptom
, , O
the DT O
tumor NN B-Sign_symptom
was VBD O
excised VBN B-Therapeutic_procedure
by IN O
performing VBG O
a DT O
lower JJR B-Therapeutic_procedure
right JJ I-Therapeutic_procedure
lobectomy NN I-Therapeutic_procedure
6 CD O
months NNS O
after IN O
the DT O
initial JJ O
admission NN O
. . O

The DT O
final JJ O
histological JJ B-Diagnostic_procedure
examination NN I-Diagnostic_procedure
confirmed VBD O
a DT O
peribronchial NN B-Biological_structure
and CC O
infiltrating VBG B-Detailed_description
S100 NNP B-Diagnostic_procedure
positive JJ B-Lab_value
tumor NN O
supporting VBG O
the DT O
Schwann NNP O
cell NN O
origin NN O
theory NN O
with IN O
very RB B-Lab_value
low JJ I-Lab_value
growth NN B-Diagnostic_procedure
rate NN I-Diagnostic_procedure
of IN O
2 CD B-Lab_value
% NN I-Lab_value
and CC O
a DT O
size NN B-Diagnostic_procedure
of IN O
15 CD B-Distance
mm NNS I-Distance
( ( O
Figure NNP O
3 CD O
) ) O
. . O

-DOCSTART- NN -X-

A DT O
40 CD B-Age
- : I-Age
year NN I-Age
- : I-Age
old JJ I-Age
woman NN O
visited VBD O
the DT O
Department NNP B-Nonbiological_location
of IN I-Nonbiological_location
Obstetrics NNP I-Nonbiological_location
and CC I-Nonbiological_location
Gynecology NNP I-Nonbiological_location
in IN O
our PRP$ B-Nonbiological_location
hospital NN I-Nonbiological_location
because IN O
of IN O
a DT O
complaint NN O
of IN O
sudden JJ B-Detailed_description
dyspnea NN B-Sign_symptom
on IN B-Detailed_description
effort NN I-Detailed_description
. . O

She PRP O
was VBD O
previously RB O
diagnosed VBN O
with IN O
endometriosis NN B-Disease_disorder
and CC O
prescribed VBD O
a DT O
combination NN B-Detailed_description
oral JJ O
contraceptive NN B-Medication
pill NN O
( ( O
drospirenone JJ B-Medication
/ NNP O
ethinylestradiol NN B-Medication
betadex NN I-Medication
, , O
trade NN B-Detailed_description
name NN I-Detailed_description
; : I-Detailed_description
Yaz NNP I-Detailed_description
™ NNP I-Detailed_description
, , O
Bayer NNP B-Detailed_description
, , I-Detailed_description
Leverkusen NNP I-Detailed_description
, , I-Detailed_description
Germany NNP I-Detailed_description
) ) O
. . O

Following VBG O
the DT O
Kumamoto NNP B-Other_event
Earthquakes NNP I-Other_event
and CC O
subsequent JJ O
aftershocks NNS B-Other_event
in IN O
April NNP O
2016 CD O
, , O
she PRP O
spent VBD B-Activity
7 CD B-Duration
nights NNS I-Duration
in IN O
a DT O
vehicle NN B-Nonbiological_location
. . O

She PRP O
noticed VBD O
sudden JJ B-Detailed_description
dyspnea NN B-Sign_symptom
on IN B-Detailed_description
effort NN I-Detailed_description
when WRB O
she PRP O
walked VBD O
outside IN B-Nonbiological_location
the DT O
car NN O
on IN O
the DT O
8th CD O
morning NN O
after IN O
the DT O
first JJ B-Other_event
earthquake NN I-Other_event
. . O

Although IN O
she PRP O
walked VBD B-Activity
around IN I-Activity
for IN O
personal JJ O
reasons NNS O
during IN O
the DT O
daytime NN O
, , O
she PRP O
spent VBD B-Activity
nights NNS I-Activity
in IN O
her PRP$ O
small JJ B-Nonbiological_location
car NN I-Nonbiological_location
with IN O
her PRP$ O
legs NNS B-Biological_structure
in IN O
a DT O
hanging JJ B-Detailed_description
position NN I-Detailed_description
. . O

She PRP O
noticed VBD O
swelling VBG B-Sign_symptom
and CC O
pain NN B-Sign_symptom
in IN O
her PRP$ O
left JJ B-Biological_structure
lower JJR I-Biological_structure
extremity NN I-Biological_structure
, , O
and CC O
her PRP$ O
serum NN B-Diagnostic_procedure
D NNP I-Diagnostic_procedure
- : I-Diagnostic_procedure
dimer NN I-Diagnostic_procedure
levels NNS O
were VBD O
13 CD B-Lab_value
. . I-Lab_value
2 CD I-Lab_value
μg JJ I-Lab_value
/ NNP I-Lab_value
mL NN I-Lab_value
. . O

Deep JJ B-Disease_disorder
vein NN I-Disease_disorder
thrombosis NN I-Disease_disorder
( ( O
DVT NNP B-Disease_disorder
) ) O
was VBD O
suspected VBN O
by IN O
her PRP$ O
home NN B-Nonbiological_location
doctor NN I-Nonbiological_location
. . O

A DT O
contrast NN B-Detailed_description
- : I-Detailed_description
enhanced VBN I-Detailed_description
computed JJ B-Diagnostic_procedure
tomography NN I-Diagnostic_procedure
( ( O
CT NNP B-Diagnostic_procedure
) ) O
- : O
scan JJ O
revealed VBD O
a DT O
contrast NN B-Sign_symptom
deficit NN I-Sign_symptom
in IN O
the DT O
bilateral JJ B-Biological_structure
pulmonary JJ I-Biological_structure
artery NN I-Biological_structure
( ( O
Fig NNP O
. . O
2A CD O
) ) O
and CC O
in IN O
the DT O
left NN B-Biological_structure
lower JJR I-Biological_structure
extremity NN I-Biological_structure
( ( O
posterior JJ B-Detailed_description
tibial NN I-Detailed_description
, , I-Detailed_description
soleus NN I-Detailed_description
and CC I-Detailed_description
gastrocnemius VB I-Detailed_description
vein NN I-Detailed_description
) ) O
( ( O
Fig NNP O
. . O
2B CD O
) ) O
. . O

Her PRP$ O
right JJ B-Diagnostic_procedure
ventricular JJ I-Diagnostic_procedure
function NN I-Diagnostic_procedure
was VBD O
intact JJ B-Lab_value
( ( O
estimated VBN O
pulmonary JJ B-Diagnostic_procedure
artery NN I-Diagnostic_procedure
pressure NN I-Diagnostic_procedure
= VBZ O
29 CD B-Lab_value
/ NN I-Lab_value
8 CD I-Lab_value
mmHg NN I-Lab_value
in IN O
cardiac JJ B-Biological_structure
ultrasound NN B-Diagnostic_procedure
) ) O
. . O

Her PRP$ O
plasma NN B-Detailed_description
brain NN B-Diagnostic_procedure
natriuretic JJ I-Diagnostic_procedure
peptide NN I-Diagnostic_procedure
and CC O
high JJ B-Detailed_description
- : I-Detailed_description
sense NN I-Detailed_description
troponin NN B-Diagnostic_procedure
T NNP I-Diagnostic_procedure
concentration NN I-Diagnostic_procedure
levels NNS O
were VBD O
97 CD B-Lab_value
. . I-Lab_value
2 CD I-Lab_value
pg JJ I-Lab_value
/ NNP I-Lab_value
mL NN I-Lab_value
and CC O
0 CD B-Lab_value
. . I-Lab_value
0061 CD I-Lab_value
ng JJ I-Lab_value
/ NNP I-Lab_value
mL NN I-Lab_value
, , O
respectively RB O
. . O

She PRP O
was VBD O
diagnosed VBN O
with IN O
PTE NNP B-Disease_disorder
and CC O
admitted VBN O
to TO O
our PRP$ O
department NN B-Nonbiological_location
. . O

On IN O
admission NN O
, , O
her PRP$ O
blood NN B-Diagnostic_procedure
pressure NN I-Diagnostic_procedure
was VBD O
129 CD B-Lab_value
/ JJ I-Lab_value
80 CD I-Lab_value
mmHg NN I-Lab_value
and CC O
her PRP$ O
heart NN B-Diagnostic_procedure
rate NN I-Diagnostic_procedure
was VBD O
72 CD B-Lab_value
beats NNS I-Lab_value
per IN I-Lab_value
minute NN I-Lab_value
. . O

Her PRP$ O
degree NN O
of IN O
oxygen NN B-Diagnostic_procedure
saturation NN I-Diagnostic_procedure
( ( O
SaO2 NNP B-Diagnostic_procedure
) ) O
in IN O
arterial JJ B-Detailed_description
blood NN I-Detailed_description
gas NN I-Detailed_description
was VBD O
97 CD B-Lab_value
. . I-Lab_value
7 CD I-Lab_value
% NN I-Lab_value
. . O

Her PRP$ O
body NN B-Diagnostic_procedure
mass NN I-Diagnostic_procedure
index NN I-Diagnostic_procedure
was VBD O
24 CD B-Lab_value
. . I-Lab_value
4 CD I-Lab_value
kg JJ I-Lab_value
/ NNP I-Lab_value
m2 NN I-Lab_value
. . O

Electrocardiography NN B-Diagnostic_procedure
and CC O
cardiac JJ B-Biological_structure
ultrasound NN B-Diagnostic_procedure
did VBD O
not RB O
indicate VB O
heart NN B-Disease_disorder
failure NN I-Disease_disorder
. . O

An DT O
investigation NN O
of IN O
most JJS O
factors NNS B-Diagnostic_procedure
related VBN I-Diagnostic_procedure
to TO I-Diagnostic_procedure
thrombus VB I-Diagnostic_procedure
formation NN I-Diagnostic_procedure
( ( O
including VBG O
protein NN B-Diagnostic_procedure
C NNP I-Diagnostic_procedure
, , O
protein NN B-Diagnostic_procedure
S NNP I-Diagnostic_procedure
, , O
antithrombin NN B-Diagnostic_procedure
, , O
and CC O
antiphospholipid JJ B-Diagnostic_procedure
antibodies NNS I-Diagnostic_procedure
) ) O
revealed VBD O
that IN O
all DT O
such JJ O
factors NNS O
were VBD O
normal JJ B-Lab_value
. . O

The DT O
discontinuation NN O
of IN O
the DT O
oral JJ O
contraceptive NN B-Medication
and CC O
the DT O
administration NN O
of IN O
rivaroxaban NN B-Medication
( ( O
30 CD B-Dosage
mg NN I-Dosage
, , I-Dosage
daily RB I-Dosage
) ) O
, , O
a DT O
direct JJ B-Detailed_description
oral JJ O
anticoagulant NN B-Medication
( ( O
trade NN B-Detailed_description
name NN I-Detailed_description
: : I-Detailed_description
Xarelto NN I-Detailed_description
™ NN I-Detailed_description
, , O
Bayer NNP B-Detailed_description
) ) O
was VBD O
initiated VBN O
according VBG B-Detailed_description
to TO I-Detailed_description
the DT I-Detailed_description
results NNS I-Detailed_description
of IN I-Detailed_description
the DT I-Detailed_description
EINSTEIN NNP I-Detailed_description
- : I-Detailed_description
PE NNP I-Detailed_description
trial NN I-Detailed_description
( ( O
3 CD O
) ) O
. . O

After IN O
7 CD O
days NNS O
, , O
a DT O
follow NN O
- : O
up IN O
contrast NN B-Detailed_description
- : I-Detailed_description
enhanced VBN I-Detailed_description
CT NNP B-Diagnostic_procedure
scan JJ O
revealed VBD O
a DT O
reduction NN O
in IN O
the DT O
thrombosis NN B-Disease_disorder
( ( O
Fig NNP O
. . O
3 CD O
) ) O
. . O

The DT O
patient NN O
was VBD O
followed VBN O
up RP O
with IN O
rivaroxaban NN B-Medication
. . O

The DT O
patient NN O
gave VBD O
her PRP$ O
consent NN O
for IN O
the DT O
publication NN O
of IN O
this DT O
study NN O
. . O

-DOCSTART- NN -X-

A DT O
68 CD B-Age
- : I-Age
year NN I-Age
- : I-Age
old JJ I-Age
man NN O
referred VBD O
to TO O
the DT O
Internal NNP B-Nonbiological_location
Medicine NNP I-Nonbiological_location
Department NNP I-Nonbiological_location
of IN O
Razi NNP B-Nonbiological_location
Hospital NNP I-Nonbiological_location
in IN O
Rasht NNP B-Nonbiological_location
( ( O
a DT B-Nonbiological_location
city NN I-Nonbiological_location
in IN I-Nonbiological_location
the DT I-Nonbiological_location
north NN I-Nonbiological_location
of IN I-Nonbiological_location
Iran NNP I-Nonbiological_location
) ) O
with IN O
a DT O
hypogastric JJ B-Biological_structure
region NN I-Biological_structure
discomfort NN B-Sign_symptom
, , O
especially RB O
in IN O
the DT O
right NN B-Biological_structure
lower RBR I-Biological_structure
quadrant NN I-Biological_structure
for IN O
one CD B-Duration
month NN I-Duration
. . O

The DT O
pain NN O
was VBD O
a DT O
colicky JJ B-Detailed_description
form NN I-Detailed_description
which WDT O
had VBD O
a DT B-Frequency
few JJ I-Frequency
episodes NNS I-Frequency
each DT I-Frequency
day NN I-Frequency
, , O
each DT B-Detailed_description
episode NN I-Detailed_description
lasting VBG I-Detailed_description
for IN I-Detailed_description
4 CD I-Detailed_description
- : I-Detailed_description
5 CD I-Detailed_description
minutes NNS I-Detailed_description
. . O

The DT O
pain NN O
radiated VBD O
to TO O
the DT O
back NN B-Nonbiological_location
and CC O
was VBD O
alleviated VBN B-Sign_symptom
by IN O
resting VBG B-Activity
to TO I-Activity
one CD I-Activity
side NN I-Activity
. . O

No DT O
association NN O
between IN O
the DT O
pain NN O
, , O
defecation NN O
, , O
and CC O
eating VBG O
were VBD O
reported VBN O
. . O

Furthermore RB O
, , O
the DT O
patient NN O
complained VBD O
of IN O
a DT O
2 CD B-Lab_value
- : I-Lab_value
3 CD I-Lab_value
kg JJ I-Lab_value
weight JJ B-Sign_symptom
loss NN I-Sign_symptom
over IN O
the DT O
last JJ B-Duration
one CD I-Duration
month NN I-Duration
followed VBN O
by IN O
anorexia NN B-Sign_symptom
. . O

However RB O
, , O
no DT O
symptoms NNS O
of IN O
nausea NN B-Sign_symptom
, , O
vomiting VBG B-Sign_symptom
, , O
fever NN B-Sign_symptom
, , O
or CC O
shaking VBG B-Sign_symptom
chills NNS I-Sign_symptom
were VBD O
demonstrated VBN O
. . O

He PRP O
was VBD O
first RB O
admitted VBN O
to TO O
another DT B-Nonbiological_location
center NN I-Nonbiological_location
for IN O
a DT B-Duration
week NN I-Duration
, , O
then RB O
was VBD O
referred VBN O
to TO O
our PRP$ B-Nonbiological_location
hospital NN I-Nonbiological_location
for IN O
further JJ O
evaluation NN O
. . O

The DT O
patient NN O
had VBD O
undergone NN O
a DT O
surgery NN B-Therapeutic_procedure
for IN O
prostatectomy JJ B-Therapeutic_procedure
seven CD O
years NNS O
before IN O
his PRP$ O
presentation NN O
to TO O
our PRP$ B-Nonbiological_location
center NN I-Nonbiological_location
. . O

Also RB O
, , O
he PRP O
had VBD O
a DT O
history NN O
of IN O
endoscopy JJ B-Diagnostic_procedure
five CD O
years NNS O
earlier RBR O
due JJ O
to TO O
dyspepsia VB B-Disease_disorder
, , O
which WDT O
was VBD O
found VBN O
to TO O
be VB O
Helicobacter NNP B-Diagnostic_procedure
pylori FW I-Diagnostic_procedure
positive JJ B-Lab_value
at IN O
that DT O
time NN O
and CC O
which WDT O
was VBD O
eradicated VBN B-Sign_symptom
after IN O
a DT O
treatment NN B-Therapeutic_procedure
course NN I-Therapeutic_procedure
. . O

No DT O
history NN O
of IN O
HIV NNP O
, , O
diabetes VBZ O
, , O
smoking NN O
, , O
or CC O
alcohol NN O
consumption NN O
was VBD O
recorded VBN O
. . O

His PRP$ O
vital JJ B-Diagnostic_procedure
signs NNS I-Diagnostic_procedure
were VBD O
normal JJ B-Lab_value
at IN O
the DT O
time NN O
of IN O
admission NN O
. . O

On IN O
physical JJ B-Diagnostic_procedure
examination NN I-Diagnostic_procedure
, , O
the DT O
abdomen NNS B-Biological_structure
was VBD O
soft JJ B-Sign_symptom
, , O
there EX O
was VBD O
no DT O
distention NN B-Sign_symptom
, , O
and CC O
bowel VB B-Diagnostic_procedure
sounds NNS I-Diagnostic_procedure
were VBD O
normoactive JJ B-Lab_value
. . O

However RB O
, , O
tenderness NN B-Sign_symptom
in IN O
the DT O
right NN B-Biological_structure
lower RBR I-Biological_structure
quadrant NN I-Biological_structure
of IN I-Biological_structure
the DT I-Biological_structure
abdomen NNS I-Biological_structure
with IN O
no DT B-Lab_value
rebound NN B-Diagnostic_procedure
state NN I-Diagnostic_procedure
was VBD O
noted VBN O
. . O

The DT O
peripheral JJ B-Diagnostic_procedure
blood NN I-Diagnostic_procedure
analysis NN I-Diagnostic_procedure
is VBZ O
shown VBN O
in IN O
Table JJ O
1 CD O
. . O

Stool NNP B-Diagnostic_procedure
examination NN I-Diagnostic_procedure
, , O
urine JJ B-Diagnostic_procedure
analysis NN I-Diagnostic_procedure
, , O
and CC O
evaluation NN B-Diagnostic_procedure
of IN I-Diagnostic_procedure
electrolytes NNS I-Diagnostic_procedure
were VBD O
all DT O
normal JJ B-Lab_value
. . O

An DT O
abdominal JJ B-Biological_structure
CT NNP B-Diagnostic_procedure
scan NN O
showed VBD O
a DT O
well RB B-Detailed_description
- : I-Detailed_description
demarcated VBN I-Detailed_description
and CC O
homogenous JJ B-Detailed_description
solitary JJ B-Detailed_description
mass NN B-Sign_symptom
in IN O
the DT O
cecum NN B-Biological_structure
with IN O
no DT O
distention NN B-Sign_symptom
in IN O
the DT O
ileum NN B-Biological_structure
. . O

The DT O
ileum NN B-Biological_structure
wall NN I-Biological_structure
was VBD O
thickened VBN B-Sign_symptom
( ( O
Figure NNP O
1 CD O
) ) O
. . O

A DT O
colonoscopy NN B-Diagnostic_procedure
revealed VBD O
a DT O
large JJ B-Lab_value
mass NN B-Detailed_description
like IN I-Detailed_description
lesion NN B-Sign_symptom
in IN O
the DT O
cecum NN B-Biological_structure
( ( O
Figure NNP O
2 CD O
) ) O
; : O
during IN O
the DT O
procedure NN O
a DT O
biopsy NN B-Diagnostic_procedure
was VBD O
taken VBN O
from IN O
the DT O
cecum NN B-Biological_structure
. . O

The DT O
lamina NN B-Biological_structure
propria NN I-Biological_structure
was VBD O
infiltrated VBN B-Sign_symptom
by IN O
a DT O
number NN O
of IN O
PMNCs NNP B-Biological_structure
admixed NN O
by IN O
some DT O
eosinophils NNS B-Biological_structure
( ( O
Figure NNP O
3 CD O
) ) O
. . O

Immunohistochemical JJ B-Diagnostic_procedure
evaluation NN I-Diagnostic_procedure
was VBD O
positive JJ B-Lab_value
for IN O
vimentin NN B-Diagnostic_procedure
and CC O
CD68 NNP B-Diagnostic_procedure
. . O

C NNP B-Diagnostic_procedure
- : I-Diagnostic_procedure
Kit NNP I-Diagnostic_procedure
( ( O
CD117 NNP B-Diagnostic_procedure
) ) O
was VBD O
negative JJ B-Lab_value
while IN O
CD34 NNP B-Diagnostic_procedure
, , O
smooth JJ B-Diagnostic_procedure
muscle NN I-Diagnostic_procedure
actin NN I-Diagnostic_procedure
( ( O
SMA NNP B-Diagnostic_procedure
) ) O
, , O
and CC O
ALK NNP B-Diagnostic_procedure
were VBD O
focally RB B-Lab_value
positive JJ I-Lab_value
. . O

There EX O
were VBD O
no DT B-Lab_value
reports NNS I-Lab_value
of IN O
cyclin NN B-Diagnostic_procedure
D1 NNP I-Diagnostic_procedure
, , O
desmin NN B-Diagnostic_procedure
, , O
or CC O
pancytokeratin NN B-Diagnostic_procedure
( ( O
Figure NNP O
4 CD O
) ) O
. . O
When WRB O
the DT O
colonoscopy NN O
was VBD O
performed VBN O
, , O
the DT O
evidences NNS O
of IN O
invasive JJ O
obstruction NN O
lead VBD O
us PRP O
to TO O
the DT O
suspicion NN O
of IN O
a DT O
malignant JJ B-Disease_disorder
tumor NN I-Disease_disorder
. . O

After IN O
pathological JJ O
confirmation NN O
of IN O
IMT NNP B-Disease_disorder
, , O
the DT O
patient NN O
was VBD O
referred VBN O
for IN O
surgery NN B-Therapeutic_procedure
in IN O
order NN O
to TO O
remove VB O
the DT O
mass NN O
. . O

On IN O
surgery NN O
, , O
approximately RB O
40 CD B-Volume
mL NNS I-Volume
ascites NNS B-Sign_symptom
were VBD O
found VBN O
in IN O
the DT O
abdomen NNS B-Biological_structure
. . O

A DT O
mass NN B-Sign_symptom
was VBD O
seen VBN O
in IN O
the DT O
cecum NN B-Biological_structure
with IN O
ileocolic JJ B-Biological_structure
intussusception NN B-Sign_symptom
. . O

Afterwards NNS O
, , O
the DT O
patient NN O
underwent JJ O
right JJ B-Detailed_description
hemicolectomy NN B-Therapeutic_procedure
with IN O
an DT O
end NN B-Detailed_description
- : I-Detailed_description
to TO I-Detailed_description
- : I-Detailed_description
end VB I-Detailed_description
anastomosis NN B-Therapeutic_procedure
of IN I-Therapeutic_procedure
ileocolic NN I-Therapeutic_procedure
. . O

No DT O
enlarge NN B-Sign_symptom
lymph RB B-Biological_structure
nodes NNS I-Biological_structure
were VBD O
observed VBN O
. . O

The DT O
patient NN O
was VBD O
discharged VBN O
seven CD O
days NNS O
after IN O
surgery NN O
and CC O
had VBD O
no DT O
complications NNS B-Sign_symptom
during IN O
follow JJ O
- : O
up RB O
. . O

-DOCSTART- NN -X-

A DT O
72 CD B-Age
- : I-Age
year NN I-Age
- : I-Age
old JJ I-Age
woman NN O
underwent JJ O
RF NNP B-Therapeutic_procedure
ablation NN I-Therapeutic_procedure
for IN O
the DT O
treatment NN O
of IN O
a DT O
metachronous JJ B-Detailed_description
solitary JJ B-Detailed_description
liver NN B-Biological_structure
metastasis NN B-Disease_disorder
from IN O
rectal JJ B-Biological_structure
adenocarcinoma NN B-Disease_disorder
, , O
which WDT O
had VBD O
been VBN O
treated VBN O
18 CD O
mo NNS O
before IN O
with IN O
preoperative JJ B-Detailed_description
chemoradiotherapy NN B-Therapeutic_procedure
and CC O
anterior JJ B-Therapeutic_procedure
resection NN I-Therapeutic_procedure
. . O

The DT O
lesion NN O
was VBD O
located VBN O
in IN O
segment NN B-Biological_structure
VIII NNP I-Biological_structure
. . O

The DT O
procedure NN O
went VBD O
well RB B-Lab_value
and CC O
the DT O
patient NN O
was VBD O
initially RB O
haemodynamically RB B-Diagnostic_procedure
stable JJ B-Lab_value
. . O

One CD B-Time
hour NN I-Time
later RB I-Time
her PRP$ O
condition NN B-Diagnostic_procedure
suddenly RB B-Severity
worsened VBD I-Severity
. . O

She PRP O
was VBD O
clinically RB O
dizzy JJ B-Sign_symptom
and CC O
had VBD O
fatigue NN B-Sign_symptom
and CC O
pallor NN B-Sign_symptom
. . O

We PRP O
detected VBD O
hypotension NN B-Sign_symptom
and CC O
tachycardia NN B-Sign_symptom
. . O

Emergency NNP O
blood NN B-Diagnostic_procedure
tests NNS I-Diagnostic_procedure
showed VBD O
a DT O
haemoglobin JJ B-Diagnostic_procedure
level NN I-Diagnostic_procedure
of IN O
< $ B-Lab_value
7 CD I-Lab_value
g NN I-Lab_value
/ NNP I-Lab_value
dL NN I-Lab_value
and CC O
markedly RB O
elevated VBD B-Lab_value
transaminase NN B-Diagnostic_procedure
levels NNS I-Diagnostic_procedure
. . O

A DT O
computed JJ B-Diagnostic_procedure
tomography NN I-Diagnostic_procedure
examination NN I-Diagnostic_procedure
revealed VBD O
an DT O
accumulation NN O
of IN O
intraperitoneal JJ B-Biological_structure
fluid NN I-Biological_structure
in IN O
the DT O
pelvis NN B-Biological_structure
and CC O
two CD B-Lab_value
liver NN B-Biological_structure
haematomas NN B-Disease_disorder
. . O

The DT O
images NNS O
showed VBD O
two CD B-Lab_value
liver NN B-Biological_structure
lacerations NNS B-Sign_symptom
, , O
one CD B-Detailed_description
following VBG I-Detailed_description
the DT I-Detailed_description
path NN I-Detailed_description
of IN I-Detailed_description
the DT I-Detailed_description
needle JJ I-Detailed_description
( ( O
Figure NNP O
( ( O
Figure1A1A NNP O
- : O
- : O
C NN O
) ) O
C NNP O
) ) O
and CC O
another DT O
, , O
unexplained JJ B-Detailed_description
laceration NN I-Detailed_description
leading VBG I-Detailed_description
away RB I-Detailed_description
from IN I-Detailed_description
the DT I-Detailed_description
first JJ I-Detailed_description
( ( O
Figure NNP O
( ( O
Figure2 NNP O
) ) O
. . O
2 CD O
) ) O
. . O

The DT O
patient NN O
had VBD O
no DT O
serious JJ O
coughing NN B-Sign_symptom
or CC O
hiccupping NN B-Sign_symptom
after IN O
the DT O
RF NNP O
treatment NN O
, , O
or CC O
any DT O
other JJ O
complications NNS O
that WDT O
might MD O
have VB O
caused VBN O
increased JJ O
abdominal JJ O
pressure NN O
and CC O
tumour JJ O
rupture NN O
. . O

Subsequently RB O
, , O
the DT O
patient NN O
received VBD O
a DT O
blood NN B-Therapeutic_procedure
transfusion NN I-Therapeutic_procedure
and CC O
close JJ B-Diagnostic_procedure
monitoring NN I-Diagnostic_procedure
. . O

She PRP O
was VBD O
haemodynamically RB B-Diagnostic_procedure
stable JJ B-Lab_value
after IN O
the DT O
second JJ B-Lab_value
blood NN B-Therapeutic_procedure
transfusion NN I-Therapeutic_procedure
and CC O
completely RB B-Sign_symptom
recovered VBD I-Sign_symptom
24 CD B-Time
h NN I-Time
later RB I-Time
. . O

The DT O
patient NN O
remained VBD B-Activity
in IN I-Activity
bed NN I-Activity
for IN O
1 CD B-Duration
wk NN I-Duration
. . O

No DT O
surgical JJ B-Therapeutic_procedure
intervention NN I-Therapeutic_procedure
was VBD O
required VBN O
. . O

-DOCSTART- NN -X-

A DT O
70 CD B-Age
- : I-Age
year NN I-Age
- : I-Age
old JJ I-Age
man NN O
was VBD O
referred VBN O
to TO O
our PRP$ O
hospital NN B-Nonbiological_location
for IN O
gastric JJ B-Biological_structure
cancer NN B-Disease_disorder
that WDT O
was VBD O
detected VBN O
during IN O
screening NN O
by IN O
esophagogastroduodenoscopy NN B-Diagnostic_procedure
( ( B-Diagnostic_procedure
EGD NNP I-Diagnostic_procedure
) ) I-Diagnostic_procedure
. . O

No DT O
significant JJ O
medical JJ O
history NN O
was VBD O
identified VBN O
, , O
except IN O
dysuria NNS B-Sign_symptom
caused VBN B-Detailed_description
by IN I-Detailed_description
bladder NN I-Detailed_description
contraction NN I-Detailed_description
. . O

Initial JJ O
laboratory NN B-Diagnostic_procedure
data NNS O
showed VBD O
a DT O
serum JJ B-Diagnostic_procedure
level NN I-Diagnostic_procedure
of IN I-Diagnostic_procedure
AFP NNP I-Diagnostic_procedure
of IN O
32 CD B-Lab_value
. . I-Lab_value
3 CD I-Lab_value
ng JJ I-Lab_value
/ NN I-Lab_value
mL NN I-Lab_value
( ( O
normal JJ O
range NN O
: : O
0 CD O
- : O
15 CD O
ng JJ O
/ NNP O
mL NN O
) ) O
, , O
but CC O
no DT B-Lab_value
other JJ I-Lab_value
abnormality NN I-Lab_value
, , O
which WDT O
included VBD O
other JJ O
tumor NN O
markers NNS O
, , O
such JJ O
as IN O
, , O
carcinoembryonic JJ B-Diagnostic_procedure
antigen NN I-Diagnostic_procedure
( ( B-Diagnostic_procedure
CEA NNP I-Diagnostic_procedure
) ) I-Diagnostic_procedure
and CC O
carbohydrate VB B-Diagnostic_procedure
antigen NN I-Diagnostic_procedure
19 CD I-Diagnostic_procedure
- : I-Diagnostic_procedure
9 CD I-Diagnostic_procedure
( ( B-Diagnostic_procedure
CA19 NNP I-Diagnostic_procedure
- : I-Diagnostic_procedure
9 CD I-Diagnostic_procedure
) ) I-Diagnostic_procedure
. . O

EGD NNP O
revealed VBD O
a DT O
5 CD B-Distance
- : I-Distance
cm NN I-Distance
ulcerofungating JJ B-Detailed_description
mass NN B-Sign_symptom
that WDT O
was VBD O
comprised VBN B-Detailed_description
of IN I-Detailed_description
three CD I-Detailed_description
septate NN I-Detailed_description
ulcers NNS I-Detailed_description
in IN B-Biological_structure
the DT I-Biological_structure
greater JJR I-Biological_structure
curvature NN I-Biological_structure
of IN I-Biological_structure
the DT I-Biological_structure
gastric JJ I-Biological_structure
antrum NN I-Biological_structure
. . O

A DT O
pathological JJ B-Diagnostic_procedure
examination NN I-Diagnostic_procedure
of IN O
endoscopic NN B-Biological_structure
biopsy NN I-Biological_structure
tissues NNS I-Biological_structure
confirmed VBD O
the DT O
presence NN O
of IN O
moderately RB B-Detailed_description
differentiated VBN I-Detailed_description
tubular JJ B-Detailed_description
adenocarcinoma NN B-Disease_disorder
. . O

Subsequent JJ O
abdominopelvic NN B-Biological_structure
computed VBD B-Diagnostic_procedure
tomography NN I-Diagnostic_procedure
visualized VBD O
a DT O
gastric JJ B-Biological_structure
mass NN B-Sign_symptom
with IN B-Detailed_description
deep JJ I-Detailed_description
ulceration NN I-Detailed_description
in IN B-Biological_structure
the DT I-Biological_structure
gastric JJ I-Biological_structure
antrum NN I-Biological_structure
with IN B-Detailed_description
perigastric JJ I-Detailed_description
lymph NN I-Detailed_description
node JJ I-Detailed_description
enlargement NN I-Detailed_description
. . O

No DT O
metastatic JJ B-Sign_symptom
lesions NNS I-Sign_symptom
were VBD O
observed VBN O
in IN O
the DT O
liver NN B-Biological_structure
, , O
lung NN B-Biological_structure
or CC O
peritoneum NN B-Biological_structure
, , O
and CC O
chest JJS B-Biological_structure
radiography NN B-Diagnostic_procedure
showed VBD O
no DT B-Sign_symptom
significant JJ I-Sign_symptom
findings NNS I-Sign_symptom
. . O

Radical JJ B-Detailed_description
subtotal JJ B-Detailed_description
gastrectomy NN B-Therapeutic_procedure
with IN O
D2 NNP B-Biological_structure
lymph NN I-Biological_structure
node NN I-Biological_structure
dissection NN B-Therapeutic_procedure
and CC O
Billroth NNP B-Detailed_description
II NNP I-Detailed_description
gastrojejunostomy NN B-Therapeutic_procedure
were VBD O
performed VBN O
. . O

Grossly RB O
, , O
the DT O
resected JJ B-Biological_structure
specimen NNS I-Biological_structure
contained VBD O
double JJ B-Lab_value
lesions NNS B-Sign_symptom
: : O
the DT O
first JJ O
was VBD O
a DT B-Detailed_description
5 CD I-Detailed_description
. . I-Detailed_description
8 CD I-Detailed_description
cm NN I-Detailed_description
× VBD I-Detailed_description
3 CD I-Detailed_description
. . I-Detailed_description
2 CD I-Detailed_description
cm NN I-Detailed_description
ulcerofungating VBG I-Detailed_description
mass NN I-Detailed_description
in IN I-Detailed_description
the DT I-Detailed_description
antrum NN I-Detailed_description
, , O
with IN O
extensive JJ B-Detailed_description
hemorrhage NN I-Detailed_description
and CC O
light JJ B-Color
gray JJ I-Color
fibrosis NN B-Detailed_description
; : O
and CC O
the DT O
second NN O
was VBD O
a DT B-Detailed_description
nearby JJ I-Detailed_description
2 CD I-Detailed_description
. . I-Detailed_description
5 CD I-Detailed_description
cm NN I-Detailed_description
× VBD I-Detailed_description
2 CD I-Detailed_description
. . I-Detailed_description
0 CD I-Detailed_description
cm JJ I-Detailed_description
ulcerative JJ I-Detailed_description
lesion NN I-Detailed_description
( ( O
Figure NNP O
1 CD O
) ) O
. . O

Microscopically RB O
, , O
massive JJ B-Lab_value
numbers NNS I-Lab_value
of IN O
pleomorphic JJ B-Detailed_description
, , O
bizarre JJ B-Detailed_description
tumor NN B-Sign_symptom
cells NNS I-Sign_symptom
with IN O
hemorrhage NN B-Detailed_description
( ( I-Detailed_description
syncytiotrophoblasts NNS I-Detailed_description
and CC I-Detailed_description
cytotrophoblasts NNS I-Detailed_description
) ) I-Detailed_description
were VBD O
observed VBN O
in IN O
the DT O
first JJ O
lesion NN O
. . O

Hematoxylin NNP B-Diagnostic_procedure
and CC I-Diagnostic_procedure
eosin NN I-Diagnostic_procedure
( ( I-Diagnostic_procedure
HE NNP I-Diagnostic_procedure
) ) I-Diagnostic_procedure
- : I-Diagnostic_procedure
stained VBN I-Diagnostic_procedure
tissues NNS I-Diagnostic_procedure
revealed VBD O
a DT O
bubbly RB B-Shape
purple JJ B-Color
cytoplasm NN B-Biological_structure
and CC O
giant JJ B-Lab_value
nuclei NN B-Biological_structure
at IN O
a DT O
magnification NN B-Detailed_description
of IN I-Detailed_description
40 CD I-Detailed_description
× NNS I-Detailed_description
( ( O
Figure NNP O
2A CD O
) ) O
and CC O
100 CD B-Detailed_description
× NN I-Detailed_description
( ( O
Figure NNP O
2B CD O
) ) O
. . O

The DT O
tumor NN O
involved VBD O
the DT O
proper JJ B-Biological_structure
muscle NN I-Biological_structure
layer NN I-Biological_structure
( ( I-Biological_structure
T2a NNP I-Biological_structure
) ) I-Biological_structure
and CC O
metastasis NN B-Sign_symptom
was VBD O
found VBN O
in IN B-Biological_structure
four CD I-Biological_structure
of IN I-Biological_structure
56 CD I-Biological_structure
regional JJ I-Biological_structure
lymph NN I-Biological_structure
nodes NNS I-Biological_structure
( ( O
N1 NNP O
) ) O
. . O

Immunohistochemical JJ B-Diagnostic_procedure
staining NN I-Diagnostic_procedure
showed VBD O
positive JJ B-Lab_value
immunoreactivity NN I-Lab_value
for IN O
β NNP B-Diagnostic_procedure
- : I-Diagnostic_procedure
human JJ I-Diagnostic_procedure
chorionic JJ I-Diagnostic_procedure
gonadotropin NN I-Diagnostic_procedure
( ( O
HCG NNP O
) ) O
( ( O
Figure NNP O
3A CD O
) ) O
and CC O
focal JJ B-Lab_value
positivity NN I-Lab_value
for IN O
AFP NNP B-Diagnostic_procedure
( ( O
Figure NNP O
3B CD O
) ) O
. . O

These DT O
findings NNS O
confirmed VBD O
the DT O
presence NN O
of IN O
gastric JJ B-Biological_structure
choriocarcinoma NN B-Disease_disorder
that WDT O
contained VBD O
small JJ O
foci NN O
of IN O
an DT O
AFP NNP B-Detailed_description
- : I-Detailed_description
producing VBG I-Detailed_description
adenocarcinoma NN B-Disease_disorder
. . O

The DT O
second JJ O
lesion NN O
was VBD O
moderately RB O
differentiated JJ O
tubular JJ B-Biological_structure
adenocarcinoma NN B-Disease_disorder
, , O
which WDT O
extended VBD B-Biological_structure
to TO I-Biological_structure
the DT I-Biological_structure
submucosal NN I-Biological_structure
layer NN I-Biological_structure
( ( O
T1b NNP O
) ) O
. . O

It PRP O
was VBD O
close JJ O
to TO O
, , O
but CC O
distinct RB O
from IN O
the DT O
first JJ O
lesion NN O
, , O
which WDT O
was VBD O
negative JJ O
by IN O
immunohistochemical JJ O
staining NN O
for IN O
β NNP O
- : O
HCG NNP O
and CC O
AFP NNP O
. . O

The DT O
patient NN O
had VBD O
an DT O
uneventful JJ B-Lab_value
postoperative JJ B-Therapeutic_procedure
course NN I-Therapeutic_procedure
and CC O
was VBD O
discharged VBN O
on IN O
postoperative JJ O
day NN O
9 CD O
. . O

Two CD O
weeks NNS O
later RB O
, , O
his PRP$ O
HCG NNP B-Diagnostic_procedure
level NN I-Diagnostic_procedure
was VBD O
176 CD B-Lab_value
mIU NN I-Lab_value
/ NN I-Lab_value
mL NN I-Lab_value
( ( O
normal JJ O
range NN O
: : O
0 CD O
- : O
10 CD O
mIU NN O
/ NNP O
mL NN O
) ) O
and CC O
his PRP$ O
AFP NNP B-Diagnostic_procedure
level NN I-Diagnostic_procedure
was VBD O
10 CD B-Lab_value
. . I-Lab_value
0 CD I-Lab_value
ng JJ I-Lab_value
/ NNP I-Lab_value
mL NN I-Lab_value
. . O

Six CD B-Frequency
cycles NNS I-Frequency
of IN O
adjuvant JJ B-Medication
chemotherapy NN I-Medication
with IN O
capecitabine NN B-Medication
( ( O
Xeloda NNP O
; : O
Hoffmann NNP O
- : O
La NNP O
Roche NNP O
Inc NNP O
. . O
, , O
Nutley NNP O
, , O
NJ NNP O
, , O
USA NNP O
) ) O
was VBD O
started VBN O
at IN O
2500 CD B-Dosage
mg NN I-Dosage
/ NNP I-Dosage
m2 NN I-Dosage
per IN I-Dosage
day NN I-Dosage
for IN I-Dosage
14 CD I-Dosage
d JJ I-Dosage
/ JJ I-Dosage
cycle NN I-Dosage
. . O

After IN O
two CD O
cycles NNS O
, , O
his PRP$ O
β SYM B-Diagnostic_procedure
- : I-Diagnostic_procedure
HCG NNP I-Diagnostic_procedure
level NN I-Diagnostic_procedure
had VBD O
declined VBN B-Lab_value
to TO O
< VB B-Lab_value
3 CD I-Lab_value
mIU NN I-Lab_value
/ NNP I-Lab_value
mL NN I-Lab_value
, , O
and CC O
has VBZ O
since IN O
remained VBN O
at IN O
this DT O
level NN O
. . O

No DT O
recurrence NN B-Sign_symptom
or CC O
distant JJ B-Sign_symptom
metastasis NN I-Sign_symptom
had VBD O
occurred VBN O
at IN O
his PRP$ O
4 CD O
- : O
year NN O
postoperative JJ O
follow NN O
- : O
up RB O
. . O

-DOCSTART- NN -X-

A DT O
41 CD B-Age
- : I-Age
year NN I-Age
- : I-Age
old JJ I-Age
man NN O
with IN O
a DT O
history NN O
of IN O
alcoholism NN O
for IN O
10 CD B-Duration
years NNS I-Duration
and CC O
sober NN O
for IN O
the DT O
last JJ B-Duration
3 CD I-Duration
years NNS I-Duration
, , O
recurrent JJ O
alcoholic JJ O
pancreatitis NN O
, , O
and CC O
no DT O
known VBN O
liver RB O
disease NN O
, , O
presented VBN O
with IN O
several JJ B-Detailed_description
episodes NNS I-Detailed_description
of IN O
hematemesis NN B-Sign_symptom
and CC O
abdominal JJ B-Biological_structure
pain NN B-Sign_symptom
for IN O
2 CD B-Duration
days NNS I-Duration
. . O

Esophagogastroduodenoscopy NNP B-Diagnostic_procedure
( ( O
EGD NNP B-Diagnostic_procedure
) ) O
, , O
performed VBD O
3 CD O
years NNS O
earlier RBR O
for IN O
abdominal JJ B-Biological_structure
pain NN B-Sign_symptom
, , O
had VBD O
revealed VBN O
no RB O
esophageal JJ B-Biological_structure
varices NNS B-Sign_symptom
, , O
gastric JJ B-Biological_structure
varices NNS B-Sign_symptom
, , O
portal JJ B-Biological_structure
hypertensive NN B-Detailed_description
gastropathy NN B-Disease_disorder
, , O
or CC O
other JJ O
GI NNP B-Biological_structure
lesions NNS B-Sign_symptom
. . O

Physical JJ B-Diagnostic_procedure
examination NN I-Diagnostic_procedure
revealed VBD O
a DT O
blood NN B-Diagnostic_procedure
pressure NN I-Diagnostic_procedure
= VBZ O
100 CD B-Lab_value
/ NN I-Lab_value
60 CD I-Lab_value
mm NN I-Lab_value
Hg NNP I-Lab_value
, , O
pulse RB B-Diagnostic_procedure
= VBZ O
60 CD B-Lab_value
beats NNS I-Lab_value
/ JJ I-Lab_value
min NN I-Lab_value
, , O
no DT O
jaundice NN B-Sign_symptom
, , O
no DT O
stigmata NN B-Sign_symptom
of IN I-Sign_symptom
chronic JJ I-Sign_symptom
liver NN I-Sign_symptom
disease NN I-Sign_symptom
, , O
a DT O
soft JJ B-Sign_symptom
abdomen NNS B-Biological_structure
with IN O
mild JJ B-Severity
epigastric JJ B-Biological_structure
tenderness NN B-Sign_symptom
but CC O
no DT O
rebound NN B-Detailed_description
tenderness RB B-Sign_symptom
, , O
no DT O
abdominal JJ B-Biological_structure
bruit NN B-Sign_symptom
, , O
and CC O
no DT O
pulsatile JJ B-Detailed_description
abdominal JJ B-Biological_structure
mass NN B-Sign_symptom
. . O

Rectal JJ B-Diagnostic_procedure
examination NN I-Diagnostic_procedure
revealed VBD O
gross JJ O
melena NN B-Sign_symptom
. . O

Laboratory NN B-Diagnostic_procedure
tests NNS I-Diagnostic_procedure
revealed VBD O
hemoglobin JJ B-Diagnostic_procedure
= RB O
12 CD B-Lab_value
. . I-Lab_value
5 CD I-Lab_value
g JJ I-Lab_value
/ NNP I-Lab_value
dL NN I-Lab_value
, , O
platelets NNS B-Diagnostic_procedure
= VBP O
301,000 CD B-Lab_value
/ JJ I-Lab_value
mL NN I-Lab_value
, , O
INR NNP B-Diagnostic_procedure
( ( O
international JJ B-Diagnostic_procedure
normalized VBN I-Diagnostic_procedure
ratio NN I-Diagnostic_procedure
) ) O
= VBZ O
1 CD B-Lab_value
. . I-Lab_value
0 CD I-Lab_value
, , O
blood NN B-Diagnostic_procedure
urea JJ I-Diagnostic_procedure
nitrogen NN I-Diagnostic_procedure
= VBD O
20 CD B-Lab_value
mg NN I-Lab_value
/ NNP I-Lab_value
dL NN I-Lab_value
, , O
and CC O
creatinine VB B-Diagnostic_procedure
= JJ O
1 CD B-Lab_value
. . I-Lab_value
1 CD I-Lab_value
mg JJ I-Lab_value
/ NNP I-Lab_value
dL NN I-Lab_value
. . O

Serum NNP B-Diagnostic_procedure
aspartate NN I-Diagnostic_procedure
aminotransferase NN I-Diagnostic_procedure
= VBD O
21 CD B-Lab_value
IU NNP I-Lab_value
/ NNP I-Lab_value
L NNP I-Lab_value
, , O
alanine JJ B-Diagnostic_procedure
aminotransferase NN I-Diagnostic_procedure
= VBD O
16 CD B-Lab_value
IU NNP I-Lab_value
/ NNP I-Lab_value
L NNP I-Lab_value
, , O
total JJ B-Diagnostic_procedure
bilirubin NN I-Diagnostic_procedure
= VBD O
0 CD B-Lab_value
. . I-Lab_value
6 CD I-Lab_value
mg JJ I-Lab_value
/ NNP I-Lab_value
dL NN I-Lab_value
, , O
alkaline JJ B-Diagnostic_procedure
phosphatase NN I-Diagnostic_procedure
= VBD O
64 CD B-Lab_value
IU NNP I-Lab_value
/ NNP I-Lab_value
L NNP I-Lab_value
, , O
albumin VBD B-Diagnostic_procedure
= JJ O
4 CD B-Lab_value
. . I-Lab_value
4 CD I-Lab_value
gm JJ I-Lab_value
/ NNP I-Lab_value
dL NN I-Lab_value
, , O
and CC O
lipase VB B-Diagnostic_procedure
= JJ O
32 CD B-Lab_value
U NNP I-Lab_value
/ NNP I-Lab_value
dL NN I-Lab_value
. . O

The DT O
hemoglobin NN B-Diagnostic_procedure
declined VBD B-Lab_value
acutely RB I-Lab_value
to TO O
9 CD B-Lab_value
. . I-Lab_value
3 CD I-Lab_value
g JJ I-Lab_value
/ NNP I-Lab_value
dL NN I-Lab_value
. . O

Abdomino NNP B-Biological_structure
- : I-Biological_structure
pelvic JJ I-Biological_structure
computerized JJ B-Diagnostic_procedure
tomography NN I-Diagnostic_procedure
( ( O
CT NNP B-Diagnostic_procedure
) ) O
, , O
with IN O
intravenous JJ B-Detailed_description
contrast NN I-Detailed_description
, , I-Detailed_description
revealed VBD O
a DT O
5 CD B-Distance
- : I-Distance
cm NN I-Distance
wide JJ O
, , O
irregular JJ B-Detailed_description
, , O
pancreatic JJ B-Biological_structure
/ NNP O
peripancreatic JJ B-Biological_structure
mass NN B-Sign_symptom
, , O
compressing VBG B-Sign_symptom
both PDT O
the DT O
lesser JJR B-Biological_structure
curvature NN I-Biological_structure
of IN I-Biological_structure
the DT I-Biological_structure
stomach NN I-Biological_structure
and CC O
the DT O
SV NNP B-Biological_structure
( ( O
Fig NNP O
. . O
1A CD O
, , O
B NNP O
) ) O
, , O
a DT O
normal JJ B-Lab_value
portal JJ B-Diagnostic_procedure
vein NN I-Diagnostic_procedure
, , O
and CC O
normal JJ B-Lab_value
liver NN B-Diagnostic_procedure
parenchyma NN I-Diagnostic_procedure
. . O

The DT O
SV NNP B-Biological_structure
compression NN B-Sign_symptom
was VBD O
pathophysiologically RB B-Lab_value
significant JJ I-Lab_value
as IN O
indicated VBN O
by IN O
proximal JJ B-Biological_structure
SV NNP I-Biological_structure
dilatation NN B-Sign_symptom
. . O

EGD NNP B-Diagnostic_procedure
revealed VBD O
in IN O
the DT O
proximal JJ B-Biological_structure
stomach NN I-Biological_structure
a DT O
fine JJ B-Detailed_description
, , O
reticular JJ B-Detailed_description
, , O
pale JJ B-Color
- : I-Color
white JJ I-Color
, , O
polygonal JJ B-Shape
, , O
mucosal NN B-Biological_structure
, , O
network NN B-Sign_symptom
in IN O
a DT O
snakeskin JJ B-Texture
pattern NN I-Texture
, , O
and CC O
characteristic NN O
of IN O
portal JJ B-Disease_disorder
hypertensive JJ I-Disease_disorder
gastropathy NN I-Disease_disorder
that WDT O
was VBD O
actively RB O
oozing VBG B-Sign_symptom
; : O
extensive JJ B-Severity
coffee NN B-Texture
- : I-Texture
ground NN I-Texture
, , O
blood NN B-Sign_symptom
clots NNS I-Sign_symptom
in IN O
the DT O
stomach NN B-Biological_structure
; : O
small JJ O
gastric JJ B-Biological_structure
cardial NN B-Biological_structure
and CC O
fundal JJ B-Biological_structure
varices NNS B-Sign_symptom
without IN O
stigmata NN B-Sign_symptom
of IN I-Sign_symptom
recent JJ I-Sign_symptom
hemorrhage NN I-Sign_symptom
( ( O
SRH NNP B-Sign_symptom
) ) O
; : O
and CC O
no DT O
esophageal JJ B-Biological_structure
varices NNS B-Sign_symptom
( ( O
Fig NNP O
. . O
2 CD O
) ) O
. . O

The DT O
extrinsic JJ O
mass NN O
produced VBD O
a DT O
large JJ B-Detailed_description
, , O
round JJ B-Shape
bulge NN B-Sign_symptom
extending VBG B-Biological_structure
into IN I-Biological_structure
the DT I-Biological_structure
lumen NNS I-Biological_structure
of IN I-Biological_structure
the DT I-Biological_structure
proximal JJ I-Biological_structure
gastric JJ I-Biological_structure
body NN I-Biological_structure
along IN O
the DT O
lesser JJR B-Biological_structure
curvature NN I-Biological_structure
( ( O
Fig NNP O
. . O
2 CD O
) ) O
. . O

Magnetic JJ B-Diagnostic_procedure
resonance NN I-Diagnostic_procedure
cholangio NN I-Diagnostic_procedure
- : I-Diagnostic_procedure
pancreatography NN I-Diagnostic_procedure
( ( O
MRCP NNP B-Diagnostic_procedure
) ) O
revealed VBD O
a DT O
5 CD B-Distance
- : I-Distance
cm NN I-Distance
wide JJ O
, , O
enhancing VBG B-Detailed_description
, , O
vascular JJ B-Biological_structure
mass NN B-Sign_symptom
likely RB O
arising VBG B-Biological_structure
from IN I-Biological_structure
the DT I-Biological_structure
LGA NNP I-Biological_structure
and CC O
located VBN O
between IN B-Biological_structure
the DT I-Biological_structure
gastric JJ I-Biological_structure
lesser NN I-Biological_structure
curvature NN I-Biological_structure
and CC I-Biological_structure
distal JJ I-Biological_structure
pancreatic JJ I-Biological_structure
body NN I-Biological_structure
; : O
compressing VBG B-Sign_symptom
the DT O
stomach NN B-Biological_structure
; : O
compressing VBG B-Sign_symptom
the DT O
middle JJ B-Biological_structure
SV NNP I-Biological_structure
; : O
and CC O
resulting VBG O
in IN O
large JJ B-Detailed_description
collateral NN B-Sign_symptom
veins NNS I-Sign_symptom
draining VBG O
the DT O
SV NNP B-Biological_structure
into IN O
the DT O
superior JJ B-Biological_structure
mesenteric JJ I-Biological_structure
vein NN I-Biological_structure
( ( O
Fig NNP O
. . O
3A CD O
, , O
B NNP O
) ) O
. . O

Abdominal NNP B-Biological_structure
ultrasound NN B-Diagnostic_procedure
with IN O
Doppler NNP B-Detailed_description
studies NNS I-Detailed_description
demonstrated VBD O
large JJ B-Detailed_description
, , O
turbulent JJ B-Detailed_description
arterial JJ B-Biological_structure
flow NN B-Sign_symptom
into IN O
this DT O
vascular JJ B-Biological_structure
mass NN O
, , O
suggesting VBG O
a DT O
large JJ B-Detailed_description
PA NNP B-Disease_disorder
( ( O
Fig NNP O
. . O
4 CD O
) ) O
. . O

Visceral JJ B-Detailed_description
arteriogram NN B-Diagnostic_procedure
showed VBD O
a DT O
5 CD B-Volume
. . I-Volume
3 CD I-Volume
× JJ I-Volume
2 CD I-Volume
. . I-Volume
2 CD I-Volume
- : I-Volume
cm NN I-Volume
- : I-Volume
wide JJ I-Volume
PA NNP B-Disease_disorder
supplied VBN O
by IN O
an DT O
LGA NNP B-Biological_structure
branch NN I-Biological_structure
( ( O
Fig NNP O
. . O
5A CD O
) ) O
, , O
which WDT O
was VBD O
embolized VBN B-Therapeutic_procedure
and CC O
occluded VBN B-Therapeutic_procedure
with IN O
microcoils NNS B-Detailed_description
( ( O
Fig NNP O
. . O
5B CD O
) ) O
. . O

Eight CD O
weeks NNS O
later RB O
, , O
the DT O
patient NN O
had VBD O
a DT O
stable JJ B-Lab_value
hemoglobin NN B-Diagnostic_procedure
level NN O
with IN O
no DT O
further JJ O
GI NNP B-Biological_structure
bleeding NN B-Sign_symptom
. . O

Abdomino NNP B-Biological_structure
- : I-Biological_structure
pelvic JJ I-Biological_structure
CT NNP B-Detailed_description
angiography NN B-Diagnostic_procedure
demonstrated VBD O
the DT O
PA NNP B-Disease_disorder
had VBD O
markedly RB O
decreased VBN B-Lab_value
in IN I-Lab_value
diameter NN I-Lab_value
, , O
contained VBD B-Detailed_description
numerous JJ I-Detailed_description
microcoils NNS I-Detailed_description
, , O
and CC O
had VBD O
no DT B-Detailed_description
blood NN I-Detailed_description
flow NN I-Detailed_description
( ( O
Fig NNP O
. . O
1C CD O
) ) O
. . O

-DOCSTART- NN -X-

A DT O
50 CD B-Age
- : I-Age
year NN I-Age
- : I-Age
old JJ I-Age
lady NN O
presented VBN O
with IN O
complaints NNS O
of IN O
pain NN B-Sign_symptom
abdomen NNS B-Biological_structure
and CC O
jaundice NN B-Sign_symptom
for IN O
one CD B-Duration
and CC I-Duration
a DT I-Duration
half JJ I-Duration
months NNS I-Duration
; : O
she PRP O
also RB O
complained VBD O
of IN O
intermittent JJ B-Detailed_description
type NN O
of IN O
fever NN B-Sign_symptom
in IN O
the DT O
last JJ B-Duration
1 CD I-Duration
week NN I-Duration
. . O

Physical JJ B-Diagnostic_procedure
examination NN I-Diagnostic_procedure
revealed VBD O
presence NN O
of IN O
icterus NN B-Sign_symptom
and CC O
a DT O
palpable JJ B-Detailed_description
tender NN B-Detailed_description
globular JJ B-Shape
mass NN B-Sign_symptom
in IN O
the DT O
right JJ B-Biological_structure
hypochondrium NN I-Biological_structure
measuring VBG O
3 CD B-Area
× JJ I-Area
3 CD I-Area
cm NN I-Area
. . O

A DT O
clinical JJ O
diagnosis NN O
of IN O
obstructive JJ B-Detailed_description
jaundice NN B-Sign_symptom
secondary JJ O
to TO O
periampullary JJ B-Disease_disorder
carcinoma NN I-Disease_disorder
was VBD O
made VBN O
. . O

Ultrasonographic JJ B-Diagnostic_procedure
examination NN I-Diagnostic_procedure
of IN O
the DT O
abdomen NNS B-Biological_structure
and CC O
pelvis NN B-Biological_structure
revealed VBD O
dilatation NN B-Sign_symptom
of IN I-Sign_symptom
the DT I-Sign_symptom
intrahepatic JJ B-Biological_structure
biliary JJ I-Biological_structure
radicles NNS I-Biological_structure
( ( O
IHBR NNP B-Biological_structure
) ) O
, , O
with IN O
multiple JJ B-Detailed_description
freely RB O
mobile JJ B-Detailed_description
gall NN B-Sign_symptom
stones NNS I-Sign_symptom
and CC O
a DT O
dilated JJ B-Sign_symptom
common JJ B-Biological_structure
bile NN I-Biological_structure
duct NN I-Biological_structure
( ( O
CBD NNP B-Biological_structure
) ) O
measuring VBG O
1 CD B-Distance
. . I-Distance
8 CD I-Distance
cm NN I-Distance
with IN O
sudden JJ B-Detailed_description
narrowing NN I-Detailed_description
at IN I-Detailed_description
its PRP$ I-Detailed_description
distal JJ I-Detailed_description
end NN I-Detailed_description
. . O

CT NNP B-Diagnostic_procedure
scan JJ I-Diagnostic_procedure
showed VBD O
moderate JJ B-Severity
dilatation NN B-Sign_symptom
of IN I-Sign_symptom
the DT I-Sign_symptom
extra JJ I-Sign_symptom
and CC I-Sign_symptom
intrahepatic JJ I-Sign_symptom
biliary NN I-Sign_symptom
radicles NNS I-Sign_symptom
, , O
cholelithiasis NN B-Sign_symptom
with IN O
suspicious JJ O
thickening NN B-Sign_symptom
of IN I-Sign_symptom
the DT I-Sign_symptom
gall NN I-Sign_symptom
bladder NN I-Sign_symptom
wall NN I-Sign_symptom
at IN O
the DT O
fundus NN B-Biological_structure
, , O
and CC O
a DT O
distal JJ B-Biological_attribute
CBD NNP I-Biological_attribute
stricture NN B-Sign_symptom
. . O

There EX O
was VBD O
no DT O
evidence NN O
of IN O
any DT O
distant JJ O
metastasis NN B-Sign_symptom
( ( O
Fig NNP O
. . O
1 CD O
) ) O
. . O

A DT O
preoperative JJ O
diagnosis NN O
of IN O
periampullary JJ B-Disease_disorder
carcinoma NN I-Disease_disorder
with IN O
chronic JJ B-Disease_disorder
cholecystitis NN I-Disease_disorder
was VBD O
made VBN O
, , O
and CC O
the DT O
patient NN O
planned VBN O
for IN O
a DT O
pancreaticoduodenectomy NN B-Therapeutic_procedure
( ( O
Whipple NNP B-Therapeutic_procedure
` `` I-Therapeutic_procedure
s JJ I-Therapeutic_procedure
procedure NN I-Therapeutic_procedure
) ) O
after IN O
optimization NN O
. . O

The DT O
patient NN O
underwent NN O
a DT O
classical JJ O
Whipple NNP B-Therapeutic_procedure
` `` I-Therapeutic_procedure
s JJ I-Therapeutic_procedure
procedure NN I-Therapeutic_procedure
; : O
table JJ B-Diagnostic_procedure
examination NN I-Diagnostic_procedure
of IN O
the DT O
resected JJ B-Biological_structure
specimen NNS I-Biological_structure
revealed VBD O
multiple JJ B-Detailed_description
gall NN B-Sign_symptom
stones NNS I-Sign_symptom
in IN O
the DT O
gall NN B-Biological_structure
bladder NN I-Biological_structure
with IN O
area NN O
of IN O
mucosal NN B-Sign_symptom
thickening VBG I-Sign_symptom
at IN O
the DT O
fundus NN B-Biological_structure
and CC O
an DT O
irregular JJ B-Detailed_description
circumferential JJ B-Detailed_description
growth NN B-Sign_symptom
involving VBG O
the DT O
intrapancreatic JJ B-Biological_structure
portion NN I-Biological_structure
of IN I-Biological_structure
the DT I-Biological_structure
CBD NNP I-Biological_structure
. . O

Postoperative JJ B-Therapeutic_procedure
period NN I-Therapeutic_procedure
was VBD O
uneventful JJ B-Lab_value
, , O
and CC O
the DT O
patient NN O
recovered VBD O
satisfactorily RB B-Lab_value
. . O

Histopathological JJ B-Diagnostic_procedure
examination NN I-Diagnostic_procedure
of IN O
the DT O
resected JJ B-Biological_structure
specimen NNS I-Biological_structure
( ( O
Figs NNP O
. . O
2 CD O
and CC O
3 CD O
) ) O
revealed VBD O
thickening NN B-Sign_symptom
of IN I-Sign_symptom
the DT I-Sign_symptom
gall NN I-Sign_symptom
bladder NN I-Sign_symptom
wall NN I-Sign_symptom
at IN O
the DT O
fundus NN B-Biological_structure
with IN O
multiple JJ B-Detailed_description
small JJ B-Detailed_description
calculi NN B-Sign_symptom
, , O
the DT O
largest JJS O
measuring NN O
1 CD B-Distance
. . I-Distance
4 CD I-Distance
cm NN I-Distance
( ( O
Fig NNP O
. . O
3 CD O
) ) O
. . O

Sections NNS O
studied VBN O
from IN O
the DT O
area NN O
of IN O
thickening VBG O
showed VBD O
features NNS O
suggestive JJ O
of IN O
adenocarcinoma NN B-Disease_disorder
limited VBN O
to TO O
the DT O
mucosa NN B-Biological_structure
. . O

Microscopic NNP B-Diagnostic_procedure
sections NNS I-Diagnostic_procedure
obtained VBD O
from IN O
the DT O
distal JJ B-Biological_structure
CBD NNP I-Biological_structure
region NN I-Biological_structure
showed VBD O
adenocarcinoma NN B-Disease_disorder
of IN O
the DT O
common JJ B-Biological_structure
bile NN I-Biological_structure
duct NN I-Biological_structure
with IN O
invasion NN B-Detailed_description
into IN O
the DT O
muscular JJ B-Biological_structure
wall NN I-Biological_structure
of IN I-Biological_structure
the DT I-Biological_structure
duodenum NN I-Biological_structure
. . O

Sections NNS B-Diagnostic_procedure
studied VBN O
from IN O
the DT O
resected VBN B-Biological_structure
lymph NN I-Biological_structure
nodes NNS I-Biological_structure
were VBD O
free JJ O
of IN O
tumor NN B-Sign_symptom
cells NNS I-Sign_symptom
. . O

A DT O
pathological JJ O
staging NN O
of IN O
pT1aN0M0 NN B-Detailed_description
for IN O
adenocarcinoma NN B-Disease_disorder
of IN O
the DT O
gall NN B-Biological_structure
bladder NN I-Biological_structure
and CC O
pT2N0M0 NN B-Detailed_description
for IN O
adenocarcinoma NN B-Disease_disorder
of IN O
the DT O
distal JJ B-Biological_structure
CBD NNP I-Biological_structure
was VBD O
made VBN O
, , O
and CC O
the DT O
patient NN O
was VBD O
not RB O
subjected VBN O
to TO O
any DT O
adjuvant JJ B-Medication
therapy NN I-Medication
. . O

The DT O
patient NN O
was VBD O
disease JJ B-Sign_symptom
- : O
free JJ O
2 CD O
years NNS O
after IN O
surgery NN O
. . O

-DOCSTART- NN -X-

The DT O
proband NN O
( ( O
II NNP O
- : O
2 CD O
in IN O
Fig NNP O
. . O
2 CD O
) ) O
is VBZ O
a DT O
45 CD B-Age
- : I-Age
year NN I-Age
old JJ I-Age
woman NN O
, , O
who WP O
first RB O
presented VBD O
to TO O
our PRP$ O
university NN B-Biological_structure
hospital NN I-Biological_structure
at IN O
the DT O
age NN O
of IN O
35 CD O
and CC O
was VBD O
referred VBN O
to TO O
us PRP O
because IN O
of IN O
her PRP$ O
pregnancy NN O
. . O

She PRP O
has VBZ O
congenital JJ O
deafness NN O
, , O
first RB O
experienced VBD O
syncope NN B-Sign_symptom
at IN O
the DT O
age NN O
of IN O
3 CD O
, , O
and CC O
was VBD O
diagnosed VBN O
with IN O
epilepsy NN O
. . O

She PRP O
was VBD O
treated VBN O
with IN O
anti JJ B-Medication
- : I-Medication
epilepsy NN I-Medication
medications NNS I-Medication
; : O
however RB O
, , O
she PRP O
subsequently RB O
experienced VBD O
several JJ B-Detailed_description
instances NNS I-Detailed_description
of IN O
syncope NN B-Sign_symptom
. . O

At IN O
the DT O
age NN O
of IN O
13 CD O
, , O
she PRP O
had VBD O
a DT O
syncope NN B-Sign_symptom
event NN O
, , O
and CC O
was VBD O
suspected VBN O
of IN O
having VBG O
JLNS NNP B-Disease_disorder
because IN O
of IN O
her PRP$ O
congenital JJ O
deafness NN O
and CC O
prolonged VBD B-Sign_symptom
QT NNP I-Sign_symptom
interval NN I-Sign_symptom
. . O

Her PRP$ O
syncope NN B-Sign_symptom
was VBD O
diagnosed VBN O
as IN O
an DT O
arrhythmic JJ B-Sign_symptom
episode NN I-Sign_symptom
when WRB O
she PRP O
was VBD O
aware JJ O
of IN O
tachycardia NN B-Sign_symptom
and CC O
as IN O
epilepsy NN B-Disease_disorder
when WRB O
she PRP O
was VBD O
not RB O
. . O

She PRP O
also RB O
had VBD O
a DT O
subarachnoid JJ B-Sign_symptom
hemorrhage NN I-Sign_symptom
at IN O
the DT O
age NN O
of IN O
29 CD O
. . O

When WRB O
she PRP O
first RB O
presented VBD O
at IN O
our PRP$ O
hospital NN B-Nonbiological_location
, , O
she PRP O
was VBD O
not RB O
taking VBG O
beta SYM B-Medication
- : I-Medication
blockers NNS I-Medication
, , O
because IN O
of IN O
a DT O
history NN O
of IN O
asthma NN O
, , O
but CC O
was VBD O
taking VBG O
mexiletine NN B-Medication
in IN O
addition NN O
to TO O
phenytoin VB B-Medication
. . O

Her PRP$ O
QTc NNP B-Diagnostic_procedure
was VBD O
found VBN O
to TO O
be VB O
prolonged VBN B-Lab_value
( ( O
584 CD B-Lab_value
ms NN I-Lab_value
) ) O
at IN O
presentation NN O
and CC O
administration NN O
of IN O
atenolol NN B-Medication
was VBD O
initiated VBN O
. . O

She PRP O
delivered VBD O
her PRP O
baby NN O
( ( O
III NNP O
- : O
1 CD O
in IN O
Fig NNP O
. . O
2 CD O
) ) O
through IN O
Caesarean JJ B-Therapeutic_procedure
operation NN I-Therapeutic_procedure
at IN O
our PRP$ O
hospital NN B-Nonbiological_location
at IN O
the DT O
age NN O
of IN O
35 CD O
. . O

At IN O
37 CD O
, , O
she PRP O
delivered VBD O
her PRP O
second JJ O
baby NN O
( ( O
III NNP O
- : O
2 CD O
in IN O
Fig NNP O
. . O
2 CD O
) ) O
through IN O
Caesarean JJ B-Therapeutic_procedure
operation NN I-Therapeutic_procedure
at IN O
our PRP$ O
hospital NN B-Nonbiological_location
. . O

Despite IN O
administration NN O
of IN O
beta JJ B-Medication
- : I-Medication
blockers NNS I-Medication
, , O
her PRP$ O
QTc NNP B-Diagnostic_procedure
remained VBD O
prolonged JJ B-Lab_value
( ( O
600 CD B-Lab_value
msec NN I-Lab_value
at IN O
the DT O
age NN O
of IN O
37 CD O
, , O
780 CD B-Lab_value
msec NN I-Lab_value
at IN O
44 CD O
) ) O
( ( O
Figs NNP O
. . O
2 CD O
and CC O
3a CD O
) ) O
, , O
which WDT O
is VBZ O
not RB O
unexpected JJ O
because IN O
treatment NN O
with IN O
beta NN O
- : O
blockers NNS O
in IN O
LQTS1 NNP O
is VBZ O
not RB O
expected VBN O
to TO O
overtly RB O
reduce VB O
QTc NNP O
[ NNP O
18 CD O
] NN O
. . O

However RB O
, , O
she PRP O
continued VBD O
to TO O
experience VB O
occasional JJ B-Detailed_description
syncope NN B-Sign_symptom
and CC O
finally RB O
underwent JJ O
an DT O
implantable JJ B-Therapeutic_procedure
cardioverter NN I-Therapeutic_procedure
defibrillator NN I-Therapeutic_procedure
( ( O
ICD NNP B-Therapeutic_procedure
) ) O
operation NN O
at IN O
38 CD O
years NNS O
of IN O
age NN O
. . O

Subsequently RB O
, , O
she PRP O
is VBZ O
in IN O
a DT O
stable JJ B-Sign_symptom
clinical JJ I-Sign_symptom
condition NN I-Sign_symptom
. . O

Because IN O
the DT O
proband NN O
was VBD O
suspected VBN O
of IN O
JLNS NNP B-Disease_disorder
and CC O
both DT O
infants NNS O
had VBD O
a DT O
measured VBN O
QTc NNP O
of IN O
500 CD O
ms NN O
or CC O
greater JJR O
within IN O
1 CD O
month NN O
after IN O
birth NN O
, , O
beta NN O
blockers NNS O
were VBD O
initiated VBN O
and CC O
both DT O
children NNS O
remain VBP O
in IN O
stable JJ O
condition NN O
at IN O
ages NNS O
10 CD O
and CC O
8 CD O
( ( O
Figs NNP O
. . O
2 CD O
and CC O
3b CD O
, , O
c NN O
) ) O
. . O

QTc NN O
of IN O
the DT O
son NN O
( ( O
III NNP O
- : O
1 CD O
in IN O
Fig NNP O
. . O
2 CD O
) ) O
was VBD O
measured VBN O
as IN O
500 CD O
ms NNS O
one CD O
month NN O
after IN O
birth NN O
, , O
while IN O
the DT O
QTc NNP O
of IN O
his PRP$ O
sister NN O
( ( O
III NNP O
- : O
2 CD O
) ) O
was VBD O
530 CD O
ms NN O
at IN O
birth NN O
. . O

The DT O
father NN O
( ( O
I PRP O
- : O
1 CD O
) ) O
and CC O
mother NN O
( ( O
I PRP O
- : O
2 CD O
) ) O
of IN O
the DT O
proband NN O
were VBD O
first JJ O
cousins NNS O
. . O

There EX O
is VBZ O
no DT O
history NN O
of IN O
sudden JJ O
unexplained JJ O
syncope NN O
or CC O
death NN O
of IN O
children NNS O
or CC O
adults NNS O
in IN O
the DT O
immediate JJ O
family NN O
members NNS O
, , O
despite IN O
the DT O
prolonged JJ O
QTc NNP O
of IN O
the DT O
children NNS O
. . O

Clinical JJ B-Diagnostic_procedure
evaluation NN I-Diagnostic_procedure
and CC O
consultation NN O
of IN O
the DT O
proband NN O
and CC O
her PRP$ O
family NN O
members NNS O
were VBD O
performed VBN O
at IN O
Chiba NNP B-Nonbiological_location
University NNP I-Nonbiological_location
Hospital NNP I-Nonbiological_location
. . O

Clinical JJ O
phenotypes NNS O
were VBD O
deduced VBN O
from IN O
the DT O
clinical JJ O
history NN O
, , O
physical JJ B-Diagnostic_procedure
examinations NNS I-Diagnostic_procedure
, , O
and CC O
ECG NNP B-Diagnostic_procedure
. . O

Blood NN B-Diagnostic_procedure
samples NNS I-Diagnostic_procedure
were VBD O
collected VBN O
from IN O
the DT O
proband NN O
and CC O
her PRP$ O
family NN O
members NNS O
following VBG O
genetic JJ O
counseling NN O
, , O
and CC O
written VBN O
informed JJ O
consent NN O
was VBD O
obtained VBN O
prior RB O
to TO O
sample VB O
collection NN O
. . O

Genomic NNP B-Diagnostic_procedure
DNA NNP I-Diagnostic_procedure
was VBD O
isolated VBN O
from IN O
peripheral JJ B-Biological_structure
blood NN I-Biological_structure
lymphocytes NNS I-Biological_structure
according VBG O
to TO O
established VBN O
protocols NNS O
at IN O
our PRP$ O
laboratory NN O
[ $ O
19 CD O
] NN O
. . O

Entire NNP O
coding NN O
exons NNS O
, , O
including VBG O
the DT O
intronic JJ O
boundaries NNS O
of IN O
the DT O
genes NNS O
, , O
of IN O
KCNQ1 NNP B-Detailed_description
( ( O
NCBI NNP O
ref NN O
: : O
NM_000218 NNP O
) ) O
and CC O
other JJ O
LQT NNP B-Detailed_description
causative JJ I-Detailed_description
genes NNS I-Detailed_description
( ( O
KCNH2 NNP B-Detailed_description
, , I-Detailed_description
SCN5A NNP I-Detailed_description
, , I-Detailed_description
KCNE1 NNP I-Detailed_description
, , I-Detailed_description
KCNE2 NNP I-Detailed_description
, , I-Detailed_description
KCNJ2 NNP I-Detailed_description
, , I-Detailed_description
SCN4B NNP I-Detailed_description
, , I-Detailed_description
KCNJ5 NNP I-Detailed_description
) ) O
were VBD O
amplified VBN O
by IN O
polymerase NN B-Diagnostic_procedure
chain NN I-Diagnostic_procedure
reaction NN I-Diagnostic_procedure
( ( O
PCR NNP B-Diagnostic_procedure
) ) O
, , O
according VBG O
to TO O
established VBN O
protocols NNS O
in IN O
our PRP$ O
laboratory NN O
. . O

Briefly NNP O
, , O
30 CD B-Detailed_description
- : I-Detailed_description
100 CD I-Detailed_description
ng NN I-Detailed_description
of IN I-Detailed_description
genomic JJ I-Detailed_description
DNA NNP I-Detailed_description
was VBD O
subjected VBN O
to TO O
PCR NNP O
amplification NN O
with IN O
DNA NNP B-Detailed_description
polymerase NN I-Detailed_description
( ( O
PrimeSTAR NNP B-Detailed_description
GXL NNP I-Detailed_description
DNA NNP I-Detailed_description
Polymerase NNP I-Detailed_description
; : I-Detailed_description
Takara NNP I-Detailed_description
Bio NNP I-Detailed_description
Inc NNP I-Detailed_description
. . I-Detailed_description
, , I-Detailed_description
Kusatsu NNP I-Detailed_description
, , I-Detailed_description
Japan NNP I-Detailed_description
) ) O
and CC O
primer JJ B-Detailed_description
sets NNS I-Detailed_description
. . O

The DT O
amplicons NNS B-Detailed_description
were VBD O
subjected VBN O
to TO O
conventional JJ B-Detailed_description
sequencing NN B-Diagnostic_procedure
with IN O
Sanger NNP B-Detailed_description
sequencers NNS I-Detailed_description
( ( O
Applied NNP B-Detailed_description
Biosystems NNP I-Detailed_description
3730 CD I-Detailed_description
/ NN I-Detailed_description
3130 CD I-Detailed_description
DNA NNP I-Detailed_description
analyzers NNS I-Detailed_description
; : I-Detailed_description
Thermo NNP I-Detailed_description
Fisher NNP I-Detailed_description
Scientific NNP I-Detailed_description
, , I-Detailed_description
Waltham NNP I-Detailed_description
, , I-Detailed_description
MA NNP I-Detailed_description
, , I-Detailed_description
USA NNP I-Detailed_description
) ) O
. . O

The DT O
sequence NN O
data NNS O
were VBD O
processed VBN B-Detailed_description
with IN I-Detailed_description
Gene NNP I-Detailed_description
Codes NNP I-Detailed_description
Sequencher NNP I-Detailed_description
Software NNP I-Detailed_description
( ( O
Takara NNP B-Detailed_description
Bio NNP I-Detailed_description
Inc NNP I-Detailed_description
. . I-Detailed_description
) ) O
and CC O
mapped VBD B-Detailed_description
to TO I-Detailed_description
the DT I-Detailed_description
human JJ I-Detailed_description
genome NN I-Detailed_description
sequence NN I-Detailed_description
( ( O
build JJ B-Detailed_description
GRCh37 NNP I-Detailed_description
/ NNP I-Detailed_description
hg19 NN I-Detailed_description
) ) O
. . O

Genetic JJ B-Diagnostic_procedure
analysis NN I-Diagnostic_procedure
was VBD O
performed VBN O
to TO O
screen VB O
all DT O
coding NN O
exons NNS O
and CC O
the DT O
exon JJ O
- : O
intron NN O
boundaries NNS O
of IN O
the DT O
KCNQ1 NNP B-Detailed_description
gene NN I-Detailed_description
( ( O
NCBI NNP O
ref NN O
: : O
NM_000218 NNP O
. . O
2 CD O
, , O
NP_000209 NNP O
. . O
2 CD O
) ) O
with IN O
concurrent JJ O
screening NN O
of IN O
other JJ O
LQT NNP B-Detailed_description
causative JJ I-Detailed_description
genes NNS I-Detailed_description
( ( O
KCNH2 NNP B-Detailed_description
, , I-Detailed_description
SCN5A NNP I-Detailed_description
, , I-Detailed_description
KCNE1 NNP I-Detailed_description
, , I-Detailed_description
KCNE2 NNP I-Detailed_description
, , I-Detailed_description
KCNJ2 NNP I-Detailed_description
, , I-Detailed_description
SCN4B NNP I-Detailed_description
, , I-Detailed_description
KCNJ5 NNP I-Detailed_description
) ) O
. . O

We PRP O
detected VBD O
a DT O
novel JJ O
homozygous JJ B-Sign_symptom
nonsense NN I-Sign_symptom
variant NN I-Sign_symptom
, , O
NM_000218 NNP B-Detailed_description
. . I-Detailed_description
2 CD I-Detailed_description
: : I-Detailed_description
c NN I-Detailed_description
. . I-Detailed_description
115G CD I-Detailed_description
> JJ I-Detailed_description
T NNP I-Detailed_description
( ( O
p NN O
. . O
Glu39X NNP O
, , O
in IN O
exon JJ O
1a CD O
) ) O
, , O
in IN O
the DT O
KCNQ1 NNP O
gene NN O
of IN O
the DT O
proband NN O
, , O
as RB O
well RB O
as IN O
a DT O
homozygous JJ B-Sign_symptom
common JJ I-Sign_symptom
variant NN I-Sign_symptom
( ( O
NM_000218 NNP B-Detailed_description
. . I-Detailed_description
2 CD I-Detailed_description
: : I-Detailed_description
c NN I-Detailed_description
. . I-Detailed_description
1343C CD I-Detailed_description
> JJ I-Detailed_description
G NNP I-Detailed_description
, , O
p NN O
. . O
Pro448Arg NNP O
) ) O
( ( O
Additional NNP O
file NN O
1 CD O
: : O
Table JJ O
S1 NNP O
) ) O
. . O

Genetic JJ B-Diagnostic_procedure
screening NN I-Diagnostic_procedure
of IN O
her PRP$ O
mother NN O
( ( O
I PRP O
- : O
2 CD O
) ) O
and CC O
children NNS O
( ( O
III NNP O
- : O
1 CD O
and CC O
III NNP O
- : O
2 CD O
) ) O
revealed VBD O
that IN O
they PRP O
were VBD O
heterozygous JJ O
for IN O
the DT O
nonsense NN O
variant NN O
( ( O
Fig NNP O
. . O
2 CD O
) ) O
. . O

Her PRP$ O
husband NN O
( ( O
II NNP O
- : O
3 CD O
) ) O
was VBD O
also RB O
screened VBN O
and CC O
found VBN O
to TO O
be VB O
heterozygous JJ O
for IN O
the DT O
common JJ O
variant NN O
( ( O
NM_000218 NNP O
. . O
2 CD O
: : O
c NN O
. . O
1343C CD O
> JJ O
G NNP O
, , O
p NN O
. . O
Pro448Arg NNP O
) ) O
. . O

The DT O
proband NN O
is VBZ O
a DT O
child NN O
from IN O
a DT O
first JJ O
- : O
cousin NN O
marriage NN O
, , O
and CC O
we PRP O
have VBP O
concluded VBN O
the DT O
homozygous JJ B-Sign_symptom
nonsense NN I-Sign_symptom
variant NN I-Sign_symptom
in IN O
the DT O
proband NN O
is VBZ O
the DT O
cause NN O
of IN O
her PRP$ O
JLNS1 NNP B-Disease_disorder
. . O

The DT O
proband NN O
was VBD O
negative JJ O
for IN O
pathogenic JJ B-Sign_symptom
variants NNS I-Sign_symptom
in IN I-Sign_symptom
other JJ I-Sign_symptom
LQT NNP I-Sign_symptom
causative JJ I-Sign_symptom
genes NNS I-Sign_symptom
, , O
including VBG O
the DT O
KCNE1 NNP O
gene NN O
( ( O
Additional NNP O
file NN O
1 CD O
: : O
Table JJ O
S1 NNP O
) ) O
. . O

-DOCSTART- NN -X-

A DT O
57 CD B-Age
- : I-Age
year NN I-Age
- : I-Age
old JJ I-Age
Jewish JJ O
man NN O
with IN O
Crohn NNP O
` `` O
s JJ O
disease NN O
( ( O
CD NNP B-Disease_disorder
) ) O
of IN O
the DT O
ileum NN B-Biological_structure
diagnosed VBD O
at IN O
the DT O
age NN O
of IN O
thirteen NN O
, , O
presented VBN O
with IN O
multiple JJ B-Detailed_description
nonmelanoma JJ B-Disease_disorder
skin NN I-Disease_disorder
cancers NNS I-Disease_disorder
( ( O
NMSCs NNP B-Disease_disorder
) ) O
; : O
these DT O
had VBD O
developed VBN O
over IN B-Duration
the DT I-Duration
past JJ I-Duration
16 CD I-Duration
years NNS I-Duration
coinciding VBG O
with IN O
the DT O
initiation NN O
of IN O
a DT O
prolonged JJ B-Dosage
course NN I-Dosage
of IN O
the DT O
thiopurine NN B-Medication
6 CD B-Medication
- : I-Medication
mercaptopurine NN I-Medication
( ( O
mercaptopurine NN B-Medication
, , O
6 CD B-Medication
- : I-Medication
MP NN I-Medication
) ) O
. . O

He PRP O
was VBD O
diagnosed VBN O
with IN O
a DT O
total NN O
of IN O
84 CD B-Lab_value
NMSC NNP B-Disease_disorder
: : O
72 CD B-Lab_value
NMSC NN O
at IN O
our PRP$ B-Nonbiological_location
clinic NN I-Nonbiological_location
, , O
12 CD B-Lab_value
from IN O
other JJ B-Nonbiological_location
clinics NNS I-Nonbiological_location
. . O

He PRP O
was VBD O
also RB O
awaiting VBG O
biopsy NN B-Diagnostic_procedure
and CC O
removal NN B-Therapeutic_procedure
for IN O
additional JJ O
lesions NNS B-Sign_symptom
. . O

His PRP$ O
CD NN B-Disease_disorder
was VBD O
initially RB O
treated VBN O
with IN O
sulfasalazine NN B-Medication
and CC O
intermittent JJ B-Frequency
steroids NNS B-Medication
at IN O
diagnosis NN O
, , O
but CC O
for IN O
the DT O
past JJ B-Duration
20 CD I-Duration
years NNS I-Duration
he PRP O
had VBD O
been VBN O
taking VBG O
6 CD B-Medication
- : I-Medication
MP JJ I-Medication
daily JJ B-Frequency
. . O

In IN O
the DT O
first JJ B-Duration
ten NN I-Duration
years NNS I-Duration
after IN O
beginning VBG O
6 CD B-Medication
- : I-Medication
MP NN I-Medication
he PRP O
developed VBD O
30 CD B-Lab_value
NMSC NNP B-Disease_disorder
; : O
14 CD B-Lab_value
were VBD O
squamous JJ B-Disease_disorder
cell NN I-Disease_disorder
carcinoma NN I-Disease_disorder
( ( O
SCC NNP B-Disease_disorder
) ) O
and CC O
16 CD B-Lab_value
were VBD O
basal VBN B-Disease_disorder
cell NN I-Disease_disorder
carcinoma NN I-Disease_disorder
( ( O
BCC NNP B-Disease_disorder
) ) O
. . O

The DT O
patient NN O
was VBD O
then RB O
treated VBN B-Therapeutic_procedure
elsewhere RB B-Nonbiological_location
for IN O
the DT O
subsequent JJ B-Duration
ten NN I-Duration
years NNS I-Duration
. . O

This DT O
past JJ O
year NN O
, , O
however RB O
, , O
he PRP O
returned VBD O
to TO O
the DT O
clinic NN B-Nonbiological_location
with IN O
over IN O
100 CD B-Lab_value
new JJ B-Lab_value
lesions NNS B-Sign_symptom
suggestive NN O
of IN O
malignancy NN B-Disease_disorder
on IN O
his PRP$ O
torso NN B-Biological_structure
and CC O
extremities NNS B-Biological_structure
. . O

Subsequent JJ O
to TO O
this DT O
exam NN O
, , O
he PRP O
had VBD O
42 CD B-Lab_value
biopsy SYM B-Diagnostic_procedure
- : O
proven JJ O
lesions NNS B-Sign_symptom
of IN O
NMCS NNP B-Disease_disorder
; : O
20 CD B-Lab_value
were VBD O
SCC NNP B-Disease_disorder
and CC O
22 CD B-Lab_value
were VBD O
BCC NNP B-Disease_disorder
. . O

In IN O
addition NN O
, , O
three CD B-Lab_value
of IN O
the DT O
SCCs NNP B-Disease_disorder
were VBD O
moderately RB B-Lab_value
differentiated VBN I-Lab_value
and CC O
two CD B-Lab_value
were VBD O
poorly RB B-Lab_value
differentiated VBN I-Lab_value
and CC O
some DT O
of IN O
his PRP$ O
larger JJR O
skin NN B-Disease_disorder
cancers NNS I-Disease_disorder
have VBP O
necessitated VBN O
Mohs NNP B-Therapeutic_procedure
surgery NN I-Therapeutic_procedure
and CC O
xenografting NN B-Therapeutic_procedure
. . O

The DT O
largest JJS B-Lab_value
of IN O
his PRP$ O
lesions NNS B-Sign_symptom
was VBD O
pretibial JJ B-Biological_structure
and CC O
measured VBD O
64x53 CD B-Area
mm NN I-Area
( ( O
Figure NNP O
1 CD O
) ) O
. . O

He PRP O
was VBD O
awaiting VBG O
biopsy NN B-Diagnostic_procedure
for IN O
many JJ O
other JJ O
suspicious JJ O
lesions NNS B-Sign_symptom
. . O

The DT O
patient NN O
had VBD O
Fitzpatrick NNP B-Lab_value
II NNP I-Lab_value
skin NN B-Diagnostic_procedure
type NN I-Diagnostic_procedure
and CC O
admitted VBN O
to TO O
excessive VB B-Detailed_description
sun NN B-Activity
exposure NN I-Activity
for IN O
25 CD B-Duration
years NNS I-Duration
in IN O
Hawai`i NNP B-Nonbiological_location
. . O

Early RB O
on IN O
he PRP O
did VBD O
not RB O
use VB O
sunscreen JJ B-Medication
, , O
and CC O
would MD O
sail VB B-Activity
a DT O
catamaran NN B-Detailed_description
during IN B-Detailed_description
peak JJ I-Detailed_description
sun NN I-Detailed_description
hours NNS I-Detailed_description
. . O

He PRP O
also RB O
revealed VBD O
that IN O
his PRP$ O
mother NN O
had VBD O
one CD B-Detailed_description
skin NN I-Detailed_description
cancer NN I-Detailed_description
lesion NN I-Detailed_description
removed VBD I-Detailed_description
and CC O
denied VBD O
ever RB O
having VBG O
been VBN O
a DT O
smoker NN B-Activity
. . O

Within IN O
the DT O
past JJ O
year NN O
he PRP O
discontinued VBD O
6 CD B-Medication
- : I-Medication
MP NN I-Medication
and CC O
began VBD O
using VBG O
mesalamine NN B-Medication
( ( O
Pentasa NNP B-Medication
) ) O
and CC O
later RB O
adalimumab NN B-Medication
( ( O
Humira NNP B-Medication
) ) O
hoping VBG O
to TO O
attenuate VB O
the DT O
progression NN O
of IN O
NMSC NNP O
, , O
and CC O
continued VBD O
to TO O
have VB O
monthly JJ B-Frequency
skin NN B-Diagnostic_procedure
exams NNS I-Diagnostic_procedure
. . O

Overall JJ O
, , O
he PRP O
was VBD O
hospitalized VBN O
16 CD B-Lab_value
times NNS I-Lab_value
for IN O
his PRP$ O
CD NN B-Disease_disorder
, , O
but CC O
never RB O
required VBD O
any DT O
intestinal JJ B-Biological_structure
resection NN B-Therapeutic_procedure
. . O

Unfortunately RB O
, , O
in IN O
his PRP$ O
most RBS O
recent JJ O
hospitalization NN O
he PRP O
was VBD O
diagnosed VBN O
with IN O
metastatic JJ B-Detailed_description
adenocarcinoma NN B-Disease_disorder
of IN O
the DT O
small JJ B-Biological_structure
bowel NN I-Biological_structure
, , O
and CC O
passed VBD O
away RB O
shortly RB O
after IN O
. . O

-DOCSTART- NN -X-

A DT O
60 CD B-Age
- : I-Age
year NN I-Age
- : I-Age
old JJ I-Age
male JJ O
patient NN O
had VBD O
previously RB O
undergone VBN O
a DT O
radical JJ B-Detailed_description
resection NN B-Therapeutic_procedure
of IN O
a DT O
T2bN0M0G3 NNP B-Detailed_description
Stage NNP I-Detailed_description
III NNP I-Detailed_description
retroperitoneal NN B-Disease_disorder
sarcoma NN I-Disease_disorder
, , O
including VBG O
right JJ B-Detailed_description
nephrectomy NN B-Therapeutic_procedure
and CC O
cholecystectomy NN B-Therapeutic_procedure
, , O
in IN O
2002 CD O
. . O

Pathologic NNP B-Diagnostic_procedure
evaluation NN I-Diagnostic_procedure
demonstrated VBD O
a DT O
25 CD B-Distance
cm NN I-Distance
high JJ B-Severity
- : I-Severity
grade NN I-Severity
liposarcoma NN B-Disease_disorder
with IN O
different JJ B-Detailed_description
histologic JJ I-Detailed_description
components NNS I-Detailed_description
, , O
including VBG O
myxoid NN B-Detailed_description
, , O
round NN B-Detailed_description
cell NN I-Detailed_description
, , O
well RB B-Detailed_description
- : I-Detailed_description
differentiated VBN I-Detailed_description
, , O
sclerosing VBG B-Detailed_description
and CC O
pleomorphic JJ B-Detailed_description
patterns NNS I-Detailed_description
. . O

Surgical JJ B-Diagnostic_procedure
margins NNS I-Diagnostic_procedure
were VBD O
negative JJ B-Lab_value
as IN O
the DT O
tumor NN B-Sign_symptom
did VBD O
not RB O
invade VB B-Sign_symptom
the DT O
kidney NN B-Biological_structure
, , O
and CC O
since IN O
the DT O
renal JJ B-Biological_structure
vein NN I-Biological_structure
and CC O
ureter NN B-Biological_structure
were VBD O
free JJ O
of IN O
tumor NN B-Sign_symptom
as IN O
well RB O
. . O

The DT O
patient NN O
did VBD O
not RB O
undergo VB O
any DT O
additional JJ O
therapy NN O
. . O

Surveillance NNP B-Detailed_description
magnetic JJ B-Diagnostic_procedure
resonance NN I-Diagnostic_procedure
imaging NN I-Diagnostic_procedure
in IN O
2007 CD O
revealed VBD O
an DT O
isolated JJ B-Detailed_description
tumor NN B-Sign_symptom
recurrence NN I-Sign_symptom
in IN O
the DT O
retroperitoneum NN B-Biological_structure
. . O

An DT O
exploratory JJ B-Detailed_description
celiotomy NN B-Diagnostic_procedure
revealed VBD O
tumor JJ B-Sign_symptom
involvement NN I-Sign_symptom
of IN O
the DT O
duodenum NN B-Biological_structure
, , O
head NN B-Biological_structure
of IN I-Biological_structure
the DT I-Biological_structure
pancreas NNS I-Biological_structure
, , O
superior JJ B-Biological_structure
mesenteric JJ I-Biological_structure
vein NN I-Biological_structure
, , O
vena FW B-Biological_structure
cava NN I-Biological_structure
and CC O
left VBD B-Biological_structure
renal JJ I-Biological_structure
vein NN I-Biological_structure
with IN O
severe JJ B-Severity
adhesive JJ B-Detailed_description
changes NNS I-Detailed_description
, , O
leading VBG O
to TO O
the DT O
intraoperative JJ O
assessment NN O
of IN O
unresectable JJ B-Disease_disorder
disease NN I-Disease_disorder
. . O

Subsequently RB O
, , O
the DT O
patient JJ O
underwent JJ O
stereotactic JJ B-Detailed_description
body NN I-Detailed_description
radiation NN B-Therapeutic_procedure
to TO O
the DT O
retroperitoneal JJ B-Biological_structure
tumor NN B-Sign_symptom
in IN O
five CD B-Dosage
fractions NNS I-Dosage
for IN O
a DT O
total JJ B-Dosage
dose NN I-Dosage
of IN I-Dosage
30 CD I-Dosage
Gy NNP I-Dosage
, , O
without IN O
complication NN B-Sign_symptom
. . O

Postradiation NN O
imaging VBG B-Diagnostic_procedure
revealed VBD O
near IN O
complete JJ O
resolution NN O
of IN O
the DT O
retroperitoneal JJ B-Biological_structure
mass NN B-Sign_symptom
. . O

One CD O
year NN O
later RB O
, , O
the DT O
patient NN O
presented VBN O
with IN O
weight JJ B-Sign_symptom
loss NN I-Sign_symptom
, , O
postprandial JJ B-Detailed_description
abdominal JJ B-Biological_structure
pain NN B-Sign_symptom
, , O
nausea NN B-Sign_symptom
and CC O
vomiting NN B-Sign_symptom
. . O

Cross NNP B-Diagnostic_procedure
- : I-Diagnostic_procedure
sectional JJ I-Diagnostic_procedure
imaging NN I-Diagnostic_procedure
revealed VBD O
a DT O
7 CD B-Distance
cm NN I-Distance
mass NN B-Sign_symptom
with IN O
involvement NN O
of IN O
the DT O
third JJ B-Biological_structure
portion NN I-Biological_structure
of IN I-Biological_structure
the DT I-Biological_structure
duodenum NN I-Biological_structure
( ( O
Figure NNP O
1 CD O
) ) O
. . O

However RB O
, , O
there EX O
was VBD O
no DT O
obvious JJ O
involvement NN B-Sign_symptom
of IN O
the DT O
pancreatic JJ B-Biological_structure
head NN I-Biological_structure
or CC O
the DT O
other JJ B-Biological_structure
structures NNS I-Biological_structure
that WDT O
were VBD O
noted VBN O
to TO O
be VB O
involved VBN O
during IN O
the DT O
previous JJ O
laparotomy NN O
. . O

We PRP O
elected VBD O
to TO O
perform VB O
another DT O
resection NN B-Therapeutic_procedure
attempt NN O
, , O
including VBG O
a DT O
possible JJ O
pancreatoduodenectomy NN O
or CC O
retroperitoneal VB O
vascular JJ O
resection NN O
if IN O
necessary JJ O
. . O

At IN O
exploration NN B-Diagnostic_procedure
, , O
the DT O
residual JJ O
tumor NN B-Sign_symptom
was VBD O
an DT O
entirely JJ O
intraduodenal JJ B-Biological_structure
, , O
pedunculated JJ B-Detailed_description
mass NN O
at IN O
the DT O
posterior JJ B-Biological_structure
duodenal JJ I-Biological_structure
wall NN I-Biological_structure
distal NN O
to TO O
the DT O
ampulla NN O
that WDT O
filled VBD O
the DT O
entire JJ O
duodenal JJ O
lumen NNS O
. . O

The DT O
patient NN O
underwent NN O
a DT O
duodenotomy NN B-Therapeutic_procedure
and CC O
stalk JJ B-Therapeutic_procedure
transection NN I-Therapeutic_procedure
of IN O
the DT O
polypoid JJ B-Detailed_description
mass NN B-Sign_symptom
, , O
followed VBN O
by IN O
partial JJ B-Detailed_description
duodenal JJ B-Biological_structure
resection NN B-Therapeutic_procedure
with IN O
hand NN B-Detailed_description
- : I-Detailed_description
sewn NN I-Detailed_description
duodenojejunal JJ B-Biological_structure
anastomosis NN B-Therapeutic_procedure
( ( O
Figure NNP O
2 CD O
) ) O
. . O

Surgical JJ B-Diagnostic_procedure
pathology NN I-Diagnostic_procedure
examination NN I-Diagnostic_procedure
revealed VBD O
a DT O
9 CD B-Distance
. . I-Distance
5 CD I-Distance
cm JJ I-Distance
recurrent NN B-Detailed_description
high JJ B-Severity
- : I-Severity
grade NN I-Severity
liposarcoma NN B-Disease_disorder
with IN O
polypoid JJ B-Detailed_description
intraluminal JJ I-Detailed_description
growth NN I-Detailed_description
containing VBG O
myxoid NN B-Detailed_description
, , O
round NN B-Detailed_description
cell NN I-Detailed_description
, , O
well RB B-Detailed_description
- : I-Detailed_description
differentiated VBN I-Detailed_description
, , O
sclerosing VBG B-Detailed_description
and CC O
focally RB B-Detailed_description
pleomorphic JJ I-Detailed_description
areas NNS I-Detailed_description
. . O

Surgical JJ B-Diagnostic_procedure
margins NNS I-Diagnostic_procedure
were VBD O
negative JJ B-Lab_value
as IN O
the DT O
tumor NN B-Sign_symptom
came VBD O
within IN B-Distance
0 CD I-Distance
. . I-Distance
1 CD I-Distance
cm NN I-Distance
of IN O
the DT O
stalk NN B-Biological_structure
margin NN I-Biological_structure
and CC O
there EX O
was VBD O
no DT O
evidence NN O
of IN O
additional JJ O
neoplastic JJ B-Sign_symptom
components NNS I-Sign_symptom
within IN O
the DT O
remaining VBG O
resected JJ O
duodenum NN B-Biological_structure
. . O

The DT O
postoperative JJ B-Therapeutic_procedure
course NN I-Therapeutic_procedure
was VBD O
uncomplicated JJ B-Lab_value
, , O
and CC O
the DT O
patient NN O
has VBZ O
demonstrated VBN O
no DT O
recurrence NN B-Sign_symptom
up RB O
to TO O
30 CD O
months NNS O
from IN O
this DT O
resection NN O
. . O

-DOCSTART- NN -X-

A DT O
71 CD B-Age
- : I-Age
year NN I-Age
- : I-Age
old JJ I-Age
African JJ O
- : O
American JJ O
woman NN O
presented VBD O
to TO O
the DT O
hospital NN O
with IN O
worsening VBG B-Lab_value
exertional JJ B-Detailed_description
dyspnoea NN B-Sign_symptom
associated VBN O
with IN O
orthopnoea NN B-Sign_symptom
and CC O
lower JJR B-Biological_structure
extremity NN I-Biological_structure
oedema NN B-Sign_symptom
for IN O
3 CD B-Duration
weeks NNS I-Duration
. . O

She PRP O
had VBD O
a DT O
long JJ O
- : O
standing VBG O
history NN O
of IN O
hypertension NN B-Sign_symptom
and CC O
documented VBN O
G6PD NNP O
deficiency NN O
with IN O
prior JJ O
episodes NNS O
of IN O
haemolysis NN B-Sign_symptom
. . O

She PRP O
was VBD O
a DT O
former JJ O
cigarette NN O
smoker NN O
and CC O
had VBD O
family NN O
members NNS O
with IN O
G6PD NNP O
deficiency NN O
, , O
hypertension NN O
and CC O
diabetes VBZ O
mellitus NNS O
. . O

Vital JJ B-Diagnostic_procedure
signs NNS I-Diagnostic_procedure
measurement NN I-Diagnostic_procedure
revealed VBD O
a DT O
blood NN B-Diagnostic_procedure
pressure NN I-Diagnostic_procedure
of IN O
150 CD B-Lab_value
/ JJ I-Lab_value
73 CD I-Lab_value
mm NN I-Lab_value
Hg NNP I-Lab_value
, , O
pulse JJ B-Diagnostic_procedure
rate NN I-Diagnostic_procedure
of IN O
70 CD B-Lab_value
bpm NN I-Lab_value
, , O
respiratory JJ B-Diagnostic_procedure
rate NN I-Diagnostic_procedure
of IN O
24 CD B-Lab_value
breaths NNS I-Lab_value
/ JJ I-Lab_value
min NN I-Lab_value
, , O
temperature NN B-Diagnostic_procedure
of IN O
36 CD B-Lab_value
. . I-Lab_value
6 CD I-Lab_value
°C NN I-Lab_value
and CC O
97 CD B-Lab_value
% NN I-Lab_value
saturation NN B-Diagnostic_procedure
on IN O
room NN B-Detailed_description
air NN I-Detailed_description
. . I-Detailed_description

She PRP O
was VBD O
comfortable JJ B-Sign_symptom
at IN O
rest NN B-Detailed_description
. . O

Her PRP$ O
physical JJ B-Diagnostic_procedure
examination NN I-Diagnostic_procedure
showed VBD O
distended JJ B-Sign_symptom
jugular NN B-Biological_structure
veins NNS I-Biological_structure
, , O
inspiratory JJ B-Detailed_description
crackles NNS B-Sign_symptom
in IN O
bilateral JJ B-Biological_structure
lung NN I-Biological_structure
bases NNS I-Biological_structure
, , O
a DT O
laterally RB B-Lab_value
displaced JJ I-Lab_value
apical JJ B-Diagnostic_procedure
impulse NN I-Diagnostic_procedure
and CC O
bipedal JJ B-Biological_structure
oedema NN B-Sign_symptom
. . O

The DT O
ECG NNP B-Diagnostic_procedure
showed VBD O
left VBD B-Biological_structure
ventricular JJ I-Biological_structure
hypertrophy NN B-Sign_symptom
and CC O
inferolateral JJ B-Detailed_description
T NNP B-Sign_symptom
- : I-Sign_symptom
wave NN I-Sign_symptom
inversions NNS I-Sign_symptom
. . O

Chest NNP B-Biological_structure
radiography NN B-Diagnostic_procedure
revealed VBD O
cardiomegaly NN B-Sign_symptom
and CC O
mild JJ B-Severity
pulmonary JJ B-Biological_structure
oedema NN B-Sign_symptom
. . O

The DT O
metabolic JJ B-Diagnostic_procedure
panel NN I-Diagnostic_procedure
and CC O
troponin NN B-Diagnostic_procedure
levels NNS O
were VBD O
normal JJ B-Lab_value
but CC O
the DT O
B NNP B-Diagnostic_procedure
- : I-Diagnostic_procedure
type NN I-Diagnostic_procedure
natriuretic JJ I-Diagnostic_procedure
peptide NN I-Diagnostic_procedure
was VBD O
increased VBN B-Lab_value
at IN O
826 CD B-Lab_value
. . I-Lab_value
5 CD I-Lab_value
pg JJ I-Lab_value
/ NNP I-Lab_value
mL NN I-Lab_value
. . O

Echocardiography NN B-Diagnostic_procedure
showed VBD O
a DT O
dilated JJ B-Sign_symptom
left JJ B-Biological_structure
ventricle NN I-Biological_structure
with IN O
an DT O
ejection NN B-Diagnostic_procedure
fraction NN I-Diagnostic_procedure
( ( O
EF NNP B-Diagnostic_procedure
) ) O
of IN O
30 CD B-Lab_value
% NN I-Lab_value
and CC O
mild VB B-Severity
right JJ B-Biological_structure
ventricular JJ I-Biological_structure
systolic JJ B-Disease_disorder
dysfunction NN I-Disease_disorder
. . O

Coronary JJ B-Biological_structure
artery NN I-Biological_structure
catheterisation NN B-Therapeutic_procedure
revealed VBD O
normal JJ B-Lab_value
coronary JJ B-Diagnostic_procedure
circulation NN I-Diagnostic_procedure
. . O

Ethacrynic JJ B-Medication
acid NN I-Medication
at IN O
50 CD B-Dosage
mg JJ I-Dosage
daily RB I-Dosage
was VBD O
chosen VBN O
for IN O
diuresis NN O
. . O

She PRP O
improved VBD B-Sign_symptom
after IN O
a DT O
day NN O
but CC O
still RB O
had VBD O
dyspnoea NNS B-Sign_symptom
, , O
so IN O
we PRP O
added VBD O
spironolactone NN B-Medication
. . O

Subsequently RB O
, , O
metoprolol JJ B-Medication
succinate NN I-Medication
and CC O
losartan NN B-Medication
were VBD O
included VBN O
in IN O
the DT O
regimen NNS O
. . O

Repeat NN O
chest JJS B-Biological_structure
radiography NN B-Diagnostic_procedure
showed VBD O
resolution NN O
of IN O
pulmonary JJ B-Biological_structure
oedema NN B-Sign_symptom
. . O

The DT O
patient NN O
` `` O
s JJ O
laboratory NN B-Diagnostic_procedure
results NNS I-Diagnostic_procedure
during IN O
her PRP$ O
hospital JJ O
stay NN O
did VBD O
not RB O
show VB O
signs NNS O
of IN O
haemolysis NN B-Sign_symptom
nor CC O
worsening VBG B-Sign_symptom
kidney NN I-Sign_symptom
function NN I-Sign_symptom
. . O

She PRP O
did VBD O
not RB O
develop VB O
ototoxicity NN B-Sign_symptom
and CC O
was VBD O
discharged VBN O
home NN B-Nonbiological_location
asymptomatic NN B-Sign_symptom
. . O

-DOCSTART- NN -X-

A DT O
35 CD B-Age
- : I-Age
year NN I-Age
- : I-Age
old JJ I-Age
woman NN O
presented VBD O
to TO O
the DT O
medical JJ B-Nonbiological_location
emergency NN I-Nonbiological_location
department NN I-Nonbiological_location
with IN O
low JJ B-Severity
- : I-Severity
grade NN I-Severity
fever NN B-Sign_symptom
for IN O
3 CD B-Duration
weeks NNS I-Duration
, , O
vomiting VBG B-Sign_symptom
for IN O
1 CD B-Duration
week NN I-Duration
and CC O
anuria NN B-Sign_symptom
for IN O
3 CD B-Duration
days NNS I-Duration
. . O

She PRP O
also RB O
reported VBD O
dysuria NNS B-Sign_symptom
and CC O
breathlessness NN B-Sign_symptom
for IN O
1 CD B-Duration
week NN I-Duration
. . O

There EX O
was VBD O
no DT O
history NN O
of IN O
decreased JJ B-Sign_symptom
urine NN I-Sign_symptom
output NN I-Sign_symptom
, , O
dialysis NN B-Therapeutic_procedure
, , O
effort NN B-Sign_symptom
intolerance NN I-Sign_symptom
, , O
chest VBP B-Biological_structure
pain NN B-Sign_symptom
or CC O
palpitation NN B-Sign_symptom
, , O
dyspnoea NN B-Sign_symptom
and CC O
weight JJ B-Sign_symptom
loss NN I-Sign_symptom
. . O

Menstrual JJ B-Diagnostic_procedure
history NN I-Diagnostic_procedure
was VBD O
within IN B-Lab_value
normal JJ I-Lab_value
limit NN I-Lab_value
but CC O
she PRP O
reported VBD O
gradually RB B-Lab_value
progressive JJ I-Lab_value
loss NN B-Sign_symptom
of IN I-Sign_symptom
appetite NN I-Sign_symptom
. . O

Family RB O
history NN O
included VBD O
smoky JJ B-Detailed_description
urine NN I-Detailed_description
in IN O
her PRP$ O
younger JJR O
brother NN O
in IN O
his PRP$ O
childhood NN O
, , O
who WP O
died VBD B-Detailed_description
in IN I-Detailed_description
an DT I-Detailed_description
accident NN I-Detailed_description
. . O

On IN O
general JJ B-Diagnostic_procedure
survey NN I-Diagnostic_procedure
, , O
the DT O
patient NN O
was VBD O
conscious JJ B-Sign_symptom
and CC O
alert NN B-Sign_symptom
. . O

She PRP O
was VBD O
dyspnoeic JJ B-Sign_symptom
and CC O
febrile NN B-Sign_symptom
. . O

Severe NNP B-Severity
pallor NN B-Sign_symptom
was VBD O
present JJ O
with IN O
mild JJ B-Severity
pedal JJ B-Biological_structure
oedema NN B-Sign_symptom
. . O

Blood NNP B-Diagnostic_procedure
pressure NN I-Diagnostic_procedure
was VBD O
180 CD B-Lab_value
/ JJ I-Lab_value
100 CD I-Lab_value
mm NN I-Lab_value
Hg NNP I-Lab_value
and CC O
pulse JJ B-Diagnostic_procedure
rate NN I-Diagnostic_procedure
of IN O
116 CD B-Lab_value
/ JJ I-Lab_value
min NN I-Lab_value
regular NN B-Lab_value
. . O

No DT O
evidence NN O
of IN O
jaundice NN B-Sign_symptom
, , O
clubbing VBG B-Detailed_description
cyanosis NN B-Sign_symptom
or CC O
lymphadenopathy NN B-Disease_disorder
was VBD O
found VBN O
. . O

Physical JJ B-Diagnostic_procedure
examination NN I-Diagnostic_procedure
revealed VBD O
bibasilar JJ B-Biological_structure
end NN B-Detailed_description
- : I-Detailed_description
inspiratory JJ I-Detailed_description
crepitations NNS B-Sign_symptom
in IN O
lungs NNS B-Biological_structure
and CC O
suprapubic JJ B-Biological_structure
tenderness NN B-Sign_symptom
. . O

There EX O
was VBD O
no DT O
hepatosplenomegaly NN B-Sign_symptom
or CC O
ascites NNS B-Sign_symptom
. . O

Cardiac JJ B-Diagnostic_procedure
examination NN I-Diagnostic_procedure
was VBD O
normal JJ B-Lab_value
. . O

She PRP O
was VBD O
found VBN O
to TO O
have VB O
severe JJ B-Severity
bilateral JJ B-Detailed_description
hearing NN B-Sign_symptom
loss NN I-Sign_symptom
, , O
which WDT O
was VBD O
gradually RB B-Lab_value
progressive JJ I-Lab_value
for IN O
5 CD B-Duration
years NNS I-Duration
. . O

The DT O
fundi NN B-Biological_structure
were VBD O
bilaterally RB B-Detailed_description
pale JJ B-Sign_symptom
. . O

The DT O
patient NN O
was VBD O
referred VBN O
to TO O
the DT O
department NN B-Nonbiological_location
of IN I-Nonbiological_location
ophthalmology NN I-Nonbiological_location
for IN O
a DT O
comprehensive JJ O
eye NN B-Diagnostic_procedure
examination NN I-Diagnostic_procedure
. . O

Her PRP$ O
visual JJ B-Diagnostic_procedure
acuity NN I-Diagnostic_procedure
was VBD O
documented VBN O
as IN O
6 CD B-Lab_value
/ $ I-Lab_value
18 CD I-Lab_value
in IN O
both DT B-Biological_structure
eyes NNS I-Biological_structure
with IN O
no DT O
obvious JJ O
lenticular JJ B-Sign_symptom
opacity NN I-Sign_symptom
. . O

Slit NNP B-Diagnostic_procedure
- : I-Diagnostic_procedure
lamp NN I-Diagnostic_procedure
examination NN I-Diagnostic_procedure
showed VBD O
bilateral JJ B-Detailed_description
anterior JJ B-Sign_symptom
lentiglobus NN I-Sign_symptom
( ( O
figure JJ O
1 CD O
) ) O
with IN O
posterior JJ B-Sign_symptom
lenticonus NN I-Sign_symptom
( ( O
figure JJ O
2 CD O
) ) O
. . O

Distant JJ B-Detailed_description
direct JJ I-Detailed_description
ophthalmoscopy NN B-Diagnostic_procedure
revealed VBD O
oil NN B-Sign_symptom
droplet NN I-Sign_symptom
sign NN I-Sign_symptom
( ( O
a DT O
suggestive JJ O
confirmation NN O
of IN O
the DT O
presence NN O
of IN O
lenticonus NN B-Sign_symptom
) ) O
; : O
and CC O
peripheral JJ B-Biological_structure
retina NN I-Biological_structure
revealed VBD O
multiple JJ B-Detailed_description
yellowish JJ B-Color
white JJ I-Color
lesion NN B-Sign_symptom
- : I-Sign_symptom
like IN I-Sign_symptom
flecks NNS I-Sign_symptom
in IN O
the DT O
mid NN B-Biological_structure
- : I-Biological_structure
periphery NN I-Biological_structure
, , O
and CC O
few JJ B-Detailed_description
blot NN B-Sign_symptom
haemorrhages NNS I-Sign_symptom
indicative VBP O
of IN O
hypertensive JJ B-Sign_symptom
changes NNS I-Sign_symptom
( ( O
figures NNS O
3 CD O
and CC O
4 CD O
) ) O
. . O

-DOCSTART- NN -X-

The DT O
patient NN O
is VBZ O
an DT O
18 CD B-Age
- : I-Age
year NN I-Age
- : I-Age
old JJ I-Age
Han NNP O
female NN O
admitted VBD O
to TO O
Peking NNP B-Nonbiological_location
Union NNP I-Nonbiological_location
Medical NNP I-Nonbiological_location
College NNP I-Nonbiological_location
Hospital NNP I-Nonbiological_location
due JJ O
to TO O
adrenal JJ B-Disease_disorder
crisis NN I-Disease_disorder
triggered VBN O
by IN O
pneumonia NN B-Disease_disorder
. . O

She PRP O
has VBZ O
developed VBN O
recurrent JJ B-Detailed_description
respiratory NN B-Biological_structure
infections NNS B-Disease_disorder
since IN O
age NN O
5 CD O
, , O
and CC O
failed VBD O
to TO O
respond VB O
to TO O
multiple VB B-Detailed_description
hepatitis NN B-Detailed_description
B NNP I-Detailed_description
virus NN I-Detailed_description
( ( O
HBV NNP B-Detailed_description
) ) O
vaccinations NNS B-Medication
. . O

Reduced VBN B-Lab_value
serum JJ B-Detailed_description
cortisol NN B-Diagnostic_procedure
and CC O
ACTH NNP B-Diagnostic_procedure
levels NNS O
were VBD O
discovered VBN O
at IN O
16 CD O
when WRB O
glucocorticoid JJ O
replacement NN O
was VBD O
initiated VBN O
. . O

In IN O
addition NN O
, , O
hair NN B-Sign_symptom
loss NN I-Sign_symptom
started VBD O
from IN O
age NN O
4 CD O
, , O
and CC O
absence NN B-Sign_symptom
of IN I-Sign_symptom
pubic NN I-Sign_symptom
and CC I-Sign_symptom
axillary JJ I-Sign_symptom
hair NN I-Sign_symptom
was VBD O
noticed VBN O
after IN O
development NN B-Other_event
of IN I-Other_event
regular JJ I-Other_event
menstruation NN I-Other_event
. . O

Her PRP$ O
history NN O
includes VBZ O
nephrotic JJ O
syndrome NN O
, , O
which WDT O
was VBD O
confirmed VBN O
to TO O
be VB O
minimal JJ B-Disease_disorder
change NN I-Disease_disorder
nephropathy NN I-Disease_disorder
by IN O
renal JJ B-Biological_structure
biopsy NN B-Diagnostic_procedure
. . O

Physical JJ B-Diagnostic_procedure
examination NN I-Diagnostic_procedure
at IN O
admission NN O
revealed VBD O
alopecia NN B-Disease_disorder
totalis NN I-Disease_disorder
, , O
oral JJ B-Biological_structure
candidiasis NN B-Disease_disorder
, , O
hypohidrosis NN B-Disease_disorder
, , O
and CC O
trachyonychia NN B-Sign_symptom
. . O

Facial NNP B-Biological_structure
or CC O
dental JJ B-Biological_structure
abnormalities NNS B-Sign_symptom
was VBD O
not RB O
noted VBN O
. . O

She PRP O
is VBZ O
the DT O
only JJ O
child NN O
in IN O
her PRP$ O
family NN O
. . O

Symptom NNP O
and CC O
signs NNS O
of IN O
the DT O
above JJ O
disorders NNS O
were VBD O
not RB O
identified VBN O
among IN O
her PRP$ O
nonconsanguineous JJ O
parents NNS O
. . O

Initial JJ O
immunologic NN B-Diagnostic_procedure
tests NNS I-Diagnostic_procedure
revealed VBD O
remarkable JJ O
panhypogammaglobulinemia NN B-Sign_symptom
and CC O
reduced VBN B-Lab_value
cell NN B-Diagnostic_procedure
counts NNS I-Diagnostic_procedure
of IN O
B NNP B-Diagnostic_procedure
cells NNS I-Diagnostic_procedure
, , O
T NNP B-Diagnostic_procedure
cells NNS I-Diagnostic_procedure
, , O
and CC O
natural JJ B-Diagnostic_procedure
killer NN I-Diagnostic_procedure
( ( I-Diagnostic_procedure
NK NNP I-Diagnostic_procedure
) ) I-Diagnostic_procedure
cells NNS I-Diagnostic_procedure
( ( O
Table NNP O
( ( O
Table1 NNP O
) ) O
. . O
1 CD O
) ) O
. . O

CD4 NNP B-Diagnostic_procedure
/ NNP I-Diagnostic_procedure
CD8 NNP I-Diagnostic_procedure
ratio NN I-Diagnostic_procedure
, , O
as RB O
well RB O
as IN O
expression NN B-Diagnostic_procedure
levels NNS I-Diagnostic_procedure
of IN O
various JJ O
T NNP B-Diagnostic_procedure
- : I-Diagnostic_procedure
cell NN I-Diagnostic_procedure
activation NN I-Diagnostic_procedure
markers NNS I-Diagnostic_procedure
were VBD O
in IN O
normal JJ B-Lab_value
range NN I-Lab_value
, , O
except IN O
increased VBN B-Lab_value
proportion NN B-Diagnostic_procedure
of IN I-Diagnostic_procedure
CD8 NNP I-Diagnostic_procedure
+ NNP I-Diagnostic_procedure
/ NNP I-Diagnostic_procedure
HLA NNP I-Diagnostic_procedure
- : I-Diagnostic_procedure
DR NNP I-Diagnostic_procedure
+ NNP I-Diagnostic_procedure
subset NN I-Diagnostic_procedure
. . O

Antinuclear JJ B-Diagnostic_procedure
antibodies NNS I-Diagnostic_procedure
( ( O
ANA NNP B-Diagnostic_procedure
) ) O
and CC O
antineutrophil JJ B-Diagnostic_procedure
cytoplasmic JJ I-Diagnostic_procedure
antibodies NNS I-Diagnostic_procedure
( ( O
ANCA NNP B-Diagnostic_procedure
) ) O
were VBD O
negative JJ B-Lab_value
. . O

When WRB O
regular JJ O
hydrocortisone NN B-Medication
replacement NN I-Medication
was VBD O
suspended VBN O
, , O
her PRP O
8:00 CD B-Time
am VBP I-Time
serum JJ B-Detailed_description
cortisol NN B-Diagnostic_procedure
was VBD O
measured VBN O
at IN O
0 CD B-Lab_value
. . I-Lab_value
93 CD I-Lab_value
μg JJ I-Lab_value
/ NNP I-Lab_value
dL NN I-Lab_value
, , O
with IN O
ACTH NNP B-Diagnostic_procedure
< NNP B-Lab_value
5 CD I-Lab_value
. . I-Lab_value
00 CD I-Lab_value
pg JJ I-Lab_value
/ NNP I-Lab_value
mL NN I-Lab_value
. . O

Serum NNP B-Detailed_description
levels NNS O
of IN O
other JJ O
anterior JJ B-Diagnostic_procedure
pituitary JJ I-Diagnostic_procedure
hormones NNS I-Diagnostic_procedure
, , O
as RB O
well RB O
as IN O
serum NN B-Detailed_description
and CC O
urine JJ B-Detailed_description
osmolality NN B-Diagnostic_procedure
were VBD O
within IN B-Lab_value
reference NN I-Lab_value
range NN I-Lab_value
. . O

Both DT O
antiperoxidase NN B-Diagnostic_procedure
antibody NN I-Diagnostic_procedure
and CC O
antithyroglobulin NN B-Diagnostic_procedure
antibody NN I-Diagnostic_procedure
were VBD O
negative JJ B-Lab_value
. . O

She PRP O
had VBD O
positive JJ B-Lab_value
antiprotein NNS B-Diagnostic_procedure
tyrosine JJ I-Diagnostic_procedure
phosphatase NN I-Diagnostic_procedure
antibody NN I-Diagnostic_procedure
, , O
with IN O
fasting VBG B-Diagnostic_procedure
blood NN I-Diagnostic_procedure
glucose NN I-Diagnostic_procedure
at IN O
5 CD B-Lab_value
. . I-Lab_value
9 CD I-Lab_value
mmol JJ I-Lab_value
/ NNP I-Lab_value
L NNP I-Lab_value
. . O

Magnetic JJ B-Diagnostic_procedure
resonance NN I-Diagnostic_procedure
imaging VBG I-Diagnostic_procedure
with IN O
contrast NN B-Detailed_description
suggested VBD O
a DT O
normal JJ B-Lab_value
pituitary NN B-Diagnostic_procedure
. . O

She PRP O
was VBD O
diagnosed VBN O
with IN O
CVID NNP B-Disease_disorder
, , O
isolated VBD B-Disease_disorder
ACTH NNP I-Disease_disorder
deficiency NN I-Disease_disorder
, , O
and CC O
ectodermal JJ B-Disease_disorder
dysplasia NN I-Disease_disorder
. . O

Symptoms NNS O
of IN O
fever NN B-Sign_symptom
, , O
cough NN B-Sign_symptom
, , O
and CC O
vomiting VBG B-Sign_symptom
cleared VBN O
with IN O
antibiotics NNS B-Medication
and CC O
stress NN B-Detailed_description
- : I-Detailed_description
dose NN I-Detailed_description
hydrocortisone NN B-Medication
treatment NN O
. . O

Intravenous JJ B-Medication
immunoglobulin NN I-Medication
( ( O
IVIG NNP B-Medication
) ) O
therapy NN O
was VBD O
suggested VBN O
but CC O
denied VBN O
by IN O
the DT O
parents NNS O
. . O

At IN O
follow SYM O
- : O
up RB O
1 CD O
year NN O
after IN O
her PRP$ O
discharge NN O
, , O
she PRP O
reported VBD O
no DT O
infection NN B-Disease_disorder
events NNS O
during IN B-Duration
the DT I-Duration
previous JJ I-Duration
year NN I-Duration
as IN O
she PRP O
stayed VBD O
at IN O
home NN B-Nonbiological_location
and CC O
avoided VBD O
outdoor JJ B-Activity
activities NNS I-Activity
. . O

Her PRP$ O
glucocorticoid JJ B-Medication
replacement NN I-Medication
was VBD O
withdrawn VBN O
4 CD O
months NNS O
after IN O
discharge NN O
, , O
and CC O
she PRP O
has VBZ O
only RB O
received VBN O
traditional JJ B-Medication
Chinese JJ I-Medication
medicine NN I-Medication
ever RB O
since IN O
. . O

Lymphocyte NNP B-Diagnostic_procedure
subsets VBZ I-Diagnostic_procedure
test VB I-Diagnostic_procedure
done VBN O
at IN O
the DT O
follow NN O
- : O
up RB O
documented VBN O
increased JJ B-Lab_value
levels NNS O
of IN O
B NNP B-Diagnostic_procedure
cells NNS I-Diagnostic_procedure
and CC O
T NNP B-Diagnostic_procedure
cells NNS I-Diagnostic_procedure
, , O
while IN O
NK NNP B-Diagnostic_procedure
cell NN I-Diagnostic_procedure
count NN I-Diagnostic_procedure
remained VBD O
below IN B-Lab_value
normal JJ I-Lab_value
limit NN I-Lab_value
. . O

To TO O
assess VB O
her PRP$ O
NK NNP O
- : O
cell NN O
activity NN O
, , O
a DT O
flow NN B-Diagnostic_procedure
cytometric JJ I-Diagnostic_procedure
procedure NN I-Diagnostic_procedure
was VBD O
done VBN O
following VBG O
previously RB O
described VBN O
method NN O
. . O
[ CC O
10,11 CD O
] JJ O
Effector NNP O
to TO O
target VB O
cell NN O
ratio NN O
was VBD O
set VBN O
at IN O
10:1 CD O
. . O

Less JJR O
apoptosis NN O
of IN O
target NN O
cell NN O
line NN O
( ( O
12 CD O
. . O
43 CD O
% NN O
, , O
reference NN O
range NN O
15 CD O
. . O
11 CD O
- : O
26 CD O
. . O
91 CD O
% NN O
) ) O
was VBD O
observed VBN O
when WRB O
cocultured VBN O
with IN O
patient JJ O
` `` O
s JJ O
peripheral JJ O
blood NN O
mononuclear NN O
cells NNS O
( ( O
PBMC NNP O
) ) O
, , O
indicating VBG O
a DT O
deficient NN O
NK NNP O
- : O
cell NN O
cytotoxicity NN O
. . O

-DOCSTART- NN -X-

A DT O
30 CD B-Age
- : I-Age
year NN I-Age
- : I-Age
old JJ I-Age
female NN O
( ( O
65 CD O
kg NN O
) ) O
underwent NN O
rhinoplasty NN B-Therapeutic_procedure
under IN O
general JJ B-Medication
anaesthesia NN I-Medication
, , O
which WDT O
was VBD O
induced VBN O
using VBG O
a DT O
combination NN O
of IN O
a DT O
bolus NN O
of IN O
Remifentanyl NNP B-Medication
( ( O
0 CD B-Dosage
. . I-Dosage
5 CD I-Dosage
μg JJ I-Dosage
/ NNP I-Dosage
kg NN I-Dosage
) ) O
and CC O
Propofol $ B-Medication
2 CD B-Dosage
mg NN I-Dosage
/ NNP I-Dosage
kg NN I-Dosage
. . O

Muscle NNP B-Disease_disorder
paralysis NN I-Disease_disorder
was VBD O
obtained VBN O
with IN O
Cisatracurium NNP B-Medication
( ( O
0 CD B-Dosage
. . I-Dosage
15 CD I-Dosage
μg JJ I-Dosage
/ NNP I-Dosage
kg NN I-Dosage
) ) O
. . O

Transoral JJ B-Detailed_description
intubation NN B-Therapeutic_procedure
was VBD O
performed VBN O
with IN O
a DT O
Macintosh NNP B-Therapeutic_procedure
blade NN I-Therapeutic_procedure
( ( O
No NNP B-Detailed_description
. . I-Detailed_description
3 CD I-Detailed_description
) ) O
and CC O
a DT O
size NN O
7 CD B-Detailed_description
mm NN I-Detailed_description
diameter NN I-Detailed_description
reinforced VBD B-Detailed_description
tracheal JJ B-Therapeutic_procedure
tube NN I-Therapeutic_procedure
was VBD O
easily RB O
and CC O
gently RB O
placed VBN O
in IN O
the DT O
trachea NN B-Biological_structure
, , O
on IN O
the DT O
first JJ O
attempt NN O
and CC O
was VBD O
then RB O
fixed VBN O
to TO O
the DT O
right JJ B-Biological_structure
corner NN I-Biological_structure
of IN I-Biological_structure
the DT I-Biological_structure
mouth NN I-Biological_structure
. . O

No DT O
problems NNS B-Disease_disorder
were VBD O
encountered VBN O
during IN O
laryngoscopy NN B-Therapeutic_procedure
and CC O
intubation NN O
. . O

The DT O
cuff NN O
of IN O
the DT O
tube NN O
was VBD O
inflated VBN O
with IN O
a DT O
pressure NN B-Lab_value
≤ VBZ I-Lab_value
20 CD I-Lab_value
cm NN I-Lab_value
H2O NNP I-Lab_value
. . O

No DT O
adjustment NN B-Therapeutic_procedure
of IN I-Therapeutic_procedure
cuff NN I-Therapeutic_procedure
volume NN I-Therapeutic_procedure
was VBD O
made VBN O
intra JJ O
- : O
operatively RB O
. . O

N2O NNP B-Medication
was VBD O
not RB O
used VBN O
for IN O
inhalation NN O
anaesthesia NN O
. . O

The DT O
throat NN B-Therapeutic_procedure
pack NN I-Therapeutic_procedure
was VBD O
placed VBN O
in IN O
the DT O
pharynx NN B-Biological_structure
to TO O
avoid VB O
the DT O
passage NN O
of IN O
blood NN O
in IN O
the DT O
aero NN O
- : O
digestive JJ O
tract NN O
. . O

General NNP B-Medication
anaesthesia NN I-Medication
was VBD O
maintained VBN O
with IN O
Sevofluorane NNP B-Medication
in IN O
oxygen NN O
/ NNP O
air NN O
and CC O
Remifentanyl NNP B-Medication
in IN O
continuous JJ O
infusion NN O
0 CD B-Dosage
. . I-Dosage
25 CD I-Dosage
μg JJ I-Dosage
/ NNP I-Dosage
kg NN I-Dosage
/ NNP I-Dosage
min NN I-Dosage
. . O

Moderate NNP B-Severity
arterial JJ B-Sign_symptom
hypotension NN I-Sign_symptom
was VBD O
maintained VBN O
with IN O
a DT O
cuff NN O
systolic JJ B-Diagnostic_procedure
artery JJ I-Diagnostic_procedure
pressure NN I-Diagnostic_procedure
of IN O
approximately RB O
90 CD B-Lab_value
mmHg NNS I-Lab_value
. . O

The DT O
operation NN O
was VBD O
carried VBN O
out RP O
in IN O
a DT O
semi JJ B-Therapeutic_procedure
- : I-Therapeutic_procedure
supine JJ I-Therapeutic_procedure
position NN I-Therapeutic_procedure
with IN O
the DT O
head NN B-Detailed_description
slightly RB I-Detailed_description
inclined JJ I-Detailed_description
forward NN I-Detailed_description
and CC O
laterally RB O
and CC O
trunk VB B-Detailed_description
slightly RB I-Detailed_description
elevated VBN I-Detailed_description
. . O

Duration NN O
of IN O
the DT O
operation NN B-Therapeutic_procedure
was VBD O
100 CD B-Duration
minutes NNS I-Duration
. . O

The DT O
patient NN O
was VBD O
extubated VBN B-Therapeutic_procedure
, , O
after IN O
removal NN O
of IN O
the DT O
throat NN B-Therapeutic_procedure
pack NN I-Therapeutic_procedure
without IN O
problems NNS B-Disease_disorder
. . O

The DT O
following JJ O
day NN O
the DT O
patient NN O
complained VBD O
of IN O
difficulty NN B-Sign_symptom
in IN I-Sign_symptom
swallowing VBG I-Sign_symptom
, , O
dysphonia NN B-Sign_symptom
and CC O
hoarseness NN B-Sign_symptom
. . O

Examination NN B-Diagnostic_procedure
revealed VBD O
deviation NN B-Sign_symptom
of IN O
the DT O
tongue NN B-Biological_structure
to TO O
the DT O
right JJ B-Detailed_description
side NN I-Detailed_description
and CC O
vocal JJ B-Biological_structure
cord NN I-Biological_structure
paralysis NN B-Disease_disorder
, , O
expression NN O
of IN O
hypoglossal NN B-Biological_structure
and CC O
recurrent JJ B-Detailed_description
laryngeal NN B-Biological_structure
nerve NN B-Disease_disorder
injury NN I-Disease_disorder
without IN O
local JJ B-Detailed_description
oedema NN B-Sign_symptom
or CC O
haematoma NN B-Sign_symptom
. . O

The DT O
movements NNS B-Diagnostic_procedure
of IN O
the DT O
pharynx NN B-Biological_structure
and CC O
soft JJ B-Biological_structure
palate NN I-Biological_structure
were VBD O
normal JJ B-Lab_value
. . O

Meticulous JJ O
neurological JJ B-Diagnostic_procedure
examination NN I-Diagnostic_procedure
, , O
including VBG O
also RB O
magnetic JJ B-Diagnostic_procedure
resonance NN I-Diagnostic_procedure
imaging NN I-Diagnostic_procedure
( ( O
MRN NNP B-Diagnostic_procedure
) ) O
revealed VBD O
no DT O
other JJ O
evidence NN O
of IN O
central JJ B-Biological_structure
or CC O
cranial JJ B-Biological_structure
nerve NN B-Sign_symptom
involvement NN I-Sign_symptom
. . O

Conservative JJ O
management NN O
included VBD O
steroids NNS B-Medication
, , O
vitamins VBZ B-Medication
together RB O
with IN O
speech NN B-Detailed_description
and CC O
swallowing VBG B-Detailed_description
therapy NN B-Therapeutic_procedure
. . O

Full JJ B-Lab_value
recovery NN I-Lab_value
of IN O
lingual JJ B-Biological_structure
and CC O
laryngeal JJ B-Biological_structure
functions NNS B-Diagnostic_procedure
was VBD O
obtained VBN O
within IN O
four CD O
months NNS O
after IN O
surgery NN O
. . O

-DOCSTART- NN -X-

A DT O
21 CD B-Age
- : I-Age
year NN I-Age
- : I-Age
old JJ I-Age
man NN O
presented VBN O
to TO O
the DT O
emergency NN B-Nonbiological_location
department NN I-Nonbiological_location
with IN O
a DT O
rash NN B-Sign_symptom
on IN O
his PRP$ O
arms NNS B-Biological_structure
and CC O
neck NN B-Biological_structure
( ( O
figure NN O
1 CD O
) ) O
. . O

It PRP O
had VBD O
developed VBN O
over IN B-Duration
the DT I-Duration
course NN I-Duration
of IN I-Duration
36 CD I-Duration
h NN I-Duration
from IN O
discrete JJ B-Detailed_description
` `` I-Detailed_description
pin NN I-Detailed_description
prick NN I-Detailed_description
` `` I-Detailed_description
areas NNS I-Detailed_description
of IN O
erythema NN B-Sign_symptom
into IN O
a DT O
maculopapular JJ B-Detailed_description
rash NN B-Sign_symptom
with IN O
vesicles NNS B-Detailed_description
( ( O
figure NN O
2 CD O
) ) O
. . O

It PRP O
covered VBD O
his PRP$ O
forearms NNS B-Biological_structure
from IN O
the DT O
dorsal NN B-Biological_structure
aspect NN I-Biological_structure
of IN I-Biological_structure
the DT I-Biological_structure
hands NNS I-Biological_structure
to TO O
the DT O
flexor JJ B-Biological_structure
surface NN I-Biological_structure
of IN I-Biological_structure
the DT I-Biological_structure
elbows NNS I-Biological_structure
. . O

It PRP O
was VBD O
also RB O
beginning VBG O
to TO O
develop VB O
around IN O
his PRP$ O
neck NN B-Biological_structure
( ( O
figure NN O
3 CD O
) ) O
. . O

He PRP O
described VBD O
the DT O
rash NN B-Sign_symptom
as IN O
itchy NN B-Detailed_description
and CC O
painful JJ B-Detailed_description
, , O
and CC O
was VBD O
feeling VBG B-Diagnostic_procedure
` `` O
under IN B-Lab_value
the DT I-Lab_value
weather NN I-Lab_value
` `` O
. . O

The DT O
patient NN O
had VBD O
no DT O
previous JJ O
dermatological NN O
or CC O
other JJ O
medical JJ O
history NN O
of IN O
note NN O
. . O

He PRP O
took VBD O
no DT O
medication NN B-Medication
. . O

He PRP O
worked VBD B-Occupation
in IN I-Occupation
a DT I-Occupation
supermarket NN I-Occupation
handling VBG I-Occupation
food NN I-Occupation
items NNS I-Occupation
but CC O
there EX O
was VBD O
no DT O
history NN O
of IN O
occupational JJ O
chemical NN O
exposure NN O
. . O

He PRP O
had VBD O
not RB O
recently RB O
had VBD O
any DT O
change NN O
in IN O
washing VBG O
powder NN O
or CC O
personal JJ O
hygiene NN O
products NNS O
. . O

Physiological JJ B-Diagnostic_procedure
observations NNS I-Diagnostic_procedure
were VBD O
entirely RB O
normal JJ B-Lab_value
and CC O
systemic JJ B-Diagnostic_procedure
examination NN I-Diagnostic_procedure
unremarkable JJ B-Lab_value
. . O

Closer NNP O
examination NN B-Diagnostic_procedure
of IN O
the DT O
rash NN B-Sign_symptom
revealed VBD O
that IN O
it PRP O
was VBD O
present JJ O
only RB O
on IN O
skin NNS B-Biological_structure
exposed VBN B-Activity
to TO I-Activity
the DT I-Activity
sun NN I-Activity
when WRB O
wearing VBG B-Activity
a DT I-Activity
short JJ I-Activity
- : I-Activity
sleeved JJ I-Activity
shirt NN I-Activity
; : O
the DT O
most RBS O
striking JJ O
feature NN O
was VBD O
the DT O
` `` B-Other_entity
V NNP I-Other_entity
` `` I-Other_entity
shape NN I-Other_entity
on IN I-Other_entity
the DT I-Other_entity
patient NN I-Other_entity
` `` I-Other_entity
s JJ I-Other_entity
chest NN I-Other_entity
in IN O
keeping VBG O
with IN O
the DT O
neck NN O
line NN O
of IN O
a DT O
polo NN O
shirt NN O
. . O

On IN O
further JJ O
questioning VBG O
the DT O
patient NN O
described VBD O
a DT O
period NN O
of IN O
time NN O
48 CD O
h NN O
prior RB O
to TO O
presentation NN O
( ( O
and CC O
12 CD O
h NN O
prior RB O
to TO O
the DT O
development NN O
of IN O
the DT O
rash NN B-Sign_symptom
) ) O
spent VBD O
strimming VBG B-Activity
the DT I-Activity
grass NN I-Activity
under IN O
the DT O
hedges NNS O
in IN O
his PRP$ O
garden NN O
. . O

Blood NN B-Diagnostic_procedure
tests NNS I-Diagnostic_procedure
including VBG O
full JJ B-Diagnostic_procedure
blood NN I-Diagnostic_procedure
count NN I-Diagnostic_procedure
, , O
urea JJ B-Diagnostic_procedure
and CC O
electrolytes NNS B-Diagnostic_procedure
, , O
liver NN B-Diagnostic_procedure
function NN I-Diagnostic_procedure
test NN I-Diagnostic_procedure
and CC O
C NNP B-Diagnostic_procedure
- : I-Diagnostic_procedure
reactive JJ I-Diagnostic_procedure
protein NN I-Diagnostic_procedure
were VBD O
all DT O
within IN B-Lab_value
normal JJ I-Lab_value
reference NN I-Lab_value
ranges NNS I-Lab_value
. . O

The DT O
list NN O
of IN O
potential JJ O
differential JJ O
diagnoses NNS O
for IN O
a DT O
maculopapular JJ O
rash NN O
is VBZ O
long RB O
, , O
but CC O
given VBN O
the DT O
distribution NN O
of IN O
the DT O
rash NN O
and CC O
the DT O
history NN O
of IN O
plant NN O
material NN O
exposure NN O
a DT O
diagnosis NN O
of IN O
phytophotodermatitis NN B-Disease_disorder
was VBD O
made VBN O
. . O

The DT O
patient NN O
was VBD O
discharged VBN O
with IN O
chlorphenamine NN B-Medication
, , O
simple JJ B-Medication
analgesia NN I-Medication
and CC O
the DT O
advice NN B-Other_event
to TO I-Other_event
wear VB I-Other_event
a DT I-Other_event
long JJ I-Other_event
- : I-Other_event
sleeved VBN I-Other_event
t JJ I-Other_event
- : I-Other_event
shirt NN I-Other_event
and CC I-Other_event
sunscreen NN I-Other_event
when WRB O
gardening NN O
in IN O
the DT O
future NN O
. . O

The DT O
rash NN B-Sign_symptom
resolved VBD O
over IN O
a DT O
period NN B-Duration
of IN I-Duration
3 CD I-Duration
weeks NNS I-Duration
. . O

It PRP O
remained VBD O
pruritic JJ B-Detailed_description
throughout IN O
healing VBG O
but CC O
the DT O
associated JJ O
pain NN B-Sign_symptom
settled VBD O
over RP B-Duration
a DT I-Duration
few JJ I-Duration
days NNS I-Duration
. . O

Residual JJ O
scarring NN B-Sign_symptom
is VBZ O
beginning VBG O
to TO O
fade VB O
2 CD O
months NNS O
after IN O
presentation NN O
. . O

-DOCSTART- NN -X-

A DT O
58 CD B-Age
- : I-Age
year NN I-Age
- : I-Age
old JJ I-Age
man NN O
had VBD O
been VBN O
suffering VBG O
from IN O
general JJ B-Sign_symptom
fatigue NN I-Sign_symptom
and CC O
severe JJ B-Severity
anemia NN B-Sign_symptom
for IN O
several JJ B-Duration
months NNS I-Duration
. . O

His PRP$ O
hemoglobin NN B-Diagnostic_procedure
levels NNS I-Diagnostic_procedure
were VBD O
6 CD B-Lab_value
. . I-Lab_value
6 CD I-Lab_value
g JJ I-Lab_value
/ NN I-Lab_value
dl NN I-Lab_value
( ( O
normal JJ O
range NN O
: : O
12 CD O
- : O
16 CD O
g NN O
/ NNP O
dl NN O
) ) O
. . O

He PRP O
had VBD O
no DT O
medical JJ O
history NN O
and CC O
did VBD O
not RB O
take VB O
any DT O
medicine NN O
. . O

Esophagogastroduodenoscopy NN B-Diagnostic_procedure
and CC O
colonoscopy NN B-Diagnostic_procedure
did VBD O
not RB O
reveal VB O
any DT O
significant JJ O
bleeding NN B-Sign_symptom
. . O

Abdominal NNP B-Biological_structure
computer NN B-Diagnostic_procedure
tomography NN I-Diagnostic_procedure
revealed VBD O
a DT O
2 CD B-Distance
- : I-Distance
cm NN I-Distance
hypervascular JJ B-Detailed_description
tumor NN B-Sign_symptom
in IN O
the DT O
small JJ B-Biological_structure
intestine NN I-Biological_structure
( ( O
Fig NNP O
. . O
1 CD O
) ) O
. . O

Oral JJ O
DBE NNP B-Diagnostic_procedure
detected VBD O
a DT O
2 CD B-Distance
- : I-Distance
cm NN I-Distance
- : I-Distance
diameter NN I-Distance
reddish NN B-Color
, , O
submucosal JJ B-Biological_structure
tumor SYM B-Detailed_description
- : I-Detailed_description
like IN I-Detailed_description
lesion NN B-Sign_symptom
with IN O
surface NN B-Detailed_description
ulceration NN I-Detailed_description
in IN O
the DT O
jejunum NN B-Biological_structure
, , O
approximately RB O
20 CD B-Biological_structure
cm NNS I-Biological_structure
away RB I-Biological_structure
from IN I-Biological_structure
the DT I-Biological_structure
Treitz NNP I-Biological_structure
ligament NN I-Biological_structure
( ( O
Fig NNP O
. . O
2 CD O
) ) O
. . O

We PRP O
did VBD O
not RB O
perform VB O
biopsy NN B-Diagnostic_procedure
because IN O
it PRP O
can MD O
be VB O
difficult JJ O
to TO O
stop VB O
bleeding NN O
in IN O
the DT O
case NN O
of IN O
hypervascular JJ O
lesions NNS O
. . O

Under IN O
the DT O
diagnosis NN O
of IN O
a DT O
small JJ B-Disease_disorder
bowel NN I-Disease_disorder
tumor NN I-Disease_disorder
, , O
gastrointestinal JJ B-Disease_disorder
stromal JJ I-Disease_disorder
tumor NN I-Disease_disorder
( ( O
GIST NNP B-Disease_disorder
) ) O
, , O
malignant JJ B-Disease_disorder
lymphoma NN I-Disease_disorder
, , O
or CC O
cancer NN B-Disease_disorder
, , O
we PRP O
performed VBD O
laparoscopic SYM B-Detailed_description
- : I-Detailed_description
assisted VBN I-Detailed_description
segmental JJ B-Detailed_description
resection NN B-Therapeutic_procedure
of IN O
the DT O
jejunum NN B-Biological_structure
with IN O
the DT O
dissection NN B-Detailed_description
of IN I-Detailed_description
lymph NN I-Detailed_description
nodes NNS I-Detailed_description
. . O

Examination NN B-Diagnostic_procedure
of IN O
the DT O
resected JJ B-Detailed_description
tumor NN B-Sign_symptom
showed VBD O
that IN O
it PRP O
measured VBD O
19 CD B-Area
× $ I-Area
16 CD I-Area
mm NN I-Area
in IN O
diameter NN O
( ( O
Fig NNP O
. . O
3 CD O
) ) O
. . O

Histology NNP B-Diagnostic_procedure
revealed VBD O
the DT O
proliferation NN B-Sign_symptom
of IN I-Sign_symptom
blood NN I-Sign_symptom
capillaries NNS I-Sign_symptom
and CC O
granulation NN B-Sign_symptom
tissue NN I-Sign_symptom
, , O
which WDT O
was VBD O
consistent JJ O
with IN O
PG NNP B-Disease_disorder
( ( O
Fig NNP O
. . O
4 CD O
) ) O
. . O

The DT O
patient NN O
was VBD O
discharged VBN O
on IN O
postoperative JJ O
day NN O
9 CD O
without IN O
complication NN B-Sign_symptom
and CC O
his PRP$ O
anemia NN B-Sign_symptom
improved VBD B-Lab_value
gradually RB O
without IN O
the DT O
need NN O
for IN O
oral JJ B-Medication
iron NN I-Medication
after IN O
surgery NN O
. . O

-DOCSTART- NN -X-

A DT O
24 CD B-Age
- : I-Age
year NN I-Age
- : I-Age
old JJ I-Age
Azeri NNP O
male NN O
presented VBN O
with IN O
a DT O
chief JJ O
complaint NN O
of IN O
blurred JJ B-Sign_symptom
vision NN I-Sign_symptom
in IN O
both DT B-Biological_structure
eyes NNS I-Biological_structure
. . O

He PRP O
was VBD O
diagnosed VBN O
with IN O
achondroplasia NN O
in IN O
early JJ O
childhood NN O
. . O

He PRP O
was VBD O
born VBN O
at IN O
term NN O
with IN O
normal JJ O
birth NN O
weight NN O
. . O

There EX O
was VBD O
no DT O
history NN O
of IN O
hereditary JJ O
ocular NN O
or CC O
systemic JJ O
disease NN O
. . O

This DT O
patient NN O
had VBD O
characteristic JJ B-Sign_symptom
features NNS I-Sign_symptom
of IN I-Sign_symptom
achondroplasia NN I-Sign_symptom
( ( O
i JJ O
. . O
e NN O
. . O
, , O
short JJ O
stature NN O
, , O
lumbar NN O
lordosis NN O
, , O
short JJ O
proximal NN O
long JJ O
bones NNS O
, , O
large JJ O
hands NNS O
, , O
frontal JJ O
bossing NN O
, , O
and CC O
flat JJ O
nasal NN O
bridge NN O
) ) O
[ VBZ O
Figure $ O
1 CD O
] NN O
. . O

His PRP$ O
height NN O
was VBD O
108 CD B-Height
cm NN I-Height
. . O

Best NNP O
corrected VBD B-Detailed_description
visual JJ B-Diagnostic_procedure
acuity NN I-Diagnostic_procedure
was VBD O
20 CD B-Lab_value
/ JJ I-Lab_value
70 CD I-Lab_value
in IN O
the DT O
right JJ B-Biological_structure
eye NN I-Biological_structure
with IN O
− JJ B-Lab_value
0 CD I-Lab_value
. . I-Lab_value
75 CD I-Lab_value
+ JJ I-Lab_value
1 CD I-Lab_value
. . I-Lab_value
25 CD I-Lab_value
× JJ I-Lab_value
60 CD I-Lab_value
° NN I-Lab_value
and CC O
20 CD B-Lab_value
/ NN I-Lab_value
70 CD I-Lab_value
in IN O
the DT O
left NN B-Biological_structure
eye NN I-Biological_structure
with IN O
OS NNP B-Biological_structure
: : O
+0 NN B-Lab_value
. . I-Lab_value
25 CD I-Lab_value
+ JJ I-Lab_value
0 CD I-Lab_value
. . I-Lab_value
50 CD I-Lab_value
× JJ I-Lab_value
130 CD I-Lab_value
° NN I-Lab_value
. . O

Pupils NNS B-Biological_structure
were VBD O
equal JJ B-Detailed_description
in IN I-Detailed_description
size NN I-Detailed_description
, , O
round NN B-Detailed_description
and CC O
reactive JJ B-Detailed_description
to TO I-Detailed_description
light JJ I-Detailed_description
with IN O
no DT O
reverse NN B-Sign_symptom
afferent NN I-Sign_symptom
pupillary JJ I-Sign_symptom
defect NN I-Sign_symptom
. . O

Ocular JJ B-Diagnostic_procedure
motility NN I-Diagnostic_procedure
was VBD O
normal JJ B-Lab_value
in IN O
both DT B-Biological_structure
eyes NNS I-Biological_structure
and CC O
slit NN B-Diagnostic_procedure
lamp NN I-Diagnostic_procedure
examination NN I-Diagnostic_procedure
was VBD O
unremarkable JJ B-Lab_value
. . O

The DT O
intraocular JJ B-Diagnostic_procedure
pressure NN I-Diagnostic_procedure
was VBD O
12 CD B-Lab_value
mm NN I-Lab_value
Hg NNP I-Lab_value
by IN O
Goldmann NNP B-Detailed_description
applanation NN I-Detailed_description
tonometry NN I-Detailed_description
. . O

Central JJ B-Diagnostic_procedure
corneal NN I-Diagnostic_procedure
thickness NN I-Diagnostic_procedure
values NNS I-Diagnostic_procedure
of IN O
the DT O
right NN B-Biological_structure
and CC I-Biological_structure
left VBD B-Biological_structure
eyes NNS I-Biological_structure
were VBD O
, , O
561 CD B-Lab_value
and CC I-Lab_value
557 CD B-Lab_value
μ NN I-Lab_value
, , O
respectively RB O
. . O

Dilated VBN B-Diagnostic_procedure
fundus JJ I-Diagnostic_procedure
examination NN I-Diagnostic_procedure
revealed VBD O
a DT O
well RB B-Detailed_description
- : I-Detailed_description
demarcated VBN I-Detailed_description
circular JJ B-Shape
macular JJ B-Biological_structure
lesion NN B-Sign_symptom
in IN O
both DT B-Biological_structure
eyes NNS I-Biological_structure
. . O

In IN O
the DT O
right NN B-Biological_structure
eye NN I-Biological_structure
, , O
this DT O
lesion NN B-Sign_symptom
was VBD O
approximately RB O
2 CD B-Distance
. . I-Distance
5 CD I-Distance
disc NN I-Distance
diameters NNS I-Distance
( ( I-Distance
DD NNP I-Distance
) ) I-Distance
in IN I-Distance
width NN I-Distance
and CC O
2 CD B-Distance
. . I-Distance
7 CD I-Distance
DD NNP I-Distance
in IN I-Distance
length NN I-Distance
. . O

In IN O
the DT O
left NN B-Biological_structure
eye NN I-Biological_structure
, , O
this DT O
lesion NN B-Sign_symptom
was VBD O
approximately RB O
2 CD B-Distance
. . I-Distance
5 CD I-Distance
DD NNP I-Distance
in IN I-Distance
width NN I-Distance
and CC O
2 CD B-Distance
. . I-Distance
8 CD I-Distance
DD NNP I-Distance
in IN I-Distance
length NN I-Distance
. . O

The DT O
border NN B-Detailed_description
of IN O
the DT O
lesions NNS B-Sign_symptom
was VBD O
pigmented VBN B-Detailed_description
. . O

Underlying VBG O
choroidal NN B-Biological_structure
and CC O
overlying VBG O
retinal JJ B-Biological_structure
vasculature NN B-Biological_structure
appeared VBD O
normal JJ B-Lab_value
. . O

In IN O
addition NN O
, , O
a DT O
stalk NN B-Sign_symptom
of IN I-Sign_symptom
tissue NN I-Sign_symptom
emanated VBN O
from IN B-Biological_structure
the DT I-Biological_structure
optic JJ I-Biological_structure
disc NN I-Biological_structure
and CC O
coursed VBD O
into IN B-Biological_structure
the DT I-Biological_structure
vitreous JJ I-Biological_structure
[ JJ O
Figure NN O
2 CD O
] NN O
. . O

Fluorescein NNP B-Detailed_description
angiography NN B-Diagnostic_procedure
of IN O
the DT O
posterior JJ B-Biological_structure
segment NN I-Biological_structure
and CC O
optical JJ B-Diagnostic_procedure
coherence NN I-Diagnostic_procedure
tomography NN I-Diagnostic_procedure
of IN O
the DT O
optic JJ B-Biological_structure
nerve NN I-Biological_structure
head NN I-Biological_structure
( ( O
Stratus NNP O
; : O
Carl NNP O
Zeiss NNP O
GmbH NNP O
, , O
Jena NNP O
, , O
Germany NNP O
) ) O
were VBD O
performed VBN O
[ JJ O
Figures NNS O
[ VBP O
Figures3 NNP O
and CC O
4 CD O
] NN O
. . O

Due JJ O
to TO O
the DT O
background NN O
maculopathy NN O
, , O
the DT O
patient NN O
could MD O
not RB O
appropriately RB O
fixate VB O
on IN O
the DT O
target NN O
during IN O
image NN O
acquisition NN O
resulting VBG O
in IN O
slightly RB O
decentered VBN O
fluorescein NN O
angiography NN O
images NNS O
[ VBP O
Figure NNP O
3 CD O
] NN O
. . O

-DOCSTART- NN -X-

A DT O
70 CD B-Age
- : I-Age
year NN I-Age
- : I-Age
old JJ I-Age
female NN O
presented VBN O
to TO O
the DT O
Emergency NNP B-Nonbiological_location
Department NNP I-Nonbiological_location
with IN O
palpitations NNS B-Sign_symptom
, , O
dyspnea NN B-Sign_symptom
and CC O
anterior JJ B-Detailed_description
epistaxis NN B-Sign_symptom
. . O

She PRP O
had VBD O
a DT O
3 CD B-Duration
years NNS I-Duration
history NN O
of IN O
atrial JJ B-Disease_disorder
fibrillation NN I-Disease_disorder
and CC O
chronic JJ B-Detailed_description
heart NN B-Disease_disorder
failure NN I-Disease_disorder
NYHA NNP B-Lab_value
class NN I-Lab_value
III NNP I-Lab_value
. . O

She PRP O
was VBD O
treated VBN O
with IN O
aspirin JJ B-Medication
100 CD B-Dosage
mg JJ I-Dosage
/ NNP I-Dosage
day NN I-Dosage
. . O

Physical JJ B-Diagnostic_procedure
examination NN I-Diagnostic_procedure
revealed VBD O
an DT O
irregular JJ B-Lab_value
pulse NN B-Diagnostic_procedure
of IN O
148 CD B-Lab_value
beats NNS I-Lab_value
/ JJ I-Lab_value
min NN I-Lab_value
, , O
blood NN B-Diagnostic_procedure
pressure NN I-Diagnostic_procedure
of IN O
130 CD B-Lab_value
/ JJ I-Lab_value
100 CD I-Lab_value
mmHg NN I-Lab_value
, , O
pansystolic JJ B-Detailed_description
mitral JJ B-Biological_structure
murmur NN B-Sign_symptom
of IN O
2 CD B-Lab_value
/ JJ I-Lab_value
6 CD I-Lab_value
grade NN I-Lab_value
, , O
murmur NN B-Sign_symptom
of IN O
tricuspid JJ B-Biological_structure
regurgitation NN B-Detailed_description
of IN O
3 CD B-Lab_value
/ JJ I-Lab_value
6 CD I-Lab_value
grade NN I-Lab_value
, , O
lower JJR B-Biological_structure
extremities NNS I-Biological_structure
swelling VBG B-Sign_symptom
. . O

The DT O
oto NN B-Diagnostic_procedure
- : I-Diagnostic_procedure
rhino NN I-Diagnostic_procedure
- : I-Diagnostic_procedure
laryngology NN I-Diagnostic_procedure
exam JJ I-Diagnostic_procedure
conclusion NN O
was VBD O
of IN O
anterior JJ B-Detailed_description
epistaxis NN B-Sign_symptom
. . O

The DT O
12 CD B-Detailed_description
- : I-Detailed_description
lead NN I-Detailed_description
electrocardiogram NN B-Diagnostic_procedure
revealed VBD O
atrial JJ B-Disease_disorder
fibrillation NN I-Disease_disorder
, , O
inferior JJ B-Detailed_description
ischemia NN B-Sign_symptom
. . O

Her PRP$ O
International NNP B-Diagnostic_procedure
Normalized NNP I-Diagnostic_procedure
Ratio NNP I-Diagnostic_procedure
( ( O
INR NNP B-Diagnostic_procedure
) ) O
was VBD O
of IN O
1,24 CD B-Lab_value
. . O

The DT O
two CD B-Detailed_description
- : I-Detailed_description
dimensional JJ I-Detailed_description
transthoracic NN B-Biological_structure
echocardiography NN B-Diagnostic_procedure
showed VBD O
the DT O
thickening NN B-Sign_symptom
of IN I-Sign_symptom
the DT I-Sign_symptom
mitral JJ I-Sign_symptom
valves NNS I-Sign_symptom
with IN O
a DT O
moderate JJ B-Severity
mitral JJ B-Sign_symptom
insufficiency NN I-Sign_symptom
and CC O
a DT O
mobile JJ B-Detailed_description
round NN B-Shape
mass NN B-Sign_symptom
in IN O
the DT O
left NN B-Biological_structure
atrium NN I-Biological_structure
, , O
heterogeneous JJ B-Detailed_description
, , O
inhomogeneous JJ B-Detailed_description
, , O
of IN O
18 CD B-Distance
mm NNS I-Distance
in IN O
size NN O
, , O
attached VBN B-Detailed_description
with IN I-Detailed_description
a DT I-Detailed_description
narrow JJ I-Detailed_description
stalk NN I-Detailed_description
to TO O
the DT O
interatrial JJ B-Biological_structure
septum NN I-Biological_structure
. . O

It PRP O
showed VBD O
a DT O
tumor NN B-Detailed_description
- : I-Detailed_description
like IN I-Detailed_description
movement NN I-Detailed_description
with IN I-Detailed_description
a DT I-Detailed_description
cardiac JJ I-Detailed_description
cycle NN I-Detailed_description
, , O
reaching VBG O
the DT O
mitral JJ B-Biological_structure
annular JJ I-Biological_structure
plane NN I-Biological_structure
( ( O
Figure NNP O
1 CD O
, , O
Figure NNP O
2 CD O
) ) O
. . O

Also RB O
, , O
echocardiography NN B-Diagnostic_procedure
showed VBD O
tricuspid JJ B-Sign_symptom
insufficiency NN I-Sign_symptom
with IN O
a DT O
maximum JJ B-Diagnostic_procedure
gradient NN I-Diagnostic_procedure
of IN O
30 CD B-Lab_value
mmHg NNS I-Lab_value
, , O
intact JJ B-Sign_symptom
interatrial JJ I-Sign_symptom
septum NN I-Sign_symptom
, , O
akinesia NN B-Sign_symptom
of IN O
two CD B-Biological_structure
thirds NNS I-Biological_structure
of IN I-Biological_structure
basal NN I-Biological_structure
inferior JJ I-Biological_structure
wall NN I-Biological_structure
, , O
ejection NN B-Diagnostic_procedure
fraction NN I-Diagnostic_procedure
of IN O
42 CD B-Lab_value
% NN I-Lab_value
. . O

There EX O
was VBD O
no DT O
mass NN B-Sign_symptom
in IN O
the DT O
left JJ B-Biological_structure
atrial JJ I-Biological_structure
appendage NN I-Biological_structure
. . O

The DT O
two CD B-Detailed_description
- : I-Detailed_description
dimensional JJ I-Detailed_description
transesophageal NN B-Biological_structure
echocardiography NN B-Diagnostic_procedure
confirmed VBD O
the DT O
presence NN O
of IN O
the DT O
intraatrial JJ B-Biological_structure
mass NN B-Sign_symptom
. . O

Epistaxis NNP B-Sign_symptom
was VBD O
considered VBN O
to TO O
be VB O
due JJ O
to TO O
heart NN B-Disease_disorder
failure NN I-Disease_disorder
and CC O
the DT O
increased VBN B-Lab_value
venous JJ B-Sign_symptom
pressure NN I-Sign_symptom
. . O

The DT O
patient NN O
was VBD O
referred VBN O
to TO O
the DT O
cardiovascular JJ B-Nonbiological_location
surgery NN I-Nonbiological_location
clinic NN I-Nonbiological_location
, , O
but CC O
she PRP O
refused VBD O
surgery NN B-Therapeutic_procedure
. . O

Anticoagulation NN B-Therapeutic_procedure
with IN O
fraxiparine NN B-Medication
of IN O
0,6 CD B-Dosage
ml NNS I-Dosage
/ JJ I-Dosage
day NN I-Dosage
was VBD O
started VBN O
and CC O
continued VBN O
for IN B-Duration
3 CD I-Duration
weeks NNS I-Duration
, , O
after IN O
cessation NN O
of IN O
epistaxis NN B-Sign_symptom
by IN O
nasal JJ B-Therapeutic_procedure
tamponament NN I-Therapeutic_procedure
. . O

After IN O
3 CD O
weeks NNS O
the DT O
echocardiography NN B-Diagnostic_procedure
was VBD O
repeated VBN O
, , O
with IN O
no DT O
remnant JJ O
mass NN B-Sign_symptom
in IN O
the DT O
left JJ O
atrium NN O
. . O

The DT O
conclusion NN O
was VBD O
that IN O
the DT O
mass NN O
must MD O
have VB O
been VBN O
a DT O
thrombus NN B-Sign_symptom
that WDT O
has VBZ O
melted VBN O
away RB O
. . O

In IN O
this DT O
particular JJ O
case NN O
, , O
the DT O
left JJ O
intraatrial JJ O
thrombus NN O
may MD O
have VB O
been VBN O
due JJ O
to TO O
the DT O
presence NN O
of IN O
atrial JJ O
fibrillation NN O
. . O

-DOCSTART- NN -X-

A DT O
61 CD B-Age
- : I-Age
year NN I-Age
- : I-Age
old JJ I-Age
Chinese JJ O
woman NN O
complained VBD O
of IN O
dizziness NN B-Sign_symptom
for IN O
3 CD B-Duration
weeks NNS I-Duration
and CC O
was VBD O
admitted VBN O
to TO O
our PRP$ O
hospital NN B-Nonbiological_location
after IN O
a DT O
bifrontal JJ B-Biological_structure
mass NN B-Sign_symptom
was VBD O
found VBN O
radiologically RB B-Diagnostic_procedure
. . O

Other JJ O
than IN O
dizziness NN B-Sign_symptom
, , O
the DT O
patient NN O
presented VBD O
no DT O
signs NNS B-Sign_symptom
or CC I-Sign_symptom
symptoms NNS I-Sign_symptom
that WDT I-Sign_symptom
are VBP I-Sign_symptom
commonly RB I-Sign_symptom
associated VBN I-Sign_symptom
with IN I-Sign_symptom
neurological JJ I-Sign_symptom
disease NN I-Sign_symptom
, , O
such JJ O
as IN O
headache NN B-Sign_symptom
, , O
vomiting VBG B-Sign_symptom
, , O
sensory JJ B-Sign_symptom
disturbances NNS I-Sign_symptom
, , O
altered VBD B-Sign_symptom
consciousness NN I-Sign_symptom
, , O
or CC O
seizures NNS B-Sign_symptom
. . O

Except IN O
for IN O
a DT O
20 CD O
- : O
year NN O
history NN O
of IN O
hypertension NN O
, , O
which WDT O
was VBD O
properly RB O
controlled VBN O
with IN O
angiotensin NN B-Medication
- : I-Medication
converting VBG I-Medication
enzyme JJ I-Medication
inhibitors NNS I-Medication
, , O
the DT O
patient NN O
was VBD O
otherwise RB O
healthy JJ B-Sign_symptom
. . O

No DT O
special JJ O
circumstances NNS O
were VBD O
identified JJ O
regarding VBG O
her PRP$ O
personal JJ O
or CC O
family NN O
history NN O
, , O
and CC O
the DT O
patient NN O
was VBD O
found VBN O
to TO O
be VB O
normal JJ B-Lab_value
upon JJ O
neurological JJ B-Diagnostic_procedure
examination NN I-Diagnostic_procedure
. . O

Plain NN B-Detailed_description
and CC O
contrast NN B-Detailed_description
- : I-Detailed_description
enhanced VBN I-Detailed_description
magnetic JJ B-Diagnostic_procedure
resonance NN I-Diagnostic_procedure
imaging NN I-Diagnostic_procedure
( ( O
MRI NNP B-Diagnostic_procedure
) ) O
of IN O
the DT O
head NN B-Biological_structure
showed VBD O
a DT O
space NN B-Detailed_description
- : I-Detailed_description
occupying VBG I-Detailed_description
lesion NN B-Sign_symptom
in IN O
the DT O
bifrontal JJ B-Biological_structure
lobe NN I-Biological_structure
, , O
mainly RB B-Biological_structure
on IN I-Biological_structure
the DT I-Biological_structure
right JJ I-Biological_structure
side NN I-Biological_structure
, , O
clinging VBG B-Biological_structure
to TO I-Biological_structure
the DT I-Biological_structure
sagittal JJ I-Biological_structure
sinus NN I-Biological_structure
and CC O
the DT O
cerebral JJ B-Biological_structure
falx NN I-Biological_structure
. . O

The DT O
5 CD B-Volume
. . I-Volume
7 CD I-Volume
× JJ I-Volume
5 CD I-Volume
. . I-Volume
0 CD I-Volume
× JJ I-Volume
5 CD I-Volume
. . I-Volume
0 CD I-Volume
cm JJ I-Volume
dural JJ O
- : O
based VBN O
mass NN O
growing VBG O
across IN B-Biological_structure
the DT I-Biological_structure
sagittal JJ I-Biological_structure
midline NN I-Biological_structure
revealed VBN O
isointensity NN B-Sign_symptom
on IN O
the DT O
T1 NNP B-Diagnostic_procedure
- : I-Diagnostic_procedure
weighted JJ I-Diagnostic_procedure
image NN I-Diagnostic_procedure
and CC O
a DT O
slight JJ O
hyperintensity NN B-Sign_symptom
on IN O
the DT O
T2 NNP B-Diagnostic_procedure
- : I-Diagnostic_procedure
weighted JJ I-Diagnostic_procedure
image NN I-Diagnostic_procedure
and CC O
was VBD O
homogenously RB O
enhanced VBN O
with IN O
a DT O
characteristic JJ B-Detailed_description
` `` I-Detailed_description
dural JJ I-Detailed_description
- : I-Detailed_description
tail NN I-Detailed_description
` `` I-Detailed_description
sign NN I-Detailed_description
( ( O
Fig NNP O
. . O
1 CD O
) ) O
. . O

Diagnosis NN O
of IN O
a DT O
parasagittal JJ B-Detailed_description
- : I-Detailed_description
parafalcine NN I-Detailed_description
meningioma NN B-Disease_disorder
was VBD O
made VBN O
, , O
and CC O
a DT O
craniotomic JJ B-Detailed_description
meningioma NN O
resection NN B-Therapeutic_procedure
was VBD O
chosen VBN O
as IN O
treatment NN O
. . O

The DT O
blood NN B-Diagnostic_procedure
cell NN I-Diagnostic_procedure
examination NN I-Diagnostic_procedure
; : O
coagulation NN B-Diagnostic_procedure
function NN I-Diagnostic_procedure
, , O
liver NN B-Diagnostic_procedure
and CC I-Diagnostic_procedure
renal JJ I-Diagnostic_procedure
function NN I-Diagnostic_procedure
tests NNS O
; : O
urinalysis NN B-Diagnostic_procedure
; : O
chest JJS B-Biological_structure
x SYM B-Diagnostic_procedure
- : I-Diagnostic_procedure
rays NNS I-Diagnostic_procedure
and CC O
electrocardiogram NNS B-Diagnostic_procedure
were VBD O
normal JJ B-Lab_value
. . O

The DT O
albumin NN B-Diagnostic_procedure
was VBD O
36 CD B-Lab_value
g JJ I-Lab_value
/ NNP I-Lab_value
L NNP I-Lab_value
, , O
the DT O
total JJ B-Diagnostic_procedure
bilirubin NN I-Diagnostic_procedure
( ( O
TBil NNP B-Diagnostic_procedure
) ) O
was VBD O
12 CD B-Lab_value
. . I-Lab_value
2 CD I-Lab_value
μmol JJ I-Lab_value
/ NNP I-Lab_value
L NNP I-Lab_value
, , O
and CC O
the DT O
direct JJ B-Diagnostic_procedure
bilirubin NN I-Diagnostic_procedure
( ( O
DBil NNP B-Diagnostic_procedure
) ) O
was VBD O
4 CD B-Lab_value
. . I-Lab_value
1 CD I-Lab_value
μmol JJ I-Lab_value
/ NNP I-Lab_value
L NNP I-Lab_value
. . O

Alanine NNP B-Diagnostic_procedure
transaminase NN I-Diagnostic_procedure
( ( O
ALT NNP B-Diagnostic_procedure
) ) O
was VBD O
17 CD B-Lab_value
U NNP I-Lab_value
/ NNP I-Lab_value
L NNP I-Lab_value
, , O
and CC O
the DT O
international JJ B-Diagnostic_procedure
normalized JJ I-Diagnostic_procedure
ratio NN I-Diagnostic_procedure
( ( O
INR NNP B-Diagnostic_procedure
) ) O
for IN O
coagulation NN O
values NNS O
was VBD O
1 CD B-Lab_value
. . I-Lab_value
02 CD I-Lab_value
. . O

Because IN O
of IN O
the DT O
patient NN O
` `` O
s NN O
advanced JJ O
age NN O
and CC O
history NN O
of IN O
hypertension NN O
, , O
we PRP O
performed VBD O
an DT O
echocardiograph NN B-Diagnostic_procedure
and CC O
a DT O
blood NN B-Diagnostic_procedure
gas NN I-Diagnostic_procedure
analysis NN I-Diagnostic_procedure
and CC O
tested VBD O
her PRP$ O
creatine JJ B-Diagnostic_procedure
kinase NN I-Diagnostic_procedure
levels NNS O
and CC O
pulmonary JJ B-Diagnostic_procedure
functions NNS I-Diagnostic_procedure
. . O

The DT O
results NNS O
revealed VBD O
no DT B-Lab_value
surgical JJ I-Lab_value
contraindications NNS I-Lab_value
. . O

Written NNP O
consent NN O
was VBD O
obtained VBN O
from IN O
the DT O
patient NN O
. . O

Five CD B-Dosage
hundred JJ I-Dosage
milligrams NNS I-Dosage
of IN O
VPA NNP B-Medication
twice RB B-Dosage
per IN I-Dosage
day NN I-Dosage
was VBD O
initiated VBN O
3 CD O
days NNS O
before IN O
the DT O
operation NN O
. . O

The DT O
patient NN O
tolerated VBD O
the DT O
administration NN O
well RB O
. . O

A DT O
craniotomy NN B-Therapeutic_procedure
was VBD O
then RB O
performed VBN O
with IN O
a DT O
radical JJ O
tumor NN B-Therapeutic_procedure
resection NN I-Therapeutic_procedure
( ( O
Simpson NNP O
II NNP O
) ) O
. . O

The DT O
tumor NN O
was VBD O
pink JJ B-Color
and CC O
solid JJ B-Detailed_description
and CC O
had VBD O
a DT O
moderate JJ B-Detailed_description
blood NN I-Detailed_description
supply NN I-Detailed_description
, , O
and CC O
its PRP$ O
texture NN O
was VBD O
medium NN B-Texture
. . O

Thirty NNP B-Time
minutes NNS I-Time
before IN I-Time
the DT I-Time
end NN I-Time
of IN I-Time
surgery NN I-Time
, , O
800 CD B-Dosage
mg NN I-Dosage
of IN O
VPA NNP B-Medication
was VBD O
administered VBN O
by IN O
intravenous JJ O
infusion NN O
. . O

After IN O
the DT O
operation NN O
, , O
the DT O
patient NN O
regained VBD O
consciousness NN B-Sign_symptom
within IN B-Time
30 CD I-Time
minutes NNS I-Time
and CC O
scored VBD O
15 CD B-Lab_value
on IN O
the DT O
Glasgow NNP B-Diagnostic_procedure
coma NN I-Diagnostic_procedure
scale NN I-Diagnostic_procedure
( ( O
GCS NNP B-Diagnostic_procedure
) ) O
. . O

Two CD O
hours NNS O
later RB O
as IN O
she PRP O
was VBD O
being VBG O
transported VBN O
back RB O
to TO O
her PRP$ O
ward NN B-Nonbiological_location
, , O
the DT O
patient JJ O
underwent JJ O
UGH NNP B-Disease_disorder
. . O

The DT O
vomitus NN B-Sign_symptom
( ( O
approximately RB B-Volume
50 CD I-Volume
mL NN I-Volume
) ) O
was VBD O
composed VBN O
of IN O
coffee NN B-Color
- : I-Color
colored JJ I-Color
blood NN B-Detailed_description
. . O

Excluding VBG O
the DT O
possible JJ O
etiology NN O
of IN O
endotracheal JJ B-Biological_structure
intubation NN B-Detailed_description
damage NN B-Sign_symptom
, , O
we PRP O
diagnosed VBD O
the DT O
patient NN O
as IN O
experiencing VBG O
acute JJ B-Detailed_description
erosive JJ B-Detailed_description
- : I-Detailed_description
hemorrhagic NN I-Detailed_description
gastritis NN B-Disease_disorder
, , O
a DT O
reaction NN O
to TO O
the DT O
craniotomy JJ B-Detailed_description
injury NN B-Sign_symptom
. . O

The DT O
patient NN O
was VBD O
given VBN O
omeprazole JJ B-Medication
to TO O
inhibit VB O
gastric JJ O
acid NN O
secretion NN O
, , O
and CC O
the DT O
hematemesis NN B-Sign_symptom
ceased VBD O
. . O

The DT O
patient NN O
was VBD O
administered VBN O
VPA NNP B-Medication
( ( O
1200 CD B-Dosage
mg NN I-Dosage
, , O
intravenously RB O
) ) O
during IN O
the DT O
first JJ O
2 CD O
postoperative JJ O
days NNS O
. . O

Because IN O
of IN O
her PRP$ O
stomach NN O
and CC O
intestine JJ O
functional JJ O
recovery NN O
, , O
the DT O
VPA NNP B-Medication
dosage NN O
was VBD O
changed VBN O
to TO O
500 CD B-Dosage
mg NN I-Dosage
via IN O
oral JJ O
administration NN O
twice RB B-Dosage
a DT I-Dosage
day NN I-Dosage
. . O

A DT O
brain NN B-Biological_structure
MRI NNP B-Diagnostic_procedure
was VBD O
performed VBN O
on IN O
postoperative JJ O
day NN O
3 CD O
, , O
and CC O
it PRP O
revealed VBD O
that IN O
the DT O
tumor NN B-Sign_symptom
was VBD O
radically RB O
removed VBN O
and CC O
the DT O
operative JJ B-Diagnostic_procedure
field NN I-Diagnostic_procedure
was VBD O
clean JJ B-Lab_value
( ( O
Fig NNP O
. . O
2A CD O
and CC O
B NNP O
) ) O
. . O

A DT O
subsequent JJ O
paraffin NN B-Detailed_description
histological JJ B-Diagnostic_procedure
examination NN I-Diagnostic_procedure
confirmed VBD O
the DT O
diagnosis NN O
of IN O
meningioma NN B-Disease_disorder
. . O

At IN O
3 CD B-Time
am VBP I-Time
on IN O
postoperative JJ O
day NN B-Time
4 CD I-Time
, , O
the DT O
patient NN O
was VBD O
suddenly RB O
found VBN O
in IN O
a DT O
deep JJ B-Severity
coma NN B-Disease_disorder
. . O

Her PRP$ O
pupils NNS B-Sign_symptom
were VBD I-Sign_symptom
dilated VBN I-Sign_symptom
to TO O
3 CD B-Distance
. . I-Distance
0 CD I-Distance
mm NN I-Distance
and CC O
round NN B-Shape
, , O
and CC O
the DT O
light JJ B-Diagnostic_procedure
reflex NN I-Diagnostic_procedure
was VBD O
sensitive JJ B-Lab_value
. . O

The DT O
neurological JJ B-Diagnostic_procedure
examination NN I-Diagnostic_procedure
was VBD O
unremarkable JJ B-Lab_value
, , O
and CC O
her PRP$ O
vital JJ B-Diagnostic_procedure
signs NNS I-Diagnostic_procedure
were VBD O
stable JJ B-Lab_value
; : O
however RB O
, , O
her PRP O
mental JJ B-Diagnostic_procedure
state NN I-Diagnostic_procedure
gradually RB B-Lab_value
changed VBD I-Lab_value
to TO O
a DT O
deep JJ B-Lab_value
coma NN B-Disease_disorder
( ( O
GCS NNP B-Diagnostic_procedure
= NNP O
8 CD B-Lab_value
) ) O
, , O
which WDT O
we PRP O
believed VBD O
was VBD O
caused VBN O
by IN O
intracranial JJ B-Biological_structure
lesions NNS B-Sign_symptom
. . O

A DT O
computerized JJ B-Diagnostic_procedure
tomography NN I-Diagnostic_procedure
( ( O
CT NNP B-Diagnostic_procedure
) ) O
scan NN O
of IN O
the DT O
brain NN B-Biological_structure
was VBD O
immediately RB O
performed VBN O
; : O
however RB O
, , O
it PRP O
failed VBD B-Lab_value
to TO I-Lab_value
reveal VB I-Lab_value
any DT I-Lab_value
abnormalities NNS I-Lab_value
, , O
such JJ O
as IN O
severe JJ B-Severity
brain NN B-Biological_structure
swelling NN B-Sign_symptom
, , O
intracranial JJ B-Disease_disorder
hemorrhage NN I-Disease_disorder
, , O
or CC O
cerebral JJ B-Disease_disorder
infarction NN I-Disease_disorder
( ( O
Fig NNP O
. . O
2C CD O
) ) O
. . O

Because IN O
a DT O
possible JJ O
cerebral JJ B-Disease_disorder
infarction NN I-Disease_disorder
could MD O
not RB O
be VB O
excluded VBN O
within IN B-Time
24 CD I-Time
hours NNS I-Time
, , O
glucocorticoid NN B-Medication
, , O
mannitol NN B-Medication
, , O
and CC O
a DT O
vasodilator NN B-Medication
were VBD O
used VBN O
. . O

The DT O
patient NN O
` `` O
s JJ O
routine JJ O
laboratory NN B-Diagnostic_procedure
results NNS I-Diagnostic_procedure
for IN O
blood NN B-Biological_structure
cell NN I-Biological_structure
, , O
liver NN B-Biological_structure
, , O
and CC O
renal JJ B-Biological_structure
functions NNS B-Diagnostic_procedure
were VBD O
in IN O
relatively RB B-Lab_value
normal JJ I-Lab_value
ranges NNS I-Lab_value
. . O

The DT O
albumin NN B-Diagnostic_procedure
was VBD O
33 CD B-Lab_value
g JJ I-Lab_value
/ NNP I-Lab_value
L NNP I-Lab_value
, , O
the DT O
TBil NNP B-Diagnostic_procedure
was VBD O
13 CD B-Lab_value
. . I-Lab_value
3 CD I-Lab_value
μmol JJ I-Lab_value
/ NNP I-Lab_value
L NNP I-Lab_value
, , O
and CC O
the DT O
DBil NNP B-Diagnostic_procedure
was VBD O
4 CD B-Lab_value
. . I-Lab_value
5 CD I-Lab_value
μmol JJ I-Lab_value
/ NNP I-Lab_value
L NNP I-Lab_value
. . O

ALT NNP B-Diagnostic_procedure
was VBD O
12 CD B-Lab_value
U NNP I-Lab_value
/ NNP I-Lab_value
L NNP I-Lab_value
, , O
and CC O
the DT O
INR NNP B-Diagnostic_procedure
for IN O
coagulation NN O
values NNS O
was VBD O
1 CD B-Lab_value
. . I-Lab_value
01 CD I-Lab_value
. . O

Because IN O
of IN O
her PRP$ O
history NN O
of IN O
UGH NNP O
, , O
we PRP O
checked VBD O
her PRP O
blood NN B-Diagnostic_procedure
ammonia NN I-Diagnostic_procedure
levels NNS O
and CC O
performed VBD O
a DT O
fecal JJ B-Diagnostic_procedure
occult NN I-Diagnostic_procedure
blood NN I-Diagnostic_procedure
test NN I-Diagnostic_procedure
and CC O
blood NN B-Diagnostic_procedure
gas NN I-Diagnostic_procedure
analysis NN I-Diagnostic_procedure
. . O

Her PRP$ O
blood NN O
ammonia NN O
was VBD O
elevated VBN B-Lab_value
( ( O
181 CD B-Lab_value
. . I-Lab_value
6 CD I-Lab_value
μmol JJ I-Lab_value
/ NNP I-Lab_value
L NNP I-Lab_value
; : O
normal JJ O
range NN O
is VBZ O
11 CD O
- : O
32 CD O
μmol JJ O
/ NNP O
L NNP O
) ) O
, , O
whereas IN O
the DT O
fecal JJ O
occult NN O
blood NN O
test NN O
was VBD O
positive JJ B-Lab_value
. . O

Thus RB O
, , O
considering VBG O
her PRP$ O
history NN O
and CC O
elevated VBD O
blood NN O
ammonia NN O
, , O
she PRP O
was VBD O
diagnosed VBN O
with IN O
UGH NNP B-Disease_disorder
- : O
induced VBD O
hepatic JJ B-Disease_disorder
encephalopathy NN I-Disease_disorder
, , O
and CC O
the DT O
oral JJ O
administration NN O
of IN O
VPA NNP B-Medication
was VBD O
changed VBN O
to TO O
intravenous JJ O
administration NN O
to TO O
prevent VB O
seizures NNS O
. . O

Lactulose NNP B-Medication
, , O
vitamin NN B-Medication
B NNP I-Medication
, , O
and CC O
L NNP B-Medication
- : I-Medication
arginine NN I-Medication
were VBD O
administered VBN O
, , O
clysis NN B-Therapeutic_procedure
with IN O
vinegar NN B-Detailed_description
was VBD O
performed VBN O
, , O
and CC O
the DT O
patient NN O
was VBD O
fasted VBN B-Therapeutic_procedure
. . O

The DT O
patient NN O
` `` O
s JJ O
blood NN B-Diagnostic_procedure
ammonia NN I-Diagnostic_procedure
level NN O
fluctuated VBD B-Lab_value
( ( O
144 CD B-Lab_value
. . I-Lab_value
8 CD I-Lab_value
- : I-Lab_value
207 CD I-Lab_value
. . I-Lab_value
7 CD I-Lab_value
μmol JJ I-Lab_value
/ NNP I-Lab_value
L NNP I-Lab_value
) ) O
, , O
and CC O
she PRP O
remained VBD O
unconscious JJ B-Sign_symptom
during IN O
the DT O
following JJ B-Duration
3 CD I-Duration
days NNS I-Duration
. . O

Because IN O
of IN O
the DT O
unremarkable JJ O
progress NN B-Lab_value
in IN O
the DT O
patient NN O
` `` O
s JJ O
mental NN B-Diagnostic_procedure
state NN I-Diagnostic_procedure
and CC O
blood NN B-Diagnostic_procedure
ammonia NN I-Diagnostic_procedure
level NN O
, , O
we PRP O
held VBD O
a DT O
multidisciplinary JJ O
conference NN O
to TO O
discuss VB O
diagnosis NN O
and CC O
treatment NN O
, , O
initially RB O
considering VBG O
hemodialysis NN O
or CC O
peritoneal JJ O
dialysis NN O
. . O

After IN O
the DT O
multidisciplinary JJ O
discussion NN O
, , O
a DT O
suspected JJ O
diagnosis NN O
of IN O
VHE NNP B-Disease_disorder
was VBD O
finally RB O
made VBN O
, , O
even RB O
though IN O
the DT O
blood NN B-Diagnostic_procedure
VPA NNP I-Diagnostic_procedure
level NN O
was VBD O
within IN O
the DT O
normal JJ B-Lab_value
range NN I-Lab_value
. . O

We PRP O
decided VBD O
to TO O
stop VB O
VPA NNP B-Medication
administration NN O
before IN O
performing VBG O
any DT O
dialysis NN O
and CC O
administered VBD O
levetiracetam JJ O
instead RB O
of IN O
VPA NNP O
. . O

The DT O
patient NN O
` `` O
s JJ O
blood NN O
VPA NNP O
and CC O
ammonia NN O
levels NNS O
were VBD O
then RB O
routinely RB O
monitored VBN O
. . O

The DT O
patient NN O
` `` O
s JJ O
mental JJ B-Diagnostic_procedure
state NN I-Diagnostic_procedure
began VBD O
to TO O
improve VB B-Lab_value
from IN O
the DT O
first JJ B-Time
24 CD I-Time
hours NNS I-Time
of IN O
VPA NNP O
discontinuation NN O
, , O
and CC O
she PRP O
achieved VBD O
complete JJ B-Detailed_description
consciousness NN B-Sign_symptom
within IN O
48 CD O
hours NNS O
( ( O
GCS NNP B-Diagnostic_procedure
= NNP O
15 CD B-Lab_value
) ) O
. . O

The DT O
ammonia NN B-Diagnostic_procedure
levels NNS I-Diagnostic_procedure
in IN O
her PRP$ O
blood NN B-Biological_structure
decreased VBN B-Lab_value
dramatically RB O
and CC O
returned VBN O
to TO O
normal JJ B-Lab_value
within IN O
4 CD O
days NNS O
( ( O
Fig NNP O
. . O
3 CD O
) ) O
. . O

On IN O
postoperative JJ O
day NN O
15 CD O
( ( O
8 CD O
days NNS O
after IN O
the DT O
discontinuation NN O
of IN O
VPA NNP O
) ) O
, , O
the DT O
patient NN O
was VBD O
discharged VBN O
with IN O
no DT O
complications NNS B-Sign_symptom
. . O

The DT O
follow NN O
- : O
up RB O
interviews NNS O
in IN O
postoperative JJ O
month NN O
5 CD O
witnessed VBD O
her PRP$ O
full JJ B-Detailed_description
consciousness NN B-Sign_symptom
and CC O
non JJ O
- : O
recurrence NN B-Sign_symptom
of IN O
the DT O
primary JJ B-Detailed_description
tumor NN I-Detailed_description
( ( O
Fig NNP O
. . O
2D CD O
) ) O
. . O

The DT O
patient NN O
` `` O
s JJ O
GCS NNP B-Diagnostic_procedure
score NN O
was VBD O
15 CD B-Lab_value
, , O
and CC O
she PRP O
reported VBD O
enjoying VBG O
a DT O
satisfying JJ B-Lab_value
quality NN B-Diagnostic_procedure
of IN I-Diagnostic_procedure
postoperative JJ I-Diagnostic_procedure
life NN I-Diagnostic_procedure
. . O

-DOCSTART- NN -X-

In IN O
January NNP O
2009 CD O
, , O
a DT O
57 CD B-Age
- : I-Age
year NN I-Age
- : I-Age
old JJ I-Age
woman NN O
emergently RB O
presented VBN O
with IN O
acute JJ B-Detailed_description
shortness NN B-Sign_symptom
of IN I-Sign_symptom
breath NN I-Sign_symptom
. . O

She PRP O
had VBD O
a DT O
1 CD B-Duration
- : I-Duration
month NN I-Duration
history NN O
of IN O
progressive JJ B-Detailed_description
shortness NN B-Sign_symptom
of IN I-Sign_symptom
breath NN I-Sign_symptom
and CC O
a DT O
gradual JJ B-Lab_value
decrease NN I-Lab_value
in IN O
exercise NN B-Diagnostic_procedure
capacity NN I-Diagnostic_procedure
secondary JJ O
to TO O
mild VB B-Severity
dyspnea NN B-Sign_symptom
. . O

She PRP O
reported VBD O
no DT O
additional JJ B-Sign_symptom
symptoms NNS I-Sign_symptom
. . O

At IN O
age NN O
40 CD O
, , O
she PRP O
had VBD O
been VBN O
diagnosed VBN O
with IN O
a DT O
stage NN B-Lab_value
IIA NNP I-Lab_value
, , O
T1bN1 NNP B-Lab_value
, , O
left VBD B-Detailed_description
- : I-Detailed_description
sided VBN I-Detailed_description
breast NN B-Disease_disorder
cancer NN I-Disease_disorder
. . O

Initial JJ O
treatment NN O
had VBD O
included VBN O
a DT O
lumpectomy NN B-Therapeutic_procedure
and CC O
axillary JJ B-Biological_structure
node NN B-Therapeutic_procedure
dissection NN I-Therapeutic_procedure
. . O

She PRP O
subsequently RB O
underwent VBD O
4 CD B-Dosage
cycles NNS I-Dosage
of IN O
DOX NNP B-Medication
therapy NN I-Medication
( ( O
75 CD B-Dosage
mg NN I-Dosage
/ NNP I-Dosage
m2 NN I-Dosage
) ) O
, , O
followed VBN O
by IN O
8 CD B-Dosage
cycles NNS I-Dosage
of IN O
cyclophosphamide NN B-Medication
, , O
methotrexate NN B-Medication
, , O
and CC O
5 CD B-Medication
- : I-Medication
fluorouracil NN I-Medication
. . O

Multigated JJ B-Diagnostic_procedure
acquisition NN I-Diagnostic_procedure
scans NNS I-Diagnostic_procedure
before IN O
and CC O
after IN O
chemotherapy NN B-Medication
showed VBD O
normal JJ B-Lab_value
cardiac JJ B-Diagnostic_procedure
function NN I-Diagnostic_procedure
. . O

After IN O
chemotherapy NN B-Medication
, , O
she PRP O
underwent JJ O
left VBD B-Biological_structure
whole JJ I-Biological_structure
- : I-Biological_structure
breast NN I-Biological_structure
radiation NN B-Therapeutic_procedure
with IN O
an DT O
axillary JJ B-Detailed_description
boost NN I-Detailed_description
. . O

Because IN O
the DT O
tumor NN B-Sign_symptom
had VBD O
been VBN O
estrogen JJ B-Detailed_description
receptor NN I-Detailed_description
- : I-Detailed_description
positive JJ I-Detailed_description
, , O
her PRP$ O
subsequent JJ O
medical JJ O
regimen NNS O
consisted VBD O
only RB O
of IN O
anti JJ B-Medication
- : I-Medication
estrogen NN I-Medication
therapy NN I-Medication
. . O

She PRP O
took VBD O
tamoxifen NN B-Medication
for IN O
5 CD B-Duration
years NNS I-Duration
, , O
and CC O
, , O
ever RB O
since IN O
, , O
the DT O
aromatase NN O
inhibitor NN O
letrozole NN B-Medication
. . O

In IN O
the DT O
17 CD B-Duration
years NNS I-Duration
after IN I-Duration
chemotherapy NN O
, , O
she PRP O
had VBD O
been VBN O
active JJ B-Sign_symptom
and CC O
in IN O
relatively RB B-Lab_value
good JJ I-Lab_value
health NN B-Diagnostic_procedure
. . O

In IN O
addition NN O
to TO O
her PRP$ O
other JJ O
symptoms NNS O
, , O
she PRP O
now RB O
presented VBD O
with IN O
tachycardia NN B-Sign_symptom
, , O
tachypnea NN B-Sign_symptom
, , O
and CC O
hypertension NN B-Sign_symptom
. . O

She PRP O
had VBD O
marked VBN O
jugular JJ B-Biological_structure
venous JJ I-Biological_structure
distention NN B-Sign_symptom
, , O
an DT O
S3 NNP B-Sign_symptom
, , O
pulmonary JJ B-Sign_symptom
rales NNS I-Sign_symptom
, , O
and CC O
trace JJ B-Severity
peripheral JJ B-Detailed_description
edema NN B-Sign_symptom
. . O

Initial JJ O
laboratory NN B-Diagnostic_procedure
values NNS I-Diagnostic_procedure
were VBD O
within IN B-Lab_value
normal JJ I-Lab_value
limits NNS I-Lab_value
except IN O
for IN O
an DT O
elevated JJ B-Lab_value
level NN O
of IN O
N NNP B-Diagnostic_procedure
- : I-Diagnostic_procedure
terminal JJ I-Diagnostic_procedure
pro FW I-Diagnostic_procedure
- : I-Diagnostic_procedure
brain NN I-Diagnostic_procedure
natriuretic JJ I-Diagnostic_procedure
peptide NN I-Diagnostic_procedure
( ( O
> JJ B-Lab_value
2,000 CD I-Lab_value
pg NN I-Lab_value
/ NNP I-Lab_value
mL NN I-Lab_value
) ) O
. . O

Results NNS O
of IN O
investigation NN O
into IN O
the DT O
new JJ O
- : O
onset NN O
cardiomyopathy NN B-Disease_disorder
included VBD O
normal JJ B-Lab_value
cardiac JJ B-Diagnostic_procedure
enzyme NN I-Diagnostic_procedure
levels NNS O
, , O
an DT O
electrocardiogram NN B-Diagnostic_procedure
( ( O
ECG NNP B-Diagnostic_procedure
) ) O
that WDT O
revealed VBD O
no DT O
ischemic JJ B-Sign_symptom
changes NNS I-Sign_symptom
, , O
and CC O
a DT O
coronary JJ B-Biological_structure
angiogram NN B-Diagnostic_procedure
of IN O
normal JJ B-Lab_value
appearance NN O
. . O

The DT O
ECG NNP B-Diagnostic_procedure
showed VBD O
sinus JJ B-Detailed_description
tachycardia NN B-Sign_symptom
with IN O
frequent JJ B-Frequency
premature NN B-Sign_symptom
ventricular NN I-Sign_symptom
complexes NNS I-Sign_symptom
, , O
left VBD B-Sign_symptom
- : I-Sign_symptom
axis NN I-Sign_symptom
deviation NN I-Sign_symptom
, , O
left VBD B-Biological_structure
atrial JJ I-Biological_structure
enlargement NN B-Sign_symptom
, , O
and CC O
low JJ B-Detailed_description
- : I-Detailed_description
voltage NN I-Detailed_description
QRS NNP B-Sign_symptom
complexes NNS I-Sign_symptom
with IN O
nonspecific JJ B-Detailed_description
ST NNP B-Sign_symptom
changes NNS I-Sign_symptom
( ( O
Fig NNP O
. . O
1 CD O
) ) O
. . O

A DT O
2 CD B-Detailed_description
- : I-Detailed_description
dimensional JJ I-Detailed_description
echocardiogram NN B-Diagnostic_procedure
revealed VBD O
a DT O
left JJ B-Diagnostic_procedure
ventricular JJ I-Diagnostic_procedure
ejection NN I-Diagnostic_procedure
fraction NN I-Diagnostic_procedure
( ( O
LVEF NNP B-Diagnostic_procedure
) ) O
of IN O
0 CD B-Lab_value
. . I-Lab_value
20 CD I-Lab_value
, , O
severe JJ B-Severity
diffuse NN B-Detailed_description
left VBD B-Biological_structure
ventricular JJ I-Biological_structure
( ( O
LV NNP B-Biological_structure
) ) O
hypokinesis NN B-Sign_symptom
, , O
and CC O
a DT O
mildly RB B-Severity
dilated VBN B-Sign_symptom
left JJ B-Biological_structure
atrium NN I-Biological_structure
. . O

To TO O
better JJR O
define VB O
the DT O
cause NN O
of IN O
the DT O
LV NNP O
systolic JJ O
dysfunction NN O
, , O
cardiovascular JJ B-Diagnostic_procedure
magnetic JJ I-Diagnostic_procedure
resonance NN I-Diagnostic_procedure
( ( O
CMR NNP B-Diagnostic_procedure
) ) O
was VBD O
performed VBN O
. . O

It PRP O
confirmed VBD O
the DT O
LVEF NNP B-Diagnostic_procedure
of IN O
0 CD B-Lab_value
. . I-Lab_value
20 CD I-Lab_value
. . O

The DT O
T2 NNP B-Diagnostic_procedure
- : I-Diagnostic_procedure
weighted VBD I-Diagnostic_procedure
sequence NN I-Diagnostic_procedure
showed VBD O
slow JJ B-Lab_value
flow NN B-Diagnostic_procedure
secondary NN O
to TO O
LV NNP B-Biological_structure
dysfunction NN B-Disease_disorder
, , O
and CC O
no DT O
myocardial JJ B-Biological_structure
edema NN B-Sign_symptom
( ( O
Fig NNP O
. . O
2A CD O
) ) O
. . O

Late JJ B-Detailed_description
gadolinium NN B-Diagnostic_procedure
enhancement NN I-Diagnostic_procedure
disclosed VBD O
diffuse RB B-Detailed_description
myocardial JJ B-Biological_structure
thinning NN B-Sign_symptom
and CC O
no DT O
scarring NN B-Sign_symptom
( ( O
Fig NNP O
. . O
2B CD O
) ) O
. . O

The DT O
patient NN O
was VBD O
treated VBN B-Therapeutic_procedure
medically RB I-Therapeutic_procedure
. . O

Her PRP$ O
symptoms NNS B-Sign_symptom
progressively RB O
improved VBN B-Lab_value
during IN O
therapy NN B-Therapeutic_procedure
, , O
which WDT O
consisted VBD O
of IN O
a DT O
β NNP B-Medication
- : I-Medication
blocker NN I-Medication
, , O
an DT O
angiotensin NN B-Medication
- : I-Medication
converting VBG I-Medication
enzyme JJ I-Medication
inhibitor NN I-Medication
, , O
digoxin NN B-Medication
, , O
and CC O
a DT O
diuretic JJ B-Medication
. . O

The DT O
therapy NN O
was VBD O
slowly RB O
tapered VBN B-Lab_value
, , O
and CC O
her PRP$ O
LVEF NNP B-Diagnostic_procedure
increased VBD B-Lab_value
from IN O
0 CD B-Lab_value
. . I-Lab_value
20 CD I-Lab_value
to TO O
0 CD B-Lab_value
. . I-Lab_value
55 CD I-Lab_value
during IN O
an DT O
8 CD B-Duration
- : I-Duration
month NN I-Duration
period NN I-Duration
. . O

All DT O
medications NNS B-Medication
except IN O
for IN O
low JJ B-Dosage
- : I-Dosage
dose NN I-Dosage
metoprolol NNS B-Medication
were VBD O
discontinued VBN B-Lab_value
after IN O
1 CD O
year NN O
, , O
and CC O
she PRP O
remained VBD O
asymptomatic JJ B-Sign_symptom
. . O

-DOCSTART- NN -X-

A DT O
60 CD B-Age
- : I-Age
year NN I-Age
- : I-Age
old JJ I-Age
Caucasian JJ O
woman NN O
with IN O
no DT O
significant JJ O
medical JJ O
history NN O
developed VBD O
exercise NN B-Sign_symptom
intolerance NN I-Sign_symptom
, , O
fatigue NN B-Sign_symptom
and CC O
shortness NN B-Sign_symptom
of IN I-Sign_symptom
breath NN I-Sign_symptom
on IN O
exertion NN B-Detailed_description
over IN O
the DT O
several JJ B-Duration
months NNS I-Duration
prior RB I-Duration
to TO O
her PRP$ O
presentation NN O
to TO O
our PRP$ O
outpatient JJ B-Nonbiological_location
clinic NN I-Nonbiological_location
. . O

At IN O
the DT O
time NN O
of IN O
presentation NN O
, , O
she PRP O
also RB O
reported VBD O
of IN O
dry JJ B-Detailed_description
cough NN B-Sign_symptom
, , O
orthopnea NN B-Sign_symptom
, , O
paroxysmal JJ B-Detailed_description
nocturnal JJ B-Detailed_description
dyspnoea NN B-Sign_symptom
, , O
generalised VBD B-Detailed_description
weakness NN B-Sign_symptom
and CC O
intermittent JJ B-Detailed_description
numbness NN B-Sign_symptom
of IN O
her PRP$ O
hands NNS B-Biological_structure
and CC O
feet NNS B-Biological_structure
. . O

Social NNP O
history NN O
was VBD O
negative JJ O
for IN O
smoking NN B-Activity
, , O
alcohol NN B-Activity
or CC O
illicit NN B-Activity
drugs NNS I-Activity
. . O

Physical JJ B-Diagnostic_procedure
examination NN I-Diagnostic_procedure
was VBD O
unremarkable JJ B-Lab_value
, , O
except IN O
for IN O
jugular JJ B-Biological_structure
venous JJ I-Biological_structure
distension NN B-Sign_symptom
, , O
audible JJ O
S1 NNP B-Sign_symptom
and CC I-Sign_symptom
S2 NNP I-Sign_symptom
sounds VBZ I-Sign_symptom
, , O
bilateral JJ B-Detailed_description
crackles NNS B-Sign_symptom
on IN O
lung NN B-Diagnostic_procedure
auscultation NN I-Diagnostic_procedure
and CC O
bilateral JJ B-Detailed_description
pitting NN B-Detailed_description
oedema NN B-Sign_symptom
. . O

Chest NNP B-Biological_structure
X NNP B-Diagnostic_procedure
- : I-Diagnostic_procedure
ray NN I-Diagnostic_procedure
showed VBD O
cardiomegaly NN B-Sign_symptom
, , O
pulmonary JJ B-Sign_symptom
oedema NN I-Sign_symptom
and CC O
small JJ B-Severity
- : I-Severity
sized JJ I-Severity
bilateral JJ B-Detailed_description
pleural JJ B-Sign_symptom
effusions NNS I-Sign_symptom
. . O

A DT O
12 CD B-Detailed_description
- : I-Detailed_description
lead NN I-Detailed_description
ECG NNP B-Diagnostic_procedure
demonstrated VBD O
normal JJ B-Lab_value
sinus NN B-Diagnostic_procedure
rhythm NN I-Diagnostic_procedure
, , O
low JJ B-Sign_symptom
- : I-Sign_symptom
voltage NN I-Sign_symptom
complexes NNS I-Sign_symptom
and CC O
extreme NN B-Severity
right RB B-Sign_symptom
- : I-Sign_symptom
axis JJ I-Sign_symptom
deviation NN I-Sign_symptom
( ( O
figure JJ O
1 CD O
) ) O
. . O

Transthoracic NNP B-Diagnostic_procedure
echocardiogram NN I-Diagnostic_procedure
( ( O
TTE NNP B-Diagnostic_procedure
) ) O
demonstrated VBD O
asymmetric JJ B-Detailed_description
biventricular JJ B-Biological_structure
hypertrophy NN B-Sign_symptom
with IN O
preserved JJ B-Lab_value
ejection NN B-Diagnostic_procedure
fraction NN I-Diagnostic_procedure
of IN O
60 CD B-Lab_value
% NN I-Lab_value
, , O
elevated VBN B-Lab_value
right JJ B-Biological_structure
- : I-Biological_structure
ventricular JJ I-Biological_structure
systolic JJ B-Diagnostic_procedure
pressure NN I-Diagnostic_procedure
of IN O
36 CD B-Lab_value
mm NNS I-Lab_value
Hg NNP I-Lab_value
and CC O
abnormal JJ B-Lab_value
myocardial JJ B-Diagnostic_procedure
texture NN I-Diagnostic_procedure
, , O
described VBN O
as IN O
` `` O
granular JJ B-Texture
sparkling NN I-Texture
` `` O
( ( O
figure NN O
2 CD O
) ) O
. . O

Coronary JJ B-Biological_structure
CT NNP B-Diagnostic_procedure
angiogram NN I-Diagnostic_procedure
demonstrated VBD O
normal JJ B-Lab_value
coronary JJ B-Biological_structure
arteries NNS I-Biological_structure
. . O

Subsequently RB O
, , O
cardiac JJ B-Biological_structure
MRI NNP B-Diagnostic_procedure
demonstrated VBD O
early JJ B-Detailed_description
and CC O
diffuse JJ B-Detailed_description
subendocardial JJ B-Biological_structure
delayed VBN B-Sign_symptom
enhancement NN I-Sign_symptom
, , O
concerning VBG O
for IN O
infiltrative JJ B-Disease_disorder
myocardial JJ I-Disease_disorder
disease NN I-Disease_disorder
and CC O
for IN O
diffuse NN B-Detailed_description
biventricular JJ B-Biological_structure
hypertrophy NN B-Sign_symptom
, , O
with IN O
normal JJ B-Lab_value
ejection NN B-Diagnostic_procedure
fraction NN I-Diagnostic_procedure
( ( O
figure JJ O
3 CD O
) ) O
. . O

The DT O
patient NN O
underwent JJ O
right JJ B-Detailed_description
heart NN B-Therapeutic_procedure
catheterisation NN I-Therapeutic_procedure
with IN O
endomyocardial JJ B-Biological_structure
biopsy NN B-Diagnostic_procedure
, , O
revealing VBG O
diffuse NN B-Detailed_description
amyloidosis NN B-Disease_disorder
with IN O
amorphous JJ B-Detailed_description
proteinaceous JJ B-Sign_symptom
material NN I-Sign_symptom
around IN O
cardiac JJ B-Biological_structure
myocytes NNS I-Biological_structure
and CC O
within IN O
blood NN B-Biological_structure
vessels NNS I-Biological_structure
, , O
which WDT O
was VBD O
positive JJ B-Lab_value
for IN O
Congo NNP B-Diagnostic_procedure
red JJ I-Diagnostic_procedure
stain NN I-Diagnostic_procedure
( ( O
figure JJ O
4 CD O
) ) O
. . O

Subsequent JJ O
laboratory NN B-Diagnostic_procedure
evaluation NN I-Diagnostic_procedure
registered VBD O
elevated VBN B-Lab_value
, , O
free JJ B-Diagnostic_procedure
λ NN I-Diagnostic_procedure
light NN I-Diagnostic_procedure
chains NNS I-Diagnostic_procedure
( ( O
86 CD B-Lab_value
. . I-Lab_value
3 CD I-Lab_value
mg JJ I-Lab_value
/ NN I-Lab_value
L NNP I-Lab_value
( ( O
normal JJ O
: : O
5 CD O
. . O
7 CD O
- : O
26 CD O
. . O
3 CD O
mg JJ O
/ NNP O
L NNP O
) ) O
) ) O
and CC O
positive JJ B-Lab_value
Bence NNP B-Diagnostic_procedure
- : I-Diagnostic_procedure
Jones NNP I-Diagnostic_procedure
protein NN I-Diagnostic_procedure
( ( O
0 CD B-Lab_value
. . I-Lab_value
37 CD I-Lab_value
g JJ I-Lab_value
/ $ I-Lab_value
24 CD I-Lab_value
h NN I-Lab_value
) ) O
in IN O
the DT O
urine NN B-Detailed_description
. . O

Bone NNP B-Biological_structure
marrow NN I-Biological_structure
biopsy NN B-Diagnostic_procedure
revealed VBD O
greater JJR B-Lab_value
than IN I-Lab_value
10 CD I-Lab_value
% NN I-Lab_value
infiltration NN B-Diagnostic_procedure
of IN O
CD19 NNP B-Detailed_description
− NNP I-Detailed_description
CD56 NNP I-Detailed_description
+ NNP I-Detailed_description
CD138 NNP I-Detailed_description
+ NNP I-Detailed_description
plasma NN I-Detailed_description
cells NNS I-Detailed_description
with IN O
reversal NN B-Lab_value
of IN O
marrow NN B-Diagnostic_procedure
κ NNP I-Diagnostic_procedure
/ NNP I-Diagnostic_procedure
λ NNP I-Diagnostic_procedure
ratio NN I-Diagnostic_procedure
( ( O
< JJ B-Lab_value
1:2 CD I-Lab_value
, , O
normal JJ O
: : O
2:1 CD O
) ) O
, , O
consistent JJ O
with IN O
MM NNP B-Disease_disorder
. . O

The DT O
patient NN O
was VBD O
eventually RB O
diagnosed VBN O
with IN O
systemic JJ B-Detailed_description
AL NNP B-Detailed_description
amyloidosis NN B-Disease_disorder
with IN O
advanced JJ B-Severity
, , O
stage NN B-Detailed_description
III NNP I-Detailed_description
, , O
cardiac JJ B-Biological_structure
amyloidosis NN B-Disease_disorder
due JJ O
to TO O
underlying VBG O
MM NNP B-Disease_disorder
. . O

Given VBN O
her PRP$ O
advanced JJ B-Severity
cardiac JJ B-Biological_structure
amyloidosis NN B-Disease_disorder
, , O
the DT O
patient NN O
was VBD O
deemed VBN O
a DT O
poor JJ O
candidate NN O
for IN O
autologous JJ B-Therapeutic_procedure
stem NN I-Therapeutic_procedure
- : I-Therapeutic_procedure
cell NN I-Therapeutic_procedure
transplantation NN I-Therapeutic_procedure
. . O

The DT O
patient NN O
was VBD O
started VBN O
on IN O
systemic JJ B-Detailed_description
chemotherapy NN B-Medication
with IN O
melphalan NN B-Medication
and CC O
dexamethasone NN B-Medication
. . O

Despite IN O
receiving VBG O
standard JJ O
therapy NN O
for IN O
heart NN O
failure NN O
- : O
including VBG O
diuretics NNS B-Medication
, , O
β SYM B-Medication
- : I-Medication
blockers NNS I-Medication
and CC O
ACE NNP B-Medication
inhibitors NNS I-Medication
- : O
the DT O
patient NN O
` `` O
s JJ O
condition NN B-Diagnostic_procedure
continued VBD O
to TO O
worsen VB B-Lab_value
and CC O
she PRP O
succumbed VBD O
to TO O
sudden JJ B-Disease_disorder
cardiac JJ I-Disease_disorder
death NN I-Disease_disorder
. . O

-DOCSTART- NN -X-

The DT O
patient NN O
was VBD O
a DT O
38 CD B-Age
- : I-Age
year NN I-Age
- : I-Age
old JJ I-Age
Caucasian JJ O
man NN O
of IN O
Spanish JJ O
origin NN O
. . O

His PRP$ O
height NN O
was VBD O
165 CD B-Height
cm NN I-Height
and CC O
his PRP$ O
parents NNS O
were VBD O
cousins NNS O
. . O

Both DT O
parents NNS O
were VBD O
of IN O
normal JJ B-Detailed_description
height NN I-Detailed_description
and CC O
neither DT B-Detailed_description
showed VBD I-Detailed_description
any DT I-Detailed_description
minor JJ I-Detailed_description
anomalies NNS I-Detailed_description
of IN I-Detailed_description
the DT I-Detailed_description
EvC NNP I-Detailed_description
syndrome NN I-Detailed_description
spectrum NN I-Detailed_description
. . O

The DT O
patient NN O
had VBD O
two CD O
healthy JJ B-Detailed_description
sisters NNS O
. . O

His PRP$ O
morphological JJ B-Diagnostic_procedure
features NNS I-Diagnostic_procedure
were VBD O
: : O
( ( O
a DT O
) ) O
normal JJ B-Sign_symptom
mouth NN I-Sign_symptom
opening VBG I-Sign_symptom
with IN O
missing VBG B-Sign_symptom
lower JJR I-Sign_symptom
incisors NNS I-Sign_symptom
( ( O
Fig NNP O
. . O
1 CD O
) ) O
; : O
( ( O
b NN O
) ) O
small JJ B-Sign_symptom
chest NN I-Sign_symptom
, , O
as IN O
determined VBN O
by IN O
a DT O
cardiothoracic JJ B-Diagnostic_procedure
examination NN I-Diagnostic_procedure
; : O
and CC O
( ( O
c NN O
) ) O
disproportionately RB O
short JJ B-Sign_symptom
extremities NNS I-Sign_symptom
with IN O
one CD B-Detailed_description
additional JJ B-Sign_symptom
postaxial NN I-Sign_symptom
digit NN I-Sign_symptom
on IN O
each DT B-Biological_structure
hand NN I-Biological_structure
( ( O
Fig NNP O
. . O
2 CD O
) ) O
. . O

Although IN O
no DT O
sensory JJ B-Sign_symptom
- : I-Sign_symptom
motor NN I-Sign_symptom
deficit NN I-Sign_symptom
was VBD O
noted VBN O
, , O
the DT O
patient NN O
presented VBN O
with IN O
mild JJ B-Detailed_description
mental JJ B-Disease_disorder
retardation NN I-Disease_disorder
. . O

Genetic JJ B-Diagnostic_procedure
analysis NN I-Diagnostic_procedure
in IN O
his PRP$ O
early JJ O
infancy NN O
showed VBD O
a DT O
previously RB O
reported VBN O
homozygous JJ B-Detailed_description
nonsense JJ B-Detailed_description
mutation NN B-Sign_symptom
c NN B-Detailed_description
. . I-Detailed_description
1195 CD I-Detailed_description
C1T NNP I-Detailed_description
, , I-Detailed_description
p NN I-Detailed_description
. . I-Detailed_description
Arg399X NNP I-Detailed_description
of IN I-Detailed_description
EvC2 NNP I-Detailed_description
, , O
resulting VBG O
in IN O
loss NN B-Detailed_description
of IN I-Detailed_description
function NN I-Detailed_description
of IN I-Detailed_description
the DT I-Detailed_description
protein NN I-Detailed_description
. . O
( ( O
5 CD O
) ) O
His PRP$ O
parents NNS O
were VBD O
heterozygous JJ B-Detailed_description
carriers NNS I-Detailed_description
of IN O
the DT O
mutation NN O
. . O

In IN O
1998 CD O
, , O
the DT O
patient NN O
underwent JJ O
successful JJ O
ostium NN B-Biological_structure
primum JJ I-Biological_structure
atrial JJ B-Therapeutic_procedure
septal NN I-Therapeutic_procedure
defect NN I-Therapeutic_procedure
closure NN I-Therapeutic_procedure
through IN O
a DT O
midsternotomy NN B-Therapeutic_procedure
. . O

He PRP O
re VBZ O
- : O
presented VBN O
with IN O
embolic JJ B-Detailed_description
cerebral JJ B-Biological_structure
ictus NN B-Sign_symptom
in IN O
2007 CD O
, , O
and CC O
cavotricuspid JJ B-Biological_structure
isthmus NN I-Biological_structure
ablation NN B-Therapeutic_procedure
for IN O
common JJ B-Detailed_description
atrial JJ B-Disease_disorder
flutter NN I-Disease_disorder
was VBD O
performed VBN O
successfully RB O
. . O

There EX O
were VBD O
no DT O
serious JJ B-Severity
aftereffects NNS B-Sign_symptom
. . O

During IN O
a DT O
routine JJ O
examination NN B-Diagnostic_procedure
in IN O
2012 CD O
, , O
a DT O
high JJ B-Detailed_description
- : I-Detailed_description
pitched VBN I-Detailed_description
systolic JJ B-Detailed_description
murmur NN B-Sign_symptom
was VBD O
discovered VBN O
. . O

Electrocardiography NN B-Diagnostic_procedure
showed VBD O
sinus JJ B-Lab_value
rhythm NN I-Lab_value
with IN O
hemiblock NN B-Disease_disorder
and CC O
right JJ B-Disease_disorder
bundle NN I-Disease_disorder
branch NN I-Disease_disorder
block NN I-Disease_disorder
, , O
while IN O
echocardiography NN B-Diagnostic_procedure
revealed VBD O
a DT O
dilated JJ B-Sign_symptom
and CC O
hypertrophic JJ B-Sign_symptom
left VBD B-Biological_structure
ventricle NN I-Biological_structure
. . O

These DT O
abnormalities NNS O
produced VBD O
a DT O
flow NN B-Sign_symptom
that WDT O
was VBD O
directed VBN B-Biological_structure
to TO I-Biological_structure
the DT I-Biological_structure
left VBN I-Biological_structure
atrial JJ I-Biological_structure
appendage NN I-Biological_structure
, , O
leading VBG O
to TO O
severe JJ O
mitral JJ B-Sign_symptom
valve NN I-Sign_symptom
regurgitation NN I-Sign_symptom
. . O

The DT O
patient NN O
` `` O
s JJ O
systolic JJ B-Detailed_description
pulmonary JJ B-Diagnostic_procedure
artery NN I-Diagnostic_procedure
pressure NN I-Diagnostic_procedure
was VBD O
50 CD B-Lab_value
mmHg NN I-Lab_value
and CC O
his PRP$ O
aortic JJ B-Sign_symptom
valve NN I-Sign_symptom
was VBD I-Sign_symptom
normal JJ I-Sign_symptom
. . O

His PRP$ O
medical JJ O
treatment NN O
included VBD O
ramipril NN B-Medication
, , O
duloxetine NN B-Medication
, , O
alprazolam NN B-Medication
and CC O
acenocumarol NN B-Medication
. . O

The DT O
patient NN O
was VBD O
scheduled VBN O
for IN O
mitral JJ B-Therapeutic_procedure
valve NN I-Therapeutic_procedure
surgery NN I-Therapeutic_procedure
. . O

In IN O
the DT O
operating NN O
theatre NN O
, , O
the DT O
patient NN O
` `` O
s RB O
right JJ B-Biological_structure
femoral JJ I-Biological_structure
artery NN I-Biological_structure
was VBD O
cannulated VBN B-Therapeutic_procedure
. . O

A DT O
right JJ B-Detailed_description
thoracotomy NN B-Therapeutic_procedure
was VBD O
performed VBN O
on IN O
the DT O
fourth JJ B-Biological_structure
intercostal JJ I-Biological_structure
space NN I-Biological_structure
and CC O
bicaval JJ B-Detailed_description
cannulation NN B-Therapeutic_procedure
was VBD O
established VBN O
. . O

Both DT B-Detailed_description
veins NNS I-Detailed_description
were VBD I-Detailed_description
excluded VBN I-Detailed_description
. . O

The DT O
operation NN O
used VBD O
a DT O
normothermic JJ B-Detailed_description
cardiopulmonary JJ B-Therapeutic_procedure
bypass NN I-Therapeutic_procedure
without IN B-Detailed_description
cross NN I-Detailed_description
- : I-Detailed_description
clamping NN I-Detailed_description
of IN I-Detailed_description
the DT I-Detailed_description
aorta NN I-Detailed_description
in IN I-Detailed_description
the DT I-Detailed_description
beating JJ I-Detailed_description
heart NN I-Detailed_description
. . O

To TO O
avoid VB O
air NN O
embolisms NNS O
, , O
continuous JJ B-Therapeutic_procedure
carbon NN I-Therapeutic_procedure
dioxide NN I-Therapeutic_procedure
( ( I-Therapeutic_procedure
CO2 NNP I-Therapeutic_procedure
) ) I-Therapeutic_procedure
field NN I-Therapeutic_procedure
flooding NN I-Therapeutic_procedure
was VBD O
applied VBN O
using VBG O
a DT O
CarbonAid NNP B-Detailed_description
CO2 NNP I-Detailed_description
diffuser NN I-Detailed_description
( ( O
Cardia NNP B-Detailed_description
Innovation NNP I-Detailed_description
AB NNP I-Detailed_description
, , I-Detailed_description
Stockholm NNP I-Detailed_description
, , I-Detailed_description
Sweden NNP I-Detailed_description
) ) O
. . O

The DT O
attempt NN O
to TO O
perform VB O
a DT O
mitral JJ B-Therapeutic_procedure
valve NN I-Therapeutic_procedure
repair NN I-Therapeutic_procedure
was VBD O
unsuccessful JJ O
and CC O
a DT O
bileaflet NN B-Detailed_description
mechanical JJ I-Detailed_description
valve NN I-Detailed_description
( ( O
no DT B-Detailed_description
. . I-Detailed_description
29 CD I-Detailed_description
) ) O
was VBD O
implanted VBN B-Therapeutic_procedure
. . O

No DT O
complications NNS B-Sign_symptom
associated VBN B-Detailed_description
with IN I-Detailed_description
anaesthesia NN I-Detailed_description
occurred VBD O
. . O

The DT O
patient NN O
` `` O
s RB O
postoperative JJ B-Therapeutic_procedure
recovery NN I-Therapeutic_procedure
was VBD O
uneventful JJ B-Lab_value
and CC O
he PRP O
was VBD O
discharged VBN O
on IN O
postoperative JJ O
day NN O
10 CD O
. . O

After IN O
two CD B-Duration
years NNS I-Duration
of IN O
follow NN O
- : O
up RB O
, , O
echocardiography NN B-Diagnostic_procedure
revealed VBD O
optimal JJ B-Lab_value
function NN I-Lab_value
of IN O
the DT O
mitral JJ B-Biological_structure
valve NN I-Biological_structure
and CC O
a DT O
decrease NN B-Lab_value
in IN O
systolic JJ B-Detailed_description
pulmonary JJ B-Diagnostic_procedure
artery NN I-Diagnostic_procedure
pressure NN I-Diagnostic_procedure
( ( O
30 CD B-Lab_value
mmHg NN I-Lab_value
) ) O
. . O

-DOCSTART- NN -X-

A DT O
71 CD B-Age
- : I-Age
year NN I-Age
- : I-Age
old JJ I-Age
woman NN O
with IN O
known VBN O
diastolic JJ B-Detailed_description
congestive JJ B-Disease_disorder
heart NN I-Disease_disorder
failure NN I-Disease_disorder
( ( B-Disease_disorder
CHF NNP I-Disease_disorder
) ) I-Disease_disorder
presented VBD O
to TO O
the DT O
ER NNP B-Nonbiological_location
with IN O
exacerbation NN B-Detailed_description
of IN O
CHF NNP B-Disease_disorder
and CC O
a DT O
decreased JJ B-Lab_value
level NN B-Sign_symptom
of IN I-Sign_symptom
consciousness NN I-Sign_symptom
. . O

Brachial JJ B-Biological_structure
blood NN B-Sign_symptom
pressure NN I-Sign_symptom
( ( B-Sign_symptom
BP NNP I-Sign_symptom
) ) I-Sign_symptom
was VBD O
measured VBN O
at IN O
55 CD B-Lab_value
/ $ I-Lab_value
40 CD I-Lab_value
mmHg NN I-Lab_value
. . O

The DT O
patient NN O
had VBD O
four CD B-Lab_value
recent JJ B-Detailed_description
admissions NNS O
with IN O
exacerbation NN B-Detailed_description
of IN O
CHF NNP B-Disease_disorder
. . O

Her PRP$ O
medical JJ O
history NN O
was VBD O
also RB O
significant JJ O
for IN O
autoimmune JJ B-Detailed_description
hepatitis NN B-Disease_disorder
, , O
but CC O
preserved VBD B-Detailed_description
liver JJS B-Diagnostic_procedure
function NN I-Diagnostic_procedure
; : O
esophageal CC B-Biological_structure
varices NNS I-Biological_structure
with IN O
a DT O
bleeding NN B-Detailed_description
episode NN I-Detailed_description
; : O
and CC O
long JJ B-Detailed_description
- : I-Detailed_description
term NN I-Detailed_description
corticosteroid JJ B-Medication
therapy NN I-Medication
complicated VBN O
by IN O
adrenal JJ B-Disease_disorder
insufficiency NN I-Disease_disorder
, , O
type NN B-Disease_disorder
2 CD I-Disease_disorder
diabetes NNS I-Disease_disorder
mellitus NN I-Disease_disorder
and CC O
osteoporosis NN B-Disease_disorder
. . O

Recent JJ O
echocardiography NN B-Diagnostic_procedure
had VBD O
revealed VBN O
moderate JJ B-Severity
concentric NN B-Detailed_description
left VBD B-Biological_structure
ventricular JJ I-Biological_structure
hypertrophy NN B-Disease_disorder
with IN O
diastolic JJ B-Detailed_description
dysfunction NN I-Detailed_description
, , O
and CC O
mild VB B-Severity
to TO O
moderate VB B-Severity
mitral JJ B-Disease_disorder
regurgitation NN I-Disease_disorder
. . O

Cardiac JJ B-Diagnostic_procedure
catheterization NN I-Diagnostic_procedure
in IN O
a DT O
recent JJ O
admission NN O
demonstrated VBD O
50 CD B-Lab_value
% NN I-Lab_value
stenosis NN B-Disease_disorder
in IN O
the DT O
second JJ B-Biological_structure
diagonal JJ I-Biological_structure
artery NN I-Biological_structure
, , O
with IN O
mild JJ B-Severity
diffuse NN B-Detailed_description
disease NN O
in IN O
the DT O
other JJ B-Biological_structure
coronary JJ I-Biological_structure
arteries NNS I-Biological_structure
. . O

Right RB B-Detailed_description
ventricular JJ I-Detailed_description
endomyocardial JJ I-Detailed_description
biopsy NN B-Diagnostic_procedure
had VBD O
ruled VBN O
out RP O
myocarditis NN B-Disease_disorder
and CC O
infiltrative JJ B-Detailed_description
cardiomyopathies NNS B-Disease_disorder
, , O
but CC O
healing VBG B-Detailed_description
ischemic JJ B-Disease_disorder
microinfarcts NNS I-Disease_disorder
with IN O
atheroemboli NNS B-Disease_disorder
were VBD O
observed VBN O
. . O

Previous JJ O
BP NNP B-Diagnostic_procedure
values NNS I-Diagnostic_procedure
were VBD O
also RB O
low JJ B-Lab_value
; : O
systolic JJ B-Diagnostic_procedure
BP NNP I-Diagnostic_procedure
was VBD O
between IN O
60 CD B-Lab_value
mmHg NNS I-Lab_value
and CC O
65 CD B-Lab_value
mmHg NN I-Lab_value
, , O
and CC O
diastolic JJ B-Diagnostic_procedure
BP NNP I-Diagnostic_procedure
was VBD O
between IN O
40 CD B-Lab_value
mmHg NNS I-Lab_value
and CC O
45 CD B-Lab_value
mmHg NN I-Lab_value
. . O

Following VBG O
intubation NN B-Therapeutic_procedure
, , O
dopamine NN B-Medication
was VBD O
started VBN O
for IN O
hypotension NN B-Therapeutic_procedure
management NN I-Therapeutic_procedure
and CC O
was VBD O
later RB O
replaced VBN O
with IN O
noradrenaline NN B-Medication
. . O

The DT O
patient NN O
developed VBD O
atrial JJ B-Disease_disorder
flutter NN I-Disease_disorder
but CC O
successfully RB O
converted VBN O
to TO O
sinus VB B-Sign_symptom
rhythm NN I-Sign_symptom
with IN O
two CD B-Lab_value
direct JJ B-Detailed_description
current JJ I-Detailed_description
electric JJ B-Therapeutic_procedure
shocks NNS I-Therapeutic_procedure
. . O

Cardiology NNP B-Diagnostic_procedure
consultation NN I-Diagnostic_procedure
resulted VBD O
in IN O
admission NN O
to TO O
the DT O
coronary JJ B-Nonbiological_location
care NN I-Nonbiological_location
unit NN I-Nonbiological_location
( ( B-Nonbiological_location
CCU NNP I-Nonbiological_location
) ) I-Nonbiological_location
. . O

On IN O
admission NN O
to TO O
the DT O
CCU NNP B-Biological_structure
, , O
BP NNP B-Diagnostic_procedure
was VBD O
measured VBN O
at IN O
56 CD B-Lab_value
/ $ I-Lab_value
36 CD I-Lab_value
mmHg NN I-Lab_value
in IN O
the DT O
left JJ B-Biological_structure
arm NN I-Biological_structure
but CC O
was VBD O
not RB B-Lab_value
detectable JJ I-Lab_value
in IN O
the DT O
right JJ B-Biological_structure
arm NN I-Biological_structure
. . O

An DT O
arterial JJ B-Diagnostic_procedure
line NN I-Diagnostic_procedure
was VBD O
inserted VBN O
via IN O
the DT O
femoral JJ B-Biological_structure
artery NN I-Biological_structure
, , O
and CC O
BP NNP B-Diagnostic_procedure
was VBD O
measured VBN O
at IN O
191 CD B-Lab_value
/ $ I-Lab_value
92 CD I-Lab_value
mmHg NN I-Lab_value
. . O

BP NNP B-Diagnostic_procedure
values NNS I-Diagnostic_procedure
were VBD O
consistently RB B-Detailed_description
much JJ B-Severity
higher JJR B-Lab_value
through IN B-Detailed_description
the DT I-Detailed_description
femoral JJ I-Detailed_description
arterial JJ I-Detailed_description
line NN I-Detailed_description
than IN I-Detailed_description
the DT I-Detailed_description
cuff NN I-Detailed_description
on IN I-Detailed_description
the DT I-Detailed_description
arms NNS I-Detailed_description
, , O
and CC O
was VBD O
higher JJR B-Lab_value
in IN B-Detailed_description
the DT I-Detailed_description
left NN B-Biological_structure
arm NN I-Biological_structure
than IN I-Detailed_description
in IN I-Detailed_description
the DT I-Detailed_description
right JJ B-Biological_structure
arm NN I-Biological_structure
. . O

For IN O
instance NN O
, , O
on IN O
the DT O
first JJ O
day NN O
post VB O
- : O
CCU NNP O
admission NN O
, , O
BP NNP B-Diagnostic_procedure
at IN B-Time
one CD I-Time
point NN I-Time
was VBD O
measured VBN O
at IN O
170 CD B-Lab_value
/ $ I-Lab_value
80 CD I-Lab_value
mmHg NN I-Lab_value
through IN O
the DT O
arterial JJ O
line NN O
, , O
while IN O
cuff JJ O
readings NNS O
on IN O
the DT O
arms NNS O
were VBD O
83 CD B-Lab_value
/ JJ I-Lab_value
74 CD I-Lab_value
mmHg NN I-Lab_value
on IN O
the DT O
left NN B-Biological_structure
and CC I-Biological_structure
60 CD B-Lab_value
/ NNS I-Lab_value
39 CD I-Lab_value
mmHg NN I-Lab_value
on IN I-Biological_structure
the DT I-Biological_structure
right JJ B-Biological_structure
arm NN I-Biological_structure
. . O

To TO O
investigate VB O
the DT O
inconsistency NN O
between IN O
brachial JJ B-Biological_structure
and CC O
femoral JJ B-Biological_structure
BP NNP B-Diagnostic_procedure
values NNS I-Diagnostic_procedure
, , O
a DT O
computed VBN B-Diagnostic_procedure
tomography NN I-Diagnostic_procedure
( ( B-Diagnostic_procedure
CT NNP I-Diagnostic_procedure
) ) I-Diagnostic_procedure
scan NN I-Diagnostic_procedure
of IN O
the DT O
thorax NN B-Biological_structure
was VBD O
obtained VBN O
using VBG O
1 CD B-Distance
. . I-Distance
25 CD I-Distance
mm NN I-Distance
slices NNS B-Diagnostic_procedure
, , O
both DT O
before IN O
and CC O
after IN O
intravenous JJ O
contrast NN B-Diagnostic_procedure
injection NN I-Diagnostic_procedure
with IN O
sagittal JJ B-Detailed_description
and CC I-Detailed_description
coronal JJ I-Detailed_description
planar NN I-Detailed_description
reformatting NN I-Detailed_description
of IN O
maximum JJ B-Diagnostic_procedure
- : I-Diagnostic_procedure
intensity NN I-Diagnostic_procedure
projection NN I-Diagnostic_procedure
images NNS I-Diagnostic_procedure
. . O

Analysis NN O
of IN O
the DT O
initial JJ B-Detailed_description
unenhanced JJ B-Detailed_description
CT NNP O
images NNS O
showed VBD O
densely RB B-Severity
calcified VBN B-Detailed_description
plaque NN B-Sign_symptom
or CC O
thrombus NN B-Sign_symptom
at IN O
the DT O
origins NNS B-Biological_structure
of IN I-Biological_structure
both DT I-Biological_structure
subclavian JJ I-Biological_structure
arteries NNS I-Biological_structure
and CC I-Biological_structure
the DT I-Biological_structure
right JJ I-Biological_structure
common JJ I-Biological_structure
carotid NN I-Biological_structure
artery NN I-Biological_structure
. . O

The DT O
CT NNP B-Diagnostic_procedure
angiogram NN I-Diagnostic_procedure
showed VBD O
absence NN O
of IN O
flow NN B-Sign_symptom
in IN O
the DT O
right JJ O
subclavian JJ O
artery NN O
, , O
a DT O
very RB B-Severity
tight JJ B-Detailed_description
stenosis NN B-Disease_disorder
at IN O
the DT O
origin NN O
of IN O
the DT O
left JJ O
subclavian JJ O
artery NN O
and CC O
a DT O
tight JJ B-Detailed_description
stenosis NN B-Disease_disorder
at IN O
the DT O
origin NN O
of IN O
the DT O
right JJ O
common JJ O
carotid NN O
artery NN O
. . O

Both DT O
vertebral JJ O
arteries NNS O
showed VBD O
normal JJ B-Lab_value
calibre NN B-Sign_symptom
and CC O
flow NN B-Sign_symptom
( ( O
Figure NNP O
1 CD O
) ) O
. . O

Further JJ B-Therapeutic_procedure
management NN I-Therapeutic_procedure
following VBG O
the DT O
insertion NN O
of IN O
the DT O
femoral JJ B-Diagnostic_procedure
arterial JJ I-Diagnostic_procedure
line NN I-Diagnostic_procedure
was VBD O
based VBN O
on IN O
femoral JJ B-Detailed_description
BP NNP B-Diagnostic_procedure
readings NNS I-Diagnostic_procedure
with IN O
diuretics NNS B-Medication
and CC O
BP NNP B-Medication
- : I-Medication
lowering VBG I-Medication
agents NNS I-Medication
. . O

The DT O
patient NN O
was VBD O
eventually RB O
discharged VBN O
in IN O
stable JJ B-Lab_value
condition NN B-Diagnostic_procedure
. . O

She PRP O
remained VBD O
stable JJ O
during IN B-Duration
the DT I-Duration
eight CD I-Duration
months NNS I-Duration
between IN I-Duration
discharge NN I-Duration
and CC I-Duration
the DT I-Duration
time NN I-Duration
the DT I-Duration
present JJ I-Duration
report NN I-Duration
was VBD I-Duration
written VBN I-Duration
, , O
without IN O
further JJ B-Detailed_description
exacerbation NN I-Detailed_description
of IN O
CHF NNP B-Disease_disorder
or CC O
related VBN O
ER JJ O
visits NNS O
. . O

-DOCSTART- NN -X-

The DT O
institutional JJ O
review NN O
board NN O
( ( O
Chengdu NNP O
Military NNP O
General NNP O
Hospital NNP O
) ) O
approved VBD O
this DT O
work NN O
and CC O
waived VBD O
the DT O
need NN O
for IN O
informed JJ O
consent NN O
. . O

In IN O
2013 CD O
, , O
a DT O
66 CD B-Age
- : I-Age
year NN I-Age
- : I-Age
old JJ I-Age
farmer NN B-Occupation
with IN O
a DT O
history NN O
of IN O
ventricular JJ O
tachycardia NN O
( ( O
VT NNP O
) ) O
and CC O
hypertension NN O
presented VBN O
to TO O
the DT O
Emergency NNP B-Nonbiological_location
Department NNP I-Nonbiological_location
with IN O
continuous JJ B-Detailed_description
palpitation NN B-Sign_symptom
, , O
chest NN B-Sign_symptom
tightness NN I-Sign_symptom
, , O
profuse IN B-Severity
sweating VBG B-Sign_symptom
and CC O
nausea NN B-Sign_symptom
with IN O
no DT O
obvious JJ O
predisposing NN O
causes NNS B-Disease_disorder
. . O

The DT O
patient NN O
experienced VBD O
a DT O
sudden JJ B-Lab_value
drop NN I-Lab_value
in IN O
blood NN B-Diagnostic_procedure
pressure NN I-Diagnostic_procedure
and CC O
acute JJ B-Detailed_description
confusion NN B-Sign_symptom
. . O

After IN O
an DT O
immediate JJ B-Detailed_description
electrical JJ B-Therapeutic_procedure
conversion NN I-Therapeutic_procedure
, , O
his PRP$ O
consciousness NN B-Sign_symptom
was VBD O
gradually RB O
restored VBN O
, , O
and CC O
symptoms NNS B-Sign_symptom
relieved VBN O
. . O

Then RB O
, , O
this DT O
patient NN O
was VBD O
transferred VBN O
to TO O
the DT O
Department NNP B-Nonbiological_location
of IN I-Nonbiological_location
Cardiology NNP I-Nonbiological_location
for IN O
further JJ O
evaluations NNS B-Diagnostic_procedure
and CC O
treatments NNS B-Therapeutic_procedure
. . O

The DT O
patient NN O
` `` O
s JJ O
blood NN B-Diagnostic_procedure
pressure NN I-Diagnostic_procedure
was VBD O
105 CD B-Lab_value
/ JJ I-Lab_value
75 CD I-Lab_value
mm NN I-Lab_value
Hg NNP I-Lab_value
upon IN O
admission NN O
, , O
with IN O
a DT O
heart NN B-Diagnostic_procedure
rate NN I-Diagnostic_procedure
of IN O
75 CD B-Lab_value
beats NNS I-Lab_value
/ JJ I-Lab_value
min NN I-Lab_value
, , O
body NN B-Diagnostic_procedure
temperature NN I-Diagnostic_procedure
of IN O
36 CD B-Lab_value
. . I-Lab_value
6 CD I-Lab_value
°C NN I-Lab_value
and CC O
respiration NN B-Diagnostic_procedure
rate NN I-Diagnostic_procedure
of IN O
18 CD B-Lab_value
times NNS I-Lab_value
/ JJ I-Lab_value
min NN I-Lab_value
. . O

The DT O
heart NN B-Biological_structure
border NN I-Biological_structure
extended VBD B-Sign_symptom
to TO B-Lab_value
the DT I-Lab_value
left NN I-Lab_value
, , O
with IN O
the DT O
apical JJ B-Diagnostic_procedure
impulse NN I-Diagnostic_procedure
located VBN O
in IN O
the DT O
left NN B-Lab_value
5th CD I-Lab_value
intercostal JJ I-Lab_value
space NN I-Lab_value
, , O
1 CD B-Distance
. . I-Distance
0 CD I-Distance
cm JJ I-Distance
lateral JJ I-Distance
to TO I-Distance
the DT I-Distance
midclavicular JJ I-Distance
line NN I-Distance
. . O

The DT O
patient NN O
had VBD O
a DT O
history NN O
of IN O
hypertension NN B-Disease_disorder
over IN O
30 CD B-Duration
years NNS I-Duration
without IN O
regular JJ O
antihypertensive JJ B-Medication
medication NN I-Medication
. . O

The DT O
highest JJS B-Detailed_description
blood NN B-Diagnostic_procedure
pressure NN I-Diagnostic_procedure
was VBD O
170 CD B-Lab_value
/ JJ I-Lab_value
110 CD I-Lab_value
mm NN I-Lab_value
Hg NNP I-Lab_value
. . O

There EX O
was VBD O
no DT O
family NN O
history NN O
of IN O
early JJ O
coronary JJ O
artery NN O
disease NN O
or CC O
sudden JJ O
cardiac JJ O
death NN O
. . O

He PRP O
did VBD O
not RB O
smoke VB B-Activity
cigarettes NNS I-Activity
or CC O
use VB B-Activity
illicit JJ I-Activity
drugs NNS I-Activity
, , O
and CC O
rarely RB O
consumed VBD B-Activity
alcohol NN I-Activity
. . O

He PRP O
also RB O
reported VBD O
no DT O
known JJ O
contacts NNS O
with IN O
sick JJ O
persons NNS O
and CC O
no DT O
recent JJ O
travel NN O
. . O

Twelve NNP B-Detailed_description
- : I-Detailed_description
lead NN I-Detailed_description
surface NN B-Detailed_description
electrocardiogram NN B-Diagnostic_procedure
( ( O
ECG NNP B-Diagnostic_procedure
) ) O
of IN O
VT NNP B-Disease_disorder
indicated VBD O
that IN O
the DT O
origin NN O
of IN O
VT NNP O
was VBD O
at IN O
the DT O
boundary NN B-Biological_structure
between IN I-Biological_structure
right JJ B-Biological_structure
ventricular NN I-Biological_structure
outflow IN I-Biological_structure
tract NN I-Biological_structure
( ( O
RVOT NNP B-Biological_structure
) ) O
and CC O
tricuspid JJ B-Biological_structure
valve NN I-Biological_structure
. . O

When WRB O
VT NNP B-Disease_disorder
increased VBD B-Lab_value
to TO O
150 CD B-Lab_value
beats NNS I-Lab_value
/ VBP I-Lab_value
min NN I-Lab_value
or CC I-Lab_value
higher JJR I-Lab_value
, , O
no DT O
epsilon NN B-Sign_symptom
waves NNS I-Sign_symptom
were VBD O
found VBN O
in IN O
the DT O
precordial JJ B-Diagnostic_procedure
leads NNS I-Diagnostic_procedure
( ( O
Figure1A NNP O
and CC O
B NNP O
) ) O
. . O

In IN O
contrast NN O
, , O
when WRB O
VT NNP B-Disease_disorder
decreased VBD B-Lab_value
to TO O
120 CD B-Lab_value
beats NNS I-Lab_value
/ VBP I-Lab_value
min NN I-Lab_value
or CC I-Lab_value
lower JJR I-Lab_value
, , O
epsilon JJ B-Sign_symptom
waves NNS I-Sign_symptom
appeared VBD O
in IN O
leads NNS B-Diagnostic_procedure
V1 NNP I-Diagnostic_procedure
- : I-Diagnostic_procedure
V2 NNP I-Diagnostic_procedure
( ( O
Figure1C NNP O
) ) O
. . O

Notably RB O
, , O
the DT O
epsilon NN B-Sign_symptom
waves VBZ I-Sign_symptom
preceded VBN B-Lab_value
QRS NNP I-Lab_value
waves NNS I-Lab_value
in IN O
leads NNS B-Diagnostic_procedure
V1 NNP I-Diagnostic_procedure
- : I-Diagnostic_procedure
V2 NNP I-Diagnostic_procedure
, , O
while IN O
endocardiac JJ B-Diagnostic_procedure
tracing NN I-Diagnostic_procedure
confirmed VBD O
that IN O
the DT O
corresponding JJ O
local JJ B-Lab_value
potential NN I-Lab_value
originating VBG O
from IN O
RVOT NNP B-Biological_structure
appeared VBD O
prior RB B-Detailed_description
to TO I-Detailed_description
the DT I-Detailed_description
ventricular JJ I-Detailed_description
rhythm NN I-Detailed_description
( ( O
Figure NNP O
( ( O
Figure1D NNP O
) ) O
. . O
1D CD O
) ) O
. . O

Sinus NNP B-Detailed_description
ECG NNP B-Diagnostic_procedure
in IN O
the DT O
year NN O
of IN O
2013 CD O
suggested VBD O
a DT O
slight JJ B-Lab_value
left JJ I-Lab_value
deviation NN I-Lab_value
of IN O
electric JJ B-Diagnostic_procedure
axis NN I-Diagnostic_procedure
, , O
with IN O
a DT O
heart NN B-Diagnostic_procedure
rate NN I-Diagnostic_procedure
of IN O
87 CD B-Lab_value
beats NNS I-Lab_value
/ VBP I-Lab_value
min NN I-Lab_value
and CC O
flat JJ B-Lab_value
T NNP I-Lab_value
waves NNS I-Lab_value
in IN O
lead JJ B-Diagnostic_procedure
II NNP I-Diagnostic_procedure
. . O

T NNP B-Sign_symptom
wave VBP I-Sign_symptom
inversions NNS I-Sign_symptom
were VBD O
found VBN O
in IN O
leads NNS B-Diagnostic_procedure
III NNP I-Diagnostic_procedure
, , I-Diagnostic_procedure
avF NN I-Diagnostic_procedure
and CC I-Diagnostic_procedure
V1 NNP I-Diagnostic_procedure
- : I-Diagnostic_procedure
V3 NNP I-Diagnostic_procedure
, , O
meanwhile RB O
epsilon NN B-Sign_symptom
waves NNS I-Sign_symptom
were VBD O
found VBN O
following VBG B-Lab_value
QRS NNP I-Lab_value
complex JJ I-Lab_value
in IN O
leads NNS B-Diagnostic_procedure
V1 NNP I-Diagnostic_procedure
- : I-Diagnostic_procedure
V3 NNP I-Diagnostic_procedure
( ( O
Figure NNP O
( ( O
Figure2B NNP O
) ) O
. . O
2B CD O
) ) O
. . O

When WRB O
the DT O
lead NN B-Diagnostic_procedure
avR NN I-Diagnostic_procedure
was VBD O
amplified VBN B-Detailed_description
, , O
epsilon VBP B-Sign_symptom
waves NNS I-Sign_symptom
were VBD O
also RB O
found VBN O
behind IN B-Lab_value
QRS NNP I-Lab_value
waves NNS I-Lab_value
( ( O
Figure NNP O
2C CD O
) ) O
. . O

Atrial JJ B-Biological_structure
premature NN B-Sign_symptom
beats NNS I-Sign_symptom
appeared VBD O
occasionally RB B-Frequency
. . O

Moreover RB O
, , O
ventricular JJ B-Biological_structure
premature NN B-Sign_symptom
beats NNS I-Sign_symptom
were VBD O
also RB O
found VBN O
to TO O
originate VB O
from IN O
the DT O
right JJ B-Biological_structure
ventricular NN I-Biological_structure
apex NN I-Biological_structure
, , O
with IN O
epsilon NN B-Sign_symptom
waves NNS I-Sign_symptom
appearing VBG O
behind IN B-Lab_value
QRS NNP I-Lab_value
waves NNS I-Lab_value
( ( O
Figure NNP O
( ( O
Figure2B NNP O
) ) O
. . O
2B CD O
) ) O
. . O

In IN O
contrast NN O
, , O
sinus CC B-Biological_structure
ECG NNP B-Diagnostic_procedure
obtained VBD O
in IN O
the DT O
year NN O
of IN O
1999 CD O
revealed VBD O
similar JJ O
left JJ B-Lab_value
deviation NN I-Lab_value
of IN O
electric JJ B-Diagnostic_procedure
axis NN I-Diagnostic_procedure
, , O
flat JJ B-Sign_symptom
T NNP I-Sign_symptom
waves NNS I-Sign_symptom
and CC O
T NNP B-Sign_symptom
wave VBP I-Sign_symptom
inversions NNS I-Sign_symptom
, , O
but CC O
absence NN O
of IN O
epsilon NN B-Sign_symptom
waves NNS I-Sign_symptom
( ( O
Figure NNP O
( ( O
Figure2A NNP O
) ) O
. . O
2A CD O
) ) O
. . O

Data NNS O
from IN O
biochemical JJ B-Diagnostic_procedure
assays NNS I-Diagnostic_procedure
were VBD O
as IN O
follows VBZ O
: : O
cardiac JJ B-Diagnostic_procedure
troponin NN I-Diagnostic_procedure
I PRP I-Diagnostic_procedure
level VBP O
was VBD O
0 CD B-Lab_value
. . I-Lab_value
714 CD I-Lab_value
μg JJ I-Lab_value
/ NN I-Lab_value
L NNP I-Lab_value
( ( O
normal JJ O
range NN O
, , O
0 CD O
- : O
0 CD O
. . O
06 CD O
μg JJ O
/ NNP O
L NNP O
) ) O
, , O
serum NN B-Diagnostic_procedure
B NNP I-Diagnostic_procedure
- : I-Diagnostic_procedure
type NN I-Diagnostic_procedure
natriuretic JJ I-Diagnostic_procedure
peptide NN I-Diagnostic_procedure
level NN O
was VBD O
466 CD B-Lab_value
. . I-Lab_value
530 CD I-Lab_value
pg JJ I-Lab_value
/ NN I-Lab_value
mL NN I-Lab_value
( ( O
normal JJ O
range NN O
, , O
0 CD O
- : O
100 CD O
pg NN O
/ NNP O
mL NN O
) ) O
, , O
serum JJ B-Diagnostic_procedure
d SYM I-Diagnostic_procedure
- : I-Diagnostic_procedure
dimer NN I-Diagnostic_procedure
level NN O
was VBD O
8 CD B-Lab_value
. . I-Lab_value
14 CD I-Lab_value
mg JJ I-Lab_value
/ NN I-Lab_value
L NNP I-Lab_value
( ( O
normal JJ O
range NN O
, , O
0 CD O
- : O
0 CD O
. . O
55 CD O
mg JJ O
/ NNP O
L NNP O
) ) O
, , O
blood VBD B-Diagnostic_procedure
urea JJ I-Diagnostic_procedure
level NN O
was VBD O
11 CD B-Lab_value
. . I-Lab_value
69 CD I-Lab_value
mmol JJ I-Lab_value
/ NN I-Lab_value
L NNP I-Lab_value
( ( O
normal JJ O
range NN O
, , O
2 CD O
. . O
90 CD O
- : O
7 CD O
. . O
20 CD O
mmol JJ O
/ NNP O
L NNP O
) ) O
, , O
serum JJ B-Diagnostic_procedure
creatinine NN I-Diagnostic_procedure
level NN O
was VBD O
144 CD B-Lab_value
. . I-Lab_value
00 CD I-Lab_value
μmol JJ I-Lab_value
/ NN I-Lab_value
L NNP I-Lab_value
( ( O
normal JJ O
range NN O
, , O
44 CD O
- : O
133 CD O
μmol JJ O
/ NNP O
L NNP O
) ) O
, , O
serum JJ B-Diagnostic_procedure
uric JJ I-Diagnostic_procedure
acid NN I-Diagnostic_procedure
level NN O
was VBD O
611 CD B-Lab_value
. . I-Lab_value
40 CD I-Lab_value
μmol JJ I-Lab_value
/ NN I-Lab_value
L NNP I-Lab_value
( ( O
normal JJ O
range NN O
, , O
100 CD O
- : O
432 CD O
μmol JJ O
/ NNP O
L NNP O
) ) O
, , O
and CC O
endogenous JJ B-Diagnostic_procedure
creatinine NN I-Diagnostic_procedure
clearing VBG I-Diagnostic_procedure
value NN O
was VBD O
57 CD B-Lab_value
. . I-Lab_value
90 CD I-Lab_value
mL JJ I-Lab_value
/ NNP I-Lab_value
min NN I-Lab_value
( ( O
normal JJ O
range NN O
, , O
> VBZ O
80 CD O
mL NN O
/ NNP O
min NN O
) ) O
. . O

Echo NNP B-Diagnostic_procedure
data NNS O
revealed VBD O
remarkably RB B-Severity
enlarged VBN B-Sign_symptom
right JJ B-Biological_structure
atrium NN I-Biological_structure
and CC O
right JJ B-Biological_structure
ventricle NN I-Biological_structure
, , O
and CC O
widened VBD B-Sign_symptom
ROVT NNP B-Biological_structure
. . O

Uncoordinated JJ B-Sign_symptom
motions NNS I-Sign_symptom
of IN O
the DT O
left NN B-Biological_structure
and CC I-Biological_structure
right JJ I-Biological_structure
ventricular NN I-Biological_structure
walls NNS I-Biological_structure
were VBD O
also RB O
detected VBN O
. . O

Moreover RB O
, , O
we PRP O
also RB O
found VBD O
aortic JJ B-Biological_structure
valve NNS I-Biological_structure
degradation NN B-Sign_symptom
with IN O
slight JJ B-Severity
regurgitation NN B-Sign_symptom
, , O
slight JJ B-Severity
mitral JJ B-Biological_structure
regurgitation NN B-Sign_symptom
, , O
and CC O
moderate VB B-Severity
to TO I-Severity
severe VB I-Severity
tricuspid JJ B-Biological_structure
regurgitation NN B-Sign_symptom
. . O

The DT O
left NN B-Diagnostic_procedure
ventricular JJ I-Diagnostic_procedure
diastolic JJ I-Diagnostic_procedure
function NN I-Diagnostic_procedure
was VBD O
reduced VBN B-Lab_value
to TO O
55 CD B-Lab_value
% NN I-Lab_value
( ( O
Figure NNP O
3A CD O
and CC O
B NNP O
) ) O
. . O

The DT O
coronary JJ B-Diagnostic_procedure
angiogram NN I-Diagnostic_procedure
revealed VBD O
no DT O
vascular JJ B-Disease_disorder
stenosis NN I-Disease_disorder
( ( O
Figure NNP O
3C CD O
- : O
E NN O
) ) O
. . O

Based VBN O
on IN O
the DT O
above JJ O
- : O
mentioned JJ O
examinations NNS O
, , O
this DT O
patient NN O
met VBD O
at IN O
least JJS O
2 CD O
major JJ O
criteria NNS O
, , O
the DT O
bilateral JJ O
ventricular JJ O
dilation NN O
and CC O
the DT O
existence NN O
of IN O
epsilon NN O
waves NNS O
, , O
providing VBG O
diagnostic JJ O
support NN O
for IN O
ARVC NNP B-Disease_disorder
. . O

A DT O
diet JJ B-Therapeutic_procedure
with IN O
low JJ B-Detailed_description
salt NNS I-Detailed_description
and CC O
low JJ B-Detailed_description
fat NN I-Detailed_description
was VBD O
suggested VBN O
. . O

The DT O
patient NN O
was VBD O
also RB O
treated VBN O
with IN O
metoprolol JJ B-Medication
succinate NN I-Medication
sustained VBN O
- : O
release NN O
tablets NNS O
( ( O
23 CD B-Dosage
. . I-Dosage
75 CD I-Dosage
mg JJ I-Dosage
daily RB I-Dosage
, , O
p NN O
. . O
o NN O
. . O
) ) O
, , O
amiodarone NN B-Medication
( ( O
200 CD B-Dosage
mg NNS I-Dosage
daily RB I-Dosage
, , O
p NN O
. . O
o NN O
. . O
) ) O
, , O
furosemide RB B-Medication
( ( O
20 CD B-Dosage
mg NNS I-Dosage
daily RB I-Dosage
, , O
i NN O
. . O
v NN O
. . O
) ) O
, , O
and CC O
compound NN B-Detailed_description
α NNP B-Medication
- : I-Medication
ketoacid NN I-Medication
tablets NNS O
( ( O
2 CD B-Dosage
. . I-Dosage
52 CD I-Dosage
g JJ I-Dosage
daily RB I-Dosage
, , O
p NN O
. . O
o NN O
. . O
) ) O
. . O

Moreover RB O
, , O
VTs NNP B-Disease_disorder
with IN O
different JJ B-Detailed_description
morphologies NNS I-Detailed_description
and CC I-Detailed_description
cycle NN I-Detailed_description
lengths NNS I-Detailed_description
were VBD O
found VBN O
during IN O
radiofrequency NN B-Therapeutic_procedure
ablation NN I-Therapeutic_procedure
( ( O
Figure NNP O
4 CD O
) ) O
. . O

The DT O
substrate NN B-Diagnostic_procedure
voltage NN I-Diagnostic_procedure
mapping NN I-Diagnostic_procedure
revealed VBD O
that IN O
the DT O
anterior JJ B-Biological_structure
wall NN I-Biological_structure
of IN I-Biological_structure
RVOT NNP I-Biological_structure
was VBD O
wrapped VBN O
by IN O
circular JJ B-Shape
scar NN B-Sign_symptom
( ( O
Figure NNP O
5A CD O
) ) O
. . O

Considering VBG O
the DT O
association NN O
of IN O
VT NNP O
with IN O
scar NN O
areas NNS O
, , O
substrate JJ B-Therapeutic_procedure
ablation NN I-Therapeutic_procedure
was VBD O
chosen VBN O
for IN O
this DT O
patient NN O
. . O

The DT O
residual JJ O
potentials NNS O
in IN O
the DT O
scar NN O
areas NNS O
were VBD O
searched VBN O
, , O
and CC O
then RB O
linear JJ B-Detailed_description
and CC O
focal JJ B-Detailed_description
ablations NNS B-Therapeutic_procedure
were VBD O
performed VBN O
( ( O
Figure NNP O
5B CD O
) ) O
. . O

Neither DT O
programmed JJ B-Detailed_description
stimulation NN B-Diagnostic_procedure
nor CC O
induced JJ B-Detailed_description
stimulation NN B-Diagnostic_procedure
could MD O
induce VB O
VT NNP B-Disease_disorder
after IN O
the DT O
procedure NN O
was VBD O
completed VBN O
, , O
indicating VBG O
the DT O
success NN O
of IN O
operation NN O
. . O

The DT O
ECG NNP B-Diagnostic_procedure
after IN O
radiofrequency NN O
ablation NN O
showed VBD O
sinus JJ B-Sign_symptom
rhythm NN I-Sign_symptom
, , O
with IN O
a DT O
heart NN B-Diagnostic_procedure
rate NN I-Diagnostic_procedure
of IN O
61 CD B-Lab_value
beats NNS I-Lab_value
/ JJ I-Lab_value
min NN I-Lab_value
, , O
T NNP B-Sign_symptom
wave VBP I-Sign_symptom
inversions NNS I-Sign_symptom
in IN O
leads NNS B-Diagnostic_procedure
III NNP I-Diagnostic_procedure
and CC I-Diagnostic_procedure
avF NN I-Diagnostic_procedure
, , O
and CC O
epsilon NN B-Sign_symptom
waves NNS I-Sign_symptom
and CC O
T NNP B-Sign_symptom
wave VBP I-Sign_symptom
inversions NNS I-Sign_symptom
in IN O
leads NNS B-Diagnostic_procedure
V1 NNP I-Diagnostic_procedure
- : I-Diagnostic_procedure
V3 NNP I-Diagnostic_procedure
( ( O
Figure NNP O
2D CD O
) ) O
. . O

This DT O
patient NN O
was VBD O
discharged VBN O
from IN O
hospital NN B-Nonbiological_location
on IN O
day NN O
9 CD O
with IN O
a DT O
regimen NNS O
of IN O
metoprolol NN B-Medication
succinate NN I-Medication
sustained VBN O
- : O
release NN O
tablets NNS O
( ( O
23 CD B-Dosage
. . I-Dosage
75 CD I-Dosage
mg JJ I-Dosage
daily RB I-Dosage
, , O
p NN O
. . O
o NN O
. . O
) ) O
, , O
amiodarone JJ B-Medication
hydrochloride NN I-Medication
tablets NNS O
( ( O
200 CD B-Dosage
mg NNS I-Dosage
daily RB I-Dosage
, , O
p NN O
. . O
o NN O
. . O
) ) O
, , O
spironolactone JJ B-Medication
tablets NNS O
( ( O
40 CD B-Dosage
mg NNS I-Dosage
daily RB I-Dosage
, , O
p NN O
. . O
o NN O
. . O
) ) O
, , O
and CC O
fosinopril JJ B-Medication
sodium NN I-Medication
tablets NNS O
( ( O
10 CD B-Dosage
mg NNS I-Dosage
daily RB I-Dosage
, , O
p NN O
. . O
o NN O
. . O
) ) O
. . O

The DT O
patient NN O
was VBD O
followed VBN O
up RP O
3 CD O
months NNS O
after IN O
discharge NN O
. . O

He PRP O
had VBD O
no DT O
recurrent JJ O
palpitation NN B-Sign_symptom
, , O
chest NN B-Biological_structure
tightness NN B-Sign_symptom
, , O
profuse VBP B-Severity
sweating VBG B-Sign_symptom
or CC O
nausea NN B-Sign_symptom
. . O

Although IN B-Other_entity
ARVC NNP I-Other_entity
was VBD I-Other_entity
the DT I-Other_entity
main JJ I-Other_entity
diagnosis NN I-Other_entity
at IN I-Other_entity
the DT I-Other_entity
time NN I-Other_entity
of IN I-Other_entity
this DT I-Other_entity
patient NN I-Other_entity
` `` I-Other_entity
s JJ I-Other_entity
initial JJ I-Other_entity
presentation NN I-Other_entity
, , I-Other_entity
it PRP I-Other_entity
is VBZ I-Other_entity
essential JJ I-Other_entity
in IN I-Other_entity
such JJ I-Other_entity
cases NNS I-Other_entity
to TO I-Other_entity
perform VB I-Other_entity
a DT I-Other_entity
reassessment NN I-Other_entity
for IN I-Other_entity
the DT I-Other_entity
presence NN I-Other_entity
of IN I-Other_entity
structural JJ I-Other_entity
heart NN I-Other_entity
disease NN I-Other_entity
, , I-Other_entity
which WDT I-Other_entity
can MD I-Other_entity
evolve VB I-Other_entity
over IN I-Other_entity
time NN I-Other_entity
. . O

-DOCSTART- NN -X-

A DT O
33 CD B-Age
- : I-Age
year NN I-Age
- : I-Age
old JJ I-Age
man NN O
presented VBN O
with IN O
left JJ B-Biological_structure
flank NN I-Biological_structure
dull JJ B-Detailed_description
ache NN B-Sign_symptom
. . O

On IN O
the DT O
abdominal JJ B-Biological_structure
computed JJ B-Diagnostic_procedure
tomography NN I-Diagnostic_procedure
, , O
a DT O
solid JJ B-Detailed_description
renal JJ B-Biological_structure
mass NN B-Sign_symptom
in IN O
the DT O
upper JJ B-Biological_structure
portion NN I-Biological_structure
of IN I-Biological_structure
the DT I-Biological_structure
left JJ I-Biological_structure
kidney NN I-Biological_structure
was VBD O
identified VBN O
. . O

The DT O
mass NN O
was VBD O
measured VBN O
2 CD B-Volume
. . I-Volume
8 CD I-Volume
cm NN I-Volume
× VBD I-Volume
2 CD I-Volume
. . I-Volume
8 CD I-Volume
cm NN I-Volume
× VBD I-Volume
2 CD I-Volume
. . I-Volume
5 CD I-Volume
cm NN I-Volume
in IN O
size NN O
, , O
was VBD O
well RB B-Detailed_description
- : I-Detailed_description
defined VBN I-Detailed_description
. . O

The DT O
patient NN O
had VBD O
no DT O
other JJ B-Sign_symptom
abnormal JJ I-Sign_symptom
findings NNS I-Sign_symptom
, , O
such JJ O
as IN O
suspected JJ O
distant JJ B-Detailed_description
metastasis NN B-Sign_symptom
or CC O
lymph NN B-Biological_structure
node JJ I-Biological_structure
metastasis NN B-Sign_symptom
. . O

Radical JJ B-Detailed_description
nephrectomy NN B-Therapeutic_procedure
was VBD O
performed VBN O
on IN O
14 CD O
/ JJ O
9 CD O
/ JJ O
2005 CD O
. . O

On IN O
gross JJ B-Diagnostic_procedure
examination NN I-Diagnostic_procedure
, , O
the DT O
nephrectomy JJ B-Detailed_description
specimen NNS I-Detailed_description
measured VBD O
11 CD B-Volume
. . I-Volume
5 CD I-Volume
cm NN I-Volume
× VBD I-Volume
6 CD I-Volume
. . I-Volume
5 CD I-Volume
cm NN I-Volume
× VBD I-Volume
4 CD I-Volume
. . I-Volume
5 CD I-Volume
cm NN I-Volume
and CC O
the DT O
tumor NN O
was VBD O
a DT O
solid JJ B-Detailed_description
, , O
grayish JJ B-Color
- : I-Color
brown JJ I-Color
mass NN O
measured VBD O
3 CD B-Volume
. . I-Volume
5 CD I-Volume
cm NN I-Volume
× VBD I-Volume
2 CD I-Volume
. . I-Volume
5 CD I-Volume
cm NN I-Volume
× VBD I-Volume
2 CD I-Volume
. . I-Volume
2 CD I-Volume
cm NN I-Volume
in IN O
size NN O
. . O

Histologic NNP B-Diagnostic_procedure
examination NN I-Diagnostic_procedure
demonstrated VBD O
trabecular JJ B-Lab_value
and CC I-Lab_value
ribbonlike JJ I-Lab_value
patterns NNS I-Lab_value
with IN O
minimal JJ B-Lab_value
fibrotic JJ I-Lab_value
stroma NN I-Lab_value
. . O

The DT O
cytoplasm NN B-Diagnostic_procedure
was VBD O
granular JJ B-Lab_value
and CC O
eosinophilic JJ B-Lab_value
with IN O
uniform JJ B-Lab_value
round NN I-Lab_value
to TO I-Lab_value
oval VB I-Lab_value
nuclei JJ I-Lab_value
with IN O
finely RB B-Lab_value
stippled VBN I-Lab_value
chromatin NN I-Lab_value
and CC O
inconspicuous JJ B-Lab_value
nucleoli NNS I-Lab_value
. . O

Mitoses NNS B-Diagnostic_procedure
were VBD O
not RB B-Lab_value
found VBN I-Lab_value
( ( O
0 CD B-Lab_value
per IN I-Lab_value
10 CD I-Lab_value
high JJ I-Lab_value
- : I-Lab_value
power NN I-Lab_value
fields NNS I-Lab_value
) ) O
on IN O
H&E NNP B-Diagnostic_procedure
stain NN I-Diagnostic_procedure
. . O

The DT O
final JJ O
pathologic NN B-Diagnostic_procedure
examination NN I-Diagnostic_procedure
revealed VBD O
a DT O
well RB B-Detailed_description
- : I-Detailed_description
differentiated VBN I-Detailed_description
neuroendocrine NN B-Disease_disorder
( ( I-Disease_disorder
carcinoid NN I-Disease_disorder
) ) I-Disease_disorder
tumor NN I-Disease_disorder
confined VBD O
to TO O
the DT O
kidney NN B-Biological_structure
( ( O
Fig NNP O
. . O
1 CD O
) ) O
. . O

Immunohistochemical JJ B-Diagnostic_procedure
stains NNS I-Diagnostic_procedure
demonstrated VBD O
labeling VBG B-Lab_value
with IN O
chromogranin NN B-Diagnostic_procedure
, , O
neuron SYM B-Diagnostic_procedure
- : I-Diagnostic_procedure
specific JJ I-Diagnostic_procedure
enolase NN I-Diagnostic_procedure
and CC O
synaptophysin NN B-Diagnostic_procedure
( ( O
Fig NNP O
. . O
2 CD O
) ) O
, , O
and CC O
the DT O
proliferation NN B-Diagnostic_procedure
index NN I-Diagnostic_procedure
was VBD O
less JJR B-Lab_value
than IN I-Lab_value
2 CD I-Lab_value
% NN I-Lab_value
as IN O
measured VBN O
by IN O
immunohistochemistry NN B-Diagnostic_procedure
for IN I-Diagnostic_procedure
Ki NNP I-Diagnostic_procedure
- : I-Diagnostic_procedure
67 CD I-Diagnostic_procedure
. . O

Further JJ O
radiation NN B-Therapeutic_procedure
and CC O
chemotherapy NN B-Medication
were VBD O
not RB O
received VBN O
. . O

Nine CD O
years NNS O
after IN O
radical JJ O
nephrectomy NN O
, , O
computed VBD B-Diagnostic_procedure
tomography NN I-Diagnostic_procedure
of IN O
the DT O
abdomen NNS B-Biological_structure
demonstrated VBD O
a DT O
2 CD B-Area
cm NN I-Area
× VBD I-Area
1 CD I-Area
. . I-Area
8 CD I-Area
cm JJ I-Area
cyst NN B-Detailed_description
mass NN B-Sign_symptom
in IN O
the DT O
right JJ B-Biological_structure
liver NN I-Biological_structure
and CC O
multiple JJ B-Detailed_description
high JJ B-Sign_symptom
density NN I-Sign_symptom
shadow NN I-Sign_symptom
in IN O
gallbladder NN B-Biological_structure
. . O

No DT O
enlarged JJ B-Sign_symptom
lymph NN B-Biological_structure
nodes NNS I-Biological_structure
were VBD O
found VBN O
in IN O
the DT O
abdominal JJ B-Biological_structure
cavity NN I-Biological_structure
. . O

Cholecystectomy NNP B-Therapeutic_procedure
and CC O
extirpation NN B-Therapeutic_procedure
for IN O
hepatic JJ B-Disease_disorder
cyst NN I-Disease_disorder
were VBD O
performed VBN O
by IN O
laparoscopy NN B-Therapeutic_procedure
surgery NN I-Therapeutic_procedure
. . O

Histologic NNP B-Diagnostic_procedure
examination NN I-Diagnostic_procedure
demonstrated VBD O
trabecular JJ B-Lab_value
and CC I-Lab_value
glandlike JJ I-Lab_value
growth NN I-Lab_value
( ( O
Fig NNP O
. . O
3 CD O
) ) O
, , O
moderate JJ B-Lab_value
and CC I-Lab_value
uniform JJ I-Lab_value
nuclei NN I-Lab_value
and CC O
mitoses NNS B-Diagnostic_procedure
were VBD B-Lab_value
n`t JJ I-Lab_value
found VBN I-Lab_value
( ( O
0 CD B-Lab_value
per IN I-Lab_value
10 CD I-Lab_value
high JJ I-Lab_value
- : I-Lab_value
power NN I-Lab_value
fields NNS I-Lab_value
) ) O
. . O

Advanced NNP B-Detailed_description
immunohistochemistry NN B-Diagnostic_procedure
revealed VBD O
that IN O
the DT O
lesion NN O
was VBD O
positive JJ B-Lab_value
for IN O
synaptophysin NN B-Diagnostic_procedure
( ( O
Fig NNP O
. . O
4 CD O
) ) O
and CC O
CD56 NNP O
, , O
but CC O
negative JJ B-Lab_value
for IN O
chromogranin NN B-Diagnostic_procedure
and CC O
neuron NN B-Diagnostic_procedure
- : I-Diagnostic_procedure
specific JJ I-Diagnostic_procedure
enolase NN I-Diagnostic_procedure
. . O

These DT O
features NNS O
are VBP O
supported VBN O
in IN O
a DT O
neuroendocrine JJ B-Disease_disorder
tumor NN I-Disease_disorder
. . O

Due JJ O
to TO O
the DT O
similar JJ O
pathologic NN O
characteristics NNS O
between IN O
the DT O
primary JJ O
renal JJ O
carcinoid NN O
tumor NN O
and CC O
liver JJ O
tumor NN O
. . O

The DT O
final JJ O
pathology NN O
report NN O
indicated VBD O
a DT O
carcinoid JJ B-Disease_disorder
tumor NN I-Disease_disorder
of IN O
the DT O
left JJ B-Biological_structure
kidney NN I-Biological_structure
with IN O
liver JJ B-Biological_structure
metastasis NN B-Sign_symptom
. . O

-DOCSTART- NN -X-

The DT O
patient NN O
is VBZ O
a DT O
57 CD B-Age
- : I-Age
year NN I-Age
- : I-Age
old JJ I-Age
woman NN O
who WP O
had VBD O
noted VBN O
a DT O
rapidly RB B-Lab_value
enlarging VBG I-Lab_value
mass NN B-Sign_symptom
on IN O
the DT O
left JJ B-Biological_structure
side NN I-Biological_structure
of IN I-Biological_structure
her PRP$ I-Biological_structure
neck NN I-Biological_structure
in IN O
2010 CD O
. . O

She PRP O
underwent VBD O
a DT O
total JJ B-Detailed_description
thyroidectomy NN B-Therapeutic_procedure
and CC O
central JJ B-Biological_structure
neck NN I-Biological_structure
dissection NN B-Therapeutic_procedure
, , O
which WDT O
revealed VBD O
a DT O
3 CD B-Distance
. . I-Distance
8 CD I-Distance
- : I-Distance
cm NN I-Distance
anaplastic JJ B-Detailed_description
thyroid NN B-Disease_disorder
cancer NN I-Disease_disorder
arising VBG O
in IN O
a DT O
background NN O
of IN O
an DT O
oncocytic JJ B-Detailed_description
variant NN I-Detailed_description
of IN O
poorly RB B-Detailed_description
differentiated VBN I-Detailed_description
thyroid JJ B-Disease_disorder
cancer NN I-Disease_disorder
( ( O
Fig NNP O
. . O
1A CD O
, , O
and CC O
Fig NNP O
. . O
S1 NNP O
in IN O
Supplementary NNP O
Appendix NNP O
1 CD O
, , O
available JJ O
with IN O
the DT O
full JJ O
text NN O
of IN O
this DT O
article NN O
at IN O
NEJM NNP O
. . O
org NN O
) ) O
. . O

Resection NN B-Diagnostic_procedure
margins NNS I-Diagnostic_procedure
were VBD O
positive JJ B-Lab_value
, , O
and CC O
3 CD B-Lab_value
of IN I-Lab_value
12 CD I-Lab_value
lymph NN B-Biological_structure
nodes NNS I-Biological_structure
were VBD O
involved VBN B-Sign_symptom
. . O

At IN O
3 CD O
weeks NNS O
after IN O
surgery NN O
, , O
the DT O
serum NN B-Detailed_description
thyroglobulin NN B-Diagnostic_procedure
level NN O
was VBD O
17 CD B-Lab_value
. . I-Lab_value
2 CD I-Lab_value
ng JJ I-Lab_value
per IN I-Lab_value
milliliter NN I-Lab_value
, , O
with IN O
undetectable JJ B-Lab_value
thyroglobulin NN B-Diagnostic_procedure
antibodies NNS I-Diagnostic_procedure
. . O

The DT O
patient NN O
received VBD O
concurrent JJ O
radiation NN B-Therapeutic_procedure
therapy NN I-Therapeutic_procedure
and CC O
weekly JJ O
carboplatin NN B-Medication
and CC O
paclitaxel NN B-Medication
chemotherapy NN B-Medication
. . O

The DT O
serum NN B-Detailed_description
thyroglobulin NN B-Diagnostic_procedure
level NN O
at IN O
4 CD O
weeks NNS O
after IN O
the DT O
completion NN O
of IN O
chemotherapy NN O
and CC O
radiation NN O
therapy NN O
was VBD O
12 CD B-Lab_value
. . I-Lab_value
0 CD I-Lab_value
ng JJ I-Lab_value
per IN I-Lab_value
milliliter NN I-Lab_value
. . O

Restaging VBG O
scans NNS B-Diagnostic_procedure
obtained VBD O
3 CD O
months NNS O
later RB O
revealed VBD O
a DT O
new JJ O
, , O
right JJ B-Biological_structure
- : I-Biological_structure
sided VBD I-Biological_structure
hilar JJ I-Biological_structure
mass NN B-Sign_symptom
( ( O
Fig NNP O
. . O
1C CD O
) ) O
, , O
and CC O
the DT O
patient NN O
enrolled VBD O
in IN O
a DT O
phase NN B-Detailed_description
2 CD I-Detailed_description
clinical JJ O
trial NN O
of IN O
everolimus NN B-Medication
, , O
which WDT O
was VBD O
administered VBN O
at IN O
a DT O
dose NN O
of IN O
10 CD B-Dosage
mg JJ I-Dosage
daily RB I-Dosage
. . O

Within IN O
6 CD O
months NNS O
, , O
follow VBP O
- : O
up RB O
scans NNS B-Diagnostic_procedure
showed VBD O
that IN O
the DT O
lesion NN O
had VBD O
greatly RB O
diminished VBN B-Sign_symptom
in IN I-Sign_symptom
size NN I-Sign_symptom
( ( O
from IN O
3 CD B-Area
. . I-Area
0 CD I-Area
by IN I-Area
2 CD I-Area
. . I-Area
6 CD I-Area
cm NN I-Area
to TO O
1 CD B-Area
. . I-Area
1 CD I-Area
by IN I-Area
0 CD I-Area
. . I-Area
8 CD I-Area
cm NN I-Area
) ) O
( ( O
Fig NNP O
. . O
1D CD O
) ) O
. . O

After IN O
18 CD B-Duration
months NNS I-Duration
of IN O
a DT O
sustained JJ O
response NN B-Sign_symptom
to TO O
everolimus VB B-Medication
, , O
scans NNS B-Diagnostic_procedure
revealed VBD O
progressive JJ B-Disease_disorder
disease NN I-Disease_disorder
( ( O
Fig NNP O
. . O
1E CD O
) ) O
. . O

The DT O
patient NN O
underwent NN O
a DT O
mediastinoscopy NN B-Diagnostic_procedure
with IN O
removal NN B-Therapeutic_procedure
of IN O
an DT O
enlarged JJ B-Sign_symptom
lymph NN B-Biological_structure
node NN I-Biological_structure
, , O
which WDT O
contained VBD O
metastatic JJ B-Detailed_description
anaplastic JJ B-Detailed_description
thyroid NN B-Disease_disorder
cancer NN I-Disease_disorder
( ( O
Fig NNP O
. . O
1B CD O
, , O
and CC O
Fig NNP O
. . O
S1 NNP O
in IN O
Supplementary NNP O
Appendix NNP O
1 CD O
) ) O
. . O

Whole JJ B-Detailed_description
- : I-Detailed_description
exome NN I-Detailed_description
sequencing NN B-Diagnostic_procedure
was VBD O
performed VBN O
on IN O
biopsy NN B-Diagnostic_procedure
samples NNS O
of IN O
the DT O
pretreatment NN B-Detailed_description
and CC I-Detailed_description
resistant JJ I-Detailed_description
tumors NNS I-Detailed_description
as RB O
well RB O
as IN O
on IN O
a DT O
blood NN B-Detailed_description
sample NN I-Detailed_description
. . O

-DOCSTART- NN -X-

A DT O
woman NN O
in IN O
her PRP$ O
early JJ B-Age
70s CD I-Age
presented VBN O
to TO O
our PRP$ O
emergency NN B-Nonbiological_location
room NN I-Nonbiological_location
30 CD B-Time
min NN I-Time
after IN I-Time
her PRP$ O
husband NN O
expired VBD O
with IN O
8 CD B-Lab_value
/ NNS I-Lab_value
10 CD I-Lab_value
, , O
substernal JJ B-Biological_structure
chest NN B-Biological_structure
pain NN B-Sign_symptom
with IN O
concurrent JJ O
diaphoresis NN B-Sign_symptom
and CC O
dyspnoea NN B-Sign_symptom
. . O

The DT O
patient NN O
` `` O
s JJ O
husband NN O
had VBD O
an DT O
out RP B-Detailed_description
- : I-Detailed_description
of IN I-Detailed_description
- : I-Detailed_description
hospital NN I-Detailed_description
cardiac NN I-Detailed_description
arrest NN I-Detailed_description
earlier RBR B-Time
that DT I-Time
day NN I-Time
and CC O
was VBD O
brought VBN B-Detailed_description
to TO I-Detailed_description
our PRP$ I-Detailed_description
emergency NN I-Detailed_description
room NN I-Detailed_description
and CC O
subsequently RB O
admitted VBN B-Detailed_description
to TO I-Detailed_description
the DT I-Detailed_description
coronary JJ I-Detailed_description
care NN I-Detailed_description
unit NN I-Detailed_description
. . O

He PRP O
had VBD O
recurrent JJ B-Detailed_description
ventricular JJ I-Detailed_description
fibrillation NN I-Detailed_description
and CC O
could MD B-Detailed_description
not RB I-Detailed_description
be VB I-Detailed_description
successfully RB I-Detailed_description
resuscitated VBN I-Detailed_description
. . O

The DT O
patient NN O
` `` O
s JJ O
medical JJ O
history NN O
included VBD O
hypertension NN O
and CC O
hypothyroidism NN O
. . O

She PRP O
denied VBD O
having VBG O
had VBD O
a DT O
similar JJ O
episode NN O
of IN O
pain NN O
. . O

She PRP O
had VBD O
regular JJ O
appointments NNS O
with IN O
her PRP$ O
primary JJ O
care NN O
physician NN O
. . O

Her PRP$ O
medication NN B-Medication
included VBD O
oral JJ O
furosemide RB B-Medication
20 CD B-Dosage
mg NNS I-Dosage
and CC O
levothyroxine JJ B-Medication
100 CD B-Dosage
µg NN I-Dosage
, , O
both DT O
once RB B-Dosage
daily JJ I-Dosage
. . O

She PRP O
denied VBD O
allergies NNS O
. . O

On IN O
presentation NN O
, , O
the DT O
patient NN O
was VBD O
afebrile JJ B-Sign_symptom
, , O
with IN O
a DT O
blood NN B-Diagnostic_procedure
pressure NN I-Diagnostic_procedure
of IN O
105 CD B-Lab_value
/ JJ I-Lab_value
55 CD I-Lab_value
, , O
heart NN B-Diagnostic_procedure
rate NN I-Diagnostic_procedure
of IN O
93 CD B-Lab_value
bpm NN I-Lab_value
, , O
respiratory JJ B-Diagnostic_procedure
rate NN I-Diagnostic_procedure
of IN O
20 CD B-Lab_value
/ JJ I-Lab_value
min NN I-Lab_value
and CC O
an DT O
oxygen NN B-Diagnostic_procedure
saturation NN I-Diagnostic_procedure
of IN O
98 CD B-Lab_value
% NN I-Lab_value
on IN O
room NN B-Detailed_description
air NN I-Detailed_description
. . O

On IN O
physical JJ B-Diagnostic_procedure
examination NN I-Diagnostic_procedure
, , O
she PRP O
was VBD O
in IN O
significant JJ B-Severity
distress NN B-Sign_symptom
due JJ O
to TO O
pain VB B-Sign_symptom
. . O

Her PRP$ O
skin NN B-Diagnostic_procedure
was VBD O
warm JJ B-Lab_value
and CC O
moist NN B-Lab_value
, , O
with IN O
minimal JJ B-Lab_value
crackles NNS I-Lab_value
in IN O
bilateral JJ B-Diagnostic_procedure
bases NNS I-Diagnostic_procedure
, , O
regular JJ B-Lab_value
rate NN B-Diagnostic_procedure
and CC I-Diagnostic_procedure
rhythm NN I-Diagnostic_procedure
, , O
2 CD B-Lab_value
/ NN I-Lab_value
6 CD I-Lab_value
systolic JJ I-Lab_value
murmur NN B-Sign_symptom
of IN B-Detailed_description
the DT I-Detailed_description
apex NN I-Detailed_description
without IN I-Detailed_description
radiation NN I-Detailed_description
, , O
no DT O
rubs NN B-Sign_symptom
, , O
elevated VBD B-Lab_value
jugular JJ B-Biological_structure
vein JJ I-Biological_structure
distention NN B-Sign_symptom
of IN O
8 CD B-Distance
cm NN I-Distance
, , O
strong JJ B-Lab_value
peripheral JJ B-Detailed_description
pulses NNS B-Diagnostic_procedure
and CC O
no DT O
peripheral JJ B-Detailed_description
oedema NN B-Sign_symptom
. . O

The DT O
abdomen NNS B-Diagnostic_procedure
was VBD O
soft JJ B-Lab_value
, , O
non JJ B-Lab_value
- : I-Lab_value
tender NN I-Lab_value
, , O
non SYM B-Lab_value
- : I-Lab_value
distended VBN I-Lab_value
, , O
with IN B-Lab_value
bowel NN I-Lab_value
sounds NNS I-Lab_value
, , O
and CC O
the DT O
patient NN O
was VBD O
alert JJ B-Sign_symptom
and CC O
oriented VBN B-Sign_symptom
without IN O
focal JJ B-Detailed_description
neurological JJ B-Sign_symptom
deficits NNS I-Sign_symptom
. . O

The DT O
complete JJ B-Diagnostic_procedure
blood NN I-Diagnostic_procedure
count NN I-Diagnostic_procedure
, , O
basic JJ B-Diagnostic_procedure
metabolic JJ I-Diagnostic_procedure
panel NN I-Diagnostic_procedure
and CC O
coagulation NN B-Diagnostic_procedure
tests NNS I-Diagnostic_procedure
were VBD O
within IN B-Lab_value
normal JJ I-Lab_value
limits NNS I-Lab_value
. . O

The DT O
cardiac JJ B-Diagnostic_procedure
enzymes NNS I-Diagnostic_procedure
were VBD O
increased VBN B-Lab_value
with IN O
a DT O
troponin NN B-Diagnostic_procedure
I PRP I-Diagnostic_procedure
of IN O
2 CD B-Lab_value
. . I-Lab_value
59 CD I-Lab_value
ng JJ I-Lab_value
/ NN I-Lab_value
mL NN I-Lab_value
( ( O
normal JJ O
range NN O
0 CD O
. . O
015 CD O
- : O
0 CD O
. . O
045 CD O
ng JJ O
/ NNP O
mL NN O
) ) O
, , O
creatine JJ B-Diagnostic_procedure
phosphokinase NN I-Diagnostic_procedure
of IN O
84 CD B-Lab_value
U NNP I-Lab_value
/ NNP I-Lab_value
L NNP I-Lab_value
( ( O
normal JJ O
range NN O
26 CD O
- : O
192 CD O
U NNP O
/ NNP O
L NNP O
) ) O
. . O

ECG NNP B-Diagnostic_procedure
on IN O
admission NN O
revealed VBN O
normal JJ B-Lab_value
sinus NNS B-Diagnostic_procedure
rhythm VBP I-Diagnostic_procedure
with IN O
2 CD B-Lab_value
- : I-Lab_value
3 CD I-Lab_value
mm NN I-Lab_value
ST NNP I-Lab_value
segment NN I-Lab_value
elevations NNS I-Lab_value
in IN I-Lab_value
leads NNS I-Lab_value
V2 NNP I-Lab_value
- : I-Lab_value
V3 NNP I-Lab_value
and CC O
Q NNP B-Lab_value
waves NNS I-Lab_value
in IN I-Lab_value
leads NNS I-Lab_value
V1 NNP I-Lab_value
- : I-Lab_value
V3 NNP I-Lab_value
, , O
suggestive NN O
of IN O
anterior JJ B-Biological_structure
wall NN I-Biological_structure
infarct NN B-Disease_disorder
( ( O
figure JJ O
2 CD O
) ) O
. . O

An DT O
echocardiogram NN B-Diagnostic_procedure
revealed VBD O
left VBD B-Diagnostic_procedure
ventricular JJ I-Diagnostic_procedure
ejection NN I-Diagnostic_procedure
fraction NN I-Diagnostic_procedure
of IN O
30 CD B-Lab_value
- : I-Lab_value
35 CD I-Lab_value
% NN I-Lab_value
with IN O
mild JJ B-Severity
concentric JJ B-Detailed_description
left VBD B-Biological_structure
ventricular JJ I-Biological_structure
hypertrophy NN B-Sign_symptom
, , O
akinesis NN B-Sign_symptom
of IN O
the DT O
apex NN B-Biological_structure
and CC O
2 CD B-Biological_structure
/ JJ I-Biological_structure
3 CD I-Biological_structure
of IN I-Biological_structure
the DT I-Biological_structure
inferoseptum NN I-Biological_structure
and CC O
apical JJ B-Biological_structure
inferior JJ I-Biological_structure
- : I-Biological_structure
anterior RB I-Biological_structure
wall NN I-Biological_structure
segments NNS I-Biological_structure
, , O
suggesting VBG O
ischaemic JJ B-Sign_symptom
damage NN I-Sign_symptom
at IN O
the DT O
left NN B-Biological_structure
anterior JJ I-Biological_structure
descending VBG I-Biological_structure
artery JJ I-Biological_structure
distribution NN O
versus NN O
takotsubo NN B-Disease_disorder
cardiomyopathy NN I-Disease_disorder
( ( O
figures VBZ O
3 CD O
and CC O
4 CD O
) ) O
. . O

The DT O
patient NN O
received VBD O
aspirin JJ B-Medication
162 CD B-Dosage
mg NN I-Dosage
and CC O
prasugrel NN B-Medication
60 CD B-Dosage
mg NN I-Dosage
, , O
and CC O
was VBD O
taken VBN O
to TO O
the DT O
cardiac JJ B-Nonbiological_location
catheterisation NN I-Nonbiological_location
laboratory NN I-Nonbiological_location
. . O

The DT O
angiogram NN B-Diagnostic_procedure
showed VBD O
non JJ B-Detailed_description
- : I-Detailed_description
obstructive JJ I-Detailed_description
coronary JJ B-Disease_disorder
artery NN I-Disease_disorder
disease NN I-Disease_disorder
with IN O
luminal JJ B-Biological_structure
irregularities NNS B-Sign_symptom
( ( O
figures NNS O
5 CD O
and CC O
6 CD O
) ) O
. . O

The DT O
left NN B-Diagnostic_procedure
ventriculography NN I-Diagnostic_procedure
showed VBD O
an DT O
ejection NN B-Diagnostic_procedure
fraction NN I-Diagnostic_procedure
of IN O
35 CD B-Lab_value
% NN I-Lab_value
with IN O
akinesis NN B-Sign_symptom
of IN O
apical JJ B-Biological_structure
wall NN I-Biological_structure
and CC O
hyperkinesis NN B-Sign_symptom
of IN O
basal NN B-Biological_structure
segments NNS I-Biological_structure
( ( O
figures NNS O
7 CD O
and CC O
8 CD O
) ) O
. . O

The DT O
patient NN O
remained VBD O
haemodynamically RB B-Diagnostic_procedure
stable JJ B-Lab_value
and CC O
was VBD O
started VBN O
on IN O
oral JJ O
heart NN B-Medication
failure NN I-Medication
medications NNS I-Medication
, , O
including VBG O
lisinopril JJ B-Medication
2 CD B-Dosage
. . I-Dosage
5 CD I-Dosage
mg JJ I-Dosage
daily JJ I-Dosage
and CC O
metoprolol JJ B-Medication
tartrate NN I-Medication
12 CD B-Dosage
. . I-Dosage
5 CD I-Dosage
mg NN I-Dosage
two CD I-Dosage
times NNS I-Dosage
a DT I-Dosage
day NN I-Dosage
. . O

Her PRP$ O
pain NN B-Sign_symptom
and CC O
shortness NN B-Sign_symptom
of IN I-Sign_symptom
breath NN I-Sign_symptom
resolved VBN O
and CC O
she PRP O
was VBD O
discharged VBN O
home NN B-Nonbiological_location
after IN O
48 CD O
h NN O
of IN O
hospitalisation NN O
in IN O
stable JJ B-Lab_value
condition NN B-Diagnostic_procedure
. . O

A DT O
repeat NN O
echocardiogram JJ B-Diagnostic_procedure
2 CD O
months NNS O
later RB O
showed VBD O
resolution NN O
of IN O
her PRP$ O
cardiomyopathy NN B-Disease_disorder
and CC O
an DT O
ejection NN B-Diagnostic_procedure
fraction NN I-Diagnostic_procedure
of IN O
65 CD B-Lab_value
- : I-Lab_value
70 CD I-Lab_value
% NN I-Lab_value
, , O
with IN O
normal JJ B-Lab_value
left VBD B-Diagnostic_procedure
ventricular JJ I-Diagnostic_procedure
motion NN I-Diagnostic_procedure
. . O

-DOCSTART- NN -X-

A DT O
63 CD B-Age
- : I-Age
year NN I-Age
- : I-Age
old JJ I-Age
woman NN O
with IN O
no DT O
known JJ O
cardiac JJ O
history NN O
presented VBN O
with IN O
a DT O
sudden JJ B-Detailed_description
onset NN I-Detailed_description
of IN O
dyspnea NN B-Sign_symptom
requiring VBG O
intubation NN B-Therapeutic_procedure
and CC O
ventilatory JJ B-Therapeutic_procedure
support NN I-Therapeutic_procedure
out IN B-Nonbiological_location
of IN I-Nonbiological_location
hospital NN I-Nonbiological_location
. . O

She PRP O
denied VBD O
preceding VBG O
symptoms NNS O
of IN O
chest JJS B-Biological_structure
discomfort NN B-Sign_symptom
, , O
palpitations NNS B-Sign_symptom
, , O
syncope NN B-Sign_symptom
or CC O
infection NN B-Disease_disorder
. . O

The DT O
patient NN O
was VBD O
afebrile JJ B-Sign_symptom
and CC O
normotensive JJ B-Sign_symptom
, , O
with IN O
a DT O
sinus JJ B-Detailed_description
tachycardia NN B-Sign_symptom
of IN O
140 CD B-Lab_value
beats NNS I-Lab_value
/ JJ I-Lab_value
min NN I-Lab_value
. . O

The DT O
cardiorespiratory NN B-Diagnostic_procedure
examination NN I-Diagnostic_procedure
was VBD O
remarkable JJ O
for IN O
an DT O
elevated JJ B-Lab_value
jugular NN B-Diagnostic_procedure
venous JJ I-Diagnostic_procedure
pressure NN I-Diagnostic_procedure
at IN O
the DT O
angle NN B-Biological_structure
of IN I-Biological_structure
the DT I-Biological_structure
jaw NN I-Biological_structure
, , O
a DT O
left JJ B-Detailed_description
- : I-Detailed_description
sided JJ I-Detailed_description
third JJ B-Sign_symptom
heart NN I-Sign_symptom
sound NN I-Sign_symptom
and CC O
bibasilar JJ B-Detailed_description
crackles NNS B-Sign_symptom
in IN O
both DT B-Biological_structure
lung NN I-Biological_structure
fields NNS O
. . O

The DT O
complete JJ B-Diagnostic_procedure
blood NN I-Diagnostic_procedure
cell NN I-Diagnostic_procedure
count NN I-Diagnostic_procedure
, , O
electrolytes NNS B-Diagnostic_procedure
and CC O
cardiac JJ B-Diagnostic_procedure
biomarkers NNS I-Diagnostic_procedure
were VBD O
within IN B-Lab_value
normal JJ I-Lab_value
limits NNS I-Lab_value
. . O

An DT O
initial JJ O
electrocardiogram NN B-Diagnostic_procedure
revealed VBD O
ST NNP B-Sign_symptom
depression NN I-Sign_symptom
in IN O
leads VBZ B-Diagnostic_procedure
V2 NNP I-Diagnostic_procedure
to TO I-Diagnostic_procedure
V6 NNP I-Diagnostic_procedure
, , O
suggestive NN O
of IN O
anterolateral JJ B-Disease_disorder
ischemia NN I-Disease_disorder
( ( O
Figure NNP O
1 CD O
) ) O
. . O

A DT O
chest NN B-Biological_structure
radiograph NN B-Diagnostic_procedure
demonstrated VBD O
pulmonary JJ B-Biological_structure
vascular JJ B-Sign_symptom
congestion NN I-Sign_symptom
consistent NN O
with IN O
a DT O
diagnosis NN O
of IN O
pulmonary JJ B-Disease_disorder
edema NN I-Disease_disorder
( ( O
Figure NNP O
2 CD O
) ) O
. . O

An DT O
echocardiographic JJ B-Diagnostic_procedure
examination NN I-Diagnostic_procedure
revealed VBD O
normal JJ B-Lab_value
cardiac JJ B-Diagnostic_procedure
dimensions NNS I-Diagnostic_procedure
, , O
normal JJ B-Lab_value
wall NN B-Diagnostic_procedure
motion NN I-Diagnostic_procedure
and CC O
mild JJ B-Severity
diastolic JJ B-Disease_disorder
dysfunction NN I-Disease_disorder
with IN O
an DT O
early JJ B-Diagnostic_procedure
diastolic NN I-Diagnostic_procedure
to TO I-Diagnostic_procedure
late VB I-Diagnostic_procedure
diastolic JJ I-Diagnostic_procedure
transmitral JJ I-Diagnostic_procedure
ratio NN I-Diagnostic_procedure
of IN O
less JJR B-Lab_value
than IN I-Lab_value
1 CD I-Lab_value
, , O
prolonged VBN B-Lab_value
deceleration NN B-Diagnostic_procedure
time NN I-Diagnostic_procedure
( ( O
250 CD B-Lab_value
ms NN I-Lab_value
) ) O
and CC O
a DT O
reduced VBN B-Lab_value
early JJ B-Diagnostic_procedure
diastolic NN I-Diagnostic_procedure
annular JJ I-Diagnostic_procedure
velocity NN I-Diagnostic_procedure
of IN O
the DT O
lateral JJ B-Biological_structure
mitral JJ I-Biological_structure
valve NN I-Biological_structure
annulus NN I-Biological_structure
. . O

Following VBG O
aggressive JJ B-Lab_value
diuresis NN B-Therapeutic_procedure
and CC O
requiring VBG O
minimal JJ B-Lab_value
ventilatory NN B-Therapeutic_procedure
support NN I-Therapeutic_procedure
, , O
the DT O
patient NN O
was VBD O
extubated JJ B-Therapeutic_procedure
one CD O
day NN O
following VBG O
her PRP$ O
initial JJ O
presentation NN O
. . O

Within IN B-Time
1 CD I-Time
h NN I-Time
of IN O
extubation NN O
, , O
the DT O
patient NN O
developed VBD O
recurrent JJ B-Detailed_description
pulmonary JJ B-Disease_disorder
edema NN I-Disease_disorder
clinically RB O
and CC O
radiographically RB B-Diagnostic_procedure
, , O
requiring VBG O
mechanical JJ B-Therapeutic_procedure
ventilation NN I-Therapeutic_procedure
. . O

Cardiac JJ B-Diagnostic_procedure
catheterization NN I-Diagnostic_procedure
was VBD O
performed VBN O
and CC O
revealed VBN O
normal JJ B-Lab_value
coronary JJ B-Biological_structure
arteries NNS I-Biological_structure
. . O

On IN O
day NN O
4 CD O
of IN O
the DT O
coronary JJ B-Nonbiological_location
care NN I-Nonbiological_location
unit NN I-Nonbiological_location
admission NN O
, , O
the DT O
patient NN O
failed VBD O
a DT O
repeat NN O
attempt NN O
at IN O
extubation NN B-Therapeutic_procedure
. . O

A DT O
computed JJ B-Diagnostic_procedure
tomographic JJ I-Diagnostic_procedure
scan NN O
revealed VBD O
a DT O
4 CD B-Area
cm NN I-Area
× VBD I-Area
9 CD I-Area
cm NN I-Area
multinodular JJ B-Detailed_description
goiter NN B-Disease_disorder
extending VBG O
into IN O
the DT O
mediastinum NN B-Biological_structure
and CC O
suspected VBD O
associated VBN O
tracheal JJ B-Biological_structure
stenosis NN B-Sign_symptom
( ( O
Figure NNP O
3 CD O
) ) O
. . O

With IN O
a DT O
diagnosis NN O
of IN O
NPPE NNP B-Disease_disorder
secondary JJ O
to TO O
an DT O
enlarged JJ B-Severity
goiter NN B-Disease_disorder
, , O
the DT O
patient JJ O
underwent JJ O
surgical JJ B-Therapeutic_procedure
intervention NN I-Therapeutic_procedure
for IN O
a DT O
thyroidectomy NN B-Therapeutic_procedure
. . O

Intraoperative JJ B-Detailed_description
bronchoscopy NN B-Diagnostic_procedure
revealed VBD O
tracheal JJ B-Biological_structure
stenosis NN B-Sign_symptom
of IN O
greater JJR B-Lab_value
than IN I-Lab_value
50 CD I-Lab_value
% NN I-Lab_value
. . O

The DT O
postoperative JJ B-Diagnostic_procedure
course NN I-Diagnostic_procedure
was VBD O
uncomplicated JJ B-Lab_value
, , O
and CC O
three CD O
months NNS O
following VBG O
discharge NN O
, , O
the DT O
patient NN O
returned VBD O
to TO O
her PRP$ O
previous JJ B-Detailed_description
activity NN I-Detailed_description
level NN I-Detailed_description
without IN O
subjective JJ O
dyspnea NN B-Sign_symptom
. . O

-DOCSTART- NN -X-

We PRP O
present VBP O
the DT O
case NN O
of IN O
a DT O
22 CD B-Age
- : I-Age
year NN I-Age
- : I-Age
old JJ I-Age
woman NN O
who WP O
was VBD O
diagnosed VBN O
in IN O
childhood NN O
with IN O
type JJ O
IIb NNP O
VHL NNP O
, , O
with IN O
known VBN O
multiple JJ O
retinal JJ O
angiomas NN O
, , O
pancreatic JJ O
cysts NNS O
, , O
and CC O
spinal JJ O
and CC O
cerebellar JJ O
hemangioblastomas NN O
. . O

She PRP O
was VBD O
admitted VBN O
to TO O
our PRP$ O
hospital NN B-Nonbiological_location
complaining NN O
of IN O
progressive JJ B-Detailed_description
dyspnea NN B-Sign_symptom
and CC O
palpitations NNS B-Sign_symptom
. . O

On IN O
examination NN B-Diagnostic_procedure
, , O
her PRP$ O
blood NN B-Diagnostic_procedure
pressure NN I-Diagnostic_procedure
was VBD O
159 CD B-Lab_value
/ JJ I-Lab_value
119 CD I-Lab_value
mm NN I-Lab_value
Hg NNP I-Lab_value
and CC O
her PRP$ O
pulse NN B-Diagnostic_procedure
was VBD O
123 CD B-Lab_value
bpm NN I-Lab_value
. . O

Physical JJ B-Diagnostic_procedure
examination NN I-Diagnostic_procedure
revealed VBD O
a DT O
systolic JJ B-Detailed_description
murmur NN B-Sign_symptom
at IN O
the DT O
mitral JJ B-Biological_structure
focus NN I-Biological_structure
with IN O
irradiation NN B-Biological_structure
to TO I-Biological_structure
the DT I-Biological_structure
axilla NN I-Biological_structure
and CC O
pulmonary JJ B-Sign_symptom
rales NNS I-Sign_symptom
. . O

Electrocardiography NNP B-Diagnostic_procedure
revealed VBD O
no DT B-Lab_value
remarkable JJ I-Lab_value
findings NNS I-Lab_value
, , O
except IN O
for IN O
sinus JJ B-Detailed_description
tachycardia NN B-Sign_symptom
. . O

Laboratory NN B-Diagnostic_procedure
tests NNS I-Diagnostic_procedure
showed VBD O
an DT O
elevated VBN B-Lab_value
N NNP B-Detailed_description
- : I-Detailed_description
terminal JJ I-Detailed_description
pro FW B-Diagnostic_procedure
- : I-Diagnostic_procedure
brain NN I-Diagnostic_procedure
natriuretic JJ I-Diagnostic_procedure
peptide NN I-Diagnostic_procedure
and CC O
chest NN B-Biological_structure
X NNP B-Diagnostic_procedure
- : I-Diagnostic_procedure
ray NN I-Diagnostic_procedure
showed VBD O
signs NNS O
of IN O
pulmonary JJ B-Sign_symptom
interstitial JJ I-Sign_symptom
edema NN I-Sign_symptom
. . O

The DT O
patient NN O
was VBD O
admitted VBN O
to TO O
the DT O
Department NNP B-Biological_structure
of IN I-Biological_structure
Cardiology NNP I-Biological_structure
with IN O
the DT O
diagnosis NN O
of IN O
acute NN B-Detailed_description
decompensated VBN B-Detailed_description
heart NN B-Disease_disorder
failure NN I-Disease_disorder
. . O

Transthoracic NNP B-Detailed_description
echocardiography NN B-Diagnostic_procedure
showed VBD O
a DT O
dilated JJ B-Sign_symptom
left JJ B-Biological_structure
ventricle NN I-Biological_structure
with IN O
severely RB B-Lab_value
depressed JJ I-Lab_value
ejection NN B-Diagnostic_procedure
fraction NN I-Diagnostic_procedure
due JJ O
to TO O
generalized JJ B-Detailed_description
hypokinesia NN B-Sign_symptom
and CC O
a DT O
mild JJ B-Severity
mitral JJ B-Sign_symptom
regurgitation NN I-Sign_symptom
( ( O
fig NN O
. . O
1a CD O
) ) O
. . O

During IN O
admission NN O
, , O
the DT O
patient NN O
had VBD O
several JJ B-Detailed_description
episodes NNS I-Detailed_description
of IN O
paroxysmal JJ B-Detailed_description
dyspnea NN B-Sign_symptom
despite IN O
treatment NN O
with IN O
β NNP B-Medication
- : I-Medication
blockers NNS I-Medication
and CC O
diuretics NNS B-Medication
. . O

Due JJ O
to TO O
the DT O
clinical JJ O
suspicion NN O
of IN O
adrenal JJ B-Disease_disorder
gland NN I-Disease_disorder
disease NN I-Disease_disorder
, , O
24 CD B-Detailed_description
- : I-Detailed_description
hour NN I-Detailed_description
urinary JJ B-Biological_structure
catecholamine NN B-Diagnostic_procedure
and CC O
metanephrine NN B-Diagnostic_procedure
tests NNS I-Diagnostic_procedure
were VBD O
requested VBN O
. . O

Cardiac NNP B-Biological_structure
MRI NNP B-Diagnostic_procedure
was VBD O
performed VBN O
in IN O
order NN O
to TO O
complete VB O
the DT O
cardiomyopathy NN B-Diagnostic_procedure
study NN I-Diagnostic_procedure
, , O
and CC O
confirmed VBD O
the DT O
echocardiographic JJ O
findings NNS O
as RB O
well RB O
as IN O
revealed VBN O
an DT O
incidental JJ O
finding NN O
of IN O
a DT O
great JJ B-Detailed_description
left JJ B-Biological_structure
renal JJ I-Biological_structure
mass NN B-Sign_symptom
. . O

The DT O
24 CD O
- : O
hour NN O
urine JJ O
laboratory NN O
tests NNS O
showed VBD O
markedly RB B-Lab_value
elevated JJ I-Lab_value
levels NNS O
of IN O
norepinephrine NN B-Diagnostic_procedure
, , O
total JJ B-Diagnostic_procedure
catecholamines NNS I-Diagnostic_procedure
, , O
normetanephrine NN B-Diagnostic_procedure
and CC O
metanephrine NN B-Diagnostic_procedure
with IN O
normal JJ O
epinephrine JJ B-Diagnostic_procedure
values NNS O
: : O
24 CD O
- : O
hour NN O
norepinephrine JJ O
468 CD B-Lab_value
μg NN I-Lab_value
( ( O
normal JJ O
range NN O
: : O
23 CD O
- : O
105 CD O
) ) O
, , O
24 CD O
- : O
hour NN O
epinephrine NN O
13 CD B-Lab_value
μg NN I-Lab_value
( ( O
normal JJ O
range NN O
: : O
4 CD O
- : O
20 CD O
) ) O
, , O
24 CD O
- : O
hour NN O
total JJ O
catecholamines NNS O
658 CD B-Lab_value
μg NNP I-Lab_value
( ( O
normal JJ O
range NN O
: : O
217 CD O
- : O
575 CD O
) ) O
, , O
24 CD O
- : O
hour NN O
normetanephrine JJ O
2,988 CD B-Lab_value
μg NN I-Lab_value
( ( O
normal JJ O
range NN O
: : O
105 CD O
- : O
354 CD O
) ) O
, , O
24 CD O
- : O
hour NN O
total JJ O
metanephrine NN O
3,013 CD B-Lab_value
μg NN I-Lab_value
( ( O
normal JJ O
range NN O
: : O
0 CD O
- : O
1,000 CD O
) ) O
. . O

Therefore RB O
, , O
an DT O
abdominal JJ B-Biological_structure
MRI NNP B-Diagnostic_procedure
was VBD O
performed VBN O
, , O
which WDT O
showed VBD O
the DT O
presence NN O
of IN O
two CD B-Detailed_description
cystic JJ B-Detailed_description
masses NNS B-Sign_symptom
( ( O
fig NN O
. . O
2 CD O
) ) O
located VBN O
at IN O
the DT O
left JJ B-Biological_structure
hypochondrium NN I-Biological_structure
. . O

Surgical JJ B-Detailed_description
resection NN B-Therapeutic_procedure
of IN O
both DT O
masses NNS O
was VBD O
performed VBN O
( ( O
after IN O
α NNP B-Therapeutic_procedure
- : I-Therapeutic_procedure
blockade NN I-Therapeutic_procedure
with IN O
phenoxybenzamine NN B-Medication
and CC O
β NNP B-Therapeutic_procedure
- : I-Therapeutic_procedure
blockade NN I-Therapeutic_procedure
with IN O
propranolol NN B-Medication
) ) O
through IN O
a DT O
laparoscopic JJ B-Therapeutic_procedure
approach NN I-Therapeutic_procedure
, , O
confirming VBG O
the DT O
diagnosis NN O
of IN O
pheochromocytoma NN B-Disease_disorder
and CC O
clear JJ B-Detailed_description
cell NN I-Detailed_description
renal JJ B-Therapeutic_procedure
carcinoma NN I-Therapeutic_procedure
on IN O
histology NN B-Diagnostic_procedure
. . O

During IN O
follow JJ O
- : O
up RB O
, , O
blood NN B-Diagnostic_procedure
pressure NN I-Diagnostic_procedure
and CC O
heart NN B-Diagnostic_procedure
rate NN I-Diagnostic_procedure
values NNS O
normalized VBN B-Lab_value
( ( O
124 CD B-Lab_value
/ RB I-Lab_value
77 CD I-Lab_value
mm NN I-Lab_value
Hg NNP I-Lab_value
, , O
78 CD B-Lab_value
bpm NN I-Lab_value
) ) O
, , O
24 CD B-Detailed_description
- : I-Detailed_description
hour NN I-Detailed_description
urinary JJ B-Biological_structure
catecholamine NN B-Diagnostic_procedure
values NNS O
returned VBN O
to TO O
normal JJ B-Lab_value
range NN I-Lab_value
( ( O
norepinephrine JJ B-Diagnostic_procedure
69 CD B-Lab_value
μg JJ I-Lab_value
/ $ O
24 CD O
h NN O
, , O
total JJ B-Diagnostic_procedure
catecholamine NN I-Diagnostic_procedure
221 CD B-Lab_value
μg NNP I-Lab_value
/ VBD O
24 CD O
h NN O
, , O
normetanephrine JJ B-Diagnostic_procedure
202 CD B-Lab_value
μg JJ I-Lab_value
/ $ O
24 CD O
h NN O
and CC O
total JJ B-Diagnostic_procedure
metanephrine NN I-Diagnostic_procedure
259 CD B-Lab_value
μg NNP I-Lab_value
/ VBD O
24 CD O
h NN O
) ) O
and CC O
the DT O
patient NN O
had VBD O
no DT O
new JJ O
episodes NNS O
of IN O
palpitations NNS B-Sign_symptom
or CC O
dyspnea NN B-Sign_symptom
. . O

Six CD O
months NNS O
after IN O
surgical JJ O
resection NN O
, , O
echocardiography NN B-Diagnostic_procedure
was VBD O
repeated VBN O
and CC O
showed VBD O
a DT O
left JJ B-Biological_structure
ventricle NN I-Biological_structure
with IN O
normal JJ B-Sign_symptom
diameters NNS I-Sign_symptom
and CC O
preserved VBN B-Lab_value
ejection NN B-Diagnostic_procedure
fraction NN I-Diagnostic_procedure
( ( O
fig NN O
. . O
1b CD O
) ) O
. . O

Genetic JJ B-Diagnostic_procedure
analysis NN I-Diagnostic_procedure
revealed VBD O
a DT O
germline JJ B-Sign_symptom
mutation NN I-Sign_symptom
( ( O
exon JJ B-Detailed_description
3 CD I-Detailed_description
deletion NN I-Detailed_description
) ) O
of IN O
the DT O
VHL NNP B-Detailed_description
tumor NN I-Detailed_description
suppressor NN I-Detailed_description
gene NN I-Detailed_description
on IN O
the DT O
short JJ B-Detailed_description
arm NN I-Detailed_description
of IN I-Detailed_description
chromosome NN I-Detailed_description
3 CD I-Detailed_description
. . O

As IN O
the DT O
patient NN O
had VBD O
no DT O
family NN O
history NN O
of IN O
VHL NNP O
, , O
it PRP O
was VBD O
concluded VBN O
that IN O
it PRP O
was VBD O
a DT O
de FW B-Detailed_description
novo FW I-Detailed_description
mutation NN I-Detailed_description
. . O

-DOCSTART- NN -X-

A DT O
49 CD B-Age
- : I-Age
year NN I-Age
- : I-Age
old JJ I-Age
woman NN O
was VBD O
admitted VBN O
to TO O
the DT O
Department NNP B-Nonbiological_location
of IN I-Nonbiological_location
Radiology NNP I-Nonbiological_location
of IN O
the DT O
Second NNP B-Nonbiological_location
Affiliated NNP I-Nonbiological_location
Hospital NNP I-Nonbiological_location
of IN I-Nonbiological_location
Zhejiang NNP I-Nonbiological_location
University NNP I-Nonbiological_location
in IN O
October NNP O
2004 CD O
with IN O
right JJ B-Biological_structure
upper JJ I-Biological_structure
quadrant NN I-Biological_structure
pain NN B-Sign_symptom
and CC O
weight JJ B-Sign_symptom
loss NN I-Sign_symptom
. . O

She PRP O
was VBD O
a DT O
hepatitis NN B-Disease_disorder
B NNP I-Disease_disorder
virus NN O
carrier NN O
. . O

Her PRP$ O
α JJ B-Diagnostic_procedure
- : I-Diagnostic_procedure
fetoprotein NN I-Diagnostic_procedure
level NN O
was VBD O
1185 CD B-Lab_value
. . I-Lab_value
3 CD I-Lab_value
ng JJ I-Lab_value
/ NNP I-Lab_value
mL NN I-Lab_value
. . O

Ultrasonography NN B-Diagnostic_procedure
and CC O
computed VBN B-Diagnostic_procedure
tomography NN I-Diagnostic_procedure
( ( O
CT NNP B-Diagnostic_procedure
) ) O
revealed VBD O
a DT O
10 CD B-Distance
- : I-Distance
cm NN I-Distance
mass NN B-Sign_symptom
in IN O
the DT O
posterior JJ B-Biological_structure
segments NNS I-Biological_structure
of IN O
the DT O
right JJ B-Biological_structure
liver NN I-Biological_structure
lobe NN I-Biological_structure
. . O

A DT O
1 CD B-Distance
. . I-Distance
5 CD I-Distance
- : I-Distance
cm NN I-Distance
mass NN B-Sign_symptom
was VBD O
also RB O
found VBN O
in IN O
the DT O
left JJ B-Biological_structure
lateral JJ I-Biological_structure
segment NN I-Biological_structure
. . O

These DT O
clinical JJ O
signs NNS O
indicated VBD O
that IN O
the DT O
patient NN O
had VBD O
inoperable JJ B-Detailed_description
HCC NNP B-Disease_disorder
and CC O
Child NNP B-Detailed_description
- : I-Detailed_description
Pugh NNP I-Detailed_description
class NN I-Detailed_description
A NNP I-Detailed_description
cirrhosis NN B-Disease_disorder
. . O

TACE NNP B-Therapeutic_procedure
was VBD O
offered VBN O
to TO O
the DT O
patient NN O
. . O

Angiogram NNP B-Diagnostic_procedure
demonstrated VBD O
no DT O
obvious JJ O
hepatic JJ B-Biological_structure
arterio NN B-Sign_symptom
- : I-Sign_symptom
venous JJ I-Sign_symptom
shunt NN I-Sign_symptom
, , O
but CC O
multiple JJ B-Detailed_description
smaller JJR B-Detailed_description
masses NNS B-Sign_symptom
in IN O
both DT B-Biological_structure
lobes NNS I-Biological_structure
of IN I-Biological_structure
the DT I-Biological_structure
liver NN I-Biological_structure
. . O

An DT O
emulsion NN O
of IN O
oxaliplatin NN B-Medication
, , O
pirarubicin NN B-Medication
, , O
hydroxycamptothecin NN B-Medication
and CC O
lipiodol NN B-Medication
were VBD O
prepared VBN O
, , O
35 CD B-Dosage
mL NN I-Dosage
and CC O
3 CD B-Dosage
mL NN I-Dosage
of IN O
the DT O
mixture NN B-Medication
were VBD O
administered VBN O
intra JJ O
- : O
arterially RB O
to TO O
the DT O
right NN B-Biological_structure
and CC I-Biological_structure
left VBD I-Biological_structure
hepatic JJ I-Biological_structure
artery NN I-Biological_structure
, , O
respectively RB O
. . O

The DT O
patient NN O
experienced VBD O
right JJ B-Biological_structure
upper JJ I-Biological_structure
quadrant NN I-Biological_structure
pain NN B-Sign_symptom
after IN O
TACE NNP O
and CC O
had VBD O
an DT O
uneventful JJ B-Lab_value
recovery NN B-Diagnostic_procedure
. . O

One CD O
month NN O
later RB O
, , O
a DT O
second JJ B-Detailed_description
TACE NNP B-Therapeutic_procedure
procedure NN O
was VBD O
performed VBN O
via IN O
the DT O
right JJ B-Biological_structure
hepatic JJ I-Biological_structure
artery NN I-Biological_structure
and CC O
40 CD B-Dosage
mL NN I-Dosage
of IN O
the DT O
mixture NN O
was VBD O
administered VBN O
. . O

On IN O
the DT O
next JJ O
day NN O
, , O
she PRP O
experienced VBD O
sudden JJ B-Detailed_description
acute NN B-Detailed_description
dyspnoea NN B-Sign_symptom
and CC O
the DT O
peripheral JJ B-Diagnostic_procedure
oxygen NN I-Diagnostic_procedure
saturation NN I-Diagnostic_procedure
decreased VBD B-Lab_value
to TO O
90 CD B-Lab_value
% NN I-Lab_value
. . O

The DT O
chest JJS B-Biological_structure
X SYM B-Diagnostic_procedure
- : I-Diagnostic_procedure
ray NN I-Diagnostic_procedure
showed VBD O
some DT O
increased VBN B-Detailed_description
reticular JJ B-Detailed_description
shadows NNS B-Sign_symptom
in IN O
the DT O
left NN B-Biological_structure
lung NN I-Biological_structure
, , O
especially RB O
in IN O
the DT O
lower JJR B-Biological_structure
zones NNS I-Biological_structure
, , O
and CC O
a DT O
chest NN B-Biological_structure
CT NNP B-Diagnostic_procedure
scan NN O
revealed VBD O
multiple JJ B-Detailed_description
iodized JJ B-Detailed_description
oil NN B-Detailed_description
- : I-Detailed_description
like IN I-Detailed_description
high JJ B-Detailed_description
- : I-Detailed_description
density NN I-Detailed_description
materials NNS B-Sign_symptom
in IN O
parenchyma NN B-Biological_structure
of IN I-Biological_structure
the DT I-Biological_structure
lung NN I-Biological_structure
( ( O
Figure NNP O
1 CD O
) ) O
. . O

After IN O
10 CD B-Dosage
mg NN I-Dosage
dexamethasone NN B-Medication
i NN O
. . O
v NN O
. . O
and CC O
other JJ O
supportive JJ B-Therapeutic_procedure
therapies NNS I-Therapeutic_procedure
were VBD O
administered VBN O
, , O
the DT O
respiratory NN O
symptom NN O
was VBD O
attenuated VBN O
. . O

Two CD O
days NNS O
later RB O
, , O
the DT O
patient NN O
suffered VBD O
from IN O
a DT O
serious JJ B-Severity
headache NN B-Sign_symptom
and CC O
transient JJ B-Detailed_description
consciousness NN B-Sign_symptom
loss NN I-Sign_symptom
, , O
accompanying VBG O
nausea NN B-Sign_symptom
and CC O
vomiting NN B-Sign_symptom
followed VBN O
by IN O
confusion NN B-Sign_symptom
, , O
lower JJR B-Biological_structure
extremity NN I-Biological_structure
weakness NN B-Sign_symptom
. . O

Non NNP B-Detailed_description
- : I-Detailed_description
contrast NN I-Detailed_description
enhanced VBD I-Detailed_description
CT NNP B-Diagnostic_procedure
scanning VBG O
showed VBD O
multiple JJ B-Detailed_description
disseminated VBN B-Detailed_description
hyper JJ B-Detailed_description
- : I-Detailed_description
intense JJ I-Detailed_description
lesions NNS B-Sign_symptom
in IN O
the DT O
brain NN B-Biological_structure
, , O
consistent JJ O
with IN O
deposition NN B-Sign_symptom
of IN O
iodized JJ B-Detailed_description
oil NN I-Detailed_description
( ( O
Figure NNP O
2 CD O
) ) O
. . O

One CD O
week NN O
later RB O
, , O
her PRP O
respiratory NN B-Biological_structure
and CC O
neurologic JJ B-Biological_structure
symptoms NNS B-Sign_symptom
disappeared VBD O
completely RB O
, , O
and CC O
she PRP O
was VBD O
discharged VBN O
. . O

The DT O
patient NN O
also RB O
consequently RB O
completed VBN O
the DT O
other JJ B-Detailed_description
three CD I-Detailed_description
TACE NNP B-Therapeutic_procedure
procedures NNS O
, , O
during IN O
which WDT O
no DT O
similar JJ B-Detailed_description
symptoms NNS B-Sign_symptom
occurred VBD O
. . O

-DOCSTART- NN -X-

A DT O
64 CD B-Age
- : I-Age
year NN I-Age
- : I-Age
old JJ I-Age
female NN O
was VBD O
found VBN O
lying VBG B-Activity
down RB I-Activity
after IN O
10 CD B-Duration
- : I-Duration
12 CD I-Duration
hours NNS I-Duration
of IN O
binge NN B-Activity
drinking NN I-Activity
. . O

She PRP O
was VBD O
taken VBN O
to TO O
an DT O
outlying VBG O
emergency NN B-Nonbiological_location
department NN I-Nonbiological_location
( ( O
ED NNP B-Nonbiological_location
) ) O
, , O
and CC O
subsequently RB O
transferred VBN O
to TO O
our PRP$ O
hospital NN B-Nonbiological_location
with IN O
mental JJ B-Sign_symptom
status NN I-Sign_symptom
changes NNS I-Sign_symptom
and CC O
respiratory NN B-Sign_symptom
distress NN I-Sign_symptom
and CC O
hypoxia NN B-Sign_symptom
for IN O
further JJ O
management NN O
. . O

She PRP O
had VBD O
a DT O
past JJ O
history NN O
of IN O
rheumatoid NN O
arthritis NN O
, , O
congestive JJ O
heart NN O
failure NN O
, , O
controlled VBN O
hypertension NN O
, , O
and CC O
alcoholism NN O
. . O

She PRP O
smoked VBD O
two CD O
packs NNS O
a DT O
day NN O
for IN O
the DT O
past JJ O
50 CD O
years NNS O
. . O

On IN O
presentation NN O
, , O
she PRP O
had VBD O
a DT O
blood NN B-Diagnostic_procedure
pressure NN I-Diagnostic_procedure
of IN O
176 CD B-Lab_value
/ JJ I-Lab_value
80 CD I-Lab_value
mm NN I-Lab_value
/ NNP I-Lab_value
Hg NNP I-Lab_value
, , O
heart NN B-Diagnostic_procedure
rate NN I-Diagnostic_procedure
of IN O
80 CD B-Lab_value
bpm NN I-Lab_value
, , O
respirations NNS B-Diagnostic_procedure
24 CD B-Lab_value
bpm NN I-Lab_value
, , O
temperature NN B-Diagnostic_procedure
98 CD B-Lab_value
°F NN I-Lab_value
( ( O
36 CD B-Lab_value
. . I-Lab_value
7 CD I-Lab_value
°C NN I-Lab_value
) ) O
. . O

Arterial JJ B-Diagnostic_procedure
blood NN I-Diagnostic_procedure
gases NNS I-Diagnostic_procedure
on IN O
room NN B-Detailed_description
air NN I-Detailed_description
showed VBD O
a DT O
pH NN B-Diagnostic_procedure
of IN O
7 CD B-Lab_value
. . I-Lab_value
30 CD I-Lab_value
, , O
PaCO2 NNP B-Diagnostic_procedure
60 CD B-Lab_value
, , O
PaO2 NNP B-Diagnostic_procedure
61 CD B-Lab_value
mm NN I-Lab_value
/ NNP I-Lab_value
Hg NNP I-Lab_value
, , O
H NNP B-Diagnostic_procedure
− NNP I-Diagnostic_procedure
CO3 NNP I-Diagnostic_procedure
29 CD B-Lab_value
mEq NN I-Lab_value
/ NNP I-Lab_value
L NNP I-Lab_value
, , O
and CC O
saturation NN B-Diagnostic_procedure
92 CD B-Lab_value
% NN I-Lab_value
which WDT O
improved VBD O
to TO O
95 CD B-Lab_value
% NN I-Lab_value
with IN O
oxygen NN B-Therapeutic_procedure
by IN O
a DT O
high JJ B-Detailed_description
flow NN I-Detailed_description
non SYM I-Detailed_description
- : I-Detailed_description
rebreather NN I-Detailed_description
mask NN I-Detailed_description
. . O

On IN O
physical JJ B-Diagnostic_procedure
examination NN I-Diagnostic_procedure
she PRP O
was VBD O
lethargic JJ B-Sign_symptom
, , O
disoriented VBN B-Sign_symptom
, , O
dysarthritic JJ B-Sign_symptom
, , O
but CC O
without IN O
neurological JJ B-Sign_symptom
focalization NN I-Sign_symptom
. . O

Scattered NNP B-Detailed_description
expiratory NN B-Sign_symptom
wheezes NNS I-Sign_symptom
were VBD O
noted VBN O
bilaterally RB B-Biological_structure
along RB O
with IN O
normal JJ B-Lab_value
heart NN B-Diagnostic_procedure
sounds VBZ I-Diagnostic_procedure
. . O

The DT O
remaining VBG O
results NNS O
of IN O
her PRP$ O
physical JJ O
examination NN O
and CC O
routine JJ O
laboratory NN B-Diagnostic_procedure
results NNS I-Diagnostic_procedure
were VBD O
unremarkable JJ B-Lab_value
with IN O
the DT O
exception NN O
of IN O
a DT O
leukocyte JJ B-Diagnostic_procedure
count NN I-Diagnostic_procedure
of IN O
14,000 CD B-Lab_value
/ NNS I-Lab_value
dL NN I-Lab_value
with IN O
88 CD B-Lab_value
% NN I-Lab_value
neutrophils NNS I-Lab_value
. . O

Repeated VBN O
vitals NNS B-Diagnostic_procedure
signs NNS I-Diagnostic_procedure
were VBD O
consistent JJ O
with IN O
a DT O
normal JJ B-Lab_value
blood NN B-Diagnostic_procedure
pressure NN I-Diagnostic_procedure
but CC O
evidence NN O
of IN O
tachycardia NN B-Sign_symptom
in IN O
the DT O
monitor NN O
. . O

Repeated VBN O
ABG NNP B-Diagnostic_procedure
` `` I-Diagnostic_procedure
s NN I-Diagnostic_procedure
on IN O
the DT O
non JJ B-Therapeutic_procedure
- : I-Therapeutic_procedure
rebreather NN I-Therapeutic_procedure
mask NN I-Therapeutic_procedure
showed VBD O
: : O
pH NN B-Diagnostic_procedure
7 CD B-Lab_value
. . I-Lab_value
22 CD I-Lab_value
, , O
PaCO2 NNP B-Diagnostic_procedure
78 CD B-Lab_value
, , O
PaO2 NNP B-Diagnostic_procedure
140 CD B-Lab_value
mm NN I-Lab_value
Hg NNP I-Lab_value
, , O
H NNP B-Diagnostic_procedure
− NNP I-Diagnostic_procedure
CO3 NNP I-Diagnostic_procedure
30 CD B-Lab_value
mEq NN I-Lab_value
/ NNP I-Lab_value
L NNP I-Lab_value
, , O
and CC O
hemoglobin VB B-Diagnostic_procedure
SaO2 NNP I-Diagnostic_procedure
97 CD B-Lab_value
% NN I-Lab_value
. . O

In IN O
the DT O
ED NNP B-Nonbiological_location
she PRP O
was VBD O
started VBN O
on IN O
IV NNP O
steroids NNS B-Medication
and CC O
antibiotics NNS B-Medication
for IN O
a DT O
COPD NNP B-Disease_disorder
exacerbation NN B-Detailed_description
. . O

As IN O
part NN O
of IN O
the DT O
diagnostic JJ B-Diagnostic_procedure
workup NN I-Diagnostic_procedure
, , O
she PRP O
underwent VBD O
a DT O
chest NN B-Biological_structure
x NN B-Diagnostic_procedure
ray NN I-Diagnostic_procedure
that WDT O
did VBD O
not RB O
show VB O
any DT O
infiltrates NNS B-Sign_symptom
or CC O
any DT O
major JJ O
abnormal JJ B-Sign_symptom
findings NNS I-Sign_symptom
. . O

The DT O
ECG NNP B-Diagnostic_procedure
was VBD O
only RB O
significant JJ O
for IN O
sinus JJ B-Biological_structure
tachycardia NN B-Sign_symptom
. . O

Given VBN O
the DT O
negative JJ O
findings NNS O
on IN O
chest JJS O
x NN O
ray NN O
, , O
sinus JJ O
tachycardia NN O
on IN O
ECG NNP O
, , O
and CC O
an DT O
increased VBN O
A NNP O
- : O
a DT O
gradient NN O
, , O
the DT O
patient NN O
was VBD O
sent VBN O
for IN O
a DT O
spiral JJ B-Detailed_description
chest NN B-Biological_structure
CT NNP B-Diagnostic_procedure
with IN B-Detailed_description
contrast NN I-Detailed_description
to TO O
rule VB O
out RP O
a DT O
pulmonary JJ B-Biological_structure
embolism NN B-Disease_disorder
. . O

During IN O
CT NNP O
about IN O
100 CD B-Volume
- : I-Volume
150 CD I-Volume
mL NN I-Volume
of IN O
air NN O
was VBD O
inadvertently RB O
injected VBN O
through IN O
the DT O
right JJ B-Biological_structure
antecubital NN I-Biological_structure
vein NN I-Biological_structure
using VBG O
a DT O
power NN B-Detailed_description
contrast NN I-Detailed_description
injector NN I-Detailed_description
( ( O
estimated VBN O
by IN O
the DT O
technician JJ O
and CC O
approximation NN O
of IN O
volumes NNS O
on IN O
available JJ O
imaging NN O
) ) O
. . O

Concurrent JJ B-Detailed_description
imaging NN B-Diagnostic_procedure
( ( O
CT NNP O
) ) O
showed VBD O
a DT O
significant JJ B-Severity
amount NN B-Sign_symptom
of IN I-Sign_symptom
air NN I-Sign_symptom
in IN O
the DT O
right JJ B-Biological_structure
atrium NN I-Biological_structure
and CC O
right JJ B-Biological_structure
ventricular NN I-Biological_structure
cavity NN I-Biological_structure
( ( O
Figure NNP O
1 CD O
) ) O
, , O
and CC O
air NN B-Sign_symptom
mixed JJ I-Sign_symptom
with IN I-Sign_symptom
contrast NN I-Sign_symptom
in IN O
the DT O
main JJ B-Biological_structure
pulmonary JJ I-Biological_structure
artery NN I-Biological_structure
and CC O
its PRP$ O
proximal JJ B-Biological_structure
branches NNS I-Biological_structure
divisions NNS I-Biological_structure
of IN I-Biological_structure
the DT I-Biological_structure
pulmonary JJ I-Biological_structure
circulation NN I-Biological_structure
( ( O
Figure NNP O
2 CD O
) ) O
. . O

Concurrently RB O
, , O
a DT O
filling NN B-Sign_symptom
defect NN I-Sign_symptom
was VBD O
noted VBN O
in IN O
the DT O
right NN B-Biological_structure
lower JJR I-Biological_structure
lobe NN I-Biological_structure
artery NN I-Biological_structure
consistent NN O
with IN O
pulmonary JJ B-Biological_structure
thromboembolism NN B-Disease_disorder
( ( O
Figures NNS O
3 CD O
, , O
,4 NN O
) ) O
. . O
4 CD O
) ) O
. . O

The DT O
patient NN O
maintained VBD O
hemodynamic JJ B-Diagnostic_procedure
stability NN I-Diagnostic_procedure
with IN O
Trendelenburg NNP B-Therapeutic_procedure
, , O
and CC O
left VBD B-Therapeutic_procedure
lateral JJ I-Therapeutic_procedure
decubitus NN I-Therapeutic_procedure
positioning NN I-Therapeutic_procedure
( ( O
Durant NNP B-Therapeutic_procedure
` `` I-Therapeutic_procedure
s RB I-Therapeutic_procedure
maneuver NN I-Therapeutic_procedure
) ) O
, , O
and CC O
supportive JJ B-Therapeutic_procedure
care NN I-Therapeutic_procedure
alone RB O
and CC O
she PRP O
was VBD O
transferred VBN O
to TO O
the DT O
intensive JJ B-Nonbiological_location
care NN I-Nonbiological_location
unit NN I-Nonbiological_location
( ( O
ICU NNP B-Nonbiological_location
) ) O
for IN O
observation NN O
. . O

Her PRP$ O
respiratory NN B-Sign_symptom
distress NN I-Sign_symptom
worsened VBD O
, , O
and CC O
she PRP O
was VBD O
placed VBN O
temporarily RB O
on IN O
non JJ B-Therapeutic_procedure
- : I-Therapeutic_procedure
invasive JJ I-Therapeutic_procedure
positive JJ I-Therapeutic_procedure
pressure NN I-Therapeutic_procedure
ventilation NN I-Therapeutic_procedure
( ( O
NIPPV NNP B-Therapeutic_procedure
) ) O
without IN O
improvement NN B-Sign_symptom
and CC O
a DT B-Time
few JJ I-Time
hours NNS I-Time
later RB I-Time
she PRP O
was VBD O
intubated VBN B-Therapeutic_procedure
and CC O
placed VBN O
on IN O
mechanical JJ B-Therapeutic_procedure
ventilation NN I-Therapeutic_procedure
. . O

Intravenous JJ O
full JJ B-Detailed_description
dose NN I-Detailed_description
heparin NN B-Medication
infusion NN O
( ( O
initial JJ B-Dosage
bolus NN I-Dosage
, , I-Dosage
80 CD I-Dosage
units NNS I-Dosage
/ NNP I-Dosage
kg NN I-Dosage
, , I-Dosage
followed VBN I-Dosage
by IN I-Dosage
18 CD I-Dosage
units NNS I-Dosage
/ VBP I-Dosage
kg JJ I-Dosage
/ NNP I-Dosage
hour NN I-Dosage
) ) O
was VBD O
initiated VBN O
for IN O
treatment NN O
of IN O
concurrent JJ O
thromboembolism NN B-Disease_disorder
. . O

Echocardiography NN B-Diagnostic_procedure
did VBD O
not RB O
show VB O
any DT O
evidence NN O
of IN O
right NN B-Sign_symptom
or CC I-Sign_symptom
left VBD I-Sign_symptom
ventricular JJ I-Sign_symptom
failure NN I-Sign_symptom
. . O

Subsequent JJ O
echocardiography NN B-Diagnostic_procedure
done VBN O
24 CD B-Time
hours NNS I-Time
later RB I-Time
did VBD O
not RB O
show VB O
any DT O
evidence NN O
of IN O
intracardiac JJ B-Biological_structure
air NN B-Sign_symptom
and CC O
complete JJ O
resolution NN O
of IN O
the DT O
air NN O
embolism NN B-Disease_disorder
. . O

During IN B-Duration
the DT I-Duration
next JJ I-Duration
48 CD I-Duration
hours NNS I-Duration
, , O
she PRP O
remained VBD O
hemodynamically RB B-Diagnostic_procedure
stable JJ B-Lab_value
with IN O
no DT O
requirements NNS O
of IN O
vasoactive JJ B-Medication
agents NNS I-Medication
. . O

She PRP O
was VBD O
finally RB O
extubated VBN B-Therapeutic_procedure
48 CD O
hours NNS O
after IN O
the DT O
initial JJ O
presentation NN O
. . O

She PRP O
was VBD O
later RB O
discharged VBN O
home NN B-Nonbiological_location
on IN O
warfarin NN B-Medication
with IN O
subsequent JJ O
outpatient NN O
follow SYM O
- : O
up RB O
. . O

-DOCSTART- NN -X-

An DT O
84 CD B-Age
- : I-Age
year NN I-Age
- : I-Age
old JJ I-Age
male JJ O
patient NN O
with IN O
a DT O
history NN O
of IN O
coronary JJ O
artery NN O
disease NN O
and CC O
right JJ O
coronary JJ O
artery NN O
( ( O
RCA NNP O
) ) O
stenting NN O
was VBD O
admitted VBN O
to TO O
our PRP$ O
university NN B-Nonbiological_location
hospital NN I-Nonbiological_location
in IN O
February NNP O
2012 CD O
because IN O
of IN O
progressive JJ B-Detailed_description
dyspnoea NN B-Sign_symptom
and CC O
recurring VBG B-Detailed_description
syncopes NNS B-Sign_symptom
. . O

Cardiological JJ B-Diagnostic_procedure
work NN I-Diagnostic_procedure
- : I-Diagnostic_procedure
up RB I-Diagnostic_procedure
revealed VBD O
a DT O
grade NN B-Lab_value
III NNP I-Lab_value
severe JJ B-Severity
symptomatic JJ B-Detailed_description
aortic JJ B-Disease_disorder
stenosis NN I-Disease_disorder
. . O

Due JJ O
to TO O
relevant JJ O
comorbidities NNS O
( ( O
logistic JJ B-Diagnostic_procedure
EuroSCORE NNP I-Diagnostic_procedure
of IN O
19 CD B-Lab_value
points NNS I-Lab_value
) ) O
and CC O
severe JJ B-Severity
femoral JJ B-Biological_structure
arteriopathy NN B-Disease_disorder
, , O
he PRP O
was VBD O
scheduled VBN O
for IN O
trans NNS B-Detailed_description
- : I-Detailed_description
subclavian JJ I-Detailed_description
TAVI NNP B-Therapeutic_procedure
. . O

After IN O
successful JJ O
implantation NN O
of IN O
a DT O
CoreValve NNP B-Detailed_description
prosthesis NN I-Detailed_description
( ( O
Medtronic NNP B-Detailed_description
) ) O
[ NNP O
Medtronic NNP B-Detailed_description
World NNP I-Detailed_description
Headquarters NNP I-Detailed_description
Medtronic NNP I-Detailed_description
Parkway NNP I-Detailed_description
Minneapolis NNP I-Detailed_description
, , I-Detailed_description
Minnesota NNP I-Detailed_description
, , I-Detailed_description
USA NNP I-Detailed_description
] NNP O
( ( O
diameter NN B-Detailed_description
31 CD I-Detailed_description
mm NN I-Detailed_description
) ) O
and CC O
initial JJ O
discharge NN O
, , O
he PRP O
was VBD O
referred VBN O
back RB O
to TO O
the DT O
hospital NN B-Biological_structure
because IN O
of IN O
dyspnoea NN B-Sign_symptom
due JJ O
to TO O
bilateral JJ B-Detailed_description
pleural JJ B-Disease_disorder
effusions NNS I-Disease_disorder
. . O

Transoesophageal NNP B-Diagnostic_procedure
echocardiography NN I-Diagnostic_procedure
( ( O
TEE NNP B-Diagnostic_procedure
) ) O
showed VBD O
a DT O
severe JJ B-Severity
mitral JJ B-Sign_symptom
regurgitation NN I-Sign_symptom
( ( O
MR NNP B-Sign_symptom
) ) O
, , O
which WDT O
was VBD O
subsequently RB O
treated VBN O
by IN O
interventional JJ B-Detailed_description
mitral JJ B-Therapeutic_procedure
valve NN I-Therapeutic_procedure
repair NN I-Therapeutic_procedure
using VBG O
the DT O
MitraClip NNP B-Biological_structure
( ( O
Abbott NNP B-Detailed_description
Vascular NNP I-Detailed_description
, , I-Detailed_description
Abbott NNP I-Detailed_description
Laboratories NNPS I-Detailed_description
, , I-Detailed_description
Abbott NNP I-Detailed_description
Park NNP I-Detailed_description
, , I-Detailed_description
Illinois NNP I-Detailed_description
, , I-Detailed_description
U NNP I-Detailed_description
. . I-Detailed_description
S NNP I-Detailed_description
. . I-Detailed_description
A NNP I-Detailed_description
. . I-Detailed_description
) ) O
and CC O
procedurally RB O
dependent JJ O
atrial JJ B-Therapeutic_procedure
septal NN I-Therapeutic_procedure
defect NN I-Therapeutic_procedure
( ( I-Therapeutic_procedure
ASD NNP I-Therapeutic_procedure
) ) I-Therapeutic_procedure
closure NN I-Therapeutic_procedure
AMPLATZER NNP B-Detailed_description
™ NNP I-Detailed_description
PFO NNP I-Detailed_description
Occluder NNP I-Detailed_description
( ( O
St NNP O
. . O

Jude NNP O
Medical NNP O
GmbH NNP O
, , O
Helfmann NNP O
- : O
Park NN O
7 CD O
, , O
Eschborn NNP O
, , O
Germany NNP O
) ) O
. . O

Two CD O
weeks NNS O
after IN O
secondary JJ B-Detailed_description
discharge NN O
, , O
the DT O
patient NN O
developed VBD O
progressive JJ B-Detailed_description
heart NN B-Disease_disorder
failure NN I-Disease_disorder
in IN O
combination NN O
with IN O
acute JJ B-Detailed_description
renal JJ B-Disease_disorder
failure NN I-Disease_disorder
. . O

Immediate NNP B-Detailed_description
echocardiography NN B-Diagnostic_procedure
revealed VBD O
a DT O
moderate JJ B-Severity
- : I-Severity
to TO I-Severity
- : I-Severity
severe JJ I-Severity
aortic JJ B-Sign_symptom
regurgitation NN I-Sign_symptom
and CC O
recurrent NN B-Detailed_description
severe JJ B-Severity
MR NNP B-Sign_symptom
. . O

Valvular JJ B-Sign_symptom
defects NNS I-Sign_symptom
resulted VBD O
from IN O
a DT O
slight JJ B-Severity
but CC I-Severity
significant JJ I-Severity
aortic JJ B-Sign_symptom
valve NN I-Sign_symptom
prosthesis NN I-Sign_symptom
migration NN I-Sign_symptom
towards IN O
the DT O
left NN B-Biological_structure
ventricular JJ I-Biological_structure
outflow JJ I-Biological_structure
tract NN I-Biological_structure
, , O
which WDT O
had VBD O
caused VBN O
aortic JJ B-Sign_symptom
paravalvular JJ I-Sign_symptom
leakage NN I-Sign_symptom
and CC O
partial JJ B-Detailed_description
posterior JJ B-Detailed_description
mitral JJ B-Sign_symptom
leaflet NN I-Sign_symptom
detachment NN I-Sign_symptom
( ( O
Fig NNP O
. . O
1 CD O
) ) O
. . O

As IN O
a DT O
consequence NN O
of IN O
these DT O
findings NNS O
, , O
the DT O
patient NN O
was VBD O
transferred VBN O
to TO O
our PRP$ O
cardiac JJ B-Nonbiological_location
surgery NN I-Nonbiological_location
department NN I-Nonbiological_location
. . O

Preoperative JJ O
coronary JJ B-Biological_structure
angiography NN B-Diagnostic_procedure
revealed VBD O
a DT O
progression NN O
of IN O
the DT O
coronary JJ B-Disease_disorder
artery NN I-Disease_disorder
disease NN I-Disease_disorder
. . O

Consequently RB O
the DT O
patient NN O
was VBD O
scheduled VBN O
for IN O
conventional JJ B-Detailed_description
aortic JJ B-Biological_structure
and CC O
mitral JJ B-Biological_structure
valve NN B-Therapeutic_procedure
replacement NN I-Therapeutic_procedure
, , O
as RB O
well RB O
as IN O
coronary JJ B-Therapeutic_procedure
artery NN I-Therapeutic_procedure
bypass NN I-Therapeutic_procedure
surgery NN I-Therapeutic_procedure
. . O

The DT O
operation NN O
was VBD O
performed VBN O
via IN O
median JJ B-Therapeutic_procedure
sternotomy NN I-Therapeutic_procedure
. . O

On IN O
initialization NN O
of IN O
cardiopulmonary JJ B-Therapeutic_procedure
bypass NN I-Therapeutic_procedure
, , O
the DT O
ascending VBG B-Biological_structure
aorta NN I-Biological_structure
was VBD O
opened VBN B-Therapeutic_procedure
for IN O
exploration NN B-Detailed_description
of IN I-Detailed_description
the DT I-Detailed_description
aortic JJ I-Detailed_description
valve NN I-Detailed_description
( ( O
Fig NNP O
. . O
2A CD O
) ) O
. . O

After IN O
careful JJ O
removal NN B-Therapeutic_procedure
of IN O
the DT O
CoreValve NNP B-Detailed_description
prosthesis NN I-Detailed_description
, , O
an DT O
Edwards NNP B-Detailed_description
Perimount NNP I-Detailed_description
aortic JJ B-Detailed_description
valve NN I-Detailed_description
prosthesis NN I-Detailed_description
( ( O
diameter JJ B-Detailed_description
25 CD I-Detailed_description
mm NN I-Detailed_description
) ) O
was VBD O
implanted VBN B-Therapeutic_procedure
. . O

After IN O
vein SYM B-Therapeutic_procedure
- : I-Therapeutic_procedure
grafting NN I-Therapeutic_procedure
of IN O
the DT O
circumflex JJ B-Biological_structure
coronary JJ I-Biological_structure
artery NN I-Biological_structure
, , O
the DT O
mitral JJ B-Biological_structure
valve NN I-Biological_structure
was VBD O
explored VBN B-Detailed_description
via IN I-Detailed_description
the DT I-Detailed_description
left JJ I-Detailed_description
atrium NN I-Detailed_description
and CC O
excised VBN B-Therapeutic_procedure
with IN O
the DT O
attached JJ B-Detailed_description
clip NN I-Detailed_description
. . O

Thereafter RB O
, , O
an DT O
Edwards NNP B-Detailed_description
Perimount NNP I-Detailed_description
mitral JJ B-Detailed_description
valve NN I-Detailed_description
prosthesis NN I-Detailed_description
( ( O
diameter JJ B-Detailed_description
31 CD I-Detailed_description
mm NN I-Detailed_description
) ) O
was VBD O
implanted VBN B-Therapeutic_procedure
. . O

More RBR O
recently RB O
, , O
the DT O
atrial JJ B-Therapeutic_procedure
septal JJ I-Therapeutic_procedure
occluder NN I-Therapeutic_procedure
was VBD I-Therapeutic_procedure
removed VBN I-Therapeutic_procedure
prior RB O
to TO O
direct JJ O
closure NN B-Therapeutic_procedure
of IN O
the DT O
resulting VBG O
septal JJ B-Sign_symptom
defect NN I-Sign_symptom
with IN O
a DT O
single JJ B-Detailed_description
- : I-Detailed_description
suture NN I-Detailed_description
line NN I-Detailed_description
( ( O
Fig NNP O
. . O
2B CD O
) ) O
. . O

Intraoperative JJ B-Detailed_description
echocardiography NN B-Diagnostic_procedure
revealed VBD O
adequate JJ B-Lab_value
function NN I-Lab_value
of IN I-Lab_value
both DT I-Lab_value
prostheses NNS I-Lab_value
and CC O
the DT O
operation NN O
was VBD O
completed VBN O
in IN O
the DT O
usual JJ O
manner NN O
. . O

During IN O
the DT O
postoperative JJ O
phase NN O
, , O
the DT O
patient NN O
recovered VBD B-Sign_symptom
well RB B-Lab_value
from IN O
surgery NN O
although IN O
hospitalization NN O
was VBD O
prolonged VBN O
by IN O
transient JJ B-Detailed_description
renal JJ B-Disease_disorder
failure NN I-Disease_disorder
and CC O
recurring VBG B-Detailed_description
pleural JJ B-Disease_disorder
effusions NNS I-Disease_disorder
. . O

After IN O
a DT O
month NN O
of IN O
postoperative JJ B-Therapeutic_procedure
care NN I-Therapeutic_procedure
, , O
the DT O
patient NN O
was VBD O
discharged VBN O
from IN O
hospital NN B-Nonbiological_location
to TO O
rehabilitation NN B-Therapeutic_procedure
in IN O
a DT O
good JJ B-Lab_value
condition NN B-Diagnostic_procedure
, , O
without IN O
signs NNS B-Sign_symptom
for IN I-Sign_symptom
heart NN I-Sign_symptom
failure NN I-Sign_symptom
. . O

At IN O
follow SYM O
- : O
up RB O
three CD O
months NNS O
after IN O
surgery NN O
, , O
the DT O
patient NN O
was VBD O
still RB O
in IN O
a DT O
cardiopulmonary JJ B-Lab_value
stable JJ I-Lab_value
condition NN B-Diagnostic_procedure
, , O
undergoing VBG O
additional JJ O
physiotherapy NN B-Therapeutic_procedure
. . O

-DOCSTART- NN -X-

A DT O
3 CD B-Age
- : I-Age
month NN I-Age
- : I-Age
old JJ I-Age
infant NN O
from IN O
the DT O
UAE NNP O
with IN O
a DT O
genetically RB O
- : O
confirmed VBN O
diagnosis NN O
of IN O
Jarcho NNP O
- : O
Levin NNP O
syndrome NN O
and CC O
dependent NN O
on IN O
mechanical JJ O
ventilation NN O
since IN O
birth NN O
was VBD O
admitted VBN O
to TO O
our PRP$ O
centre NN B-Nonbiological_location
for IN O
the DT O
implantation NN B-Therapeutic_procedure
of IN I-Therapeutic_procedure
VEPTRs NNP I-Therapeutic_procedure
. . O

We PRP O
received VBD O
an DT O
intubated JJ B-Therapeutic_procedure
patient NN O
, , O
mechanically RB B-Detailed_description
ventilated VBN B-Therapeutic_procedure
in IN O
a DT O
volume NN B-Detailed_description
- : I-Detailed_description
controlled JJ I-Detailed_description
mode NN I-Detailed_description
, , O
with IN O
a DT O
0 CD B-Lab_value
. . I-Lab_value
30 CD I-Lab_value
- : I-Lab_value
0 CD I-Lab_value
. . I-Lab_value
45 CD I-Lab_value
fraction NN I-Lab_value
of IN I-Lab_value
inspired JJ I-Lab_value
oxygen NN I-Lab_value
( ( O
FiO2 NNP O
) ) O
( ( O
peak JJ B-Lab_value
inspiratory NN I-Lab_value
pressures NNS I-Lab_value
( ( I-Lab_value
PIP NNP I-Lab_value
) ) I-Lab_value
of IN I-Lab_value
23 CD I-Lab_value
- : I-Lab_value
45 CD I-Lab_value
cm NN I-Lab_value
H2O NNP I-Lab_value
, , O
positive JJ B-Lab_value
end NN I-Lab_value
- : I-Lab_value
expiratory JJ I-Lab_value
pressure NN I-Lab_value
( ( I-Lab_value
PEEP NNP I-Lab_value
) ) I-Lab_value
of IN I-Lab_value
7 CD I-Lab_value
cm NN I-Lab_value
H2O NNP I-Lab_value
, , O
backup JJ B-Lab_value
respiratory NN I-Lab_value
rate NN I-Lab_value
( ( I-Lab_value
RR NNP I-Lab_value
) ) I-Lab_value
of IN I-Lab_value
34 CD I-Lab_value
) ) O
. . O

A DT O
chest NN B-Biological_structure
X SYM B-Diagnostic_procedure
- : I-Diagnostic_procedure
ray NN I-Diagnostic_procedure
of IN O
the DT O
thorax NN B-Biological_structure
was VBD O
performed VBN O
on IN O
admission NN O
( ( O
figure JJ O
1A CD O
) ) O
, , O
and CC O
a DT O
month NN O
after IN O
the DT O
first JJ O
surgery NN B-Therapeutic_procedure
( ( O
figure NN O
1B CD O
) ) O
, , O
showing VBG O
improvement NN O
of IN O
the DT O
bilateral JJ B-Detailed_description
posterior JJ B-Detailed_description
atelectasis NN B-Disease_disorder
in IN O
the DT O
base NN B-Biological_structure
of IN I-Biological_structure
the DT I-Biological_structure
lungs NNS I-Biological_structure
. . O

Owing VBG O
to TO O
the DT O
difficulty NN O
of IN O
progressing VBG O
in IN O
the DT O
weaning VBG O
process NN O
from IN O
mechanical JJ O
ventilation NN O
after IN O
the DT O
VEPTRs NNP O
were VBD O
implanted VBN O
to TO O
expand VB O
the DT O
thorax NN O
, , O
a DT O
bronchoscopy NN B-Therapeutic_procedure
was VBD O
performed VBN O
, , O
showing VBG O
bronchomalacia NNS B-Disease_disorder
predominantly RB O
in IN O
both DT B-Biological_structure
upper JJ I-Biological_structure
lobar NN I-Biological_structure
bronchi NN I-Biological_structure
. . O

As IN O
prolonged JJ B-Detailed_description
mechanical JJ B-Detailed_description
ventilation NN B-Therapeutic_procedure
was VBD O
expected VBN O
, , O
a DT O
tracheostomy NN B-Therapeutic_procedure
was VBD O
previously RB O
performed VBN O
. . O

After IN O
an DT O
initial JJ O
CT NNP B-Diagnostic_procedure
scan NN O
( ( O
figure JJ O
2A CD O
) ) O
, , O
a DT O
follow NN O
- : O
up RB O
CT NNP B-Diagnostic_procedure
scan JJ O
( ( O
figure JJ O
2B CD O
) ) O
a DT O
month NN O
after IN O
the DT O
surgery NN O
showed VBD O
a DT O
resolution NN O
of IN O
the DT O
posterior JJ B-Detailed_description
- : I-Detailed_description
basal NN I-Detailed_description
atelectasis NN B-Disease_disorder
, , O
coinciding VBG O
with IN O
a DT O
decrease NN B-Lab_value
of IN O
FiO2 NNP B-Diagnostic_procedure
to TO O
0 CD B-Lab_value
. . I-Lab_value
21 CD I-Lab_value
. . O

Postoperatively RB O
, , O
the DT O
patient NN O
was VBD O
on IN O
the DT O
Servo NNP B-Detailed_description
- : I-Detailed_description
i NN I-Detailed_description
ventilator NN B-Therapeutic_procedure
in IN O
a DT O
volume NN B-Detailed_description
- : I-Detailed_description
controlled VBN I-Detailed_description
mode NN I-Detailed_description
and CC O
needed VBN O
variable JJ B-Detailed_description
PIPs NNP B-Diagnostic_procedure
between IN B-Lab_value
25 CD I-Lab_value
and CC I-Lab_value
45 CD I-Lab_value
cm NN I-Lab_value
H2O NNP I-Lab_value
and CC O
PEEP NNP B-Diagnostic_procedure
values NNS O
of IN O
7 CD B-Lab_value
- : I-Lab_value
11 CD I-Lab_value
cm NN I-Lab_value
H2O NNP I-Lab_value
. . O

During IN O
the DT O
attempts NNS O
to TO O
wean VB O
the DT O
patient NN O
off IN O
the DT O
ventilator NN O
in IN O
the DT O
following JJ O
months NNS O
, , O
he PRP O
was VBD O
unable JJ O
to TO O
activate VB O
the DT O
inspiratory NN O
flow NN O
trigger NN O
and CC O
required VBN O
significant JJ O
sedoanalgesia NN B-Medication
to TO O
adapt VB O
to TO O
the DT O
ventilator NN O
due JJ O
to TO O
repeated JJ O
episodes NNS O
of IN O
desaturation NN B-Sign_symptom
, , O
on IN O
some DT O
occasions NNS O
with IN O
bradycardia NN B-Sign_symptom
, , O
associated VBN O
to TO O
bronchial JJ B-Disease_disorder
collapse NN I-Disease_disorder
. . O

He PRP O
continued VBD O
to TO O
have VB O
asynchrony NN B-Sign_symptom
which WDT O
required VBD O
boluses NNS O
of IN O
sedation NN B-Medication
in IN O
addition NN O
to TO O
existing VBG O
medications NNS O
. . O

He PRP O
initially RB O
received VBD O
fentanyl JJ B-Medication
and CC O
midazolam VBZ B-Medication
through IN O
a DT O
continuous JJ O
infusion NN O
pump NN O
with IN O
progressive JJ B-Dosage
increase NN I-Dosage
in IN I-Dosage
the DT I-Dosage
doses NNS I-Dosage
as RB O
well RB O
as IN O
continuous JJ B-Dosage
cisatracurium NN B-Medication
as IN O
a DT O
muscular JJ B-Medication
relaxant NN I-Medication
to TO O
adapt VB O
to TO O
mechanical JJ O
ventilation NN O
( ( O
figure JJ O
3 CD O
) ) O
. . O

As IN O
clinical JJ B-Sign_symptom
stabilisation NN I-Sign_symptom
was VBD O
achieved VBN O
, , O
the DT O
muscular JJ B-Medication
relaxant NN I-Medication
was VBD O
withdrawn VBN O
and CC O
a DT O
progressive JJ B-Dosage
decrease NN I-Dosage
of IN O
sedation NN B-Medication
was VBD O
initiated VBN O
along IN O
with IN O
a DT O
change NN O
in IN O
the DT O
drug NN O
regimen NNS O
. . O

During IN O
this DT O
period NN O
, , O
the DT O
patient NN O
developed VBD O
an DT O
ocular JJ B-Sign_symptom
flutter NN I-Sign_symptom
which WDT O
was VBD O
attributed VBN O
to TO O
a DT O
pharmacological JJ O
cause NN O
after IN O
neurological JJ O
alterations NNS O
were VBD O
ruled VBN O
out RP O
with IN O
normal JJ B-Lab_value
EEG NNP B-Diagnostic_procedure
, , O
ophthalmoscopy NN B-Diagnostic_procedure
, , O
metabolic JJ B-Diagnostic_procedure
workup NN I-Diagnostic_procedure
and CC O
cranial JJ B-Biological_structure
MRI NNP B-Diagnostic_procedure
. . O

At IN O
5 CD O
months NNS O
of IN O
age NN O
, , O
the DT O
NAVA NNP B-Therapeutic_procedure
mode NN I-Therapeutic_procedure
started VBD O
to TO O
improve VB B-Lab_value
the DT O
patient NN O
` `` O
s JJ O
adaptation NN B-Diagnostic_procedure
to TO I-Diagnostic_procedure
the DT I-Diagnostic_procedure
ventilator NN I-Diagnostic_procedure
through IN O
the DT O
use NN O
of IN O
a DT O
neural JJ B-Therapeutic_procedure
trigger NN I-Therapeutic_procedure
. . O

The DT O
NAVA NNP B-Therapeutic_procedure
catheter NN I-Therapeutic_procedure
additionally RB O
costs VBZ B-Detailed_description
around IN I-Detailed_description
$ $ I-Detailed_description
200 CD I-Detailed_description
per IN I-Detailed_description
catheter NN I-Detailed_description
; : O
according VBG B-Other_entity
to TO I-Other_entity
the DT I-Other_entity
manufacturer NN I-Other_entity
it PRP I-Other_entity
should MD I-Other_entity
be VB I-Other_entity
changed VBN I-Other_entity
every DT I-Other_entity
5 CD I-Other_entity
days NNS I-Other_entity
. . O

It PRP O
was VBD O
required VBN O
for IN B-Duration
7 CD I-Duration
months NNS I-Duration
; : O
nevertheless RB O
the DT O
catheters NNS B-Therapeutic_procedure
were VBD I-Therapeutic_procedure
changed VBN I-Therapeutic_procedure
every DT B-Frequency
15 CD I-Frequency
days NNS I-Frequency
without IN O
observing VBG O
a DT O
deterioration NN B-Sign_symptom
of IN I-Sign_symptom
the DT I-Sign_symptom
Edi NNP I-Sign_symptom
signal NN I-Sign_symptom
. . O

According VBG B-Other_entity
to TO I-Other_entity
the DT I-Other_entity
literature NN I-Other_entity
, , I-Other_entity
Jarcho NNP I-Other_entity
- : I-Other_entity
Levin NNP I-Other_entity
syndrome NN I-Other_entity
does VBZ I-Other_entity
not RB I-Other_entity
appear VB I-Other_entity
with IN I-Other_entity
mental JJ I-Other_entity
retardation NN I-Other_entity
and CC I-Other_entity
life NN I-Other_entity
expectancy NN I-Other_entity
is VBZ I-Other_entity
pretty RB I-Other_entity
long RB I-Other_entity
, , I-Other_entity
so RB I-Other_entity
ethically RB I-Other_entity
, , I-Other_entity
we PRP I-Other_entity
considered VBD I-Other_entity
that IN I-Other_entity
this DT I-Other_entity
patient NN I-Other_entity
should MD I-Other_entity
have VB I-Other_entity
an DT I-Other_entity
opportunity NN I-Other_entity
to TO I-Other_entity
overcome VB I-Other_entity
his PRP$ I-Other_entity
thoracic NN I-Other_entity
insufficiency NN I-Other_entity
if IN I-Other_entity
it PRP I-Other_entity
were VBD I-Other_entity
technically RB I-Other_entity
possible JJ I-Other_entity
. . O

Tachypnoea NNP B-Sign_symptom
was VBD O
initially RB O
observed VBN O
with IN O
a DT O
RR NNP B-Diagnostic_procedure
of IN O
55 CD B-Lab_value
without IN O
other JJ O
signs NNS O
of IN O
increase NN O
in IN O
his PRP$ O
work NN B-Sign_symptom
of IN I-Sign_symptom
breathing VBG I-Sign_symptom
and CC O
his PRP$ O
RR NNP B-Diagnostic_procedure
eventually RB O
returned VBD O
to TO O
normal JJ B-Lab_value
for IN O
his PRP$ O
age NN O
( ( O
40 CD B-Lab_value
) ) O
over IN O
the DT O
next JJ O
few JJ O
days NNS O
. . O

The DT O
synchrony NN B-Sign_symptom
achieved VBN O
with IN O
the DT O
ventilator NN B-Therapeutic_procedure
allowed VBD O
a DT O
progressive JJ O
decrease NN O
of IN O
the DT O
sedoanalgesia NN B-Medication
he PRP O
received VBD O
until IN O
it PRP O
was VBD O
completely RB O
withdrawn VBN O
in IN O
10 CD O
days NNS O
; : O
and CC O
the DT O
need NN O
for IN O
extra JJ O
boluses NNS O
of IN O
sedation NN B-Medication
was VBD O
reduced VBN O
to TO O
zero CD O
. . O

Concurrently RB O
to TO O
the DT O
reduction NN O
of IN O
sedation NN O
, , O
his PRP$ O
ocular JJ B-Sign_symptom
flutter NN I-Sign_symptom
disappeared VBD O
and CC O
he PRP O
showed VBD O
significant JJ O
progress NN B-Lab_value
in IN O
his PRP$ O
psychomotor NN B-Diagnostic_procedure
development NN I-Diagnostic_procedure
. . O

The DT O
settings NNS O
used VBN O
were VBD O
: : O
NAVA NNP B-Lab_value
level NN I-Lab_value
of IN I-Lab_value
1 CD I-Lab_value
cm NNS I-Lab_value
H2O NNP I-Lab_value
/ NNP I-Lab_value
µV NNP I-Lab_value
, , O
PEEP NNP B-Lab_value
11 CD I-Lab_value
cm NN I-Lab_value
H2O NNP I-Lab_value
, , O
Edi NNP B-Lab_value
trigger NN I-Lab_value
0 CD I-Lab_value
. . I-Lab_value
5 CD I-Lab_value
µV NN I-Lab_value
. . O

The DT O
patient NN O
had VBD O
tidal VBN B-Diagnostic_procedure
volumes NNS I-Diagnostic_procedure
( ( O
Vt NNP B-Diagnostic_procedure
) ) O
of IN O
6 CD B-Lab_value
- : I-Lab_value
7 CD I-Lab_value
mL NN I-Lab_value
/ NN I-Lab_value
kg NN I-Lab_value
( ( O
figure JJ O
3 CD O
) ) O
. . O

After IN O
10 CD O
days NNS O
on IN O
the DT O
NAVA NNP B-Therapeutic_procedure
mode NN I-Therapeutic_procedure
, , O
he PRP O
did VBD O
not RB O
require VB O
any DT O
type NN O
of IN O
sedation NN B-Medication
and CC O
the DT O
sporadic JJ O
episodes NNS O
of IN O
bronchial JJ B-Disease_disorder
collapse NN I-Disease_disorder
were VBD O
resolved VBN O
with IN O
a DT O
quick JJ O
increase NN O
of IN O
PEEP NNP B-Diagnostic_procedure
to TO O
20 CD B-Lab_value
cm NN I-Lab_value
H2O NNP I-Lab_value
or CC O
manual JJ B-Detailed_description
ventilation NN B-Therapeutic_procedure
with IN O
the DT O
self NN B-Detailed_description
- : I-Detailed_description
inflating NN I-Detailed_description
bag NN I-Detailed_description
. . O

Once RB O
he PRP O
was VBD O
stabilised VBN O
on IN O
the DT O
NAVA NNP B-Therapeutic_procedure
mode NN I-Therapeutic_procedure
, , O
his PRP$ O
PIPs NNP B-Diagnostic_procedure
oscillated VBD O
between IN B-Lab_value
15 CD I-Lab_value
and CC I-Lab_value
45 CD I-Lab_value
cm NNS I-Lab_value
H2O NNP I-Lab_value
with IN O
a DT O
NAVA NNP B-Lab_value
level NN I-Lab_value
of IN I-Lab_value
0 CD I-Lab_value
. . I-Lab_value
4 CD I-Lab_value
and CC O
Edi NNP B-Diagnostic_procedure
peaks NNS I-Diagnostic_procedure
between IN B-Lab_value
15 CD I-Lab_value
and CC I-Lab_value
100 CD I-Lab_value
µV NN I-Lab_value
. . O

A DT O
posterior JJ B-Detailed_description
pulmonary JJ B-Biological_structure
CT NNP B-Diagnostic_procedure
scan NN O
performed VBD O
2 CD O
months NNS O
after IN O
the DT O
first JJ O
surgery NN O
, , O
1 CD O
month NN O
after IN O
starting VBG O
NAVA NNP O
and CC O
prior RB O
to TO O
the DT O
first JJ O
thoracic NN O
expansion NN O
, , O
showed VBD O
a DT O
significant JJ O
reduction NN O
in IN O
the DT O
posterobasal NN B-Detailed_description
atelectases VBZ B-Disease_disorder
previously RB O
observed VBN O
( ( O
figure JJ O
2B CD O
) ) O
. . O

When WRB O
he PRP O
turned VBD O
1 CD O
year NN O
old JJ O
, , O
after IN O
several JJ O
attempts NNS O
with IN O
different JJ B-Therapeutic_procedure
devices NNS I-Therapeutic_procedure
Trilogy VBP B-Detailed_description
100 CD I-Detailed_description
( ( I-Detailed_description
Philips NNP I-Detailed_description
) ) I-Detailed_description
, , O
Astral JJ B-Detailed_description
150 CD I-Detailed_description
( ( I-Detailed_description
ResMed NNP I-Detailed_description
) ) I-Detailed_description
, , O
the DT O
patient NN O
finally RB O
tolerated VBD O
mechanical JJ B-Detailed_description
ventilation NN B-Therapeutic_procedure
with IN O
a DT O
home NN B-Detailed_description
ventilator NN I-Detailed_description
( ( O
Monnal NNP B-Detailed_description
T NNP I-Detailed_description
- : I-Detailed_description
50 CD I-Detailed_description
, , I-Detailed_description
Air NNP I-Detailed_description
Liquide NNP I-Detailed_description
) ) O
in IN O
a DT O
volume NN B-Detailed_description
assisted VBN I-Detailed_description
/ NNP I-Detailed_description
controlled VBD I-Detailed_description
mode NN I-Detailed_description
with IN I-Detailed_description
the DT I-Detailed_description
following JJ I-Detailed_description
settings NNS I-Detailed_description
: : O
Vt NNP B-Lab_value
80 CD I-Lab_value
mL NN I-Lab_value
( ( I-Lab_value
9 CD I-Lab_value
mL NN I-Lab_value
/ NNP I-Lab_value
kg NN I-Lab_value
) ) I-Lab_value
, , O
PEEP NNP B-Lab_value
10 CD I-Lab_value
cm NN I-Lab_value
H2O NNP I-Lab_value
, , O
flow NN B-Lab_value
trigger NN I-Lab_value
0 CD I-Lab_value
. . I-Lab_value
5 CD I-Lab_value
L NNP I-Lab_value
/ NNP I-Lab_value
min NN I-Lab_value
. . O

His PRP$ O
PIPs NN B-Diagnostic_procedure
were VBD O
around RB B-Lab_value
30 CD I-Lab_value
cm NN I-Lab_value
H2O NNP I-Lab_value
. . O

He PRP O
did VBD O
not RB O
tolerate VB B-Sign_symptom
a DT O
decrease NN B-Lab_value
of IN O
PEEP NNP B-Diagnostic_procedure
below IN B-Lab_value
9 CD I-Lab_value
cm NN I-Lab_value
H2O NNP I-Lab_value
or CC O
short JJ B-Detailed_description
disconnections NNS I-Detailed_description
from IN O
the DT O
ventilator NN B-Therapeutic_procedure
. . O

Currently RB O
, , O
the DT O
patient NN O
is VBZ O
19 CD O
months NNS O
old JJ O
, , O
is VBZ O
able JJ B-Sign_symptom
to TO I-Sign_symptom
walk VB I-Sign_symptom
and CC O
his PRP$ O
neurodevelopment NN B-Diagnostic_procedure
seems VBZ O
to TO O
be VB O
normal JJ B-Lab_value
. . O

-DOCSTART- NN -X-

A DT O
female JJ O
outpatient NN O
in IN O
her PRP$ O
50s CD O
had VBD O
routinely RB O
visited VBN O
our PRP$ O
hospital NN B-Nonbiological_location
because IN O
of IN O
liver JJ O
cirrhosis NN O
resulting VBG O
from IN O
hepatitis NN O
B NNP O
virus NN O
and CC O
biliary JJ O
duct NN O
stones NNS O
. . O

At IN O
65 CD B-Age
years NNS I-Age
of IN I-Age
age NN I-Age
, , O
she PRP O
suffered VBD O
from IN O
HCC NNP B-Disease_disorder
with IN O
BCLC NNP B-Lab_value
early JJ I-Lab_value
stage NN I-Lab_value
A DT I-Lab_value
. . O

Her PRP$ O
liver NN B-Diagnostic_procedure
function NN I-Diagnostic_procedure
was VBD O
well RB B-Lab_value
preserved VBN I-Lab_value
, , O
and CC O
Child NNP B-Diagnostic_procedure
- : I-Diagnostic_procedure
Pugh NNP I-Diagnostic_procedure
score NN I-Diagnostic_procedure
was VBD O
A DT B-Lab_value
. . O

She PRP O
underwent JJ O
left VBD B-Detailed_description
lateral JJ I-Detailed_description
segmentectomy NN B-Therapeutic_procedure
for IN O
HCC NNP B-Disease_disorder
, , O
without IN O
other JJ B-Therapeutic_procedure
preoperative JJ I-Therapeutic_procedure
treatments NNS I-Therapeutic_procedure
. . O

Histopathological JJ B-Diagnostic_procedure
findings NNS I-Diagnostic_procedure
revealed VBD O
bridging VBG B-Detailed_description
fibrosis NN B-Disease_disorder
and CC O
pseudolobule NN B-Disease_disorder
formation NN I-Disease_disorder
. . O

Serum NNP B-Biological_structure
levels NNS O
of IN O
alpha NN B-Diagnostic_procedure
- : I-Diagnostic_procedure
fetoprotein NN I-Diagnostic_procedure
( ( O
AFP NNP B-Diagnostic_procedure
) ) O
and CC O
protein NN B-Diagnostic_procedure
induced VBN I-Diagnostic_procedure
by IN I-Diagnostic_procedure
vitamin NN I-Diagnostic_procedure
K NNP I-Diagnostic_procedure
absence NN I-Diagnostic_procedure
- : I-Diagnostic_procedure
II NNP I-Diagnostic_procedure
normalized VBD B-Lab_value
after IN O
primary JJ O
resection NN O
( ( O
Figure NNP O
1 CD O
) ) O
. . O

In IN O
imaging VBG B-Diagnostic_procedure
studies NNS I-Diagnostic_procedure
, , O
no DT O
LN NNP B-Biological_structure
metastasis NN B-Sign_symptom
was VBD O
detected VBN O
at IN O
the DT O
time NN O
of IN O
primary JJ O
resection NN O
of IN O
HCC NNP O
. . O

Two CD O
and CC O
a DT O
half JJ O
years NNS O
postoperatively RB O
, , O
the DT O
patient NN O
` `` O
s JJ O
AFP NNP B-Diagnostic_procedure
level NN I-Diagnostic_procedure
increased VBD B-Lab_value
dramatically RB I-Lab_value
to TO O
780 CD B-Lab_value
. . I-Lab_value
2 CD I-Lab_value
ng JJ I-Lab_value
/ NNP I-Lab_value
ml NN I-Lab_value
. . O

A DT O
lobular JJ B-Shape
lesion NN B-Sign_symptom
with IN O
fine JJ B-Detailed_description
enhancement NN I-Detailed_description
was VBD O
detected VBN O
by IN O
contrast NN B-Detailed_description
- : I-Detailed_description
enhanced VBN I-Detailed_description
magnetic JJ B-Diagnostic_procedure
resonance NN I-Diagnostic_procedure
imaging NN I-Diagnostic_procedure
. . O

The DT O
tumor NN O
measured VBD O
27 CD B-Distance
mm NN I-Distance
in IN I-Distance
diameter NN I-Distance
and CC O
was VBD O
located VBN O
caudally RB B-Biological_structure
on IN I-Biological_structure
the DT I-Biological_structure
left JJ I-Biological_structure
kidney NN I-Biological_structure
. . O

In IN O
contrast NN B-Detailed_description
- : I-Detailed_description
enhanced VBN I-Detailed_description
computed JJ B-Diagnostic_procedure
tomography NN I-Diagnostic_procedure
, , O
the DT O
tumor NN O
showed VBD O
strong JJ B-Detailed_description
enhancement NN B-Sign_symptom
in IN O
the DT O
arterial JJ B-Biological_structure
phase NN I-Biological_structure
( ( O
Figure NNP O
2A CD O
, , O
2B CD O
) ) O
and CC O
a DT O
relatively RB B-Detailed_description
low JJ I-Detailed_description
density NN B-Sign_symptom
in IN O
the DT O
portal JJ B-Biological_structure
phase NN I-Biological_structure
( ( O
Figure NNP O
2C CD O
, , O
2D CD O
) ) O
. . O

These DT O
enhancement JJ O
findings NNS O
appeared VBD O
consistent JJ O
with IN O
a DT O
typical JJ B-Detailed_description
HCC NNP B-Disease_disorder
pattern NN O
. . O

Detailed VBN O
imaging JJ O
studies NNS O
of IN O
both DT O
magnetic JJ O
resonance NN O
imaging NN O
and CC O
computed VBN O
tomography NN O
were VBD O
performed VBN O
in IN O
this DT O
case NN O
because IN O
a DT O
very RB O
rare JJ O
metastatic JJ O
LN NNP O
initially RB O
seemed VBD O
to TO O
be VB O
debatable JJ O
and CC O
we PRP O
needed VBD O
to TO O
rule VB O
out RP O
exclusion NN O
diagnoses NNS O
. . O

Three CD B-Diagnostic_procedure
- : I-Diagnostic_procedure
dimensional JJ I-Diagnostic_procedure
imaging NN I-Diagnostic_procedure
proved VBD O
that IN O
the DT O
tumor NN O
was VBD O
fed VBN B-Biological_structure
by IN I-Biological_structure
a DT I-Biological_structure
main JJ I-Biological_structure
vessel NN I-Biological_structure
from IN I-Biological_structure
the DT I-Biological_structure
inferior JJ I-Biological_structure
mesenteric JJ I-Biological_structure
artery NN I-Biological_structure
( ( O
red JJ O
arrow NN O
) ) O
and CC O
by IN O
an DT O
accessory JJ B-Biological_structure
feeder NN I-Biological_structure
from IN I-Biological_structure
the DT I-Biological_structure
superior JJ I-Biological_structure
mesenteric JJ I-Biological_structure
artery NN I-Biological_structure
( ( O
Figure NNP O
3 CD O
) ) O
. . O

Fluorine NNP B-Diagnostic_procedure
- : I-Diagnostic_procedure
18 CD I-Diagnostic_procedure
- : I-Diagnostic_procedure
fluorodeoxyglucose JJ I-Diagnostic_procedure
positron NN I-Diagnostic_procedure
emission NN I-Diagnostic_procedure
tomography NN I-Diagnostic_procedure
( ( O
FDG NNP B-Diagnostic_procedure
- : I-Diagnostic_procedure
PET NN I-Diagnostic_procedure
) ) O
and CC O
positron $ B-Diagnostic_procedure
emission NN I-Diagnostic_procedure
tomography NN I-Diagnostic_procedure
- : I-Diagnostic_procedure
computed VBN I-Diagnostic_procedure
tomography NN I-Diagnostic_procedure
did VBD O
not RB O
detect VB O
the DT O
tumor NN O
( ( O
Figure NNP O
4 CD O
) ) O
, , O
although IN O
we PRP O
thought VBD O
positron NN O
emission NN O
tomography NN O
- : O
computed VBD O
tomography NN O
was VBD O
helpful JJ O
to TO O
identify VB O
other JJ O
metastatic JJ O
tumors NNS O
. . O

Further RB O
imaging VBG O
findings NNS O
revealed VBN O
no DT O
other JJ O
intrahepatic JJ B-Biological_structure
or CC O
extrahepatic JJ B-Biological_structure
metastasis NN B-Sign_symptom
. . O

Based VBN O
on IN O
the DT O
tumor NN O
location NN O
, , O
the DT O
clinical JJ O
diagnosis NN O
was VBD O
solitary JJ B-Detailed_description
metastasis NN B-Sign_symptom
to TO O
a DT O
mesocolic JJ B-Biological_structure
LN NNP I-Biological_structure
or CC O
HCC NNP B-Disease_disorder
dissemination NN B-Detailed_description
. . O

Determining VBG O
the DT O
ideal JJ O
therapeutic JJ O
strategy NN O
for IN O
solitary JJ O
but CC O
extrahepatic JJ O
rare JJ O
metastasis NN O
was VBD O
difficult JJ O
. . O

Although IN O
rapid JJ O
growth NN O
was VBD O
a DT O
critical JJ O
concern NN O
in IN O
this DT O
case NN O
, , O
the DT O
tumor NN B-Sign_symptom
was VBD O
solitary JJ B-Detailed_description
and CC O
not RB O
accompanied VBN O
by IN O
other JJ B-Detailed_description
metastases NNS B-Sign_symptom
. . O

Considering VBG O
both DT O
diagnostic JJ O
and CC O
therapeutic JJ O
viewpoints NNS O
, , O
we PRP O
finally RB O
chose VBD O
surgical JJ B-Therapeutic_procedure
resection NN I-Therapeutic_procedure
in IN O
this DT O
case NN O
. . O

No DT O
disseminative JJ B-Sign_symptom
nodules NNS I-Sign_symptom
, , O
lymphadenopathy JJ B-Disease_disorder
, , O
or CC O
ascites NNS B-Sign_symptom
was VBD O
observed VBN O
during IN O
surgery NN O
. . O

The DT O
tumor NN O
was VBD O
located VBN O
in IN O
the DT O
mesocolon NN B-Biological_structure
nearly RB O
at IN B-Biological_structure
the DT I-Biological_structure
wall NN I-Biological_structure
of IN I-Biological_structure
the DT I-Biological_structure
descending NN I-Biological_structure
colon NN I-Biological_structure
, , O
and CC O
partial JJ O
resection NN O
of IN O
the DT O
descending VBG B-Biological_structure
colon NN I-Biological_structure
with IN O
regional JJ B-Biological_structure
mesocolon NN I-Biological_structure
was VBD O
performed VBN O
. . O

The DT O
patient NN O
` `` O
s JJ O
postoperative JJ B-Therapeutic_procedure
course NN I-Therapeutic_procedure
was VBD O
uneventful JJ B-Lab_value
, , O
and CC O
she PRP O
was VBD O
discharged VBN O
on IN O
postoperative JJ O
day NN O
8 CD O
. . O

Serum NNP B-Biological_structure
levels NNS O
of IN O
tumor NN B-Diagnostic_procedure
marker NN I-Diagnostic_procedure
decreased VBD B-Lab_value
immediately RB I-Lab_value
after IN O
surgery NN O
( ( O
Figure NNP O
1 CD O
) ) O
. . O

Macroscopically RB B-Diagnostic_procedure
, , O
the DT O
mesocolic JJ O
tumor NN O
was VBD O
a DT O
solid JJ B-Lab_value
and CC O
elastic JJ B-Lab_value
mass NN O
with IN O
a DT O
smooth JJ B-Texture
surface NN I-Texture
( ( O
Figure NNP O
5A CD O
) ) O
. . O

A DT O
yellowish JJ B-Color
nodule NN B-Sign_symptom
was VBD O
encapsulated VBN B-Detailed_description
in IN I-Detailed_description
the DT I-Detailed_description
cut NN I-Detailed_description
surface NN I-Detailed_description
( ( O
Figure NNP O
5B CD O
) ) O
. . O

The DT O
enlarged JJ B-Detailed_description
LN NNP I-Detailed_description
contained VBD O
metastatic JJ B-Detailed_description
HCC NNP B-Disease_disorder
with IN O
a DT O
ductal JJ B-Detailed_description
structure NN I-Detailed_description
( ( O
Figure NNP O
6A CD O
) ) O
, , O
and CC O
immunohistochemically RB B-Diagnostic_procedure
, , O
the DT O
tumor NN O
was VBD O
positive JJ B-Lab_value
for IN O
AFP NNP B-Diagnostic_procedure
and CC O
negative JJ B-Lab_value
for IN O
CK NNP B-Diagnostic_procedure
- : I-Diagnostic_procedure
20 CD I-Diagnostic_procedure
, , O
which WDT O
was VBD O
consistent JJ O
with IN O
the DT O
pattern NN O
of IN O
primary JJ B-Detailed_description
HCC NNP B-Disease_disorder
( ( O
Figure NNP O
6B CD O
) ) O
. . O

The DT O
histopathological JJ O
diagnosis NN O
was VBD O
metastatic JJ B-Detailed_description
HCC NNP B-Disease_disorder
to TO O
a DT O
mesocolic JJ B-Biological_structure
LN NNP I-Biological_structure
. . O

As IN O
of IN O
the DT O
writing NN O
of IN O
this DT O
report NN O
, , O
the DT O
patient NN O
has VBZ O
remained VBN O
free JJ O
of IN O
recurrence NN B-Sign_symptom
for IN O
13 CD O
months NNS O
after IN O
the DT O
second JJ O
surgery NN O
, , O
and CC O
has VBZ O
also RB O
been VBN O
carefully RB O
followed VBN O
up RP O
. . O

No DT O
adjuvant JJ B-Medication
therapies NNS I-Medication
have VBP O
been VBN O
performed VBN O
. . O

-DOCSTART- NN -X-

A DT O
5 CD B-Age
- : I-Age
year NN I-Age
- : I-Age
old JJ I-Age
Caucasian JJ O
male NN B-Age
presented VBN O
to TO O
the DT O
Children NNP B-Nonbiological_location
` `` I-Nonbiological_location
s NN I-Nonbiological_location
Emergency NNP I-Nonbiological_location
Department NNP I-Nonbiological_location
with IN O
epistaxis NN B-Sign_symptom
, , O
bleeding VBG B-Sign_symptom
from IN O
the DT O
dental JJ B-Therapeutic_procedure
extraction NN I-Therapeutic_procedure
site NN B-Biological_structure
and CC O
a DT O
widespread JJ B-Detailed_description
purpuric NN B-Detailed_description
rash NN B-Sign_symptom
, , O
secondary JJ O
to TO O
acute VB B-Detailed_description
idiopathic JJ B-Detailed_description
thrombocytopenia NN B-Sign_symptom
. . O

Two CD O
days NNS O
prior RB O
to TO O
this DT O
, , O
he PRP O
developed VBD O
a DT O
generalised JJ B-Detailed_description
chickenpox NN B-Sign_symptom
rash NN I-Sign_symptom
. . O

While IN O
in IN O
the DT O
department NN O
it PRP O
was VBD O
noted VBN O
that IN O
his PRP$ O
heart NN B-Diagnostic_procedure
rate NN I-Diagnostic_procedure
ranged VBD O
between IN B-Lab_value
50 CD I-Lab_value
and CC I-Lab_value
60 CD I-Lab_value
beats NNS I-Lab_value
per IN I-Lab_value
min NN I-Lab_value
, , O
he PRP O
was VBD O
otherwise RB O
haemo JJ B-Sign_symptom
- : I-Sign_symptom
dynamically RB I-Sign_symptom
stable JJ I-Sign_symptom
with IN O
a DT O
normal JJ B-Lab_value
blood NN B-Diagnostic_procedure
pressure NN I-Diagnostic_procedure
and CC O
oxygen NN B-Diagnostic_procedure
saturations NNS I-Diagnostic_procedure
in IN O
air NN B-Detailed_description
. . O

He PRP O
had VBD O
a DT O
short JJ B-Detailed_description
systolic NN B-Detailed_description
murmur NN B-Sign_symptom
grade VBD B-Lab_value
2 CD I-Lab_value
/ JJ I-Lab_value
6 CD I-Lab_value
at IN O
the DT O
left JJ B-Biological_structure
sternal JJ I-Biological_structure
border NN I-Biological_structure
. . O

He PRP O
had VBD O
no DT O
clinical JJ O
evidence NN O
of IN O
myocarditis NN B-Disease_disorder
or CC O
heart NN B-Disease_disorder
failure NN I-Disease_disorder
. . O

He PRP O
had VBD O
extensive JJ B-Severity
generalised VBN B-Detailed_description
petechiae NN B-Sign_symptom
and CC O
purpuric JJ B-Detailed_description
rash NN B-Sign_symptom
( ( O
figure JJ O
1 CD O
) ) O
secondary NN O
to TO O
acute VB B-Detailed_description
thrombocytopenia NN B-Sign_symptom
presumed VBN O
to TO O
be VB O
due JJ O
to TO O
varicella VB B-Disease_disorder
infection NN I-Disease_disorder
. . O

Apparently RB O
he PRP O
was VBD O
healthy JJ B-Sign_symptom
prior RB O
to TO O
this DT O
admission NN O
. . O

There EX O
was VBD O
no DT O
history NN O
of IN O
maternal JJ O
lupus NN O
. . O

An DT O
ECG NNP B-Diagnostic_procedure
was VBD O
performed VBN O
which WDT O
showed VBD O
complete JJ B-Severity
heart NN B-Disease_disorder
block NN I-Disease_disorder
( ( O
figure NN O
2 CD O
) ) O
. . O

He PRP O
was VBD O
admitted VBN O
to TO O
the DT O
high JJ B-Nonbiological_location
dependency NN I-Nonbiological_location
unit NN I-Nonbiological_location
for IN O
close JJ B-Detailed_description
overnight JJ B-Duration
monitoring NN B-Therapeutic_procedure
. . O

The DT O
presumed JJ O
diagnosis NN O
was VBD O
complete JJ O
heart NN B-Disease_disorder
block NN I-Disease_disorder
secondary JJ O
to TO O
varicella VB B-Disease_disorder
infection NN I-Disease_disorder
. . O
1 CD O
2 CD O
The DT O
initial JJ O
investigation NN O
showed VBD O
normal JJ B-Lab_value
electrolytes NNS B-Diagnostic_procedure
, , O
calcium NN B-Diagnostic_procedure
, , O
phosphate NN B-Diagnostic_procedure
, , O
glucose NN B-Diagnostic_procedure
and CC O
magnesium NN B-Diagnostic_procedure
levels NNS O
. . O

The DT O
full JJ B-Diagnostic_procedure
blood NN I-Diagnostic_procedure
count NN I-Diagnostic_procedure
showed VBD O
a DT O
normal JJ B-Lab_value
haemoglobin NN B-Diagnostic_procedure
and CC O
white JJ B-Diagnostic_procedure
cell NN I-Diagnostic_procedure
count NN I-Diagnostic_procedure
. . O

But CC O
the DT O
platelet NN B-Diagnostic_procedure
count NN I-Diagnostic_procedure
was VBD O
low JJ B-Lab_value
that DT O
is VBZ O
, , O
13 CD B-Lab_value
× NN I-Lab_value
109 CD I-Lab_value
/ NN I-Lab_value
l NN I-Lab_value
. . O

The DT O
platelet NN B-Diagnostic_procedure
count NN I-Diagnostic_procedure
normalised VBD B-Lab_value
within IN O
10 CD O
days NNS O
without IN O
any DT O
intervention NN B-Therapeutic_procedure
. . O

The DT O
antinuclear JJ B-Diagnostic_procedure
antibody NN I-Diagnostic_procedure
titres NNS O
and CC O
the DT O
autoimmune NN B-Diagnostic_procedure
screen NN I-Diagnostic_procedure
were VBD O
negative JJ B-Lab_value
. . O

Maternal NNP O
autoimmune NN B-Detailed_description
screen NN I-Detailed_description
was VBD I-Detailed_description
negative JJ I-Detailed_description
. . O

The DT O
echocardiogram NN B-Diagnostic_procedure
showed VBD O
a DT O
structurally RB B-Sign_symptom
normal JJ I-Sign_symptom
heart NN B-Biological_structure
and CC O
follow VB O
- : O
up RB O
24 CD O
h NN O
tape NN O
showed VBD O
persistence NN O
of IN O
complete JJ B-Severity
heart NN B-Disease_disorder
block NN I-Disease_disorder
. . O

Following VBG O
these DT O
investigations NNS O
a DT O
diagnosis NN O
of IN O
congenital JJ B-Detailed_description
complete JJ B-Severity
heart NN B-Disease_disorder
block NN I-Disease_disorder
was VBD O
made VBN O
. . O

On IN O
follow SYM O
- : O
up RB O
after IN O
6 CD O
months NNS O
his PRP$ O
heart NN B-Diagnostic_procedure
rate NN I-Diagnostic_procedure
remains VBZ O
between IN B-Lab_value
50 CD I-Lab_value
and CC I-Lab_value
60 CD I-Lab_value
beats NNS I-Lab_value
per IN I-Lab_value
min NN I-Lab_value
, , O
but CC O
he PRP O
remains VBZ O
asymptomatic JJ B-Sign_symptom
without IN O
any DT O
intervention NN B-Therapeutic_procedure
. . O

The DT O
need NN O
for IN O
a DT O
pacemaker NN B-Therapeutic_procedure
is VBZ O
being VBG O
considered VBN O
on IN O
follow NN O
- : O
up RB O
. . O

The DT O
incidental JJ O
finding NN O
of IN O
complete JJ O
heart NN O
block NN O
was VBD O
congenital JJ O
in IN O
aetiology NN O
with IN O
no DT O
association NN O
with IN O
varicella JJ O
infection NN O
or CC O
acute JJ O
thrombocytopenia NN O
. . O

This DT O
case NN O
highlights VBZ O
that IN O
asymptomatic JJ O
late JJ O
- : O
presenting VBG O
congenital JJ O
complete JJ O
heart NN O
block NN O
must MD O
be VB O
considered VBN O
as IN O
a DT O
differential JJ O
diagnosis NN O
in IN O
children NNS O
presenting VBG O
with IN O
asymptomatic JJ O
bradycardia NN O
to TO O
the DT O
emergency NN O
department NN O
. . O

-DOCSTART- NN -X-

A DT O
44 CD B-Age
- : I-Age
year NN I-Age
- : I-Age
old JJ I-Age
Chinese JJ O
man NN O
with IN O
a DT O
7 CD O
pack NN O
- : O
year NN O
smoking VBG B-Activity
history NN O
was VBD O
referred VBN O
to TO O
Shanghai NNP B-Nonbiological_location
Pulmonary NNP I-Nonbiological_location
Hospital NNP I-Nonbiological_location
in IN O
February NNP O
2013 CD O
for IN O
a DT O
left JJ B-Biological_structure
upper JJ I-Biological_structure
lobe NN I-Biological_structure
lung NN B-Biological_structure
mass NN B-Sign_symptom
with IN O
multiple JJ B-Detailed_description
bilateral JJ B-Detailed_description
intrapulmonary JJ B-Biological_structure
metastases NNS B-Sign_symptom
, , O
left VBD B-Detailed_description
pleural JJ B-Disease_disorder
effusion NN I-Disease_disorder
, , O
and CC O
2R CD B-Lab_value
/ NNS I-Lab_value
4R CD I-Lab_value
/ $ I-Lab_value
10L CD I-Lab_value
/ $ I-Lab_value
11L CD I-Lab_value
lymphadenopathy NN B-Disease_disorder
. . O

Pleural NNP B-Biological_structure
fluid NN I-Biological_structure
cytology NN B-Diagnostic_procedure
revealed VBD O
adenocarcinoma NN B-Disease_disorder
and CC O
Scorpion NNP B-Diagnostic_procedure
Amplification NNP I-Diagnostic_procedure
Refractory NNP I-Diagnostic_procedure
Mutation NNP I-Diagnostic_procedure
system NN I-Diagnostic_procedure
( ( O
AmoyDx NNP B-Detailed_description
Co NNP I-Detailed_description
. . I-Detailed_description
, , I-Detailed_description
Xiamen NNS I-Detailed_description
, , I-Detailed_description
China NNP I-Detailed_description
) ) O
. . O

showed VBD O
no DT O
detectable JJ O
epidermal JJ B-Sign_symptom
growth NN I-Sign_symptom
factor NN I-Sign_symptom
receptor NN I-Sign_symptom
mutation NN I-Sign_symptom
. . O

He PRP O
commenced VBD O
chemotherapy NN B-Medication
with IN O
gemcitabine NN B-Medication
and CC O
cisplatin NN B-Medication
. . O

However RB O
, , O
after IN O
a DT O
single JJ O
cycle NN O
, , O
his PRP$ O
symptoms NNS B-Sign_symptom
worsened VBD O
and CC O
imaging VBG O
confirmed VBN O
progressive JJ B-Detailed_description
disease NN B-Disease_disorder
. . O

A DT O
second JJ O
opinion NN O
was VBD O
requested VBN O
from IN O
the DT O
University NNP B-Nonbiological_location
of IN I-Nonbiological_location
Colorado NNP I-Nonbiological_location
and CC O
a DT O
computed JJ B-Detailed_description
tomography NN I-Detailed_description
- : I-Detailed_description
guided VBD I-Detailed_description
biopsy NN B-Diagnostic_procedure
of IN O
the DT O
left JJ B-Biological_structure
upper JJ I-Biological_structure
lobe NN I-Biological_structure
lesion NN B-Sign_symptom
was VBD O
performed VBN O
to TO O
permit VB O
additional JJ O
molecular JJ O
testing NN O
. . O

In IN O
the DT O
interim NN O
, , O
the DT O
patient NN O
commenced VBD O
pemetrexed JJ B-Medication
and CC O
nedaplatin NN B-Medication
. . O

Unfortunately RB O
, , O
after IN O
two CD O
cycles NNS O
his PRP$ O
shortness NN B-Sign_symptom
of IN I-Sign_symptom
breath NN I-Sign_symptom
worsened VBN O
, , O
with IN O
evidence NN O
of IN O
further JJ B-Sign_symptom
progression NN I-Sign_symptom
on IN O
his PRP$ O
scans NNS B-Diagnostic_procedure
( ( O
Fig NNP O
. . O
1A CD O
) ) O
. . O

Molecular JJ O
testing VBG O
on IN O
his PRP$ O
repeat NN O
biopsy NN B-Diagnostic_procedure
specimen NNS O
revealed VBD O
no DT O
mutations NNS B-Sign_symptom
by IN O
SNaPshot NNP B-Detailed_description
multiplex NNP I-Detailed_description
PCR NNP B-Diagnostic_procedure
testing NN I-Diagnostic_procedure
( ( O
Life NNP O
Technologies NNPS O
, , O
Carlsbad NNP O
, , O
CA NNP O
) ) O
. . O

However RB O
, , O
although IN O
technically RB O
negative JJ O
, , O
the DT O
ALK NNP B-Detailed_description
break SYM I-Detailed_description
- : I-Detailed_description
apart RB I-Detailed_description
FISH NNP B-Diagnostic_procedure
test NN I-Diagnostic_procedure
showed VBD O
an DT O
atypical JJ B-Lab_value
negative JJ I-Lab_value
pattern NN I-Lab_value
. . O

Specifically RB O
, , O
68 CD B-Lab_value
% NN I-Lab_value
of IN I-Lab_value
cells NNS I-Lab_value
demonstrated VBN I-Lab_value
single JJ I-Lab_value
copies NNS I-Lab_value
of IN I-Lab_value
the DT I-Lab_value
5 CD I-Lab_value
′ NN I-Lab_value
ALK NNP I-Lab_value
signal NN I-Lab_value
and CC O
numerous JJ B-Lab_value
cells NNS I-Lab_value
with IN I-Lab_value
doublets NNS I-Lab_value
of IN I-Lab_value
the DT I-Lab_value
5 CD I-Lab_value
′ NN I-Lab_value
ALK NNP I-Lab_value
signal NN I-Lab_value
combined VBN I-Lab_value
with IN I-Lab_value
one CD I-Lab_value
3 CD I-Lab_value
′ NN I-Lab_value
ALK NNP I-Lab_value
signal NN I-Lab_value
( ( O
Fig NNP O
. . O
2A CD O
) ) O
. . O

Subsequently RB O
, , O
confirmatory JJ O
diagnostic JJ B-Diagnostic_procedure
assays NNS I-Diagnostic_procedure
demonstrated VBD O
ALK NNP B-Lab_value
protein NN I-Lab_value
expression NN I-Lab_value
by IN O
IHC NNP B-Diagnostic_procedure
using VBG O
the DT O
D5F3 NNP B-Detailed_description
antibody NN I-Detailed_description
( ( O
Cell NNP B-Detailed_description
Signaling NNP I-Detailed_description
Technology NNP I-Detailed_description
Inc NNP I-Detailed_description
. . I-Detailed_description
, , I-Detailed_description
Danvers NNPS I-Detailed_description
, , I-Detailed_description
MA NNP I-Detailed_description
; : O
H NNP O
score VBD O
= JJ O
150 CD O
; : O
Fig NNP O
. . O
2B CD O
) ) O
and CC O
the DT O
presence NN B-Lab_value
of IN I-Lab_value
an DT I-Lab_value
echinoderm JJ I-Lab_value
microtubule NN I-Lab_value
- : I-Lab_value
associated VBN I-Lab_value
protein SYM I-Lab_value
- : I-Lab_value
like IN I-Lab_value
4 CD I-Lab_value
( ( I-Lab_value
EML4 NNP I-Lab_value
) ) I-Lab_value
- : I-Lab_value
ALK $ I-Lab_value
transcript NN I-Lab_value
( ( O
E13 NNP O
; : O
A20 NNP O
) ) O
by IN O
RT NNP B-Diagnostic_procedure
- : I-Diagnostic_procedure
PCR NNP I-Diagnostic_procedure
( ( O
Fig NNP O
. . O
2C CD O
) ) O
. . O

The DT O
patient NN O
then RB O
received VBD O
crizotinib NNS B-Medication
( ( O
250 CD B-Dosage
mg NN I-Dosage
twice RB I-Dosage
daily RB I-Dosage
) ) O
as IN O
third JJ O
- : O
line NN O
therapy NN O
in IN O
May NNP O
2013 CD O
with IN O
an DT O
impressive JJ O
symptomatic JJ B-Sign_symptom
improvement NN I-Sign_symptom
and CC O
CT NNP O
response NN O
after IN O
1 CD O
month NN O
of IN O
therapy NN O
( ( O
Fig NNP O
. . O
1B CD O
) ) O
. . O

He PRP O
remains VBZ O
on IN O
treatment NN O
with IN O
crizotinib NN B-Medication
with IN O
no DT O
evidence NN O
of IN O
progression NN B-Sign_symptom
as IN O
of IN O
September NNP O
2013 CD O
. . O

-DOCSTART- NN -X-

In IN O
2013 CD O
, , O
a DT O
50 CD B-Age
- : I-Age
year NN I-Age
- : I-Age
old JJ I-Age
man NN O
patient NN O
visited VBD O
hospital JJ B-Nonbiological_location
complaining NN O
of IN O
local JJ B-Detailed_description
bone NN B-Biological_structure
pain NN B-Sign_symptom
in IN O
the DT O
left NN B-Biological_structure
leg NN I-Biological_structure
. . O

On IN O
August NNP O
14 CD O
, , O
2013 CD O
, , O
the DT O
patient NN O
underwent NN O
a DT O
left JJ B-Biological_structure
distal JJ I-Biological_structure
femoral JJ I-Biological_structure
tumor NN B-Sign_symptom
en JJ B-Detailed_description
bloc NN I-Detailed_description
resection NN B-Therapeutic_procedure
and CC O
reconstruction NN B-Therapeutic_procedure
with IN O
a DT O
modular JJ B-Detailed_description
femoral JJ I-Detailed_description
prosthetic JJ I-Detailed_description
system NN I-Detailed_description
. . O

Pathology NNP B-Diagnostic_procedure
diagnosis NN I-Diagnostic_procedure
confirmed VBD O
osteoblastic JJ B-Detailed_description
osteosarcoma NN B-Disease_disorder
( ( O
Fig NNP O
. . O
2 CD O
) ) O
. . O

One CD B-Dosage
cycle NN I-Dosage
of IN O
neoadjuvant JJ B-Detailed_description
chemotherapy NN B-Medication
and CC O
4 CD B-Dosage
cycles NNS I-Dosage
of IN O
adjuvant JJ B-Detailed_description
chemotherapy NN B-Medication
with IN O
MAP NNP B-Medication
regimen NNS I-Medication
( ( O
high JJ B-Dosage
- : I-Dosage
dose NN I-Dosage
methotrexate NN B-Medication
, , O
cisplatin NN B-Medication
, , O
and CC O
doxorubicin NN B-Medication
) ) O
were VBD O
administered VBN O
. . O

In IN O
January NNP O
2015 CD O
, , O
a DT O
mass NN B-Sign_symptom
was VBD O
found VBN O
on IN O
the DT O
left JJ B-Biological_structure
upper JJ I-Biological_structure
crus NN I-Biological_structure
area NN I-Biological_structure
. . O

Tumor NN O
recurrence NN B-Sign_symptom
was VBD O
confirmed VBN O
by IN O
biopsy NN B-Diagnostic_procedure
on IN O
January NNP O
23 CD O
, , O
2015 CD O
. . O

However RB O
, , O
only RB O
an DT O
upper JJ B-Biological_structure
femur NN I-Biological_structure
amputation NN B-Therapeutic_procedure
was VBD O
carried VBN O
out RP O
, , O
as IN O
the DT O
patient NN O
refused VBD O
hip NN B-Biological_structure
joint JJ B-Therapeutic_procedure
replacement NN I-Therapeutic_procedure
. . O

After IN O
wound NN B-Therapeutic_procedure
healing NN I-Therapeutic_procedure
, , O
the DT O
patient NN O
went VBD O
back RB O
to TO O
his PRP$ O
normal JJ O
life NN O
in IN O
the DT O
help NN O
of IN O
artificial JJ B-Therapeutic_procedure
limb NN I-Therapeutic_procedure
, , O
but CC O
refused VBD O
to TO O
receive VB O
further JJ O
chemotherapy NN B-Medication
due JJ O
to TO O
concerns NNS O
regarding VBG O
the DT O
chemotherapy NN O
toxicities NNS O
such JJ O
as IN O
nausea NN O
, , O
vomiting VBG O
, , O
leucopenia NN O
, , O
deadlimb NN O
, , O
and CC O
headache NN O
. . O

About IN O
half PDT O
a DT O
year NN O
after IN O
the DT O
amputation NN O
, , O
the DT O
patient NN O
got VBD O
occasional JJ B-Detailed_description
cough NN B-Sign_symptom
and CC O
chest NN B-Biological_structure
tightness NN B-Sign_symptom
. . O

Then RB O
a DT O
thin JJ B-Detailed_description
chest NN B-Biological_structure
computed VBN B-Diagnostic_procedure
tomography NN I-Diagnostic_procedure
( ( O
CT NNP B-Diagnostic_procedure
) ) O
was VBD O
performed VBN O
on IN O
July NNP O
15 CD O
, , O
2015 CD O
. . O

The DT O
CT NNP O
results NNS O
revealed VBD O
multiple JJ B-Detailed_description
pulmonary JJ B-Biological_structure
nodules NNS B-Sign_symptom
( ( O
Table JJ O
1 CD O
) ) O
, , O
considering VBG O
the DT O
possibility NN O
of IN O
metastases NNS B-Sign_symptom
. . O

The DT O
patient NN O
still RB O
rejected VBD O
further JJ O
chemotherapy NN B-Medication
. . O

Immunophenotype NN B-Diagnostic_procedure
was VBD O
suggestive JJ O
of IN O
CD31 NNP B-Detailed_description
+ NNP I-Detailed_description
and CC O
CD34 NNP B-Detailed_description
+ NNP I-Detailed_description
tumor NN B-Sign_symptom
cells NNS O
( ( O
Fig NNP O
. . O
3 CD O
) ) O
. . O

Furthermore RB O
, , O
most JJS O
cells NNS O
showed VBD O
strong JJ B-Lab_value
positive JJ I-Lab_value
staining NN B-Diagnostic_procedure
for IN I-Diagnostic_procedure
VEGFR NNP I-Diagnostic_procedure
- : I-Diagnostic_procedure
2 CD I-Diagnostic_procedure
( ( O
Fig NNP O
. . O
3 CD O
) ) O
. . O

Apatinib NNP B-Medication
was VBD O
administered VBN O
at IN O
a DT O
dose NN O
of IN O
500 CD B-Dosage
mg JJ I-Dosage
daily RB I-Dosage
. . O

Half PDT O
a DT O
month NN O
later RB O
, , O
the DT O
symptoms NNS B-Sign_symptom
disappeared VBD O
, , O
but CC O
a DT O
progressive JJ B-Detailed_description
wound NN B-Sign_symptom
necrosis NN I-Sign_symptom
appeared VBD O
. . O

A DT O
debridement NN B-Therapeutic_procedure
surgery NN I-Therapeutic_procedure
was VBD O
finally RB O
conducted VBN O
and CC O
an DT O
enlarged JJ B-Sign_symptom
lymph NN B-Biological_structure
node NN I-Biological_structure
near IN B-Biological_structure
iliac JJ I-Biological_structure
vessels NNS I-Biological_structure
was VBD O
resected VBN B-Therapeutic_procedure
on IN O
February NNP O
24 CD O
, , O
2016 CD O
( ( O
Fig NNP O
. . O
( ( O
Fig NNP O
. . O
4 CD O
) ) O
. . O
4 CD O
) ) O
. . O

The DT O
result NN O
of IN O
pathological JJ B-Diagnostic_procedure
examination NN I-Diagnostic_procedure
revealed VBD O
an DT O
inflammatory JJ B-Detailed_description
hyperplasia NN B-Sign_symptom
lymph NN B-Biological_structure
node NN I-Biological_structure
. . O

Apatinib NNP B-Medication
administration NN O
was VBD O
stopped VBN O
during IN O
the DT O
3 CD B-Duration
weeks NNS I-Duration
of IN O
wound NN B-Therapeutic_procedure
healing NN I-Therapeutic_procedure
period NN O
. . O

The DT O
thin JJ B-Detailed_description
chest NN B-Biological_structure
CT NNP B-Diagnostic_procedure
was VBD O
performed VBN O
7 CD O
and CC O
11 CD O
months NNS O
following VBG O
apatinib JJ O
administration NN O
. . O

At IN O
the DT O
7 CD O
- : O
month NN O
follow SYM O
- : O
up RP O
time NN O
point NN O
, , O
2 CD B-Lab_value
out IN I-Lab_value
of IN I-Lab_value
5 CD I-Lab_value
measurable JJ I-Lab_value
and CC O
9 CD B-Lab_value
out IN I-Lab_value
of IN I-Lab_value
17 CD I-Lab_value
non JJ I-Lab_value
- : I-Lab_value
measurable JJ I-Lab_value
lesions NNS B-Sign_symptom
disappeared VBD O
, , O
but CC O
1 CD B-Lab_value
new JJ I-Lab_value
measurable JJ I-Lab_value
nodule NN B-Sign_symptom
and CC O
6 CD B-Lab_value
new JJ I-Lab_value
non JJ I-Lab_value
- : I-Lab_value
measurable JJ I-Lab_value
lesions NNS B-Sign_symptom
were VBD O
observed VBN O
( ( O
Table JJ O
1 CD O
, , O
Fig NNP O
. . O
5 CD O
) ) O
, , O
which WDT O
considered VBD O
PD NNP B-Lab_value
according VBG O
to TO O
the DT O
Response NNP B-Diagnostic_procedure
Evaluation NNP I-Diagnostic_procedure
Criteria NNP I-Diagnostic_procedure
in IN I-Diagnostic_procedure
Solid NNP I-Diagnostic_procedure
Tumors NNP I-Diagnostic_procedure
( ( O
RECIST NNP B-Diagnostic_procedure
) ) O
1 CD B-Detailed_description
. . I-Detailed_description
1 CD I-Detailed_description
standard NN O
. . O

However RB O
, , O
at IN O
the DT O
11 CD O
- : O
month NN O
follow SYM O
- : O
up RP O
time NN O
point NN O
, , O
a DT O
total NN O
of IN O
9 CD B-Lab_value
lesions NNS B-Sign_symptom
disappeared VBD O
, , O
including VBG O
1 CD B-Lab_value
measurable JJ I-Lab_value
nodule NN I-Lab_value
and CC O
2 CD B-Lab_value
non JJ I-Lab_value
- : I-Lab_value
measurable JJ I-Lab_value
lesions NNS I-Lab_value
presented VBN O
before IN O
apatinib JJ O
treatment NN O
as RB O
well RB O
as IN O
6 CD B-Lab_value
non SYM I-Lab_value
- : I-Lab_value
measureable JJ I-Lab_value
lesions NNS I-Lab_value
presented VBD O
7 CD O
months NNS O
after IN O
apatinib JJ O
treatment NN O
. . O

No DT O
new JJ O
lesion NN O
was VBD O
raised VBN O
. . O

After IN O
target NN O
lesion NN B-Detailed_description
measurement NN B-Diagnostic_procedure
according VBG O
to TO O
the DT O
RECIST NNP B-Diagnostic_procedure
1 CD I-Diagnostic_procedure
. . I-Diagnostic_procedure
1 CD I-Diagnostic_procedure
standard NN I-Diagnostic_procedure
, , O
it PRP O
was VBD O
narrowly RB O
considered VBN O
PR NNP B-Lab_value
. . O

The DT O
toxicities NNS O
the DT O
patient NN O
experienced VBD O
included JJ O
mild JJ B-Severity
hand NN B-Disease_disorder
- : I-Disease_disorder
foot NN I-Disease_disorder
syndrome NN I-Disease_disorder
and CC O
slight JJ B-Severity
high JJ B-Sign_symptom
blood NN I-Sign_symptom
pressure NN I-Sign_symptom
. . O

Both DT O
were VBD O
well RB B-Lab_value
controlled VBN I-Lab_value
after IN I-Lab_value
appropriate JJ I-Lab_value
treatment NN I-Lab_value
. . O

No DT O
severe JJ B-Severity
toxicities NNS B-Sign_symptom
and CC O
other JJ O
treatment NN B-Detailed_description
- : I-Detailed_description
related JJ I-Detailed_description
adverse JJ B-Sign_symptom
events NNS I-Sign_symptom
were VBD O
observed VBN O
. . O

The DT O
patient NN O
continued VBD O
to TO O
use VB O
apatinib NN B-Medication
as IN O
maintenance NN O
therapy NN O
without IN O
major JJ O
toxic NN B-Sign_symptom
effects NNS I-Sign_symptom
, , O
and CC O
went VBD O
back RB O
to TO O
normal JJ O
life NN O
, , O
even RB O
driving VBG B-Activity
an DT O
automatic JJ B-Detailed_description
car NN I-Detailed_description
. . O

-DOCSTART- NN -X-

A DT O
34 CD B-Age
- : I-Age
year NN I-Age
- : I-Age
old JJ I-Age
Hispanic JJ O
male NN O
without IN O
significant JJ O
past JJ O
medical JJ O
history NN O
presented VBN O
to TO O
our PRP$ O
hospital NN B-Nonbiological_location
with IN O
a DT O
one CD B-Duration
month NN I-Duration
history NN O
of IN O
cough NN B-Sign_symptom
; : O
productive NN O
of IN O
whitish JJ B-Color
sputum NN B-Sign_symptom
. . O

At IN O
presentation NN O
, , O
he PRP O
denied VBD O
fever NN B-Sign_symptom
, , O
chills NNS B-Sign_symptom
, , O
night NN B-Sign_symptom
sweats NNS I-Sign_symptom
, , O
chest JJS B-Biological_structure
pain NN B-Sign_symptom
, , O
hemoptysis NN B-Sign_symptom
, , O
back RB B-Biological_structure
pain NN B-Sign_symptom
, , O
recent JJ B-Detailed_description
travel NN O
or CC O
sick JJ B-Detailed_description
contacts NNS O
. . O

He PRP O
reported VBD O
that IN O
he PRP O
had VBD O
approximately RB O
a DT O
15 CD B-Lab_value
- : I-Lab_value
20 CD I-Lab_value
pound NN I-Lab_value
weight VBD B-Sign_symptom
loss NN I-Sign_symptom
during IN O
the DT O
last JJ B-Duration
six CD I-Duration
months NNS I-Duration
. . O

He PRP O
denied VBD O
smoking NN B-Activity
, , O
socially RB O
drank JJ B-Activity
alcohol NN I-Activity
, , O
and CC O
had VBD O
unprotected VBN B-Detailed_description
sexual JJ B-Activity
intercourse NN I-Activity
with IN O
multiple JJ B-Detailed_description
partners NNS I-Detailed_description
in IN O
the DT O
past NN O
. . O

On IN O
admission NN O
, , O
his PRP$ O
temperature NN B-Diagnostic_procedure
was VBD O
97 CD B-Lab_value
. . I-Lab_value
9 CD I-Lab_value
°F NN I-Lab_value
; : O
heart NN B-Diagnostic_procedure
rate NN I-Diagnostic_procedure
was VBD O
85 CD B-Lab_value
beats NNS I-Lab_value
per IN I-Lab_value
minute NN I-Lab_value
, , O
respiratory NN B-Diagnostic_procedure
rate NN I-Diagnostic_procedure
was VBD O
16 CD B-Lab_value
breaths NNS I-Lab_value
per IN I-Lab_value
minute NN I-Lab_value
, , O
blood NN B-Diagnostic_procedure
pressure NN I-Diagnostic_procedure
was VBD O
107 CD B-Lab_value
/ JJ I-Lab_value
66 CD I-Lab_value
mm NN I-Lab_value
Hg NNP I-Lab_value
, , O
and CC O
oxygen NN B-Diagnostic_procedure
saturation NN I-Diagnostic_procedure
was VBD O
100 CD B-Lab_value
% NN I-Lab_value
on IN O
room NN B-Detailed_description
air NN I-Detailed_description
. . O

Examination NN B-Diagnostic_procedure
showed VBD O
oral JJ B-Biological_structure
thrush NN B-Sign_symptom
, , O
decreased VBN B-Lab_value
breath NN B-Diagnostic_procedure
sounds NNS I-Diagnostic_procedure
and CC O
crackles NNS B-Sign_symptom
on IN O
the DT O
right NN B-Biological_structure
lower RBR I-Biological_structure
lung NN I-Biological_structure
base NN I-Biological_structure
. . O

No DT O
cutaneous JJ B-Biological_structure
lesions NNS B-Sign_symptom
were VBD O
reported VBN O
and CC O
the DT O
rest NN O
of IN O
clinical JJ B-Diagnostic_procedure
examination NN I-Diagnostic_procedure
was VBD O
unremarkable JJ B-Lab_value
. . O

His PRP$ O
complete JJ B-Diagnostic_procedure
blood NN I-Diagnostic_procedure
count NN I-Diagnostic_procedure
( ( O
CBC NNP B-Diagnostic_procedure
) ) O
showed VBD O
hemoglobin NN B-Diagnostic_procedure
of IN O
9 CD B-Lab_value
. . I-Lab_value
7 CD I-Lab_value
g JJ I-Lab_value
/ NNP I-Lab_value
dL NN I-Lab_value
, , O
WBCs NNP B-Diagnostic_procedure
2 CD B-Lab_value
. . I-Lab_value
3 CD I-Lab_value
× JJ I-Lab_value
109 CD I-Lab_value
/ JJ I-Lab_value
L NNP I-Lab_value
, , O
and CC O
platelets NNS B-Diagnostic_procedure
of IN O
164 CD B-Lab_value
× JJ I-Lab_value
109 CD I-Lab_value
/ JJ I-Lab_value
L NNP I-Lab_value
. . O

His PRP$ O
creatinine NN B-Diagnostic_procedure
was VBD O
0 CD B-Lab_value
. . I-Lab_value
62 CD I-Lab_value
mg JJ I-Lab_value
/ NNP I-Lab_value
dL NN I-Lab_value
, , O
and CC O
blood NN B-Diagnostic_procedure
urea JJ I-Diagnostic_procedure
nitrogen NN I-Diagnostic_procedure
was VBD O
10 CD B-Lab_value
mg NN I-Lab_value
/ NNP I-Lab_value
dL NN I-Lab_value
. . O

Radiograph NNP B-Diagnostic_procedure
of IN O
the DT O
chest NN B-Biological_structure
showed VBD O
extensive JJ B-Severity
right NN B-Biological_structure
and CC O
left VBD B-Biological_structure
perihilar JJ B-Biological_structure
opacity NN B-Sign_symptom
more RBR B-Biological_structure
on IN I-Biological_structure
the DT I-Biological_structure
right JJ I-Biological_structure
side NN I-Biological_structure
, , O
and CC O
computed VBD B-Diagnostic_procedure
tomography NN I-Diagnostic_procedure
( ( O
CT NNP B-Diagnostic_procedure
) ) O
scan NN O
of IN O
the DT O
chest NN B-Biological_structure
showed VBD O
a DT O
right NN B-Biological_structure
sided VBN I-Biological_structure
large JJ B-Severity
perihilar JJ B-Biological_structure
mass NN B-Sign_symptom
( ( O
Figure NNP O
1 CD O
) ) O
with IN O
multiple JJ B-Detailed_description
thoracic NN B-Biological_structure
and CC O
lumbar NN B-Biological_structure
vertebrae NN B-Biological_structure
, , O
ribs NN B-Biological_structure
, , O
and CC O
sternal JJ B-Biological_structure
tiny JJ B-Severity
lytic JJ B-Detailed_description
lesions NNS B-Sign_symptom
consistent JJ O
with IN O
bony JJ B-Biological_structure
metastasis NN B-Disease_disorder
( ( O
Figure NNP O
2 CD O
) ) O
. . O

Blood NN B-Biological_structure
and CC O
sputum NN B-Biological_structure
cultures NNS B-Diagnostic_procedure
were VBD O
negative JJ B-Lab_value
. . O

Tuberculosis NN B-Disease_disorder
was VBD O
ruled VBN O
out RP O
by IN O
three CD B-Detailed_description
consecutive JJ I-Detailed_description
negative JJ B-Lab_value
sputum NN B-Diagnostic_procedure
smears NNS I-Diagnostic_procedure
for IN O
acid JJ B-Detailed_description
fast JJ I-Detailed_description
bacilli NN I-Detailed_description
and CC O
a DT O
negative JJ B-Lab_value
QUANTIferon NNP B-Diagnostic_procedure
gold NN I-Diagnostic_procedure
test NN I-Diagnostic_procedure
. . O

He PRP O
tested VBD O
positive JJ B-Lab_value
for IN O
human JJ B-Disease_disorder
immunodeficiency NN I-Disease_disorder
virus NN I-Disease_disorder
( ( O
HIV NNP B-Disease_disorder
) ) O
and CC O
his PRP$ O
CD4 NN B-Diagnostic_procedure
counts NNS I-Diagnostic_procedure
came VBD O
back RB O
at IN O
7 CD B-Lab_value
cells NNS I-Lab_value
/ JJ I-Lab_value
uL NN I-Lab_value
. . O

He PRP O
was VBD O
started VBN O
on IN O
prophylaxis NN B-Therapeutic_procedure
with IN O
bactrim JJ B-Medication
80 CD B-Dosage
- : I-Dosage
160 CD I-Dosage
mg JJ I-Dosage
daily JJ I-Dosage
and CC O
azithromycin JJ B-Medication
1200 CD B-Dosage
mg JJ I-Dosage
weekly JJ I-Dosage
for IN O
opportunistic JJ O
infections NNS O
. . O

Bronchoscopy NN B-Diagnostic_procedure
with IN O
biopsy NN B-Diagnostic_procedure
was VBD O
performed VBN O
but CC O
was VBD O
unrevealing JJ B-Lab_value
and CC O
he PRP O
underwent VBD O
a DT O
video NN B-Detailed_description
assisted VBN I-Detailed_description
mediastinoscopy NN B-Diagnostic_procedure
with IN O
biopsies NNS B-Diagnostic_procedure
of IN O
the DT O
right JJ B-Biological_structure
hilar JJ I-Biological_structure
mass NN B-Sign_symptom
. . O

Pathology NN B-Diagnostic_procedure
showed VBD O
spindle JJ B-Sign_symptom
cells NNS I-Sign_symptom
positive JJ B-Lab_value
for IN O
CD34 NNP B-Diagnostic_procedure
, , O
BCL2 NNP B-Diagnostic_procedure
, , O
vimentin NN B-Diagnostic_procedure
, , O
and CC O
HHV NNP B-Diagnostic_procedure
- : I-Diagnostic_procedure
8 CD I-Diagnostic_procedure
with IN O
diffuse NN B-Detailed_description
positivity NN B-Lab_value
for IN O
CD31 NNP B-Diagnostic_procedure
diagnostic NN O
of IN O
KS NNP B-Disease_disorder
. . O

He PRP O
started VBD O
treatment NN O
with IN O
HAART NNP B-Medication
in IN O
the DT O
form NN O
of IN O
emtricitabine NN B-Medication
and CC I-Medication
tenofovir NN I-Medication
disoproxil NN I-Medication
fumarate VBP I-Medication
200 CD B-Lab_value
/ $ I-Lab_value
300 CD I-Lab_value
mg NN I-Lab_value
and CC O
dolutegravir NN B-Medication
50 CD B-Lab_value
mg NN I-Lab_value
. . O

The DT O
patient NN O
was VBD O
actively RB B-Detailed_description
involved VBN I-Detailed_description
in IN O
decisions NNS O
regarding VBG O
management NN B-Detailed_description
options NNS I-Detailed_description
. . O

He PRP O
favored VBD O
HAART NNP B-Medication
isolated VBD O
regimen NNS O
without IN O
additional JJ B-Medication
chemotherapy NN I-Medication
. . O

His PRP$ O
condition NN O
showed VBD O
continuing VBG O
clinical JJ B-Sign_symptom
improvement NN I-Sign_symptom
; : O
a DT O
repeat NN O
CT NNP B-Diagnostic_procedure
scan NN O
of IN O
the DT O
chest NN B-Biological_structure
at IN O
three CD O
months NNS O
showed VBD O
profound JJ O
regression NN B-Sign_symptom
of IN O
the DT O
disease NN O
with IN O
disappearance NN O
of IN O
most JJS O
of IN O
the DT O
lesions NNS B-Sign_symptom
( ( O
Figure NNP O
3 CD O
) ) O
. . O

-DOCSTART- NN -X-

A DT O
18 CD B-Age
- : I-Age
year NN I-Age
- : I-Age
old JJ I-Age
man NN O
presented VBN O
with IN O
a DT O
history NN O
of IN O
a DT O
palpable JJ B-Detailed_description
lump NN B-Sign_symptom
in IN O
the DT O
presternal JJ B-Biological_structure
area NN I-Biological_structure
, , O
which WDT O
was VBD O
found VBN O
incidentally RB O
after IN O
weight JJ B-Sign_symptom
reduction NN I-Sign_symptom
. . O

The DT O
patient NN O
had VBD O
no DT O
other JJ O
relevant JJ O
medical JJ O
or CC O
trauma JJ O
history NN O
. . O

On IN O
physical JJ B-Diagnostic_procedure
examination NN I-Diagnostic_procedure
, , O
the DT O
lesion NN O
was VBD O
found VBN O
to TO O
be VB O
a DT O
nonmovable JJ B-Detailed_description
, , O
firm JJ B-Texture
mass NN B-Sign_symptom
with IN O
no DT O
tenderness NN B-Sign_symptom
or CC O
associated VBN O
skin JJ B-Sign_symptom
changes NNS I-Sign_symptom
, , O
detected VBN O
at IN O
the DT O
midline JJ B-Biological_structure
position NN I-Biological_structure
over IN I-Biological_structure
the DT I-Biological_structure
sternum NN I-Biological_structure
( ( O
at IN O
the DT O
manubrium NN B-Biological_structure
level NN I-Biological_structure
) ) O
. . O

There EX O
was VBD O
no DT O
visible JJ O
fistulous JJ B-Sign_symptom
opening NN I-Sign_symptom
or CC O
discharge NN B-Sign_symptom
from IN O
the DT O
lesion NN O
. . O

On IN O
ultrasonography NN B-Diagnostic_procedure
, , O
we PRP O
detected VBD O
a DT O
well NN B-Detailed_description
- : I-Detailed_description
circumscribed NN I-Detailed_description
, , O
oval NN B-Shape
, , O
anechoic JJ B-Lab_value
mass NN B-Sign_symptom
, , O
with IN O
posterior JJ B-Detailed_description
acoustic JJ I-Detailed_description
enhancement NN I-Detailed_description
, , O
that WDT O
measured VBD O
about IN O
3 CD B-Volume
. . I-Volume
3 CD I-Volume
× JJ I-Volume
1 CD I-Volume
. . I-Volume
7 CD I-Volume
× JJ I-Volume
3 CD I-Volume
. . I-Volume
1 CD I-Volume
cm NN I-Volume
, , O
and CC O
was VBD O
located VBN O
in IN O
the DT O
subcutaneous JJ B-Biological_structure
fat JJ I-Biological_structure
layer NN I-Biological_structure
over IN O
the DT O
sternum NN B-Biological_structure
. . O

In IN O
the DT O
dependent JJ B-Biological_structure
portion NN I-Biological_structure
of IN O
the DT O
mass NN O
was VBD O
an DT O
internal JJ B-Detailed_description
, , O
well RB B-Detailed_description
- : I-Detailed_description
circumscribed NN I-Detailed_description
, , O
heterogeneously RB B-Detailed_description
hypoechoic NN B-Lab_value
, , O
egg NN B-Shape
- : I-Shape
shaped VBN I-Shape
lesion NN B-Sign_symptom
( ( O
Fig NNP O
. . O
1A CD O
and CC O
B NNP O
) ) O
showing VBG O
a DT O
movement NN B-Detailed_description
according VBG I-Detailed_description
to TO I-Detailed_description
patient JJ I-Detailed_description
movement NN I-Detailed_description
. . O

The DT O
mass NN O
could MD O
be VB O
compressed VBN B-Lab_value
using VBG O
the DT O
linear JJ B-Therapeutic_procedure
transducer NN I-Therapeutic_procedure
( ( O
Fig NNP O
. . O
2A CD O
and CC O
B NNP O
) ) O
. . O

A DT O
color NN B-Detailed_description
Doppler NNP B-Diagnostic_procedure
study NN I-Diagnostic_procedure
showed VBD O
no DT O
vascularity NN B-Sign_symptom
within IN O
the DT O
cystic JJ O
mass NN O
or CC O
the DT O
internal JJ B-Detailed_description
hypoechoic NN B-Lab_value
lesion NN O
( ( O
Fig NNP O
. . O
1C CD O
) ) O
. . O

Surgical JJ B-Therapeutic_procedure
excision NN I-Therapeutic_procedure
of IN O
the DT O
mass NN B-Sign_symptom
was VBD O
performed VBN O
without IN O
postoperative JJ B-Disease_disorder
complications NNS I-Disease_disorder
. . O

Grossly RB O
, , O
the DT O
excised JJ O
mass NN O
was VBD O
a DT O
well RB B-Lab_value
- : I-Lab_value
defined VBN I-Lab_value
, , O
ovoid PRP B-Shape
, , O
cystic JJ B-Lab_value
mass NN O
gray JJ B-Color
- : I-Color
tan NN I-Color
in IN O
color NN O
. . O

On IN O
section NN O
, , O
it PRP O
was VBD O
found VBN O
to TO O
be VB O
a DT O
unilocular JJ B-Lab_value
cyst NN B-Sign_symptom
filled VBN O
with IN O
whitish JJ B-Color
mucous JJ B-Sign_symptom
material NN I-Sign_symptom
. . O

Microscopically RB O
, , O
the DT O
mass NN O
was VBD O
lined VBN O
with IN O
ciliated JJ O
pseudostratified JJ O
columnar NN O
epithelium NN O
suggestive NN O
of IN O
respiratory NN O
type NN O
- : O
mucosa NN O
( ( O
Fig NNP O
. . O
3 CD O
) ) O
. . O

There EX O
was VBD O
nonspecific JJ B-Lab_value
collagenous JJ B-Detailed_description
fibrosis NN B-Sign_symptom
around IN O
the DT O
cyst NN O
. . O

The DT O
differential JJ O
diagnosis NN O
of IN O
subcutaneous JJ O
cyst NN O
included VBD O
epidermal JJ B-Disease_disorder
inclusion NN I-Disease_disorder
cyst NN I-Disease_disorder
, , O
thyroglossal JJ B-Disease_disorder
duct NN I-Disease_disorder
cyst NN I-Disease_disorder
, , O
branchial JJ B-Disease_disorder
cleft NN I-Disease_disorder
cyst NN I-Disease_disorder
, , O
and CC O
dermoid JJ B-Disease_disorder
cyst NN I-Disease_disorder
. . O

There EX O
was VBD O
no DT O
histological JJ B-Sign_symptom
evidence NN I-Sign_symptom
of IN O
squamous JJ B-Detailed_description
epithelium NN I-Detailed_description
, , O
keratin NN B-Detailed_description
, , O
thyroid JJ B-Detailed_description
tissue NN I-Detailed_description
, , O
or CC O
skin JJ B-Detailed_description
appendage NN I-Detailed_description
in IN O
the DT O
cystic JJ O
wall NN O
of IN O
the DT O
present JJ O
case NN O
. . O

The DT O
mass NN O
was VBD O
diagnosed VBN O
as IN O
a DT O
bronchogenic JJ B-Disease_disorder
cyst NN I-Disease_disorder
. . O

-DOCSTART- NN -X-

A DT O
68 CD B-Age
- : I-Age
year NN I-Age
- : I-Age
old JJ I-Age
man NN O
was VBD O
referred VBN O
by IN O
his PRP$ O
optometrist NN O
to TO O
HES NNP B-Nonbiological_location
with IN O
suspected JJ O
LTG NNP B-Disease_disorder
due JJ O
to TO O
repeatedly RB B-Detailed_description
irregular JJ I-Detailed_description
visual JJ B-Diagnostic_procedure
field NN I-Diagnostic_procedure
test NN I-Diagnostic_procedure
results NNS I-Diagnostic_procedure
, , O
advanced VBD B-Detailed_description
optic JJ B-Diagnostic_procedure
disc NN I-Diagnostic_procedure
cupping NN I-Diagnostic_procedure
, , O
normal JJ B-Lab_value
intraocular JJ B-Diagnostic_procedure
pressures NNS I-Diagnostic_procedure
( ( O
IOPs NNP B-Diagnostic_procedure
) ) O
and CC O
a DT O
family NN O
history NN O
of IN O
glaucoma NN O
. . O

The DT O
patient NN O
subjectively RB O
felt VBD O
that DT O
vision NN B-Sign_symptom
in IN O
his PRP$ O
` `` O
good JJ B-Detailed_description
` `` O
left VBN B-Biological_structure
eye NN I-Biological_structure
( ( O
LE NNP B-Biological_structure
) ) O
, , O
which WDT O
normally RB O
had VBD O
a DT O
visual JJ B-Diagnostic_procedure
acuity NN I-Diagnostic_procedure
of IN O
6 CD B-Lab_value
/ JJ I-Lab_value
6 CD I-Lab_value
N5 NNP I-Lab_value
, , O
started VBD O
to TO O
deteriorate VB B-Detailed_description
6 CD O
months NNS O
earlier RB O
; : O
at IN O
the DT O
point NN O
of IN O
referral JJ O
it PRP O
was VBD O
best RB O
corrected VBN O
to TO O
6 CD B-Lab_value
/ NNS I-Lab_value
7 CD I-Lab_value
. . I-Lab_value
5 CD I-Lab_value
N6 NNP I-Lab_value
. . O

His PRP$ O
right NN B-Biological_structure
eye NN I-Biological_structure
( ( O
RE NNP B-Biological_structure
) ) O
was VBD O
known VBN O
to TO O
be VB O
amblyopic VBN B-Disease_disorder
with IN O
a DT O
visual JJ B-Diagnostic_procedure
acuity NN I-Diagnostic_procedure
of IN O
6 CD B-Lab_value
/ JJ I-Lab_value
18 CD I-Lab_value
N12 NNP I-Lab_value
. . O

His PRP$ O
medical JJ O
history NN O
included VBD O
considerable JJ O
risk NN O
factors NNS O
for IN O
systemic JJ B-Detailed_description
vasculopathy NN B-Disease_disorder
, , O
such JJ O
as IN O
hypertension NN O
, , O
hypercholesterolaemia NN O
, , O
50 CD B-Lab_value
pack NN I-Lab_value
- : I-Lab_value
years NNS I-Lab_value
of IN O
smoking NN O
and CC O
type NN O
2 CD O
diabetes NNS O
with IN O
no DT O
diabetic JJ O
retinopathy NN O
. . O

Despite IN O
detailed JJ O
questioning NN O
, , O
he PRP O
denied VBD O
any DT O
new JJ B-Sign_symptom
systemic JJ I-Sign_symptom
symptoms NNS I-Sign_symptom
apart RB O
from IN O
experiencing VBG O
increased VBN B-Lab_value
lethargy NN B-Sign_symptom
. . O

Clinical JJ B-Diagnostic_procedure
examination NN I-Diagnostic_procedure
at IN O
HES NNP B-Nonbiological_location
revealed VBD O
advanced JJ B-Detailed_description
bilateral JJ I-Detailed_description
cupped VBD B-Diagnostic_procedure
optic JJ I-Diagnostic_procedure
discs NN I-Diagnostic_procedure
with IN O
a DT O
cup NN B-Diagnostic_procedure
- : I-Diagnostic_procedure
to TO I-Diagnostic_procedure
- : I-Diagnostic_procedure
disc NN I-Diagnostic_procedure
ratio NN I-Diagnostic_procedure
right RB B-Detailed_description
0 CD B-Lab_value
. . I-Lab_value
9 CD I-Lab_value
( ( O
90 CD B-Lab_value
% NN I-Lab_value
) ) O
and CC O
left VBD B-Detailed_description
0 CD B-Lab_value
. . I-Lab_value
8 CD I-Lab_value
( ( O
80 CD B-Lab_value
% NN I-Lab_value
; : O
figure CC O
1 CD O
) ) O
. . O

Furthermore RB O
, , O
the DT O
findings NNS O
from IN O
the DT O
referring VBG B-Detailed_description
optometrist NN O
of IN O
equal JJ O
and CC O
reactive JJ O
pupils NNS O
, , O
normal JJ B-Lab_value
eye NN B-Diagnostic_procedure
movements NNS I-Diagnostic_procedure
and CC O
IOPs NNP O
in IN O
mid NNP B-Age
- : I-Age
teens NNS I-Age
were VBD O
confirmed VBN O
. . O

Computerised VBN B-Diagnostic_procedure
perimetry NN I-Diagnostic_procedure
showed VBD O
constricted JJ B-Detailed_description
visual JJ B-Diagnostic_procedure
fields NNS I-Diagnostic_procedure
in IN O
both DT B-Lab_value
eyes NNS B-Biological_structure
, , O
albeit IN O
with IN O
considerably RB B-Lab_value
raised VBN I-Lab_value
false JJ B-Diagnostic_procedure
- : I-Diagnostic_procedure
negative JJ I-Diagnostic_procedure
error NN I-Diagnostic_procedure
rates NNS I-Diagnostic_procedure
in IN B-Lab_value
excess NN I-Lab_value
of IN I-Lab_value
30 CD I-Lab_value
% NN I-Lab_value
( ( O
figure JJ O
2A CD O
) ) O
. . O

Since IN O
this DT O
can MD O
be VB O
a DT O
result NN O
of IN O
poor JJ B-Severity
concentration NN B-Sign_symptom
and CC O
attention NN B-Sign_symptom
span NN I-Sign_symptom
with IN B-Detailed_description
testing VBG I-Detailed_description
compounded VBN I-Detailed_description
, , O
especially RB O
with IN O
an DT O
amblyopic NN B-Disease_disorder
RE NNP B-Biological_structure
, , O
the DT O
field NN B-Diagnostic_procedure
test NN I-Diagnostic_procedure
was VBD O
repeated VBN O
4 CD O
weeks NNS O
later RB O
with IN B-Detailed_description
similar JJ I-Detailed_description
results NNS I-Detailed_description
( ( O
figure JJ O
2B CD O
) ) O
. . O

At IN O
this DT O
visit NN O
, , O
the DT O
patient NN O
experienced VBD O
further JJ B-Lab_value
deterioration NN I-Lab_value
of IN O
his PRP$ O
` `` O
good JJ B-Detailed_description
` `` O
LE NNS B-Biological_structure
. . O

Visual JJ B-Diagnostic_procedure
acuities NNS I-Diagnostic_procedure
measured VBD O
6 CD B-Lab_value
/ NNS I-Lab_value
24 CD I-Lab_value
( ( I-Lab_value
loss NN B-Detailed_description
of IN I-Detailed_description
one CD I-Detailed_description
Snellen NNP I-Detailed_description
line NN I-Detailed_description
) ) I-Lab_value
N36 NN I-Lab_value
in IN O
his PRP$ O
amblyopic NN B-Disease_disorder
RE NNP B-Biological_structure
, , O
and CC O
6 CD B-Lab_value
/ NNS I-Lab_value
18 CD I-Lab_value
( ( I-Lab_value
loss NN B-Detailed_description
of IN I-Detailed_description
two CD I-Detailed_description
Snellen NNP I-Detailed_description
lines NNS I-Detailed_description
) ) I-Lab_value
N36 NNP I-Lab_value
in IN O
his PRP$ O
LE NNP B-Biological_structure
, , O
which WDT O
now RB O
also RB O
showed VBD O
depressed JJ B-Lab_value
colour NN B-Diagnostic_procedure
vision NN I-Diagnostic_procedure
. . O

An DT O
urgent JJ B-Detailed_description
scan NN B-Diagnostic_procedure
of IN O
the DT O
patient NN O
` `` O
s JJ O
head NN B-Biological_structure
and CC O
orbit NN B-Biological_structure
was VBD O
requested VBN O
to TO O
rule VB O
out RP O
a DT O
compressive JJ B-Detailed_description
lesion NN B-Disease_disorder
and CC O
blood NN B-Diagnostic_procedure
analysis NN I-Diagnostic_procedure
was VBD O
carried VBN O
out IN O
to TO O
screen VB O
for IN O
other JJ B-Diagnostic_procedure
causes NNS I-Diagnostic_procedure
of IN I-Diagnostic_procedure
optic JJ B-Disease_disorder
neuropathy JJ I-Disease_disorder
including VBG O
vitamin NN B-Diagnostic_procedure
B12 NNP I-Diagnostic_procedure
, , O
folate NN B-Diagnostic_procedure
levels NNS I-Diagnostic_procedure
and CC O
inflammatory JJ B-Diagnostic_procedure
markers NNS I-Diagnostic_procedure
. . O

MRI NNP B-Diagnostic_procedure
revealed VBD O
a DT O
large JJ B-Biological_attribute
mass NN B-Disease_disorder
centred VBD O
at IN O
the DT O
pituitary JJ B-Biological_structure
fossa NN I-Biological_structure
measuring VBG O
approximately RB O
4 CD B-Volume
. . I-Volume
5 CD I-Volume
cm NN I-Volume
× VBD I-Volume
5 CD I-Volume
. . I-Volume
1 CD I-Volume
cm NN I-Volume
× VBD I-Volume
4 CD I-Volume
. . I-Volume
8 CD I-Volume
cm NN I-Volume
( ( O
figure NN O
3A CD O
- : O
C NN O
) ) O
extending VBG O
into IN O
the DT O
suprasellar JJ B-Biological_structure
cistern NN I-Biological_structure
and CC O
infrasellar JJ B-Biological_structure
sphenoid NN I-Biological_structure
sinuses NNS I-Biological_structure
. . O

The DT O
optic JJ B-Biological_structure
chiasm NN I-Biological_structure
and CC O
both DT B-Lab_value
optic JJ B-Biological_structure
nerves NNS I-Biological_structure
were VBD O
displaced VBN B-Detailed_description
superiorly RB I-Detailed_description
and CC O
compressed VBN B-Detailed_description
on IN I-Detailed_description
both DT I-Detailed_description
sides NNS I-Detailed_description
. . O

The DT O
mass NN B-Disease_disorder
showed VBD O
heterogeneous JJ B-Detailed_description
T1 NNP B-Diagnostic_procedure
and CC I-Diagnostic_procedure
T2 NNP B-Diagnostic_procedure
signals NNS I-Diagnostic_procedure
with IN O
multiple JJ B-Lab_value
fluid NN B-Diagnostic_procedure
levels NNS I-Diagnostic_procedure
most RBS O
likely JJ O
due JJ O
to TO O
previous JJ O
haemorrhage NN O
and CC O
low JJ O
- : O
signal JJ O
components NNS O
suggesting VBG O
calcifications NNS B-Disease_disorder
. . O

The DT O
appearance NN O
was VBD O
probably RB O
due JJ O
to TO O
a DT O
craniopharyngioma NN B-Disease_disorder
or CC O
haemorrhagic JJ B-Detailed_description
pituitary JJ B-Disease_disorder
adenoma NN I-Disease_disorder
. . O

The DT O
patient NN O
was VBD O
referred VBN O
urgently RB O
to TO O
the DT O
neurosurgery NN B-Nonbiological_location
unit NN I-Nonbiological_location
and CC O
was VBD O
found VBN O
to TO O
have VB O
markedly RB B-Lab_value
raised VBN I-Lab_value
prolactin NN B-Diagnostic_procedure
levels NNS I-Diagnostic_procedure
of IN O
greater JJR B-Lab_value
than IN I-Lab_value
200 CD I-Lab_value
000 CD I-Lab_value
mIU NN I-Lab_value
/ NNP I-Lab_value
L NNP I-Lab_value
, , O
confirming VBG O
the DT O
diagnosis NN O
of IN O
a DT O
giant JJ B-Severity
prolactinoma NN B-Disease_disorder
. . O

In IN O
cooperation NN O
with IN O
the DT O
local JJ B-Nonbiological_location
endocrinology NN I-Nonbiological_location
service NN I-Nonbiological_location
, , O
he PRP O
was VBD O
started VBN O
on IN O
cabergoline NN B-Medication
500 CD B-Dosage
µg NN I-Dosage
and CC O
dexamethasone NN B-Medication
8 CD B-Dosage
mg NN I-Dosage
. . O

Within IN O
a DT O
week NN O
this DT O
led VBN O
to TO O
a DT O
dramatic JJ B-Lab_value
improvement NN I-Lab_value
of IN O
the DT O
patient NN O
` `` O
s JJ O
visual JJ B-Diagnostic_procedure
fields NNS I-Diagnostic_procedure
and CC I-Diagnostic_procedure
acuities NNS I-Diagnostic_procedure
to TO O
6 CD B-Lab_value
/ NNS I-Lab_value
18 CD I-Lab_value
RE NNP B-Biological_structure
and CC O
to TO O
6 CD B-Lab_value
/ NNS I-Lab_value
9 CD I-Lab_value
LE NNP B-Biological_structure
. . O

His PRP$ O
prolactin NN B-Diagnostic_procedure
levels NNS I-Diagnostic_procedure
showed VBD O
a DT O
similar JJ O
dramatic JJ B-Lab_value
response NN I-Lab_value
with IN I-Lab_value
levels NNS I-Lab_value
coming VBG I-Lab_value
down RB I-Lab_value
to TO O
336 CD B-Lab_value
mIU NNS I-Lab_value
/ JJ I-Lab_value
L NNP I-Lab_value
. . O

Three CD O
months NNS O
later RB O
his PRP$ O
visual JJ B-Diagnostic_procedure
acuity NN I-Diagnostic_procedure
in IN O
his PRP$ O
RE NNP B-Biological_structure
and CC O
LE NNP B-Biological_structure
were VBD O
6 CD B-Lab_value
/ JJ I-Lab_value
18 CD I-Lab_value
and CC O
6 CD B-Lab_value
/ NN I-Lab_value
5 CD I-Lab_value
, , O
respectively RB O
, , O
and CC O
visual JJ B-Diagnostic_procedure
field NN I-Diagnostic_procedure
examination NN I-Diagnostic_procedure
showed VBD O
striking JJ B-Detailed_description
recovery NN I-Detailed_description
with IN O
almost RB B-Detailed_description
normal JJ I-Detailed_description
results NNS I-Detailed_description
( ( O
figure JJ O
2C CD O
) ) O
. . O

-DOCSTART- NN -X-

A DT O
51 CD B-Age
- : I-Age
year NN I-Age
- : I-Age
old JJ I-Age
G1P1 NNP O
Caucasian NNP O
female NN O
with IN O
lifelong JJ O
neurogenic JJ O
bladder NN O
secondary JJ O
to TO O
spina VB O
bifida NN O
occulta NN O
was VBD O
referred VBN O
for IN O
symptoms NNS O
of IN O
constipation NN B-Sign_symptom
and CC O
( ( O
FI NNP B-Sign_symptom
) ) O
. . O

She PRP O
averaged VBD O
one CD O
Bristol NNP B-Diagnostic_procedure
Type NNP I-Diagnostic_procedure
1 CD B-Lab_value
- : I-Lab_value
2 CD I-Lab_value
stool NN B-Activity
every DT B-Frequency
5 CD I-Frequency
days NNS I-Frequency
requiring VBG O
frequent JJ B-Detailed_description
manual JJ B-Therapeutic_procedure
disimpaction NN I-Therapeutic_procedure
. . O

Additionally RB O
, , O
she PRP O
reported VBD O
twice RB B-Frequency
weekly JJ I-Frequency
episodes NNS O
of IN O
urgent JJ B-Severity
fecal JJ B-Sign_symptom
seepage NN I-Sign_symptom
, , O
which WDT O
required VBD O
the DT O
use NN O
of IN O
daily JJ B-Frequency
continence NN B-Therapeutic_procedure
pads NNS I-Therapeutic_procedure
. . O

Her PRP$ O
symptoms NNS O
did VBD O
not RB O
improve VB O
with IN O
the DT O
addition NN O
of IN O
psyllium NN B-Medication
and CC O
bisacodyl JJ B-Medication
suppositories NNS O
. . O

A DT O
defecography NN B-Diagnostic_procedure
suggested VBD O
atrophy NN B-Sign_symptom
of IN O
the DT O
puborectalis NN B-Biological_structure
and CC O
poor JJ B-Sign_symptom
squeeze NN I-Sign_symptom
with IN O
EAS NNP B-Biological_structure
muscle NN I-Biological_structure
atrophy NN B-Sign_symptom
. . O

Anorectal JJ B-Diagnostic_procedure
manometry NN I-Diagnostic_procedure
( ( O
ARM NNP B-Diagnostic_procedure
) ) O
showed VBD O
a DT O
normal JJ B-Lab_value
resting NN B-Diagnostic_procedure
pressure NN I-Diagnostic_procedure
with IN O
no DT O
augmentation NN B-Sign_symptom
of IN I-Sign_symptom
squeeze NN I-Sign_symptom
pressure NN I-Sign_symptom
, , O
consistent JJ O
with IN O
weak JJ B-Disease_disorder
EAS NNP I-Disease_disorder
( ( O
Figure NNP O
1 CD O
) ) O
. . O

During IN O
bearing VBG B-Activity
down RP I-Activity
, , O
fixed JJ B-Sign_symptom
perineal NN I-Sign_symptom
descent NN I-Sign_symptom
was VBD O
noted VBN O
with IN O
the DT O
inability NN B-Lab_value
to TO I-Lab_value
widen VB I-Lab_value
the DT O
posterior JJ B-Diagnostic_procedure
anorectal JJ I-Diagnostic_procedure
angle NN I-Diagnostic_procedure
and CC O
poor JJ B-Lab_value
evacuation NN B-Diagnostic_procedure
of IN I-Diagnostic_procedure
contrast NN I-Diagnostic_procedure
with IN O
straining NN B-Sign_symptom
, , O
consistent JJ O
with IN O
DD NNP B-Disease_disorder
. . O

With IN O
pushing VBG B-Activity
, , O
ARM NNP B-Diagnostic_procedure
similarly RB O
demonstrated VBD O
type JJ B-Lab_value
IV NNP I-Lab_value
DD NNP B-Disease_disorder
, , O
which WDT O
is VBZ O
classified VBN O
as IN O
inability NN O
to TO O
generate VB O
adequate JJ O
propulsive JJ O
forces NNS O
along IN O
with IN O
absent NN O
or CC O
incomplete JJ O
relaxation NN O
of IN O
the DT O
anal JJ O
sphincter NN O
[ VBD O
8 CD O
] NNP O
( ( O
Figure NNP O
2 CD O
) ) O
. . O

Reflex NNP B-Diagnostic_procedure
and CC I-Diagnostic_procedure
sensory JJ I-Diagnostic_procedure
testing VBG I-Diagnostic_procedure
indicated VBD O
an DT O
intact JJ B-Lab_value
rectoanal JJ B-Diagnostic_procedure
inhibitory NN I-Diagnostic_procedure
reflex NN I-Diagnostic_procedure
and CC O
rectal JJ B-Biological_structure
hypersensitivity NN B-Sign_symptom
. . O

The DT O
patient NN O
failed VBD O
management NN B-Sign_symptom
with IN O
home NN B-Detailed_description
and CC O
conventional JJ B-Detailed_description
biofeedback NN B-Therapeutic_procedure
therapy NN I-Therapeutic_procedure
. . O

Following VBG O
a DT O
successful JJ O
trial NN O
of IN O
temporary JJ B-Detailed_description
SNS NNP B-Therapeutic_procedure
with IN O
improvement NN O
in IN O
FI NNP B-Sign_symptom
symptoms NNS O
by IN O
75 CD B-Lab_value
% NN I-Lab_value
, , O
the DT O
patient NN O
had VBD O
a DT O
permanent JJ B-Detailed_description
SNS NNP B-Therapeutic_procedure
placed VBD O
. . O

One CD O
year NN O
later RB O
, , O
the DT O
patient NN O
reports NNS O
sustained VBD O
improvement NN O
in IN O
constipation NN B-Sign_symptom
and CC O
FI NNP B-Sign_symptom
symptoms NNS O
. . O

-DOCSTART- NN -X-

An DT O
82 CD B-Age
- : I-Age
year NN I-Age
- : I-Age
old JJ I-Age
male NN O
was VBD O
admitted VBN O
in IN O
our PRP$ O
outside JJ B-Nonbiological_location
hospital NN I-Nonbiological_location
` `` I-Nonbiological_location
s JJ I-Nonbiological_location
emergency NN I-Nonbiological_location
room NN I-Nonbiological_location
due JJ O
to TO O
abdominal JJ B-Biological_structure
pain NN B-Sign_symptom
and CC O
faint NN B-Sign_symptom
. . O

He PRP O
had VBD O
a DT O
previous JJ O
history NN O
of IN O
auricular JJ B-Sign_symptom
fibrillation NN I-Sign_symptom
in IN O
treatment NN O
with IN O
a DT O
dicumarinic JJ O
anticoagulant NN O
and CC O
a DT O
previous JJ O
episode NN O
of IN O
abdominal JJ B-Biological_structure
pain NN B-Sign_symptom
which WDT O
was VBD O
diagnosed VBN O
as IN O
spontaneous JJ B-Detailed_description
mesenchimal JJ B-Disease_disorder
haematoma NN I-Disease_disorder
and CC O
treated VBD B-Therapeutic_procedure
non RB I-Therapeutic_procedure
operatively RB I-Therapeutic_procedure
. . O

He PRP O
denied VBD O
any DT O
kind NN O
of IN O
trauma NN B-Sign_symptom
, , O
and CC O
had VBD O
no DT O
hematemesis NN B-Sign_symptom
or CC O
melena NN B-Sign_symptom
. . O

At IN O
physical JJ B-Diagnostic_procedure
examination NN I-Diagnostic_procedure
the DT O
patient NN O
was VBD O
stable JJ B-Lab_value
and CC O
suffered VBD O
from IN O
intense JJ B-Severity
pain NN B-Sign_symptom
at IN O
the DT O
right NN B-Biological_structure
lower JJR I-Biological_structure
abdomen NNS I-Biological_structure
with IN O
no DT O
defense NN O
. . O

Blood NN B-Diagnostic_procedure
tests NNS I-Diagnostic_procedure
showed VBD O
a DT O
haemoglobin JJ B-Diagnostic_procedure
level NN I-Diagnostic_procedure
of IN O
10 CD B-Lab_value
g NNS I-Lab_value
/ JJ I-Lab_value
dl NN I-Lab_value
. . O

Coagulation NN B-Diagnostic_procedure
was VBD O
altered VBN B-Lab_value
as IN O
expected VBN O
. . O

CT NNP B-Diagnostic_procedure
scan JJ I-Diagnostic_procedure
showed VBD O
massive JJ B-Severity
hemoperitoneum NN B-Sign_symptom
( ( O
Figure NNP O
1 CD O
) ) O
and CC O
the DT O
already RB O
known VBN O
mesenteric JJ B-Disease_disorder
hematoma NN I-Disease_disorder
( ( O
Figure NNP O
2 CD O
) ) O
. . O

Assuming VBG O
the DT O
diagnosis NN O
of IN O
expansive JJ B-Detailed_description
mesenteric JJ B-Disease_disorder
hematoma NN I-Disease_disorder
plus CC O
ongoing JJ B-Detailed_description
bleeding VBG B-Sign_symptom
a DT O
laparotomy NN B-Therapeutic_procedure
was VBD O
performed VBN O
. . O

During IN O
first JJ O
exploration NN O
, , O
3 CD B-Volume
liters NNS I-Volume
of IN O
fresh JJ B-Sign_symptom
and CC I-Sign_symptom
old JJ I-Sign_symptom
blood NN I-Sign_symptom
clots NNS I-Sign_symptom
were VBD O
found VBN O
. . O

At IN O
90 CD B-Distance
cm NN I-Distance
from IN I-Distance
the DT O
ileocecal JJ B-Biological_structure
valve NN I-Biological_structure
a DT O
torsionated VBN B-Detailed_description
and CC O
perforated VBN B-Detailed_description
meckel NNS B-Disease_disorder
diverticulum NN I-Disease_disorder
with IN O
intradiverticular JJ B-Biological_structure
bleeding NN B-Sign_symptom
was VBD O
found VBN O
( ( O
Figure NNP O
3 CD O
) ) O
and CC O
a DT O
diverticular JJ B-Biological_structure
resection NN B-Therapeutic_procedure
was VBD O
performed VBN O
. . O

The DT O
postoperatory NN B-Therapeutic_procedure
was VBD O
uneventful JJ B-Lab_value
and CC O
the DT O
patient NN O
was VBD O
discharged VBN O
home NN O
at IN O
the DT O
9th CD O
postoperative JJ O
day NN O
. . O

-DOCSTART- NN -X-

A DT O
48 CD B-Age
year NN I-Age
- : I-Age
old JJ I-Age
female NN O
presented VBN O
with IN O
vaginal JJ B-Biological_structure
bleeding NN B-Sign_symptom
and CC O
abnormal JJ B-Lab_value
Pap NNP B-Diagnostic_procedure
smears NNS I-Diagnostic_procedure
. . O

Upon IN O
diagnosis NN O
of IN O
invasive JJ B-Detailed_description
non NN B-Detailed_description
- : I-Detailed_description
keratinizing VBG I-Detailed_description
SCC NNP B-Disease_disorder
of IN O
the DT O
cervix NN B-Biological_structure
, , O
she PRP O
underwent VBD O
a DT O
radical JJ B-Detailed_description
hysterectomy NN B-Therapeutic_procedure
with IN O
salpingo JJ B-Therapeutic_procedure
- : I-Therapeutic_procedure
oophorectomy NN I-Therapeutic_procedure
which WDT O
demonstrated VBD O
positive JJ B-Sign_symptom
spread NN I-Sign_symptom
to TO O
the DT O
pelvic JJ B-Biological_structure
lymph NN I-Biological_structure
nodes NNS I-Biological_structure
and CC O
the DT O
parametrium NN B-Biological_structure
. . O

Pathological JJ B-Diagnostic_procedure
examination NN I-Diagnostic_procedure
revealed VBD O
that IN O
the DT O
tumour NN O
also RB O
extensively RB O
involved VBD O
the DT O
lower JJR B-Biological_structure
uterine JJ I-Biological_structure
segment NN I-Biological_structure
. . O

5 CD O
months NNS O
after IN O
this DT O
surgery NN O
, , O
the DT O
woman NN O
underwent JJ O
external JJ B-Detailed_description
beam NN I-Detailed_description
radiotherapy NN B-Therapeutic_procedure
and CC O
intracavitary JJ B-Detailed_description
brachytherapy NN B-Therapeutic_procedure
. . O

Two CD O
years NNS O
later RB O
, , O
the DT O
patient NN O
presented VBN O
with IN O
a DT O
three CD B-Duration
- : I-Duration
month NN I-Duration
history NN O
of IN O
a DT O
productive JJ B-Detailed_description
cough NN B-Sign_symptom
, , O
shortness NN B-Sign_symptom
of IN I-Sign_symptom
breath NN I-Sign_symptom
, , O
and CC O
a DT O
2 CD B-Duration
- : I-Duration
3 CD I-Duration
week NN I-Duration
history NN O
of IN O
progressive JJ B-Detailed_description
exertional JJ B-Detailed_description
dyspnea NN B-Sign_symptom
. . O

X LS B-Diagnostic_procedure
- : I-Diagnostic_procedure
rays NNS I-Diagnostic_procedure
of IN O
the DT O
chest NN B-Biological_structure
demonstrated VBD O
a DT O
reticular JJ O
nodular JJ O
pattern NN O
, , O
and CC O
CT NNP B-Diagnostic_procedure
scans NNS I-Diagnostic_procedure
revealed VBD O
multiple JJ O
bilateral JJ B-Detailed_description
patchy NN I-Detailed_description
areas NNS I-Detailed_description
of IN O
ground NN B-Texture
glass NN I-Texture
opacity NN I-Texture
scarring VBG B-Sign_symptom
with IN O
focal JJ O
areas NNS O
of IN O
subsegmental JJ B-Detailed_description
atelectasis NN B-Sign_symptom
within IN O
both DT B-Biological_structure
lungs NNS I-Biological_structure
. . O

A DT O
differential JJ O
diagnosis NN O
included VBD O
interstitial JJ B-Detailed_description
pneumonia NN B-Disease_disorder
versus NN O
non SYM B-Detailed_description
- : I-Detailed_description
cardiogenic JJ I-Detailed_description
edema NN B-Sign_symptom
. . O

The DT O
woman NN O
underwent VBD O
a DT O
bronchoscopy NN B-Diagnostic_procedure
, , O
left VBD B-Detailed_description
thoracoscopy NN B-Diagnostic_procedure
, , O
and CC O
an DT O
open JJ B-Detailed_description
wedge NN I-Detailed_description
left VBD B-Biological_structure
lung NN I-Biological_structure
biopsy NN B-Diagnostic_procedure
. . O

Pathological JJ B-Diagnostic_procedure
examination NN I-Diagnostic_procedure
of IN O
the DT O
left NN B-Biological_structure
lung NN I-Biological_structure
biopsy NN O
confirmed VBD O
the DT O
presence NN O
of IN O
neoplastic JJ B-Sign_symptom
sheets NNS I-Sign_symptom
of IN I-Sign_symptom
cells NNS I-Sign_symptom
classically RB O
distributed VBN O
along IN B-Biological_structure
the DT I-Biological_structure
septal JJ I-Biological_structure
vessels NNS I-Biological_structure
, , O
perivascular NN B-Biological_structure
, , O
peribronchial JJ B-Biological_structure
, , O
and CC O
subpleural JJ B-Biological_structure
lymphatics NNS B-Biological_structure
. . O

Subpleural JJ B-Biological_structure
nodules NNS B-Sign_symptom
were VBD O
also RB O
identified VBN O
with IN O
the DT O
presence NN O
of IN O
neoplastic JJ O
cells NNS O
distending VBG O
the DT O
subpleural JJ B-Biological_structure
lymphatics NNS I-Biological_structure
confirming VBG O
LC NNP B-Disease_disorder
( ( O
Figures NNS O
1A CD O
, , O
1B CD O
, , O
1C CD O
) ) O
. . O

On IN O
immunohistochemical JJ B-Diagnostic_procedure
analysis NN I-Diagnostic_procedure
, , O
the DT O
lesional JJ O
cells NNS O
were VBD O
strongly RB O
positive JJ B-Lab_value
to TO O
p16 VB B-Diagnostic_procedure
( ( O
Figure NNP O
1D CD O
) ) O
, , O
high JJ B-Diagnostic_procedure
and CC I-Diagnostic_procedure
low JJ I-Diagnostic_procedure
molecular JJ I-Diagnostic_procedure
weight NN I-Diagnostic_procedure
keratins NNS I-Diagnostic_procedure
( ( O
Figure NNP O
1E CD O
) ) O
, , O
cytokeratin SYM B-Diagnostic_procedure
- : I-Diagnostic_procedure
7 CD I-Diagnostic_procedure
( ( O
CK7 NNP O
) ) O
( ( O
Figure NNP O
1F CD O
) ) O
, , O
CK19 NNP B-Diagnostic_procedure
, , O
and CC O
pan NN B-Diagnostic_procedure
keratin NN I-Diagnostic_procedure
, , O
and CC O
negative JJ B-Lab_value
to TO O
CK20 NNP B-Diagnostic_procedure
, , O
p63 NN B-Diagnostic_procedure
, , O
and CC O
EGFR NNP B-Diagnostic_procedure
. . O

Based VBN O
on IN O
these DT O
findings NNS O
, , O
she PRP O
was VBD O
diagnosed VBN O
to TO O
have VB O
lymphangitic JJ B-Disease_disorder
carcinomatosis NN I-Disease_disorder
in IN O
the DT O
lung NN B-Biological_structure
metastatic NN B-Sign_symptom
from IN O
SCC NNP B-Disease_disorder
of IN O
the DT O
cervix NN B-Biological_structure
. . O

She PRP O
was VBD O
started VBN O
on IN O
chemotherapy NN B-Medication
( ( O
Carbo NNP B-Medication
/ NNP O
Taxol NNP B-Medication
) ) O
with IN O
corticosteroids NNS B-Medication
while IN O
in IN O
the DT O
hospital NN O
, , O
and CC O
was VBD O
discharged VBN O
ten JJ O
days NNS O
later RB O
. . O

Post NNP O
- : O
treatment NN O
improvement NN B-Lab_value
of IN O
clinical JJ B-Sign_symptom
symptoms NNS I-Sign_symptom
was VBD O
paralleled VBN O
by IN O
radiographic JJ B-Diagnostic_procedure
imaging NN I-Diagnostic_procedure
that WDT O
showed VBD O
marked JJ O
interval JJ O
improvement NN B-Lab_value
of IN O
the DT O
nodular JJ B-Sign_symptom
opacifications NNS I-Sign_symptom
and CC O
the DT O
interstitial JJ B-Sign_symptom
thickening NN I-Sign_symptom
that WDT O
had VBD O
previously RB O
been VBN O
noted VBN O
. . O

Despite IN O
this DT O
improvement NN O
, , O
she PRP O
subsequently RB O
died VBD O
13 CD O
months NNS O
after IN O
the DT O
initial JJ O
diagnosis NN O
. . O

-DOCSTART- NN -X-

A DT O
35 CD B-Age
- : I-Age
year NN I-Age
- : I-Age
old JJ I-Age
woman NN O
presented VBD O
to TO O
the DT O
ear NN B-Nonbiological_location
, , I-Nonbiological_location
nose JJ I-Nonbiological_location
and CC I-Nonbiological_location
throat JJ I-Nonbiological_location
outpatient NN I-Nonbiological_location
department NN I-Nonbiological_location
with IN O
headache NN B-Sign_symptom
and CC O
a DT O
blocked JJ B-Sign_symptom
left SYM I-Sign_symptom
- : I-Sign_symptom
sided VBN I-Sign_symptom
nasal JJ I-Sign_symptom
canal JJ I-Sign_symptom
with IN O
epistaxis NN B-Sign_symptom
for IN O
2 CD B-Duration
years NNS I-Duration
. . O

Medical JJ O
history NN O
revealed VBD O
secondary JJ B-Detailed_description
amenorrhoea NN B-Sign_symptom
for IN O
the DT O
past JJ O
19 CD B-Duration
years NNS I-Duration
with IN O
regression NN B-Sign_symptom
of IN I-Sign_symptom
secondary JJ I-Sign_symptom
sexual JJ I-Sign_symptom
characteristics NNS I-Sign_symptom
with IN O
no DT O
galactorrhoea NN B-Sign_symptom
. . O

Physical JJ B-Diagnostic_procedure
and CC O
ophthalmological JJ B-Diagnostic_procedure
examinations NNS I-Diagnostic_procedure
were VBD O
within IN B-Lab_value
normal JJ I-Lab_value
limits NNS I-Lab_value
. . O

Nasal NNP B-Diagnostic_procedure
examination NN I-Diagnostic_procedure
revealed VBD O
a DT O
left JJ B-Biological_structure
- : I-Biological_structure
sided VBD I-Biological_structure
choanal JJ B-Biological_structure
mass NN B-Sign_symptom
. . O

As IN O
the DT O
mass NN O
was VBD O
bleeding VBG B-Detailed_description
on IN I-Detailed_description
palpation NN I-Detailed_description
, , O
imaging NN B-Diagnostic_procedure
was VBD O
advised VBN O
prior RB O
to TO O
performing VBG O
a DT O
biopsy NN O
. . O

MRI NNP B-Diagnostic_procedure
of IN O
the DT O
head NN B-Biological_structure
showed VBD O
a DT O
sellar JJ B-Biological_structure
and CC O
infra JJ B-Biological_structure
- : I-Biological_structure
sellar JJ I-Biological_structure
mass NN B-Sign_symptom
extending VBG B-Biological_structure
into IN I-Biological_structure
the DT I-Biological_structure
nasopharynx NN I-Biological_structure
( ( O
figure JJ O
1 CD O
) ) O
. . O

The DT O
patient NN O
was VBD O
then RB O
referred VBN O
to TO O
the DT O
endocrinologist NN B-Nonbiological_location
for IN O
further JJ O
hormonal JJ B-Diagnostic_procedure
investigation NN I-Diagnostic_procedure
. . O

Her PRP$ O
serum NN B-Diagnostic_procedure
prolactin NN I-Diagnostic_procedure
was VBD O
very RB B-Lab_value
high JJ I-Lab_value
- : O
7443 CD B-Lab_value
µg NN I-Lab_value
/ NNP I-Lab_value
L NNP I-Lab_value
( ( O
N NNP O
< NNP O
20 CD O
) ) O
. . O

Other JJ B-Diagnostic_procedure
pituitary JJ I-Diagnostic_procedure
hormones NNS I-Diagnostic_procedure
were VBD O
within IN B-Lab_value
normal JJ I-Lab_value
limits NNS I-Lab_value
. . O

A DT O
final JJ O
diagnosis NN O
of IN O
giant JJ B-Disease_disorder
prolactinoma NN I-Disease_disorder
was VBD O
made VBN O
and CC O
the DT O
patient NN O
was VBD O
prescribed VBN O
cabergoline JJ B-Medication
0 CD B-Dosage
. . I-Dosage
25 CD I-Dosage
mg JJ I-Dosage
twice RB I-Dosage
per IN I-Dosage
week NN I-Dosage
with IN O
the DT O
associated JJ O
risks NNS O
explained VBN O
in IN O
advance NN O
. . O

-DOCSTART- NN -X-

A DT O
47 CD B-Age
- : I-Age
year NN I-Age
- : I-Age
old JJ I-Age
female JJ O
patient NN O
presented VBD O
progressively RB B-Detailed_description
worsening VBG I-Detailed_description
pain NN B-Sign_symptom
in IN O
the DT O
chest JJS B-Biological_structure
wall NN I-Biological_structure
, , O
back RB B-Biological_structure
, , O
and CC O
bilateral JJ B-Biological_structure
lower JJR I-Biological_structure
extremities NNS I-Biological_structure
as RB O
well RB O
as IN O
muscle NN B-Sign_symptom
weakness NN I-Sign_symptom
. . O

She PRP O
did VBD O
not RB O
have VB O
a DT O
family NN O
history NN O
of IN O
bone NN O
disease NN O
or CC O
fractures NNS O
. . O

Physical JJ B-Diagnostic_procedure
examination NN I-Diagnostic_procedure
was VBD O
unremarkable JJ B-Lab_value
excluding VBG B-Detailed_description
bone NN I-Detailed_description
and CC I-Detailed_description
muscular JJ I-Detailed_description
abnormalities NNS I-Detailed_description
. . O

Bone NNP B-Biological_structure
scintigraphy NN B-Diagnostic_procedure
using VBG B-Detailed_description
technetium JJ I-Detailed_description
- : I-Detailed_description
99m CD I-Detailed_description
methylenediphosphate NN I-Detailed_description
showed VBD O
increased JJ O
uptake NN B-Sign_symptom
in IN O
the DT O
shoulder NN B-Biological_structure
, , O
multiple JJ B-Biological_structure
ribs NN I-Biological_structure
, , O
thoracic NN B-Biological_structure
and CC I-Biological_structure
lumbar NN I-Biological_structure
spines NNS I-Biological_structure
, , O
bilateral JJ B-Biological_structure
sacroiliac NN I-Biological_structure
joints NNS I-Biological_structure
, , O
left VBD B-Biological_structure
ilium NN I-Biological_structure
, , O
and CC O
left VBD B-Biological_structure
foot NN I-Biological_structure
( ( O
Fig NNP O
. . O
1 CD O
) ) O
. . O

Plain NNP B-Detailed_description
radiographs NN B-Diagnostic_procedure
revealed VBD O
osteoporosis JJ B-Disease_disorder
change NN O
of IN O
thoracic NN B-Biological_structure
and CC I-Biological_structure
lumbar NN I-Biological_structure
spine NN I-Biological_structure
as RB O
well RB O
as IN O
compression NN B-Sign_symptom
change NN O
of IN O
several JJ B-Biological_structure
spines NNS I-Biological_structure
, , O
consistent JJ O
with IN O
findings NNS O
of IN O
magnetic JJ B-Diagnostic_procedure
resonance NN I-Diagnostic_procedure
imaging NN I-Diagnostic_procedure
and CC O
computed VBN B-Diagnostic_procedure
tomography NN I-Diagnostic_procedure
( ( O
CT NNP B-Diagnostic_procedure
) ) O
( ( O
Fig NNP O
. . O
1 CD O
) ) O
. . O

Decreased VBN B-Lab_value
bone NN B-Diagnostic_procedure
mass NN I-Diagnostic_procedure
was VBD O
presented VBN O
in IN O
the DT O
lumbar NN B-Biological_structure
spine NN I-Biological_structure
( ( O
T NNP B-Lab_value
- : I-Lab_value
score NN I-Lab_value
: : I-Lab_value
− JJ I-Lab_value
3 CD I-Lab_value
. . I-Lab_value
4 CD I-Lab_value
) ) O
, , O
femoral JJ B-Biological_structure
neck NN I-Biological_structure
( ( O
T NNP B-Lab_value
- : I-Lab_value
score NN I-Lab_value
: : I-Lab_value
− JJ I-Lab_value
3 CD I-Lab_value
. . I-Lab_value
1 CD I-Lab_value
) ) O
, , O
and CC O
hip NN B-Biological_structure
( ( O
T NNP B-Lab_value
- : I-Lab_value
score NN I-Lab_value
: : I-Lab_value
− JJ I-Lab_value
3 CD I-Lab_value
. . I-Lab_value
5 CD I-Lab_value
) ) O
. . O

Main NNP O
laboratory NN O
data NNS O
are VBP O
shown VBN O
in IN O
Table JJ O
1 CD O
. . O

She PRP O
demonstrated VBD O
hypophosphatemia NN B-Sign_symptom
, , O
hypokalemia NN B-Sign_symptom
, , O
hypouricemia NN B-Sign_symptom
, , O
elevated VBD B-Lab_value
level NN O
of IN O
ALP NNP B-Diagnostic_procedure
, , O
C NNP B-Diagnostic_procedure
- : I-Diagnostic_procedure
telopeptides NNS I-Diagnostic_procedure
and CC O
chloride NN B-Diagnostic_procedure
, , O
and CC O
decreased JJ B-Lab_value
carbon NN B-Diagnostic_procedure
dioxide NN I-Diagnostic_procedure
combining VBG I-Diagnostic_procedure
power NN I-Diagnostic_procedure
. . O

The DT O
urinalysis NN B-Diagnostic_procedure
revealed VBD O
a DT O
high JJ B-Lab_value
pH NN B-Diagnostic_procedure
value NN O
, , O
increased VBD B-Lab_value
level NN O
of IN O
potassium NN B-Diagnostic_procedure
, , O
and CC O
decreased VBD B-Lab_value
level NN O
of IN O
specific JJ B-Diagnostic_procedure
gravity NN I-Diagnostic_procedure
, , O
chlorine NN B-Diagnostic_procedure
, , O
and CC O
phosphate NN B-Diagnostic_procedure
. . O

Persistent JJ B-Detailed_description
glycosuria NN B-Sign_symptom
and CC O
proteinuria NNS B-Sign_symptom
were VBD O
repeatedly RB O
found VBN O
, , O
despite IN O
normal JJ B-Lab_value
HbA1c NNP B-Diagnostic_procedure
and CC O
plasma VBP B-Diagnostic_procedure
glucose JJ I-Diagnostic_procedure
level NN O
. . O

Other JJ O
laboratory JJ B-Diagnostic_procedure
test NN I-Diagnostic_procedure
results NNS O
including VBG O
thyroid JJ B-Diagnostic_procedure
function NN I-Diagnostic_procedure
test NN O
, , O
serum NN B-Diagnostic_procedure
parathyroid NN I-Diagnostic_procedure
hormone NN I-Diagnostic_procedure
, , O
25 CD B-Diagnostic_procedure
- : I-Diagnostic_procedure
hydroxyvitamin NN I-Diagnostic_procedure
D NNP I-Diagnostic_procedure
, , O
and CC O
protein JJ B-Diagnostic_procedure
electrophoresis NN I-Diagnostic_procedure
were VBD O
within IN B-Lab_value
normal JJ I-Lab_value
range NN I-Lab_value
. . O

In IN O
addition NN O
, , O
all DT O
of IN O
serum JJ B-Diagnostic_procedure
tumor NN I-Diagnostic_procedure
markers NNS I-Diagnostic_procedure
were VBD O
negative JJ B-Lab_value
. . O

Due NNP O
to TO O
limited JJ O
technique NN O
, , O
we PRP O
can MD O
not RB O
determine VB O
the DT O
level NN O
of IN O
serum JJ B-Diagnostic_procedure
fibroblast JJ I-Diagnostic_procedure
growth NN I-Diagnostic_procedure
factor NN I-Diagnostic_procedure
23 CD I-Diagnostic_procedure
. . O

With IN O
the DT O
clinical JJ O
diagnosis NN O
of IN O
HO NNP B-Disease_disorder
, , O
fluorodeoxyglucose JJ B-Diagnostic_procedure
positron NN I-Diagnostic_procedure
emission NN I-Diagnostic_procedure
tomography NN I-Diagnostic_procedure
/ NNP O
computed VBD B-Diagnostic_procedure
tomography NN I-Diagnostic_procedure
( ( O
18F CD B-Diagnostic_procedure
- : I-Diagnostic_procedure
FDG NNP I-Diagnostic_procedure
PET NNP I-Diagnostic_procedure
/ NNP O
CT NNP B-Diagnostic_procedure
) ) O
and CC O
technetium JJ B-Detailed_description
- : I-Detailed_description
99m CD I-Detailed_description
octreotide NN I-Detailed_description
( ( O
99mTc CD B-Detailed_description
- : I-Detailed_description
OCT NN I-Detailed_description
) ) O
scintigraphy NN B-Diagnostic_procedure
were VBD O
performed VBN O
to TO O
confirm VB O
whether IN O
the DT O
occult NN B-Detailed_description
causative JJ B-Detailed_description
tumor NN B-Sign_symptom
exist NN O
. . O

However RB O
, , O
the DT O
results NNS O
of IN O
these DT O
2 CD O
tests NNS O
were VBD O
negative JJ B-Lab_value
except IN O
that DT O
mild JJ B-Severity
uptake NN B-Sign_symptom
in IN O
the DT O
seventh JJ B-Biological_structure
rib NN I-Biological_structure
was VBD O
found VBN O
on IN O
PET NNP B-Diagnostic_procedure
/ NNP O
CT NNP B-Diagnostic_procedure
, , O
which WDT O
identified VBD O
no DT O
evidence NN O
of IN O
a DT O
neoplastic JJ B-Detailed_description
lesion NN B-Sign_symptom
potentially RB O
responsible JJ O
for IN O
HO NNP O
( ( O
Fig NNP O
. . O
2 CD O
) ) O
. . O

The DT O
immunological JJ B-Diagnostic_procedure
examination NN I-Diagnostic_procedure
showed VBD O
elevated JJ B-Lab_value
level NN O
of IN O
serum NN B-Diagnostic_procedure
IgG NNP I-Diagnostic_procedure
, , O
IgM NNP B-Diagnostic_procedure
, , O
and CC O
IgA NNP B-Diagnostic_procedure
, , O
as RB O
well RB O
as IN O
positive JJ B-Lab_value
antinuclear IN B-Diagnostic_procedure
antibody NN I-Diagnostic_procedure
, , O
anti SYM B-Diagnostic_procedure
- : I-Diagnostic_procedure
SSA NNP I-Diagnostic_procedure
antibody NN I-Diagnostic_procedure
, , O
and CC O
rheumatic JJ B-Diagnostic_procedure
factor NN I-Diagnostic_procedure
. . O

Subsequently RB O
, , O
Schirmer NNP B-Diagnostic_procedure
test NN I-Diagnostic_procedure
was VBD O
abnormal JJ B-Lab_value
and CC O
lip JJ B-Biological_structure
biopsy NN B-Diagnostic_procedure
supported VBD O
the DT O
diagnosis NN O
of IN O
SS NNP B-Disease_disorder
( ( O
Fig NNP O
. . O
3 CD O
) ) O
. . O

Eventually RB O
, , O
this DT O
patient NN O
was VBD O
diagnosed VBN O
with IN O
HO NNP B-Disease_disorder
secondary JJ O
to TO O
SS NNP B-Disease_disorder
, , O
and CC O
she PRP O
was VBD O
then RB O
treated VBN O
with IN O
alkalinization NN B-Therapeutic_procedure
( ( O
citrate JJ B-Medication
4 CD B-Dosage
g JJ I-Dosage
/ NNP I-Dosage
day NN I-Dosage
and CC O
potassium NN B-Medication
citrate NN I-Medication
3 CD B-Dosage
g JJ I-Dosage
/ NNP I-Dosage
day NN I-Dosage
for IN O
2 CD B-Duration
weeks NNS I-Duration
) ) O
, , O
steroids NNS B-Medication
( ( O
prednisone NN B-Medication
20 CD B-Dosage
mg NN I-Dosage
/ NNP I-Dosage
day NN I-Dosage
for IN O
1 CD B-Duration
month NN I-Duration
, , O
10 CD B-Dosage
mg NN I-Dosage
/ NNP I-Dosage
day NN I-Dosage
for IN O
4 CD B-Duration
months NNS I-Duration
) ) O
, , O
neutral JJ B-Medication
phosphate NN I-Medication
( ( O
1 CD B-Dosage
. . I-Dosage
0 CD I-Dosage
g JJ I-Dosage
/ NNP I-Dosage
day NN I-Dosage
for IN O
5 CD B-Duration
months NNS I-Duration
) ) O
, , O
calcium JJ B-Medication
supplements NNS I-Medication
( ( O
600 CD B-Dosage
mg NNS I-Dosage
/ JJ I-Dosage
day NN I-Dosage
for IN O
5 CD B-Duration
months NNS I-Duration
) ) O
, , O
and CC O
together RB O
with IN O
activated JJ B-Medication
vitamin NN I-Medication
D NNP I-Medication
( ( O
0 CD B-Dosage
. . I-Dosage
5 CD I-Dosage
g JJ I-Dosage
/ NNP I-Dosage
day NN I-Dosage
for IN O
5 CD B-Duration
months NNS I-Duration
) ) O
. . O

So RB O
far RB O
, , O
she PRP O
recovered VBD B-Sign_symptom
uneventfully RB O
with IN O
relieved VBN O
pain NN B-Sign_symptom
and CC O
increased VBD B-Lab_value
serum NN B-Diagnostic_procedure
phosphorus NN I-Diagnostic_procedure
level NN O
. . O

This DT O
case NN O
report NN O
was VBD O
approved VBN O
by IN O
the DT O
ethics NNS O
committee NN O
of IN O
West NNP O
China NNP O
Hospital NNP O
of IN O
Sichuan NNP O
University NNP O
, , O
Chengdu NNP O
, , O
China NNP O
, , O
and CC O
the DT O
written VBN O
informed JJ O
consent NN O
was VBD O
obtained VBN O
. . O

-DOCSTART- NN -X-

A DT O
23 CD B-Age
- : I-Age
year NN I-Age
- : I-Age
old JJ I-Age
woman NN O
with IN O
a DT O
history NN O
of IN O
carnitine NN O
deficiency NN O
presented VBN O
with IN O
exertional JJ B-Detailed_description
dyspnea NN B-Sign_symptom
and CC O
fatigue NN B-Sign_symptom
. . O

She PRP O
was VBD O
first RB O
diagnosed VBN O
with IN O
nonischemic JJ B-Detailed_description
cardiomyopathy NN B-Disease_disorder
at IN O
age NN O
10 CD O
years NNS O
, , O
when WRB O
she PRP O
presented VBD O
with IN O
symptoms NNS O
of IN O
congestive JJ B-Detailed_description
heart NN B-Disease_disorder
failure NN I-Disease_disorder
and CC O
transthoracic NN O
echocardiography NN O
( ( O
TTE NNP B-Diagnostic_procedure
) ) O
revealed VBD O
severe JJ B-Severity
left VBN B-Disease_disorder
ventricular JJ I-Disease_disorder
( ( I-Disease_disorder
LV NNP B-Disease_disorder
) ) I-Disease_disorder
dysfunction NN I-Disease_disorder
. . O

At IN O
that DT O
time NN O
, , O
her PRP$ O
total JJ O
carnitine JJ O
level NN O
was VBD O
< JJ B-Lab_value
3 CD I-Lab_value
μmol JJ I-Lab_value
/ NN I-Lab_value
L NNP I-Lab_value
( ( O
normal JJ O
range NN O
, , O
25 CD O
- : O
69 CD O
μmol JJ O
/ NNP O
L NNP O
) ) O
, , O
and CC O
her PRP$ O
free JJ O
carnitine NN O
level NN O
was VBD O
< JJ B-Lab_value
3 CD I-Lab_value
μmol JJ I-Lab_value
/ NN I-Lab_value
L NNP I-Lab_value
( ( O
normal JJ O
range NN O
, , O
16 CD O
- : O
60 CD O
μmol JJ O
/ NNP O
L NNP O
) ) O
. . O

The DT O
cardiomyopathy NN O
was VBD O
attributed VBN O
to TO O
carnitine VB O
deficiency NN O
. . O

After IN O
5 CD B-Duration
months NNS I-Duration
of IN O
therapy NN O
with IN O
carnitine NN O
supplements NNS O
, , O
her PRP$ O
total JJ O
carnitine NN O
and CC O
free JJ O
carnitine NN O
levels NNS O
had VBD O
increased VBN O
to TO O
86 CD B-Lab_value
μmol NNS I-Lab_value
/ JJ I-Lab_value
L NNP I-Lab_value
and CC O
48 CD B-Lab_value
μmol NN I-Lab_value
/ NNP I-Lab_value
L NNP I-Lab_value
, , O
respectively RB O
, , O
and CC O
her PRP$ O
left JJ B-Biological_structure
ventricular JJ I-Biological_structure
systolic JJ B-Diagnostic_procedure
function NN I-Diagnostic_procedure
had VBD O
normalized VBN B-Lab_value
, , O
with IN O
fractional JJ O
shortening NN O
of IN O
34 CD B-Lab_value
. . I-Lab_value
7 CD I-Lab_value
% NN I-Lab_value
. . O

At IN O
the DT O
current JJ O
admission NN O
, , O
the DT O
patient NN O
reported VBD O
that IN O
, , O
over IN B-Duration
the DT I-Duration
past JJ I-Duration
10 CD I-Duration
years NNS I-Duration
, , O
she PRP O
had VBD O
only RB O
been VBN O
intermittently RB B-Detailed_description
compliant JJ I-Detailed_description
with IN O
her PRP$ O
carnitine NN B-Medication
supplement NN I-Medication
regimen NNS I-Medication
, , O
and CC O
that IN O
, , O
approximately RB O
6 CD O
months NNS O
before IN O
presentation NN O
, , O
her PRP$ O
total JJ B-Diagnostic_procedure
carnitine NN I-Diagnostic_procedure
and CC I-Diagnostic_procedure
free JJ B-Diagnostic_procedure
carnitine NN I-Diagnostic_procedure
levels NNS I-Diagnostic_procedure
had VBD O
dropped VBN O
to TO O
18 CD B-Lab_value
μmol NNS I-Lab_value
/ JJ I-Lab_value
L NNP I-Lab_value
and CC O
17 CD B-Lab_value
μmol NN I-Lab_value
/ NNP I-Lab_value
L NNP I-Lab_value
, , O
respectively RB O
. . O

She PRP O
underwent VBD O
TTE NNP B-Diagnostic_procedure
followed VBN O
by IN O
cardiac JJ B-Diagnostic_procedure
magnetic JJ I-Diagnostic_procedure
resonance NN I-Diagnostic_procedure
( ( O
CMR NNP B-Diagnostic_procedure
) ) O
with IN O
gadolinium NN B-Diagnostic_procedure
enhancement NN I-Diagnostic_procedure
. . O

The DT O
TTE NNP B-Diagnostic_procedure
showed VBD O
normal JJ B-Lab_value
LV NNP B-Diagnostic_procedure
function NN I-Diagnostic_procedure
and CC O
mild NN B-Severity
, , O
concentric JJ B-Detailed_description
LV NNP B-Disease_disorder
hypertrophy NN I-Disease_disorder
( ( O
Fig NNP O
. . O
1 CD O
) ) O
. . O

Results NNS O
of IN O
CMR NNP B-Diagnostic_procedure
confirmed VBD O
normal JJ B-Lab_value
LV NNP B-Diagnostic_procedure
size NN I-Diagnostic_procedure
and CC I-Diagnostic_procedure
function NN I-Diagnostic_procedure
but CC O
showed VBD O
focal JJ B-Detailed_description
increased VBD B-Lab_value
wall NN B-Diagnostic_procedure
thickness NN I-Diagnostic_procedure
at IN O
the DT O
basal NN B-Biological_structure
and CC I-Biological_structure
mid JJ B-Biological_structure
lateral JJ I-Biological_structure
wall NN I-Biological_structure
( ( O
end VB B-Diagnostic_procedure
- : I-Diagnostic_procedure
diastolic JJ I-Diagnostic_procedure
thickness NN I-Diagnostic_procedure
, , O
1 CD B-Distance
. . I-Distance
6 CD I-Distance
cm NN I-Distance
) ) O
( ( O
Fig NNP O
. . O
2 CD O
) ) O
with IN O
patchy JJ B-Detailed_description
delayed JJ B-Diagnostic_procedure
gadolinium NN I-Diagnostic_procedure
enhancement NN I-Diagnostic_procedure
( ( O
Fig NNP O
. . O
3 CD O
) ) O
. . O

On IN O
the DT O
basis NN O
of IN O
the DT O
patient NN O
` `` O
s JJ O
family NN O
history NN O
of IN O
sudden JJ O
cardiac JJ O
death NN O
, , O
abnormal JJ B-Lab_value
myocardial JJ B-Diagnostic_procedure
structure NN I-Diagnostic_procedure
, , O
and CC O
underlying VBG O
disease NN O
process NN O
, , O
a DT O
dual JJ B-Detailed_description
- : I-Detailed_description
chamber NN I-Detailed_description
implantable JJ B-Therapeutic_procedure
cardioverter NN I-Therapeutic_procedure
- : I-Therapeutic_procedure
defibrillator NN I-Therapeutic_procedure
was VBD O
placed VBN O
for IN O
primary JJ O
prevention NN O
of IN O
sudden JJ O
cardiac JJ O
death NN O
from IN O
both DT O
bradyarrhythmias NNS O
and CC O
tachyarrhythmias NNS O
. . O

-DOCSTART- NN -X-

A DT O
38 CD B-Age
- : I-Age
year NN I-Age
- : I-Age
old JJ I-Age
woman NN O
presented VBD O
to TO O
our PRP$ O
Emergency NNP B-Nonbiological_location
Department NNP I-Nonbiological_location
with IN O
severe JJ B-Severity
abdominal JJ B-Biological_structure
pain NN B-Sign_symptom
. . O

She PRP O
had VBD O
no DT O
history NN O
of IN O
drug NN O
use NN O
or CC O
constipation NN O
. . O

She PRP O
said VBD O
that IN O
she PRP O
had VBD O
intermittent JJ B-Detailed_description
bloody NN B-Detailed_description
diarrhea NN B-Sign_symptom
. . O

Physical JJ B-Diagnostic_procedure
examination NN I-Diagnostic_procedure
revealed VBD O
rebound NN B-Detailed_description
tenderness NN B-Sign_symptom
and CC O
guarding NN B-Sign_symptom
over IN O
the DT O
abdomen NNS B-Biological_structure
. . O

Stool NNP B-Diagnostic_procedure
microscopy NN I-Diagnostic_procedure
was VBD O
negative JJ B-Lab_value
for IN O
amoeba JJ B-Diagnostic_procedure
trophozoites NNS I-Diagnostic_procedure
or CC O
any DT O
parasites NNS B-Diagnostic_procedure
. . O

Fecal JJ B-Diagnostic_procedure
occult NN I-Diagnostic_procedure
blood NN I-Diagnostic_procedure
was VBD O
found VBN B-Lab_value
. . O

Sedimentation NN B-Diagnostic_procedure
was VBD O
27 CD B-Lab_value
mm NN I-Lab_value
/ NNP I-Lab_value
s NN I-Lab_value
, , O
CRP NNP B-Diagnostic_procedure
( ( O
nephelometry NN B-Diagnostic_procedure
) ) O
was VBD O
65 CD B-Lab_value
. . I-Lab_value
6 CD I-Lab_value
mg JJ I-Lab_value
/ NN I-Lab_value
L NNP I-Lab_value
( ( O
normal JJ O
range NN O
0 CD O
- : O
5 CD O
) ) O
, , O
anti SYM B-Diagnostic_procedure
- : I-Diagnostic_procedure
nuclear JJ I-Diagnostic_procedure
antibody NN I-Diagnostic_procedure
was VBD O
0 CD B-Lab_value
. . I-Lab_value
4 CD I-Lab_value
( ( O
0 CD O
- : O
0 CD O
. . O
8 CD O
negative JJ O
) ) O
, , O
anti SYM B-Diagnostic_procedure
- : I-Diagnostic_procedure
ds NN I-Diagnostic_procedure
DNA NNP I-Diagnostic_procedure
< VBZ B-Lab_value
10 CD I-Lab_value
( ( O
< JJ O
20 CD O
negative JJ O
) ) O
, , O
white JJ B-Diagnostic_procedure
blood NN I-Diagnostic_procedure
cell NN I-Diagnostic_procedure
count NN I-Diagnostic_procedure
was VBD O
14 CD B-Lab_value
. . I-Lab_value
98 CD I-Lab_value
( ( O
normal JJ O
range NN O
4 CD O
- : O
10 CD O
) ) O
, , O
hemoglobin JJ B-Diagnostic_procedure
level NN O
was VBD O
10 CD B-Lab_value
. . I-Lab_value
9 CD I-Lab_value
, , O
neutro SYM B-Diagnostic_procedure
- : I-Diagnostic_procedure
phil NN I-Diagnostic_procedure
count NN I-Diagnostic_procedure
was VBD O
13 CD B-Lab_value
. . I-Lab_value
14 CD I-Lab_value
, , O
platelet NN B-Diagnostic_procedure
count NN I-Diagnostic_procedure
was VBD O
473 CD B-Lab_value
( ( O
100 CD O
- : O
300 CD O
) ) O
, , O
urea JJ B-Diagnostic_procedure
level NN O
was VBD O
17 CD B-Lab_value
mg NN I-Lab_value
/ NNP I-Lab_value
dl NN I-Lab_value
, , O
BUN NNP B-Diagnostic_procedure
level NN O
was VBD O
7 CD B-Lab_value
. . I-Lab_value
94 CD I-Lab_value
mg JJ I-Lab_value
/ NNP I-Lab_value
dl NN I-Lab_value
, , O
creatinine VBP B-Diagnostic_procedure
level NN O
was VBD O
0 CD B-Lab_value
. . I-Lab_value
56 CD I-Lab_value
mg JJ I-Lab_value
/ NNP I-Lab_value
dl NN I-Lab_value
, , O
AST NNP B-Diagnostic_procedure
was VBD O
20 CD B-Lab_value
U NNP I-Lab_value
/ NNP I-Lab_value
L NNP I-Lab_value
, , O
and CC O
ALT NNP B-Diagnostic_procedure
was VBD O
24 CD B-Lab_value
U NNP I-Lab_value
/ NNP I-Lab_value
L NNP I-Lab_value
. . O

HIV NNP B-Diagnostic_procedure
was VBD O
negative JJ B-Lab_value
. . O

Abdominal NNP B-Biological_structure
ultrasound NN B-Diagnostic_procedure
scanning VBG O
showed VBD O
free JJ B-Sign_symptom
fluid NN I-Sign_symptom
at IN O
the DT O
right JJ B-Biological_structure
paracolic NN I-Biological_structure
, , O
perihepatic JJ B-Biological_structure
, , O
left VBD B-Biological_structure
paracolic JJ I-Biological_structure
gutters NNS B-Biological_structure
and CC O
pelvis NN B-Biological_structure
. . O

Upon IN O
detection NN O
of IN O
air NN B-Sign_symptom
- : I-Sign_symptom
fluid NN I-Sign_symptom
level NN I-Sign_symptom
and CC O
free JJ B-Sign_symptom
air NN I-Sign_symptom
under IN B-Biological_structure
the DT I-Biological_structure
diaphragm NN I-Biological_structure
on IN O
erect JJ B-Detailed_description
abdominal JJ B-Biological_structure
x NNP B-Diagnostic_procedure
- : I-Diagnostic_procedure
ray NN I-Diagnostic_procedure
, , O
emergency NN B-Detailed_description
laparotomy NN B-Therapeutic_procedure
was VBD O
performed VBN O
. . O

In IN O
the DT O
operation NN O
, , O
multiple JJ B-Detailed_description
perforation NN B-Sign_symptom
areas NNS O
were VBD O
found VBN O
in IN O
the DT O
sigmoid NN B-Biological_structure
colon NN I-Biological_structure
, , O
descending VBG B-Biological_structure
colon NN I-Biological_structure
, , O
and CC O
transverse JJ B-Biological_structure
colon NN I-Biological_structure
. . O

Wide NNP B-Detailed_description
resection NN B-Therapeutic_procedure
of IN O
the DT O
transverse NN B-Biological_structure
colon NN I-Biological_structure
with IN O
descending NN B-Biological_structure
and CC I-Biological_structure
sigmoid JJ I-Biological_structure
colon NN I-Biological_structure
resection NN B-Therapeutic_procedure
was VBD O
undertaken JJ O
( ( O
Figure NNP O
1 CD O
) ) O
. . O

Pathergy NNP B-Diagnostic_procedure
test NN I-Diagnostic_procedure
was VBD O
positive JJ B-Lab_value
. . O

The DT O
patient NN O
had VBD O
recurrent JJ O
oral JJ B-Biological_structure
and CC O
genital JJ B-Biological_structure
aphthous JJ B-Detailed_description
ulcers NNS B-Disease_disorder
4 CD B-Lab_value
- : I-Lab_value
5 CD I-Lab_value
times NNS I-Lab_value
within IN O
the DT O
past JJ O
year NN O
. . O

Eye NNP B-Diagnostic_procedure
examination NN I-Diagnostic_procedure
results NNS O
were VBD O
normal JJ B-Lab_value
. . O

Computed VBN B-Diagnostic_procedure
tomography NN I-Diagnostic_procedure
revealed VBD O
extensive JJ B-Detailed_description
thrombus NN B-Disease_disorder
within IN O
the DT O
inferior JJ B-Biological_structure
vena NN I-Biological_structure
cava NN I-Biological_structure
extending VBG O
through IN O
the DT O
right NN B-Biological_structure
and CC I-Biological_structure
middle JJ I-Biological_structure
hepatic JJ I-Biological_structure
vein NN I-Biological_structure
( ( O
Figure NNP O
2 CD O
) ) O
. . O

The DT O
patient NN O
received VBD O
corticosteroid JJ B-Medication
, , O
anticoagulant JJ B-Medication
, , O
and CC O
immunosuppressive JJ B-Therapeutic_procedure
therapy NN I-Therapeutic_procedure
. . O

Our PRP$ O
patient NN O
is VBZ O
still RB O
alive JJ B-Sign_symptom
and CC O
healthy JJ B-Sign_symptom
53 CD O
weeks NNS O
later RB O
( ( O
Figure NNP O
3 CD O
) ) O
. . O

In IN O
macroscopy NN B-Diagnostic_procedure
, , O
the DT O
transverse NN B-Diagnostic_procedure
colon NN I-Diagnostic_procedure
was VBD O
50 CD B-Distance
cm NN I-Distance
and CC O
sigmoid NN B-Lab_value
and CC O
descending VBG B-Diagnostic_procedure
colon NN I-Diagnostic_procedure
specimens NNS I-Diagnostic_procedure
were VBD O
27 CD B-Distance
cm NN I-Distance
in IN O
length NN O
. . O

Specimens NNS B-Diagnostic_procedure
of IN I-Diagnostic_procedure
both DT I-Diagnostic_procedure
colon NN I-Diagnostic_procedure
segments NNS I-Diagnostic_procedure
were VBD O
4 CD B-Distance
cm NN I-Distance
in IN O
diameter NN O
. . O

Perforation NNP B-Disease_disorder
areas NNS O
were VBD O
evident JJ O
in IN O
the DT O
serosal NN B-Biological_structure
surface NN I-Biological_structure
. . O

Colonic NNP B-Biological_structure
wall NN I-Biological_structure
and CC O
bowel NN B-Biological_structure
mucosa NN I-Biological_structure
was VBD O
edematous JJ B-Sign_symptom
and CC O
hyperemic JJ B-Sign_symptom
. . O

Plicae NNP B-Diagnostic_procedure
were VBD O
regular JJ B-Lab_value
in IN O
their PRP$ O
course NN O
. . O

There EX O
were VBD O
3 CD B-Lab_value
roundish JJ B-Shape
, , O
punched VBD B-Detailed_description
- : I-Detailed_description
out RP I-Detailed_description
perforations NNS B-Disease_disorder
in IN O
the DT O
transverse NN B-Biological_structure
colon NN I-Biological_structure
and CC O
4 CD B-Lab_value
in IN O
the DT O
descending NN B-Biological_structure
and CC I-Biological_structure
sigmoid JJ I-Biological_structure
colon NN I-Biological_structure
, , O
which WDT O
were VBD O
somewhat RB O
separate JJ B-Detailed_description
from IN I-Detailed_description
the DT I-Detailed_description
colonic NN I-Detailed_description
wall NN I-Detailed_description
, , O
with IN O
the DT O
largest JJS B-Distance
being VBG I-Distance
2 CD I-Distance
cm NN I-Distance
in IN O
diameter NN O
( ( O
Figure NNP O
4 CD O
) ) O
. . O

There EX O
were VBD O
multiple JJ B-Detailed_description
ulcers NNS B-Disease_disorder
( ( O
the DT O
largest JJS B-Distance
was VBD I-Distance
1 CD I-Distance
cm NN I-Distance
in IN O
diameter NN O
) ) O
in IN O
different JJ O
locations NNS O
, , O
which WDT O
were VBD O
not RB B-Detailed_description
merging VBG I-Detailed_description
together RB I-Detailed_description
, , O
and CC O
were VBD O
somewhat RB B-Detailed_description
separate JJ I-Detailed_description
from IN I-Detailed_description
the DT I-Detailed_description
surrounding VBG I-Detailed_description
mucosa NN I-Detailed_description
via IN I-Detailed_description
a DT I-Detailed_description
certain JJ I-Detailed_description
limit NN I-Detailed_description
, , O
covered VBN B-Detailed_description
with IN I-Detailed_description
exudate NN I-Detailed_description
and CC O
surrounded VBN B-Detailed_description
by IN O
a DT O
hyperemic JJ B-Sign_symptom
region NN I-Sign_symptom
. . O

There EX O
were VBD O
no DT O
macroscopic NN B-Sign_symptom
lymph VBZ I-Sign_symptom
nodes NNS I-Sign_symptom
in IN O
the DT O
serosa NN B-Biological_structure
. . O

Numerous JJ O
samples NNS O
were VBD O
taken VBN O
from IN O
ulcerated JJ O
and CC O
perforated JJ O
regions NNS O
and CC O
normal JJ O
mucosa NN O
. . O

The DT O
samples NNS O
were VBD O
submitted VBN O
for IN O
routine JJ O
microscopic NN B-Diagnostic_procedure
tissue NN I-Diagnostic_procedure
follow SYM I-Diagnostic_procedure
- : I-Diagnostic_procedure
up RB I-Diagnostic_procedure
. . O

Hematoxylin NNP B-Diagnostic_procedure
- : I-Diagnostic_procedure
eosin NN I-Diagnostic_procedure
, , O
tissue NN B-Diagnostic_procedure
Giemsa NNP I-Diagnostic_procedure
and CC O
PAS NNP B-Diagnostic_procedure
- : I-Diagnostic_procedure
stained VBD I-Diagnostic_procedure
slides NNS I-Diagnostic_procedure
were VBD O
prepared VBN O
for IN O
examination NN O
. . O

In IN O
microscopic NN O
examination NN O
, , O
there EX O
were VBD O
neutrophil JJ B-Biological_structure
leukocyte NN I-Biological_structure
and CC O
lymphocyte JJ B-Biological_structure
reaction NN B-Sign_symptom
around IN O
and CC O
within IN O
the DT O
walls NNS B-Biological_structure
and CC I-Biological_structure
lumens NNS I-Biological_structure
of IN I-Biological_structure
arterioles NNS I-Biological_structure
, , O
and CC O
venules NNS B-Sign_symptom
around IN O
the DT O
perforated JJ B-Detailed_description
and CC O
ulcerated JJ B-Detailed_description
lesions NNS B-Sign_symptom
( ( O
Figures NNS O
5 CD O
and CC O
and6 NN O
) ) O
. . O
6 CD O
) ) O
. . O

There EX O
were VBD O
well RB B-Detailed_description
- : I-Detailed_description
organized VBN I-Detailed_description
thrombi NN B-Sign_symptom
and CC O
intimal JJ B-Sign_symptom
proliferation NN I-Sign_symptom
within IN O
some DT B-Biological_structure
vessels NNS I-Biological_structure
( ( O
Figures NNS O
7 CD O
and CC O
and8 NN O
) ) O
. . O
8 CD O
) ) O
. . O

There EX O
was VBD O
marked VBN O
acute JJ B-Detailed_description
peritonitis NN B-Disease_disorder
. . O

Surface NNP B-Diagnostic_procedure
epithelium NN I-Diagnostic_procedure
and CC O
colonic JJ B-Diagnostic_procedure
crypts NNS I-Diagnostic_procedure
were VBD O
regular JJ B-Lab_value
within IN O
the DT O
colonic JJ B-Biological_structure
mucosa NNS I-Biological_structure
apart RB O
from IN O
the DT O
ulcerated JJ O
or CC O
perforated JJ O
lesions NNS O
. . O

Samples NNS O
were VBD O
free JJ O
of IN O
parasites NNS B-Disease_disorder
or CC O
their PRP$ O
eggs NNS O
. . O

-DOCSTART- NN -X-

The DT O
proband NN O
is VBZ O
a DT O
19 CD B-Age
- : I-Age
year NN I-Age
- : I-Age
old JJ I-Age
woman NN O
, , O
first JJ O
child NN O
of IN O
healthy JJ O
unrelated JJ O
parents NNS O
. . O

Her PRP$ O
family NN O
history NN O
was VBD O
unremarkable JJ O
. . O

She PRP O
was VBD O
born VBN O
at IN O
term NN O
after IN O
a DT O
normal JJ O
pregnancy NN O
. . O

The DT O
perinatal JJ B-Diagnostic_procedure
period NN I-Diagnostic_procedure
was VBD O
uneventful JJ B-Lab_value
and CC O
her PRP$ O
early JJ B-Diagnostic_procedure
development NN I-Diagnostic_procedure
was VBD O
referred VBN O
to TO O
as IN O
normal JJ B-Lab_value
, , O
but CC O
after IN O
1 CD O
year NN O
of IN O
age NN O
, , O
psychomotor NN B-Disease_disorder
delay NN I-Disease_disorder
became VBD O
evident JJ B-Severity
. . O

She PRP O
started VBD O
walking VBG B-Activity
autonomously RB B-Detailed_description
at IN O
22 CD O
months NNS O
, , O
with IN O
poor JJ B-Lab_value
balance NN B-Diagnostic_procedure
and CC O
frequent JJ B-Frequency
falls NNS B-Sign_symptom
. . O

At IN O
3 CD O
years NNS O
of IN O
age NN O
, , O
she PRP O
developed VBD O
a DT O
demyelinating NN B-Disease_disorder
sensorimotor NN I-Disease_disorder
neuropathy JJ I-Disease_disorder
and CC O
a DT O
brain NN B-Biological_structure
MRI NNP B-Diagnostic_procedure
disclosed VBD O
supratentorial JJ B-Biological_structure
leukodystrophy NN B-Disease_disorder
. . O

During IN O
her PRP$ O
childhood NN O
, , O
the DT O
clinical JJ B-Diagnostic_procedure
signs NNS I-Diagnostic_procedure
remained VBD O
stable JJ B-Lab_value
. . O

At IN O
10 CD O
years NNS O
, , O
her PRP$ O
walking VBG B-Disease_disorder
difficulties NNS I-Disease_disorder
worsened VBN B-Lab_value
, , O
and CC O
limb NN B-Biological_structure
weakness NN B-Sign_symptom
and CC O
tremor NN B-Sign_symptom
ensued VBN O
. . O

The DT O
neurological JJ B-Diagnostic_procedure
evaluation NN I-Diagnostic_procedure
showed VBD O
dysarthria NNS B-Sign_symptom
, , O
dysmetria NNS B-Sign_symptom
, , O
ataxic JJ B-Lab_value
gait NN B-Diagnostic_procedure
and CC O
hyporeflexia NN B-Sign_symptom
in IN O
the DT O
four CD B-Biological_structure
limbs NNS I-Biological_structure
with IN O
muscle NN B-Disease_disorder
wasting NN I-Disease_disorder
. . O

She PRP O
was VBD O
able JJ O
to TO O
walk VB B-Activity
alone RB B-Detailed_description
only RB B-Lab_value
for IN I-Lab_value
a DT I-Lab_value
few JJ I-Lab_value
steps NNS I-Lab_value
with IN O
an DT O
ataxic JJ B-Lab_value
gait NN B-Diagnostic_procedure
. . O

Mild NNP B-Severity
cognitive JJ B-Disease_disorder
impairment NN I-Disease_disorder
was VBD O
documented VBN O
( ( O
IQ NNP B-Diagnostic_procedure
75 CD B-Lab_value
, , O
WISC NNP B-Detailed_description
- : I-Detailed_description
R NNP I-Detailed_description
scale NN I-Detailed_description
) ) O
. . O

Histological JJ B-Diagnostic_procedure
analysis NN I-Diagnostic_procedure
of IN O
a DT O
muscle NN B-Biological_structure
biopsy NN B-Diagnostic_procedure
showed VBD O
hypo JJ B-Sign_symptom
/ NNP I-Sign_symptom
atrophy NN I-Sign_symptom
of IN O
fibres NNS B-Biological_structure
. . O

The DT O
clinical JJ B-Diagnostic_procedure
evolution NN I-Diagnostic_procedure
was VBD O
slowly RB B-Lab_value
progressive JJ I-Lab_value
. . O

At IN O
her PRP$ O
last JJ O
follow JJ O
- : O
up IN O
examination NN O
, , O
at IN O
19 CD O
years NNS O
of IN O
age NN O
, , O
she PRP O
was VBD O
able JJ O
to TO O
walk VB B-Activity
alone RB B-Detailed_description
only RB O
with IN O
ankle JJ B-Detailed_description
- : I-Detailed_description
foot NN I-Detailed_description
orthotic JJ B-Therapeutic_procedure
aids NNS I-Therapeutic_procedure
and CC O
had VBD O
developed VBN O
a DT O
marked VBN B-Severity
dorsal NN B-Biological_structure
- : I-Biological_structure
lumbar NN I-Biological_structure
scoliosis NN B-Disease_disorder
. . O

Other JJ O
clinical JJ B-Diagnostic_procedure
signs NNS I-Diagnostic_procedure
were VBD O
stable JJ B-Lab_value
. . O

Neurophysiological JJ B-Diagnostic_procedure
studies NNS I-Diagnostic_procedure
confirmed VBD O
worsening NN B-Lab_value
of IN O
her PRP$ O
mixed JJ B-Detailed_description
axonal JJ B-Biological_structure
demyelinating VBG B-Disease_disorder
peripheral JJ I-Disease_disorder
neuropathy NN I-Disease_disorder
. . O

Brain NNP B-Biological_structure
and CC O
spinal JJ B-Biological_structure
cord NN I-Biological_structure
MRI NNP B-Diagnostic_procedure
showed VBD O
mild JJ B-Severity
extension NN B-Lab_value
of IN O
signal JJ B-Sign_symptom
abnormalities NNS I-Sign_symptom
and CC O
extensive JJ B-Severity
cavitations NNS B-Sign_symptom
in IN O
the DT O
cerebral JJ B-Biological_structure
white JJ I-Biological_structure
matter NN I-Biological_structure
; : O
the DT O
cerebellum NN B-Biological_structure
and CC O
brainstem NN B-Biological_structure
were VBD O
spared VBN B-Sign_symptom
but CC O
the DT O
spinal JJ B-Biological_structure
cord NN I-Biological_structure
was VBD O
thin JJ B-Sign_symptom
with IN O
no DT O
obvious JJ O
focal JJ B-Detailed_description
lesions NNS B-Sign_symptom
( ( O
figure NN O
1A CD O
) ) O
. . O

Plasma NNP B-Diagnostic_procedure
lactate NN I-Diagnostic_procedure
was VBD O
2 CD B-Lab_value
. . I-Lab_value
9 CD I-Lab_value
mM NN I-Lab_value
( ( O
n JJ O
. . O
v NN O
. . O
< $ O
2 CD O
. . O
1 CD O
) ) O
. . O

-DOCSTART- NN -X-

A DT O
36 CD B-Age
- : I-Age
year NN I-Age
- : I-Age
old JJ I-Age
white JJ O
woman NN O
at IN O
40 CD B-Lab_value
week NN I-Lab_value
of IN O
gestation NN O
was VBD O
admitted VBN O
to TO O
a DT O
local JJ B-Nonbiological_location
obstetric NN I-Nonbiological_location
clinic NN I-Nonbiological_location
for IN O
elective JJ B-Detailed_description
repeated VBN B-Detailed_description
cesarean JJ B-Therapeutic_procedure
delivery NN I-Therapeutic_procedure
due JJ O
to TO O
slanting VBG B-Detailed_description
position NN I-Detailed_description
of IN O
the DT O
fetus NN O
. . O

Both DT O
her PRP$ O
previous JJ O
and CC O
current JJ O
pregnancy NN O
were VBD O
uncomplicated VBN O
. . O

Her PRP$ O
past JJ O
medical JJ O
history NN O
was VBD O
unremarkable JJ O
and CC O
no DT O
family NN O
history NN O
of IN O
cardiac JJ O
disease NN O
was VBD O
reported VBN O
. . O

The DT O
caesarean JJ B-Therapeutic_procedure
delivery NN I-Therapeutic_procedure
was VBD O
performed VBN O
following VBG O
the DT O
administration NN O
of IN O
standard JJ B-Detailed_description
spinal JJ B-Biological_structure
anesthesia NN B-Medication
. . O

During IN O
surgery PDT O
the DT O
patient NN O
became VBD O
hypotensive JJ B-Sign_symptom
and CC O
ephedrine NN B-Medication
was VBD O
injected VBN O
to TO O
maintain VB O
her PRP$ O
blood NN B-Diagnostic_procedure
pressure NN I-Diagnostic_procedure
in IN O
the DT O
normal JJ B-Lab_value
range NN I-Lab_value
. . O

Three CD B-Time
hours NNS I-Time
after IN I-Time
delivery NN O
of IN O
healthy JJ B-Detailed_description
male NN B-Detailed_description
infant NN O
, , O
the DT O
patient NN O
complained VBD O
of IN O
nausea NN B-Sign_symptom
, , O
increasing VBG O
dyspnoea NN B-Sign_symptom
and CC O
palpitations NNS B-Sign_symptom
. . O

On IN O
physical JJ B-Diagnostic_procedure
examination NN I-Diagnostic_procedure
tachycardia NN B-Sign_symptom
with IN O
ventricular JJ B-Biological_structure
extra JJ B-Sign_symptom
systoles NNS I-Sign_symptom
and CC O
pulmonary JJ B-Biological_structure
rales NNS B-Sign_symptom
were VBD O
detected VBN O
. . O

Her PRP$ O
blood NN B-Diagnostic_procedure
pressure NN I-Diagnostic_procedure
was VBD O
80 CD B-Lab_value
/ JJ I-Lab_value
40 CD I-Lab_value
mmHg NN I-Lab_value
and CC O
demanded VBD O
the DT O
administration NN O
of IN O
inotropic JJ B-Medication
agents NNS I-Medication
( ( O
initially RB O
continuous JJ O
infusion NN O
of IN O
norepinephrine JJ B-Medication
0 CD B-Dosage
. . I-Dosage
5 CD I-Dosage
mg JJ I-Dosage
/ NN I-Dosage
h NN I-Dosage
followed VBN O
by IN O
dobutamine NN B-Medication
7 CD B-Dosage
μg NN I-Dosage
/ NNP I-Dosage
kg NNP I-Dosage
/ NNP I-Dosage
min NN I-Dosage
) ) O
. . O

Owing VBG O
to TO O
worsening VBG B-Lab_value
of IN O
oxygen NN B-Diagnostic_procedure
saturation NN I-Diagnostic_procedure
up RB B-Lab_value
to TO I-Lab_value
70 CD I-Lab_value
% NN I-Lab_value
and CC O
gradual JJ B-Severity
deterioration NN B-Sign_symptom
of IN I-Sign_symptom
consciousness NN I-Sign_symptom
, , O
mechanical JJ B-Therapeutic_procedure
ventilation NN I-Therapeutic_procedure
was VBD O
applied VBN O
and CC O
the DT O
patient NN O
was VBD O
transferred VBN O
to TO O
intensive JJ B-Nonbiological_location
care NN I-Nonbiological_location
unit NN I-Nonbiological_location
. . O

Chest NNP B-Biological_structure
X NNP B-Diagnostic_procedure
ray NN I-Diagnostic_procedure
indicated VBD O
pulmonary JJ B-Disease_disorder
congestion NN I-Disease_disorder
. . O

Emergency NNP B-Detailed_description
computer NN B-Diagnostic_procedure
tomography NN I-Diagnostic_procedure
excluded VBD O
pulmonary JJ B-Disease_disorder
thromboembolism NN I-Disease_disorder
( ( O
PE NNP B-Disease_disorder
) ) O
and CC O
confirmed VBN O
severe JJ B-Severity
pulmonary JJ B-Disease_disorder
oedema NN I-Disease_disorder
( ( O
Fig NNP O
. . O
1 CD O
) ) O
. . O

The DT O
patient NN O
received VBD O
loop JJ B-Medication
diuretic JJ I-Medication
, , O
furosemide RB B-Medication
, , O
at IN O
initial JJ O
daily JJ B-Dosage
dose VB I-Dosage
80 CD I-Dosage
mg NN I-Dosage
, , O
which WDT O
was VBD O
progressively RB B-Lab_value
reduced VBN I-Lab_value
. . O

The DT O
diuretic NN O
was VBD O
discontinued VBN O
after IN O
12 CD O
days NNS O
of IN O
treatment NN O
. . O

The DT O
electrocardiogram NN B-Diagnostic_procedure
disclosed VBD O
sinus JJ B-Sign_symptom
tachycardia NN I-Sign_symptom
with IN O
ST NNP B-Sign_symptom
- : I-Sign_symptom
segment NN I-Sign_symptom
elevation NN I-Sign_symptom
of IN O
1,5 CD B-Lab_value
mm NNS I-Lab_value
with IN O
negative JJ B-Sign_symptom
T NNP I-Sign_symptom
waves NNS I-Sign_symptom
in IN O
aVL NN B-Diagnostic_procedure
and CC O
ST NNP B-Sign_symptom
- : I-Sign_symptom
segment NN I-Sign_symptom
depression NN I-Sign_symptom
of IN O
1 CD B-Lab_value
mm NNS I-Lab_value
in IN O
II NNP B-Diagnostic_procedure
, , O
III NNP B-Diagnostic_procedure
, , O
aVF NN B-Diagnostic_procedure
, , O
V5 NNP B-Diagnostic_procedure
- : I-Diagnostic_procedure
V6 NNP I-Diagnostic_procedure
( ( O
Fig NNP O
. . O
2 CD O
) ) O
. . O

Laboratory NN B-Diagnostic_procedure
tests NNS I-Diagnostic_procedure
showed VBD O
elevated VBN B-Lab_value
troponin NN B-Diagnostic_procedure
up RB B-Lab_value
to TO I-Lab_value
908 CD I-Lab_value
pg NNS I-Lab_value
/ JJ I-Lab_value
ml NN I-Lab_value
( ( O
normal JJ O
value NN O
< VBD O
14 CD O
pg NN O
/ NNP O
ml NN O
) ) O
, , O
NT NNP B-Diagnostic_procedure
- : I-Diagnostic_procedure
pro FW I-Diagnostic_procedure
BNP FW I-Diagnostic_procedure
6236 CD B-Lab_value
pg NN I-Lab_value
/ NNP I-Lab_value
ml NN I-Lab_value
( ( O
normal JJ O
value NN O
< VBD O
125 CD O
pg NN O
/ NNP O
ml NN O
) ) O
. . O

The DT O
bedside NN B-Detailed_description
transthoracic NN B-Diagnostic_procedure
echocardiography NN I-Diagnostic_procedure
( ( O
TTE NNP B-Diagnostic_procedure
) ) O
revealed VBD O
severe JJ B-Severity
left VBN B-Biological_structure
ventricular JJ I-Biological_structure
( ( O
LV NNP B-Biological_structure
) ) O
systolic JJ B-Disease_disorder
dysfunction NN I-Disease_disorder
. . O

Therefore RB O
the DT O
patient NN O
was VBD O
transferred VBN O
to TO O
Intensive NNP B-Biological_structure
Cardiac NNP I-Biological_structure
Therapy NNP I-Biological_structure
Clinic NNP I-Biological_structure
. . O

Repeated VBN O
TTE NNP B-Diagnostic_procedure
showed VBD O
LV NNP B-Biological_structure
ejection NN B-Diagnostic_procedure
fraction NN I-Diagnostic_procedure
30 CD B-Lab_value
% NN I-Lab_value
with IN O
hypokinesis NN B-Sign_symptom
of IN O
the DT O
mid NN B-Detailed_description
and CC I-Detailed_description
basal NN I-Detailed_description
segments NNS I-Detailed_description
of IN O
posterior NN B-Biological_structure
, , I-Biological_structure
anterior JJ I-Biological_structure
and CC I-Biological_structure
lateral JJ I-Biological_structure
wall NN I-Biological_structure
with IN O
preserved JJ B-Lab_value
contractility NN B-Diagnostic_procedure
of IN O
the DT O
apical JJ B-Biological_structure
segments NNS I-Biological_structure
. . O

Urgent JJ B-Detailed_description
coronary JJ B-Diagnostic_procedure
angiography NN I-Diagnostic_procedure
presented VBN O
normal JJ B-Lab_value
coronary JJ B-Biological_structure
arteries NNS I-Biological_structure
. . O

The DT O
diagnosis NN O
of IN O
inverted JJ B-Detailed_description
stress NN B-Detailed_description
- : I-Detailed_description
induced VBN I-Detailed_description
cardiomyopathy NN B-Disease_disorder
was VBD O
set VBN O
upon IN O
the DT O
overall JJ O
clinical JJ O
data NNS O
. . O

After IN O
3 CD O
days NNS O
the DT O
patient NN O
was VBD O
weaned VBN O
from IN O
respirator NN B-Therapeutic_procedure
and CC O
extubated VBN B-Therapeutic_procedure
. . O

Following VBG O
hemodynamic JJ B-Diagnostic_procedure
improvement NN B-Lab_value
, , O
inotropic NN B-Medication
agents NNS I-Medication
were VBD O
tapered VBN O
gradually RB O
. . O

Both DT O
TTE NNP B-Diagnostic_procedure
and CC O
magnetic JJ B-Diagnostic_procedure
resonance NN I-Diagnostic_procedure
imaging NN I-Diagnostic_procedure
( ( O
Figs NNP O
. . O
3 CD O
and CC O
4 CD O
) ) O
performed VBN O
on IN O
the DT O
fifth JJ O
day NN O
showed VBD O
complete JJ B-Lab_value
recovery NN I-Lab_value
of IN O
myocardial JJ B-Diagnostic_procedure
function NN I-Diagnostic_procedure
. . O

The DT O
patient NN O
was VBD O
discharged VBN O
after IN O
15 CD O
days NNS O
in IN O
good JJ B-Lab_value
overall JJ B-Diagnostic_procedure
condition NN I-Diagnostic_procedure
. . O

At IN O
12 CD O
- : O
month NN O
follow SYM O
- : O
up IN O
she PRP O
remained VBD O
asymptomatic JJ B-Sign_symptom
with IN O
no DT O
echocardiographic JJ B-Sign_symptom
abnormalities NNS I-Sign_symptom
. . O

-DOCSTART- NN -X-

A DT O
54 CD B-Age
- : I-Age
year NN I-Age
- : I-Age
old JJ I-Age
woman NN O
with IN O
stage NN B-Detailed_description
IV NNP I-Detailed_description
NSCLC NNP B-Disease_disorder
was VBD O
treated VBN O
with IN O
carboplatin NN B-Medication
and CC O
paclitaxel NN B-Medication
without IN B-Detailed_description
disease NN I-Detailed_description
response NN I-Detailed_description
. . O

Molecular JJ B-Diagnostic_procedure
analysis NN I-Diagnostic_procedure
of IN O
tumor NN B-Diagnostic_procedure
tissue NN I-Diagnostic_procedure
was VBD O
unavailable JJ B-Detailed_description
at IN O
that DT O
time NN O
. . O

However RB O
, , O
her PRP O
demographic JJ O
profile NN O
( ( O
Asian JJ O
, , O
minimal JJ B-Severity
smoking VBG O
history NN O
, , O
non SYM B-Detailed_description
- : I-Detailed_description
small JJ I-Detailed_description
cell NN I-Detailed_description
histology NN O
) ) O
predicted VBD O
her PRP$ O
disease NN O
would MD O
harbor VB O
EGFR NNP B-Diagnostic_procedure
TKI NNP I-Diagnostic_procedure
sensitive JJ I-Diagnostic_procedure
cells NNS I-Diagnostic_procedure
[ VBP O
2 CD O
] NN O
. . O

Therefore RB O
, , O
she PRP O
then RB O
initiated VBD O
standard JJ B-Detailed_description
daily JJ B-Dosage
dosing NN I-Dosage
of IN O
erlotinib NN B-Medication
( ( O
150 CD B-Lab_value
mg NN I-Lab_value
) ) O
and CC O
her PRP$ O
disease NN O
responded VBD B-Detailed_description
. . O

Twenty NNP O
- : O
eight CD O
months NNS O
later RB O
, , O
she PRP O
acquired VBD O
resistance NN B-Other_event
to TO O
erlotinib VB B-Medication
with IN O
progression NN B-Detailed_description
of IN O
disease NN O
systemically RB B-Detailed_description
. . O

Following VBG O
further JJ O
progression NN O
through IN O
an DT O
experimental JJ B-Detailed_description
angiogenesis NN B-Medication
inhibitor NN I-Medication
, , O
she PRP O
initiated VBD O
pemetrexed JJ B-Medication
and CC O
resumed JJ O
standard NN O
dose NN O
erlotinib NN O
. . O

After IN O
initial JJ O
response NN O
, , O
11 CD O
months NNS O
later RB O
, , O
her PRP$ O
disease NN O
again RB O
progressed VBD B-Detailed_description
. . O

DNA NN B-Biological_structure
was VBD O
extracted VBN O
from IN O
biopsy NN B-Diagnostic_procedure
of IN O
a DT O
progressing NN B-Detailed_description
lung NN B-Biological_structure
lesion NN B-Disease_disorder
and CC O
examined VBD O
using VBG O
established VBN O
techniques NNS O
for IN O
analysis NN O
of IN O
EGFR NNP B-Diagnostic_procedure
mutations NNS I-Diagnostic_procedure
[ VBP O
5 CD O
] NN O
. . O

Direct JJ B-Diagnostic_procedure
sequencing NN I-Diagnostic_procedure
of IN O
exons NNS B-Detailed_description
18 CD I-Detailed_description
- : I-Detailed_description
21 CD I-Detailed_description
encoding VBG O
the DT O
kinase NN B-Detailed_description
domain NN I-Detailed_description
of IN O
EGFR NNP B-Diagnostic_procedure
revealed VBD O
the DT O
L858R NNP B-Diagnostic_procedure
mutation NN I-Diagnostic_procedure
associated VBN O
with IN O
EGFR NNP B-Detailed_description
TKI NNP I-Detailed_description
sensitivity NN I-Detailed_description
( ( O
Fig NNP O
. . O
1 CD O
) ) O
[ VBD O
2 CD O
] NN O
. . O

It PRP O
also RB O
demonstrated VBD O
the DT O
T790M NNP B-Diagnostic_procedure
mutation NN I-Diagnostic_procedure
associated VBN O
with IN O
acquired VBN B-Detailed_description
EGFR NNP I-Detailed_description
TKI NNP I-Detailed_description
resistance NN I-Detailed_description
( ( O
Fig NNP O
. . O
1 CD O
) ) O
[ VBD O
2 CD O
] NN O
. . O

She PRP O
also RB O
developed VBD O
headaches NNS B-Sign_symptom
and CC O
there EX O
was VBD O
a DT O
high JJ O
clinical JJ O
suspicion NN O
of IN O
CNS NNP B-Biological_structure
metastases NNS B-Disease_disorder
despite IN O
negative JJ B-Lab_value
imaging NN B-Diagnostic_procedure
( ( O
not RB O
shown VBN O
) ) O
. . O

She PRP O
refused VBD O
a DT O
lumbar NN B-Therapeutic_procedure
puncture NN I-Therapeutic_procedure
. . O

She PRP O
initiated VBD O
empiric JJ B-Detailed_description
temozolomide NN B-Medication
plus CC O
standard JJ B-Detailed_description
dose NN I-Detailed_description
erlotinib NN B-Medication
( ( O
150 CD B-Dosage
mg NNS I-Dosage
daily RB I-Dosage
) ) O
for IN O
presumed VBN O
CNS NNP B-Disease_disorder
disease NN I-Disease_disorder
, , O
but CC O
after IN B-Time
one CD I-Time
cycle NN I-Time
her PRP$ O
headaches NNS B-Sign_symptom
worsened VBN B-Lab_value
, , O
and CC O
she PRP O
developed VBD O
nausea NN B-Sign_symptom
and CC O
vomiting VBG B-Sign_symptom
concerning VBG O
for IN O
CNS NNP B-Disease_disorder
metastases NNS I-Disease_disorder
with IN O
associated VBN O
raised VBN B-Lab_value
intracranial JJ B-Diagnostic_procedure
pressure NN I-Diagnostic_procedure
. . O

Magnetic JJ B-Diagnostic_procedure
resonance NN I-Diagnostic_procedure
imaging NN I-Diagnostic_procedure
( ( B-Diagnostic_procedure
MRI NNP I-Diagnostic_procedure
) ) I-Diagnostic_procedure
of IN O
the DT O
brain NN B-Biological_structure
now RB O
demonstrated JJ O
LM NNP B-Disease_disorder
( ( O
Fig NNP O
. . O
2 CD O
) ) O
confirmed VBN O
by IN O
CSF NNP B-Diagnostic_procedure
cytology NN I-Diagnostic_procedure
( ( O
not RB O
shown VBN O
) ) O
. . O

By IN O
direct JJ B-Detailed_description
sequencing NN B-Diagnostic_procedure
, , O
DNA NN B-Biological_structure
from IN O
CSF NNP B-Diagnostic_procedure
cells NNS I-Diagnostic_procedure
harbored VBD O
L858R NNP B-Diagnostic_procedure
predicting VBG O
EGFR NNP B-Diagnostic_procedure
TKI NNP I-Diagnostic_procedure
sensitivity NN I-Diagnostic_procedure
( ( O
Fig NNP O
. . O
3 CD O
, , O
left VBD O
panel NN O
) ) O
but CC O
not RB O
the DT O
T790M NNP B-Diagnostic_procedure
resistance NN I-Diagnostic_procedure
mutation NN I-Diagnostic_procedure
( ( O
data NNS O
not RB O
shown VBN O
) ) O
. . O

Because IN O
the DT O
result NN O
for IN O
T790M NNP B-Diagnostic_procedure
was VBD O
negative JJ B-Lab_value
in IN O
this DT O
sample NN O
, , O
we PRP O
performed VBD O
a DT O
more RBR B-Lab_value
sensitive JJ I-Lab_value
fluorescence NN B-Detailed_description
detection NN I-Detailed_description
PCR NNP B-Detailed_description
- : I-Detailed_description
based VBN I-Detailed_description
assay VBP B-Diagnostic_procedure
that IN O
takes VBZ O
advantage NN O
of IN O
a DT O
PCR NNP B-Diagnostic_procedure
restriction NN I-Diagnostic_procedure
fragment NN I-Diagnostic_procedure
length NN I-Diagnostic_procedure
polymorphism NN I-Diagnostic_procedure
generated VBN O
by IN O
the DT O
specific JJ O
missense NN O
mutation NN O
( ( O
Fig NNP O
. . O
3 CD O
, , O
right JJ O
panel NN O
, , O
arrow NN O
, , O
positive JJ O
control NN O
) ) O
[ VBZ O
6 CD O
] NN O
. . O

That DT O
result NN O
was VBD O
also RB O
negative JJ B-Lab_value
, , O
as IN O
only RB O
the DT O
wild JJ B-Diagnostic_procedure
type NN I-Diagnostic_procedure
peak NN I-Diagnostic_procedure
was VBD O
detected VBN O
( ( O
Fig NNP O
. . O
3 CD O
, , O
right JJ O
panel NN O
, , O
bottom NN O
) ) O
. . O

Therefore RB O
, , O
we PRP O
hypothesized VBD O
that IN O
the DT O
LM NNP O
remained VBD O
sensitive JJ O
to TO O
an DT O
EGFR NNP O
TKI NNP O
if IN O
sufficiently RB O
high JJ O
concentrations NNS O
of IN O
drug NN O
could MD O
be VB O
achieved VBN O
in IN O
the DT O
CSF NNP O
. . O

The DT O
erlotinib JJ O
concentration NN O
required VBN O
to TO O
inhibit VB O
growth NN O
of IN O
cell NN O
lines NNS O
harboring VBG O
L858R NNP O
by IN O
50 CD O
% NN O
( ( O
IC50 NNP O
) ) O
is VBZ O
100 CD O
nM NN O
( ( O
nM JJ O
) ) O
[ VBP O
2 CD O
] NN O
. . O

Standard NNP O
dose NN O
erlotinib NN O
( ( O
150 CD O
mg NNS O
daily RB O
) ) O
achieves VBZ O
3000 CD O
nM NN O
in IN O
plasma NN O
[ $ O
7 CD O
] NN O
, , O
but CC O
CSF NNP O
concentrations NNS O
of IN O
EGFR NNP O
TKIs NNP O
are VBP O
as RB O
low JJ O
as IN O
1 CD O
% NN O
plasma NN O
levels NNS O
below IN O
the DT O
IC50 NNP O
[ NNP O
3 CD O
, , O
8 CD O
] NN O
. . O

Increasing VBG O
the DT O
daily JJ O
dose NN O
of IN O
gefitinib NN O
to TO O
enhance VB O
CSF NNP O
penetration NN O
has VBZ O
been VBN O
an DT O
effective JJ O
strategy NN O
[ VBZ O
3 CD O
] NN O
, , O
but CC O
gefitinib NN O
is VBZ O
no RB O
longer RBR O
available JJ O
in IN O
the DT O
United NNP O
States NNPS O
following VBG O
failure NN O
in IN O
phase NN O
III NNP O
NSCLC NNP O
trials NNS O
. . O

An DT O
analogous JJ O
increase NN O
of IN O
the DT O
daily JJ O
erlotinib NN O
dose NN O
above IN O
150 CD O
- : O
200 CD O
mg JJ O
daily JJ O
induces NNS O
unacceptable JJ O
toxicity NN O
. . O

However RB O
, , O
weekly RB O
high JJ O
- : O
dose NN O
erlotinib VBZ O
up IN O
to TO O
2000 CD O
mg NN O
is VBZ O
tolerable JJ O
[ JJ O
4 CD O
] NN O
. . O

Pharmacokinetic JJ B-Diagnostic_procedure
analysis NN I-Diagnostic_procedure
of IN O
CSF NNP B-Biological_structure
from IN O
another DT O
patient NN O
with IN O
NSCLC NNP B-Disease_disorder
LM NNP B-Disease_disorder
( ( O
not RB O
shown VBN O
) ) O
treated VBN O
with IN O
1500 CD B-Dosage
mg NN I-Dosage
erlotinib JJ B-Medication
weekly RB I-Dosage
demonstrated VBD O
a DT O
peak JJ B-Diagnostic_procedure
plasma JJ I-Diagnostic_procedure
concentration NN I-Diagnostic_procedure
of IN O
11,300 CD B-Lab_value
nM NNS I-Lab_value
with IN O
a DT O
concurrent NN O
CSF NNP B-Diagnostic_procedure
concentration NN I-Diagnostic_procedure
of IN O
130 CD B-Lab_value
nM NNS I-Lab_value
. . O

Therefore RB O
, , O
such JJ O
high JJ O
dose JJ O
weekly JJ O
administration NN O
of IN O
erlotinib NN O
achieved VBD O
a DT O
CSF NNP O
concentration NN O
exceeding VBG B-Detailed_description
the DT I-Detailed_description
IC50 NNP I-Detailed_description
. . O

Therefore RB O
, , O
to TO O
increase VB O
CSF NNP O
penetrance NN O
over IN O
standard JJ O
daily JJ O
erlotinib NN O
dosing NN O
in IN O
this DT O
patient NN O
, , O
we PRP O
initiated VBD O
high JJ B-Dosage
- : I-Dosage
dose JJ I-Dosage
weekly JJ I-Dosage
erlotinib NN B-Medication
at IN O
1000 CD B-Lab_value
mg NN I-Lab_value
then RB O
1200 CD B-Lab_value
mg NN I-Lab_value
; : O
persistent JJ B-Detailed_description
nausea NN B-Sign_symptom
precluded VBD O
higher JJR O
doses NNS O
. . O

Pharmacokinetic JJ B-Diagnostic_procedure
analysis NN I-Diagnostic_procedure
was VBD O
not RB O
undertaken VBN O
in IN O
this DT O
patient NN O
. . O

After IN O
1 CD O
month NN O
there RB O
was VBD O
a DT O
partial JJ B-Diagnostic_procedure
radiographic JJ I-Diagnostic_procedure
response NN I-Diagnostic_procedure
of IN O
LM NNP B-Disease_disorder
on IN O
brain NN B-Biological_structure
MRI NNP B-Diagnostic_procedure
( ( O
Fig NNP O
. . O
2b CD O
) ) O
and CC O
after IN O
2 CD O
months NNS O
in IN O
the DT O
cauda NN B-Biological_structure
equina NN I-Biological_structure
( ( O
not RB O
shown VBN O
) ) O
. . O

However RB O
, , O
hydrocephalus NN B-Disease_disorder
and CC O
persistent NN B-Detailed_description
symptoms NNS B-Sign_symptom
referable JJ O
to TO O
increased VBN B-Lab_value
intracranial JJ B-Diagnostic_procedure
pressure NN I-Diagnostic_procedure
led VBD O
to TO O
a DT O
VP NNP B-Therapeutic_procedure
shunt NN I-Therapeutic_procedure
and CC O
whole JJ B-Biological_structure
- : I-Biological_structure
brain NN I-Biological_structure
radiation NN B-Therapeutic_procedure
therapy NN I-Therapeutic_procedure
, , O
after IN O
which WDT O
she PRP O
resumed VBD O
treatment NN O
with IN O
1500 CD B-Dosage
mg JJ I-Dosage
weekly JJ I-Dosage
erlotinib NN B-Medication
. . O

One CD O
month NN O
later RB O
, , O
progressive JJ B-Detailed_description
intra NN B-Disease_disorder
- : I-Disease_disorder
thoracic NN I-Disease_disorder
disease NN I-Disease_disorder
led VBD O
to TO O
initiation NN O
of IN O
cetixumab NN B-Medication
and CC O
erlotinib NN B-Medication
was VBD O
continued VBN O
but CC O
changed VBN O
to TO O
low VB B-Dosage
dose NN I-Dosage
( ( I-Dosage
100 CD B-Lab_value
mg NN I-Lab_value
) ) I-Dosage
daily RB I-Dosage
. . O

She PRP O
survived VBD B-Sign_symptom
14 CD O
months NNS O
following VBG O
the DT O
diagnosis NN O
of IN O
CNS NNP B-Disease_disorder
disease NN I-Disease_disorder
. . O

-DOCSTART- NN -X-

A DT O
65 CD B-Age
- : I-Age
year NN I-Age
- : I-Age
old JJ I-Age
man NN O
was VBD O
referred VBN O
to TO O
our PRP$ O
hospital NN B-Nonbiological_location
for IN O
evaluation NN O
of IN O
stuttering VBG B-Detailed_description
chest JJS B-Biological_structure
pain NN B-Sign_symptom
for IN O
10 CD B-Duration
days NNS I-Duration
, , O
and CC O
he PRP O
was VBD O
a DT O
common JJ B-Occupation
worker NN I-Occupation
. . O

There EX O
was VBD O
no DT B-Lab_value
positive JJ I-Lab_value
finding NN I-Lab_value
from IN O
the DT O
relevant JJ O
physical JJ B-Diagnostic_procedure
examination NN I-Diagnostic_procedure
. . O

He PRP O
has VBZ O
no DT O
medical JJ O
, , O
family NN O
, , O
and CC O
psychosocial JJ O
history NN O
including VBG O
co JJ O
- : O
morbidities NNS O
, , O
and CC O
relevant JJ O
genetic JJ O
information NN O
. . O

His PRP$ O
electrocardiogram NN B-Diagnostic_procedure
showed VBD O
T NNP B-Sign_symptom
- : I-Sign_symptom
wave NN I-Sign_symptom
inversion NN I-Sign_symptom
over IN O
leads VBZ B-Detailed_description
V1 NNP I-Detailed_description
to TO I-Detailed_description
V4 NNP I-Detailed_description
( ( O
Figure NNP O
1 CD O
) ) O
. . O

Coronary JJ B-Diagnostic_procedure
angiography NN I-Diagnostic_procedure
showed VBD O
90 CD B-Lab_value
% NN I-Lab_value
stenosis NN B-Sign_symptom
in IN O
the DT O
mid NN B-Biological_structure
- : I-Biological_structure
left VBD I-Biological_structure
anterior JJ I-Biological_structure
descending VBG I-Biological_structure
coronary JJ I-Biological_structure
artery NN I-Biological_structure
( ( O
LAD NNP B-Biological_structure
) ) O
, , O
which WDT O
was VBD O
stented VBN B-Therapeutic_procedure
( ( O
Figure NNP O
2 CD O
) ) O
. . O

T NNP B-Detailed_description
- : I-Detailed_description
wave NN I-Detailed_description
still RB O
inversion NN B-Sign_symptom
over IN O
leads VBZ B-Detailed_description
V1 NNP I-Detailed_description
to TO I-Detailed_description
V4 NNP I-Detailed_description
after IN O
the DT O
percutaneous JJ B-Therapeutic_procedure
coronary JJ I-Therapeutic_procedure
intervention NN I-Therapeutic_procedure
( ( O
PCI NNP B-Therapeutic_procedure
) ) O
( ( O
Figure NNP O
3 CD O
) ) O
. . O

The DT O
patient NN O
discharged VBD O
after IN O
the DT O
PCI NNP O
in IN O
5 CD O
days NNS O
and CC O
recharged VBN O
in IN O
the DT O
hospital NN B-Nonbiological_location
because IN O
of IN O
a DT O
palpation NN B-Sign_symptom
. . O

His PRP$ O
electrocardiogram NN B-Diagnostic_procedure
demonstrated VBD O
ventricular JJ B-Disease_disorder
tachycardia NN I-Disease_disorder
( ( O
Figure NNP O
4 CD O
) ) O
, , O
and CC O
severe JJ B-Severity
hypertension NN B-Sign_symptom
, , O
remarkable JJ O
blood NN B-Sign_symptom
pressure NN I-Sign_symptom
fluctuation NN I-Sign_symptom
between IN B-Lab_value
224 CD I-Lab_value
/ $ I-Lab_value
76 CD I-Lab_value
and CC I-Lab_value
70 CD I-Lab_value
/ NNS I-Lab_value
50 CD I-Lab_value
mm NN I-Lab_value
Hg NNP I-Lab_value
. . O

Although IN O
several JJ O
antihypertensive JJ B-Medication
drugs NNS I-Medication
were VBD O
used VBN O
, , O
ventricular JJ B-Disease_disorder
tachycardia NN I-Disease_disorder
still RB O
occurred VBD O
on IN O
him PRP O
for IN O
2 CD B-Detailed_description
times NNS I-Detailed_description
, , O
each DT O
was VBD O
preceded VBN O
by IN O
a DT O
period NN O
of IN O
blood NN B-Sign_symptom
pressure NN I-Sign_symptom
fluctuation NN I-Sign_symptom
and CC O
burst VB O
out RP O
concomitantly RB O
at IN O
the DT O
peak NN O
of IN O
a DT O
hypertension NN B-Disease_disorder
crisis NN I-Disease_disorder
. . O

The DT O
patient NN O
felt VBD O
abdominal JJ B-Biological_structure
pain NN B-Sign_symptom
and CC O
his PRP$ O
abdominal JJ B-Biological_structure
ultrasound NN B-Diagnostic_procedure
showed VBD O
suspicious JJ O
right JJ B-Biological_structure
adrenal JJ I-Biological_structure
gland NN I-Biological_structure
tumor NN B-Sign_symptom
. . O

Enhanced NNP B-Detailed_description
computed VBD B-Diagnostic_procedure
tomography NN I-Diagnostic_procedure
of IN O
adrenal JJ B-Biological_structure
gland NN I-Biological_structure
conformed VBD O
that IN O
there EX O
was VBD O
a DT O
tumor NN B-Sign_symptom
in IN O
right JJ B-Biological_structure
adrenal JJ I-Biological_structure
gland NN I-Biological_structure
accompanied VBN O
by IN O
an DT O
upset JJ B-Lab_value
level NN O
of IN O
aldosterone NN B-Diagnostic_procedure
( ( O
Figure NNP O
5 CD O
) ) O
. . O

The DT O
tumor NN B-Sign_symptom
was VBD O
removed VBN B-Therapeutic_procedure
by IN O
laparoscope NN B-Therapeutic_procedure
, , O
and CC O
pathological JJ B-Diagnostic_procedure
examination NN I-Diagnostic_procedure
showed VBD O
pheochromocytoma NN B-Disease_disorder
( ( O
Figure NNP O
6 CD O
) ) O
. . O

After IN O
the DT O
surgery NN O
, , O
the DT O
blood NN B-Diagnostic_procedure
pressure NN I-Diagnostic_procedure
turned VBD O
normal JJ B-Lab_value
gradually RB O
. . O

There EX O
was VBD O
no DT O
T NNP B-Sign_symptom
- : I-Sign_symptom
wave NN I-Sign_symptom
inversion NN I-Sign_symptom
in IN O
lead NN B-Detailed_description
V1 NNP I-Detailed_description
- : I-Detailed_description
V4 NNP I-Detailed_description
( ( O
Figure NNP O
7 CD O
) ) O
. . O

-DOCSTART- NN -X-

A DT O
37 CD B-Age
- : I-Age
year NN I-Age
- : I-Age
old JJ I-Age
African JJ O
American NNP O
female NN O
with IN O
a DT O
past JJ O
medical JJ O
history NN O
significant JJ O
for IN O
stage NN B-Lab_value
1 CD I-Lab_value
sarcoidosis NN B-Disease_disorder
presented VBN O
to TO O
our PRP$ O
facility NN B-Nonbiological_location
with IN O
a DT O
chief JJ O
complaint NN O
of IN O
shortness NN B-Sign_symptom
of IN I-Sign_symptom
breath NN I-Sign_symptom
. . O

Ten CD O
years NNS O
prior RB O
, , O
she PRP O
presented VBD O
with IN O
bilateral JJ B-Detailed_description
uveitis NN B-Disease_disorder
and CC O
lupus NN B-Sign_symptom
pernio NN I-Sign_symptom
( ( O
LP NNP B-Sign_symptom
) ) O
on IN O
her PRP$ O
right JJ B-Biological_structure
ear NN I-Biological_structure
and CC O
was VBD O
subsequently RB O
diagnosed VBN O
with IN O
sarcoidosis NN B-Disease_disorder
. . O

She PRP O
was VBD O
successfully RB B-Lab_value
treated VBN B-Therapeutic_procedure
for IN O
these DT O
conditions NNS O
and CC O
her PRP$ O
sarcoidosis NN B-Disease_disorder
remained VBD O
quiescent JJ B-Lab_value
until IN O
three CD O
years NNS O
ago RB O
, , O
when WRB O
, , O
at IN O
an DT O
outside JJ B-Nonbiological_location
institution NN I-Nonbiological_location
, , O
she PRP O
was VBD O
discovered VBN O
to TO O
have VB O
laryngeal JJ B-Biological_structure
involvement NN B-Sign_symptom
. . O

She PRP O
was VBD O
treated VBN B-Therapeutic_procedure
with IN O
prednisone NN B-Medication
60 CD B-Dosage
mg JJ I-Dosage
daily RB I-Dosage
for IN O
several JJ B-Duration
months NNS I-Duration
and CC O
eventually RB O
tapered VBD O
to TO O
10 CD B-Dosage
mg NNS I-Dosage
daily RB I-Dosage
. . O

Her PRP$ O
sarcoidosis NN B-Disease_disorder
remained VBD O
well RB B-Lab_value
- : I-Lab_value
controlled VBN I-Lab_value
on IN O
this DT O
maintenance NN B-Dosage
dose NN I-Dosage
of IN O
prednisone NN B-Medication
until IN O
six CD O
months NNS O
prior RB O
, , O
at IN O
which WDT O
time NN O
she PRP O
self VBD B-Lab_value
- : I-Lab_value
discontinued VBN I-Lab_value
her PRP$ O
prednisone NN B-Medication
in IN O
favor NN O
of IN O
the DT O
homeopathic JJ B-Therapeutic_procedure
treatment NN I-Therapeutic_procedure
Nopalea NNP B-Medication
cactus NN I-Medication
juice NN I-Medication
, , O
which WDT O
unsubstantially RB O
claimed VBD O
to TO O
have VB O
anti VBN O
- : O
inflammatory NN O
properties NNS O
[ VBP O
4 CD O
] NN O
. . O

Subsequently RB O
, , O
she PRP O
developed VBD O
dyspnea NN B-Sign_symptom
on IN B-Detailed_description
exertion NN I-Detailed_description
progressing VBG O
to TO O
dyspnea VB B-Sign_symptom
at IN B-Detailed_description
rest NN I-Detailed_description
. . O

During IN O
this DT O
time NN O
her PRP$ O
voice NN B-Activity
became VBD O
increasingly RB O
hoarse JJ B-Sign_symptom
and CC O
she PRP O
experienced VBD O
frequent JJ B-Frequency
episodes NNS O
of IN O
difficulty NN B-Sign_symptom
swallowing NN I-Sign_symptom
. . O

In IN O
our PRP$ O
emergency NN B-Nonbiological_location
department NN I-Nonbiological_location
, , O
her PRP$ O
physical JJ B-Diagnostic_procedure
examination NN I-Diagnostic_procedure
was VBD O
concerning VBG O
for IN O
respiratory NN B-Sign_symptom
distress NN I-Sign_symptom
as IN O
she PRP O
presented VBD O
with IN O
inspiratory JJ B-Sign_symptom
stridor NN I-Sign_symptom
and CC O
hoarseness NN B-Sign_symptom
. . O

She PRP O
also RB O
had VBD O
chronic JJ B-Lab_value
- : I-Lab_value
appearing NN I-Lab_value
, , O
indurated JJ B-Lab_value
lesions NNS B-Sign_symptom
on IN O
her PRP$ O
right JJ B-Biological_structure
ear NN I-Biological_structure
. . O

Given VBN O
that IN O
she PRP O
had VBD O
signs NNS O
of IN O
upper JJ B-Disease_disorder
airway NN I-Disease_disorder
disease NN I-Disease_disorder
for IN O
impending VBG B-Lab_value
respiratory JJ B-Disease_disorder
failure NN I-Disease_disorder
, , O
an DT O
emergent JJ B-Detailed_description
bedside NN B-Detailed_description
laryngoscopy NN B-Diagnostic_procedure
was VBD O
performed VBN O
, , O
revealing VBG O
an DT O
obstructed JJ B-Disease_disorder
airway NN B-Biological_structure
with IN O
the DT O
epiglottis NN B-Biological_structure
retroflexed VBD B-Sign_symptom
over IN O
the DT O
glottis NN B-Biological_structure
and CC O
significant JJ B-Lab_value
edema NN B-Sign_symptom
in IN O
the DT O
arytenoids NNS B-Biological_structure
and CC O
aryepiglottic JJ B-Biological_structure
folds NNS I-Biological_structure
. . O

She PRP O
was VBD O
immediately RB O
treated VBN O
with IN O
high JJ B-Dosage
- : I-Dosage
dose RB I-Dosage
intravenous JJ O
dexamethasone NN B-Medication
and CC O
taken VBN O
emergently RB O
to TO O
the DT O
operating NN B-Nonbiological_location
room NN I-Nonbiological_location
( ( O
OR NNP B-Nonbiological_location
) ) O
to TO O
secure VB B-Therapeutic_procedure
her PRP$ O
airway NN B-Biological_structure
for IN O
concern NN O
for IN O
complete JJ B-Lab_value
upper JJ B-Biological_structure
airway NN I-Biological_structure
obstruction NN B-Disease_disorder
, , O
which WDT O
was VBD O
confirmed VBN O
with IN O
direct JJ B-Diagnostic_procedure
visualization NN I-Diagnostic_procedure
of IN O
her PRP$ O
larynx NN B-Biological_structure
in IN O
the DT O
OR NNP B-Nonbiological_location
. . O

She PRP O
was VBD O
intubated VBN B-Therapeutic_procedure
for IN O
a DT O
surgical JJ B-Therapeutic_procedure
airway NN I-Therapeutic_procedure
, , O
and CC O
after IN O
taking VBG O
biopsies NNS B-Diagnostic_procedure
from IN O
the DT O
lingual JJ B-Biological_structure
surface NN I-Biological_structure
of IN O
her PRP$ O
epiglottis NN B-Biological_structure
, , O
a DT O
# # B-Detailed_description
4 CD I-Detailed_description
cuffed NN I-Detailed_description
Shiley NNP B-Detailed_description
™ NNP O
tracheostomy NN B-Therapeutic_procedure
was VBD O
placed VBN O
. . O

Her PRP$ O
respiratory NN B-Diagnostic_procedure
status NN I-Diagnostic_procedure
immediately RB O
stabilized VBD B-Lab_value
, , O
was VBD O
extubated VBN B-Therapeutic_procedure
, , O
and CC O
transferred VBD O
to TO O
our PRP$ O
medical JJ B-Nonbiological_location
intensive JJ I-Nonbiological_location
care NN I-Nonbiological_location
unit NN I-Nonbiological_location
. . O

Her PRP$ O
tracheostomy NN B-Therapeutic_procedure
was VBD O
exchanged VBN O
to TO O
a DT O
# # B-Detailed_description
4 CD I-Detailed_description
cuffless NN I-Detailed_description
Shiley NNP B-Detailed_description
on IN O
postoperative JJ O
day NN O
5 CD O
. . O

During IN O
this DT O
time NN O
she PRP O
was VBD O
transitioned VBN O
from IN O
intravenous JJ O
dexamethasone NN B-Medication
to TO O
prednisone VB B-Medication
60 CD B-Dosage
mg JJ I-Dosage
daily RB I-Dosage
. . O

Biopsies NNS B-Diagnostic_procedure
ultimately RB O
revealed VBD O
non JJ B-Detailed_description
- : I-Detailed_description
necrotizing VBG I-Detailed_description
epithelioid JJ B-Detailed_description
granulomas NN B-Sign_symptom
consistent NN O
with IN O
sarcoidosis NN B-Disease_disorder
( ( O
Figure NNP O
1 CD O
) ) O
. . O

She PRP O
was VBD O
prescribed VBN O
this DT O
high JJ B-Dosage
- : I-Dosage
dose NN I-Dosage
prednisone NN B-Medication
for IN O
three CD B-Duration
months NNS I-Duration
, , O
and CC O
after IN O
receiving VBG O
education NN O
for IN O
self JJ B-Therapeutic_procedure
- : I-Therapeutic_procedure
tracheostomy NN I-Therapeutic_procedure
care NN I-Therapeutic_procedure
, , O
she PRP O
was VBD O
discharged VBN O
home NN B-Nonbiological_location
. . O

At IN O
her PRP$ O
subsequent JJ O
one CD O
- : O
month NN O
and CC O
three CD O
- : O
month NN O
follow SYM O
- : O
up IN O
visits NNS O
, , O
she PRP O
denied VBD O
any DT O
further JJ O
respiratory NN B-Sign_symptom
issues NNS I-Sign_symptom
. . O

Repeat NN O
laryngoscopies NNS B-Diagnostic_procedure
showed VBD O
significant JJ O
improvement NN B-Lab_value
in IN O
the DT O
edema NN B-Sign_symptom
in IN O
the DT O
arytenoids NNS B-Biological_structure
and CC O
aryepiglottic JJ B-Biological_structure
folds NNS I-Biological_structure
, , O
but CC O
the DT O
epiglottis NN B-Biological_structure
continued VBD O
to TO O
obscure VB B-Disease_disorder
the DT O
glottis NN B-Biological_structure
despite IN O
therapy NN O
with IN O
high JJ B-Dosage
- : I-Dosage
dose NN I-Dosage
prednisone NN B-Medication
. . O

Methotrexate NNP B-Medication
was VBD O
initiated VBN O
while IN O
prednisone NN B-Medication
was VBD O
tapered VBN O
to TO O
10 CD B-Dosage
mg NNS I-Dosage
daily RB I-Dosage
; : O
however RB O
, , O
this DT O
regimen NNS O
failed VBD O
and CC O
her PRP$ O
prednisone NN B-Medication
dosage NN O
was VBD O
increased VBN O
to TO O
20 CD B-Dosage
mg NNS I-Dosage
daily RB I-Dosage
to TO O
reduce VB O
edema NN O
. . O

Because IN O
she PRP O
declined VBD O
surgical JJ B-Therapeutic_procedure
treatment NN I-Therapeutic_procedure
, , O
she PRP O
will MD O
continue VB O
with IN O
medical JJ B-Therapeutic_procedure
management NN I-Therapeutic_procedure
with IN O
immunosuppressive JJ B-Therapeutic_procedure
therapy NN I-Therapeutic_procedure
to TO O
facilitate VB O
eventual JJ O
de FW O
- : O
cannulation NN O
. . O

-DOCSTART- NN -X-

A DT O
7 CD B-Age
- : I-Age
year NN I-Age
- : I-Age
old JJ I-Age
boy NN O
with IN O
Goldenhar NNP O
syndrome NN O
with IN O
post NN O
- : O
natal JJ O
genetic JJ O
diagnosis NN O
was VBD O
referred VBN O
to TO O
our PRP$ O
Department NNP B-Nonbiological_location
of IN I-Nonbiological_location
Radiology NNP I-Nonbiological_location
for IN O
imaging VBG B-Diagnostic_procedure
study NN I-Diagnostic_procedure
of IN O
the DT O
temporal JJ B-Biological_structure
bone NN I-Biological_structure
. . O

The DT O
patient NN O
underwent VBD O
a DT O
3D CD B-Diagnostic_procedure
- : I-Diagnostic_procedure
CT NN I-Diagnostic_procedure
scan JJ I-Diagnostic_procedure
. . O

Brilliance NNP B-Diagnostic_procedure
CT NNP I-Diagnostic_procedure
- : I-Diagnostic_procedure
64 CD I-Diagnostic_procedure
- : I-Diagnostic_procedure
channel NN I-Diagnostic_procedure
( ( O
Philips NNP B-Nonbiological_location
Medical NNP I-Nonbiological_location
Systems NNP I-Nonbiological_location
, , I-Nonbiological_location
Amsterdam NNP I-Nonbiological_location
, , I-Nonbiological_location
The DT I-Nonbiological_location
Netherlands NNP I-Nonbiological_location
) ) O
was VBD O
employed VBN O
. . O

The DT O
protocol NN O
generated VBD O
120 CD B-Lab_value
kV NNS I-Lab_value
and CC O
a DT O
current JJ O
of IN O
150 CD B-Lab_value
mA NN I-Lab_value
. . O

Slice NNP B-Diagnostic_procedure
thickness NN I-Diagnostic_procedure
of IN O
the DT O
images NNS O
was VBD O
1 CD B-Distance
- : I-Distance
mm NN I-Distance
with IN O
a DT O
0 CD B-Distance
. . I-Distance
5 CD I-Distance
- : I-Distance
mm NN I-Distance
increment NN B-Diagnostic_procedure
. . O

Images NNS B-Diagnostic_procedure
in IN O
DICOM NNP B-Detailed_description
format NN I-Detailed_description
were VBD O
processed VBN B-Detailed_description
on IN I-Detailed_description
a DT I-Detailed_description
PC NN I-Detailed_description
using VBG I-Detailed_description
commercial JJ I-Detailed_description
software NN I-Detailed_description
, , O
obtaining VBG O
a DT O
three CD B-Diagnostic_procedure
- : I-Diagnostic_procedure
dimensional JJ I-Diagnostic_procedure
reconstruction NN I-Diagnostic_procedure
of IN O
skeletal JJ B-Biological_structure
structures NNS I-Biological_structure
. . O

The DT O
3 CD B-Diagnostic_procedure
- : I-Diagnostic_procedure
dimensional JJ I-Diagnostic_procedure
reconstruction NN I-Diagnostic_procedure
of IN O
the DT O
skin NN B-Biological_structure
plans NNS I-Biological_structure
showed VBD O
hypoplasia NN B-Disease_disorder
of IN O
the DT O
auricle NN B-Biological_structure
that WDT O
on IN O
the DT O
right JJ B-Detailed_description
side NN I-Detailed_description
consisted VBD O
of IN O
a DT O
simple JJ B-Detailed_description
dysmorphic JJ B-Sign_symptom
rough NN I-Sign_symptom
. . O

The DT O
left JJ B-Biological_structure
auricle NN I-Biological_structure
had VBD O
regular JJ B-Lab_value
dimensions NNS B-Diagnostic_procedure
and CC O
morphology NN B-Diagnostic_procedure
. . O

Atresia NNP B-Disease_disorder
of IN O
the DT O
right JJ B-Biological_structure
auditory NN I-Biological_structure
conduit NN I-Biological_structure
and CC O
a DT O
normal JJ B-Lab_value
left JJ B-Biological_structure
auditory NN I-Biological_structure
conduit NN I-Biological_structure
were VBD O
observed VBN B-Diagnostic_procedure
. . O

The DT O
upper JJ B-Detailed_description
images NNS B-Diagnostic_procedure
showed VBD O
partial JJ B-Severity
ossification NN B-Other_event
of IN O
the DT O
cranium NN B-Biological_structure
typical JJ B-Detailed_description
in IN I-Detailed_description
paediatric JJ I-Detailed_description
age NN I-Detailed_description
. . O

Description NN O
of IN O
the DT O
profile NN O
: : O
typical JJ B-Detailed_description
II NNP I-Detailed_description
class NN I-Detailed_description
very RB B-Severity
convex JJ B-Diagnostic_procedure
profile NN I-Diagnostic_procedure
with IN O
interposition NN B-Detailed_description
of IN O
the DT O
inferior JJ B-Biological_structure
lip NN I-Biological_structure
and CC O
a DT O
reduced VBN B-Lab_value
neck NN B-Biological_structure
- : I-Biological_structure
chin NN I-Biological_structure
angle NN I-Biological_structure
. . O
( ( O
Fig NNP O
. . O
1 CD O
) ) O
. . O

Skeletal JJ B-Diagnostic_procedure
studies NNS I-Diagnostic_procedure
show VBP O
that IN O
the DT O
mandibular JJ B-Biological_structure
condyle NN I-Biological_structure
, , I-Biological_structure
ramus NN I-Biological_structure
and CC I-Biological_structure
corpus NN I-Biological_structure
were VBD O
shorter JJR B-Detailed_description
on IN I-Detailed_description
the DT I-Detailed_description
affected JJ I-Detailed_description
side NN I-Detailed_description
. . O

Tilting NN B-Detailed_description
of IN O
oral JJ B-Biological_structure
rhyme NN I-Biological_structure
, , O
occlusal JJ B-Biological_structure
plane NN I-Biological_structure
and CC O
mandibular JJ B-Biological_structure
plane NN I-Biological_structure
were VBD O
evident JJ O
. . O

Number NNP B-Disease_disorder
or CC I-Disease_disorder
form JJ B-Disease_disorder
abnormalities NNS I-Disease_disorder
were VBD O
not RB O
found VBN O
during IN O
mixed JJ B-Diagnostic_procedure
dentition NN I-Diagnostic_procedure
. . O

Mandibular JJ B-Biological_structure
condyles NNS I-Biological_structure
and CC O
temporo SYM B-Biological_structure
- : I-Biological_structure
mandibular JJ I-Biological_structure
joints NNS I-Biological_structure
seemed VBD O
to TO O
be VB O
asymmetric JJ B-Detailed_description
, , O
and CC O
in IN O
particular JJ O
the DT O
right JJ B-Biological_structure
condyle NN I-Biological_structure
was VBD O
deformed VBN B-Biological_attribute
, , O
shorter JJR B-Lab_value
and CC I-Lab_value
wider JJR B-Lab_value
than IN I-Lab_value
the DT I-Lab_value
other JJ I-Lab_value
side NN I-Lab_value
( ( O
mandibular JJ B-Biological_structure
condyle NN I-Biological_structure
dimensions NNS B-Diagnostic_procedure
were VBD O
11 CD B-Area
× JJ I-Area
7 CD I-Area
mm NN I-Area
right NN B-Detailed_description
and CC O
14 CD B-Area
× NNS I-Area
7 CD I-Area
mm NN I-Area
left VBD B-Detailed_description
) ) O
. . O

The DT O
3 CD B-Diagnostic_procedure
- : I-Diagnostic_procedure
dimensional JJ I-Diagnostic_procedure
reconstruction NN I-Diagnostic_procedure
of IN O
the DT O
skeleton NN B-Biological_structure
planes NNS I-Biological_structure
showed VBD O
the DT O
different JJ O
morphology NN B-Diagnostic_procedure
of IN O
the DT O
right NN B-Biological_structure
and CC I-Biological_structure
left VBD B-Biological_structure
hemimandibula NN I-Biological_structure
. . O

Mandibular JJ B-Biological_structure
3 CD B-Diagnostic_procedure
- : I-Diagnostic_procedure
dimensional JJ I-Diagnostic_procedure
reconstruction NN I-Diagnostic_procedure
showed VBD O
in IN O
detail NN O
the DT O
shift NN B-Detailed_description
of IN O
the DT O
medial JJ B-Biological_structure
axis NN I-Biological_structure
to TO O
the DT O
hypoplastic JJ B-Disease_disorder
right JJ B-Detailed_description
side NN I-Detailed_description
and CC O
the DT O
asymmetry NN B-Detailed_description
of IN O
the DT O
right JJ B-Biological_structure
mandibular NN I-Biological_structure
condyles NNS I-Biological_structure
that WDT O
appears VBZ O
dysmorphic JJ B-Detailed_description
short JJ B-Lab_value
and CC O
wide JJ B-Lab_value
in IN O
axial JJ B-Detailed_description
and CC O
coronal JJ B-Detailed_description
scansions NNS B-Diagnostic_procedure
( ( O
Figs NNP O
. . O
2 CD O
, , O
3 CD O
) ) O
. . O

The DT O
study NN O
of IN O
the DT O
temporal JJ B-Biological_structure
bone NN I-Biological_structure
showed VBD O
on IN O
the DT O
right JJ B-Detailed_description
side NN I-Detailed_description
an DT O
external JJ B-Biological_structure
auditory NN I-Biological_structure
canal JJ I-Biological_structure
atresia NN B-Disease_disorder
, , O
hypoplasia NN B-Disease_disorder
of IN O
tympanic JJ B-Biological_structure
cavity NN I-Biological_structure
that WDT O
was VBD O
not RB O
pneumatized VBN B-Disease_disorder
and CC O
occupied VBN B-Detailed_description
by IN I-Detailed_description
dense JJ I-Detailed_description
materials NNS I-Detailed_description
from IN I-Detailed_description
soft JJ I-Detailed_description
parts NNS I-Detailed_description
. . O

No DT O
pneumatization NN B-Disease_disorder
was VBD O
present JJ O
in IN O
right JJ B-Biological_structure
mastoid NN I-Biological_structure
cells NNS I-Biological_structure
. . O

Left NNP B-Biological_structure
external JJ I-Biological_structure
auditory NN I-Biological_structure
canal JJ I-Biological_structure
dimensions NNS B-Diagnostic_procedure
and CC O
morphology NN B-Diagnostic_procedure
were VBD O
normal JJ B-Lab_value
. . O

The DT O
left NN B-Biological_structure
tympanic JJ I-Biological_structure
cavity NN I-Biological_structure
was VBD O
normally RB B-Detailed_description
formed VBN I-Detailed_description
and CC O
totally RB B-Detailed_description
occupied VBN I-Detailed_description
by IN I-Detailed_description
dense JJ I-Detailed_description
materials NNS I-Detailed_description
from IN I-Detailed_description
soft JJ I-Detailed_description
tissues NNS I-Detailed_description
. . O

Both DT O
right JJ B-Biological_structure
and CC I-Biological_structure
left JJ B-Biological_structure
ears NNS I-Biological_structure
presented VBD O
minor JJ B-Severity
hypoplasia NN B-Disease_disorder
of IN O
auricle NN B-Biological_structure
bones NNS I-Biological_structure
in IN O
the DT O
right JJ B-Detailed_description
side NN I-Detailed_description
. . O

In IN O
agreement NN O
with IN O
the DT O
resolution NN O
of IN O
our PRP$ O
instrument NN O
, , O
normal JJ B-Detailed_description
representation NN I-Detailed_description
of IN O
the DT O
malleus NN B-Biological_structure
head NN I-Biological_structure
that WDT O
seemed VBD O
articulated VBN O
with IN O
a DT O
dysmorphic JJ B-Sign_symptom
rough NN I-Sign_symptom
of IN O
a DT O
deformed JJ B-Detailed_description
incus NN B-Biological_structure
was VBD O
observed VBN O
; : O
it PRP O
was VBD O
impossible JJ B-Detailed_description
to TO I-Detailed_description
see VB I-Detailed_description
the DT O
staples NNS B-Biological_structure
. . O

The DT O
left NN B-Biological_structure
malleus NN I-Biological_structure
and CC O
incus NN B-Biological_structure
were VBD O
visible JJ B-Detailed_description
and CC O
appeared VBD O
to TO O
be VB O
articulated VBN B-Detailed_description
in IN I-Detailed_description
an DT I-Detailed_description
abnormal JJ I-Detailed_description
manner NN I-Detailed_description
( ( O
reduce VB B-Detailed_description
contact NN I-Detailed_description
surface NN I-Detailed_description
) ) O
; : O
the DT O
staples NNS B-Biological_structure
was VBD O
difficult JJ B-Detailed_description
to TO I-Detailed_description
observe VB I-Detailed_description
but CC O
seemed VBD O
to TO O
have VB O
regular JJ B-Detailed_description
morphology NN B-Diagnostic_procedure
. . O

Dimensions NNS B-Diagnostic_procedure
and CC O
morphology NN B-Diagnostic_procedure
of IN O
cochlea NN B-Biological_structure
semicircular JJ I-Biological_structure
canals NNS I-Biological_structure
, , I-Biological_structure
vestibulum NN I-Biological_structure
and CC I-Biological_structure
utriculum NN I-Biological_structure
were VBD O
unaltered JJ B-Detailed_description
( ( O
Figs NNP O
. . O
4 CD O
- : O
7 CD O
) ) O
. . O

In IN O
conclusion NN O
, , O
through IN O
3D CD B-Diagnostic_procedure
- : I-Diagnostic_procedure
CT NNP I-Diagnostic_procedure
valuation NN I-Diagnostic_procedure
of IN O
this DT O
young JJ O
patient NN O
we PRP O
observed VBD O
asymmetry NN B-Detailed_description
of IN O
the DT O
condyles NNS B-Biological_structure
; : O
in IN O
particular JJ O
, , O
the DT O
right JJ B-Biological_structure
condyle NN I-Biological_structure
was VBD O
dysmorphic JJ B-Detailed_description
, , O
short JJ B-Lab_value
and CC O
wide JJ B-Lab_value
; : O
the DT O
auricle NN B-Biological_structure
of IN O
the DT O
right JJ B-Biological_structure
external JJ I-Biological_structure
ear NN I-Biological_structure
was VBD O
hypoplastic JJ B-Disease_disorder
, , O
only RB O
a DT O
dysmorphic JJ B-Sign_symptom
rough NN I-Sign_symptom
was VBD O
present JJ O
; : O
the DT O
right NN B-Biological_structure
middle NN I-Biological_structure
ear NN I-Biological_structure
had VBD O
a DT O
hypoplastic JJ B-Disease_disorder
tympanic JJ B-Biological_structure
cavity NN I-Biological_structure
; : O
the DT O
right JJ B-Biological_structure
internal JJ I-Biological_structure
ear NN I-Biological_structure
has VBZ O
an DT O
atresic JJ B-Disease_disorder
auditory NN B-Biological_structure
conduit NN I-Biological_structure
. . O

-DOCSTART- NN -X-

A DT O
48 CD B-Age
- : I-Age
year NN I-Age
- : I-Age
old JJ I-Age
man NN O
presented VBN O
at IN O
our PRP$ O
hospital NN B-Nonbiological_location
complaining NN O
of IN O
intracranial JJ B-Biological_structure
bruits NNS B-Sign_symptom
. . O

The DT O
cranial JJ B-Diagnostic_procedure
nerve NN I-Diagnostic_procedure
and CC O
laboratory NN B-Diagnostic_procedure
examinations NNS I-Diagnostic_procedure
were VBD O
normal JJ B-Lab_value
. . O

A DT O
DVAF NNP B-Disease_disorder
was VBD O
considered VBN O
, , O
conventional JJ B-Diagnostic_procedure
digital JJ I-Diagnostic_procedure
subtraction NN I-Diagnostic_procedure
angiography NN I-Diagnostic_procedure
was VBD O
performed VBN O
, , O
which WDT O
showed VBD O
a DT O
Cognard NNP B-Disease_disorder
II NNP I-Disease_disorder
DVAF NNP I-Disease_disorder
in IN O
the DT O
location NN O
of IN O
right JJ B-Biological_structure
hypoglossal NN I-Biological_structure
canal NN I-Biological_structure
( ( O
HC NNP B-Biological_structure
) ) O
. . O

The DT O
DVAF NNP O
was VBD O
fed VBN O
by IN O
the DT O
meningeal JJ B-Biological_structure
branches NNS I-Biological_structure
of IN O
the DT O
bilateral JJ B-Biological_structure
ascending NN I-Biological_structure
pharyngeal NN I-Biological_structure
arteries NNS I-Biological_structure
, , O
and CC O
the DT O
right JJ B-Biological_structure
anterior NN I-Biological_structure
condylar NN I-Biological_structure
veins NNS I-Biological_structure
within IN O
the DT O
hypoglossal JJ B-Biological_structure
canal NN I-Biological_structure
that WDT O
was VBD O
the DT O
fistulous JJ B-Sign_symptom
point NN I-Sign_symptom
mainly RB O
drained VBD B-Detailed_description
into IN I-Detailed_description
the DT I-Detailed_description
jugular JJ I-Detailed_description
vein NN I-Detailed_description
. . O

Endovascular JJ B-Therapeutic_procedure
treatment NN I-Therapeutic_procedure
was VBD O
insisted VBN O
upon IN O
by IN O
the DT O
patient NN O
because IN O
of IN O
the DT O
associated VBN O
intolerable JJ B-Detailed_description
intracranial JJ B-Biological_structure
bruit NN O
. . O

Treatment NN O
was VBD O
performed VBN O
by IN O
transarterial JJ B-Therapeutic_procedure
approach NN I-Therapeutic_procedure
under IN O
general JJ B-Medication
anesthesia NN I-Medication
using VBG O
a DT O
biplane NN B-Therapeutic_procedure
angiographic JJ I-Therapeutic_procedure
unit NN I-Therapeutic_procedure
. . O

Standard NNP B-Therapeutic_procedure
coaxial NN I-Therapeutic_procedure
techniques NNS I-Therapeutic_procedure
were VBD O
used VBN O
. . O

The DT O
guide NN B-Therapeutic_procedure
catheter NN I-Therapeutic_procedure
was VBD I-Therapeutic_procedure
navigated VBN I-Therapeutic_procedure
into IN O
the DT O
left JJ B-Biological_structure
ascendingtrawt NN I-Biological_structure
pharyngeal NN I-Biological_structure
artery NN I-Biological_structure
. . O

Marathon NNP B-Therapeutic_procedure
flow NN I-Therapeutic_procedure
directed VBD I-Therapeutic_procedure
catheter NN I-Therapeutic_procedure
( ( I-Therapeutic_procedure
eV3 NN I-Therapeutic_procedure
) ) I-Therapeutic_procedure
was VBD I-Therapeutic_procedure
subsequently RB I-Therapeutic_procedure
navigated VBN I-Therapeutic_procedure
over IN O
a DT O
Mirage NNP O
. . O
008 CD O
microwire NN O
( ( O
eV3 NN O
) ) O
to TO O
reach VB O
as RB O
near IN O
as IN O
possible JJ O
to TO O
the DT O
fistula NN B-Sign_symptom
. . O

The DT O
microcatheter NN B-Therapeutic_procedure
was VBD I-Therapeutic_procedure
flushed VBN I-Therapeutic_procedure
with IN O
10 CD B-Volume
mL NNS I-Volume
of IN O
normal JJ B-Biological_structure
saline NN I-Biological_structure
. . O

The DT O
dead JJ O
space NN O
of IN O
the DT O
microcatheter NN B-Therapeutic_procedure
was VBD I-Therapeutic_procedure
subsequently RB I-Therapeutic_procedure
filled VBN I-Therapeutic_procedure
with IN O
dimethyl JJ B-Medication
sulfoxide NN I-Medication
( ( O
DMSO NNP O
) ) O
. . O

Onyx NNP B-Medication
- : I-Medication
18 CD I-Medication
was VBD O
then RB O
injected VBN B-Therapeutic_procedure
over IN O
two CD B-Duration
minutes NNS I-Duration
to TO O
fill VB O
the DT O
microcatheter NN O
and CC O
to TO O
replace VB O
the DT O
DMSO NNP O
in IN O
the DT O
dead JJ O
space NN O
. . O

The DT O
injection NN B-Therapeutic_procedure
was VBD I-Therapeutic_procedure
stopped VBN I-Therapeutic_procedure
until IN O
unwanted JJ O
flow NN O
into IN O
branches NNS O
of IN O
the DT O
right JJ O
ascending VBG O
pharyngeal JJ O
artery NN O
was VBD O
observed VBN O
. . O

The DT O
follow NN B-Detailed_description
- : I-Detailed_description
up IN I-Detailed_description
angiogram NN B-Diagnostic_procedure
showed VBD O
no DT O
residual JJ B-Sign_symptom
shunt NN I-Sign_symptom
( ( O
Figure NNP O
1 CD O
) ) O
. . O

The DT O
intracranial JJ B-Biological_structure
bruits NNS B-Sign_symptom
disappeared VBD O
immediately RB O
after IN O
the DT O
operation NN O
. . O

For IN O
the DT O
toxicity NN O
of IN O
DMSO NNP O
, , O
10 CD B-Dosage
mg NN I-Dosage
dexamethasone NN B-Medication
was VBD O
intravenously RB O
injected VBN O
for IN O
three CD B-Duration
days NNS I-Duration
. . O

On IN O
the DT O
second JJ O
day NN O
after IN O
endovascular JJ O
treatment NN O
, , O
the DT O
patient NN O
complainted VBD O
of IN O
difficulty NN B-Sign_symptom
moving VBG I-Sign_symptom
his PRP$ I-Sign_symptom
tongue NN I-Sign_symptom
to TO O
the DT O
left NN O
. . O

Cranial NNP B-Biological_structure
nerve NN I-Biological_structure
examination NN B-Diagnostic_procedure
was VBD O
only RB O
significant JJ O
for IN O
a DT O
right JJ B-Sign_symptom
hypoglossal NN I-Sign_symptom
nerve RB I-Sign_symptom
palsy NN I-Sign_symptom
. . O

The DT O
patient NN O
was VBD O
discharged VBN O
from IN O
our PRP$ O
hospital JJ B-Nonbiological_location
four CD O
days NNS O
after IN O
treatment NN O
without IN O
continuative JJ B-Medication
pharmacotherapy NN I-Medication
. . O

At IN O
two CD O
months NNS O
follow VBP O
- : O
up RB O
, , O
the DT O
patient NN O
` `` O
s JJ O
main JJ O
complaint NN O
were VBD O
difficulty NN O
swallowing VBG O
( ( O
dysphagia NN B-Sign_symptom
) ) O
and CC O
slurred VBN O
speech NN O
( ( O
dysarthria NN B-Sign_symptom
) ) O
. . O

In IN O
addition NN O
, , O
his PRP$ O
tongue NN B-Lab_value
deviated VBD I-Lab_value
toward IN I-Lab_value
the DT I-Lab_value
right NN I-Lab_value
during IN O
tongue JJ B-Diagnostic_procedure
protrusion NN I-Diagnostic_procedure
, , O
and CC O
marked VBD B-Detailed_description
right JJ B-Detailed_description
- : I-Detailed_description
sided VBD I-Detailed_description
hemiatrophy NN B-Sign_symptom
was VBD O
observed VBN O
( ( O
Figure NNP O
2 CD O
) ) O
. . O

The DT O
cranial JJ B-Biological_structure
nerve NN I-Biological_structure
examation NN B-Diagnostic_procedure
showed VBD O
right JJ O
hypoglossal NN O
nerve RB O
palsy RB O
persisted VBN O
. . O

We PRP O
telephone NN O
the DT O
patient NN O
at IN O
three CD O
months NNS O
follow VBP O
- : O
up RB O
and CC O
requested VBD O
a DT O
vocal JJ B-Diagnostic_procedure
cord NN I-Diagnostic_procedure
evaluation NN I-Diagnostic_procedure
by IN O
an DT O
ENT NNP O
specialist NN O
in IN O
a DT O
local JJ B-Nonbiological_location
hospital NN I-Nonbiological_location
. . O

Vocal JJ B-Biological_structure
cord NN I-Biological_structure
paralysis NN B-Sign_symptom
was VBD O
not RB O
found VBN O
, , O
and CC O
there EX O
was VBD O
no DT O
evidence NN O
of IN O
vagus NN B-Biological_structure
nerve NN I-Biological_structure
dysfunction NN B-Sign_symptom
. . O

Oral JJ B-Medication
Vitamin NNP I-Medication
B12 NNP I-Medication
was VBD O
used VBN O
and CC O
his PRP$ O
prognosis NN O
was VBD O
still RB O
at IN O
a DT O
long JJ O
follow NN O
- : O
up RB O
. . O

-DOCSTART- NN -X-

The DT O
36 CD B-Age
- : I-Age
year NN I-Age
- : I-Age
old JJ I-Age
male JJ O
patient NN O
in IN O
this DT O
case NN O
had VBD O
a DT O
6 CD B-Duration
- : I-Duration
year NN I-Duration
history NN O
of IN O
diffuse NN B-Detailed_description
cutaneous JJ B-Biological_structure
SSc NNP B-Disease_disorder
( ( O
Fig NNP O
. . O
1 CD O
) ) O
and CC O
had VBD O
not RB O
received VBN O
regular JJ O
follow SYM O
- : O
up RB O
or CC O
medication NN B-Medication
therapy NN O
. . O

He PRP O
had VBD O
experienced VBN O
malaise NN B-Sign_symptom
, , O
poor JJ B-Sign_symptom
appetite NN I-Sign_symptom
, , O
and CC O
progressive JJ B-Detailed_description
shortness NN B-Sign_symptom
of IN I-Sign_symptom
breath NN I-Sign_symptom
for IN O
1 CD B-Duration
month NN I-Duration
and CC O
oligouria NN B-Sign_symptom
for IN O
3 CD B-Duration
days NNS I-Duration
. . O

He PRP O
was VBD O
admitted VBN O
to TO O
our PRP$ O
hospital NN B-Nonbiological_location
with IN O
renal JJ B-Disease_disorder
failure NN I-Disease_disorder
and CC O
pulmonary JJ B-Biological_structure
edema NN B-Sign_symptom
. . O

In IN O
the DT O
emergency NN O
department NN O
, , O
his PRP$ O
blood NN B-Diagnostic_procedure
pressure NN I-Diagnostic_procedure
, , O
pulse JJ B-Diagnostic_procedure
rate NN I-Diagnostic_procedure
, , O
and CC O
respiratory JJ B-Diagnostic_procedure
rate NN I-Diagnostic_procedure
were VBD O
174 CD B-Lab_value
/ JJ I-Lab_value
127 CD I-Lab_value
mm NN I-Lab_value
Hg NNP I-Lab_value
, , O
88 CD B-Lab_value
/ NN I-Lab_value
min NN I-Lab_value
, , O
and CC O
22 CD B-Lab_value
/ NN I-Lab_value
min NN I-Lab_value
, , O
respectively RB O
. . O

Laboratory NN B-Diagnostic_procedure
analysis NN I-Diagnostic_procedure
revealed VBD O
the DT O
following JJ O
values NNS O
: : O
white JJ B-Diagnostic_procedure
blood NN I-Diagnostic_procedure
cell NN I-Diagnostic_procedure
count NN I-Diagnostic_procedure
, , O
7730 CD B-Lab_value
/ NN I-Lab_value
μL NNP I-Lab_value
( ( O
3500 CD O
- : O
11,000 CD O
/ NNP O
μL NNP O
) ) O
; : O
hemoglobin UH B-Diagnostic_procedure
, , O
8 CD B-Lab_value
. . I-Lab_value
6 CD I-Lab_value
g JJ I-Lab_value
/ NN I-Lab_value
dL NN I-Lab_value
( ( O
12 CD O
- : O
16 CD O
g NN O
/ NNP O
dL NN O
) ) O
: : O
platelet NN B-Diagnostic_procedure
count NN I-Diagnostic_procedure
, , O
87000 CD B-Lab_value
/ NN I-Lab_value
μL NNP I-Lab_value
( ( O
150,000 CD O
- : O
400,000 CD O
/ NNP O
μL NNP O
) ) O
; : O
blood NN B-Diagnostic_procedure
urea JJ I-Diagnostic_procedure
nitrogen NN I-Diagnostic_procedure
, , O
78 CD B-Lab_value
mg NN I-Lab_value
/ NN I-Lab_value
dL NN I-Lab_value
( ( O
6 CD O
- : O
21 CD O
mg NN O
/ NNP O
dL NN O
) ) O
; : O
creatinine NN B-Diagnostic_procedure
, , O
8 CD B-Lab_value
. . I-Lab_value
9 CD I-Lab_value
mg JJ I-Lab_value
/ NN I-Lab_value
dL NN I-Lab_value
( ( O
1 CD O
. . O
1 CD O
- : O
1 CD O
. . O
5 CD O
mg JJ O
/ NNP O
dL NN O
) ) O
; : O
calcium NN B-Diagnostic_procedure
, , O
8 CD B-Lab_value
. . I-Lab_value
2 CD I-Lab_value
mg JJ I-Lab_value
/ NN I-Lab_value
dL NN I-Lab_value
( ( O
8 CD O
. . O
8 CD O
- : O
10 CD O
. . O
3 CD O
mg JJ O
/ NNP O
dL NN O
) ) O
; : O
phosphorus NN B-Diagnostic_procedure
, , O
5 CD B-Lab_value
. . I-Lab_value
4 CD I-Lab_value
mg JJ I-Lab_value
/ NN I-Lab_value
dL NN I-Lab_value
( ( O
2 CD O
. . O
7 CD O
- : O
4 CD O
. . O
5 CD O
mg JJ O
/ NNP O
dL NN O
) ) O
; : O
haptoglobin UH B-Diagnostic_procedure
, , O
< JJ B-Lab_value
6 CD I-Lab_value
. . I-Lab_value
56 CD I-Lab_value
mg JJ I-Lab_value
/ NN I-Lab_value
dL NN I-Lab_value
( ( O
30 CD O
- : O
200 CD O
mg NN O
/ NNP O
dL NN O
) ) O
; : O
and CC O
lactate VB B-Diagnostic_procedure
dehydrogenase NN I-Diagnostic_procedure
, , O
547 CD B-Lab_value
U NNP I-Lab_value
/ NNP I-Lab_value
L NNP I-Lab_value
( ( O
106 CD O
- : O
211 CD O
U NNP O
/ NNP O
L NNP O
) ) O
. . O

A DT O
routine JJ O
urinalysis NN B-Diagnostic_procedure
revealed VBD O
a DT O
proteinuria NN B-Lab_value
score NN I-Lab_value
of IN I-Lab_value
2 CD I-Lab_value
+ NNS I-Lab_value
( ( O
200 CD B-Lab_value
mg NN I-Lab_value
/ NNP I-Lab_value
dL NN I-Lab_value
) ) O
, , O
white JJ B-Diagnostic_procedure
blood NN I-Diagnostic_procedure
cell NN I-Diagnostic_procedure
count NN I-Diagnostic_procedure
of IN O
3 CD B-Lab_value
- : I-Lab_value
5 CD I-Lab_value
/ RB I-Lab_value
high JJ I-Lab_value
power NN I-Lab_value
field NN I-Lab_value
, , O
and CC O
red JJ B-Diagnostic_procedure
blood NN I-Diagnostic_procedure
cell NN I-Diagnostic_procedure
count NN I-Diagnostic_procedure
of IN O
25 CD B-Lab_value
- : I-Lab_value
50 CD I-Lab_value
/ RB I-Lab_value
high JJ I-Lab_value
power NN I-Lab_value
field NN I-Lab_value
. . O

The DT O
autoimmune NN B-Diagnostic_procedure
profile NN I-Diagnostic_procedure
indicated VBD O
an DT O
antinuclear JJ B-Diagnostic_procedure
antibody NN I-Diagnostic_procedure
level NN O
of IN O
1:320 CD B-Lab_value
( ( O
speckles NNS B-Lab_value
; : I-Lab_value
normal JJ I-Lab_value
, , O
< JJ B-Lab_value
1:40 CD I-Lab_value
) ) O
. . O

Tests NNS O
for IN O
anti JJ B-Diagnostic_procedure
- : I-Diagnostic_procedure
Scl70 NN I-Diagnostic_procedure
, , O
anti SYM B-Diagnostic_procedure
- : I-Diagnostic_procedure
double JJ I-Diagnostic_procedure
- : I-Diagnostic_procedure
stranded VBD I-Diagnostic_procedure
DNA NNP I-Diagnostic_procedure
, , O
anti SYM B-Diagnostic_procedure
- : I-Diagnostic_procedure
Ro NN I-Diagnostic_procedure
, , O
anti SYM B-Diagnostic_procedure
- : I-Diagnostic_procedure
La NNP I-Diagnostic_procedure
, , O
and CC O
anticardiolipin JJ B-Diagnostic_procedure
antibodies NNS I-Diagnostic_procedure
were VBD O
all DT O
negative JJ B-Lab_value
. . O

Kidney NNP B-Biological_structure
echogram NN B-Diagnostic_procedure
showed VBD O
a DT O
decreased JJ B-Sign_symptom
bilateral JJ I-Sign_symptom
kidney NN I-Sign_symptom
size NN I-Sign_symptom
without IN O
hydronephrosis NN B-Sign_symptom
. . O

Despite IN O
the DT O
chronic JJ O
changes NNS O
visible JJ O
on IN O
the DT O
echogram NN O
, , O
the DT O
patient NN O
had VBD O
developed VBN O
acute JJ O
pulmonary JJ B-Biological_structure
edema NN B-Sign_symptom
and CC O
oligouria VBZ B-Sign_symptom
only RB O
3 CD O
days NNS O
before IN O
admission NN O
. . O

Accordingly RB O
, , O
a DT O
clinical JJ O
diagnosis NN O
of IN O
acute JJ B-Detailed_description
- : I-Detailed_description
on IN I-Detailed_description
- : I-Detailed_description
chronic JJ I-Detailed_description
renal JJ B-Disease_disorder
failure NN I-Disease_disorder
was VBD O
made VBN O
. . O

A DT O
further JJ O
diagnosis NN O
of IN O
SRC NNP B-Disease_disorder
was VBD O
supported VBN O
by IN O
the DT O
presence NN O
of IN O
renal JJ B-Disease_disorder
failure NN I-Disease_disorder
with IN O
microangiopathic JJ B-Detailed_description
hemolytic JJ B-Detailed_description
anemia NN B-Sign_symptom
and CC O
hypertension NN B-Sign_symptom
, , O
and CC O
the DT O
patient NN O
was VBD O
started VBN O
on IN O
captopril NN B-Medication
therapy NN O
. . O

The DT O
sustained JJ O
deterioration NN B-Sign_symptom
in IN I-Sign_symptom
renal JJ I-Sign_symptom
function NN I-Sign_symptom
and CC O
anuria NN B-Sign_symptom
had VBD O
led VBN O
to TO O
a DT O
requirement NN O
for IN O
regular JJ B-Detailed_description
hemodialysis NN B-Therapeutic_procedure
from IN O
admission NN O
. . O

After IN O
3 CD O
days NNS O
, , O
captopril NN B-Medication
was VBD O
changed VBN O
to TO O
amlodipine VB B-Medication
because IN O
the DT O
patient NN O
developed VBD O
a DT O
severe JJ B-Severity
, , O
intolerable JJ B-Detailed_description
cough NN B-Sign_symptom
thought VBD O
to TO O
be VB O
associated VBN O
with IN O
captopril NN O
. . O

His PRP$ O
systolic JJ B-Diagnostic_procedure
blood NN I-Diagnostic_procedure
pressure NN I-Diagnostic_procedure
was VBD O
controlled VBN B-Lab_value
between IN B-Lab_value
140 CD I-Lab_value
and CC I-Lab_value
180 CD I-Lab_value
mm NN I-Lab_value
Hg NNP I-Lab_value
. . O

At IN O
approximately RB O
3 CD O
weeks NNS O
after IN O
the DT O
initiation NN O
of IN O
maintenance NN O
hemodialysis NN O
, , O
the DT O
patient NN O
newly RB O
developed VBD O
a DT O
generalized VBN B-Detailed_description
tonic JJ B-Detailed_description
- : I-Detailed_description
clonic JJ I-Detailed_description
seizure NN B-Disease_disorder
disorder NN I-Disease_disorder
. . O

A DT O
brain NN B-Biological_structure
computed VBN B-Diagnostic_procedure
tomography NN I-Diagnostic_procedure
( ( O
CT NNP B-Diagnostic_procedure
) ) O
scan VBP O
revealed VBD O
a DT O
small JJ B-Severity
lacunar NN B-Detailed_description
infarct NN B-Disease_disorder
over IN O
the DT O
left JJ B-Biological_structure
basal NN I-Biological_structure
ganglion NN I-Biological_structure
without IN O
intracranial JJ B-Biological_structure
hemorrhage NN B-Disease_disorder
or CC O
large JJ B-Severity
infarct NN B-Disease_disorder
. . O

The DT O
seizure NN B-Sign_symptom
resolved VBD O
spontaneously RB O
without IN O
anticonvulsants NNS B-Medication
, , O
and CC O
the DT O
patient NN O
was VBD O
finally RB O
discharged VBN O
home NN B-Nonbiological_location
without IN O
incident NN O
and CC O
scheduled VBN O
for IN O
regular JJ O
hemodialysis NN B-Therapeutic_procedure
thrice NN B-Frequency
weekly RB I-Frequency
. . O

However RB O
, , O
at IN O
1 CD O
week NN O
after IN O
discharge NN O
, , O
the DT O
patient NN O
developed VBD O
a DT O
sudden JJ B-Detailed_description
- : I-Detailed_description
onset NN I-Detailed_description
headache NN B-Sign_symptom
and CC O
vomiting VBG B-Sign_symptom
with IN O
confusion NN B-Sign_symptom
and CC O
recurrence NN O
of IN O
the DT O
generalized VBN B-Detailed_description
tonic JJ B-Detailed_description
- : I-Detailed_description
clonic JJ I-Detailed_description
seizure NN B-Sign_symptom
. . O

He PRP O
presented VBD O
at IN O
the DT O
emergency NN B-Nonbiological_location
department NN I-Nonbiological_location
with IN O
a DT O
blood NN B-Diagnostic_procedure
pressure NN I-Diagnostic_procedure
of IN O
183 CD B-Lab_value
/ JJ I-Lab_value
100 CD I-Lab_value
mm NN I-Lab_value
Hg NNP I-Lab_value
, , O
platelet NN B-Diagnostic_procedure
count NN I-Diagnostic_procedure
of IN O
149,000 CD B-Lab_value
/ JJ I-Lab_value
μL NN I-Lab_value
, , O
serum JJ B-Diagnostic_procedure
LDH NNP I-Diagnostic_procedure
of IN O
332 CD B-Lab_value
U NNP I-Lab_value
/ NNP I-Lab_value
L NNP I-Lab_value
, , O
and CC O
a DT O
peripheral JJ B-Diagnostic_procedure
blood NN I-Diagnostic_procedure
smear NN I-Diagnostic_procedure
containing VBG B-Lab_value
2 CD I-Lab_value
- : I-Lab_value
3 CD I-Lab_value
schizocytes NNS I-Lab_value
/ JJ I-Lab_value
HPF NNP I-Lab_value
( ( O
Fig NNP O
. . O
2 CD O
) ) O
. . O

Brain NNP B-Biological_structure
CT NNP B-Diagnostic_procedure
revealed VBD O
no DT B-Lab_value
interval JJ I-Lab_value
change NN I-Lab_value
, , O
and CC O
lumbar JJ B-Diagnostic_procedure
puncture NN I-Diagnostic_procedure
revealed VBD O
traumatic JJ B-Lab_value
tapping VBG I-Lab_value
only RB I-Lab_value
. . O

Cerebrospinal NNP B-Biological_structure
fluid NN B-Diagnostic_procedure
cultures NNS I-Diagnostic_procedure
were VBD O
negative JJ B-Lab_value
for IN O
bacteria NNS B-Detailed_description
, , O
mycobacteria NNS B-Detailed_description
, , O
and CC O
viruses NNS B-Detailed_description
. . O

Brain NNP B-Biological_structure
magnetic JJ B-Diagnostic_procedure
resonance NN I-Diagnostic_procedure
imaging NN I-Diagnostic_procedure
( ( O
MRI NNP B-Diagnostic_procedure
) ) O
showed VBD O
bilateral JJ B-Detailed_description
hyperintensity NN B-Sign_symptom
in IN O
the DT O
occipital JJ B-Biological_structure
and CC I-Biological_structure
parietal JJ I-Biological_structure
lobes NNS I-Biological_structure
on IN O
a DT O
fluid NN B-Detailed_description
- : I-Detailed_description
attenuated VBN I-Detailed_description
inversion NN I-Detailed_description
recovery NN I-Detailed_description
( ( I-Detailed_description
FLAIR NNP I-Detailed_description
) ) I-Detailed_description
sequence NN I-Detailed_description
( ( O
Fig NNP O
. . O
3 CD O
) ) O
. . O

Finally RB O
, , O
the DT O
patient NN O
was VBD O
diagnosed VBN O
with IN O
PRES NNP B-Disease_disorder
. . O

We PRP O
resumed VBD O
captopril JJ B-Medication
therapy NN O
at IN O
a DT O
dose NN O
of IN O
25 CD B-Dosage
mg JJ I-Dosage
thrice JJ I-Dosage
daily RB I-Dosage
. . O

As IN O
it PRP O
was VBD O
difficult JJ O
to TO O
differentiate VB O
SRC NNP O
from IN O
TTP NNP O
, , O
we PRP O
also RB O
considered VBD O
plasma JJ O
exchange NN O
treatment NN O
. . O

However RB O
, , O
the DT O
patient NN O
` `` O
s JJ O
mental NN B-Diagnostic_procedure
status NN I-Diagnostic_procedure
returned VBD O
to TO O
normal JJ B-Lab_value
within IN O
3 CD O
days NNS O
in IN O
the DT O
absence NN O
of IN O
plasma JJ B-Therapeutic_procedure
exchange NN I-Therapeutic_procedure
, , O
and CC O
a DT O
follow JJ O
- : O
up RB O
MRI NNP B-Diagnostic_procedure
of IN O
the DT O
brain NN B-Biological_structure
2 CD O
months NNS O
later RB O
showed VBD O
complete JJ O
resolution NN O
of IN O
cerebral JJ B-Biological_structure
edema NN B-Sign_symptom
( ( O
Fig NNP O
. . O
4 CD O
) ) O
. . O

Therefore RB O
, , O
SRC NNP B-Detailed_description
- : I-Detailed_description
related JJ I-Detailed_description
PRES NNP B-Disease_disorder
was VBD O
confirmed VBN O
. . O

Although IN O
the DT O
patient NN O
experienced VBD O
a DT O
full JJ B-Sign_symptom
neurologic JJ I-Sign_symptom
recovery NN I-Sign_symptom
, , O
his PRP$ O
renal JJ B-Diagnostic_procedure
function NN I-Diagnostic_procedure
did VBD B-Lab_value
not RB I-Lab_value
improve VB I-Lab_value
and CC O
he PRP O
remained VBD O
dialysis NN B-Therapeutic_procedure
dependent NN B-Detailed_description
. . O

-DOCSTART- NN -X-

The DT O
patient NN O
was VBD O
a DT O
34 CD B-Age
- : I-Age
yr NN I-Age
- : I-Age
old JJ I-Age
man NN O
who WP O
presented VBD O
with IN O
complaints NNS O
of IN O
fever NN B-Sign_symptom
and CC O
a DT O
chronic JJ B-Detailed_description
cough NN B-Sign_symptom
. . O

He PRP O
was VBD O
a DT O
smoker NN O
and CC O
had VBD O
a DT O
history NN O
of IN O
pulmonary JJ B-Biological_structure
tuberculosis NN B-Disease_disorder
that WDT O
had VBD O
been VBN O
treated VBN B-Lab_value
and CC I-Lab_value
cured VBN I-Lab_value
. . O

A DT O
computed JJ B-Diagnostic_procedure
tomographic NN I-Diagnostic_procedure
( ( B-Diagnostic_procedure
CT NNP I-Diagnostic_procedure
) ) I-Diagnostic_procedure
scan VBD O
revealed JJ O
multiple JJ B-Detailed_description
tiny JJ B-Detailed_description
nodules NNS B-Sign_symptom
in IN O
both DT B-Biological_structure
lungs NNS I-Biological_structure
. . O

A DT O
thoracoscopic NN B-Detailed_description
lung NN B-Biological_structure
biopsy NN B-Diagnostic_procedure
was VBD O
taken VBN O
from IN O
the DT O
right JJ B-Biological_structure
upper JJ I-Biological_structure
lobe NN I-Biological_structure
. . O

The DT O
microscopic NN B-Diagnostic_procedure
examination NN I-Diagnostic_procedure
revealed VBD O
a DT O
typical JJ O
LCH NNP B-Sign_symptom
. . O

The DT O
tumor NN O
cells NNS O
had VBD O
vesicular JJ B-Detailed_description
and CC O
grooved JJ B-Texture
nuclei NN B-Biological_structure
, , O
and CC O
they PRP O
formed VBD O
small JJ B-Biological_attribute
aggregations NNS B-Biological_attribute
around IN B-Biological_structure
the DT I-Biological_structure
bronchioles NNS I-Biological_structure
( ( O
Fig NNP O
. . O
1 CD O
) ) O
. . O

The DT O
tumor NN O
cells NNS O
were VBD O
strongly RB B-Severity
positive JJ B-Lab_value
for IN O
S NNP B-Diagnostic_procedure
- : I-Diagnostic_procedure
100 CD I-Diagnostic_procedure
protein NN I-Diagnostic_procedure
, , O
vimentin NN B-Diagnostic_procedure
, , O
CD68 NNP B-Diagnostic_procedure
and CC O
CD1a NNP B-Diagnostic_procedure
. . O

There EX O
were VBD O
infiltrations NNS B-Biological_structure
of IN O
lymphocytes NNS B-Biological_structure
and CC O
eosinophils NNS B-Biological_structure
around IN O
the DT O
tumor NN O
cells NNS O
. . O

With IN O
performing VBG O
additional JJ O
radiologic NN B-Diagnostic_procedure
examinations NNS I-Diagnostic_procedure
, , O
no DT B-Sign_symptom
other JJ I-Sign_symptom
organs NNS I-Sign_symptom
were VBD I-Sign_symptom
thought VBN I-Sign_symptom
to TO I-Sign_symptom
be VB I-Sign_symptom
involved VBN I-Sign_symptom
. . O

He PRP O
quit VBD B-Activity
smoking NN I-Activity
, , O
but CC O
he PRP O
received VBD O
no DT O
other JJ O
specific JJ O
treatment NN O
. . O

He PRP O
was VBD O
well RB B-Sign_symptom
for IN B-Duration
the DT I-Duration
following VBG I-Duration
one CD I-Duration
year NN I-Duration
. . O

After IN O
this DT O
, , O
a DT O
follow NN O
- : O
up RB O
CT NNP B-Diagnostic_procedure
scan NN I-Diagnostic_procedure
was VBD O
performed VBN O
and CC O
it PRP O
showed VBD O
a DT O
4 CD B-Shape
cm NN I-Shape
- : I-Shape
sized JJ I-Shape
mass NN B-Sign_symptom
in IN O
the DT O
left NN B-Biological_structure
lower JJR I-Biological_structure
lobe NN I-Biological_structure
, , O
in IN O
addition NN O
to TO O
the DT O
multiple JJ B-Detailed_description
tiny JJ B-Detailed_description
nodules NNS B-Sign_symptom
in IN O
both DT B-Biological_structure
lungs NNS I-Biological_structure
( ( O
Fig NNP O
. . O
2 CD O
) ) O
. . O

A DT O
needle JJ B-Detailed_description
biopsy NN B-Diagnostic_procedure
specimen NNS O
revealed VBD O
the DT O
possibility NN B-Sign_symptom
of IN I-Sign_symptom
a DT I-Sign_symptom
sarcoma NN I-Sign_symptom
; : O
therefore RB O
, , O
a DT O
lobectomy NN B-Therapeutic_procedure
was VBD O
performed VBN O
. . O

Grossly RB O
, , O
a DT O
4 CD B-Shape
cm NN I-Shape
- : I-Shape
sized VBN I-Shape
poorly RB B-Detailed_description
- : I-Detailed_description
circumscribed NN I-Detailed_description
lobulated VBD B-Detailed_description
gray JJ B-Color
- : I-Color
white JJ I-Color
mass NN B-Sign_symptom
was VBD O
found VBN O
( ( O
Fig NNP O
. . O
3 CD O
) ) O
, , O
and CC O
there EX O
were VBD O
a DT O
few JJ O
small JJ B-Detailed_description
satellite NN B-Detailed_description
nodules NNS B-Sign_symptom
around IN O
the DT O
main JJ O
mass NN O
. . O

Microscopically RB B-Diagnostic_procedure
, , O
the DT O
tumor NN O
cells NNS O
were VBD O
aggregated VBN B-Detailed_description
in IN I-Detailed_description
large JJ I-Detailed_description
sheets NNS I-Detailed_description
and CC O
they PRP O
showed VBD O
an DT O
infiltrative JJ B-Biological_structure
growth NN I-Biological_structure
. . O

The DT O
cytologic JJ B-Biological_attribute
features NNS I-Biological_attribute
of IN O
some DT O
of IN O
the DT O
tumor NN O
cells NNS O
were VBD O
similar JJ B-Detailed_description
to TO I-Detailed_description
those DT I-Detailed_description
seen VBN I-Detailed_description
in IN I-Detailed_description
a DT I-Detailed_description
typical JJ I-Detailed_description
LCH NNP I-Detailed_description
. . O

However RB O
, , O
many JJ O
tumor NN O
cells NNS O
showed VBD O
overtly RB O
malignant JJ O
cytologic NN B-Biological_attribute
features NNS I-Biological_attribute
such JJ O
as IN O
pleomorphic JJ B-Detailed_description
/ NNP I-Detailed_description
hyperchromatic JJ I-Detailed_description
nuclei NN B-Biological_structure
and CC O
prominent JJ B-Detailed_description
nucleoli NN B-Biological_attribute
( ( O
Fig NNP O
. . O
4 CD O
) ) O
, , O
and CC O
multinucleated VBD B-Detailed_description
tumor NN B-Biological_structure
giant NN I-Biological_structure
cells NNS I-Biological_structure
were VBD O
also RB O
found VBN O
. . O

There EX O
were VBD O
numerous JJ B-Detailed_description
mitotic JJ B-Biological_structure
figures NNS I-Biological_structure
ranging VBG O
from IN O
30 CD B-Lab_value
to TO I-Lab_value
60 CD I-Lab_value
per IN I-Lab_value
10 CD I-Lab_value
high JJ I-Lab_value
power NN I-Lab_value
fields NNS I-Lab_value
, , O
and CC O
some DT B-Detailed_description
of IN I-Detailed_description
them PRP I-Detailed_description
were VBD I-Detailed_description
abnormal JJ I-Detailed_description
. . O

A DT O
few JJ B-Detailed_description
foci NN I-Detailed_description
of IN O
typical JJ B-Sign_symptom
LCH NNP I-Sign_symptom
remained VBD O
around IN B-Detailed_description
the DT I-Detailed_description
main JJ I-Detailed_description
tumor NN I-Detailed_description
mass NN I-Detailed_description
. . O

Immunohistochemically RB B-Diagnostic_procedure
, , O
the DT O
tumor NN O
cells NNS O
were VBD O
strongly RB B-Severity
positive JJ B-Lab_value
for IN O
S NNP B-Diagnostic_procedure
- : I-Diagnostic_procedure
100 CD I-Diagnostic_procedure
protein NN I-Diagnostic_procedure
( ( O
Fig NNP O
. . O
5 CD O
) ) O
and CC O
vimentin $ B-Diagnostic_procedure
; : O
they PRP O
were VBD O
also RB O
positive JJ B-Lab_value
for IN O
CD68 NNP B-Diagnostic_procedure
( ( O
Dako NNP O
N1577 NNP O
, , O
Clone NNP O
KPI NNP O
) ) O
, , O
and CC O
focally RB B-Detailed_description
positive JJ B-Lab_value
for IN O
CD1a NNP B-Diagnostic_procedure
( ( O
Fig NNP O
. . O
6 CD O
) ) O
, , O
and CC O
they PRP O
were VBD O
negative JJ B-Lab_value
for IN O
cytokeratin NN B-Diagnostic_procedure
, , O
epithelial JJ B-Diagnostic_procedure
membrane NN I-Diagnostic_procedure
antigen NN I-Diagnostic_procedure
, , O
CD3 NNP B-Diagnostic_procedure
, , O
CD20 NNP B-Diagnostic_procedure
and CC O
HMB45 NNP B-Diagnostic_procedure
. . O

The DT O
ultrastructural JJ B-Diagnostic_procedure
analysis NN I-Diagnostic_procedure
failed VBD B-Sign_symptom
to TO I-Sign_symptom
demonstrate VB I-Sign_symptom
any DT I-Sign_symptom
Birbeck NNP I-Sign_symptom
granules NNS I-Sign_symptom
in IN O
the DT O
cytoplasm NN B-Biological_structure
of IN O
the DT O
tumor NN B-Sign_symptom
cells NNS I-Sign_symptom
. . O

Now RB O
, , O
at IN O
five CD O
months NNS O
after IN O
lobectomy NN O
, , O
the DT O
patient NN O
is VBZ O
doing VBG O
well RB O
with IN O
no DT B-Sign_symptom
significant JJ I-Sign_symptom
change NN I-Sign_symptom
in IN I-Sign_symptom
the DT I-Sign_symptom
radiologic JJ I-Sign_symptom
findings NNS I-Sign_symptom
. . O

-DOCSTART- NN -X-

A DT O
woman NN O
aged VBD B-Age
31 CD I-Age
years NNS I-Age
, , O
G2P2 NNP O
, , O
without IN O
any DT O
pathological JJ O
past NN O
history NN O
, , O
with IN O
good JJ B-Lab_value
prenatal NN B-Therapeutic_procedure
care NN I-Therapeutic_procedure
, , O
with IN O
a DT O
normal JJ B-Lab_value
prenatal JJ B-Diagnostic_procedure
analysis NN I-Diagnostic_procedure
, , O
blood NN B-Diagnostic_procedure
pressure NN I-Diagnostic_procedure
during IN O
the DT O
follow JJ O
- : O
up RB O
was VBD O
normal JJ B-Lab_value
, , O
admitted VBN O
for IN O
elective JJ O
caesarian JJ B-Therapeutic_procedure
section NN I-Therapeutic_procedure
at IN O
38 CD B-Duration
weeks NNS I-Duration
of IN O
amenorrhea NN B-Sign_symptom
. . O

During IN O
realization NN O
of IN O
the DT O
spinal JJ B-Biological_structure
anesthesia NN B-Therapeutic_procedure
the DT O
patient NN O
presented VBD O
peak NN O
of IN O
the DT O
hypertensive NN B-Sign_symptom
( ( O
180 CD B-Lab_value
/ RB I-Lab_value
100 CD I-Lab_value
mm NNS I-Lab_value
Hg NNP I-Lab_value
) ) O
which WDT O
normalized VBN B-Lab_value
after IN B-Time
a DT I-Time
few JJ I-Time
minutes NNS I-Time
without IN O
treatment NN B-Therapeutic_procedure
. . O

In IN O
post NN O
- : O
partum NN O
, , O
after IN B-Time
12 CD I-Time
hours NNS I-Time
of IN O
the DT O
caesarian JJ O
section NN O
the DT O
lady NN O
presented VBD O
a DT O
severe JJ B-Severity
headache NN B-Sign_symptom
with IN O
apyrexia NN B-Sign_symptom
then RB O
she PRP O
developed VBD O
three CD B-Detailed_description
episodes NNS I-Detailed_description
of IN O
generalized JJ B-Detailed_description
tonico NN B-Detailed_description
- : I-Detailed_description
clonic JJ I-Detailed_description
convulsions NNS B-Sign_symptom
. . O

The DT O
1st CD B-Detailed_description
convulsion NN B-Sign_symptom
ceased VBD O
1 CD B-Time
min NN I-Time
after IN I-Time
the DT O
measures NNS O
of IN O
resuscitation NN B-Therapeutic_procedure
and CC O
injection NN O
of IN O
diazepam NN B-Medication
IV NNP I-Medication
. . O

The DT O
post NN O
- : O
critical JJ O
clinical JJ B-Diagnostic_procedure
examination NN I-Diagnostic_procedure
found VBD O
an DT O
afebrile JJ B-Sign_symptom
patient NN O
and CC O
blood NN B-Diagnostic_procedure
pressure NN I-Diagnostic_procedure
at IN O
140 CD B-Lab_value
/ $ I-Lab_value
90 CD I-Lab_value
mmHg NN I-Lab_value
and CC O
with IN O
Glasgow NNP B-Diagnostic_procedure
coma NN I-Diagnostic_procedure
scale NN I-Diagnostic_procedure
at IN O
14 CD B-Lab_value
without IN O
any DT O
neurological JJ B-Sign_symptom
deficit NN I-Sign_symptom
, , O
there EX O
was VBD O
no DT O
neck NN B-Biological_structure
rigidity NN B-Sign_symptom
, , O
diuresis NN B-Sign_symptom
was VBD O
preserved VBN O
. . O

The DT O
examination NN B-Diagnostic_procedure
of IN I-Diagnostic_procedure
urines NNS I-Diagnostic_procedure
by IN O
urinary JJ B-Detailed_description
strip NN I-Detailed_description
was VBD O
positive JJ B-Lab_value
( ( O
+ JJ O
+ NNP O
+ NNP O
) ) O
. . O

The DT O
2nd CD B-Detailed_description
and CC I-Detailed_description
3th CD I-Detailed_description
convulsive JJ B-Sign_symptom
crisis NN I-Sign_symptom
stoped VBD O
spontaneously RB O
within IN B-Time
few JJ I-Time
seconds NNS I-Time
. . O

Laboratory JJ B-Diagnostic_procedure
findings NNS I-Diagnostic_procedure
of IN O
HELLP NNP B-Disease_disorder
syndrome NNP I-Disease_disorder
include VBP O
raised VBN B-Lab_value
liver RB B-Diagnostic_procedure
enzymes RB I-Diagnostic_procedure
( ( O
ASAT NNP B-Diagnostic_procedure
525 CD B-Lab_value
IU NNP I-Lab_value
/ NNP I-Lab_value
L NNP I-Lab_value
and CC O
ALAT NNP B-Diagnostic_procedure
214 CD B-Lab_value
IU NNP I-Lab_value
/ NNP I-Lab_value
L NNP I-Lab_value
) ) O
, , O
hemolysis NN B-Sign_symptom
( ( O
hemoglobinemia NN B-Sign_symptom
in IN O
7 CD B-Lab_value
mg NNS I-Lab_value
/ NNP I-Lab_value
dl NN I-Lab_value
) ) O
and CC O
low JJ B-Lab_value
platelet NN B-Diagnostic_procedure
count NN I-Diagnostic_procedure
( ( O
44 CD B-Lab_value
000 CD I-Lab_value
platelet NN I-Lab_value
/ NNP I-Lab_value
mL NN I-Lab_value
) ) O
. . O

Other JJ O
investigations NNS O
included VBD O
the DT O
renal JJ B-Diagnostic_procedure
function NN I-Diagnostic_procedure
tests NNS I-Diagnostic_procedure
, , O
the DT O
inflammatory NN B-Diagnostic_procedure
markers NNS I-Diagnostic_procedure
, , O
the DT O
thyroid JJ B-Diagnostic_procedure
hormones NNS I-Diagnostic_procedure
were VBD O
normal JJ B-Lab_value
. . O

The DT O
viral JJ B-Diagnostic_procedure
serology NN I-Diagnostic_procedure
was VBD O
negative JJ B-Lab_value
. . O

The DT O
patient NN O
was VBD O
transferred VBN O
to TO O
intensive JJ B-Nonbiological_location
care NN I-Nonbiological_location
unit NN I-Nonbiological_location
; : O
she PRP O
was VBD O
treated VBN O
immediately RB O
by IN O
magnesium NN B-Medication
sulfate NN I-Medication
associated VBN O
to TO O
calcium VB B-Medication
channel NN I-Medication
blocker NN I-Medication
( ( O
nicardipine NN B-Medication
) ) O
, , O
antiepileptic JJ B-Medication
( ( O
phenobarbital JJ B-Medication
) ) O
and CC O
preventive JJ O
dose NN O
of IN O
low JJ B-Detailed_description
molecular JJ I-Detailed_description
weight NN I-Detailed_description
heparin NN B-Medication
. . O

The DT O
anemia NN B-Sign_symptom
and CC O
thrombopenia NN B-Sign_symptom
corrected VBN O
by IN O
transfusion NN B-Therapeutic_procedure
of IN O
packed JJ B-Medication
red JJ I-Medication
blood NN I-Medication
cells NNS I-Medication
and CC O
platelet NN B-Medication
respectively RB O
. . O

The DT O
magnetic JJ B-Diagnostic_procedure
resonance NN I-Diagnostic_procedure
imaging NN I-Diagnostic_procedure
( ( O
MRI NNP B-Diagnostic_procedure
) ) O
, , O
realized VBD O
one CD B-Time
hour NN I-Time
after IN I-Time
the DT O
first JJ O
episode NN O
of IN O
convulsion NN O
showed VBD O
zones NNS B-Sign_symptom
in IN O
hyposignal JJ B-Diagnostic_procedure
T1 NNP I-Diagnostic_procedure
, , O
hypersignal JJ B-Diagnostic_procedure
T2 NNP I-Diagnostic_procedure
and CC O
flair NN B-Diagnostic_procedure
sequences NNS I-Diagnostic_procedure
, , O
interesting VBG O
the DT O
cerebral JJ B-Biological_structure
cortex NN I-Biological_structure
, , O
parietal JJ B-Biological_structure
and CC O
occipital JJ B-Biological_structure
sub NN I-Biological_structure
- : I-Biological_structure
cortical JJ I-Biological_structure
and CC O
the DT O
white JJ B-Biological_structure
matter NN I-Biological_structure
. . O

Intracranial NNP B-Biological_structure
venous JJ I-Biological_structure
sinuses NNS I-Biological_structure
were VBD O
permeable JJ B-Sign_symptom
. . O

The DT O
diagnosis NN O
of IN O
the DT O
PRES NNP B-Disease_disorder
syndrome VBP I-Disease_disorder
secondary JJ O
to TO O
the DT O
severe JJ B-Severity
preeclampsia NN B-Disease_disorder
immediate JJ O
post NN O
- : O
partum NN O
was VBD O
retained VBN O
( ( O
Figure NNP O
1 CD O
) ) O
. . O

The DT O
electroencephalogram NN B-Diagnostic_procedure
( ( O
EEG NNP B-Diagnostic_procedure
) ) O
realized VBN O
in IN O
the DT O
second JJ O
day NN O
did VBD O
not RB O
showed VBN O
anomaly NN B-Sign_symptom
. . O

The DT O
evolution NN O
was VBD O
marked VBN O
by IN O
the DT O
normalization NN B-Lab_value
of IN O
blood NN B-Diagnostic_procedure
pressure NN I-Diagnostic_procedure
, , O
the DT O
normalization NN B-Lab_value
of IN O
the DT O
neurological JJ B-Diagnostic_procedure
state NN I-Diagnostic_procedure
and CC O
of IN O
the DT O
biological JJ B-Diagnostic_procedure
analysis NN I-Diagnostic_procedure
. . O

The DT O
patient NN O
discharged VBN O
in IN O
good JJ B-Lab_value
condition NN B-Diagnostic_procedure
on IN O
day NN O
5 CD O
, , O
with IN O
beta SYM B-Medication
- : I-Medication
blocker NN I-Medication
and CC O
sodium NN B-Medication
valproate NN I-Medication
maintained VBD O
during IN O
three CD B-Duration
months NNS I-Duration
. . O

THE DT O
MRI NNP B-Diagnostic_procedure
of IN O
the DT O
controle NN O
made VBD O
three CD O
months NNS O
later RB O
showed VBD O
complete JJ O
resolution NN O
of IN O
cerebral JJ B-Biological_structure
edema JJ B-Sign_symptom
Figure NN O
2 CD O
. . O

